0001493152-24-011503.txt : 20240327 0001493152-24-011503.hdr.sgml : 20240327 20240327161849 ACCESSION NUMBER: 0001493152-24-011503 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 146 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Draganfly Inc. CENTRAL INDEX KEY: 0001786286 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-40688 FILM NUMBER: 24790865 BUSINESS ADDRESS: STREET 1: 2108 ST. GEORGE AVENUE CITY: SASKATOON STATE: A9 ZIP: S7M 0K7 BUSINESS PHONE: 403-781-6671 MAIL ADDRESS: STREET 1: 235 103RD ST. E. CITY: SASKATOON STATE: A9 ZIP: S7N 1Y8 20-F 1 form20-f.htm
false FY 0001786286 0001786286 2023-01-01 2023-12-31 0001786286 dei:BusinessContactMember 2023-01-01 2023-12-31 0001786286 2023-12-31 0001786286 2022-12-31 0001786286 2022-01-01 2022-12-31 0001786286 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2020-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2020-12-31 0001786286 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2021-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-12-31 0001786286 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-01-01 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 DPRO:DragonflyInnovationsIncMember 2023-01-01 2023-12-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2023-01-01 2023-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ShareOptionsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001786286 DPRO:CustomerRelationshipIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-01-01 2023-12-31 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-03-27 2022-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-08-23 2022-08-23 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-05-30 2022-05-30 0001786286 DPRO:GuaranteedInvestmentCertificateOneMember 2022-08-23 2022-08-23 0001786286 DPRO:InventoryMember 2023-01-01 2023-12-31 0001786286 DPRO:InventoryMember 2022-01-01 2022-12-31 0001786286 DPRO:InventoryMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteOneMember 2023-01-01 2023-12-31 0001786286 DPRO:NoteTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:NoteOneMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteTwoMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteThreeMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteTwoMember 2021-09-09 2021-09-09 0001786286 DPRO:NoteTwoMember ifrs-full:AccumulatedImpairmentMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteThreeMember 2021-11-17 2021-11-17 0001786286 DPRO:NoteThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:PublicCompanySharesMember 2023-12-31 0001786286 DPRO:PrivateCompanySharesMember 2023-12-31 0001786286 DPRO:PublicCompanySharesMember 2022-12-31 0001786286 DPRO:PrivateCompanySharesMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 2021-10-25 2021-10-27 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 DPRO:RentalServicesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-12-31 0001786286 DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GoodwillMember 2022-12-31 0001786286 DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:GoodwillMember 2023-12-31 0001786286 DPRO:VitalAndDronelogicsMember 2022-12-31 0001786286 DPRO:VitalAndDronelogicsMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2022-12-31 0001786286 DPRO:DronelogicsMember 2021-12-31 0001786286 DPRO:VitalMember 2022-12-31 0001786286 DPRO:VitalMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2021-01-01 2021-12-31 0001786286 DPRO:BrandAndSoftwareMember 2022-01-01 2022-12-31 0001786286 DPRO:BrandAndSoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:BuildingsMember 2023-12-31 0001786286 ifrs-full:BuildingsMember 2022-12-31 0001786286 ifrs-full:BottomOfRangeMember 2023-12-31 0001786286 ifrs-full:TopOfRangeMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2022-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-01-01 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-01-01 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2022-12-31 0001786286 DPRO:VehicleLoanMember 2023-01-01 2023-12-31 0001786286 DPRO:VehicleLoanMember 2023-12-31 0001786286 DPRO:VehicleLoanMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-19 0001786286 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-18 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-01 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-23 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-22 2021-04-23 0001786286 DPRO:CommonStock1Member 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-12-31 0001786286 DPRO:CommonStock1Member 2022-01-01 2022-12-31 0001786286 DPRO:StockOptionsMember 2023-01-01 2023-12-31 0001786286 DPRO:StockOptionsMember 2022-01-01 2022-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2023-01-01 2023-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:USDWarrantsMember 2023-01-01 2023-12-31 0001786286 DPRO:BrokerWarrantsMember 2023-01-01 2023-12-31 0001786286 2021-03-21 2021-03-22 0001786286 ifrs-full:BottomOfRangeMember 2021-03-21 2021-03-22 0001786286 ifrs-full:TopOfRangeMember 2021-03-21 2021-03-22 0001786286 2021-03-22 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:ExercisePriceElevenMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-12-31 0001786286 DPRO:ExercisePriceElevenMember DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-01-01 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-01-01 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2021-12-31 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:Range1Member 2023-01-01 2023-12-31 0001786286 DPRO:Range1Member 2023-12-31 0001786286 DPRO:Range1Member 2022-12-31 0001786286 DPRO:Range2Member 2023-01-01 2023-12-31 0001786286 DPRO:Range2Member 2023-12-31 0001786286 DPRO:Range2Member 2022-12-31 0001786286 DPRO:Range6Member 2023-01-01 2023-12-31 0001786286 DPRO:Range6Member 2023-12-31 0001786286 DPRO:Range6Member 2022-12-31 0001786286 DPRO:Range7Member 2023-01-01 2023-12-31 0001786286 DPRO:Range7Member 2023-12-31 0001786286 DPRO:Range7Member 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2021-12-31 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:WarrantOneMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantOneMember 2023-12-31 0001786286 DPRO:WarrantTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantTwoMember 2023-12-31 0001786286 DPRO:WarrantThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantThreeMember 2023-12-31 0001786286 DPRO:WarrantFourMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantFourMember 2023-12-31 0001786286 DPRO:WarrantFiveMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantFiveMember 2023-12-31 0001786286 DPRO:DronesMember 2023-01-01 2023-12-31 0001786286 DPRO:VitalMember 2023-01-01 2023-12-31 0001786286 DPRO:CorporatesMember 2023-01-01 2023-12-31 0001786286 DPRO:DronesMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2022-01-01 2022-12-31 0001786286 DPRO:CorporatesMember 2022-01-01 2022-12-31 0001786286 DPRO:DronesMember 2021-01-01 2021-12-31 0001786286 DPRO:VitalMember 2021-01-01 2021-12-31 0001786286 DPRO:CorporatesMember 2021-01-01 2021-12-31 0001786286 DPRO:CAMember 2023-12-31 0001786286 DPRO:CAMember 2022-12-31 0001786286 DPRO:CAMember 2021-12-31 0001786286 DPRO:USCountryMember 2023-12-31 0001786286 DPRO:USCountryMember 2022-12-31 0001786286 DPRO:USCountryMember 2021-12-31 0001786286 DPRO:CAMember 2023-01-01 2023-12-31 0001786286 DPRO:CAMember 2022-01-01 2022-12-31 0001786286 DPRO:CAMember 2021-01-01 2021-12-31 0001786286 DPRO:USCountryMember 2023-01-01 2023-12-31 0001786286 DPRO:USCountryMember 2022-01-01 2022-12-31 0001786286 DPRO:USCountryMember 2021-01-01 2021-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2023-01-01 2023-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2022-01-01 2022-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2023-12-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2022-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2023-01-01 2023-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2022-01-01 2022-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2023-12-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2022-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2023-01-01 2023-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2022-01-01 2022-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2023-12-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2022-12-31 0001786286 DPRO:CEOAndDirectorMember 2023-01-01 2023-12-31 0001786286 DPRO:CEOAndDirectorMember 2022-01-01 2022-12-31 0001786286 DPRO:CEOAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:CEOMember 2023-01-01 2023-12-31 0001786286 DPRO:CEOMember 2022-01-01 2022-12-31 0001786286 DPRO:CEOMember 2021-01-01 2021-12-31 0001786286 DPRO:DirectorsMember 2023-01-01 2023-12-31 0001786286 DPRO:DirectorsMember 2022-01-01 2022-12-31 0001786286 DPRO:DirectorsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001786286 ifrs-full:CurrentMember 2023-12-31 0001786286 ifrs-full:CurrentMember 2022-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2022-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2022-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2022-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:LoanPayableMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:LoanPayableMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:LoanPayableMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2023-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2023-01-01 2023-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2022-01-01 2022-12-31 0001786286 DPRO:ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:PrefundedWarrantsMember 2024-02-06 0001786286 DPRO:PrefundedWarrantsMember 2024-02-06 2024-02-06 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember 2024-02-26 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember DPRO:PrefundedWarrantsMember 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember DPRO:PrefundedWarrantsMember 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:WarrantsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember DPRO:RangesOfExercisePricesOfWarrantsOneMember 2024-02-26 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:PrefundedWarrantsMember DPRO:UnderwrittenSharePlacementMember 2024-02-06 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember DPRO:PrefundedWarrantsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2024-02-26 0001786286 DPRO:NonadjustmentEventsMember DPRO:UnderwrittenSharePlacementMember ifrs-full:OrdinarySharesMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2024-02-26 2024-02-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CAD xbrli:shares iso4217:CAD xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 20-F

 

(Mark One)

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

  For the fiscal year ended December 31, 2023  

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report . . . . . . . . . . . . . . .

 

For the transition period from ________________ to ___________

 

Commission file number: 001-40688  

 

Draganfly Inc.

 

(Exact name of Registrant as specified in its charter)

 

N/A

 

(Translation of Registrant’s name into English)

 

British Columbia, Canada

 

(Jurisdiction of Incorporation or Organization)

 

235 103rd St E., Saskatoon, SK, S7N 1Y8, Canada

 

(Address of Principal Executive Offices)

 

Paul Sun, Chief Financial Officer

Telephone: 800.979.9794

E-mail: paul.sun@draganfly.com

235 103rd St E, Saskatoon, SK, S7N 1Y8, Canada

 

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares   DPRO   The Nasdaq Stock Market LLC

 

Securities registered or to be registered pursuant to Section 12(g) of the Act

 

None

 

(Title of Class)

 

Securities for which there is a reporting obligation pursuant to section 15(d) of the Act

 

None

 

(Title of Class)

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

49,229,563 Common Shares

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

☐Yes ☒No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

☐Yes ☒No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☐No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)

Yes ☐No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer
        Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.

 

†The term “new or revised financial accounting standard” refers to any updated issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark whether the registrant has filed a report on an attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial ‎statements of the registrant included in the filing reflect the correction of an error to previously issued financial ‎statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of ‎incentive- based compensation received by any of the registrant’s executive officers during the relevant recovery ‎period pursuant to §240.10D-1(b). ☐‎

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP   International Financial Reporting Standards as issued by the International Accounting Standards Board   Other

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

☐ Item 17 ☐ Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐Yes ☒No

 

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court

Yes ☐No

 

 

 

 
 

 

Table of Contents

 

Table of Contents i
General Matters ii
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS iii
Part I 1
  Item 1. Identity of Directors, Senior Management and Advisors 1
  Item 2. Offer Statistics and Expected TimeTable 1
  Item 3. Key Information 1
  Item 4. Information on the Company 16
  Item 4A. Unresolved Staff Comments 35
  Item 5. Operating and Financial Review and Prospects 35
  Item 6. Directors, Senior Management and Employees 35
  Item 7. Major Shareholders and Related Party Transactions 50
  Item 8. Financial Information 51
  Item 9. The Offer and Listing. 51
  Item 10. Additional Information 52
  Item 11. Quantitative and Qualitative Disclosures About Market Risk 59
  Item 12. Description of Securities Other than Equity Securities 60
PART II 61
  Item 13. Defaults, Dividend Arrearages and Delinquencies 61
  Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds 61
  Item 15. Controls and Procedures 62
  Item 16. [Reserved] 62
  Item 16A. Audit Committee Financial Expert 63
  Item 16B. Code of Ethics 63
  Item 16C. Principal Accountant Fees and Services 63
  Item 16D. Exemptions from the Listing Standards for Audit Committees 64
  Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers 64
  Item 16F. Change in Registrant’s Certifying Accountant 64
  Item 16G. Corporate Governance 64
  Item 16H. Mine Safety Disclosure 64
  Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 64
  Item 16J. Insider Trading Policies 65
  Item 16K. Cybersecurity 65
PART III 66
  Item 17: Financial Statements 66
  Item 18: Financial Statements 67
  Item 19. Exhibits 68

 

i
 

 

General Matters

 

Unless otherwise noted or the context indicates otherwise “we”, “us”, “our”, the “Company” or “Draganfly” refer to Draganfly Inc. and its subsidiaries.

 

Unless otherwise indicated, financial information in this Annual Report on Form 20-F (this “Annual Report”) has been prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB. Unless otherwise noted herein, all references to “$,” “C$,” “Canadian dollars,” or “dollars” are to the currency of Canada and “US$,” “United States dollars,” or “U.S. dollars” are to the currency of the United States.

 

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and as such, we have elected to comply with certain reduced U.S. public company reporting requirements.

 

The Company prepares and reports its consolidated financial statements in accordance with IFRS. However, this Annual Report may make reference to certain non-IFRS measures including key ‎‎performance indicators used by management. These measures are not recognized measures under IFRS ‎‎and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable ‎‎to similar measures presented by other companies. Rather, these measures are provided as additional ‎‎information to complement those IFRS measures by providing further understanding of the Company’s ‎results of ‎operations from management’s perspective. Accordingly, these measures should not be ‎considered in ‎isolation nor as a substitute for analysis of the Company’s financial information reported ‎under IFRS.

 

The ‎Company uses non-IFRS measures including “gross profit,” “gross margin” and “working capital” ‎which may be calculated ‎differently by other companies. These non-IFRS measures and metrics are used ‎to provide investors with ‎supplemental measures of the Company’s operating performance and liquidity ‎and thus highlight trends in the Company’s ‎business that may not otherwise be apparent when relying ‎solely on IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Corporation’s liquidity and its ability to meet its current obligations. The Company also ‎believes that securities analysts, investors and other ‎interested parties frequently use non-IFRS measures ‎in the evaluation of companies in similar industries. ‎Management also uses non-IFRS measures and ‎metrics in order to facilitate operating performance ‎comparisons from period to period, to prepare ‎annual operating budgets and forecasts and to determine ‎components of executive compensation. For ‎ reconciliations of these non-IFRS measures ‎to the relevant reported measures, please ‎‎see ‎the “Results of Operations – Cost of Goods Sold / Gross Margin” for a discussion of gross profit and gross margin, and for a discussion of working capital, “Selected Financial Information” sections of the Company’s Management’s Discussion and Analysis for the year ended December 31, 2023, attached to this Annual Report on Form 20-F in Exhibit ‎15.1.

 

ii
 

 

Unless otherwise indicated, the Company has obtained the market and industry data contained in this Annual Report ‎from its internal research, management’s estimates and third-party public information and other industry ‎publications. While the Company believes such internal research, management’s estimates and third-‎party public information is reliable, such internal research and management’s estimates have not been ‎verified by any independent sources and the Company has not verified any third party public ‎information. While the Company is not aware of any misstatements regarding the market and industry ‎data contained in this Annual Report, such data involves risks and uncertainties and are subject to change based on ‎various factors, including those described under “Cautionary Statement Regarding Forward-Looking ‎Information and Statements” and “Item 3.D. Risk Factors”.‎

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

 

  the intentions, plans and future actions of the Company;
  statements relating to the business and future activities of the ‎Company;
  anticipated developments in operations of the Company;
  market position, ability to compete and future ‎financial or operating performance of the Company;
  the timing and amount of funding required to execute the ‎Company’s business plans;
  capital expenditures;
  the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;
  ‎the availability of labor;
  ‎the Company’s ability to secure necessary regulatory approvals and permits
  requirements for additional capital;
  goals, strategies and future ‎growth and the success of the Company’s products;
  the adequacy of financial resources;
  expectations regarding revenues, ‎expenses and anticipated cash needs‎;
  volatility in the Company’s securities and the continued listing of the Company’s securities on Nasdaq; ‎and
  general market conditions and macroeconomic trends driven by pandemics and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, interests rates, and labor challenges, among other factors.

 

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those factors identified under the Risk Factors listed below in Item 3.D. of this Annual Report. Furthermore, unless otherwise stated, the forward-looking statements contained in this Annual Report are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes or otherwise, except as required by law.

 

iii
 

 

Part I

 

Item 1. Identity of Directors, Senior Management and Advisors

 

Not required.

 

Item 2. Offer Statistics and Expected Timetable

 

Not required.

 

Item 3. Key Information

 

3.A.

 

[Reserved]

 

3.B. Capitalization and Indebtedness

 

Not required.

 

3.C. Reasons for the Offer and Use Of Proceeds

 

Not required.

 

3.D. Risk Factors

 

An investment in the Company’s common shares, without par value, (the “Common Shares”) is highly speculative and involves significant risks. In addition to the other ‎information contained in this Annual Report and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

 

Risks Related to the Company, its Business and Industry

 

The Company has a history of losses.

 

The Company has incurred net losses since its inception. The Company cannot assure that it can ‎become profitable or avoid net losses in the future or that there will be any earnings or revenues in any ‎future quarterly or other periods. The Company expects that its operating expenses will increase as it ‎grows its business, including expending substantial resources for research, development and marketing. ‎As a result, any decrease or delay in generating revenues could result in material operating losses.‎

 

A shareholder’s holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎

 

The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎‎shareholder’s holding in the Company. ‎The Company’s articles permit the issuance of an unlimited ‎‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding ‎convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the ‎issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎‎result in further dilution to shareholder interests.‎‎

 

1
 

 

The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎

 

‎The Company’s future growth depends on penetrating new markets, adapting existing products to new ‎applications, ‎and introducing new products and services that achieve market acceptance. The Company ‎plans to incur ‎substantial research and development costs as part of its efforts to design, develop and ‎commercialize new ‎products and services and enhance its existing products. The Company believes that ‎there are significant opportunities in a number of business areas. Because the Company accounts for ‎research and development costs as ‎operating expenses, these expenditures will adversely affect its ‎earnings in the future. Further, the Company’s ‎research and development programs may not produce ‎successful results, and its new products and services may not ‎achieve market acceptance, create any ‎additional revenue or become profitable, which could materially harm the ‎Company’s business, ‎prospects, financial results and liquidity.‎

 

Shortfalls in available external research and development funding could adversely affect the Company.‎

 

‎The Company depends on its research and development activities to develop the core technologies ‎used in its UAV ‎products and for the development of the Company’s future products. A portion of the ‎Company’s research and ‎development activities can depend on funding by commercial companies and ‎the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a ‎number of variables, including general ‎economic conditions, specific companies’ financial performance ‎and competition for Canadian government ‎funding with other Canadian government-sponsored programs ‎in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial ‎governments provide energy rebates and incentives to ‎commercial companies, which directly impact the ‎amount of research and development that companies ‎appropriate for energy systems. To the extent that ‎these energy rebates and incentives are reduced or eliminated, ‎company funding for research and ‎development could be reduced. Any reductions in available research and ‎development funding could ‎harm the Company’s business, financial condition and operating results.‎

 

The Company’s adoption of new business models could fail to produce any financial returns.‎

 

‎Forecasting the Company’s revenues and profitability for new business models is inherently uncertain ‎and ‎volatile. The Company’s actual revenues and profits for its business models may be significantly ‎less ‎than the Company’s forecasts. Additionally, the new business models could fail for one or more of ‎the ‎Company’s products and/or services, resulting in the loss of Company’s investment in the ‎development and ‎infrastructure needed to support the new business models, and the opportunity cost of ‎diverting management and ‎financial resources away from more successful businesses.‎

 

The Company will be affected by operational risks and may not be adequately insured for certain risks.‎

 

‎ The Company will be affected by a number of operational risks and the Company may not be adequately ‎insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other ‎acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and ‎regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground ‎movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or ‎destruction of, the Company’s technologies, personal ‎injury or death, environmental damage, adverse ‎impacts on the Company’s operation, costs, monetary losses, ‎potential legal liability and adverse ‎governmental action, any of which could have an adverse impact on the ‎Company’s future cash flows, ‎earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain ‎loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may ‎elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact ‎on the Company’s future cash flows, earnings, results of operations and financial condition.‎

 

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and ‎future prospects.‎

 

‎The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company’s ability to do the following:‎

 

  generate sufficient revenue to reach and maintain profitability;‎

 

2
 

 

  acquire and maintain market share;‎
  achieve or manage growth in operations;‎
  develop and renew contracts;‎
  attract and retain additional engineers and other highly-qualified personnel;‎
  successfully develop and commercially market new products;‎
  adapt to new or changing policies and spending priorities of governments and government agencies; and
  access additional capital when required and on reasonable terms.‎

 

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

 

The Company operates in a competitive market.

 

The Company faces competition and new competitors will continue to emerge throughout the world. ‎Services offered by the Company’s competitors may take a larger share of consumer spending than ‎anticipated, which could cause revenue generated from the Company’s products and services to fall ‎below expectations. It is expected that competition in these markets will intensify.

 

‎If competitors of the Company develop and market more successful products or services, offer ‎competitive products or services at lower price points, or if the Company does not produce consistently ‎high-quality and well-received products and services, revenues, margins, and profitability of the ‎Company will decline.‎

 

‎The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing ‎of services and equipment, quality of customer service, development of new and enhanced products ‎and services in response to customer demands and changing technology, reach and quality of sales and ‎distribution channels and capital resources. Competition could lead to a reduction in the rate at which the ‎Company adds new customers, a decrease in the size of the Company’s market share and a decline in ‎its customers. Examples include but are not limited to competition from other companies in the UAV ‎industry.‎

 

In addition, the Company could face increased competition should there be an award of additional ‎licenses in jurisdictions in which the Company operates in.‎

 

The markets in which the Company competes are characterized by rapid technological change, which requires ‎the Company to develop new products and product enhancements and could render the Company’s existing ‎products obsolete. ‎

 

‎Continuing technological changes in the market for the Company’s products could make its products ‎less ‎competitive or obsolete, either generally or for particular applications. The Company’s future ‎success will depend ‎upon its ability to develop and introduce a variety of new capabilities and ‎enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product ‎offerings, to address the changing needs of the ‎markets in which it offers products. Delays in ‎introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives ‎or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and ‎potential customers to purchase the Company’s competitors’ products.‎

 

If the Company is unable to devote adequate resources to develop new products or cannot otherwise ‎successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, ‎its products could lose ‎market share, its revenue and profits could decline, and the Company could ‎experience operating losses.‎

 

3
 

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada.‎

 

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The Canadian Aviation Regulations (“CARs”) govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

 

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of remotely piloted aircraft systems (“RPAS”) and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit beyond visual line of sight operations. This report was the basis for the recently released Notice of Proposed Amendment (“NPA”) by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies, including the granting of certain Special Flight Operations Certificates (“SFOCs”), or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company’s ‎business, prospects, results of operations and financial condition.‎

 

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.‎

 

‎A significant portion of the Company’s business is based on the operation of RPAS. The operation of ‎‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎‎there is no assurance that an incident ‎involving an RPAS or the Company’s non-compliance would not ‎‎create a significant current or future liability for ‎the company.‎

 

The regulation of RPAS operations within the Canadian Domestic Airspace (“CDA”) is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company’s ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

 

The Company’s business and research and development activities are subject to oversight by Transport ‎‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎‎SFOC. The Company’s ability to develop, test, demonstrate, and sell products and ‎services depends on ‎‎its ability to acquire and maintain a valid SFOC.‎

 

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎‎adoption of small UAV by prospective non-military customers‎.‎

 

The Company may be subject to the risks associated with future acquisitions.

 

As part of the Company’s overall business strategy, the Company may pursue select strategic ‎acquisitions that would provide additional product or service offerings, additional industry expertise, and ‎a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if ‎completed, may expose the Company to additional potential risks, including risks associated with: (a) ‎the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the ‎diversion of resources from the Company’s existing business and technology; (d) potential inability to ‎generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss ‎of or harm to relationships with both employees and existing users resulting from its integration of new ‎businesses. In addition, any proposed acquisitions may be subject to regulatory approval.‎

 

4
 

 

The Company’s inability to retain management and key employees could impair the future success of the Company.

 

The Company’s future success depends substantially on the continued services of its executive officers ‎and its key development personnel. If one or more of its executive officers or key development ‎personnel were unable or unwilling to continue in their present positions, the Company might not be able ‎to replace them easily or at all. In addition, if any of its executive officers or key employees joins a ‎competitor or forms a competing company, the Company may lose experience, know-how, key ‎professionals and staff members as well as business partners. These executive officers and key ‎employees could develop drone technologies that could compete with and take customers and market ‎share away from the Company.‎

 

The Company faces uncertainty and adverse changes in the economy.‎

Adverse changes in the economy could negatively impact the Company’s business. Future economic ‎distress may ‎result in a decrease in demand for the Company’s products, which could have a material ‎adverse impact on the ‎Company’s operating results and financial condition. Uncertainty and adverse ‎changes in the economy could also ‎increase costs associated with developing and publishing products, ‎increase the cost and decrease the availability of ‎sources of financing, and increase the Company’s ‎exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the ‎financial condition and operating results of the Company.‎

 

The Company is subject to certain market-based financial risks associated with its operations.

 

The Company could be subject to interest rate risks, which is the risk that the value of a financial ‎instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks ‎from interest rate fluctuations, the Company manages exposure through its normal operating and ‎financing activities, however market fluctuations could increase the costs at which the Company can ‎access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate ‎of interest. In addition, the Company engages in transactions in currencies other than its functional ‎currency. Depending on the timing of these transactions and the applicable currency exchange rates, ‎conversions to the Company’s functional currency may positively or negatively impact the Company.‎

 

Negative macroeconomic and geopolitical trends could affect demand for the Company’s products and its ability ‎to access sources of ‎capital.‎

 

‎ ‎There can be no assurance that the Company’s business and corresponding financial performance will not be ‎adversely affected by general negative economic or consumer trends or events, including pandemics, public health ‎crises, weather catastrophes, acts of terrorism, war, and political instability. In particular, global economic markets ‎have seen extensive volatility over the past few years owing to the outbreak of the COVID-19 pandemic, the war ‎between Russia and Ukraine, and the war between Israel and Hamas, the closing of certain financial institutions by ‎regulators in March 2023, and political instability. These events have created, and may continue to create, ‎significant disruption of the global economy, supply chains and distribution channels, and financial and labor ‎markets. If such conditions continue, recur or worsen, this may have a material adverse effect on the Company’s ‎business, financial condition and results of operations as consumer demand and its ability to access capital on ‎favorable terms, or at all, could be negatively impacted as a result of such conditions and consequences. ‎Furthermore, such economic conditions have produced downward pressure on share prices and on the availability ‎of credit for financial institutions and corporations while also driving up interest rates, further complicating ‎borrowing and lending activities. If current levels of market disruption and volatility continue or increase, the ‎Company might experience reductions in business activity, increases in funding costs, decreases in asset values, ‎additional write-downs and impairment charges and lower profitability.‎

 

5
 

 

The Company may be subject to the risks associated with foreign operations in other countries.

 

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the ‎Company may expand to markets outside of North America and become subject to risks normally ‎associated with conducting business in other countries. As a result of such expansion, the Company ‎may be subject to the legal, political, social and regulatory requirements and economic conditions of ‎foreign jurisdictions. The Company cannot predict government positions on such matters as foreign ‎investment, intellectual property rights or taxation. A change in government positions on these issues ‎could adversely affect the Company’s business.‎

 

If the Company expands its business to foreign markets, it will need to respond to rapid changes in ‎market conditions, including differing legal, regulatory, economic, social and political conditions in these ‎countries. If the Company is not able to develop and implement policies and strategies that are effective ‎in each location in which it does business, then the Company’s business, prospects, results of ‎operations and financial condition could be materially and adversely affected.‎

 

There are tax risks the Company may be subject to in carrying on business in Canada.

 

The Company is a resident of Canada for purposes of the Income ‎Tax Act (Canada) (the “Tax Act”). Since the ‎Company ‎is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages ‎to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such ‎additional ‎adverse taxes in the future‎.‎

 

If critical components or raw materials used to manufacture the Company’s products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎

 

‎The Company obtains hardware components, various subsystems and systems from a limited group of ‎suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it ‎to continue to sell ‎components, subsystems, systems or products to the Company. The Company’s ‎reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will ‎provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will ‎increase prices for the components, ‎subsystems or systems and will perform their obligations on a ‎timely basis.‎

 

‎The global supply chain has experienced significant disruptions recently, caused by the COVID-19 ‎pandemic and ‎by geopolitical conflict, including the wars in Ukraine and Gaza, and the possibility of widening conflict in the ‎Middle East. These disruptions have impacted a ‎variety of products and goods and have had various downstream ‎effects, making it more difficult to ‎reliably and timely source and supply goods and has also resulted in shortages of ‎labor and equipment. ‎The macroeconomic impacts of the COVID-19 pandemic and global conflicts, including the ‎disruption of global shipping lanes in the Middle East, have contributed to ‎inflationary pressure, rising interest rates, ‎and increased market volatility, adding additional pricing uncertainty. These ‎conditions, if not mitigated or ‎remedied in a timely manner, could delay or preclude delivery of raw ‎materials needed to manufacture the ‎Company’s products or delivery of its products to customers, ‎particularly in international markets. If the ‎Company ‎is unable to obtain components from third-party ‎suppliers in the quantities and of the quality that it ‎requires, on a ‎timely basis and at acceptable prices, ‎then it may not be able to deliver its products on a timely or ‎cost-effective ‎basis to its customers, or at ‎all, which could cause customers to terminate their contracts with the Company, ‎‎increase the Company’s ‎costs and seriously harm its business, results of operations and financial condition. ‎‎Moreover, if any of ‎the Company’s suppliers become financially unstable, then it may have to find new suppliers. ‎‎It may take ‎several months to locate alternative suppliers, if required, or to redesign the Company’s products to ‎‎‎accommodate components from different suppliers. The Company may experience significant delays in ‎‎‎manufacturing and shipping its products to customers and incur additional development, manufacturing ‎and other ‎‎costs to establish alternative sources of supply if the Company loses any of these sources or ‎is required to redesign ‎‎its products. The Company cannot predict if it will be able to obtain replacement ‎components within the time ‎‎frames that it requires at an affordable cost, if at all.‎

 

6
 

 

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company’s products.

 

The Company’s business will involve the operation and flying of UAVs, a technology-based product ‎‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎‎businesses operated in outdoor conditions, including faulty parts, breakdowns and crashes. Although ‎‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎‎outdoor elements, which could be exacerbated due to risks associated with climate change, will not have a material adverse effect on the use and effectiveness of its products.‎

 

The Company’s products may be subject to recall or return.

 

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎‎or inaccurate ‎labeling disclosure. If any of the Company’s equipment were to be recalled due to an ‎‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company’s operations ‎‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎‎potential legal fees, costs and other expenses.‎‎

 

‎‎If the Company releases defective products or services, its operating results could suffer.‎

 

‎Products and services designed and released by the Company involve extremely complex software ‎‎programs and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎‎Company’s products and services before they have been released into ‎the marketplace. In such an ‎‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎‎services, which could significantly harm its business and operating results‎.‎

 

‎The Company’s products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎

 

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎‎electromechanical designs to accomplish their missions. Despite testing, the Company’s products have ‎contained ‎defects and errors and may in the future contain defects, errors or performance problems ‎when first introduced, ‎when new versions or enhancements are released, or even after these products ‎have been used by the Company’s ‎customers for a period of time. These problems could result in ‎expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of ‎new products or enhancements, significant increases in the ‎Company’s service and maintenance costs, ‎exposure to liability for damages, damaged customer relationships and ‎harm to the Company’s ‎reputation, any of which could materially harm the Company’s results of operations and ‎ability to achieve ‎market acceptance. In addition, increased development and warranty costs could be substantial ‎and ‎could significantly reduce the Company’s operating margins.‎

 

‎The existence of any defects, errors, or failures in the Company’s products or the misuse of the ‎Company’s ‎products could also lead to product returns, recalls, or liability claims or lawsuits against it. A defect, error or ‎failure in one of the ‎Company’s UAV could result in injury, death or property damage and significantly ‎damage the Company’s ‎reputation and support for its UAV in general. The Company anticipates this risk ‎will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company’s ‎UAV test systems also have the potential to ‎cause injury, death or property damage in the event that ‎they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.‎ Although the ‎Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎‎adequate to protect the Company from all material judgments and expenses related to potential future ‎claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A ‎successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully ‎insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company’s brand and ‎divert management’s attention and resources, which ‎could have a negative impact on the Company’s ‎business, financial condition and results of operations.‎

 

7
 

 

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company’s business.‎

 

The Company must comply with Canadian federal and provincial laws regulating the export of its ‎products. In ‎some cases, explicit authorization from the Canadian government is needed to export its ‎products. The export ‎regulations and the governing policies applicable to the Company’s business are ‎subject to change. The Company ‎cannot provide assurance that such export authorizations will be ‎available for its products in the future. ‎Compliance with these laws has not significantly limited the ‎Company’s operations or sales in the recent past, but ‎could significantly limit them in the future. Non-‎compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties ‎and sanctions. If the Company cannot obtain required government ‎approvals under applicable ‎regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which ‎could adversely affect the Company’s financial condition and results of operations.‎

 

Negative consumer perception regarding the Company’s products‎ could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company.

 

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media ‎attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific ‎research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or ‎publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, ‎litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, ‎earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the ‎Company’s ‎products and the business, results of operations, financial condition and cash flows of the ‎Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, ‎findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or ‎with merit, ‎could have a material adverse effect on the Company, the demand for the Company’s ‎products, and the ‎business, results of operations, financial condition and cash flows of the Company. ‎Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality ‎of UAV based surveys in general, or the Company’s products specifically, ‎could have a material adverse ‎effect.‎

 

If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company’s business, prospects, ‎‎financial condition and results of operations‎.

 

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎‎net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, ‎‎‎financial condition and results of operations. This will depend largely on the Company’s ability to ‎‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎‎products and services. Any negative publicity about the Company or its industry, the quality and ‎reliability of the Company’s technologies, products and services, the Company’s risk management ‎‎‎processes, changes to the Company’s technologies, products and services, its ability to effectively ‎‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory ‎activity, and the experience of sellers and buyers with the Company’s products or services, could ‎adversely affect the Company’s reputation and the confidence in and use of the ‎‎Company’s ‎technologies, products and services. Harm to the Company’s brand can arise from ‎‎many sources, ‎including; failure by the Company or its partners to satisfy expectations of service and quality; ‎inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other ‎claims; employee misconduct; and misconduct by the Company’s partners, service ‎‎providers, or other ‎counterparties. If the Company does not successfully maintain a strong and trusted brand, its business ‎could be materially and adversely affected.‎ ‎

 

8
 

 

The Company may be subject to electronic communication security risks.

 

A significant potential vulnerability of electronic communications is the security of transmission of ‎confidential ‎information over public networks. Cyberattacks could result in unauthorized access to the ‎Company’s computer ‎systems or its third-party IT service provider’s systems and, if successful, ‎misappropriate personal or confidential ‎information. Anyone who is able to circumvent the Company’s ‎security measures could misappropriate proprietary ‎information or cause interruptions in its operations. ‎The Company may be required to expend capital and other ‎resources to protect against such security ‎breaches or to alleviate problems caused by such breaches.‎

 

‎The last few years have seen an increase in the volume and sophistication ‎of targeted cyber-attacks. A failure of ‎the Company’s IT ‎infrastructure could severely limit the Company’s ability ‎to conduct ordinary operations or ‎expose the ‎Company to liability. To date, the Company’s systems have functioned capably, and it has not ‎‎experienced a material impact to its ‎operations as a result of an IT infrastructure issue. Data security breaches ‎suffered by well-known companies and institutions have attracted a substantial amount of media attention, ‎prompting new foreign, federal, provincial and state laws and legislative proposals addressing data privacy and ‎security. As a result, the Company may become subject to more extensive requirements to protect the customer ‎information that it processes in connection with the purchase of its products, resulting in increased compliance ‎costs.‎

 

While the Company has taken measures to protect against cyberattacks, even the most well-protected IT networks, ‎systems and facilities remain potentially vulnerable because ‎the techniques used in attempted security breaches are ‎continually evolving and generally are not ‎recognized until launched against a target or, in some cases, are designed ‎not to be detected and, in ‎fact, may not be detected. Any such compromise of the Company’s or its third party’s IT ‎service ‎providers’ data security and access, public disclosure, or loss of personal or confidential business ‎‎information, could result in legal claims and proceedings, liability under laws to protect privacy of ‎personal ‎information, and regulatory penalties, and could disrupt the Company’s operations, require significant ‎‎management attention and resources to remedy any damages that result, and damage its reputation and ‎customers ‎willingness to transact business with us, any of which could adversely affect our business.‎ ‎

 

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎

 

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer ‎protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, ‎contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and ‎consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and ‎applied in a manner that is inconsistent with ‎the Company’s data and/or consumer protection practices. If ‎so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders ‎requiring that the Company change its practices, which could have an ‎adverse effect on its business and ‎reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or ‎require it to change its business practices in a manner adverse to its business.‎

 

The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company’s teams.‎

 

‎The Company relies on various business partners, including third-party service providers, vendors, ‎licensing partners, ‎development partners, and licensees, among others, in some areas of the Company’s ‎business. In some cases, these ‎third parties are given access to sensitive and proprietary information in ‎order to provide services and support to the ‎Company’s teams. These third parties may misappropriate ‎the Company’s information and engage in ‎unauthorized use of it. The failure of these third parties to ‎provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or ‎update their services and technologies, could result in a disruption to ‎the Company’s business ‎operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect ‎the Company’s business partners and they may not be able to continue honoring their obligations ‎to the ‎Company. Alternative arrangements and services may not be available to the Company on commercially ‎‎reasonable terms or the Company may experience business interruptions upon a transition to an ‎alternative partner ‎or vendor. If the Company loses one or more significant business partners, the ‎Company’s business could be ‎harmed.‎

 

9
 

 

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company’s business, financial condition, and results of operations could be materially ‎harmed.‎

 

‎The Company’s success depends, in large part, on its ability to protect its intellectual property and other ‎proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and ‎unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the ‎Company’s intellectual property and ‎other proprietary rights. However, a portion of the Company’s ‎technology is not patented, and the Company may ‎be unable or may not seek to obtain patent ‎protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, ‎enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may ‎not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The ‎laws of countries other than Canada may be even less protective of intellectual property rights. ‎‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing ‎upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company’s ‎technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company’s products or ‎portions of its products or otherwise ‎obtain and use the Company’s intellectual property. Moreover, ‎many of the Company’s employees have access to ‎the Company’s trade secrets and other intellectual ‎property. If one or more of these employees leave to work for ‎one of the Company’s competitors, then ‎they may disseminate this proprietary information, which may as a result ‎damage the Company’s ‎competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, ‎then the Company’s business, results of operations or financial condition could be materially ‎harmed. ‎From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact ‎the ‎Company’s results of operations.‎

 

‎In addition, affirmatively defending the Company’s intellectual property rights and investigating whether ‎the ‎Company is pursuing a product or service development that may violate the rights of others may ‎entail significant ‎expense. Any of the Company’s intellectual property rights may be challenged by others ‎or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings ‎to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property ‎or other proprietary rights of others, then the ‎proceedings could result in significant expense to the ‎Company and divert the attention and efforts of the ‎Company’s management and technical employees, ‎even if the Company prevails.‎

 

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎

 

‎The Canadian Intellectual ‎Property Office (“CIPO”), the United States Patent and ‎Trademark Office (“USPTO”) and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company’s international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company’s business. ‎

 

While a patent may be granted by a national patent office, there is no guarantee that the granted patent ‎is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may ‎include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings ‎before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of ‎patent infringement.‎

 

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third ‎parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding ‎Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the ‎International Searching Authority does ‎not guarantee allowance of a national application derived from the ‎Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly ‎reduced before the patent is issued, and the patent’s ‎scope can be modified after issuance. It is also ‎possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

 

10
 

 

The grant of a patent does not have any bearing on whether the invention described in the patent ‎application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection ‎for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

 

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company’s ability to use certain technologies in the future.‎

 

‎The Company may become subject to claims that its technologies infringe upon the intellectual property ‎or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming ‎and expensive, and ‎could divert the Company’s management’s attention away from the execution of its ‎business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require ‎the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, ‎or otherwise restrict or prohibit the Company’s use of ‎the technology. The Company cannot assure that it ‎would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable ‎terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at ‎all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to ‎permit the Company to continue offering, and the Company’s customers to continue ‎using, the ‎Company’s affected product. An adverse determination also could prevent the Company from offering ‎‎its products to others. Infringement claims asserted against the Company may have a material adverse ‎effect on its ‎business, results of operations or financial condition.‎

 

‎The Company may not be able to protect its intellectual property rights throughout the world.‎

 

‎Filing, prosecuting, and defending patents on all of the Company’s product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.‎‎

If the Company is required to write down goodwill and other intangible assets, the Company’s financial ‎condition and results could be negatively affected. ‎

Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate ‎cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to ‎review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include ‎deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory ‎action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics ‎Systems Inc. could have a negative effect on the assets of the ‎Company.‎

 

From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎

 

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, ‎litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive ‎to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, ‎investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the ‎Company’s business, operating results, or ‎financial condition.‎

 

11
 

 

The Company’s directors and officers may have conflicts of interest in conducting their duties.

 

Because directors and officers of the Company are or may become directors or officers of other ‎‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎‎Company will establish a special committee of independent directors to review a particular matter in ‎‎which several directors, or officers, may have a conflict. In determining whether or not the Company will ‎‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎‎procedures or mechanisms to deal with conflicts of interest.‎

 

‎The Company’s Articles ‎provide that the Company must indemnify a director or former director against all judgments, ‎penalties ‎or fines to which such person is or may be liable by reason of such person being or having ‎been a director of the ‎Company and the executive officers and directors may also have rights to ‎indemnification from the Company, ‎including ‎pursuant to directors’ and officers’ liability insurance ‎policies, that will survive termination of their ‎‎agreements‎.‎

 

Changes in accounting standards and subjective assumptions, estimates and judgments by ‎management ‎related to ‎complex accounting matters could significantly affect the Company’s ‎reported financial results ‎or financial condition.‎

 

Changes in accounting standards and subjective assumptions, estimates and judgments by ‎management ‎related to ‎complex accounting matters could significantly affect the Company’s ‎reported financial results ‎or financial condition.‎

‎Generally accepted accounting principles and related accounting pronouncements, implementation ‎‎guidelines and ‎interpretations with regard to a wide range of matters that are relevant to the Company’s ‎‎business, including but not limited to ‎revenue recognition, impairment of goodwill and intangible assets, ‎‎inventory, income taxes and litigation, are highly ‎complex and involve many subjective assumptions, ‎‎estimates and judgments. Changes in these rules or their ‎interpretation or changes in underlying ‎‎assumptions, estimates or judgments could significantly change the Company’s reported ‎financial ‎‎performance or financial condition in accordance with generally accepted accounting principles.‎

 

Risks Related to the Company’s Common Shares

 

The market price of the Common Shares is highly volatile.‎

 

The market price of the Common Shares is highly volatile and has been subject to wide fluctuations ‎in response to a number of factors that are beyond the Company’s control, including but not limited ‎to‎

 

  revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎
  actual or anticipated changes or fluctuations in its results of operations;‎
  announcements by us or the Company’s competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎
  rumors and market speculation involving it or other companies in its industry;‎
  changes in its executive management team or the composition of the board of directors of the Company (the “Board”);‎
  fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎
  general market conditions and macroeconomic trends driven by factors outside the Company’s control, such as pandemics, geopolitical conflicts, supply chain disruptions, market volatility, inflation, rising interest rates, political instability, and labor challenges, among other factors;
  actual or anticipated developments in its business or its competitors’ businesses or the competitive ‎landscape generally;‎

 

12
 

 

  litigation involving us, the Company’s industry or both, or investigations by regulators into its operations or those of ‎competitors;‎
  announced or completed acquisitions of businesses or technologies by the Company or its competitors;‎
  new laws or regulations or new interpretations of existing laws or regulations applicable to its ‎business;‎
  shareholder activism and related publicity;‎
  foreign exchange rates; and
  other risk factors as set out in this Annual Report and in the documents incorporated by ‎reference into this Annual Report.‎

 

If the market price of the Company’s Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against it, regardless of the merits of such claims. Such a lawsuit could cause it to incur substantial ‎costs and could divert the time and attention of management and other resources from the Company’s business, which ‎could harm its business, results of operations and financial condition.‎

 

There is no guarantee that an active trading market for the Company’s Common Shares will be maintained on ‎the CSE and/or Nasdaq. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎

 

The Company’s Common Shares are currently listed on the Canadian Stock Exchange (“CSE”), the Nasdaq Stock Market, LLC (“Nasdaq”), and the Frankfurt Stock Exchange, ‎however, it shareholders may be unable to sell significant quantities of Common Shares into the public ‎‎trading markets without a significant reduction in the price of their Common Shares, or at all and there ‎can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can ‎be no assurance that ‎there will be sufficient liquidity of its Common Shares on the trading market, and ‎that we will continue to meet ‎the listing requirements of the CSE, Nasdaq or any other public listing ‎exchange.‎

 

Failure to meet Nasdaq’s continued listing requirements could result in the delisting of the Company’s Common Shares, negatively impact the price of the Company’s Common Shares and negatively impact its ability to raise additional capital.

 

If the Company fails to satisfy the continued listing requirements of the Nasdaq, such as corporate governance requirements or the minimum closing bid price requirement, the exchange may take steps to delist the Company’s Common Shares. Such a delisting would likely have a negative effect on the price of the Company’s Common Shares and would impair shareholders’ ability to sell or purchase its Common Shares when they wish to do so.

 

As previously disclosed, on September 22, 2023, the Company received a letter from the Listing Qualifications ‎Department of Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid ‎Price Rule”) by failing to maintain a minimum bid price for the Company’s common shares of at least $1.00 per ‎share for 30 consecutive business days. The Company was allowed an initial 180-day grace period, or until March ‎‎20, 2024, (the “Bid Price Compliance Period”), to regain compliance with the Bid Price Rule. To regain compliance ‎with the Bid Price Rule the closing bid price of the Company’s common shares needed to be at least $1.00 per share ‎for a minimum of ten consecutive business days during the Bid Price Compliance Period.

 

On March 21, 2024, the Company received notification that it had failed to regain compliance with the Bid Price ‎Rule and is not eligible for a second 180 day compliance period because of its failure to comply with the $5 million ‎minimum stockholders’ equity initial listing requirement for the period ended September 30, 2023. Unless the ‎Company timely requests a hearing before an independent Nasdaq Hearings Panel (the “Nasdaq Panel”), the ‎Company’s securities will be subject to delisting. Accordingly, the Company will request a hearing before the ‎Nasdaq Panel. The hearing request will automatically stay any suspension or delisting action pending the hearing ‎and the expiration of any additional extension period granted by the Nasdaq Panel following the hearing. In that ‎regard, pursuant to the Nasdaq Listing Bid Price Rules, the Nasdaq Panel has the discretion to grant an additional ‎extension period that can expire as late as September 17, 2024. At the hearing, the Company will be asked to ‎provide a plan to regain compliance to the Nasdaq Panel. The Company intends to present a plan to regain ‎compliance with the Bid Price Rule and request the continued listing of its common shares on Nasdaq pending such ‎compliance. However, there can be no assurance that the Nasdaq Panel will grant the Company’s request or that ‎the Company will ultimately regain compliance with all applicable requirements for continued listing on Nasdaq.‎

 

13
 

 

Future issuances of equity securities by us or sales by the Company’s existing shareholders may cause the price ‎of its Common Shares to fall.‎

 

The market price of the Company’s Common Shares could decline as a result of issuances of securities or sales by its ‎existing shareholders in the market, including by its directors, executive officers and significant ‎shareholders, or ‎the perception that these sales could occur. Sales of the Company’s Common Shares by ‎shareholders might also make it ‎more difficult for it to sell Common Shares at a time and price that it ‎deems appropriate. The Company also expects to ‎issue Common Shares in the future. Future issuances of Common ‎Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading ‎prices of the Common Shares.‎

 

We may never pay dividends over the foreseeable future.‎

 

Investors should not rely on an investment in the Company’s Common Shares to provide dividend ‎income. The ‎Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the ‎foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its ‎operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors ‎must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only ‎way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not ‎purchase the ‎Company’s Common Shares.‎

 

United States investors may not be able to obtain enforcement of civil liabilities against us.

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this Annual Report reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this Annual Report.

 

We are an emerging growth company and intend to take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make the Company’s Common Shares less attractive to ‎investors.

 

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.07 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the Securities Act); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the ‎market value of the Company’s Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).‎

 

14
 

 

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. ‎We cannot predict whether investors will find the Company’s Common Shares less attractive if it relies on these ‎‎exemptions. If some investors find the Company’s Common Shares less attractive as a result, there may be a less ‎active ‎trading market for its Common Shares and the price of its Common Shares may be more volatile. ‎

 

We will incur increased costs as a result of operating as a public company in the United States ‎and the ‎Company’s management will be required to devote substantial time to new compliance initiatives.‎

 

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as ‎defined ‎‎under the JOBS Act, we incur significant legal, accounting and other expenses, in addition to ‎those we ‎incur as a ‎Canadian public company, that we did not incur prior to being listed on Nasdaq. In ‎‎addition, the Sarbanes-Oxley ‎Act, and rules implemented by the SEC and Nasdaq impose various other ‎‎requirements on public companies, and ‎the Company spends time and resources to ensure compliance with its ‎‎reporting obligations in both Canada and the ‎United States.‎

 

For example, pursuant to Section 404, we are required to furnish a report by our management on our ‎internal ‎control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth ‎company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered ‎public accounting firm. ‎To achieve compliance with Section 404, we must document and evaluate our ‎ICFR, ‎which is both costly and challenging. In this regard, we must dedicate internal resources, ‎potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through ‎testing that ‎controls are functioning as documented and implement a continuous reporting and ‎improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent ‎registered public accounting firm will ‎be able to conclude that our ICFR is effective as required by ‎Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ‎ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the ‎reliability of our consolidated ‎financial statements.‎

 

In addition, becoming a public company in the United States has increased legal and financial ‎compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and has made some of our ‎public company obligations ‎more time consuming. We invest resources to comply with evolving laws, ‎regulations and standards in ‎both Canada and the United States, and this investment results in increased ‎general and administrative ‎expenses and increased diversion of management’s time and attention from ‎revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, ‎regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal ‎proceedings against us and our business ‎may be harmed.‎

 

Being a public company in the United States and complying with applicable rules and ‎regulations also ‎makes it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎‎coverage. This factor may also make it more difficult for us to attract and retain qualified executive ‎officers and ‎members of our Board of Directors.‎

 

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available to the Company’s U.S. shareholders.‎

 

We currently qualify as a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer ‎would file with the SEC, although we are required to file ‎with or furnish to the SEC the continuous ‎disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, ‎the Company’s officers, directors and principal shareholders are exempt from the ‎reporting and “short swing” profit ‎recovery provisions of Section 16 of the Exchange Act. Therefore, the Company’s ‎shareholders may not know on as ‎timely a basis when its officers, directors and principal shareholders purchase ‎or sell our securities as ‎the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In ‎addition, as a foreign private issuer, the Company is exempt from the proxy rules under the Exchange Act. The Company is ‎also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material ‎non-‎public information. While the Company expects to comply with the corresponding requirements relating to proxy ‎statements ‎and disclosure of material non-public information under Canadian securities laws, these ‎requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not ‎expect to receive in every case the ‎same information at the same time as such information is provided ‎by U.S. domestic issuers.

 

15
 

 

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate ‎governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities ‎laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and ‎describe the Canadian ‎practices we follow instead. We rely on this exemption in part. As a result, the Company’s ‎shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that ‎are subject to all U.S. corporate ‎governance requirements.

 

At some point in the future, we may cease to be a foreign private issuer. If we cease to ‎qualify, we will ‎be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎‎domestic issuer, which may increase the Company’s costs of being a public company in the ‎United States.‎

 

Item 4. Information on the Company

 

4.A. History and Development of the Company

 

Name, Address and Incorporation

 

The Company was incorporated as Drone Acquisition Corp. (“DAC”) under the Business Corporations Act (British Columbia) (the “BCBCA”) on June 1, 2018 ‎for the purpose of reorganizing and recapitalizing the business of Draganfly Innovations Inc. (“Former Draganfly”). Effective July 17, 2019, the Company amended its articles to ‎remove various classes of ‎authorized but unissued preferred shares and replace them with only one class of preferred ‎shares (the “Preferred Shares”). Effective August 15, 2019, the Company changed its name to “Draganfly Inc.” On ‎August 22, 2019, the Company amended its articles to re-designate its Class A Common Shares as ‎Common ‎Shares‎.‎

 

The Company’s head office is located at 235 103rd St E, Saskatoon, SK, S7N 1Y8, Canada. The Company’s telephone number is (800) 979-9794. The Company’s registered office is located at Suite 2700, 1133 Melville Street, Vancouver, British ‎Columbia V6E 4E5. ‎ The Company’s registered agent in the United States is C T Corporation System, 1015 15th Street N.W., Suite 1000, Washington, D.C., 20005 and its telephone number is (202) 572-3133.

 

General Development of the Business of the Company

 

Founded in 1998, we believe that Former Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. Zenon Dragan is the founder of Former Draganfly and is a recognized leading expert on UAV.

 

Former Draganfly introduced its first systems in 1999 and since evolved and shaped the UAV industry. The Company’s aircraft are widely used by public safety agencies worldwide and we believe that we were one of the first UAV to receive a FAA (Federal Aviation Administration) Certificate of ‎‎Authorization in the fall of 2009 with the Mesa County Colorado Sheriff’s Office. In 2013, the Royal Canadian Mounted Police flew one of the Company’s drones to locate and save the life of an accident victim.

 

We believe that Draganfly aircraft have achieved many industry firsts, including:

 

  one of the first public safety UAV to shoot aerial photos documenting a manned aircraft accident in an urban area;
     
  one of the first UAV operated by a public safety organization flown at night to locate and save a life;
     
  one of the first UAV helicopter to be granted a county wide U.S. FAA Certificate of ‎‎Authorization;
     
  named as a test platform at one of the U.S. FAA’s certified test sites;
     
  one of the first to have a drone included in the Smithsonian National Air and Space Museum; and
     
  four of the first six compliance certifications for its products issued by Transport ‎Canada.

 

16
 

 

Three Year History

 

A detailed description on the significant developments of the business of the Company over the last three completed financial years is set out below.

 

Financial year ended December 31, 2021

 

On January 6, 2021, the Company announced the awarding of a new patent for a vertical take-off and landing cargo delivery drone with variable center of gravity.

 

On January 21, 2021, the Company announced that it had been selected to provide engineering and development services for a drone-based air support defense system for Integrated Launcher Solutions Inc. (“ILS”). The Company entered into a memorandum of understanding with ILS with the objective to create the terms and conditions surrounding a project management and development agreement for the production of ILS’s multi-launching air support defense system. The development of the system has not yet been completed.

 

On March 2, 2021, the Company announced that it will be the exclusive supplier of drones to Woz ED’s drone program across its ‎national K-12 curriculum with the expected deployment of approximately 3000 drones in ‎‎2021‎. The Company entered into a memorandum of understanding with Woz ED with the objective to create the terms and conditions surrounding a business agreement. The memorandum of understanding automatically terminated after 60 days.

 

On March 9, 2021, the Company announced that it completed the final closing of the Regulation A+ Offering. The Company issued 32,443,457 units at price of US$0.47 per unit for gross proceeds in the amount of approximately US$15.3 million in the final closing. Each unit is comprised of one Common Share and one Common Share purchase warrant, with each warrant entitling the holder to acquire one Common Share at a price of US$0.71 per Common Share for a period of two years from the date of issuance. The Common Shares and Warrants issued in connection with the offering were subject to a nine month hold period.

 

On March 9, 2021, the Company also announced that it entered into an asset purchase agreement with Vital Intelligence Inc. (“Vital”) to purchase all the assets of Vital (the “Vital Asset Acquisition”) in consideration for: (a) a cash payment of $500,000 with $50,000 paid upon execution of the asset purchase agreement, $200,000 to be paid at closing and $250,000 to be paid on the six-month anniversary date of closing; and (b) 6,000,000 units of the Company with each unit being comprised of one Common Share and one common share purchase warrant. The units were subsequently consolidated on a 5:1 basis, resulting in 1,200,000 units outstanding. Each warrant will entitle the holder to acquire one Common Share for a period of 24 months following closing at an exercise price of $2.67 per Common Share and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow following closing with 300,000 units being released at closing and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. The Company completed the Vital Asset Acquisition on March 25, 2021. The revenue milestone targets attributable to the purchased assets under the ‎Vital Asset Acquisition have not been met, and accordingly, the Company is in the process of cancelling the 900,000 shares issuable pursuant to the units issued in connection with the Vital Asset Acquisition.

 

On March 23, 2021, the Company announced that it signed a services deal to deploy EagleEye™ AI flight services with Windfall Geotek Inc. Windfall Geotek Inc. contractually agreed to have Draganfly provide $1,000,000 in flight services over the course of the next year with $500,000 already directly funded and allocated as of the date of the agreement.

 

17
 

 

On May 13, 2021, the Company announced that it entered into a definitive agreement with Coldchain Technology Services LLC (“Coldchain”) to develop, deploy and operate solutions for the delivery of medical supplies, medicine, and vaccines. The definitive agreement provides for phase one of a planned five-phase roll-out for the comprehensive development, deployment, and operation of a medical drone delivery service as well as the development of a solution for the timely delivery of medical supplies, medicine, and vaccines. Phase one will also include working with various regulatory bodies, including the FAA, to obtain licenses and approvals for initial non-commercial beta test delivery routes. Phase one has a value of US$125,000, to be executed over a maximum of 10 months and the parties have agreed to negotiate an extension to the definitive agreement for phase two prior to the expiry of phase one. Under phase two, Coldchain will commit to purchasing no less than US$625,000 in equipment and services from Draganfly.

 

On May 19, 2021, the Company announced that it signed a contract with ILS for the development, prototyping, and eventual production of a non-lethal 40 mm ‎multi-‎launching systems that can be mounted and deployed from drones, drone systems, robots, ‎robotic systems, and other stationary platforms or similar systems. As part of the contract, Draganfly provided ILS with strategic vendor financing of US$150,000 to assist in the development of the project and in consideration ILS granted Draganfly a worldwide royalty equal to 8% of the gross revenue received from the project for a period of five years from earlier of the repayment date or maturity date of the loan. The loan is secured against the intellectual property related to the project.

 

On July 22, 2021, the Company announced the expected listing of its Common Shares on the Nasdaq, subject to meeting the final listing requirements of Nasdaq.

 

On July 29, 2021, in connection with the proposed listing of its Common Shares on Nasdaq, the Company consolidated its Common Shares on a basis of one new Common Share for every five then issued and outstanding Common Shares under a new CSE stock symbol “DPRO”.

 

On July 29, 2021, the Company announced that its application to list its Common Shares on the Nasdaq was approved by The Nasdaq Stock Market LLC and the Common Shares began trading on July 30, 2021 under the symbol “DPRO”.

 

On August 3, 2021, the Company announced that it completed an underwritten public offering in the United States (the “US Offering”) of 5,000,000 Common Shares at a price of US$4.00 per Common Share, for total gross proceeds of approximately US$20,000,000, before deducting underwriting discounts and expenses of the US Offering.

 

On August 12, 2021, the Company announced that it launched its new, North American designed and built, Draganflyer Commander2 drone system. The Draganflyer Commander2 is a small Unmanned Aerial System (sUAS) and replaced the Company’s Commander platform launched in 2015.

 

On September 9, 2021, the Company announced that Julie Myers Wood was appointed to the Board and that Justin Hannewyk resigned from the Board.

 

On September 15, 2021, the Company announced that the over-allotment option granted to the underwriters in connection with the US Offering was exercised in respect of 95,966 Common Shares. The exercise of the over-allotment at US$4.00 per Common Share produced additional gross proceeds of US$383,864, bringing the aggregate gross proceeds to Draganfly under the US Offering to US$20,383,864, before deducting underwriting discounts and expenses of the US Offering.

 

On September 22, 2021, the Company announced that it entered into an exclusive manufacturing agreement with Valqari LLC (“Valqari”) to produce Valqari’s Drone Delivery Stations. As per the manufacturing agreement, Draganfly will be the exclusive manufacturer of Valqari’s Drone Delivery Stations. Valqari will be ordering at least $400,000 of manufacturing services during the initial phase of the agreement.

 

On October 12, 2021, the Company announced that it signed a minimum $9 million manufacturing agreement with Digital Dream Labs, Inc. (“DDL”) to design and develop an AI consumer companion robot drone. As per the terms of the agreement, Draganfly will be the exclusive manufacturer and assembler of the drone. DDL will order at least 50,000 units annually with delivery starting in 2022. The drone will be integrated into DDL’s existing product family, including support, sales and distribution channels used for its other consumer robots. Draganfly has also been granted a right of first refusal to become the exclusive manufacturer and assembler of subsequent drone or UAV-based robots to be added to DDL’s product portfolio. The parties have entered into a binding letter agreement reflecting the above terms and will use commercially reasonable efforts to enter into a definitive agreement. The binding letter agreement will govern the relationship between DDL and Draganfly and there can be no assurance that a definitive agreement will be completed or entered into amongst the parties.

 

18
 

 

Financial year ended December 31, 2022

 

On March 22, 2022, the Company announced that it had received an order for the Company’s Medical ‎Response and Search and Rescue Drones from Coldchain for immediate deployment with Revived ‎Soldiers Ukraine. Draganfly provided an immediate combined total of 10 North American-made Medical ‎Response and Search and Rescue Drones. In addition, Draganfly donated three drone systems to ‎Revived Soldiers Ukraine. The total initial order size (subject to conditions) is up to 200 units.‎

 

On May 9, 2022, the Company announced that John M. Mitnick was appointed as Chairman of the Board, ‎effective April 27, 2022.‎

 

On May 9, 2022, the Company announced that Cameron Chell, Chief Executive Officer of the Company, ‎was appointed as President of the Company, effective April 27, 2022.‎

 

On May 9, 2022, the Company announced that Scott Larson would be stepping down as Interim ‎President and appointed as Lead Director effective April 27, 2022.‎

 

On May 9, 2022, the Company announced that Paul Mullen, Vice President of Draganfly’s Vital ‎Intelligence Group, was appointed as Chief Operating Officer of the Company, effective March 1, 2022 .‎

 

One June 1, 2022, the Company announced the launch of its new North American-made Heavy Lift and ‎Commander 3 XL Drones. The Heavy Lift is capable of automated missions and manual flight operations ‎with a payload capacity of 67 pounds. The Commander 3 XL is a high-endurance, weather-resistant, ‎multirotor UAV that is designed for easy assemble and rapid deployment.‎

 

One June 7, 2022, the Company announced the launch of its new North American-made Long-range Light ‎Detection and Ranging (“LiDAR”) system. The LiDAR system provides accurate distance measurements ‎and improved resolution over conventional photogrammetry methods.‎

 

One June 21, 2022, the Company announced that Alabama State University (ASU) was offering the ‎Draganfly Drone Technology Course through ASU’s Division of Continuing Education. The program ‎provides an introduction to unmanned aerial vehicles (UAVs) and explores advanced topics including ‎regulations, airspace operations, and navigation.‎

 

On August 1, 2022, the Company announced that Deborah R. Greenberg, was appointed as Chief Legal ‎Officer of the Company, effective July 4, 2022. Her role was subsequently expanded to include the ‎Human Resources and Information Technology functions as the Chief Legal and Corporate Services ‎Officer, effective December 1, 2022.‎

 

On November 17, 2022, the Company announced DEF-C, a Ukrainian company involved in the civil and ‎‎defense sectors, had selected the Company as an exclusive provider of drones and related services.‎

 

On November 18, 2022, the Company announced the fulfillment of an additional order of 30 ‎reconnaissance drones through its channel partner DEF-C, along with continued support from DroneAid. ‎Draganfly’s drone technology is being deployed to provide valuable intelligence, surveillance, and ‎reconnaissance information. On December 7, 2022, the Company announced the launch of the Draganfly ‎UAS A.I.R. Space flight facility dedicated to the advancement of Unmanned Aircraft Systems program Adoption, Innovation & ‎Research. The facility will provide a control site for the design, validation and optimization of standard ‎operating procedures, sensor selection and data collection techniques.‎

 

19
 

 

Financial year ended December 31, 2023

 

On January 31, 2023, the Company announced Remote Sensing Instruments, a Geospatial ‎Technology company in India working in the field of Remote Sensing and Geographic Information ‎System, entered into a strategic agreement with the Company for the development of manufacturing, ‎distribution, and sales of Draganfly products in India.‎

 

On January 31, 2023, the Company entered into an equity distribution agreement with Maxim ‎Group LLC ‎‎dated January 31, 2023, pursuant to which the Company could, from time ‎to time, distribute in an ‎‎‎”at-the-‎market offering” up to US$15 million in common ‎shares of the ‎Company (the ‎‎”ATM Shares”) in the ‎United States only, on Nasdaq.‎ The Company ‎distributed 650,729 ATM Shares under the Offering at an average price of ‎‎$2.69 per share for net ‎proceeds of $1,526,810.‎

 

On February 23, 2023, the Company announced that it entered into a distribution agreement with ‎AeroCine Ventures, Inc. d/b/a Vermeer. Pursuant to the distribution agreement, Vermeer will distribute ‎Draganfly’s products that incude the Vermeer VPS (visual positioning ‎system) payload with Draganfly’s Commander 3XL. ‎

 

On March 7, 2023, Draganfly announced that it entered into a business development and partnership ‎agreement with SkyeBrowse Inc. (“SkyeBrowse”), whereby SkyeBrowse will integrate its reality capture ‎platform with Draganfly public safety drones. As per the agreement, the Company will provide consulting ‎and marketing services to SkyeBrowse for two years. ‎‎

 

On March 31, 2023, the Company announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be US$8.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering consisted of 8,000,000 common shares at a price to the public of US$1.00 per share.

 

On April 11, 2023, the Company announced that it entered into a strategic cooperation and product ‎integration agreement with CODAN Communications (“CODAN”), to supply its UAV platform for ‎integration with CODAN’s technology and communications solutions. Under the terms of the agreement, ‎CODAN and the Company agree to combine their respective capabilities in a joint effort to integrate their ‎product and services capabilities in order to submit joint proposals and enter into contracts with potential ‎customers. ‎

 

On April 19, 2023, Draganfly announced it entered into a referral agreement with AgileMesh, Inc. ‎‎(“AgileMesh”) whereby AgileMesh will add the Company’s UAV Platform to its wireless surveillance ‎product line and refer potential customers to Draganfly. As per the agreement, AgileMesh will receive ‎commissions based on the aggregate amount of revenue recognized by the Company from customers ‎that are introduced to Draganfly by AgileMesh. ‎

 

On June 21, 2023, the Company announced it had entered into an agreement with HEAL-Corp, a Non-Government Organization (“NGO”), and the Ukrainian National Academy of Internal Affairs (the “National Academy”) regarding the development of a training program on the use of drones and their countermeasure systems. Working in conjunction with the National Academy, Draganfly will implement a designed curriculum to be used within the training program. Recently, HEAL-Corp delivered Trauma Resuscitation and Evacuation Casualty Care training to the Ministry of Internal Affairs.

 

On August 3, 2023, Draganfly announced its new manufacturing facility in Saskatoon, Saskatchewan is scheduled to come online in Q3. This expansion is part of Draganfly’s commitment to meeting the increasing market potential for products and solutions. The Saskatoon facility is specifically designed to accommodate a growing demand for UAV systems and components, including those engineered for the Heavy Lift, Commander 3 XL, and the Company’s newest product, the Precision Delivery System.

 

On August 23, 2023, the Company announced it will be providing drone pilot crews and drone technology to a Canadian Provincial Government to assist with firefighting mitigation, preparedness, response, and recovery efforts. Draganfly’s advanced drone technology and highly trained personnel will aid emergency services in their mission to protect lives, property, infrastructure, and ecosystems.

 

On September 7, 2023, Draganfly announced that Tim Dunnigan was appointed to Draganfly’s Advisory Board to help lead Company’s initiatives for the new Pentagon Replicator program, a Department of Defence initiative announced in August 2023. The program aims to rapidly expand domestic sUAS production & innovation for military applications.

 

20
 

 

On September 12, 2023, the Company announced it was awarded a contract to provide its Vital Intelligence technology to a state corrections agency to its facilities enhance security and efficiency for the benefit of the community, the staff, and the inmates.

 

On September 22, 2023, the Nasdaq notified the Company that the closing price of its Common Shares for the 30 ‎consecutive business day period from August 10, 2023 to September 21, 2023 did not meet the Minimum Bid Price ‎Requirement of Nasdaq’s rules. The notice has no immediate effect on the listing of the Common Shares, and the ‎Common Shares continued trade on the Nasdaq under the symbol “DPRO”. Pursuant to Nasdaq Listing Rule ‎‎5810(c)(3)(A), the Company was given 180 calendar days (or until March 20, 2024) to regain compliance with the ‎Minimum Bid Price Requirement, unless Nasdaq were to grant the Company, upon request, an additional 180 ‎calendar day extension to meet such requirements. To regain compliance, the Common Shares must have a closing ‎bid price of US$1.00 for a minimum of 10 consecutive business days. If the Company does not regain compliance ‎with the Minimum Bid Price Requirement (including through the implementation of a reverse share split or another ‎means) by March 20, 2024, the Common Shares may subject to delisting.

 

On September 27, 2023, the Company announced its new manufacturing and production facility in Saskatoon, Saskatchewan, had officially opened.

 

On October 30, 2023, Draganfly announced that it had closed its underwritten offering for gross proceeds of approximately US$3.5 million (the “October Public Offering”), before deducting underwriting discounts and offering expenses. Pursuant to the Offering, the Company issued 4,800,000 units of the Company (the “Units”) at a price of US$0.55 per Unit and 1,600,000 pre-funded units of the Company the (“Pre-Funded Units”) at a price of US$0.5499.

 

January 1, 2024 to the Effective Date

 

On February 26, 2024, the Company announced that it completed an underwritten share placement of 11,200,000 units (the “February Units”) with each February Unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units (the “February Pre-Funded Units”) consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share (the “February Public Offering”). Each February Unit was sold at a price of US$0.27 with each February Pre-Funded Unit being sold at a price of US$0.2699 for gross proceeds of approximately US$3.6 million. The pre-funded warrants have an exercise price of US$0.0001 and were exercised on the date of issue. The remaining warrants have an exercise price of US$0.36 and are exercisable immediately with a term of 5 years. As part of the February Public Offering, 670,000 warrants were issued to the underwriter with an exercise price of US$0.3375 USD and will have a term of 3 years.

 

On March 13, 2024, the Company announced that Knightscope, Inc. had selected Draganfly to jointly develop an autonomous security solution that combines Draganfly drones with Knightscope Autonomous Security Robots (ASRs), emergency communications devices & Knightscope Security Operations Center (KSOC) user interface & remote monitoring platform.

 

As previously disclosed, on September 22, 2023, the Company received a letter from the Listing Qualifications ‎Department of Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Bid ‎Price Rule”) by failing to maintain a minimum bid price for the Company’s common shares of at least $1.00 per ‎share for 30 consecutive business days. The Company was allowed an initial 180-day grace period, or until March ‎‎20, 2024, (the “Bid Price Compliance Period”), to regain compliance with the Bid Price Rule. To regain compliance ‎with the Bid Price Rule the closing bid price of the Company’s common shares needed to be at least $1.00 per share ‎for a minimum of ten consecutive business days during the Bid Price Compliance Period.

 

‎On March 21, 2024, the Company received notification that it had failed to regain compliance with the Bid Price ‎Rule and is not eligible for a second 180 day compliance period because of its failure to comply with the $5 million ‎minimum stockholders’ equity initial listing requirement for the period ended September 30, 2023. Unless the ‎Company timely requests a hearing before the Nasdaq Panel, the Company’s securities will be subject to delisting. ‎Accordingly, the Company will request a hearing before the Nasdaq Panel. The hearing request will automatically ‎stay any suspension or delisting action pending the hearing and the expiration of any additional extension period ‎granted by the Nasdaq Panel following the hearing. In that regard, pursuant to the Nasdaq Listing Bid Price Rules, ‎the Nasdaq Panel has the discretion to grant an additional extension period that can expire as late as September 17, ‎‎2024. At the hearing, the Company will be asked to provide a plan to regain compliance to the Nasdaq Panel. The ‎Company intends to present a plan to regain compliance with the Bid Price Rule and request the continued listing of ‎its common shares on Nasdaq pending such compliance. However, there can be no assurance that the Nasdaq ‎Panel will grant the Company’s request or that the Company will ultimately regain compliance with all applicable ‎requirements for continued listing on Nasdaq.‎

 

Significant Acquisitions During 2023

 

Draganfly did not complete any significant acquisitions during its most recently completed financial year for which disclosure is required under Part 8 of National Instrument 51-102 — Continuous Disclosure Obligations of the Canadian Securities Administrators.

 

Market for Securities

 

Trading Price and Volume of Common Shares

 

The Common Shares are listed and posted for trading on the CSE and Nasdaq under the symbol “DPRO”. The ‎following table sets forth the price range (high and low prices) in Canadian dollars of the Common ‎Shares and volume traded on the CSE, for the periods indicated ‎(as reported by the CSE)‎‎.

 

21
 

 

Period  High (C$)   Low (C$)   Volume 
2023               
January   3.00    1.00    1,971,827 
February   3.25    2.13    1,877,541 
March   3.30    1.42    1,549,495 
April   1.82    1.03    1,136,064 
May   1.46    1.04    430,076 
June   2.00    1.15    945,413 
July(1)    1.70    1.29    390,332 
August   1.42    1.05    304,315 
September   1.25    1.00    278,217 
October   1.12    0.78    347,737 
November   0.96    0.67    316,381 
December   0.81    0.57    647,771 
2024               
January   ‎0.69‎    0.47    ‎612,188‎ 
February   0.64    0.19    4,550,499 
March 1 - 25   0.29    0.20    1,515,704 

 

The ‎following table sets forth the price range (high and low prices) in United States dollars of the Common ‎Shares and volume traded on the Nasdaq, for the periods indicated ‎(as reported by the Nasdaq)‎‎.

 

Period  High ($)   Low ($)   Volume 
2023               
January   2.28    0.73    13,716,956 
February   2.47    1.56    14,658,876 
March   2.45    1.06    11,127,171 
April   1.34    0.76    12,336,681 
May   1.07    0.76    4,093,398 
June   1.48    0.83    8,128,820 
July(1)    1.27    0.96    4,645,529 
August   1.06    0.78    5,368,500 
September   0.92    0.75    3,709,700 
October   ‎0.80‎    0.55    3,999,639 
November   0.59    0.51    4,087,691 
December   0.60    0.42    6,829,532 
2024               
January   ‎0.50    ‎0.34‎    ‎‎4,574,668‎‎ 
February   0.47    0.13    36,962,400 
March 1 - 25   0.20    0.15    18,028,400 

 

Prior Sales

 

The following tables summarize the issuances of unlisted securities for the year ended December 31, ‎‎2023 and issuances subsequent to December 31, 2023 and as of the date of this report: ‎

 

22
 

 

Warrants

 

Date of Issuance  Number of Warrants Issued   Exercise Price 
October 30, 2023   ‎6,400,000‎(1) 

US$
0.6123 
October 30, 2023   1,600,000(2)  US$0.0001 
October 30, 2023   320,000(3)  US$0.6875 
February 26, 2024   11,200,000(4)  US$0.36 
February 26, 2024   ‎2,200,000‎(5)  US$0.0001 
February 26, 2024   670,000(6)  US$0.3375 

 

Notes:

 

(1)Pursuant to the October Public Offering, 6,400,000 Common Share purchase Warrants were issued (the “October Warrants”). Each October Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.6123, subject to adjustment, until October 30, 2028.
(2)Pursuant to the October Public Offering, 1,600,000 pre-funded warrants were issued (the “October Pre-Funded Warrants”). Each October Pre-Funded Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.0001.
(3)‎Pursuant to the October Public Offering, 320,000 underwriter warrants were issued (the “October Underwriter Warrants”). Each October Underwriter Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.6875 until October 30, 2026.‎
(4)Pursuant to the February Public Offering, 11,200,000 Common Share purchase Warrants were issued (the “February Warrants”). Each February Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.36, subject to adjustment, until February 26, 2029.
(5)Pursuant to the February Public Offering, 2,200,000 pre-funded warrants were issued (the “February Pre-Funded Warrants”). Each February Pre-Funded Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.0001.
(6)Pursuant to the February Public Offering, 670,000 underwriter warrants were issued (the “February Underwriter Warrants”). Each February Underwriter Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$0.3375 until February 26, 2027.‎

 

Stock Options

 

Date of Grant  Number of Stock
Options Granted
   Exercise Price 
November 9, 2023   30,000(1)  C$0.6260 

 

Note:

 

(1)Each stock option is exercisable into one Common Share by November 9, 2033.

 

Restricted Share Units

 

The Company granted restricted share units (“RSUs”) pursuant to its share compensation plan exercisable for an aggregate of 1,685,316 Common Shares.

 

Date of Grant  Number of
RSUs Granted
   Grant Date
Fair Value
 
May 29, 2023   1,685,316   C$1.13 

 

Escrowed Securities

 

The following table summarizes the Company’s securities that remain in escrow or subject to restrictions ‎‎on transfer as of the date hereof:

 

Designation of Class‎ 

Number of
securities held in ‎

escrow or that
are subject to ‎

contractual
restriction on
transfer

   Percentage
of Class
 
October Underwriter Warrants   320,000(1)   100%
February Underwriter Warrants   670,000(2)   100%

 

23
 

 

Notes:

 

(1)Pursuant to the October Public Offering, 320,000 October Underwriter Warrants were issued and are subject to a contractual restriction on exercising such that these warrants may only be exercised after April 30, 2024, and may not be transferred, other than pursuant to exceptions under FINRA Rule 5110(e)(2) for a period of 180 days from the commencement of sales made under the October Public Offering.
(2)Pursuant to the February Public Offering, 670,000 February Underwriter Warrants were issued and are subject to a contractual restriction on exercising such that these warrants may only be exercised after August 21, 2024, and may not be transferred, other than pursuant to exceptions under FINRA Rule 5110(e)(2) for a period of 180 days from the commencement of sales made under the February Public Offering.

 

Dividends

 

The Company has not declared or paid a dividend. Other than the requirements of the BCBCA, there are ‎‎no restrictions on the Company that would prevent it from paying a dividend. However, as of March 27, 2024, the Board intends to retain any future earnings (when available) for ‎reinvestment in ‎the Company’s business, and therefore, it has no current intention to declare or pay ‎dividends on the ‎Common Shares in the foreseeable future. Any future determination to pay dividends ‎on the Common ‎Shares will be at the sole discretion of the Board of Directors after considering a variety ‎of factors and ‎conditions existing from time to time including its earnings, financial condition and other ‎relevant factors.

 

Legal Proceedings and Regulatory Actions

 

Draganfly is not, and has not been at any time within the most recently completed financial year, a party ‎to any legal proceedings, nor is or was Draganfly’s property the subject of any legal proceedings, known ‎or contemplated, that involves a claim for damages exclusive of interest and costs that met or exceeded ‎‎10% of the Company’s current assets.‎

 

Further, there have not been any (a) penalties or sanctions imposed against the Company by a court ‎relating to securities legislation or by a securities regulatory authority during the year ended December ‎‎31, 2023, (b) any other penalties or sanctions imposed by a court or regulatory body against the ‎Company that would likely be considered important to a reasonable investor in making an investment ‎decision, or (c) settlement agreements entered into by the Company before a court relating to securities ‎legislation or with a securities regulatory authority during the year ended December 31, 2023‎.

 

Interests of Management and Others in Material Transactions

 

Other than as set forth herein, or as previously disclosed, the Company is not aware of any material ‎interests, ‎direct or indirect, by way of beneficial ownership of securities or otherwise, of any director or ‎executive officer ‎or any shareholder holding more than 10% of the Common Shares or any associate or ‎affiliate of any of the ‎foregoing in any transaction within the three most recently completed financial ‎years or during the current ‎financial year or any proposed or ongoing transaction of the Company which ‎has or will materially affect the ‎Company.

 

Auditor, Transfer Agent and Registrar

 

The auditors of the Company are Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional ‎Accountants, 1500-1700, 1140 W Pender Street, Vancouver, BC V6E 4G1.‎

 

Endeavor Trust Corporation is the transfer agent and registrar for the Common Shares at its principal ‎office in Vancouver, British Columbia‎.

 

Interests of Experts

 

There is no person or company whose profession or business gives authority to a statement made by ‎such person or company and who is named as having prepared or certified a statement, report or ‎valuation described or included in a filing, or referred to in a filing, made under NI 51-102 by the ‎Company during, or related to, the Company’s most recently completed financial year other than Dale ‎Matheson Carr-Hilton Labonte LLP, the Company’s auditors.‎

 

24
 

 

Dale Matheson Carr-Hilton Labonte LLP are the auditors of the Company and have confirmed that they ‎are independent with respect to the Company within the meaning of the relevant rules and related ‎interpretations prescribed by the relevant bodies in Canada and any applicable legislation or regulations.‎

 

Denis Silva, a director of the Company, is a lawyer at DLA Piper (Canada) LLP, which law firm provides ‎legal services to the Company. As of the date hereof, the associates and partners of DLA Piper ‎‎(Canada) LLP, as a group, beneficially own, directly or indirectly, less than 1% of the outstanding ‎Common Shares. ‎

 

Additional Information

 

Additional information about the Company is available on SEDAR+ at www.sedarplus.ca and on our website at www.draganfly.com. We do not incorporate the contents of our website or of www.sedar.com into this Annual Report. Information on our website does not constitute part of this Annual Report. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC which can be viewed as www.sec.gov.

 

Additional information, including directors’ and officers’ remuneration and indebtedness, principal ‎holders of ‎Draganfly’s securities and securities authorized for issuance under equity compensation ‎plans, where applicable, ‎will be contained in ‎Draganfly’s information circular for the next annual meeting ‎of shareholders that involves the ‎election of directors and additional information as provided in ‎‎Draganfly’s comparative financial statements for its ‎most recently completed financial year. Draganfly ‎will provide this information to any person, upon request made ‎to the Chief Financial Officer of ‎‎Draganfly at 235 103rd St E, Saskatoon, SK, S7N 1Y8, Canada. The ‎documents will also be ‎located on SEDAR+ at www.sedarplus.ca.‎

 

Additional financial information is provided in the Company’s comparative financial statements and ‎‎management’s discussion and analysis for the period ended December 31, 2023, which are also ‎available on ‎SEDAR+.‎

 

4.B. Business Overview

 

General

 

The Company is an award-winning, manufacturer, contract engineering, and product ‎development ‎company within the UAV space, serving the public safety, agriculture, industrial ‎inspections, and mapping and surveying ‎markets. The Company is driven by passion, ingenuity, and the ‎need to provide efficient solutions and first-class ‎services to its customers around the world with the ‎goal of saving time, money, and lives. ‎

 

The business of the Company is conducted through three wholly-owned subsidiaries: (a) Draganfly ‎Innovations Inc.; (b) ‎Draganfly Innovations USA Inc.; and (c) Dronelogics Systems Inc.‎

 

The business of Draganfly Innovations and Draganfly Innovations USA is the provision of engineering ‎services and ‎manufacture of commercial UAV, RPAS, and ‎‎UVS (unmanned vehicle system) and software, serving the public safety, ‎agriculture, industrial inspections, and ‎mapping and surveying markets. ‎

 

‎Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide ‎scope of ‎services including sales, training, rentals, maintenance, flying and data processing services. ‎

 

Drone Industry Overview

 

Drones or UAV have rapidly evolved from a military origin to commercial and civil government ‎‎applications from security to farming. The increased automation of drones provides additional value to ‎‎existing workflows, triggering more widespread adoption. A global shift to sustainable and eco-friendly ‎‎options has further increased demand for drone usage.‎

 

25
 

 

Drone applications are being utilized in multiple industries on a global basis. The Company believes that defense will remain the ‎‎largest market over the foreseeable future. However, the mobile phone industry created an affordable ‎‎technology stack for drones. The ability to carry a camera enabled many people to utilize the platforms ‎‎for media production and beyond. That demand initiated in the consumer market and has migrated along ‎‎with technological advancements into the growth of commercial drone industry.‎

 

The major segments of the drone market are drone hardware, software and services. Drone hardware are ‎‎the physical goods, including drone platforms, aerial mobility platforms and components and systems. ‎‎The software segment includes flight planning, navigation and computer vision, unmanned traffic ‎‎management (“UTM”), fleet operations, ecosystems, networks and software development kits (“SDKs”). ‎Drone ‎services include the provision of flight operations, data analysis and hardware repair and mainte‎nance. Drone service providers ‎‎(“DSPs”) include system integrators, pilot training providers, retailers ‎and marketplaces, coalitions and ‎organizations, drone test sites, insurance providers and universi-‎ty/educational facilities. The commercial drone industry has been growing rapidly in recent years, with ‎drones becoming increasingly popular for a wide range of applications. From capturing aerial footage to ‎conducting inspections of infrastructure, drones offer a cost-effective and efficient solution to a range ‎of tasks. According to Teal Group, the global market for commercial drones is expected to reach $18.88 ‎billion by 2030, with strong demand coming from industries such as agriculture, construction, and logis‎tics. ‎

 

One of the biggest drivers of growth in the commercial drone industry is the availability of advanced ‎technologies such as Artificial Intelligence (“AI”), machine learning, and computer vision. These technolo‎gies enable drones to perform a wide range of tasks that were previously difficult or impossible, such as ‎automated inspections and precision agriculture. Additionally, the development of high-quality, light-‎weight sensors and cameras has made it possible to capture high-resolution images and video footage, ‎in challenging environments.‎

 

Drone application methods are being used by a variety of industries today. There are approximately ‎‎eight methods that are garnering the most attention: mapping, surveying, inspection, ‎‎filming/photography, dispensing/spraying, warehousing, monitoring/detection, and delivery. These ‎‎applications are being used today by the civil government, educational facilities, agricultural, ‎‎construction, health care, real estate, energy, transportation, insurance, security, and scientific industries.

 

Products and Services

 

The Company can provide its customers with an entire suite of products and services that include: quad-‎copters, ‎‎‎fixed wing ‎aircrafts, ground based robots, handheld controllers, flight training, and software ‎used for tracking, live ‎‎‎streaming, ‎and data collection. In addition, Draganfly has launched a ‎health/telehealth platform that is a set of ‎technologies ‎that remotely detects a number of biometrics ,such as heart rate, oxygen saturation and blood ‎pressure. The Company is also offering ‎sanitary spraying services to indoor and outdoor public ‎gathering spaces ‎such as sport stadiums and ‎fields to provide additional protection against the spread of contagions, such as COVID-‎‎19. ‎ ‎

 

The Company generates revenues across the following categories

 

   Revenues 
   Fiscal year ended December 31, 
Category of Activity  2023   2022   2021 
Product Sales  $‎5,287,093‎   $5,550,432   $5,103,399 
Provision of Services  $‎1,267,749‎   $2,054,627   $1,950,466 

 

The Company did not derive significant revenue from any customers that exceed 10% ‎of total revenues for ‎the year ended December 31, 2023, or December 31, 2022.

 

26
 

 

Draganfly Products

 

‎‎Manufactured Solutions

 

‎The Company is among the longest-running manufacturers of multirotor drones in the world. Draganfly’s ‎drones include the following:‎

 

Draganfly Commander 3XL - The Commander 3 XL Drone is a modular platform capable of carrying payloads of more than 20 pounds making it the ideal choice for industry leaders across a variety of major markets including public safety and agriculture. The Commander 3 XL Drone’s fuselage consists of a simple rectangular tube. Each component of the drone has been specifically designed to ensure the airframe can pack down into a transportable case.
   
Draganfly Heavy Lift Drone - The Draganfly Heavy Lift Drone is a versatile, multi-rotor unmanned aerial vehicle (UAV), designed to enhance deliveries and flight times. Compatible with a variety of interchangeable payloads, this heavy-duty drone can carry more and fly longer. The DHL Drone can be configured to carry up to 67 pounds.
   
Draganflyer Commander2 ‎– The Draganflyer Commander2 is a multi-mission, high-endurance, electric sUAS that ‎combines the signature design elements of our past Draganflyer systems with the most advanced features ‎to date. The Commander2 can be used for numerous applications across many industries including ‎agriculture, public safety, and aerial 3D modeling. Paired with powerful MAVLink-based flight planning ‎software, the Draganflyer Commander2 supports both fully- and semi-automated missions, as well as ‎manual flight operations with a pilot in the loop for a high level of system control to handle any ‎operational task.
   
Draganfly Medical Response – The Draganfly Medical Response Drone is an integrated solution that features a Draganfy Drone combined with a cold-chain logistics enclosure. This solution is able to provide first responders with visual oversight of a scene and ensures the timely delivery of temperature-sensitive medical supplies including blood, vaccines and test samples to dangerous or hard-to-reach areas.
   
Draganfly Long Range LiDAR - Draganfly’s Long Range LiDAR (DLR- LiDAR) system provides accurate distance measurements and improved resolution over conventional photogrammetry methods. The cutting-edge sensor technology can be mounted on UAV, airplanes, and helicopters for those professionals requiring precision imagery.
   
Tango2 – a high endurance, dual battery, sUAS capable of carrying a wide array of payload systems. The aircraft utilizes the Draganfly intelligent power management system to extend flight time while increasing safety. This sUAS is ideal for agricultural monitoring and research, mapping, surveying, environmental monitoring, and search and rescue.

 

Universal Control System

 

The Draganfly Universal Control System is a complete, handheld ground control system that is built to ‎‎integrate ‎with other software and hardware systems. The Draganfly Universal Control System is designed ‎‎to provide precise ‎control over sUAS helicopters, fixed-wing, and ground-based robots. Draganfly ‎‎software provides sophisticated ‎flight planning, automated takeoff, grid following, waypoints, landing, ‎‎data collection, and video downlink.‎

 

Software

 

The Draganfly Surveyor drone flight planning software is an intuitive, easy to use, application that ‎‎enables ‎customers to quickly plan, fly, and process meaningful data. Based on the project, camera type, ‎‎optics, and ‎altitude, the drone software determines the appropriate camera shutter interval, aircraft ‎‎speed, and flight plan to ‎capture the optimum required photo overlap to generate 2D and 3D maps and ‎‎models. The Draganfly Surveyor ‎directly integrates with Pix4Dmapper for survey-grade results and can ‎‎be used alongside other third-party ‎photogrammetry programs.‎

 

27
 

 

Vital Intelligence

 

The Draganfly Vital Intelligence platform is a touchless health ‎assessment system that leverages ‎proprietary machine-vision methods to measure biometrics such as heart rate, oxygen saturation and ‎blood pressure. Vital ‎Intelligence is a data platform that turns an existing camera into a touchless ‎ ‎detection system. Draganfly integrates this technology into a ‎variety of ‎platforms and camera systems – ‎both on the ground and in the air – to support use cases such as visitor intake and other general health ‎and wellness applications.‎

 

Draganfly Services

 

Custom Engineering

 

Draganfly is a contract engineering partner for government agencies, enterprise organizations, academic ‎institutions, ‎and businesses of all sizes. The Draganfly team’s truest capabilities are actualized during the ‎engineering process as ‎hardware designers, software designers, engineers, project managers, and ‎vertical-specific experts come together to ‎build custom drone solutions for its partners. Draganfly’s end-‎to-end engineering services include‎:

 

Hardware design: Component, product, and system design;
   
Software design: Custom software and interface design;
   
Development: Including integration with third party platforms, PixX4D, Pixhawk, Ardupilot, DJI ‎and ‎more‎;
   
Modeling: 3D design and modeling of mechanical components;
   
ITAR ‎(International Traffic in Arms Regulations) equipment management: Approved handling and integration ‎of ITAR, and Controlled Goods ‎technologies‎; and
   
Support: Testing, training, documentation, and repairs.

 

Training

 

Draganfly offers custom-designed training packages that are tailored to specific operations and use ‎‎cases. The ‎Company also offers basic training for new UAV owners, and advanced classes for users ‎‎who understand the ‎fundamentals and are looking for new ways to increase flight efficiency or comply ‎‎with federal regulations‎.‎

 

Flight Services

 

Draganfly has a team of qualified pilots that conduct flights on behalf of its customers. The team ‎‎specializes in ‎working with emergency services including police, fire, and search and rescue personnel. ‎‎Draganfly also supports ‎industrial applications, utility and power companies, environmental and ‎‎agricultural entities and others‎.

Geographic Information Systems (GIS) Data Services

 

Draganfly has a team of qualified GIS Data Specialists and Surveyors that support the delivery of ‎services to clients in various markets. These services include the creation and maintenance of data sets ‎of spatial analysis. ‎

 

Spraying Services

 

Draganfly operates, in partnership with a leader in natural and organic disinfectants, to ‎administer a sanitization spraying service in large public venues by misting a surface spray across the ‎entire venue in four to six hours.‎

 

Principal Markets

 

Draganfly has more than 20 years of experience designing and manufacturing professional drones for ‎military, public safety, energy, agriculture, and insurance. Draganfly has sold products and services to a number of countries but predominantly focuses on the North American market given its geographical ‎location.‎

 

28
 

 

Military and Government

 

Military and government contractors have partnered with Draganfly to improve personnel and ‎infrastructure ‎‎safety. Draganfly works with partners to design and manufacture custom airframes, design ‎and develop ‎payloads, ‎and manage complex flight operations. Draganfly team members hold advanced ‎pilot ‎certificates and are ‎approved to fly in controlled airspace and at airports. Since the Company’s ‎‎development team is cleared by ‎Canada’s Controlled Goods Program, the team is permitted to handle ‎‎ITAR equipment and technologies, and the ‎Company’s facilities are built to protect those technologies ‎‎and ensure they are only handled by approved ‎personnel.‎

 

Public Safety

 

In 2013, the Royal Canadian Mounted Police flew one of the Company’s drones to locate and save the ‎life of an ‎accident victim, which we believe was one of the first times a public safety organization used a ‎UAV to save a life. ‎Years later, the Company is still using drone technology to keep the public ‎safe. Draganfly works with its ‎partners to identify ‎unknowns, such as substances, spills, packages, and ‎chemicals while not putting human lives at ‎risk‎. ‎Draganfly builds aerial and ground systems with custom ‎payloads and sensors to scan scenes, survey ‎public ‎events, locate objects, and clear debris faster and ‎more safely than on-the-ground manpower. The ‎Company also ‎empowers its partners to maximize ‎existing infrastructures via custom application programming interface integrations ‎that ensure Draganfly’s ‎technology enhances their ‎safety systems‎.

 

Environmental and Energy

 

Draganfly offers a suite of commercial UAV solutions for energy companies and those servicing the ‎‎energy market, ‎like surveyors and consultants. Draganfly equips energy companies with the hardware ‎‎and software they need to ‎optimize existing operations, improve safety, and respond after a natural ‎‎disaster. Partners can use Draganfly ‎hardware and 3D modeling software to remotely inspect sites that ‎‎would put human lives at risk. They also conduct ‎environmental monitoring with Draganfly’s sample ‎‎collection solutions, assessing water and ground pollution, gas ‎composition, infrastructure, and other ‎‎environments.‎

 

Agriculture

 

Draganfly works with its partners to collect high-quality data, using multi- and hyper-spectral imaging, 3D ‎modeling, and a suite of sophisticated sensor technology that assesses environmental factors. Seed ‎companies use Draganfly technology to optimize growth season, measuring seed trial results throughout ‎the research and development process. Farmers can use Draganfly flight and data collection services to ‎monitor hectares of land year-round, assessing factors like fertilizer efficiency, weed production, and ‎more. ‎

 

Operations

 

Canadian Operations

 

Draganfly Innovation Inc.’s products are manufactured at its machine shop within its leased head office ‎based in Saskatoon, Saskatchewan, Canada. Draganfly Innovations Inc. operates the fully operational ‎facility located at 235 103rd St E, Saskatoon, SK, S7N 1Y8, Canada. This facility is to be used only for ‎the purposes of Draganfly Innovations Inc. operating its business of design, development, production, ‎distribution, sale and/or licensing of drones or robots, or such other use as permitted by the landlord ‎from time to time. ‎

 

Dronelogics Systems Inc.’s products and services are provided through its leased space located at Unit 319, 2999 ‎Underhill Avenue, ‎Burnaby, British Columbia‎. ‎

 

‎United States Operations

 

‎The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has an ‎office in ‎Palm Beach ‎Gardens, Florida that currently stores some inventory for operations in the ‎United States‎. ‎

 

29
 

 

The Company has derived its revenues across the following primary geographic market segments for the last three fiscal years:

 

   Revenues 
   Fiscal year ended December 31, 
Region  2023   2022   2021 
Canada  $‎6,162,672‎   $6,919,038   $4,982,373 
United States  $‎392,170‎   $686,021   $2,071,492 

 

Competitive Conditions

 

Although Draganfly is acknowledged as a drone industry pioneer that we believe was the first to develop ‎the ‎commercial multi rotor ‎helicopter, there ‎are now many drone hardware companies in the world. As ‎technology ‎has ‎improved ‎and costs for hardware and software have come down, the line between ‎consumer and commercial ‎‎‎drones has blurred, enabling the rise of Prosumer drones. A Prosumer drone ‎is a drone is designed to satisfy elements of professional and consumer segments, often featuring ‎integrated sensors designed to deliver a combination of performance and value with little ability to ‎customize the drone for the required use-case. Historically, Draganfly has serviced early adopters in the ‎public safety industry. At ‎this stage of ‎‎the commercial drone adoption curve, the average public safety ‎organization (local, ‎regional, and even federal law ‎‎enforcement, for example), has been introduced to ‎drones through the adoption of Consumer and Prosumer platforms. Hence, these ‎organizations tend to ‎use lower cost drones ‎‎that have become quite sophisticated that can accomplish ‎most of their use ‎cases. The dominant companies in the ‎industry are Chinese drone manufacturers that ‎are reputed to ‎comprise a substantial portion of the consumer and now commercial ‎drone ‎market. The majority of foreign manufactured ‎‎drones are geared towards broad applications involving the masses. Draganfly ‎has ‎moved away from ‎‎competing directly with these companies and in some cases sells these products through its subsidiary, ‎‎Dronelogics Systems Inc., or ‎has chosen to serve niche markets outside of where the foreign ‎manufactured drones tends to ‎be. ‎There are also ‎some organizations that tend to be US based that ‎either prefer or are mandated to not use ‎foreign ‎drones such as ‎those produced by China. Some of ‎these organizations are sensitive to their work ‎being exposed to that ‎of overseas ‎governments which has ‎at least for the time being, created a niche ‎market for players such as ‎Draganfly. The ‎combined shift ‎away from foreign made drones (national security issues) and regulatory improvements by the FAA ‎in ‎respect of drone usage is driving industry demand. As Draganfly has evolved to move with the industry ‎trends, ‎the ‎Company now uses some third party hardware and software as part ‎of some of its ‎customization and engineering services work. ‎Draganfly ‎has also moved into innovative engineering ‎‎procurement which is very specialized. As the drone industry matures, ‎this may bring more competitors ‎to this space or ‎the ‎Company’s customers may choose to develop the in-house ‎expertise to do the work ‎that they currently ‎‎outsource to Draganfly. However, it is the Company’s view that there ‎will be a growing ‎customer base ‎that will ‎require specialized drone hardware, software and service solutions outside of ‎the capabilities of the consumer & prosumer drone platforms that only a handful of companies can do.‎

The market remains highly competitive. Private equity continues to actively capitalize drone start-ups ‎.

 

Regulatory Framework

 

A new regulatory framework relating to the use of drones in Canada was published by Transport ‎Canada ‎‎in ‎January 2019 and came into effect on June 1, 2019. The changes, published in the ‎Canadian Aviation ‎‎Regulations ‎‎(“CARs”), Part IX, introduce new rules based on the weight of the RPA and the intended ‎‎operation. This framework ‎creates three broad ‎categories of RPAS: (i) small RPAS in limited (low risk) ‎‎operations (“Small RPAS Basic”); (ii) ‎‎small RPAS in advanced (complex) operations (“Small RPAS ‎‎Advanced”); and (iii) all other RPA ‎operations that ‎fall outside (i) and (ii) above. These regulations focus ‎‎on foundational issues ‎such as aircraft marking and ‎registration, pilot knowledge and certification, ‎‎airworthiness of the ‎aircraft, and flight rules.‎

 

‎Small RPAS Basic are defined as RPAS weighing between 250 grams and 25 kilograms and operated in ‎‎rural ‎and ‎unpopulated areas. These RPAS will require identification markings, including name, address ‎‎‎and contact ‎information of the owner and pilot of the RPA. Pilots must be at least 14 years of ‎age and ‎‎must hold a valid Basic ‎RPA licence that is specific to small drones. Additional ‎restrictions are imposed ‎‎that include that the RPA cannot ‎operate: (i) within approximately 30 meters of ‎people or open-air ‎‎assemblies of people, (ii) above 400 feet, (iii) ‎within approximately 1.85 kilometers of ‎heliports or (iv) ‎‎within approximately 5.5 kilometers of airports. These ‎regulations require the RPA to ‎always be operated ‎‎within visual line-of-sight.‎

‎ 

Small RPAS Advanced are defined as RPAS weighing between 250 grams and 25 kilograms and ‎‎operated in ‎urban ‎and/or populated areas. These RPAS will require identification, marking and ‎‎registration ‎with Transport Canada as ‎well as meeting specified design standards acceptable to ‎‎Transport ‎Canada. The RPA will be assigned a unique ‎identification/registration number issued by ‎‎Transport ‎Canada. Pilots must be at least 16 years of age and must ‎hold a valid Advanced RPAS license ‎‎‎that is specific to small drones. Approval for operation must be granted by Air ‎Traffic Control ‎when ‎‎operating in controlled airspace or near controlled aerodromes. A set of flight rules must be ‎‎followed at ‎‎all times for these more complex operations. Restrictions, including distances from ‎people, are ‎‎‎determined based on the safety certification of the RPA being operated. The RPA ‎must always be ‎‎operated within ‎visual line-of-sight.‎

 

30
 

 

The current legislation utilizes a similar Special Flight Operations Certificate (“SFOC”) application ‎‎‎process, as the ‎previous regulations, to approve any operations that do not fit within the ‎regulatory ‎‎regime set out above, such as ‎operating beyond visual-line-of-sight. For those wishing ‎to operate ‎‎outside of the regulatory framework set out in ‎CARs, part IX, there will be a variety of ‎SFOC application ‎‎processes tailored to the nature and use of the RPA. The ‎more complex and ‎riskier the proposed ‎‎operation, the more thorough and detailed the SFOC application process.‎

 

‎Those operators requiring an SFOC must apply to the Transport Canada Civil Aviation Regional ‎Office at ‎‎least 30 ‎working days prior to the date of the proposed RPAS operation. Transport ‎Canada has wide ‎‎discretion in reviewing ‎and approving SFOC applications; however, to date the ‎Company has never been ‎‎refused an SFOC for which it has ‎applied. The purpose of the SFOC ‎application review is to ensure that ‎‎the proposed operation is safe and associated ‎risks have ‎been adequately mitigated by the Company.‎

 

Draganfly operates in accordance with Part IX - Remotely Piloted Aircraft Systems, of Transport Canada’s Canadian Aviation Regulations and Standards, which is periodically updated and governs the safety assurance and operations of Remotely Piloted Aircraft Systems with Canada.

 

The Company is currently fully compliant with all current regulatory requirements and has applied ‎for, and ‎‎received ‎Transport Canada approval for several SFOCs.‎

 

Seasonality

 

In terms of financial performance, the fourth quarter tends to be the weakest quarter for the Company due to the Company’s customers closing down for a few weeks for the holiday season coupled with poorer weather conditions for flying drones and performing drone services.

 

Components

 

The Company obtains hardware components, various subsystems and systems, and raw materials from ‎a limited group of suppliers. The Company does not have long-term agreements with any of these ‎suppliers that obligate such suppliers to continue to sell components, subsystems, systems or products ‎to the Company. The Company’s reliance on these suppliers involves significant risks and uncertainties, ‎including whether suppliers will provide an adequate supply of required raw materials, components, ‎subsystems, or systems of sufficient quality, will increase prices for the raw materials, components, ‎subsystems or systems, and will perform their obligations on a timely basis. See “‎Item 3.D.‎ Risk Factors”.‎

 

Intangible Properties

 

Intangibles such as patents, software, specific technology know-how, and applications expertise all have ‎a significant effect on the Company’s business. At present, drone delivery technology cannot be ‎purchased as an off-the-shelf solution; therefore, the Company has been focused on developing ‎proprietary technology which meets or exceeds anticipated Canadian government requirements. By virtue ‎of being the first commercial ‎UAV company in the industry, the Company’s subsidiary, Draganfly ‎Innovations, holds commercial patents. ‎

 

As at the Effective Date, the Company has the following patents and patents pending in the application ‎stage in its portfolio and intends to continue to expand and grow its intellectual property portfolio: ‎

 

Title  Country  Application No.   Issue Date  Patent No.   Status
Multi Rotor UAV With Compact Folding Rotor Arms  Canada   2,917,434   4/23/2019   2,917,434   Issued
Vehicle with Aerial and Ground Mobility  Canada   2,787,279   10/22/2013   2,787,279   Issued
Vertical Takeoff and Landing Unmanned Aircraft System  Canada   2,935,793   1/15/2021   2,935,793   Issued
Wheel with Folding Segments  Canada   2,787,075   10/29/2013   2,787,075   Issued
Action Camera System for Unmanned Aerial Vehicle  United States   15/707,752  1/22/2019   10,187,580   Issued
Action Camera System for Unmanned Aerial Vehicle  United States   14/533,995  9/19/2017   9,769,387   Issued

 

31
 

 

Title  Country  Application No.   Issue Date  Patent No.   Status
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   14/642,370  7/18/2017   9,710,709   Issued
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   15/651,672  2/13/2018   9,892,322   Issued
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   15/894,292  10/8/2019   10,438,062   Issued
Dual Rotor Helicopter with Tilted Rotational Axes  United States   12/458,608  11/8/2011   8,052,081   Issued
Helicopter with Folding Rotor Arms  United States   13/200,825  10/23/2012   8,292,215   Issued
Multi Rotor UAV With Compact Folding Rotor Arms  United States   14/994,080  7/31/2018   10,035,581   Issued
Pixel Based Image Tracking System For Unmanned Aerial Vehicle (UAV) Action Camera System  United States   15/256,193  10/10/2017   9,785,147   Issued
Pixel Based Image Tracking System for Unmanned Aerial Vehicle (UAV) Action Camera System  United States   14/825,956  9/13/2016   9,442,485   Issued
Real Time Noise Reduction System for Dynamic Motor Frequencies Aboard an Unmanned Aerial Vehicle (UAV)  United States   14/642,496  11/8/2016   9,489,937   Issued
System and Method for Adaptive Y Axis Power Usage and Non Linear Battery Usage for Unmanned Aerial Vehicle Equipped with Action Camera System  United States   14/825,914  12/6/2016   9,511,878   Issued
Tandem Wing Aircraft System with Shrouded Propeller  United States   15/584,815  8/13/2019   10,377,488   Issued
Vehicle with Aerial and Ground Mobility  United States   14/641,468  3/21/2017   9,598,171   Issued
Vehicle with Aerial and Ground Mobility  United States   13/846,074  3/31/2015   8,991,740   Issued
Vertical Take Off And Landing (VTOL) Aircraft Having Variable Center Of Gravity  United States   15/706,158  10/20/2020   10,807,707   Issued
Vertical Takeoff and Landing Unmanned Aircraft System  United States   15/164,718  8/28/2018   10,059,442   Issued
Visually Intelligent Camera Device with Peripheral Control Outputs  United States   14/939,369  8/6/2019   10,375,359   Issued
Wheel with Folding Segments  United States   13/739,419  6/17/2014   8,753,155   Issued

 

32
 

 

The Company also has the following registered trademarks and pending ‎applications‎:‎

 

Description   Name/Title   Official No.   Governmental Entity
Trademark Application (Status: Filed)   DRAGANFLY   1,972,336   CIPO
Registered Trademark   DRAGANFLYER EXPLORE   TMA1,025,742   CIPO
Registered Trademark   DRAGANFLYER APEX   TMA1,025,624   CIPO
Registered Trademark   DRAGANFLYER COMMANDER   TMA1,008,809   CIPO
Registered Trademark   DRAGANFUEL   TMA997,118   CIPO
Registered Trademark   DRAGANFLY INNOVATIONS   TMA908,564   CIPO
Registered Trademark   DRAGANFLYER   TMA906,939   CIPO
Registered Trademark   DRAGANFLY & DESIGN   TMA905,935   CIPO
Registered Trademark   DRAGANFLY   TMA1,071,582   CIPO
Registered Trademark   DRAGANFLY   TMA1,069,670   CIPO
Registered Trademark   DRAGANFLYER GUARDIAN   TMA904,883   CIPO
Registered Trademark   DRAGANVIEW   TMA886,217   CIPO
Registered Trademark   DRAGANFLYER APEX   6248237   USPTO
Registered Trademark   DRAGANFLY   6373176   USPTO
Registered Trademark   DRAGANFLYER COMMANDER   5760146   USPTO
Registered Trademark   DRAGANFUEL   5563360   USPTO
Registered Trademark   DRAGANFLY INNOVATIONS   5130969   USPTO
Registered Trademark   DRAGANFLYER   4920316   USPTO
Registered Trademark   DRAGANFLY & Design   5130970   USPTO
Registered Trademark   DRAGANFLYER GUARDIAN   4995725   USPTO
Registered Trademark   DRAGANVIEW   4920317   USPTO
Trademark Application1   DRAGANFLY   88488410   USPTO

 

Note

 

1 The US application is suspended pending registration of the Canadian mark.

 

Market Opportunity

 

Drones have rapidly evolved from their military origin to commercial and civil government applications from ‎security to farming. The Company believes that an increased automation of drones provides additional value to existing workflows, triggering ‎more widespread adoption, while a global shift to sustainable and eco-friendly options has further increased demand for ‎drone usage. ‎According to Drone Industry Insights, the commercial and private drone market could grow from $22.5 billion in ‎‎2020 to $42.8 billion in 2025, representing compound annual growth rate (“CAGR”) of 13.8%.1

 

Drone application methods are being used by a variety of industries today. The most active segments are mapping, ‎surveying, inspection, filming/photography, dispensing/spraying, warehousing, monitoring/detection, and delivery. ‎These applications are being used today by the civil government, educational facilities, agricultural, construction, ‎health care, real estate, energy, transportation, insurance, security, and scientific industries for public safety, data ‎collection and profit. According to the Drone Industry Insights, the fastest growing drone application method will be ‎delivery and is forecasted at 28.6% CAGR over the next five years and it is widely believed over 100,000 new jobs will ‎be created in the drone market by 2025.2 However, regulatory hurdles and intense industry scrutiny need to be ‎addressed.‎

 

Our existing products are configured to meet the needs of multiple industries. We continue to add new customers in ‎different market verticals. We are actively designing and developing new products and services to meet increased ‎customer demands.‎

 

Growth Strategy

 

Draganfly markets its products and services as a drone solution platform that enables customer to do things not ‎easily done before and to collect data not easily available before. Draganfly provides solutions to our customers ‎utilizing drones and adjunct technologies. Sensors, software, AI and more all make up this ability to provide ‎solutions that only a company with end-to-end capabilities can provide. Draganfly grows by dealing with the ‎decision makers in organizations who generally have budget control and/or profit and loss responsibility. Draganfly will ‎continue to develop specific solutions and IP for industry verticals by working directly with customers. Draganfly ‎will also pursue an acquisition strategy focused on adding additional capabilities to its platform that strengthen its ‎value proposition of being able to provide new and total solutions that other drone companies cannot. Draganfly is focused on growth through developing new products, expanding its customer base, and pursuing accretive acquisition opportunities, both within and outside North America, in new markets that complement its existing portfolio.

 

 

1 See Global Drone Market Report 2020-2025

2 See Global Drone Market Report 2020-2025

 

33
 

 

Sales and Marketing

 

Draganfly plans to expand it sales and market capabilities in three key areas. First, Draganfly intends to implement a sales force that has the ability ‎to build relationships and sell specifically designed solutions into industry verticals. This sales force will be ‎specialized into segments that sell either direct or into a channel dependent on the specific product or service ‎solution being provided. Draganfly plans to expand business development personnel that can work with specific industries to envision ‎and develop new product lines and services not yet contemplated by our customers. Second, Draganfly plans to drive greater market ‎awareness of the Draganfly brand via public relations ‎Third, Draganfly plans targeted marketing and advertising via tradeshows/conferences which are virtual or physical as well as target digital advertising campaigns used to generate inbound inquires for specific products, services or ‎solution opportunities.

 

Customers

 

Key customers are customers looking to gain strategic advantage in particular markets via the use of drones and ‎drone technology. These are often large organization with a specific problem that they are currently solving in an ‎expensive manner which usually means the use of teams of people or expensive personnel. By designing solution ‎and providing everything from design to manufacturing to sensor development and even giving recognition on ‎patents of IP development (not with commercial interest) to providing the services and housing the data we develop ‎customer relationships that are very “sticky”. ‎

 

Specialized Skill and Knowledge

 

There is a specialized skill required for the development, operations, maintenance, sales and marketing ‎of the Company’s technology. The Company’s current staff possesses the necessary skills and ‎knowledge required for the Company’s business; however, additional employees may be added to staff ‎as needed. All operational staff hold the appropriate licenses and certificate as mandated by Transport ‎Canada.‎

 

Changes to Contracts

 

No aspect of Draganfly’s business is anticipated to ‎be affected in the current financial year by renegotiation or termination of any contract.

 

Capital Expenditures

 

During the years ended December 31, 2023, 2022 and 2021, we did not undertake any capital expenditures.

 

4.C. Organizational Structure

 

We have three wholly-owned subsidiaries. The following chart shows the Company’s subsidiaries:‎

 

 

4.D. Property, Plant and Equipment

 

Draganfly Innovation Inc.’s products are manufactured at its machine shop within its leased head office ‎located at ‎‎‎235 103rd St E, Saskatoon, SK, S7N 1Y8, Canada (approximately 6,631 square feet in size).‎

 

Dronelogics Services Inc.’s services are provided through its leased space located at Unit 319, 2999 Underhill ‎‎Avenue, ‎Burnaby, British Columbia (approximately 2,752 square feet in size). ‎‎

 

34
 

 

The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has a leased ‎office at 3910 ‎RCA Boulevard, Suite 1015, Palm Beach Gardens, Florida where inventory is stored (approximately 1,600 square ‎feet in size).‎

 

See also “‎Item 4.B.‎ Business Overview Operations – Operations”.

 

Item 4A. Unresolved Staff Comments

 

Not applicable.

 

Item 5. Operating and Financial Review and Prospects

 

The management’s discussion and analysis of the Company for the year ended December 31, 2023 is included in this Annual Report in Exhibit 15.1, which is incorporated herein by reference.

 

Item 6. Directors, Senior Management and Employees

 

6.A Directors and Senior Management

 

The following table sets forth the name, office held, age, and functions and areas of experience in the Company of each of our directors and senior management:

 

Name and Municipality

of Residence

 

Age

 

Position Held

and Date

Appointed

 

Principal Occupation within the past five years

Cameron Chell

Bowen Island, British Columbia, Canada

  55  

Chief Executive Officer, Chairman and a Director

(August 14, 2019)

  Chairman and Chief Executive Officer of the Company since ‎August ‎‎2019; President, Chairman and co-founder of ‎CurrencyWorks Inc. from ‎November 2017 to present; Chief ‎Executive Officer and co-founder of ‎Business Instincts Group ‎Inc‎., a Calgary-based Venture Creation Firm, ‎from 2009 to ‎‎2021; co-founder of BitRail, LLC from May 2019 to May ‎‎‎2020; co-creator and Chairman of KODAKOne from May ‎‎2017 to May ‎‎2020; director of Health Outcomes Worldwide ‎from June 2017 to ‎February 2021; and Chairman of TruTrace ‎Technologies Inc. from April ‎‎2017 to September 2020‎.
             

Scott Larson(3)(4)

Burnaby, British Columbia, Canada

  49  

President (July 3, 2020-May 9, 2022) and a Director

(August 14, 2019)

  President of the Company from July 3, 2020 to May 9, 2022; former Chief ‎Executive ‎Officer of Kater Technologies, a Vancouver-based ‎mobility as a service ‎‎(MaaS) company building out an ‎integrated intermodal transportation ‎‎platform incorporating ‎public transportation, buses, taxis and ride hailing ‎vehicles into ‎a single service, from January 2019 to March 2020; former ‎‎Chief Executive Officer of ‎Helios Wire, a satellite company ‎building out a ‎space-enabled IoT/M2M network‎, from 2016 to ‎‎2019; and former Chief ‎Executive Officer and founder of ‎UrtheCast ‎Corp. from 2010 to 2015‎.
             

Olen Aasen(1)(2)(3)(4)

Vancouver, British Columbia, Canada

  41  

Director

(August 14, 2019)

 

  Practicing lawyer since 2007.‎

 

35
 

 

Andrew Hill Card Jr. (2)

Jaffrey, New Hampshire, United States

  76  

Director

(November 7, 2019)

 

  Chairman of the National Endowment for Democracy (NED), ‎a non-‎profit organization ‎dedicated to the growth and ‎strengthening of ‎democratic institutions around the world, ‎from January 2018 to January ‎‎2021; Interim Chief Executive ‎Officer of the George & Barbara Bush ‎Foundation from June ‎‎2020 to December 2020; and President of ‎Franklin Pierce ‎University in New Hampshire from January 2015 to ‎August ‎‎2016‎.
             

John M. Mitnick(1)(2)

McLean, Virginia, United States

  61  

Director

(June 18, 2020)

 

  Chairman of the Company’s Board of Directors since ‎April 2022; member of the Company’s Board of ‎Directors since June 2020; consultant to the Company ‎from November 2019 to June 2020; Executive Vice ‎President, General Counsel, and Secretary of ‎Valaurum, Inc., since August 2022; member of the ‎Board of Directors of Valaurum, Inc., ‎March 2016 ‎to ‎February ‎‎2018 and since October ‎‎2019; Advisor to ‎Carbon ‎Neutral Royalty Ltd. ‎from ‎February 2022 to ‎present; General ‎Counsel of the U.S. ‎Department ‎of ‎Homeland Security from ‎February ‎‎2018 to September ‎‎2019; and ‎Senior Vice President, ‎‎General Counsel, ‎and Secretary of The Heritage ‎‎Foundation ‎from ‎March 2014 to February 2018.‎‎ ‎
             

Denis Silva(3)

Vancouver, British Columbia, Canada

  44  

Director

(August 14, 2019)

 

  Corporate and securities partner with the law firm DLA Piper (Canada) ‎LLP since July 2020; and ‎partner at the law firm Gowling WLG (Canada) LLP from 2015 to 2020.
             

Julie Myers Wood(1)(4)

McLean, Virginia, United States

  54  

Director

(September 9, 2021)

  Chief Executive Officer of Guidepost Solutions LLC since ‎May 2014; ‎Chief Executive Officer of ICS Consulting LLC; ‎and has held several ‎high level positions within the U.S. ‎government including at the ‎Departments of Justice, Homeland ‎Security, Treasury, and Commerce, ‎as well as at the White ‎House.
             

Paul Sun

Oakville, Ontario, Canada

  52  

Chief Financial Officer and Corporate Secretary

(August 14, 2019)

  Chief Financial Officer of the Company since August 2019; Chief Financial Officer of Former ‎Draganfly since July 2015; and Managing Director, ‎Institutional Equity Sales at Beacon Securities Limited‎ from January 2013 to December 2014.
             

Paul Mullen

Burnaby, British Columbia, Canada

  41   Chief Operating Officer (March 1, 2022)  

Chief Operating Officer of the company since March 1, 2022; Vice ‎President since April 13, 2021. Vice President (2019-2021) Monark ‎Ventures. Various Roles including Manager Sales, Technical Service ‎Delivery & Operations at Shaw Cablesystems G.P. from 2001-2018. ‎

 

Deborah Greenberg

Montreal, Quebec, Canada

 

  58   Chief Legal and ‎Corporate Services ‎Officer and ‎Corporate ‎Secretary (July 4, ‎‎2022)‎   Chief Legal Officer of the Company since July 4, 2022; Chief Legal and ‎Corporate Services Officer of the Company since December 1, 2022; ‎Chief Legal Officer (2017-2019) and Chief Information Officer (2019-‎‎2021) at Canada Mortgage and Housing Corporation; Various roles ‎including General Counsel at Aimia from 2007-2017.‎

 

Notes:‎

 

(1) Member of the Audit Committee.
(2) Member of the Nominating and Corporate Governance Committee.

(3)

Member of the Compensation Committee.

(4) Member of the ATM Committee.

 

36
 

 

The directors listed above will hold office until the next annual meeting of the Company or until their ‎successors are elected or appointed. ‎There are no family relationships among our directors and executive officers. There are no arrangements or understandings with major shareholders, customers, suppliers or others, pursuant to which any of our directors or executive officers was selected.

 

As at March 7, 2024, the directors and senior officers of Draganfly, as a group, beneficially own or ‎control, directly or indirectly, 1,213,132 Common Shares or 2.39% of the issued and outstanding Common ‎Shares.‎

 

Corporate Cease Trade Orders, Bankruptcies, Penalties or Sanctions

 

To the knowledge of management, no director or executive officer as at the date hereof, is or was within ‎‎10 years before the date hereof, a director, chief executive officer or chief financial officer of any ‎company (including Draganfly), that (a) was subject to an order that was issued while the director or ‎executive officer was acting in the capacity as director, chief executive officer or chief financial officer, ‎or (b) was subject to an order that was issued after the director or executive officer ceased to be a ‎director, chief executive officer or chief financial officer and which resulted from an event that occurred ‎while that person was acting in the capacity as director, chief executive officer or chief financial officer. ‎For the purposes hereof, “order” means (a) a cease trade order, (b) an order similar to a cease trade ‎order, or (c) an order that denied the relevant company access to any exemption under securities ‎legislation, that was in effect for a period of more than 30 consecutive days.‎

 

To the knowledge of management, other than as disclosed herein, no director or executive officer of ‎Draganfly, or a shareholder holding a sufficient number of securities of Draganfly to affect materially the ‎control of the company (a) is, as at the date hereof, or has been within the 10 years before the date ‎hereof, a director or executive officer of any company (including Draganfly) that, while that person was ‎acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, ‎made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted ‎any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or ‎trustee appointed to hold its assets, or (b) has, within the 10 years before the date hereof, become ‎bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject ‎to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver ‎manager or trustee appointed to hold the assets of the director, executive officer or shareholder.‎

 

By Order of the Supreme Court of Newfoundland and Labrador dated June 17, 2020, Deloitte ‎Restructuring Inc. ‎was appointed as the receiver and manager of all current and future assets, ‎undertakings, and properties of the ‎Kami Mine Limited Partnership, Kami General Partner Limited, and ‎Alderon Iron Ore Corp. The receivership was ‎initiated by a secured creditor of the Kami Mine Limited ‎Partnership after its failure to refinance the secured debt ‎due to the COVID-19 pandemic. Mr. Aasen was ‎Corporate Secretary of Alderon Iron Ore Corp. and Secretary and ‎Director of Kami General Partner ‎Limited until April 28, 2020.‎

 

Penalties or Sanctions

 

Other than as disclosed herein‎, no director, executive officer or shareholder holding a sufficient number ‎of securities of Draganfly to materially affect the control of the Company has been subject to: (i) any ‎penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory ‎authority or has entered into a settlement agreement with a securities regulatory authority; or (ii) any other ‎penalties or sanctions imposed by a court or regulatory body that would likely be considered important ‎to a reasonable investor in making an investment decision.‎

 

37
 

 

Pursuant to a settlement agreement (the “Settlement Agreement”) dated November 6, 1998 that Cameron ‎Chell, Chief Executive Officer, Chairman and a director of the Company, signed with the Alberta Stock ‎Exchange (the “ASE”), Mr. Chell agreed to the following sanctions: ‎

 

  prohibition against ASE Approval (as defined in the General By-law of the ASE) in any capacity for a ‎period of five years commencing November 6, 1998; ‎
     
  a fine in the sum of $25,000; ‎
     
  strict supervision for a period of two years following re-registration in any capacity; and ‎
     
  close supervision for a period of one year following the period of strict supervision described ‎above.‎

 

The matters respecting the Settlement Agreement are as set forth in an ASE Notice to Members dated ‎November 12, 1998, which provides that: ‎

 

  representations were made by the promoter of a company to one of Mr. Chell’s clients that he would ‎only be permitted to purchase securities in the initial public offering of that company if he would ‎agree to purchase additional securities in the secondary market following the listing on the ASE ‎and, in or around March or April, 1996, Mr. Chell disclosed confidential information to the ‎promoter of that company concerning a client’s account with respect to a cheque returned NSF ‎to Mr. Chell’s employer;‎
     
  the investment objectives for two of Mr. Chell’s clients were amended without prior knowledge or ‎consent of such clients and purchases and sales of securities were subsequently executed in the ‎accounts of such clients which were unsuitable for the clients given the stated investment ‎objectives for the accounts prior to the amendment of such investment objectives; ‎
     
  Mr. Chell executed a total of 21 transactions in the accounts of two of Mr. Chell’s clients without prior ‎knowledge or authorization of such clients;‎
     
  the signature on the new client account form for one of Mr. Chell’s clients, which purported to be that ‎of the client was not in fact the signature of the client nor did such client have any knowledge of ‎any changes made to the investment objectives for his account(s); ‎
     
  on or about June 10, 1996, the address for the account of one of Mr. Chell’s clients was changed to ‎Mr. Chell’s local post office box address without such client’s knowledge and while the client ‎was resident in Ontario. As a result, during the period of June 10 to and including September, ‎‎1996, the client did not receive any trade confirmations or accounts statements with respect to ‎her accounts with Mr. Chell;‎
     
  on or about March 19, 1996, Mr. Chell permitted one of his clients to acquire approximately 4% of ‎the total initial public offering by a company, contrary to the rules of the ASE; ‎
     
  on or about October 19, 1996, Mr. Chell purchased securities of a company in the account of one of ‎his clients without disclosing the involvement of his brother as president of that company; ‎
     
  on or about June 23, 1996, the private placement questionnaire and undertaking completed in ‎connection with the purchase by one of Mr. Chell’s clients and filed with the ASE disclosed that ‎Mr. Chell’s client was a resident of Alberta when in fact such client was a resident of Ontario. Mr. ‎Chell knew or ought to have known that it contained a misstatement of fact in that regard; ‎
     
  during the period of the summer, 1996 to and including May 1997, Mr. Chell’s day to day involvement ‎as the president and chairman of Coffee.Com Interactive Café Corp. (“Coffee.Com”) as well as ‎being a shareholder was not disclosed to Mr. Chell’s employer;‎
     
  further, Mr. Chell purchased securities offerings via private placement by Coffee.Com for certain of ‎his clients without fully disclosing his involvement with that company to such clients; ‎

 

38
 

 

  on or about March 18 and June 19, 1996, Mr. Chell executed purchase of securities for Ontario ‎residents. At the time of such purchases, Mr. Chell knew or ought to have known that he was not ‎registered in the province of Ontario; ‎
     
  during the summer of 1996, Mr. Chell represented to the ASE that certain purchasers of securities ‎offered via private placement were close friends and business associates when he knew or ‎ought to have known that such representations were untrue; and ‎
     
  during the period of June 19, 1996 and to and including May 1, 1997, Mr. Chell failed to obtain the ‎prior approval of his employer for advertisements and sales literature distributed by Mr. Chell ‎regarding Coffee.Com.‎

 

Conflicts of Interest

 

There are potential conflicts of interest to which the directors and officers of Draganfly will be subject to ‎in connection with the operations of Draganfly. In particular, certain of the directors and officers of ‎Draganfly are involved in managerial or director positions with other companies whose operations may, ‎from time to time, be in direct competition with those of Draganfly or with entities which may, from time ‎to time, provide financing to, or make equity investments in, competitors of Draganfly. ‎

 

In accordance with the applicable corporate and securities legislation, directors who have a material ‎interest or any person who is a party to a material contract or a proposed material contract with ‎Draganfly are required, subject to certain exceptions, to disclose that interest and generally abstain from ‎voting on any resolution to approve the contract. In addition, the directors are required to act honestly ‎and in good faith with a view to the best interests of Draganfly. Certain of the directors and each of the ‎executive officers of Draganfly have either other employment or other business or time restrictions ‎placed on them and accordingly, these directors of Draganfly will only be able to devote part of their ‎time to the affairs of Draganfly. To the extent that conflicts of interest arise, such conflicts will be ‎resolved in accordance with the provisions of the applicable corporate law.‎

 

6.B. Compensation

 

Summary Compensation Table

 

For the year ended December 31, 2023 our directors and executive officers received compensation for services, as follows:

 

                  

Non-Equity Incentive Plan Compensation

(C$)

             

Name and

Principal Position

  Year  

Salary

($)

  

Share-

Based Awards

($)(1)(2)

  

Option-

Based Awards

($)(3)(4)

  

Annual

Incentive

Plans(5)

  

Long-

Term

Incentive

Plans

  

Pension

Value

($)

  

All Other

Compen-

sation

($)(6)

  

Total

Compen-

sation

($)

 

Cameron Chell(8)

Chairman, CEO and Director

  2023    557,083    287,020   Nil   Nil   Nil   Nil    Nil    844,103 

Paul Sun

CFO

  2023    321,496    144,640   Nil   Nil   Nil   Nil    Nil    466,136 

Scott Larson(8)

President and Director

  2023    205,732    49,720   Nil   Nil   Nil   Nil    70,129(7)   368,475 

Olen Aasen

Director

  2023    Nil    49,720   Nil   Nil   Nil   Nil    80,071(7)   129,791 

Denis Silva

Director

  2023    Nil    49,720   Nil   Nil   Nil   Nil    60,110(7)   109,830 

Andrew Hill Card, Jr

Director

  2023    Nil    49,720   Nil   Nil   Nil   Nil    60,476(7)   110,197 

John M. Mitnick

Director

  2023    Nil    49,720   Nil   Nil   Nil   Nil    90,715(7)   140,435 

Julie Myers Wood

Director

  2023    Nil    49,720   Nil   Nil   Nil   Nil    60,477(7)   110,197 

Paul Mullen

COO

  2023    362,361    135,600   Nil   Nil   Nil   Nil    Nil    497,961 

Deborah Greenberg

Chief Legal and Corporate Services Officer

  2023    361,538    162,720   Nil   Nil   Nil   Nil    Nil    524,258 

 

39
 

 

Notes:‎

 

(1) ‎”Share-Based Award” means an award under an equity incentive plan of equity-based instruments that do not ‎have option-like features, including, for greater certainty, common shares, restricted shares, restricted share ‎units, deferred share units, phantom shares, phantom share units, common share equivalent units and stock.‎
(2) Based on the number of restricted share units (“RSUs”) granted multiplied by the market price of the underlying Common Shares on the ‎grant date. This methodology was chosen in order to be consistent with industry.
(3) ‎”Option-Based Award” means an award under an equity incentive plan of options, including, for greater certainty, ‎share options, share appreciation rights and similar instruments that have option-like features.‎ See also “Item ‎6.E. Share Ownership”.
(4) This does not represent cash paid to the individual. This figure is based on the grant date fair value of such stock options of the Company (“Options”). The grant date fair value was determined in accordance with IFRS. This methodology was chosen in order to be consistent with the accounting fair value used by the Company in its financial statements and since the Black-Scholes option pricing model is a commonly used methodology for valuing options which provides an objective and reasonable estimate of fair value. The key assumptions of this valuation include current market price of the stock, exercise price of the option, option term, risk-free interest rate, dividend yield of stock and volatility of stock return. Calculating the value of stock options using the Black-Scholes option pricing model is very different from a simple “in-the-money” value calculation. In fact, stock options that are well out-of-the-money can still have a significant “grant date fair value” based on a Black-Scholes option pricing model, especially where, as in the case of the Company, the price of the share underlying the option is highly volatile. Accordingly, caution must be exercised in comparing grant date fair value amounts with cash compensation or an in-the-money option value calculation.‎
(5) ‎Represents annual cash bonus awards that are declared and paid annually. The Company does not have a formal ‎bonus plan and the amount of bonuses paid is not set in relation to any formula or specific criteria but is ‎a result of a subjective determination by the Compensation Committee and the Board. As of March 27, 2024, the annual cash bonus awards for the executive officers of the Company for the year ended December ‎‎31, 2023 have not been determined or approved by the Board.‎
(6) This amount represents the aggregate amount of perquisites paid to the ‎individual.
(7) This amount represents director’s fees paid to such director.
(8) Mr. Chell did not receive any additional compensation for serving as director of the Corporation. Mr. Chell and Mr. Larson did receive consulting fees in connection with their roles as Officers of the Company, included above in the Salary amount.

 

6.C. Board Practices

 

All of our directors are elected at the annual general meeting of our shareholders and each holds such office until his or her successor is elected or appointed, unless his or her office is earlier vacated by way of the director’s resignation or death or under any of the relevant provisions of our Articles or the BCBCA.

 

Employment, Consulting and Directors’ Service Contracts

 

The Company is not a party to any contract, agreement, plan or arrangement that provides for ‎‎payments to a director or executive officer at, following or in connection with any termination (whether ‎‎voluntary, involuntary or constructive), resignation, retirement, a change in control of the Company, its ‎‎subsidiaries or affiliates or a change in a director or executive officer responsibilities, other than as ‎‎described below.‎

 

40
 

 

The Company’s consulting agreement, as amended, (the “Chell Consulting Agreement”) with 1502372 ‎Alberta Ltd. (the “Consultant”) and Cameron Chell requires the Company to pay monthly fees of ‎C$35,416.67 (amounting to C$425,000 annually) for the provision by of executive services by the Consultant ‎to the Company, and in this regard, has Cameron Chell hold the position of President and Chief Executive ‎Officer of the Company and contains the following provisions: (a) where termination notice is given by the ‎Company, other than for certain specified reasons as set out in the Chell Consulting Agreement, the ‎Company shall give the Consultant at least 60 days’ advance notice in writing; and (b) where termination is ‎given by the Consultant, the Consultant shall give the Company 60 days’ advance notice in writing. If the ‎Chell Consulting Agreement is terminated pursuant to either (a) or (b) above, then the Consultant will be ‎entitled to the fees earned to the effective date of termination and any expenses incurred on behalf of the ‎Company prior to the effective date of termination which are otherwise reimbursable by the Company ‎pursuant to the terms of the Chell Consulting Agreement. The Consultant is also entitled a bonus as ‎determined by the Compensation Committee equal to 100% of the Consultant annual fees. The Consultant is ‎a private company controlled by Cameron Chell. During the year ended December 31, 2021, the Company ‎and the Consultant entered into an amending agreement to the Chell Consulting Agreement to increase the ‎monthly fees from US$14,166.67 (amounting to US$170,000 annually) to C$35,416.67 (amounting to ‎C$425,000 annually). During the year ended December 31, 2022 the Company and the Consultant entered ‎into an additional amending agreement appointing Mr. Chell as President of the Company and expanding ‎the scope of the services to reflect this new role. ‎

 

The Company’s consulting agreement, (the “Larson Consulting Agreement”) with Scott Larson, which supersedes and replaces all previous agreements between Mr. Larson and the Company, requires the ‎Company pay (a) an hourly fee of $350, plus applicable taxes, and (b) as determined by the Company, an ‎annual success fee, for corporate development, operational and financial related services. The Larson ‎Consulting Agreement may be terminated by Mr. Larson upon giving the Company sixty (60) days advance ‎notice in writing, or by the Company by giving Mr. Larson four (4) months advance notice in writing or pay in ‎lieu thereof.

 

The Company’s employment agreement, as amended, (the “Sun Agreement”) with Paul Sun requires the ‎Company pay (a) an annual base salary of C$220,000 and (b) as determined by the Company’s ‎Compensation Committee, an annual bonus of up to the base salary, for the provision of executive services ‎as Chief Financial Officer to the Company. If the Sun Agreement is terminated by the Company without just ‎cause, Mr. Sun will be entitled to remuneration in the amount equal the base salary and Mr. Sun’s last bonus ‎earned divided by 12 and multiplied by six. Mr. Sun is also entitled to receive a lump sum payment equal to ‎‎18 months of his base salary and average bonus upon a change of control of the Company. During the year ‎ended December 31, 2021, the Company and Mr. Sun entered into an amending agreement to the Sun ‎Agreement to increase the annual base salary from C$150,000 to C$220,000. During the year ended ‎December 31, 2022, the Company and Mr. Sun entered into an additional amending agreement to the Sun ‎Agreement to increase the annual base salary from C$220,000 to C$250,000 and awarded Mr. Sun a ‎discretionary performance bonus determined by the Compensation Committee with regard to certain ‎milestones and achievements.‎ During the year ended ‎December 31, 2023, the Company and Mr. Sun entered into an additional amending ‎agreement to the Sun ‎Agreement to increase the annual base salary from C$250,000 to C$267,000 and awarded ‎Mr. Sun a ‎discretionary performance bonus determined by the Compensation Committee with regard to certain ‎‎milestones and achievements.‎

 

The Company’s employment agreement, as amended, (the “Mullen Agreement”) with Paul Mullen requires ‎the Company to pay (a) an annual base salary of C$210,000 and (b) as determined by the Company’s ‎Compensation Committee, an annual bonus, for the provision of executive services as Chief Operating ‎Officer to the Company. If the Company terminates the Mullen Agreement without cause, Mr. Mullen is ‎entitled to severance equaling to the his annual salary earned to the date of cessation of employment, all ‎earned but unpaid bonus payment, any outstanding vacation and reimbursement of final expenses, and an ‎additional lump sum payment equaling to three (3) months salary. If Mr. Mullen is terminated without cause ‎within twelve (12) months of a change of control, then Mr. Mullen is entitled to a lump sum payment equal to ‎twelve (12) months of his annual salary and average performance bonus.‎ During the year ended ‎December 31, 2023, the Company and Mr. Mullen entered into an amending agreement to ‎the Mullen ‎Agreement to increase the annual base salary from C$210,000 to C$250,000 and awarded Mr. Mullen ‎a ‎discretionary performance bonus determined by the Compensation Committee with regard to certain ‎milestones ‎and achievements.‎

 

41
 

 

The Company’s employment agreement, as amended, (the “Greenberg Agreement”) with Deborah ‎Greenberg requires the Company to pay (a) an annual base salary of C$275,000 and (b) as determined by ‎the Company’s Compensation Committee, an annual bonus, for the provision of executive services as Chief ‎Legal and Corporate Services Officer to the Company. If the Greenberg Agreement is terminated by the ‎Company without just cause, Ms. Greenberg will be entitled to remuneration in the amount equal the base ‎salary and Ms. Greenberg’s last bonus payable on a pro-rata basis. Mrs. Greenberg is also entitled to ‎receive a lump sum payment equal to 18 months of her base salary and the greater of her targeted annual ‎performance bonus multiplied by a factor of 1.5 or the average performance bonus paid to her over the two ‎year period to the change of control of the Company. During the year ended ‎December 31, 2023, the Company and Ms. Greenberg entered into an amending agreement ‎to the Greenberg ‎Agreement to increase the annual base salary from C$275,000 to C$300,000 and awarded Ms. ‎Greenberg a ‎discretionary performance bonus determined by the Compensation Committee with regard to certain ‎‎milestones and achievements.‎

 

Audit Committee

 

The Audit Committee is a committee of the Board to which the Board delegates its responsibility for oversight of the financial reporting process. The Audit Committee is also responsible for managing, on behalf of our shareholders, the relationship between the Company and the external auditor.

 

Pursuant to National Instrument 52-110 – Audit Committees of the Canadian Securities Administrators‎ (“NI 52-110”), the Company is required to disclose certain information with respect to its Audit Committee, as summarized below.

 

Audit Committee Terms of Reference

 

The Company must, pursuant to NI 52-110, have a written charter which sets out the duties and ‎responsibilities of its Audit Committee. The terms of reference of the Audit Committee are attached ‎hereto as Exhibit 15.2.‎

 

Audit Committee Composition

 

The following are the members of the Audit Committee:‎

 

Olen Aasen(1)   Independent(2)   Financially Literate(2)
Julie Myers Wood   Independent(2)   Financially Literate(2)
John M. ‎Mitnick   Independent(2)   Financially Literate(2)

 

Notes:

 

  (1) Chairman of the Audit Committee.
  (2) As defined by NI 52-110.

 

Relevant Education and Experience

 

All members of the Audit Committee have been either directly involved in the preparation of the financial statements, filing of quarterly and annual financial statements, dealing with auditors, or as a member of the Audit Committee. All members have the ability to read, analyze and understand the complexities surrounding the issuance of financial statements.

 

Olen Aasen

 

Mr. Aasen is a corporate and securities lawyer with more than 17 years of experience in corporate, ‎securities ‎and regulatory matters. He has been the Corporate Secretary, General Counsel or Vice ‎President, Legal at ‎various Canadian and U.S. listed companies. Mr. Aasen obtained a J.D. from the ‎University of British ‎Columbia in 2006 and was called to the British Columbia Bar in 2007. Mr. Aasen was ‎also appointed to the ‎‎2016 Legal 500 GC Powerlist for Canada‎.‎

 

42
 

 

Julie Myers Wood

 

Ms. Myers was appointed by President Bush to serve as Assistant Secretary of Homeland Security for Immigration and Customs Enforcement (ICE). Previously, Ms. Myers worked for the Office of Independent Counsel under Kenneth Starr and was appointed Assistant Secretary for Export Enforcement at the Department of Commerce. She currently is CEO for Guidepost Solutions, LLC, a leading investigative and compliance consulting firm where she leads a global team of investigators, experienced security and technology consultants, and compliance and monitoring experts across a multitude of industries including government and public service agencies.

 

John M. ‎Mitnick

 

Mr. Mitnick is an American attorney with 34 years of experience serving at the highest levels of government and the private sector. From February 2018 until September 2019, he served as the General Counsel of the U.S. Department of Homeland Security (DHS), having been confirmed for that position unanimously by the U.S. Senate. From March 2014 to February 2018, he served as Senior Vice President, General Counsel, and Secretary of The Heritage Foundation, an influential think tank, and from November 2007 to April 2013, he served as Vice President, General Counsel, and Secretary of a Raytheon division with more than US$3 billion in annual sales, more than 9,000 employees, and business operations in more than 40 countries and on all continents. Mr. Mitnick has also served on the Board of Directors of Valaurum, Inc., a private mint, from March 2016 to February 2018 and since October 2019. He received his Juris Doctor degree from the University of Virginia School of Law and a Bachelor of Arts degree in Jurisprudence from the University of Oxford. He also holds a Bachelor of Arts degree in History and Political Science (summa cum laude) from Emory University.

 

Reliance on Certain Exemptions

 

At no time since the commencement of the Company’s financial year ended December 31, 2023, has the ‎Company relied on any exemption from NI 52-110, including Section 2.4 of NI 52-110 (De Minimis Non-‎Audit Services), or an exemption granted under Part 8 of NI 52-110.‎

 

The Company has relied upon the exemption provided by section 6.1 of NI 52-110 which exempts ‎venture issuers from the requirement to comply with the restrictions on the composition of its Audit ‎Committee‎.

 

Audit Committee Oversight

 

At no time since the commencement of the Company’s most recently completed financial year was a recommendation of the Audit Committee to nominate or compensate an external auditor not adopted by the Board.

 

Pre-Approval Policies and Procedures

 

The Audit Committee is authorized by the Board to review the performance of the Company’s external ‎auditors and approve in advance provision of services other than auditing and to consider the ‎independence of the external auditors, including reviewing the range of services provided in the context ‎of all consulting services bought by the Company. The Audit Committee is authorized to approve any ‎non-audit services or additional work which the Chairman of the Audit Committee deems as necessary ‎who will notify the other members of the Audit Committee of such non-audit or additional work‎.

 

External Auditor Service Fees

 

See “Item 16C. Principal Accountant Fees and Services”‎.

 

Compensation Committee

 

The Compensation Committee is responsible for ensuring that the Company has appropriate procedures for ‎reviewing executive compensation and making recommendations to the Board with respect to the ‎compensation of the Company’s executive officers. The Compensation Committee seeks to ensure that ‎total compensation paid to all executive officers is fair and reasonable and is consistent with the ‎Company’s compensation philosophy.

43
 

 

The Compensation Committee is also responsible for recommending compensation for the directors, as well ‎as stock option (“Option”) grants, and restricted share unit (“RSU”) grants to the directors, officers, ‎employees and consultants pursuant to the Company’s share compensation plans. The Share ‎Compensation Plan (as defined below) assists the Company in employee retention and cash preservation, ‎while encouraging Common Share ownership and entrepreneurship on the part of the Company’s NEOs.

 

The Compensation Committee consists of Scott Larson (Chair), Olen Aasen and Denis Silva, all of whom ‎were affirmatively determined by the Board to be independent (outside, non-management) directors, other ‎than Scott Larson, the former President of the Company. The Board is satisfied that the composition of the ‎Compensation Committee ensures an objective process for determining compensation. Each member of the ‎Committee has direct experience relevant to their responsibilities on the Committee, including acting as ‎officers and directors of other publicly traded companies so that they are familiar with remuneration for ‎companies within the Company’s peer group.‎

 

6.D. Employees

 

As at December 31, 2023, the Company had fifty four employees (fifty employees located in Canada and four employees located in the U.S.) and two full-‎time and two part-time consultants whose ‎services were, and continue to be, used on a regular basis for day-‎to-day operations.

 

6.E. Share Ownership

 

The following table sets out the number of Common Shares, Options and RSUs owned or over which control or direction is exercised by each our directors and executive officers and, where known after reasonable enquiry, by their respective associates or affiliates as at February 15, 2024.

 

Name and position 

Number

and

Percentage

of

Common

Shares(1)

 

Type of

‎compensation

security

 

Number of‎

compensation‎

securities‎

  

Date of issue
or grant

 

Issue,

‎conversion

or exercise

price ($)

   Expiry Date(2) 

Cameron Chell

Chairman, CEO and Director

  168,216
(0.33%)
  Options
RSUs
RSUs
   

50,000

13,334(3)

169,334

   October 30, 2019
September 3, 2021
May 29, 2023
   2.50
3.87
1.13
  

October 30, 2029

September 3, 2024

March 20, 2025

 

Paul Sun

CFO

  235,851
(0.46%)
  Options
RSUs
RSUs
   33,333
10,000
85,334
   October 30, 2019
September 3, 2021
May 29, 2023
   2.50
3.87
1.13
  

October 30, 2029

September 3, 2024

March 20, 2025

 

Scott Larson

President and Director

  49,986
(0.10%)
  Options
Options
RSUs
RSUs
   50,000
100,000
23,334
29,334
   October 30, 2019
July 3, 2020
September 3, 2021
May 29, 2023
   2.50
3.20
3.87
1.13
  

October 30, 2029

July 3, 2025

September 3, 2024

March 20, 2025

 

Olen Aasen

Director

  39,173
(0.08%)
  Options
RSUs
   16,667
29,334
   October 30, 2019
May 29, 2023
   2.50
1.13
  

October 30, 2029

March 20, 2025

 

Denis Silva

Director

  85,208
(0.17%)
  Options
RSUs
   16,667
29,334
   October 30, 2019
May 29, 2023
   2.50
1.13
  

October 30, 2029

March 20, 2025

 

Andrew Hill Card, Jr

Director

  167,189
(0.33%)
  Options
RSUs
   50,000
29,334
   October 30, 2019
May 29, 2023
   2.50
1.13
  

October 30, 2029

March 20, 2025

 

John M. Mitnick

Director

  170,601
(0.34%)
  Options
RSUs
   50,000
29,334
   November 19, 2019
May 29, 2023
   2.50
1.13
  

November 19, 2029

March 20, 2025

 

Julie Myers Wood

Director

  83,275
(0.16%)
  Options
Options
RSUs
RSUs
   30,000
25,826
8,609
29,334
   April 30, 2020
September 9, 2021
September 9, 2021
May 29, 2023
   3.85
4.84
4.84
1.13
  

April 30, 2030

September 9, 2026

September 9, 2024

March 20, 2025

 

Paul Mullen

COO

  102,072
(0.20%)
  Options
RSUs
RSUs
   10,000
3,334
80,000
   April 27, 2021
April 27, 2021
May 29, 2023
   10.15
10.15
1.13
   April 27, 2031
April 30, 2024
March 20, 2025
 

Deborah Greenberg

Chief Legal and Corporate Services Officer

  111,561
(0.22%)
  RSUs   96,000   May 29, 2023   1.13   March 20, 2025 

 

44
 

 

Notes:

 

(1)Percentages based on 50,893,221 Common Shares issued and outstanding as of ‎February 15, 2024. The numbers of shares in this column are derived from Canada’s System for Electronic Disclosure by Insiders (“SEDI”).‎
(2)In connection with the RSUs, the dates represent the last vesting dates.
(3)This number represents the balance of unvested RSUs issued to 1502372 Alberta Ltd., a corporation wholly owned by Cameron Chell.

 

Share Compensation Plan

 

The Board has previously adopted the Share Compensation Plan that provides for the granting of Options and RSUs on such terms and conditions as prescribed by the Share Compensation Plan. The Share Compensation Plan is a “rolling” plan, pursuant to which the maximum number of Common Shares issuable under the Share Compensation Plan and any other share compensation arrangement of the Company including the RSUs that may be awarded under the Share Compensation Plan, is 20% of the Common Shares then issued and outstanding. The Share Compensation Plan was adopted effective August 19, 2019 and amended effective April 14, 2021.

 

The Share Compensation Plan provides participants (each, a “Participant”), who may include participants who are citizens or residents of the United States (each, a “US Participant”), with the opportunity, through RSUs and Options, to acquire an ownership interest in the Company. The RSUs will rise and fall in value based on the value of the Common Shares. Unlike the Options, the RSUs will not require the payment of any monetary consideration to the Company. Instead, each RSU represents a right to receive one Common Share following the attainment of vesting criteria determined at the time of the award. See “Restricted Share Units – Vesting Provisions” below. The Options, on the other hand, are rights to acquire Common Shares upon payment of monetary consideration (i.e., the exercise price), subject also to vesting criteria determined at the time of the grant. See “Options – Vesting Provisions” below.

 

Purpose of the Share Compensation Plan

 

The stated purpose of the Share Compensation Plan is to advance the interests of the Company and its subsidiaries, and its shareholders by: (a) ensuring that the interests of Participants are aligned with the success of the Company and its subsidiaries; (b) encouraging stock ownership by such persons; and (c) providing compensation opportunities to attract, retain and motivate such persons.

 

Eligible Persons

 

The following people are eligible to participate in the Share Compensation Plan: any officer or employee of the Company or any officer or employee of any subsidiary of the Company and, solely for purposes of the grant of Options, any director of the Company or any director of any subsidiary of the Company, and any Consultant (defined under the Share Compensation Plan as an individual (other than an employee or a director of the Company) or a corporation that is not a U.S. Person that: (a) is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Company or to an affiliate of the Company, other than services provided in relation to an offer or sale of securities of the Company in a capital raising transaction, or services that promote or maintain a market for the Company’s securities; (b) provides the services under a written contract between the Company or the affiliate and the individual or the Company, as the case may be; (c) in the reasonable opinion of the Company, spends or will spend a significant amount of time and attention on the affairs and business of the Company or an affiliate of the Company; and (d) has a relationship with the Company or an affiliate of the Company that enables the individual to be knowledgeable about the business and affairs of the Company.

 

45
 

 

Administration of the Share Compensation Plan

 

The Share Compensation Plan is administered by the Board or such other persons as may be designated by the Board (the “Administrators”) based on the recommendation of the Board or the compensation committee of the Board, if applicable. The Administrators determine the eligibility of persons to participate in the Share Compensation Plan, when RSUs and Options will be awarded or granted, the number of RSUs and Options to be awarded or granted, the vesting criteria for each award of RSUs and grant of Options and all other terms and conditions of each award and grant, in each case in accordance with applicable securities laws and the requirements of the CSE and the Nasdaq.

 

Restrictions on the Award of RSUs and Grant of Options

 

The awards of RSUs and grants of Options under the Share Compensation Plan is subject to a number of restrictions:

 

  (a) the total number of Common Shares issuable to insiders under the Share Compensation Plan and any other share compensation arrangements of the Company cannot exceed 20% of the Common Shares then outstanding; and
     
  (b) the aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of Common Shares issued during any consecutive 12 month period will not exceed the greatest of the following: (i) US$1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the Common Shares, measured at the Company’s most recent balance sheet date.

 

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of the Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may in their sole discretion make such changes or adjustments, if any, as the Administrators consider fair or equitable to reflect such change or event including, without limitation, adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

Restricted Share Units

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for RSUs

 

RSUs awarded to Participants under the Share Compensation Plan are credited to an account that is established on their behalf and maintained in accordance with the Share Compensation Plan. After the relevant date of vesting of any RSUs awarded under the Share Compensation Plan, a Participant shall be entitled to receive and the Company shall issue or pay (at its discretion): (i) a lump sum payment in cash equal to the number of vested RSUs recorded in the Participant’s account multiplied by the volume weighted average price of the Common Shares traded on the CSE for the five (5) consecutive trading days prior to the payout date; (ii) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s RSUs in the Participant’s account will be, duly issued as fully paid and non assessable shares and such Participant shall be registered on the books of the Company as the holder of the appropriate number of Common Shares; or (iii) any combination of thereof.

 

46
 

 

Vesting Provisions

 

The Share Compensation Plan provides that: (i) at the time of the award of RSUs, the Administrators will determine the vesting criteria applicable to the awarded RSUs; (ii) vesting of RSUs may include criteria such as performance vesting; (iii) each RSU shall be subject to vesting in accordance with the terms set out in an agreement evidencing the award of the RSU attached as Exhibit A to the Share Compensation Plan (or in such form as the Administrators may approve from time to time) (each an “RSU Agreement”); and (iv) all vesting and issuances or payments in respect of an RSU shall be completed no later than December 15 of the third calendar year commencing after the award date for such RSU.

 

It is the current intention that RSUs may be awarded with both time-based vesting provisions as a component of the Company’s annual incentive compensation program, and performance based vesting provisions as a component of the Company’s long term incentive compensation program.

 

Under the Share Compensation Plan, should the date of vesting of an RSU fall within a blackout period or within nine business days following the expiration of a blackout period, the date of vesting will be automatically extended to the tenth business day after the end of the blackout period.

 

Termination, Retirement and Other Cessation of Employment in connection with RSUs

 

A person participating in the Share Compensation Plan will cease to be eligible to participate in the following circumstances: (i) receipt of any notice of termination of employment or service (whether voluntary or involuntary and whether with or without cause); (ii) retirement; and (iii) any cessation of employment or service for any reason whatsoever, including disability and death (an “Event of Termination”). In such circumstances, any vested RSUs will be issued (and with respect to each RSU of a US Participant, such RSU will be settled and shares issued as soon as practicable following the date of vesting of such RSU as set forth in the applicable RSU Agreement, but in all cases within 60 days following such date of vesting; and unless otherwise determined by the Administrators in their discretion, any unvested RSUs will be automatically forfeited and cancelled (and with respect to any RSU of a US Participant, if the Administrators determine, in their discretion, to waive vesting conditions applicable to an RSU that is unvested at the time of an Event of Termination, such RSU shall not be forfeited or cancelled, but instead will be deemed to be vested and settled and shares delivered following the date of vesting date of such RSU as set forth in the applicable RSU Agreement). Notwithstanding the above, if a person retires in accordance with the Company’s retirement policy at such time, the pro rata portion of any unvested performance based RSUs will not be forfeited or cancelled and instead shall be eligible to become vested in accordance with the vesting conditions set forth in the applicable RSU Agreement after such retirement (as if retirement had not occurred), but only if the performance vesting criteria, if any, have been met on the applicable date. For greater certainty, if a person is terminated for just cause, all unvested RSUs will be forfeited and cancelled.

 

Options

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for Options

 

Each Option granted pursuant to the Share Compensation Plan will entitle the holder thereof to the issuance of one Common Share upon achievement of the vesting criteria and payment of the applicable exercise price. Options granted under the Share Compensation Plan will be exercisable for Common Shares issued from treasury once the vesting criteria established by the Administrators at the time of the grant have been satisfied. However, the Company will continue to retain the flexibility through the amendment provisions in the Share Compensation Plan to satisfy its obligation to issue Common Shares by making a lump sum cash payment of equivalent value (i.e., pursuant to a cashless exercise), provided there is a full deduction of the number of underlying Common Shares from the Share Compensation Plan’s reserve.

 

47
 

 

Vesting Provisions

 

The Share Compensation Plan provides that the Administrators may determine when any Option will become exercisable and may determine that Options shall be exercisable in instalments or pursuant to a vesting schedule. The Option agreement will disclose any vesting conditions prescribed by the Administrators.

 

Termination, Retirement and Other Cessation of Employment in connection with Options

 

A person participating in the Share Compensation Plan will cease to be eligible to participate where there is an Event of Termination. In such circumstances, unless otherwise determined by the Administrators in their discretion, any unvested Options will be automatically cancelled, terminated and not available for exercise and any vested Options may be exercised only before the earlier of: (i) the termination of the Option; and (ii) six months after the date of the Event of Termination. If a person is terminated for just cause, all Options (whether or not then exercisable) will be automatically cancelled.

 

Other Terms

 

The Administrators will determine the exercise price and term/expiration date of each Option, provided that the exercise price in respect of that Option shall not be less than the Market Price on the date of grant. “Market Price” is defined in the Share Compensation Plan, as of any date, the closing price of the Common Shares on the CSE for the last market trading day prior to the date of grant of the Option or if the Common Shares are not listed on a stock exchange, the Market Price shall be determined in good faith by the Administrators.

 

No Option shall be exercisable after ten years from the date the Option is granted. Under the Share Compensation Plan, should the term of an Option expire on a date that falls within a blackout period or within nine business days following the expiration of a blackout period, such expiration date will be automatically extended to the tenth business day after the end of the blackout period.

 

Unless otherwise determined by the Board, in the event of a change of control, any surviving or acquiring corporation shall assume any Option outstanding under the Share Compensation Plan on substantially the same economic terms and conditions or substitute or replace similar options for those Options outstanding under the Share Compensation Plan on substantially the same economic terms and conditions.

 

Transferability

 

RSUs awarded and Options granted under the Share Compensation Plan or any rights of a Participant cannot be transferred, assigned, charged, pledged or hypothecated, or otherwise alienated, whether by operation of law or otherwise.

 

Reorganization and Change of Control Adjustments

 

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may make such changes or adjustments, if any, as they consider fair or equitable, to reflect such change or event including adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

48
 

 

Amendment Provisions in the Share Compensation Plan

 

The Board may amend the Share Compensation Plan or any RSU or Option at any time without the consent of any Participant provided that such amendment shall:

 

  (a) not adversely alter or impair any RSU previously awarded or any Option previously granted, except as permitted by the adjustment provisions of the Share Compensation Plan and with respect to RSUs and Options of US Participants;
     
  (b) be subject to any regulatory approvals including, where required, the approval of the CSE or the Nasdaq; and
     
  (c) be subject to shareholder approval, where required, by the requirements of the CSE or the Nasdaq, provided that shareholder approval shall not be required for the following amendments:

 

  (i) amendments of a “housekeeping nature”, including any amendment to the Share Compensation Plan or ‎a RSU or Option that is necessary to comply with ‎applicable laws, tax or accounting provisions or the requirements of any ‎regulatory authority or Exchange and any amendment to the Share Compensation Plan or a ‎RSU or Option to correct or rectify any ambiguity, ‎defective provision, error or omission therein, including any amendment to ‎any definitions therein;‎
     
  (ii) amendments that are necessary or desirable for RUS or ‎Options to qualify for favourable treatment under any applicable tax law;‎
     
  (iii) a change to the vesting provisions of any RSU or any Option ‎‎(including any alteration, extension or acceleration thereof);‎
     
  (iv) a change to the termination provisions of any Option or RSU ‎‎(for example, relating to termination of employment, resignation, ‎retirement or death) that does not entail an extension beyond the original ‎expiration date;‎

 

  (v) the introduction of features to the Share Compensation Plan that would permit the Company to, ‎instead of issuing Common Shares from treasury upon the vesting of the ‎RSUs, retain a broker and make payments for the benefit ‎of Participants to such broker who would purchase Common Shares in ‎the open market for such Participants; ‎
     
  (vi) the amendment of the Share Compensation Plan as it relates to making lump sum payments to ‎Participants upon the vesting of the RSUs;‎ and
     
  (vii) the amendment of the cashless exercise feature set out in the Share Compensation Plan.

 

  (d) ‎be subject to disinterested shareholder approval in the event of any reduction in ‎the exercise price of any Option granted under the Share Compensation Plan to an insider Participant‎.

 

For greater certainty, shareholder approval will be required in circumstances where an amendment to the Share Compensation Plan would:

 

  (a) increase the fixed maximum percentage of issued and outstanding Common Shares issuable under the Share Compensation Plan, other than by virtue of the adjustment provisions in the Share Compensation Plan, or change from a fixed maximum percentage of issued and outstanding Common Shares to a fixed maximum number of Common Shares;
     
  (b) increase the limits referred to above under “Restrictions on the Award of RSUs and Grant of Options”;
     
  (c) reduce the exercise price of any Option (including any cancellation of an Option for the purpose of reissuance of a new Option at a lower exercise price to the same person);

 

49
 

 

  (d) extend the term of any Option beyond the original term (except if such period is being extend by virtue of a blackout period); or
     
  (e)

amend the amendment provisions in Section 6.4 of the Share Compensation Plan.

 

6.F. Action to Recover Erroneously Awarded Compensation

 

Not Applicable.

 

Item 7. Major Shareholders and Related Party Transactions

 

7.A. Major Shareholders

 

To the knowledge of the Board and executive officers of the Company, other than as disclosed below, as at March 27, 2024 no persons or ‎companies beneficially own, directly or indirectly or exercise control or direction over shares carrying 5% or ‎more of the voting rights attached to all outstanding shares of the Company‎. No holder of common shares has different voting rights from any other holders of common shares.

 

Armistice Capital, LLC and Steven Boyd (collectively “Armistice”) reported on a Schedule 13-G, filed with the SEC on February 14, 2024, that they were the beneficial owner of 4,938,978 shares, representing 9.99% of the Company’s common shares.

 

7.B. Related Party Transactions

 

Key management personnel include those persons having authority and responsibility for planning, directing and ‎controlling the activities of the Company as a whole. The Company has determined that key management personnel ‎consist of members of the Company’s Board of Directors and corporate officers.‎

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2023, the company incurred fees of $429,766 (December 31, 2022 - $442,485) which are included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $3,780 (December 31, 2022 - $30,804).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2023, the Company incurred fees of $592,500 (December 31, 2022 - $566,487) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $35,417 (December 31, 2022 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2023, the Company incurred fees of $215,019 (December 31, 2022 - $383,288) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $9,287 (December 31, 2022 - $20,745).

 

Trade payables and accrued liabilities

 

As at December 31, 2023, the Company had $nil (December 31, 2022 - $nil) receivable from related parties ‎outstanding that were included in accounts receivable and $190,664 (December 31, 2022 - $51,549) payable to related ‎parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on ‎demand.‎

 

50
 

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. ‎Compensation awarded to key management for the years ended December 31, 2023, 2022, and 2021 included:‎

 

For the year ended December 31 

2023

($)

  

2022

($)

  

2021

($)

 
Director fees   ‎600,933‎    ‎522,349‎    370,094 
Management fees paid to a company ‎controlled by CEO and director   ‎592,500‎    ‎566,487‎    290,225 
Management fees paid to a company ‎controlled by the President and ‎director   -    -    205,691 
Management fees paid to a company that the CEO holds an economic interest in   ‎429,766‎    ‎442,485‎    315,643 
Management fees paid to a company controlled by a director   ‎215,019‎    ‎383,288‎    - 
Salaries   979,154‎    ‎843,917‎    722,068 
Share-based payments   ‎1,109,232‎    ‎2,106,906‎    2,475,949 
Totals   3,926,604    4,865,432    4,379,670 

 

7.C. Interests of Experts and Counsel

 

Not applicable.

 

Item 8. Financial Information

 

The audited consolidated financial statements for the years ended December 31, 2023 and 2022 can be found under “Item 18. Financial Statements”.

 

8.B. Significant Changes

 

We are not aware of any significant change that has occurred since December 31, 2023, the date of the audited consolidated financial statements included in this Annual Report, and that has not been disclosed elsewhere in this Annual Report.

 

Item 9. The Offer and Listing.

 

9.A. Offer and Listing Details

 

The Common Shares are listed and posted for trading on the CSE under the trading symbol “DPRO”, on ‎the Nasdaq under the symbol “DPRO”, and on the Frankfurt Stock Exchange under the trading symbol “3U8A”.

 

9.B. Plan of Distribution

 

Not applicable.

 

9.C. Markets

 

A discussion of all stock exchanges and other regulated markets on which our securities are listed is provided under “Item 9.A. Offer and Listing Details.”

 

9.D. Selling Shareholders

 

Not applicable.

 

51
 

 

9.E. Dilution

 

Not applicable.

 

9.F. Expenses of the Issue

 

Not applicable.

 

Item 10. Additional Information

 

10.A. Share Capital

 

Not applicable.

 

10.B. Memorandum and Articles of Association

 

The Company was incorporated under the laws of the Province of British Columbia, Canada and was assigned the number BC1166724. The Company is governed by the BCBCA.

 

Our Articles do not contain a description of our objects and purposes.

 

Our Articles do not restrict a director’s power to vote on a proposal, arrangement or contract in which the director is materially interested, vote compensation to themselves or any other members of their body in the absence of an independent quorum or exercise borrowing powers. There is no mandatory retirement age for our directors and our directors are not required to own securities of the Company in order to serve as directors.

 

Our authorized share capital consists of an unlimited number of Common Shares of which 63,393,221 were ‎issued and ‎outstanding as of ‎‎March 26, 2024 and an unlimited number of Preferred Shares, issuable in ‎series, none of which were issued and ‎outstanding as of ‎‎March 26, 2024.

 

Each Common Share entitles the holder ‎to receive notice of and attend all meetings of the shareholders. ‎Each Common Share carries ‎the right to one vote. The ‎holders of Common Shares are entitled to receive ‎any dividends declared by the Company in respect of the ‎Common ‎Shares at such time and in such ‎amount as may be determined by the Board, in its discretion. In the event of the ‎‎liquidation, dissolution, or ‎winding up of the Company, whether voluntary or involuntary, holders of Common Shares ‎are also ‎entitled ‎to participate, rateably, in the distribution of the assets of the Company, subject to the rights of the ‎holders ‎of any other class ‎of shares ranking in priority to the Common Shares. ‎‎

 

The Preferred Shares may be issuable in series ‎and the directors may, from time to time before the issue of ‎any Preferred Shares of ‎any particular series, define and ‎attach special rights, privileges, restrictions, and ‎conditions to the Preferred Shares of any series, ‎including voting rights, ‎entitlement to dividends, and ‎redemption, conversion, and exchange rights. In the event of the liquidation, ‎dissolution, or ‎winding up of ‎the Company, whether voluntary or involuntary, holders of Preferred Shares will rank on a parity with ‎‎‎holders of the Preferred Shares of every other series and be entitled to preference over the Common ‎Shares and over ‎any other ‎shares of the Company ranking junior to the Preferred Shares.‎

 

The provisions in our Articles attaching to the Common Shares may be altered, amended, repealed, suspended or changed by the affirmative vote of the holders of not less than two-thirds of the Common Shares present in person or by proxy at any such meeting of holders.

 

Our Articles provide for our directors to hold office until the expiry of his or her term (which is stipulated to be immediately before the next election or appointment of directors at an annual general meeting of our shareholders) or until his or her successor is elected or appointed, unless their respective office is earlier vacated in accordance with our Articles or with the provisions of the BCBCA. A director appointed or elected to fill a vacancy on the Board holds office for the unexpired term of their predecessor.

 

52
 

 

An annual meeting of shareholders must be held at such time in each year that is not later than 15 months after the last preceding annual meeting and at such place as the Board may from time to time determine. The holders of not less than five percent of the issued Common Shares that carry the right to vote at a meeting may requisition our Board to call a meeting of shareholders for the purposes stated in the requisition. The quorum for the transaction of business at any meeting of shareholders is two persons who are, or represented by proxy, shareholders who, in the aggregate, hold at least 5% of the issued shares entitled to vote at the meeting. In addition to those persons who are entitled to vote at a meeting of shareholders, the only other persons entitled to be present at the meeting are the directors, the president (if any), the secretary (if any), the assistant secretary (if any), any lawyer for the Company, the auditor of the Company and any other persons invited to be present at the meeting by the directors or by the chair of the meeting and any persons entitled or required under the BCBCA or our Articles to be present at the meeting; but if any of those persons does attend the meeting, that person is not to be counted in the quorum and is not entitled to vote at the meeting unless that person is a shareholder or proxy holder entitled to vote at the meeting.

 

Except as provided in the Investment Canada Act, there are no limitations specific to the rights of non-Canadians to hold or vote the Common Shares under the laws of Canada or the Province of British Columbia, or in our charter documents.

 

Our Articles do not contain provisions that would have an effect of delaying, deferring or preventing a change in control of the Company. Our Articles do not contain any provisions that would operate only with respect to a merger, acquisition or corporate restructuring of our company.

 

Our Articles do not contain any provisions governing the ownership threshold above which shareholder ownership must be disclosed.

 

Our Articles are not significantly different from the requirements of the BCBCA and the conditions imposed by our Articles governing changes in capital are not more stringent than what is required by the BCBCA.

 

10.C. Material Contracts

 

There are no material contracts entered into by Draganfly within the two most recently completed financial ‎years, or ‎before the two most recently completed financial years but which are still in effect, other than ‎contracts entered into ‎in the ordinary course of business.

 

10.D. Exchange Controls

 

There are currently no government laws, decrees, regulations or other legislation of Canada or the United States that restrict the export or import of capital (including the availability of cash and cash equivalents) or that affect the remittance of dividends, distributions, interest or other payments to non-residents of Canada or the United States holding our Common Shares. Any remittances of dividends to United States residents and to other non-residents are, however, subject to withholding tax. See “Taxation” below.

 

10.E. Taxation

 

Certain U.S. Federal Income Tax Considerations

 

The following discussion describes the material U.S. federal income tax consequences relating to the ownership and disposition of Common Shares by U.S. Holders (as defined below). This discussion applies to U.S. Holders that hold Common Shares as capital assets (generally, property held for investment). This discussion is based on the Code, U.S. Treasury regulations promulgated thereunder and administrative and judicial interpretations thereof, all as in effect on the date hereof and all of which are subject to change, possibly with retroactive effect. This discussion does not address all of the U.S. federal income tax consequences that may be relevant to specific U.S. Holders in light of their particular circumstances or to U.S. Holders subject to special treatment under U.S. federal income tax law (such as certain financial institutions, banks, insurance companies, broker-dealers and traders in securities or other persons that generally mark their securities to market for U.S. federal income tax purposes, tax-exempt entities or government organizations, retirement plans, regulated investment companies, real estate investment trusts, certain former citizens or residents of the United States, persons who hold Common Shares as part of a “straddle,” “hedge,” “conversion transaction,” “synthetic security” or integrated investment, persons required to accelerate the recognition of any item of gross income with respect to the Common Shares as a result of such income being recognized on an applicable financial statement, persons that have a “functional currency” other than the U.S. dollar, persons that own directly, indirectly or through attribution 10% or more of the voting power or value of our shares, corporations that accumulate earnings to avoid U.S. federal income tax, partnerships and other pass-through entities (or arrangements treated as a partnership for U.S. federal income tax purposes), and investors in such pass-through entities). This discussion does not address any U.S. state or local or non-U.S. tax consequences or any U.S. federal estate, gift or alternative minimum tax consequences.

 

53
 

 

As used in this discussion, the term “U.S. Holder” means a beneficial owner of Common Shares that is, for U.S. federal income tax purposes, (1) an individual who is a citizen or resident of the United States, (2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia, (3) an estate the income of which is subject to U.S. federal income tax regardless of its source or (4) a trust (x) with respect to which a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or (y) that has elected under applicable U.S. Treasury regulations to be treated as a domestic trust for U.S. federal income tax purposes.

 

If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Common Shares, the U.S. federal income tax consequences relating to an investment in the Common Shares will depend in part upon the status and activities of such entity or arrangement and the particular partner. Any such entity or arrangement should consult its own tax advisor regarding the U.S. federal income tax consequences applicable to it and its partners of the purchase, ownership and disposition of Common Shares.

 

U.S. Holders should consult their own tax advisors as to the particular tax consequences applicable to them relating to the purchase, ownership and disposition of Common Shares, including the applicability of U.S. federal, state and local tax laws and non-U.S. tax laws.

 

Passive Foreign Investment Company Consequences

 

In general, a corporation organized outside the United States will be treated as a PFIC, for any taxable year in which either (1) at least 75% of its gross income is “passive income”, or (2) on average at least 50% of its assets, determined on a quarterly basis, are assets that produce passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things, dividends, interest, royalties, rents, and gains from the sale or exchange of property that gives rise to passive income. Assets that produce or are held for the production of passive income generally include cash, even if held as working capital or raised in a public offering, marketable securities, and other assets that may produce passive income. Generally, in determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account.

 

Based on the current and expected composition of our income and the value of our assets, we believe that we were ‎not a PFIC United States federal income tax purposes for the for the taxable year ended December 31, 2023 and ‎we expect that we will not be a PFIC for the current taxable year. Nevertheless, because our PFIC status must be ‎determined annually with respect to each taxable year and will depend on the composition and character of our ‎assets and income, including our use of proceeds from an offering of Common Shares, and the value of our assets ‎‎(which may be determined, in part, by reference to the market value of Common Shares, which may be volatile) ‎over the course of such taxable year, we may be a PFIC in any taxable year. The determination of whether we will ‎be or become a PFIC may also depend, in part, on how, and how quickly, we use our liquid assets and the cash ‎raised in an offering of Common Shares. If we determine not to deploy significant amounts of cash for active ‎purposes, our risk of being a PFIC may substantially increase. Because there are uncertainties in the application of ‎the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, ‎there can be no assurance that we will not be a PFIC for any future taxable year. In addition, it is possible that the ‎U.S. Internal Revenue Service may challenge our classification of certain income and assets as non-passive, which ‎may result in us being or becoming a PFIC in the current or subsequent years.‎

 

54
 

 

If we are a PFIC in any taxable year during which a U.S. Holder owns Common Shares, the U.S. Holder could be liable for additional taxes and interest charges under the “PFIC excess distribution regime” upon (1) a distribution paid during a taxable year that is greater than 125% of the average annual distributions paid in the three preceding taxable years, or, if shorter, the U.S. Holder’s holding period for the Common Shares, and (2) any gain recognized on a sale, exchange or other disposition, including a pledge, of the Common Shares, whether or not we continue to be a PFIC. Under the PFIC excess distribution regime, the tax on such distribution or gain would be determined by allocating the distribution or gain ratably over the U.S. Holder’s holding period for Common Shares. The amount allocated to the current taxable year (i.e., the year in which the distribution occurs or the gain is recognized) and any year prior to the first taxable year in which we are a PFIC will be taxed as ordinary income earned in the current taxable year. The amount allocated to other taxable years will be taxed at the highest marginal rates in effect for individuals or corporations, as applicable, to ordinary income for each such taxable year, and an interest charge, generally applicable to underpayments of tax, will be added to the tax.

 

If we are a PFIC for any year during which a U.S. Holder holds Common Shares, we must generally continue to be treated as a PFIC by that holder for all succeeding years during which the U.S. Holder holds the Common Shares, unless (i) we cease to meet the requirements for PFIC status and the U.S. Holder makes a “deemed sale” election with respect to the Common Shares or for the period immediately preceding our cessation in meeting the tests described above the Common Shares were subject to a mark-to-market election or (ii) the U.S. Holder makes a timely and effective “qualified electing fund” election (“QEF Election”) with respect to all taxable years during such U.S. Holder’s holding period in which the we are a PFIC. If the election is made, the U.S. Holder will be deemed to sell the Common Shares it holds at their fair market value on the last day of the last taxable year in which we qualified as a PFIC, and any gain recognized from such deemed sale would be taxed under the PFIC excess distribution regime. After the deemed sale election, the U.S. Holder’s Common Shares would not be treated as shares of a PFIC unless we subsequently become a PFIC.

 

If we are a PFIC for any taxable year during which a U.S. Holder holds Common Shares and one of our non-U.S. corporate subsidiaries is also a PFIC (i.e., a lower-tier PFIC), such U.S. Holder would be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC and would be taxed under the PFIC excess distribution regime on distributions by the lower-tier PFIC and on gain from the disposition of shares of the lower-tier PFIC even though such U.S. Holder would not receive the proceeds of those distributions or dispositions. Each U.S. Holder is advised to consult its tax advisors regarding the application of the PFIC rules to our non-U.S. subsidiaries.

 

If we are a PFIC, a U.S. Holder will not be subject to tax under the PFIC excess distribution regime on distributions or gain recognized on Common Shares if such U.S. Holder makes a valid “mark-to-market” election for our Common Shares. A mark-to-market election is available to a U.S. Holder only for “marketable stock”. Our Common Shares will be marketable stock as long as they remain listed on the Nasdaq and are regularly traded, other than in de minimis quantities, on at least 15 days during each calendar quarter. If a mark-to-market election is in effect, a U.S. Holder generally would take into account, as ordinary income each year, the excess of the fair market value of Common Shares held at the end of such taxable year over the adjusted tax basis of such Common Shares. The U.S. Holder would also take into account, as an ordinary loss each year, the excess of the adjusted tax basis of such Common Shares over their fair market value at the end of the taxable year, but only to the extent of the excess of amounts previously included in income over ordinary losses deducted as a result of the mark-to-market election. The U.S. Holder’s tax basis in Common Shares would be adjusted to reflect any income or loss recognized as a result of the mark-to-market election. Any gain from a sale, exchange or other disposition of Common Shares in any taxable year in which we are a PFIC would be treated as ordinary income and any loss from such sale, exchange or other disposition would be treated first as ordinary loss (to the extent of any net mark-to-market gains previously included in income) and thereafter as capital loss.

 

A mark-to-market election will not apply to Common Shares for any taxable year during which we are not a PFIC, but will remain in effect with respect to any subsequent taxable year in which we become a PFIC. Such election will not apply to any non-U.S. subsidiaries that we may organize or acquire in the future. Accordingly, a U.S. Holder may continue to be subject to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs that we may organize or acquire in the future notwithstanding the U.S. Holder’s mark-to-market election for the Common Shares.

 

55
 

 

A U.S. Holder who makes a QEF Election generally must report on a current basis its share of our net capital gain and ordinary earnings for any year in which were are a PFIC, whether or not we distribute any amounts to our shareholders. However, U.S. holders should be aware that there can be no assurance that we will satisfy the record keeping requirements that apply to a QEF, or that we will supply U.S. holders with information that such U.S. holders require to report under the QEF election rules, in the event that the Company is a PFIC and a U.S. holder wishes to make a QEF election.

 

Each U.S. person that is an investor of a PFIC is generally required to file an annual information return on IRS Form 8621 containing such information as the U.S. Treasury Department may require. The failure to file IRS Form 8621 could result in the imposition of penalties and the extension of the statute of limitations with respect to U.S. federal income tax.

 

The U.S. federal income tax rules relating to PFICs are very complex. U.S. Holders are strongly urged to consult their own tax advisors with respect to the impact of PFIC status on the purchase, ownership and disposition of Common Shares, the consequences to them of an investment in a PFIC, any elections available with respect to the Common Shares and the IRS information reporting obligations with respect to the purchase, ownership and disposition of Common Shares of a PFIC.

 

Distributions on the Common Shares

 

Subject to the discussion above under “— Passive Foreign Investment Company Consequences,” a U.S. Holder that receives a distribution with respect to Common Shares generally will be required to include the gross amount of such distribution (before reduction for any Canadian withholding taxes withheld therefrom) in gross income as a dividend when actually or constructively received to the extent of the U.S. Holder’s pro rata share of our current and/or accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder’s pro rata share of our current and accumulated earnings and profits, it will be treated first as a tax-free return of capital and reduce (but not below zero) the adjusted tax basis of the U.S. Holder’s Common Shares. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder’s Common Shares, the remainder will be taxed as capital gain. Because we may not account for our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should expect all distributions to be reported to them as dividends. Distributions on Common Shares that are treated as dividends generally will constitute income from sources outside the United States for foreign tax credit purposes and generally will constitute passive category income. Such dividends will not be eligible for the “dividends received” deduction generally allowed to corporate shareholders with respect to dividends received from U.S. corporations.

 

Dividends paid by a “qualified foreign corporation” are eligible for taxation in the case of non-corporate U.S. Holders at a reduced long-term capital gains rate rather than the marginal tax rates generally applicable to ordinary income provided that certain requirements are met. Each non-corporate U.S. Holder is advised to consult its tax advisors regarding the availability of the reduced tax rate on dividends with regard to its particular circumstances.

 

A non-U.S. corporation (other than a corporation that is classified as a PFIC for the taxable year in which the ‎dividend is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation (a) ‎if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury ‎of the United States determines is satisfactory for purposes of this provision and which includes an exchange of ‎information provision, or (b) with respect to any dividend it pays on Common Shares that are readily tradable on ‎an established securities market in the United States. We believe that we qualify as a resident of Canada for ‎purposes of, and are eligible for the benefits of, the U.S.-Canada Treaty, which the IRS has determined is ‎satisfactory for purposes of the qualified dividend rules and that it includes an exchange of information provision, ‎although there can be no assurance in this regard. Further, our Common Shares will generally be considered to be ‎readily tradable on an established securities market in the United States if they remain listed on the Nasdaq, as we ‎intend the Common Shares to be. Therefore, subject to the discussion above under “—Passive Foreign Investment ‎Company Consequences”, if the U.S. Treaty is applicable, or if the Common Shares are readily tradable on an ‎established securities market in the United States, dividends paid on Common Shares will generally be “qualified ‎dividend income” in the hands of non-corporate U.S. Holders, provided that certain conditions are met, including ‎conditions relating to holding period and the absence of certain risk reduction transactions.‎

 

56
 

 

Sale, Exchange or Other Disposition of Common Shares

 

Subject to the discussion above under “— Passive Foreign Investment Company Consequences,” a U.S. Holder generally will recognize capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition of Common Shares in an amount equal to the difference, if any, between the amount realized (i.e., the amount of cash plus the fair market value of any property received) on the sale, exchange or other disposition and such U.S. Holder’s adjusted tax basis in the Common Shares. Such capital gain or loss generally will be long-term capital gain taxable at a reduced rate for non-corporate U.S. Holders or long-term capital loss if, on the date of sale, exchange or other disposition, the Common Shares were held by the U.S. Holder for more than one year. Any capital gain of a non-corporate U.S. Holder that is not long-term capital gain is taxed at ordinary income rates. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by a U.S. Holder from the sale or other disposition of Common Shares will generally be gain or loss from sources within the United States for U.S. foreign tax credit purposes.

 

Medicare Tax

 

Certain U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds generally are subject to a 3.8% Medicare tax on all or a portion of their net investment income, which may include their gross dividend income and net gains from the disposition of Common Shares. If you are a U.S. person that is an individual, estate or trust, you are encouraged to consult your tax advisors regarding the applicability of this Medicare tax to your income and gains in respect of your investment in Common Shares.

 

Information Reporting and Backup Withholding

 

U.S. Holders may be required to file certain U.S. information reporting returns with the IRS with respect to an investment in Common Shares, including, among others, IRS Form 8938 (Statement of Specified Foreign Financial Assets). As described above under “Passive Foreign Investment Company Consequences”, each U.S. Holder who is a shareholder of a PFIC must file an annual report containing certain information. U.S. Holders paying more than US$100,000 for Common Shares may be required to file IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) reporting this payment. Substantial penalties may be imposed upon a U.S. Holder that fails to comply with the required information reporting.

 

Dividends on and proceeds from the sale or other disposition of Common Shares may be reported to the IRS unless the U.S. Holder establishes a basis for exemption. Backup withholding may apply to amounts subject to reporting if the holder (1) fails to provide an accurate U.S. taxpayer identification number or otherwise establish a basis for exemption, or (2) is described in certain other categories of persons. However, U.S. Holders that are corporations generally are excluded from these information reporting and backup withholding tax rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder’s U.S. federal income tax liability if the required information is furnished by the U.S. Holder on a timely basis to the IRS.

 

U.S. Holders should consult their own tax advisors regarding the backup withholding tax and information reporting rules.

 

THE ABOVE SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSIDERATIONS APPLICABLE TO U.S. HOLDERS WITH RESPECT TO THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF THE COMMON SHARES. U.S. HOLDERS SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO THE TAX CONSIDERATIONS APPLICABLE TO THEM IN THEIR OWN PARTICULAR CIRCUMSTANCES.‎

 

57
 

 

Certain Canadian Federal Income Tax Considerations for United States Residents

 

The following is, at the date of this Annual Report, a summary of certain Canadian federal income tax considerations generally applicable to the holding and disposition of Common Shares acquired by a holder who, at all relevant times, (a) for the purposes of the Tax Act (i) is not resident, or deemed to be resident, in Canada, (ii) deals at “arm’s length” with the Company, and is not “affiliated” with the Company (each as defined in the Tax Act), (iii) acquires and holds Common Shares as capital property, (iv) does not use or hold Common Shares in the course of carrying on, or otherwise in connection with, a business carried on or deemed to be carried on in Canada, and (v) is not an insurer that carries on an insurance business in Canada and elsewhere or “authorized foreign bank” (as defined in the Tax Act), or other holder of special status, and (b) for the purposes of the Canada-U.S. Tax Convention (1980) (the “Tax Treaty”), is a resident of the United States, has never been a resident of Canada, does not have and has not had, at any time, a “permanent establishment” (as defined in the Tax Treaty) of any kind in Canada, and otherwise qualifies for the full benefits of the Tax Treaty. Holders who meet all the criteria in clauses (a) and (b) above are referred to herein as “United States Holders”, and this summary only addresses such United States Holders.

 

This summary does not deal with special situations, such as the particular circumstances of traders or dealers, tax exempt entities, insurers or financial institutions, or other holders of special status or in special circumstances. Such holders, and all other holders who do not meet the criteria in clauses (a) and (b) above, should consult their own tax advisors.

 

This summary is based on the current provisions of the Tax Act, the regulations thereunder (the “Regulations”), the current provisions of the Tax Treaty (each as in force as of the date of this Annual Report) and the Company’s understanding of the administrative policies and assessing practices of the Canada Revenue Agency (the “CRA”) published in writing prior to the date hereof. This summary takes into account all specific proposals to amend the Tax Act and Regulations publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof  (the “Proposed Amendments”) and assumes that such Proposed Amendments will be enacted in the form proposed. However, such Proposed Amendments might not be enacted in the form proposed, or at all. This summary does not otherwise take into account or anticipate any changes in law or administrative policies or assessing practices, whether by legislative, governmental or judicial decision or action, nor does it take into account tax laws of any province or territory of Canada or of any other jurisdiction outside Canada, which may differ significantly from those discussed in this summary.

 

For the purposes of the Tax Act, all amounts relating to the acquisition, holding or disposition of Common Shares must generally be expressed in Canadian dollars. Amounts denominated in United States currency generally must be converted into Canadian dollars using a rate of exchange that is acceptable to the CRA.

 

This summary is of a general nature only and is not intended to be, nor should it be construed to be, legal or tax advice to any particular United States Holder, and no representation with respect to the Canadian federal income tax consequences to any particular United States Holder or prospective United States Holder is made. This summary is not exhaustive of all Canadian federal income tax considerations. Accordingly, all United States Holders should consult with their own tax advisors for advice with respect to their own particular circumstances.

 

Withholding Tax on Dividends

 

Amounts paid or credited or deemed to be paid or credited as, on account or in lieu of payment of, or in satisfaction of, dividends on Common Shares to a United States Holder will be subject to Canadian withholding tax. Under the Tax Act, the rate of withholding is 25% of the gross amount of the dividend.

 

Under the Tax Treaty, the rate of withholding on any such dividend beneficially owned by a United States Holder is ‎generally reduced to 15%, and may further be reduced to 5% if the United States Holder is a company entitled to ‎full benefits under the Tax Treaty that owns, directly or indirectly, at least 10% of the voting stock of the Company.‎

 

Dispositions of Common Shares

 

A United States Holder generally will not be subject to tax under the Tax Act in respect of a capital gain realized on ‎the disposition or deemed disposition of a Common Share, nor will a capital loss arising therefrom be recognized ‎under the Tax Act, unless such Common Share constitutes “taxable Canadian property” (as defined in the Tax Act) ‎of the United States Holder at the time of disposition and the United States Holder is not entitled to relief under the ‎Tax Treaty.‎

 

58
 

 

Provided the Common Shares are listed on a “designated stock exchange” (as defined in the Tax Act) (which currently includes the Nasdaq and CSE) and are so listed at the time of disposition, the Common Shares generally will not constitute “taxable Canadian property” of a United States Holder at that time unless, at any time during the 60-month period immediately preceding the disposition, the following two conditions are met concurrently: (i) 25% or more of the issued shares of any class or series of shares of the Company were owned by or belonged to one or any combination of (a) the United States Holder, (b) persons with whom the United States Holder did not deal at “arm’s length” (within the meaning of the Tax Act), or (c) partnerships in which the United States Holder or a person described in (b) holds a membership interest directly or indirectly through one or more partnerships; and (ii) more than 50% of the fair market value of the Common Shares was derived directly or indirectly from one or any combination of (a) real or immovable property situated in Canada, (b) “Canadian resource properties” (as defined in the Tax Act), (c) “timber resource properties” (as defined in the Tax Act), or (d) options in respect of, interests in, or, for civil law purposes, a right in, the foregoing property, whether or not such property exists. Notwithstanding the foregoing, a Common Share may be deemed to be “taxable Canadian property” in certain other circumstances. United States Holders should consult their own tax advisors as to whether their Common Shares will constitute “taxable Canadian property”.

 

United States Holders who may hold Common Shares as “taxable Canadian property” should consult their own tax advisors with respect to the application of Canadian capital gains taxation, any potential relief under the Tax Treaty, and special compliance procedures under the Tax Act, none of which are described in this summary.

 

SHAREHOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS AS TO THE CANADIAN OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON SHARES, INCLUDING, IN PARTICULAR, THE EFFECT OF ANY NON-U.S., STATE OR LOCAL TAXES.

 

10.F. Dividends and Paying Agents

 

Not applicable.

 

10.G. Statement by Experts

 

Not applicable.

 

10.H. Documents on Display

 

Documents concerning our company referred to in this Annual Report may be viewed by appointment during normal business hours at our registered and records office at Suite 2700, 1133 Melville Street, Vancouver, British ‎Columbia V6E 4E5.

 

10.I. Subsidiary Information

 

Not applicable.

 

10.J. Annual Report to Security Holders

 

The Company will prove this Annual Report to securityholders, as applicable, in electronic format in accordance with the EDGAR Filer Manual.

 

Item 11. Quantitative and Qualitative Disclosures About Market Risk

 

We are exposed in varying degrees to a variety of financial instrument related risks. The Board approves and monitors the risk management processes, inclusive of controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit Risk

 

Credit risk is the risk of an unexpected loss if a customer or third party fails to meet its contractual obligations. The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

59
 

 

Credit and liquidity risk associated with cash and the marketable security is managed by ensuring assets are placed with major financial institutions with strong investment grade ratings.

 

Credit risk on trade and other receivables reflects the risk that the Company may be unable to recover them. Trade and other receivables that are greater than 30 days are considered past due. The table below sets out the status of trade and other receivables, no allowance for doubtful accounts has been recorded as at December 31, 2023 and December 31, 2022.

 

   December 31, 2023   December 31, 2022 
0 – 30 days  $271,622   $1,020,091 
31 – 60 days   109,928    116,378 
61 – 90 days   64,259    343,364 
91 + days   203,803    609,132 
   $649,612   $2,088,965 

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a ‎planning and budgeting process in place to help determine the funds required to support the Company’s normal operating ‎requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business ‎requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. ‎Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through ‎private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access ‎to significant equity funding.‎

 

Interest Rate Risk

 

Interest rate risk is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities. The Company is exposed to minimal interest rate risk on its cash balances as they carry a floating rate of interest. We do not currently hedge our interest rate risk.

 

Foreign Currency Risk

 

We are also exposed to market risk related to change in foreign currency exchange rates. Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does engage in significant transactions and activities in currencies other than its functional currency, the Canadian dollar. Such transactions are primarily denominated in the U.S. dollar. Transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company. We do not currently hedge our foreign exchange rate risk.

 

Item 12. Description of Securities Other than Equity Securities

 

12.A. Debt Securities

 

Not applicable.

 

12.B. Warrants and Rights

 

Not applicable.

 

12.C. Other Securities

 

Not applicable.

 

12.D. American Depositary Shares

 

Not applicable.

 

60
 

 

PART II

 

Item 13. Defaults, Dividend Arrearages and Delinquencies

 

Not applicable.

 

ITEM 14. Material Modifications to the Rights of Security Holders and Use of Proceeds

 

Not applicable.

 

14.E. Use of Proceeds

 

The effective date of the registration statement on Form F-10 (File No. 333-258074) for the Company’s initial underwritten public offering of securities in the United States was July 29, 2021 (defined herein as the “US Offering”). The offering of 5,000,000 Common Shares at a price of U.S.$4.00 per share closed on August 3, 2021 for gross proceeds of U.S.$20,000,000, before deducting underwriting discounts and offering expenses of approximately U.S.$2,400,000 for total net proceeds to the Company from the offering of U.S.$17,600,000. ThinkEquity, a division of Fordham Financial Management, Inc. (“ThinkEquity”), was the sole book-running manager for the offering.

 

In addition, ThinkEquity was granted a 45-day over-allotment option following the closing date to purchase up to an additional 750,000 shares. On September 15, 2021, the Company announced the exercise of 95,966 of the over-allotment shares at a price of U.S.$4.00 per share for additional gross proceeds of U.S.$383,864, bringing the aggregate gross proceeds of the US Offering to U.S.$20,383,864 before deducting underwriting discounts and offering expenses. After deducting underwriting discounts and offering expenses of U.S.$2,400,000, the total net proceeds to the Company from the US Offering were approximately U.S.$17,983,864. None of the net proceeds of the US Offering were paid directly or indirectly to any director or officer of ours or to their associates, persons owning 10% or more of any class of our equity securities, or to any of our affiliates.

 

The Company has fully used the net proceeds of the US Offering. The proceeds that the Company has used have been used for general corporate purposes, including funding ongoing operations, growth initiatives, and working capital. There has been no material change in the use of proceeds from our initial public offering from that described in our prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act on July 30, 2021 (the “Supplement”). The Company used the net proceeds of the offering, together with existing cash, for general corporate purposes, including to fund ongoing operations, to fund growth initiatives and/or for working capital requirements including the continuing development and marketing of the Company’s core products, potential acquisitions and research and development, as set out in the Supplement.

 

61
 

 

Item 15. Controls and Procedures

 

Disclosure Controls and Procedures

 

At the end of the period covered by this Annual Report, an evaluation of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as such term is defined in Rules 13a-15(e) and Rule 15d-15(e)‎ under the Exchange Act) was carried out by the Company’s principal executive officer (the “CEO”) and principal financial officer (the “CFO”). Based upon that evaluation, the Company’s CEO and CFO have concluded that, as of the end of the period covered by this Annual Report, the design and operation of the Company’s disclosure controls and procedures are effective to ensure that (i) information required to be disclosed in reports that the Company files or submits to regulatory authorities is recorded, processed, summarized and reported within the time periods specified by regulation, and (ii) is accumulated and communicated to management, including the Company’s CEO and CFO, to allow timely decisions regarding required disclosure.

 

It should be noted that while the Company’s CEO and CFO believe that the Company’s disclosure controls and procedures provide a reasonable level of assurance that they are effective, they do not expect that the Company’s disclosure controls and procedures will prevent all errors and fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

 

Management Report on Internal Control Over Financial Reporting & Auditor Attestation

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) under the Securities Exchange Act of 1934, as amended) and has designed such internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

In designing and evaluating the Company’s internal control over financial reporting, the Company’s management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its reasonable judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

 

Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023. In making this assessment, management used the criteria set forth in “Internal Control – Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2023.

 

Attestation Report of Independent Auditor

 

In accordance with the JOBS Act enacted on April 5, 2012, the Company qualifies as an “emerging growth company,” which entitles the Company to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not EGCs. Specifically, the JOBS Act defers the requirement to have the Company’s independent auditor assess the Company’s internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act. As such, the Company is exempted from the requirement to include an auditor attestation report in this Annual Report for so long as the Company remains an EGC, which may be for as long as five years following its initial registration in the United States.

 

Changes in Internal Control over Financial Reporting

 

During the year ended December 31, 2023, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Item 16. [Reserved]

 

62
 

 

Item 16A. Audit Committee Financial Expert

 

The Company’s Audit Committee, which consists exclusively of independent directors within the meaning of NI 52-110 and the Nasdaq listing requirements, is comprised of Olen Aasen, Julie Myers Wood and John M. ‎Mitnick. Olen Aasen is the Chair of the Audit Committee. The Board of Directors has determined that Julie Myers Wood, Olen Aasen, and John M. ‎Mitnick each meet the independence requirements for directors, including the heightened independence standards for members of the audit committee under Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and NI 52-110. The Board has determined that Olen Aasen is “financially literate” within the meaning of NI 52-110 and the Nasdaq listing requirements and an “audit committee financial expert” as defined by Rule 10A-3 under the Exchange Act. For a description of the education and experience of each member of the Audit Committee, see “Item 6A. Directors, Senior Management and Employees.”

 

Item 16B. Code of Ethics

 

The Company has adopted a Code of Business Conduct and Ethics applicable to all of its directors, officers and employees, including its CEO and CFO, which is a “code of ethics” as defined in section 406(c) of the Sarbanes-Oxley Act. The Code of Business Conduct and Ethics sets out the fundamental values and standards of behavior that the Company expects from our directors, officers and employees with respect to all aspects of its business.

 

If the Company grants any waiver of the Code of Business Conduct and Ethics, whether explicit or implicit, to a director or executive officer, it will disclose the nature of such waiver on its website to the extent required by, and in accordance with, the rules and regulations of the SEC.

 

The full text of the Code of Business Conduct and Ethics is posted on the Company’s website at www.draganfly.com and the System for Electronic Document Analysis and Retrieval+ (SEDAR+) profile at www.sedarplus.ca. The information on or accessible through the website is not part of and is not incorporated by reference into this Annual Report, and the inclusion of the website address in this Annual Report is only for reference.

 

The Audit Committee is responsible for reviewing and evaluating the Code of Business Conduct and Ethics periodically and will recommend any necessary or appropriate changes thereto to the Board for consideration. The Audit Committee will also assist the Board of Directors with the monitoring of compliance with the Code of Business Conduct and Ethics.

 

Item 16C. Principal Accountant FeeS and Services

 

The following table sets forth information regarding the amount billed and accrued to the Company by Dale Matheson Carr-Hilton Labonte LLP, for the fiscal years ended December 31, 2023 ad 2022:

 

   Year Ended December 31, 
Services  2023   2022 
Audit Fees(1)  $235,000   $250,000 
Audit-Related Fees(2)  $83,000   $63,900 
Tax Fees(3)  $12,600   $11,000 
Other Fees(4)  $-   $- 

 

Notes:

 

  (1) “Audit fees” means the aggregate fees billed for professional services rendered by our principal accounting firm for the audit of the Company’s annual financial statements and the review of its comparative interim financial statements.
  (2) “Audit-related fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for the assurance and related services, which mainly included the audit and review of financial statements and are not reported under “Audit fees” above.
  (3) “Tax fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for tax compliance, tax advice and tax planning.
  (4) “Other fees” means the aggregate fees incurred in each of the fiscal years listed for the professional tax services rendered by the Company’s principal accounting firm other than services reported under “Audit fees,” “Audit-related fees” and “Tax fees.”

 

The policy of the Company’s Audit Committee is to pre-approve all audit and non-audit services provided by Dale Matheson Carr-Hilton Labonte LLP, its independent registered public accounting firm, including audit services, audit-related services, tax services, and other services as described above.

 

63
 

 

Item 16D. Exemptions from the Listing Standards for Audit Committees

 

Not Applicable.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

Not Applicable.

 

Item 16F. Change in Registrant’s Certifying Accountant

 

Not applicable.

 

Item 16G. Corporate Governance

 

The Company is a foreign private issuer and its Common Shares are listed on the Nasdaq Capital Market. Rule 5615(a)(3) of the rules of the Nasdaq Stock Market LLC Rules (the “Nasdaq Rules”) permits a foreign private issuer to follow its home country practices in lieu of certain requirements of the 5600 Series of the Nasdaq Rules, which set forth corporate governance requirements. In order to claim such an exemption, the Company must disclose the significant differences between its corporate governance practices and those required to be followed by U.S. domestic issuers under the Nasdaq Rules. Set forth below is a brief summary of such differences.

 

Quorum Requirement

 

Nasdaq Rule 5620(c) requires that each company that is not a limited partnership shall provide for a quorum as specified in its by-laws for any meeting of holders of common stock; provided, however, that in no case shall such quorum be less than 33 1/3% of the outstanding shares of the company’s common voting stock. The Company does not presently follow this Nasdaq Rule. Instead, and in accordance with the Nasdaq exemption, the Company complies with the BCBCA which does not require a quorum of no less than 33 1/3% of the outstanding shares of the Company’s common voting shares and provides that the quorum for the transaction of business at a meeting of shareholders is the quorum established by the Company’s Articles, which is two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least 5% of the issued shares entitled to be voted at the meeting.

 

Independent Compensation Committee

 

Nasdaq Rule 5605(d)(2) requires that listed companies have a compensation committee comprised entirely of independent directors. The Company does not have a compensation committee comprised entirely of independent directors. Under Canadian securities laws, National Policy 58-201 only recommends that a compensation committee be composed entirely of independent directors. The rules of the CSE likewise do not require an entirely independent compensation committee.

 

Item 16H. Mine Safety Disclosure

 

Not applicable.

 

Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable.

 

64
 

 

Item 16J. insider tRading policies

 

Not Applicable.

 

Item 16k. cybersecurity

 

Draganfly conducts annual IT general controls (ITGC) audits through a third-party firm to evaluate internal risks to key business systems. Any significant deficiencies identified are promptly addressed and documented. Additionally, to mitigate external risks, Draganfly has enlisted the services of an Extended Detection and Response (XDR) provider for continuous 24/7 monitoring, threat hunting, incident response, and vulnerability management.

 

The XDR platform aggregates data from various sources including network scanners, endpoint agents, and cloud APIs. This data undergoes rigorous analysis leveraging machine-learning-powered threat intelligence and human expertise to swiftly identify and address cybersecurity threats in real-time. Any unusual findings are promptly communicated to the Systems Administrator via ticketing. In instances of critical alerts posing a material risk to the company, affected systems are immediately quarantined at the kernel level, isolating them from network communication until remedial actions can be taken.

 

Furthermore, Draganfly conducts quarterly reviews of the XDR provider services overseen by the Systems Administrator. To mitigate the risk of the XDR provider compromising Draganfly’s systems, an air-gap approach is implemented, ensuring that the provider cannot directly intervene in Draganfly’s systems except to quarantine systems, a capability that can be terminated by the Systems Administrator at any time.

 

In addition to our robust cybersecurity measures, Draganfly prioritizes employee awareness and readiness to counter emerging threats. Regular cybersecurity training is conducted to educate our staff on recognizing and mitigating social engineering attacks. These sessions emphasize the importance of vigilance and critical thinking when encountering suspicious emails, phone calls, or other forms of communication aimed at deceiving individuals into divulging sensitive information or compromising security protocols.

 

As of the current reporting period, Draganfly has not experienced any cybersecurity incidents. However, we recognize that social engineering attacks pose a significant threat to our business operations and financial condition. While we remain vigilant and have implemented robust security measures to mitigate such risks, we acknowledge that social engineering attacks have the potential to compromise our systems and disrupt our operations.

 

The full Board receives a quarterly report and dashboard which sets out our security stance (whether there have been any incidents), and our phish-prone percentage as we believe that is our highest risk factor.

 

Management receives the same quarterly report and as the team meets weekly, any concerns or decisions ‎relating to security are brought forward by the Chief Legal and Corporate Services Officer. Should there be ‎any specific issues or incidents, the Chief Legal and Corporate Services Officer would report them ‎immediately to the Chair of the Board and the chair of the Audit Committee.‎

 

65
 

 

PART III

 

Item 17: Financial Statements

 

Refer to Item 18. Financial Statements.

 

66
 

 

Item 18: Financial Statements

 

Financial Statements Filed as Part of this Annual Report:

 

Audited Annual Financial Statements as at December 31, 2023 and 2022:

 

Independent Auditor’s Report of Dale Matheson Carr-Hilton Labonte LLP‎, dated March 27, 2024; F-2
   
Consolidated Statements of Financial Position for the years ended December 31, 2023 and 2022; F-3
   
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023 and 2022; F-4
   
Consolidated Statements of Changes in Shareholder Equity (Deficiency) for the years ended December 31, 2023 and 2022; F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022; F-6
   
Notes to the Consolidated Financial Statements F-7

 

67
 

 

Item 19. Exhibits

 

The following Exhibits are being filed as part of this Annual Report, or are incorporated by reference where indicated:

 

Exhibit Number   Description
1.1   Certificate of Incorporation dated June 1, 2018 (incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-40688) filed with the SEC on April 4, 2022)
1.2   Articles dated June 1, 2018 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021)
1.3   Certificate of Change of Name dated August 15, 2019 ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎40688) filed with the SEC on April 4, 2022)
1.4   Notice of Articles dated June 1, 2018 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021)
2.1   Specimen Option Agreement of the Company ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎40688) filed with the SEC on April 4, 2022)‎
2.2   Specimen Restricted Share Unit Agreement of the Company ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎‎40688) filed with the SEC on April 4, 2022)‎
2.3   Specimen Warrant Certificate of the Company ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎‎‎40688) filed with the SEC on April 4, 2022)‎
2.4   Specimen Warrant Certificate of the Company ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎‎‎‎40688) filed with the SEC on April 4, 2022)‎
2.5   Specimen Warrant Certificate of the Company ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎‎‎‎‎40688) filed with the SEC on April 4, 2022)‎
4.1   Business Services Agreement between the Company and Business Instincts ‎Group Inc. dated August 1, 2019 ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. 001-‎‎‎40688) filed with the SEC on April 4, 2022)‎
4.2#   Share Compensation Plan dated August 9, 2019, as amended April 14, 2021 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021)
4.3#   Consultant Agreement ‎with 1502372 Alberta Ltd., dated October 1, 2019 ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. ‎‎001-‎‎40688) filed with the SEC on April 4, 2022)
4.4*#   Independent Consultant Agreement Amending Agreement with 1502372 Alberta Ltd. dated April 1, 2022
4.5*#   Independent Consulting Agreement with Scott Larson dated April 1, 2022
4.6#   Employment Agreement with Paul Sun dated November, 2020 ‎ ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. ‎‎001-‎‎40688) filed with the SEC on April 4, 2022)
4.7#   Amending Agreement with Paul Sun, dated September 3, 2021 ‎ ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. ‎‎001-‎‎40688) filed with the SEC on April 4, 2022)
4.8*#   Employment Agreement Amending Agreement with Paul Sun dated April 1, 2022
4.9*#   Employment Agreement Amendment with Paul Sun dated April 21, 2023
4.10*#   Employment Agreement with Paul Mullen dated April 12, 2021
4.11*#   Employment Agreement Amending Agreement with Paul Mullen dated April 1, 2022
4.12*#   Employment Agreement Amendment with Paul Mullen dated April 1, 2023
4.13*#   Employment Agreement with Deborah Greenberg dated June 3, 2022
4.14*#   Employment Agreement Amendment with Deborah Greenberg dated April 1, 2023
8.1*   Subsidiaries of the Company
11.1   Code of Business Conduct and Ethics ‎ ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. ‎‎001-‎‎40688) filed with the SEC on April 4, 2022)
12.1*   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer
12.2*   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
13.1†   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
13.2†   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
15.1*   Management’s Discussion and Analysis for the fiscal year ended December 31, 2023
15.2   Audit Committee Charter ‎ ‎(incorporated herein by reference to the Company’s Annual Report on Form 20-F (File No. ‎‎001-‎‎40688) filed with the SEC on April 4, 2022)
15.3*   Consent of independent registered public accounting firm (Dale Matheson Carr-Hilton Labonte LLP)
97*   Compensation Clawback Policy
101*   The following materials from the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023, formatted in eXtensible Business Reporting Language (XBRL):

    (i) Consolidated Balance Sheets as of December 31, 2023 and 2022;
    (ii) Consolidated Statements of Operations for the years ended December 31, 2023 and 2022;
    (iii) Consolidated Statements of Comprehensive Loss for the years ended December 31, 2023 and 2022;
    (iv) Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2023 and 2022;
    (v) Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022; and
   

(vi) Notes to Consolidated Financial Statements

104*   Cover Page Interactive Data File (formatted as Inline eXtensible Business Reporting Language (iXBRL) and contained in Exhibit 101)

 

* Filed herewith.

‎† Furnished herewith

‎# Indicates management contract or compensatory plan.‎

 

68
 

 

Signatures

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

  DRAGANFLY INC.
     
    /s/ Paul Sun
  By: Paul Sun
  Title: Chief Financial Officer

 

Date: March 27, 2024

 

69
 

 

 

Draganfly Inc.

 

Consolidated Financial Statements

 

Years Ended December 31, 2023 and 2022

 

(Expressed in Canadian Dollars)

 

F-1
 

 

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of Draganfly Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Draganfly Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of comprehensive loss, changes in shareholders’ equity, and cash flows, for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and its financial performance and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred losses in developing its business, and further losses are anticipated. The Company requires additional funds to meet its obligations and the costs of its operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in this regard are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion in accordance with the standards of the PCAOB.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ DMCL

 

DALE MATHESON CARR-HILTON LABONTE LLP

CHARTERED PROFESSIONAL ACCOUNTANTS

 

We have served as the Company’s auditor since 2018

Vancouver, Canada (PCAOB ID 1173)

March 27, 2024

 

 

F-2
 

 

Draganfly Inc.

Consolidated Statements of Financial Position

Expressed in Canadian Dollars

 

 

       December 31,   December 31, 
As at  Notes   2023   2022 
             
ASSETS               
Current Assets               
Cash and cash equivalents   4   $3,093,612   $7,894,781 
Receivables   5    649,612    2,088,965 
Inventory   6    1,596,536    1,055,942 
Notes receivable   7    -    169,300 
Prepaids   8    1,342,215    2,307,724 
Total current assets        6,681,975    13,516,712 
                
Non-current Assets               
Equipment   10    680,801    404,691 
Intangible assets   11    56,426    179,801 
Investments   9    189,403    192,583 
Right of use assets   12    721,687    344,746 
TOTAL ASSETS       $8,330,292   $14,638,533 
                
LIABILITIES AND SHAREHOLDERS’ EQUITY               
Current Liabilities               
Trade payables and accrued liabilities   14,20   $2,638,981   $2,816,676 
Customer deposits        104,715    194,758 
Deferred income   15    12,112    63,690 
Loans payable   16    85,058    81,512 
Derivative liability   17    4,196,125    57,314 
Lease liabilities   13    362,001    133,962 
Total current liabilities        7,398,992    3,347,912 
                
Non-current Liabilities               
Loans payable   16    -    5,059 
Deferred income   15    95,562    - 
Lease liabilities   13    428,022    244,681 
TOTAL LIABILITIES        7,922,576    3,597,652 
                
SHAREHOLDERS’ EQUITY               
Share capital   17    97,070,976    83,600,089 
Reserves – share-based payments   17    6,870,139    7,264,340 
Accumulated deficit        (103,588,356)   (79,976,546)
Accumulated other comprehensive income (loss)        54,957    152,998 
TOTAL SHAREHOLDERS’ EQUITY        407,716    11,040,881 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY       $8,330,292   $14,638,533 

 

Nature and Continuance of Operations and Going Concern (Note 1)

Subsequent Events (Note 23)

 

Approved and authorized for issuance by the Board of Directors on March 27, 2024.

 

“Scott Larson”   “Cameron Chell”

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

Draganfly Inc.

Consolidated Statements of Comprehensive Loss

Expressed in Canadian Dollars

 

 

                        
       For the years ended December 31,  
   Note   2023   2022    2021  
REVENUE                    
Sales of goods   18   $5,287,093   $5,550,432    $ 5,103,399  
Provision of services   18    1,267,749    2,054,627      1,950,466  
TOTAL REVENUE        6,554,842    7,605,059      7,053,865  
                        
COST OF SALES   6    (4,490,728)   (6,814,384)     (4,410,777 )
                        
GROSS PROFIT        2,064,114    790,675      2,643,088  
                        
OPERATING EXPENSES                       
Amortization   11    35,960    179,482      135,966  
Depreciation   10,12    510,677    593,277      175,098  
Director fees   20    600,933    522,349      370,094  
Insurance        1,825,137    3,722,237      2,962,767  
Office and miscellaneous   19    6,303,879    5,397,961      6,455,998  
Professional fees   20    4,145,586    6,821,583      4,445,949  
Research and development        1,554,823    651,302      510,895  
Share-based payments   17    2,021,664    3,311,024      3,952,595  
Travel        704,994    396,388      143,904  
Wages and salaries   20    6,976,792    6,105,020      2,768,010  
Total operating expenses        (24,680,445)   (27,700,623)     (21,921,276 )
                        

OTHER INCOME (EXPENSE)

                       
Change in fair value of derivative liability   17    

211,110

   5,502,688      8,149,812  
Finance and other costs        83,280    44,345      5,074  
Foreign exchange gain        (249,563)   745,102      362,448  
Loss on disposal of assets   10    (944)    (10,755)     -  
Loss on write-off of notes receivable   7    (101,351)   (309,385)     (891,471 )
Government income        5,232    2,446      24,148  
Write down of deposit   8    -    (228,572)     -  
Loss on impairment of goodwill and intangibles   11    -    (6,454,914)     (4,579,763 )
Other income (expense)   17    (943,243)   (35,371)     4,968  
NET LOSS FOR THE YEAR        (23,611,810)   (27,654,364)     (16,202,972 )
                        
OTHER COMPREHENSIVE INCOME (LOSS)                       
Items that may be reclassified to profit or loss                       
Foreign exchange translation        (94,861)   447,542      136,475  
Items that will not be reclassified to profit or loss                       
Change in fair value of equity investments at FVOCI   9    (3,180)   (98,483)     (332,640 )
COMPREHENSIVE LOSS FOR THE YEAR        (23,709,851)   (27,305,305)     (16,399,137 )
                        
Net loss per share                       
Basic & diluted       $(0.56)  $(0.82)   $ (0.59 )
Weighted average number of common shares outstanding - basic & diluted        42,192,384    33,556,969      27,787,348  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4
 

 

Draganfly Inc.

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

 

 

   Number of Shares   Share Capital   Reserves – Share-Based Payments   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total
Shareholders’ Equity
 
                   Accumulated Other Comprehensive Income (Loss)     
   Number of Shares   Share Capital   Reserves – Share-Based Payments   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total
Shareholders’ Equity
 
Balance at December 31, 2020   17,218,695   $36,943,304   $3,024,007   $(36,119,210)  $-  $104   $3,848,205 
Shares issued in the acquisitions of Vital   1,200,000    2,303,999    1,241,250    -    -    -    3,545,249 
Shares issued for financing   11,584,657    36,092,187    -    -    -    -    36,092,187 
Share issue costs   -    (4,678,821)   864,060    -    -    -    (3,814,761)
Shares issued for exercise of RSU’s   448,660    1,752,052    (1,752,052)   -    -    -    - 
Shares issued for exercise of warrants   1,939,534    4,929,790    -    -    -    -    4,929,790 
Shares issued for exercise of stock options   405,499    1,937,866    (923,743)   -    -    -    1,014,123 
Shares issued in lieu of cash   371,901    1,757,988    -    -    -    -    1,757,988 
Share-based payments   -    -    3,952,595    -    -    -    3,952,595 
Net loss   -    -    -    (16,202,972)   -    -    (16,202,972)
Change in fair value of equity investments at FVOCI   -    -    -    -    (332,640)   -    (332,640)
Translation of foreign operations   -    -    -    -    -    136,475    136,475 
Balance at December 31, 2021   33,168,946   $81,038,365    $6,406,117     $(52,322,182  $(332,640)  $136,579    $34,926,239  
Shares issued for the exercise of stock options   12,500    51,875    (25,000)   -    -    -    26,875 
Shares issued for the exercise of warrants   16,538    87,170    -    -    -    -    87,170 
Shares issued for the exercise of RSUs   1,072,595    2,427,801    (2,427,801)   -    -    -    - 
Shares issue costs   -    (5,122)   -    -    -    -    (5,122)
Share-based payments   -    -    3,311,024    -    -    -    3,311,024 
Net loss   -    -    -    (27,654,364)   -    -    (27,654,364)
Change in fair value of equity investments at FVOCI   -    -    -    -    (98,483)   -    (98,483)
Translation of foreign operations   -    -    -    -    -    447,542    447,542 
Balance at December 31, 2022   34,270,579   $83,600,089   $7,264,340   $(79,976,546)  $(431,123)  $584,121   $11,040,881 
Shares issued for financing – ATM (“At-the-market”)   650,729    1,748,946    -    -    -    -    1,748,946 
Share issue costs   -    (222,136)   -    -    -    -    (222,136)
Shares issued for financing   12,800,000    11,376,230    -    -    -    -    11,376,230 
Share issue costs   -    (2,072,886)   224,868    -    -    -    (1,848,018)
Shares issued for the exercise of RSUs   1,508,255    2,640,733    (2,640,733)   -    -    -    - 
Share-based payments   -    -    2,021,664    -    -    -    2,021,664 
Net loss   -    -    -    (23,611,810)   -    -    (23,611,810)
Change in fair value of equity investments at FVOCI   -    -    -    -    (3,180)   -    (3,180)
Translation of foreign operations   -    -    -    -    -    (94,861)   (94,861)
Balance as of December 31, 2023   49,229,563   $97,070,976   $6,870,139   $(103,588,356)  $(434,303)  $489,260   $407,716 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

 

Draganfly Inc.

Consolidated Statements of Cash Flows

Expressed in Canadian Dollars

 

 

                   
   For the years ended December 31,
   2023   2022  2021  
                 
OPERATING ACTIVITIES                  
Net loss for the year  $(23,611,810)  $(27,654,364)   $ (16,202,972 )
Adjustments for:                  
Amortization   35,960    179,482      135,966  
Depreciation   510,677    593,277      175,098  
Bad debt   216,238    -      -
Change in fair value of derivative liability   (211,110   (5,502,688)     (8,149,812 )
Write down of inventory   331,671    1,976,514      -  
Impairment of notes receivable   101,351    309,385      891,471  
Impairment of goodwill and intangibles   87,415    6,454,914      4,579,763  
Write down of deposit   -    228,572      -
Finance and other costs   4,355,156    (34,427)     (926 )
(Gain) loss on sale of assets   18,426   -     

(24,148

)
Share-based payments   2,021,664    3,311,024      3,952,595  
 Adjustments for profit loss   (16,144,362)   (20,138,311)     (14,642,965 )
Net changes in non-cash working capital items:                  
Receivables   1,223,112    (681,838)     (596,336 )
Inventory   (872,265)   (150,241)     (2,157,203 )
Prepaids   965,509    2,958,581      (3,401,868 )
Trade payables and accrued liabilities   (170,782)    1,661,697      (1,044,133 )
Customer deposits   (90,043)   22,624      (213,315 )
Deferred income   43,984    (21,543)     51,186  
Cash used in operating activities   (15,044,847)   (16,349,031)     (22,004,634 )
                   
INVESTING ACTIVITIES                  
Cash paid for acquisition, net of cash received   -    -      (466,643 )
Purchase of equipment   (490,391)   (79,713)     (212,579 )
Disposal of equipment   46,976    10,755      -  
Purchase of intangible assets   -    (4,684)     -  
Purchase of investments   -    -      (623,706 )
Repayment (Issuance) of notes receivable   63,838    842,297      (2,002,678 )
Cash provided by (used in) investing activities   (379,577)   768,655      (3,305,606 )
                   
FINANCING ACTIVITIES                  
Proceeds from issuance of common shares for financing   13,125,176    -      44,255,651  
Share issue costs   (2,070,154)   (5,122)     (3,814,762 )
Proceeds from issuance of common shares for warrants exercised   -    87,170      4,929,790  
Proceeds from issuance of common shares for stock options exercised   -    26,875      1,014,123  
Proceeds from issuance of loans   -    -      60,000  
Repayment of loans   (6,747)   (6,746)     (48,747 )
Repayment of lease liabilities   (330,159)   (150,275)     (128,996 )
Cash provided by (used in) financing activities   10,718,116    (48,098)     46,267,059  
                   
Effects of exchange rate changes on cash   (94,861)   447,542      136,478  
Change in cash   (4,706,308)   (15,628,474)     20,956,819  
Cash and cash equivalents, beginning of year   7,894,781    23,075,713      1,982,416  
Cash and cash equivalents, end of year  $3,093,612   $7,894,781    $ 23,075,713  
                   
The following are included in cash flow from operating activities:                
Interest paid in cash  $57,041   $51,338    $ 31,010  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

1. NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $103,588,356. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These consolidated financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.

 

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2024.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (DII)  Canada   100%
Draganfly Innovations USA, Inc. (DI USA)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

F-7
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Foreign currency translation

 

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 

The functional currencies of the parent company and each subsidiary are as follows:

 

Draganfly Inc.   Canadian Dollar
Draganfly Innovations Inc.   Canadian Dollar
Draganfly Innovations USA, Inc.   US Dollar
Dronelogics Systems Inc.   Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

 

Share-based payments

 

The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

 

The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

 

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.
b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.
c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

F-8
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

 

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 8,574,798 warrants, 897,158 options and 1,112,967 RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 

Financial Instruments

 

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial assets/liabilities   Classification
Cash and cash equivalents   Fair value through profit or loss
Receivables   Amortized cost
Notes receivable   Fair value through profit or loss
Investments   Fair value through other comprehensive income

Trade payables

  Amortized cost
Customer deposits   Amortized cost
Loans payable   Amortized cost
Derivative liability   Fair value through profit or loss

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

F-9
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.

 

F-10
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 

Impairment of non-financial assets

 

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life; and
an intangible asset not yet available for use;

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

F-11
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Deferred income tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

 

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

F-12
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

 

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 

Deferred Income

 

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Class of intangible asset   Useful live
Customer relationship   5 years
Brand   5 years
Software   5 years
Patents   5 years

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

F-13
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

Class of equipment   Depreciation rate
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Expected lease term
Vehicles   30%

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

 

(i)the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)its intention to complete the intangible asset and use or sell it;
(iii)its ability to use or sell the intangible asset;
(iv)how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

F-14
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

New accounting standards issued not yet effective

 

Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS

 

Significant estimates and assumptions

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

F-15
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D)

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

 

Investments in Private companies

 

Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.

 

Expected credit losses on trade receivables and notes receivable

 

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment and forward-looking information.

 

F-16
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D)

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company’s consolidated financial statements include:

 

  The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
  the classification of financial instruments;
  the assessment of revenue recognition using the five-step approach under IFRS 15; and
  the determination of the functional currency of each entity in the group.

 

4. CASH AND CASH EQUIVALENTS

 

   December 31, 2023   December 31, 2022 
Cash held in banks  $3,093,612   $7,500,607 
Guaranteed investment certificates   -    394,174 
Cash and cash equivalents  $3,093,612   $7,894,781 

 

On March 27, 2022 the Company renewed a GIC for $142,852 for 1 year at a rate of 1.00% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $143,436 and purchased a new GIC for $143,436 for 1 year at a rate of 4.5% per annum.

 

On May 30, 2022 the Company renewed the GIC for $140,493 for 1 year at a rate of 0.75% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $140,738 and purchased a new GIC for $140,738 for 1 year at a rate of 4.5% per annum.

 

All GIC’s were required to be maintained and renewed upon maturity until such time as the associated credit cards were cancelled. These credit cards were cancelled and all related GIC’s were not renewed during the year ended December 31, 2023.

 

5. RECEIVABLES

 

   December 31, 2023   December 31, 2022 
Trade accounts receivable  $610,443   $1,343,795 
Taxes receivable   39,169    745,170 
Trade and other receivables  $649,612   $2,088,965 

 

During the year ended December 31, 2023 the Company recorded a provision for doubtful accounts of $216,238 (2022 - $nil).

 

The Company applies a direct customer analysis approach to measure expected credit losses. The Company assesses collectability of receivables of each customer on an individual basis using quantitative and qualitative information available to management. The historical loss rates are adjusted to reflect the current and forward-looking information on economic factors affecting the ability of the customers to make regular monthly payments on the receivables.

 

Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include business closure and/or the failure to make monthly contractual payments.

 

F-17
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

6. INVENTORY

 

  

December 31,

2023

  

December 31,

2022

 
Finished goods  $904,858   $542,934 
Parts   691,678    513,008 
Inventories  $1,596,536   $1,055,942 

 

During the year ended December 31, 2023, $3,738,980 (2022 - $6,048,348; 2021 – $3,420,713) of inventory was recognized in cost of sales including an allowance for obsolete and slow-moving inventory of $331,671 (2022 - $1,976,514; 2021 - $nil).

 

Cost of sales consist of the following:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Inventory  $3,738,980   $6,048,348    $ 3,420,713  
Consulting and services   549,448    730,170      679,345  
Other   202,300    35,866      310,719  
Cost of sales  $4,490,728   $6,814,384    $ 4,410,777  

 

7. NOTES RECEIVABLE

  

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2023

 
Note 1(1)  2023-12-15   0%  $190,396   $      -   $       -   $(101,351)  $(63,838)  $        - 
Note 2(1)  2024-09-22   5%   1,003,682    -    -    -    -    - 
Total          $1,194,078   $-   $-   $(101,351)  $(63,838)  $- 

 

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2022

 
Note 1(1)  2023-03-31   0%  $190,396   $-   $12,764   $-   $(33,860)  $169,300 
Note 2(1)  2024-09-22   5%   1,003,682    48,992    27,971    (1,080,645)   -    - 
Note 3  2022-04-26   8%   -    37,177    -    771,260    (808,437)   - 
Total          $1,194,078   $86,169   $40,735   $(309,385)  $(842,297)  $169,300 

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss with an initial maturity date of October 31, 2022. During the year ended December 31, 2022 the parties agreed on an amended maturity date of January 31, 2023. During the year ended December 31, 2023 the parties agreed to extend the maturity date to December 15, 2023. As the borrower has not repaid the loan it was impaired to $nil.

 

Note 2 was issued on September 9, 2021, bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. Management has determined that it is unlikely that the loan will be repaid and the loan was impaired to $nil during the year ended December 31, 2022.

 

Note 3 was issued on November 17, 2021 bearing interest at 8% and was due April 26, 2022. At December 31, 2021, management determined that it was unlikely that the loan would be repaid and the loan was written down to $nil. During the year ended December 31, 2022, the parties agreed on a repayment plan, with the loan and interest being repaid in the amount of $808,437.

 

F-18
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

8. PREPAIDS

 

   December 31, 2023   December 31, 2022 
Insurance  $838,445   $1,148,455 
Prepaid interest   810    1,889 
Prepaid marketing services   71,539    733,417 
Prepaid rent   21,768    12,485 
Prepaid subscriptions   48,007    29,194 
Deposits(1)   361,646    382,284 
 Prepaid expenses and deposits   $1,342,215   $2,307,724 

 

(1) A deposit in the amount of $228,572 related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.

 

9. INVESTMENTS

 

Balance at December 30, 2021   291,066 
Change in fair value   (98,483)
Balance at December 31, 2022   192,583 
Change in fair value   (3,180)
Balance at December 31, 2023  $189,403 

 

Fair value of investments is comprised of:

 

Public company shares  $57,143 
Private company shares   132,260 
Balance at December 31, 2023  $189,403 
      
Public company shares  $57,143 
Private company shares   135,440 
Balance at December 31, 2022  $192,583 

 

The Company holds 1,428,571 common shares (2022 – 1,428,571) and nil (2022 – 1,428,571) warrants of Windfall Geotek Inc. a publicly traded company. At December 31, 2023 the fair value of the shares was based on the quoted price of $0.04 (2022 - $0.04). As of the issue date of these consolidated financial statements the quoted price of the shares was $0.03. The warrants expired on March 17, 2023. The fair values of the warrants as of December 31, 2022 were estimated using the Black-Scholes Option Pricing Model with the following assumptions:

   December 31, 2022 
Risk free interest rate   4.07%
Expected volatility   116.00%
Expected life   0.21 years 
Expected dividend yield   0%

 

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. In determining the fair value of the investment (classified at level 3 in the fair value hierarchy), the Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.

 

F-19
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

10. EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
Cost                        
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
Additions   60,240    528,080    -    -    -    588,320 
Disposals   (18,688)   (36,099)   (4,352)   (29,967)   -    (89,106)
Balance at December 31, 2022  $95,662   $834,453   $-   $-   $36,033   $966,148 
Additions   58,611    320,941    86,530    -    24,310    490,394 
Disposals   (21,000)   (115,204)   -    -    -    (136,204)
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $-   $60,343   $1,320,338 
                               
Accumulated depreciation                              
Balance at December 31, 2021  $25,291   $102,277   $4,352   $24,737   $13,234   $169,891 
Charge for the year   32,627    433,855    -    -    3,435    469,917 
Disposals   (15,920)   (33,342)   (4,352)   (24,737)   -    (78,351)
Balance at December 31, 2022  $41,998   $502,790   $-   $-   $16,669   $561,457 
Charge for the year   22,762    112,361    6,790    -    12,497    154,410 
Disposals   (6,582)   (69,748)   -    -    -    (76,330)
Balance at December 31, 2023  $58,178   $545,403   $6,790   $-   $29,166   $639,537 
                               
Net book value:                              
December 31, 2022  $53,664   $331,663   $-   $-   $19,364   $404,691 
December 31, 2023  $75,095   $494,789   $79,740   $-   $31,177   $680,801 

 

During the year ended December 31, 2022 $508,607 of inventory that was used for rental services was transferred to equipment.

 

F-20
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

11. INTANGIBLE ASSETS AND GOODWILL

SCHEDULE OF INTELLECTUAL PROPERTY 

   Patents   Customer Relationships   Brand  

 

Software

   Goodwill   Total 
Cost                        
Balance at December 31, 2021  $41,931   $197,000   $23,000   $552,000   $5,940,409   $6,754,340 
Additions   -    -    -    4,684    -    4,684 
Foreign exchange translation   -    -    1,571    29,576    257,782    288,929 
Impairment   -    -    (24,571)   (462,577)   (6,198,191)   (6,685,339)
Balance at December 31, 2022  $41,931   $197,000   $-   $123,683   $-   $362,614 
Impairment   -    (87,415)   -    -    -    (87,415)
Balance at December 31, 2023  $41,931   $109,585   $-   $123,683   $-   $275,199 
                               
Accumulated amortization                              
Balance at December 31, 2021  $41,931   $60,414   $3,450   $114,235   $-   $220,030 
Charge for the year   -    27,317    4,719    147,446    -    179,482 
Foreign exchange translation   -    -    431    13,295    -    13,726 
Impairment   -    -    (8,600)   (221,825)   -    (230,425)
Balance at December 31, 2022   41,931    87,731    -    53,151    -    182,813 
Charge for the year   -    21,854    -    14,106    -    35,960 
Balance at December 31, 2023  $41,931   $109,585   $-   $67,257   $-   $218,773 
                               

Net book value:

                              
December 31, 2022  $-   $109,269   $-   $70,532   $-   $179,801 
December 31, 2023  $-   $-   $-   $56,426   $-   $56,426 

 

Goodwill

 

On December 31, 2022 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

 

  5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2% (2021 – 2%).
  Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 6.5% (2021 – 14%) for Dronelogics and 0% (2021 – 42%) for Vital Intelligence Inc. (“Vital”) respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.
  Cash flows were discounted at the weighted average cost of capital of 19% (2021 – 17%) for Dronelogics and 29% (2021 – 24%) for Vital based on peer group averages and adjusted for the Company’s risk factors.

 

Based on the annual goodwill impairment test, the Company determined that the goodwill for Dronelogics and Vital required impairment, as such the Company recorded an impairment charge of $2,166,563 (2021 – nil) for Dronelogics and $4,031,628 (2021 - $4,579,763) for Vital. In addition to the goodwill, the Company deemed that the brand and software for Vital required impairment, as such the Company recorded an impairment charge of $15,971 and $240,752 respectively.

 

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

 

  A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $104,248 for Dronelogics (2021 – $597,100) and $Nil for Vital (2021 - $570,133).

 

F-21
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

12. RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2021 and 2022  $683,117 
Additions   740,355 
Lease adjustment   - 
Balance at December 31, 2023  $1,423,472 
      
Accumulated depreciation     
Balance at December 31, 2021  $215,011 
Charge for the year   123,360 
Balance at December 31, 2022  $338,371 
Charge for the year   363,086 
Foreign exchange   328 
Balance at December 31, 2023  $701,785 
      
Net book value:     
December 31, 2022  $344,746 
December 31, 2023  $721,687 

 

The consolidated statement of financial position shows the following amounts related to leases:

   December 31, 2023   December 31, 2022 
Buildings  $721,687   $342,361 
Vehicles   -    2,385 
Right of use assets  $721,687   $344,746 

 

Additions to the right of the assets during the 2023 financial year were $740,355 (2022 - $nil).

 

13. LEASE LIABILITES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

 

   Total 
Balance at December 31, 2021  $489,123 
Interest expense   39,795 
Lease payments   (150,275)
Balance at December 31, 2022   378,643 
Interest expense   96,423 
Additions   734,903 
Lease payments   (423,410)
Foreign exchange   3,464 
Balance at December 31, 2023  $790,023 

 

Which consists of:        
         
   December 31, 2023   December 31, 2022 
Current lease liability  $362,001   $133,962 
Non-current lease liability   428,022    244,681 
Ending balance  $790,023   $378,643 

 

Maturity analysis  December 31, 2023   December 31, 2022 
Less than one year  $429,948   $147,340 
One to three years   355,879    209,078 
Four to five years   141,519    83,850 
Total undiscounted lease liabilities   927,346    440,268 
Amount representing interest   (137,323)   (61,625)
Lease liability  $790,023   $378,643 

 

Variable lease payments of $43,542 (2022 - $22,539) have been recognized in profit and loss.

 

F-22
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

14. TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2023   December 31, 2022 
Trade accounts payable  $1,259,623   $751,422 
Accrued liabilities   1,345,649    2,031,545 
Government grant payable   33,709    33,709 
Trade payables and accrued liabilities  $2,638,981   $2,816,676 

 

15. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   December 31, 2023   December 31, 2022 
Deferred, revenue beginning  $63,690   $5,233 
Revenue recognized   (64,816)   (4,939)
Unearned revenues received   108,800    63,396 
 Deferred income gross   $107,674   $63,690 
Current portion  $12,112   $63,690 
Long term portion   95,562    - 
 Deferred Income net  $107,674   $63,690 

 

Deferred revenue of $12,112 as of December 31, 2023 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangement and will be recognized according to the terms of that arrangement over the next 5 years.

 

16. LOANS PAYABLE

 

   December 31, 2023   December 31, 2022 
Opening balance  $86,571   $93,317 
Issuance of loans payable   -    - 
Fair value adjustment   -    (4,891)
Repayment of loans payable   (6,747)   (6,746)
Accretion expense   5,234    4,891 
Ending balance  $85,058   $86,571 

 

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2023   Carrying Value December 31, 2022 
CEBA  2020-05-19  2024-03-28   0%  $40,000   $37,383 
CEBA  2021-04-23  2024-03-28   0%   40,000    37,383 
Vehicle loan  2019-08-30  2024-09-11   6.99%   5,058    11,805 
Total             $85,058   $86,571 

 

F-23
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

16. LOANS PAYABLE (CONT’D)

 

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before January 18, 2024. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%. On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the entire loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.

 

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.

 

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.

 

17. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2023,

 

  The Company issued 1,508,255 common shares for the vesting of restricted share units.
  The Company issued 8,000,000 common shares in a financing for $10,856,166 with share issuance costs of $1,953,032 for net proceeds of $8,903,134.
  The Company issued 650,729 common shares in an ATM (“At – the - market”) financing for $1,748,946 with share issuance costs of $222,136 for net proceeds of $1,526,810.
  The Company issued 4,800,000 common shares in a financing for proceeds of $4,858,995 with share issuance costs of $889,623 for net proceeds of $3,969,372. Of the total share issuance costs $793,979 were expensed in other income (expense).

 

During the year ended December 31, 2022,

 

  The Company issued 16,538 common shares for the exercise of warrants for $87,170.
  The Company issued 12,500 common shares for the exercise of stock options for $26,875.
  The Company issued 1,072,595 common shares for the vesting of restricted share units.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

F-24
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

As at December 31, 2023, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $2.50    5.84    278,332    278,332 
November 19, 2019  November 19, 2029  $2.50    5.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    6.33    85,000    85,000 
April 30, 2020  April 30, 2030  $3.85    6.33    110,000    110,000 
July 3, 2020  July 3, 2025  $3.20    1.51    100,000    100,000 
November 24, 2020  November 24, 2030  $2.50    6.90    32,000    32,000 
February 2, 2021  February 2, 2031  $13.20    7.10    30,000    30,000 
March 8, 2021  March 8, 2026  $13.90    2.19    10,000    10,000 
April 27, 2021  April 27, 2031  $10.15    7.33    146,000    97,326 
September 9, 2021  September 9, 2026  $4.84    2.69    25,826    17,217 
November 9, 2023  November 9, 2033  $0.626    9.87    30,000    10,000 
                 897,158    819,875 

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2021   1,035,991   $4.60 
Exercised   (12,500)   2.15 
Forfeited   (146,334)   4.77 
Outstanding, December 31, 2022   877,157   $4.60 
Forfeited   (9,999)   3.77 
Issued   30,000    0.63 
Outstanding, December 31, 2023   897,158   $4.48 

 

During the year ended December 31, 2023,

 

  The Company granted 30,000 options to an advisor to the board. Each option is exercisable at $0.626 per share for 10 years.

 

No options were granted by the Company for the year ended December 31, 2022

 

During the year ended December 31, 2023, the Company recorded $151,174 (2022- $502,837) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

Year ended December 31,  December 31, 2023   December 31, 2022 
Risk free interest rate   4.58%   - 
Expected volatility   115.1%   - 
Expected life   10    - 
Expected dividend yield   0%   - 
Exercise price  $0.63   $- 

 

F-25
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company in its discretion and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at December 31, 2023, the Company had the following RSUs outstanding:

 

   Number of RSU’s 
Outstanding, December 31, 2021   514,832 
Vested   (1,072,595)
Issued    1,820,972 
Forfeited   (64,334)
Outstanding, December 31, 2022   1,198,875 
Vested   (1,508,255)
Issued    1,685,316 
Forfeited   (262,969)
Outstanding, December 31, 2023   1,112,967 

 

During the year ended December 31, 2023, 1,508,255 RSU’s fully vested according to the terms and the Company granted 1,687,014 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 264,668 RSU’s were forfeited by employees who have left the Company.

 

During the year ended December 31, 2022, 1,072,595 RSU’s fully vested according to the terms and the Company granted 1,820,972 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 64,334 RSU’s were forfeited by employees who have left the Company.

 

During the year ended December 31, 2023, the Company recorded share-based payment expense of $1,866,490 (2022: $2,808,187) for RSU’s, based on the fair values of RSU’s granted which are calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the year ended December 31, 2023, the Company issued 1,600,000 warrants for a purchase price of $0.5499USD with an exercise price of $0.0001USD per unit. The Company also issued 6,400,000 warrants at an exercise price $0.6123USD. Being in a currency that is not the Company’s functional currency these warrants are required to be recorded as a financial liability. As a financial liability, the portion of the warrants related to the future exercise price will be revalued at every reporting period to fair market value with the change in fair value being recorded in profit or loss. All of the above warrants have a 5 year term, expiring October 30, 2028 and vest immediately. 320,000 underwriter warrants were issued as part of the transaction with an exercise price of $0.6875USD and a term of 3 years. These warrants were treated as share issue costs.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period. At the date of issue the warrants were valued with a risk free rate of 4.8%, volatility of 115.35%, expected life of 5 years and an expected dividend yield rate of 0%. The broker warrants were valued with a risk free rate of 4.87%, volatility of 138.83%, expected life of 3 years and an expected dividend yield of 0%.

 

F-26
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

Warrant Derivative Liability

 

Balance at December 31, 2021  $4,865,772 
Change in fair value of warrants outstanding   (4,865,772)
Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110
Balance at December 31, 2023  $4,196,125 

 

Derivative liability balance at  December 31, 2023   December 31, 2022 
Warrants  $4,196,125   $- 
Contingent consideration   -    57,314 
Ending balance  $4,196,125   $57,314 

 

The contingent liability is related to an acquisition on March 22, 2021, whereby 1,200,000 warrants were issued and 900,000 were held in escrow and classified as a contingent liability that were to be released upon completion of certain milestones. The milestones were related to the recognition of revenue on the related acquisition in range of $2,000,000 to $6,000,000 which was not met. The warrants expired on March 25, 2023.

 

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price   Number of Warrants Outstanding at December 31, 2023   Fair Value at December 31, 2023   Number of Warrants Outstanding at December 31, 2022   Fair Value at December 31, 2022 
February 5, 2021 (1)  US$ 3.55    -   $-    1,319,675   $- 
March 5, 2021 (2)  US$  3.55    -    -    5,142,324    - 
October 30, 2023 (3)  US$ 0.6123    6,400,000    3,180,543    -    - 
October 30, 2023 (4)  US$0.0001    1,600,000    1,015,582    -    - 
         8,000,000   $4,196,125    6,461,999   $- 

 

  1) The warrants expired on February 5, 2023.
  2) The warrants expired on March 5, 2023.
  3) The warrants expire October 30, 2028.
  4) The warrants have no expiry date.

 

F-27
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   December 31, 2023   December 31, 2022 
Risk free interest rate   3.84%   4.07%
Expected volatility   113.78%   91.66%-93.48% 
Expected life   4.8 years    0.10-0.18 years 
Expected dividend yield   0%   0%

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2021   8,414,819   $4.99 
Exercised   (16,538)   4.51 
Issued   (481,484)   4.61 
Outstanding, December 31, 2022   7,916,797   $5.08 
Issued   8,320,000    0.50 
Expired   (7,661,999)   5.89 
Outstanding December 31, 2023   8,574,798   $0.63 

 

As at December 31, 2023, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of warrants outstanding 
July 29, 2021  July 29, 2024  US$ 5.00    250,000 
September 14, 2021  September 14, 2024  US$5.00    4,798 
October 30, 2023  October 30, 2026  US$0.6875    320,000 
October 30, 2023  October 30, 2028  US$0.6123    6,400,000 
October 30, 2023  No expiry date  US$0.0001    1,600,000 
            8,574,798 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2023, was 4.63 years (December 31, 2022 – 0.47 years).

 

18. SEGMENTED INFORMATION

 

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

F-28
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

18. SEGMENTED INFORMATION (CONT’D)

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, lead director, chief operating officer and chief financial officer.

 

December 31, 2023  Drones   Vital   Corporate   Total 
Sales of goods  $4,905,417   $381,676   $-   $5,287,093 
Provision of services   1,267,749    -    -    1,267,749 
Total revenue  $6,173,166   $381,676   $-   $6,554,842 
Segment loss  $14,743,176   $(140,366)  $8,323,731   $22,926,541 
Finance and other costs   (80,211)   -    (3,069)   (83,280)
Depreciation   499,530    -    11,148    510,677 
Amortization   35,960    -    -    35,960 
Change in fair value of derivative liability   -    -    (211,110)   (211,110)
Loss (recovery) on write-off of notes receivable   -    -    101,351    101,351 
Loss on write down of inventory   331,671    -    -    331,671 
Net loss for the year  $15,530,126   $(140,366)  $8,222,051   $23,611,810 

 

December 31, 2022  Drones   Vital   Corporate   Total 
Sales of goods  $5,388,262   $162,170   $-   $5,550,432 
Provision of services   2,054,627    -    -    2,054,627 
Total revenue  $7,442,889   $162,170   $-   $7,605,059 
Segment loss  $9,929,789   $602,580   $12,926,884   $23,459,253 
Finance and other costs   (3,529)   -    (40,186)   (44,345)
Depreciation   586,185    -    -    593,277 
Amortization   179,482    -    -    179,482 
Impairment of goodwill and intangibles   2,166,563    4,288,351    -    6,454,914 
Change in fair value of derivative liability   -    -    (5,502,688)   (5,502,688)
Loss on write-off of notes receivable   1,080,645    -    (771,260)   309,385 
Loss on write down of inventory   251,754    1,724,760    -    1,976,514 
Write down of deposit   -    228,572    -    228,572 
Net loss for the year  $14,190,889   $6,844,263   $6,619,212   $27,654,364 

 

December 31, 2021  Drones   Vital   Corporate   Total 
Sales of goods   4,957,134    146,265    -    5,103,399 
Provision of services   1,950,466    -    -    1,950,466 
Total revenue  $6,907,600   $146,265   $-   $7,053,865 
Segment loss  $7,819,739   $257,656   $10,498,164   $18,575,560 
Finance and other costs   16,272    -    (21,346)   (5,074)
Depreciation   175,098    -    -    175,098 
Amortization   135,966    -    -    135,966 
Impairment of goodwill and intangibles   -    4,579,763    -    4,579,763 
Change in fair value of derivative liability   -    -    (8,149,812)   (8,149,812)
Loss on write-off of notes receivable   -    -    891,471    891,471 
Net loss for the year  $8,147,075   $4,837,419   $3,218,477   $16,202,972 

 

 

   2023   2022      2021  
Geographic segmentation is as follows:  For the years ended December 31,  
   2023   2022    2021  
Non-current assets                  
Canada  $1,441,701   $1,121,821    $ 3,441,872  
United States   206,616    -      5,112,659  
   $1,648,317   $1,121,821    $ 8,554,531  
Revenue                  
Canada  $6,162,672   $6,919,038    $ 4,982,373  
United States   392,170    686,021      2,071,492  
Revenue  $6,554,842   $7,605,059    $ 7,053,865  

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

F-29
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

19. OFFICE AND MISCELLANEOUS

 

     2023      2022   2021 
     For the years ended December 31, 
   2023     2022   2021 
Advertising, Marketing, and Investor Relations  $ 4,243,432     $4,431,818   $5,165,791 
Compliance fees    193,250      152,826    432,874 
Impairment of accounts receivable    216,238      -    - 
Contract Work    772,003      441,798    300,975 
Other    878,956      371,519    556,358 
Office and Miscellaneous Expenses  $ 6,303,879     $5,397,961   $6,455,998 

 

20. RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2023, the Company incurred fees of $429,766 (December 31, 2022 - $442,485) which are included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $3,780 (December 31, 2022 - $30,804).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2023, the Company incurred fees of $592,500 (December 31, 2022 - $566,487) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $35,417 (December 31, 2022 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2023, the Company incurred fees of $215,019 (December 31, 2022 - $383,288) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $9,287 (December 31, 2022 - $20,745).

 

Trade receivables/payables and accrued receivables/payables:

 

As at December 31, 2023, the Company had $190,664 (December 31, 2022 - $51,549) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

F-30
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

20. RELATED PARTY TRANSACTIONS (CONT’D)

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023 and 2022 included:

 

      For the years ended December 31, 
    2023    2022   2021 
Director fees   $ 600,933     $522,349   $370,094 
Salaries     979,154      843,917    722,068 
Share-based payments     1,109,232      2,106,906    2,475,949 
Total   $ 2,689,319    $3,473,172   $3,568,111 

 

Other related party transactions

 

    For the years ended December 31,
    2023    2022   2021 
Management fees paid to a company controlled by CEO and director   $ 592,500    $566,487   $290,225 
Management fees paid to a company that the CEO holds an economic interest in     429,766     442,485    315,643 
Management fees paid to a company controlled by a director     215,019     383,288    205,691 
Management fees paid to a company, total    $ 1,237,285    $1,392,260   $811,559 

 

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers.

 

Receivables

 

Receivables primarily consist of trade receivables, accrued receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

F-31
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date abut past events, current conditions and forecasts of future economic conditions. Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

The Company’s aging of receivables was as follows:

 SCHEDULE OF AGING OF RECEIVABLES

   December 31, 2023   December 31, 2022 
0 – 30 days  $271,622   $1,020,091 
31 – 60 days   109,928    116,378 
61 – 90 days   64,259    343,364 
91 + days   203,803    609,132 
 Total receivables  $649,612   $2,088,965 

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2023:

 

 SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES

   1 year   1 – 5 years   Total 
Trade payables and accrued liabilities  $2,638,981   $-   $2,638,981 
Customer deposits   104,715    -    104,715 
Deferred income   12,112    95,562    107,674 
Loans payable   85,058    -    85,058 
Derivative liability   4,196,125    -    4,196,125 
Lease liability   429,948    497,398    927,346 
 Financial liabilities  $7,466,939   $592,960   $8,059,899 

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

F-32
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

 

   December 31, 2023   December 31, 2022 
Foreign exchange rate  $530,758   $969,977 

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the consolidated statements of financial position. These financial assets are measured at fair value through profit and loss.

 

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2023  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $       -   $132,260   $189,403 
Derivative liability   -    -    4,196,125    4,196,125 
Total  $57,413   $-   $4,328,385   $4,385,528 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $    -   $

135,440

   $192,583 
Notes receivable   -    -    169,300    169,300 
Derivative liability   -    -    57,314    57,314 
Total  $57,143   $-   $362,054   $419,197 

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

 

Type

 

 

Valuation technique

 

 

Key inputs

  Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

 

●    Share price

●    Risk free interest rate

●    Dividend yield

Key unobservable inputs

●    Expected volatility

 

The estimated fair value would increase (decrease) if:

 

     The price was higher (lower)

●     The risk-free rate was higher (lower)

●     The dividend yield was lower (higher)

●     The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
      

Year ended

December 31, 2023

  

Year ended

December 31, 2022

 
Volatility   20%  $291,149   $- 

 

Capital Management

 

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity.

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2022.

 

F-33
 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

22. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2023 and 2022:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Loss before income taxes  $23,611,810  $27,654,364    $ 16,202,972  
Canadian statutory rates   27%   27%     27 %
Expected income tax recovery   6,330,400   7,338,900      4,196,600  
Impact of different foreign statutory tax rates   -    -      34,900  
Non-deductible items   (509,800)   (1,214,400)     116,400  
Share issue costs   773,400   1,400      887,600  
Adjustments to prior years provision versus statutory tax returns   (87,600)   (742,400)     376,500  
Differences between prior year provision and final tax return   (153,400)   867,500      (206,000 )
Change in deferred tax asset not recognized   (6,353,000)   (6,251,000)     (5,406,000 )
Income tax  $-   $-    $ -  

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Deferred income tax assets (liabilities):                  
Share issuance costs  $995,000   $568,000    $ 728,000  
Non-capital losses   20,377,000    14,602,000      7,043,000  
Property and equipment   1,115,000    962,000      449,000  
Capital gain reserve   -    -      74,000  
Scientific Research and Experimental Development   365,000    367,000      291,000  
Total deferred income tax assets  $22,852,000   $16,499,000      8,585,000  
Deferred income tax not recognized   (22,852,000)   (16,499,000)     (8,585,000 )
Net deferred tax assets  $-   $-    $ -  

 

The Company has non-capital loss carry forward of approximately $67,701,122 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2030 to 2043. The Company has non-capital loss carry forward of $8,241,878 CAD ($6,231,434 USD) which may be carried forward to apply against future year income tax for tax purposes in the United States, subject to the final determination by the tax authorities, expiring in the years 2040 to 2043.

 

23. SUBSEQUENT EVENTS

 

Warrant exercise

 

On February 6, 2024 1,600,000 pre-funded warrants were exercised for proceeds of $160 USD ($216 CAD) and an equal number of shares were issued at a value of $578,200 USD ($773,624 CAD).

 

Share issuance

 

On February 26, 2024, the Company announced that it completed an underwritten share placement of 11,200,000 units with each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. Each unit was sold at a price of $0.27 USD for gross proceeds of $3.6 million ($4.8 million CAD). Net proceeds of $3.3 million USD ($4.4 million CAD) was received after share issue costs of $329,000 USD ($442,000 CAD). The pre-funded warrants have an exercise price of $0.0001 USD and were exercised on the date of issue. The remaining warrants have an exercise price of $0.36 USD and are exercisable immediately with a term of 5 years. As part of this transaction 670,000 warrants were issued to the underwriter with an exercise price of $0.3375 USD and will have a term of 3 years.

 

F-34

EX-4.4 2 ex4-4.htm

 

Exhibit 4.4

 

INDEPENDENT CONSULTANT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of April 1, 2022 (the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

1502372 ALBERTA LTD.,

 

a corporation having an address at L120, 2303 – 4 Street SW, Calgary, AB T2S 2S7

 

‎(Hereinafter referred to as the “Consultant”)

 

-and-

 

CAMERON CHELL,

 

the principal of the Consultant

 

‎(Hereinafter referred to as the “Principal”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Parties entered into an Independent Consultant Agreement dated October 1, ‎‎2019 and subsequent Independent Consultant Agreement Amending ‎Agreements dated September 30, 2021 and March 25, 2022 (together, the ‎‎”Independent Consultant Agreement”) setting out the terms and conditions of ‎the Consultant’s engagement;‎

 

B.The Company wishes to continue to engage the services of the Consultant and the ‎Principal, and the Consultant and Principal desire to continue to be engaged by the ‎Company upon the terms and subject to the conditions of the Independent Consultant ‎Agreement as amended by the terms of this Independent Consultant Agreement Amending Agreement (this “Amending Agreement”) hereinafter set ‎forth;‎

 

 

 

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Independent Consultant Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Consultant’s consulting fees and the grant of restricted share units, and in exchange for the Consultant and Principal’s continued engagement, the Parties agree to amend the Independent Consultant Agreement as follows:

 

1. Provision 3.1 entitled “Consideration for Services” in the Independent Consultant Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay to the Consultant a consulting fee in the amount of CAD $400,000 per year for the remainder of this Agreement or until any change is mutually agreed upon. All fees will be paid on a monthly basis upon submission of an invoice.

 

2. Provision 3.2 entitled “Consideration for Services” will be added into the Independent Consultant Agreement as follows:

 

As further compensation for carrying out the Services during the term of this Agreement, the Consultant will be eligible to receive an annual success fee (the “Success Fee”) ‎as determined by the Company in its sole ‎discretion. The Success Fee, if any, for a given year: (i) will be determined following the completion of the Company’s financial year ‎each year, based on performance metrics to be determined by the Company’s ‎compensation committee in its sole discretion; (ii) will be paid following the completion of such year; and (iii) is not ‎earned or accrued until and unless the Consultant is engaged on the last day of the period for ‎which the Success Fee is payable. ‎ The Consultant understands and agrees that payment of a Success Fee should not be considered to be expected compensation and the payment of a Success Fee in any one or successive years shall not create an entitlement to a Success Fee in any subsequent year.

 

Beginning in the calendar year of 2021, the Consultant’s target annual Success Fee is CDN$300,000.00, pro-rated to the date of this Amending Agreement for 2021.

 

3. Provision 3.3 entitled “Consideration for Services” will be added into the Independent Consultant Agreement as follows:

 

Subject to the receipt of all necessary regulatory approvals, the Company shall grant to the Consultant 40,000 restricted share units (“RSU”) in Draganfly Inc., which shall vest and be governed in accordance with the Company’s RSU plan.

 

4. All other terms and conditions of engagement set out in the Independent Consultant Agreement will remain unchanged and in effect.

 

-2-

 

 

5. The Consultant hereby releases the Company from any and all claims it has or may have arising in any way out of the terms of this Amending Agreement or the changes to its engagement as set out herein, specifically includes any claims under any applicable human rights, workers’ compensation, employment standards, employment or labour legislation.
   
6. This Amending Agreement amends the Independent Consultant Agreement. This Amending Agreement and the Independent Consultant Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.
   
7. This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.
   
8. If there is a conflict between any provision of this Amending Agreement and any provision of the Independent Consultant Agreement, the relevant provision(s) of this Amending Agreement are to prevail.
   
9.

This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of British Columbia. The Parties irrevocably attorn to the jurisdiction to the Courts of the Province of British Columbia.

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Amending Agreement, including the increase in the Consultant’s compensation, and in exchange for the Consultant and Principal’s continued engagement, the Parties agree to amend the Independent Consultant Agreement as follows:

 

1.Provision 3.1 entitled “Consideration for Services” in the Independent Consultant Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay to the Consultant a consulting fee in the amount of CAD$425,000.00 per year for the remainder of this Agreement or until any change is mutually agreed upon. Any such changes may be mutually agreed upon in writing, without requiring a written amendment to this Agreement, and without causing ‎termination or breach of this Agreement.‎ All fees will be paid on a monthly basis upon submission of an invoice. ‎

 

2.Provision 3.2 entitled “Consideration for Services” in the Independent Consultant Agreement will be replaced with the following:

 

As further compensation for carrying out the Services during the term of this Agreement, the Consultant will be eligible to receive an annual success fee (the “Success Fee”) ‎as determined by the Company in its sole ‎discretion. The Success Fee, if any, for a given year: (i) will be determined following the completion of the Company’s financial year ‎each year, based on performance metrics to be determined by the Company’s ‎compensation committee in its sole discretion; (ii) will be paid following the completion of such year; and (iii) is not ‎earned or accrued until and unless the Consultant is engaged on the last day of the period for ‎which the Success Fee is payable. ‎ The Consultant understands and agrees that payment of a Success Fee should not be considered to be expected compensation and the payment of a Success Fee in any one or successive years shall not create an entitlement to a Success Fee in any subsequent year.

 

-3-

 

 

The performance metrics and target Success Fee of the Consultant for any given year are attached hereto as Schedule “B”. Schedule “B” will be reviewed from time-to-time and may be amended by the Company without requiring a written amendment to this Agreement, and without causing ‎termination or breach of this Agreement.

 

3.Provision 3.3 entitled “Consideration for Services” will be added into the Independent ‎Consultant Agreement as follows:

 

The Company will ‎grant the Consultant 200,000 restricted share units of the Company (“RSUs”) to purchase up to ‎‎200,000 common shares of the Company. The grant of RSUs to the Consultant shall be made in ‎accordance with the terms and conditions of the Company’s Amended and Restated Share ‎Compensation Plan (the “Plan”) and applicable rules and requirements of the Canadian Securities ‎Exchange and NASDAQ. The RSUs shall vest in accordance with the following vesting ‎schedule:‎

 

a)‎66,666 RSUs granted on the ‎date that is ‎the 6-month ‎anniversary of ‎the Effective Date‎ of the Independent Consultant Agreement Amending Agreement;‎

 

b)‎66,667 RSUs granted on the ‎date that is ‎the 12-month ‎anniversary of ‎the Effective Date‎ of the Independent Consultant Agreement Amending Agreement‎; and‎

 

c)‎66,667 RSUs granted on the ‎date that is ‎the 18-month ‎anniversary of ‎the Effective Date‎ of the Independent Consultant Agreement Amending Agreement‎.‎

 

4.Schedule “B” entitled “Success Fee Program” will be added into the Independent ‎Consultant Agreement as follows:‎

 

For the calendar year of 2022, the Consultant’s target annual Success Fee is ‎CDN$425,000.00, based on the following milestones and achievements:

 

   % Bonus 
Revenue of $13 million (min revenue of $8M)   30%
Min $20 mill in bank on Dec 31.   20%
$15 million in new financing   15%
Net Income as per budget   25%
Institutional Coverage x2   10%
    100%

 

5.All other terms and conditions of engagement set out in the Independent Consultant ‎Agreement will remain unchanged and in effect. ‎

 

6.The Consultant hereby releases the Company from any and all claims it has or may ‎have arising in any way out of the terms of this Amending Agreement or the ‎changes to its engagement as set out herein, which specifically includes any ‎claims under any applicable human rights, workers’ compensation, ‎occupational health and safety, and employment standards legislation.‎

 

7.This Amending Agreement amends the Independent Consultant Agreement. This ‎Amending Agreement and the Independent Consultant Agreement shall be ‎read together and constitute one agreement. The Parties agree that the terms of ‎the Amending Agreement will be effective on the Effective Date. ‎

 

8.This Amending Agreement enures to the benefit of and binds the parties hereto and ‎their respective heirs, executors, legal personal representatives, successors and ‎permitted assigns.‎

 

9.If there is a conflict between any provision of this Amending Agreement and any ‎provision of the Independent Consultant Agreement, the relevant provision(s) of ‎this Amending Agreement are to prevail.‎

 

10.This Amending Agreement is governed by, and is to be construed and interpreted in ‎accordance with the laws of British Columbia. The Parties irrevocably attorn to ‎the jurisdiction to the Courts of the Province of British Columbia.‎

 

[signature page follows]

 

-4-

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this 1st day of April 2021:

 

    “/s/ Cameron Chell”

DRAGANFLY INC.

 

Authorized Signatory

I have authority to bind the Corporation

 

1502372 ALBERTA LTD.

 

by its authorized signatory,

Cameron Chell

     
    “/s/ Cameron Chell”
    CAMERON CHELL
     
    Principal of 1502372 Alberta Ltd.

 

 

 

EX-4.5 3 ex4-5.htm

 

Exhibit 4.5

 

INDEPENDENT CONSULTING AGREEMENT

 

THIS INDEPENDENT CONSULTING AGREEMENT (the “AGREEMENT”) is entered into on April 1, 2022 (the “Effective Date”)

 

BETWEEN:

 

DRAGANFLY INC.

(the “Company”)

 

and -

 

SCOTT LARSON

(“Consultant”)

 

WHEREAS The Company is builder and supplier of quality, cutting-edge unmanned aerial vehicles and geoinformation software that serves the public safety, agriculture, industrial inspections, security, and mapping and surveying markets (the “Business”);

 

AND WHEREAS The Consultant is an Consultant with relevant operational, financial and corporate development experience in the technology sector and whose skills are a material inducement for the Company to enter into this Agreement;

 

AND WHEREAS The Company desires to retain the Consultant as an Independent Contractor on a limited basis to provide corporate development, operational, financial assistance and to

 

generally assist the company in its strategic plan (the “Services”); and

 

NOW THEREFORE The Consultant agrees to provide the Services as an Independent Contractor to the Company, subject to the terms of this Agreement.

 

COMMENCEMENT AND TERM

 

1.01Term

 

This Agreement shall become effective on the Effective Date and shall remain in ‎force and effect until ‎terminated by the parties in accordance with the terms of this Agreement. ‎‎This Agreement supersedes and replaces all previous agreements between the Consultant ‎and ‎the Company.

 


ASSIGNMENT

 

2.01Position

 

‎The Consultant shall provide the Services‎ and Duties (as defined herein) as an external resource, as directed by the CEO and Board of the Company. The Consultant shall determine the manner or means by which it performs the ‎Services and Duties for the Company‎.

 

‎The Consultant shall furnish, at its own ‎expense, the equipment, supplies, tools and other materials used to perform the Services and Duties.‎

 

2.02Duties

 

As set out below, Consultant shall perform the duties and tasks as directed by the CEO and as agreed to by the Consultant (the “Duties”). In addition, Consultant shall perform such Duties and exercise such powers as prescribed or specified by the Board of Directors, and as agreed by the Consultant. Consultant further acknowledges that such Duties and responsibilities may require frequent travel and frequent performance of work at irregular times acting reasonably.

 

Consultant shall support and lead the mergers and acquisitions of the Company, and support the development and execution of the Company’s long-term strategy with a view to creating shareholder value. Consultant shall, under direction of the CEO and Board of Directors, among other things:

 

a)act as a key point of contact with potential merger or acquisition targets;

 

b)act as a direct liaison between the Board of Directors and management of the Company;

 

c)support strategic business and corporate development efforts as mutually agreed to by the Company and Consultant.

 

 

 

 

2.03Independent Contractor Relationship

 

The Consultant is and shall remain at all times an independent contractor and not an ‎employee or dependent contractor of the Company. Nothing in this Agreement shall be ‎construed to create any association, partnership, joint venture, agency, fiduciary or ‎employment relationship between the Consultant and the Company, for any purpose. ‎

 

The Consultant shall provide the Services to the Company on a non-exclusive basis, and ‎shall be free to provide its services to third parties during the term of this Agreement ‎provided that the Consultant shall not provide such services in a way that is inconsistent with ‎any of the provisions of this Agreement. ‎

 

‎Without limiting this Section 2.03, the Consultant shall not be eligible to participate in ‎any benefit or compensation plans offered by the Company to its employees, including, ‎without limitation, any payments under any employment standards legislation. ‎

 

The Company shall have no liability or responsibility for withholding or remitting any income, ‎payroll, or other federal or provincial taxes, including employment insurance remittances, ‎pension plan contributions, or employer health tax or worker’s compensation insurance ‎premiums for the Consultant. The Consultant is responsible for these withholding, remitting and ‎registration obligations, and shall indemnify the Company from and against any order, penalty, ‎interest, taxes or contributions that may be assessed against the Company due to the failure or ‎delay of the Consultant to make any such withholdings, remittances or registration, or to file any ‎information required by any law. ‎

 

REMUNERATION

 

3.01Fees

 

Commencing on the Effective Date, the Company shall pay Consultant:

 

a)An hourly fee of $350.00, plus applicable taxes (the “Basic Fee”), payable upon invoice. The Consultant shall submit to the Company’s CEO or designate a monthly timesheet detailing the hours worked ‎and a reasonable ‎description of the work performed‎; and

 

b)As further compensation for carrying out the Services during the term of this ‎Agreement, the Consultant will be eligible to receive an annual success fee (the ‎‎”Success Fee”) ‎as determined by the Company in its sole ‎discretion. In connection with the Consultant’s 2021 compensation, the Company shall pay the Consultant a Success Fee of US$51,156.00 plus C$66,150.00. The Success Fee for a given future year of service, if any: (i) will be ‎determined following the ‎completion of the Company’s ‎financial year ‎each year, ‎based on performance metrics to be ‎determined by the ‎Company’s ‎compensation committee in its ‎sole discretion; (ii) ‎will be paid following the completion of ‎such year; and (iii) is ‎not ‎earned or accrued until and unless ‎the Consultant is ‎engaged on the last day of the period for ‎‎which the Success ‎Fee is payable. ‎ The Consultant ‎understands and agrees ‎that payment of a Success Fee ‎should not be considered to ‎be expected compensation and ‎the payment of a Success ‎Fee in any one or successive ‎years shall not create an ‎entitlement to a Success Fee in any ‎subsequent year.

 

The Basic Fee and Success Fee shall be reviewed by the Company’s compensation committee following the completion of the Company’s financial year each year. The performance metrics and target Success Fee of the ‎‎Consultant for any given year will be reviewed from time-to-‎‎time and may be amended by the Company without ‎‎requiring a written amendment to this Agreement, and ‎‎without causing ‎termination or breach of this Agreement.‎

 

‎The Consultant shall have an applicable sales tax registration number and shall be ‎responsible for deducting and remitting such sales tax to the appropriate regulatory ‎authorities. ‎

 

 

 

 

3.02Equity Awards

 

Concurrent with the execution hereof and by virtue of Consultant’s position, the Company will grant the Consultant 50,000 restricted share units of the Company (“RSUs”) to purchase up to 50,000 common shares of the Company. The grant of RSUs to the Consultant shall be made in accordance with the terms and conditions of the Company’s Amended and Restated Share Compensation Plan (the “Plan”) and applicable rules and requirements of the Canadian Securities Exchange and NASDAQ. The RSUs shall vest in accordance with the following vesting schedule:

 

a)16,666 RSUs granted on the ‎date that is ‎the 6-month ‎anniversary of ‎the Effective Date‎ first listed above‎;

 

b)16,667 RSUs granted on the ‎date that is ‎the 12-month ‎anniversary of ‎the Effective Date‎ first listed above‎; and

 

c)16,667 RSUs granted on the ‎date that is ‎the 18-month ‎anniversary of ‎the Effective Date‎ first listed above‎.

 

3.03Expense Reimbursement

 

The Company shall reimburse Consultant on a monthly basis for all bona-fide business expenses (including travel, accommodation, entertainment/business expenses) incurred by Consultant on behalf of the Company upon submission of written receipts or other written evidence. Any single or series of related expenses exceeding US$5,000 and any expenses exceeding US$5,000 in the aggregate in any month shall be subject to pre-approval by the CEO.

 

DUTIES OF CONSULTANT

 

4.01Rules and Regulations

 

Consultant shall be bound by and shall faithfully observe and abide by all applicable laws and all the rules and regulations to which the Company may be subject from time to time, which are brought to Consultant’s notice or of which Consultant should reasonably be aware.

 

4.02Conflict of Interest

 

For the duration of the Consultant’s engagement by the Company, the Consultant shall refrain from any situation in which Consultant’s personal interests conflict, or may appear to conflict, with Consultant’s duties with the Company. Consultant shall not participate in the ownership of, have any financial involvement with or work for, any business that is in competition with the Company’s Business, or for any client or potential client of the Company or otherwise take steps that would benefit him personally while causing loss or damage to the Company, including reputational and/or financial loss or damage. Consultant acknowledges that if there is any doubt in this respect, Consultant shall inform the Board of Directors and obtain prior written authorization.

 

CONFIDENTIAL INFORMATION, INTELLECTUAL PROPERTY AND NON-SOLICITATION

 

5.01Definitions

 

(a)In this Agreement, unless something in the subject-matter or context is inconsistent therewith:

 

Confidential Information” means all confidential information of the Company, including but not limited to trade secrets, customer lists and other confidential information concerning the business and affairs of the Company.

 

 

 

 

Intellectual Property” means, without limitation, any domestic and foreign:

 

(i) patents, inventions, applications for patents and reissues, divisions, continuations, renewals, extensions and continuations-in-part of patents or patent applications; (ii) proprietary and non-public business information, including inventions, developments, trade secrets, know-how, methods, processes, designs, technology, technical data, schematics, formulae and client lists, and documentation relating to any of the foregoing; (iii) works of authorship, copyrights, copyright registrations and applications for copyright registration; (iv) designs, design registrations, design registration applications and integrated circuit topographies; (v) trade names, business names, corporate names, domain names, website names and world wide web addresses, common law trade-marks, trade-mark registrations, trade mark applications, trade dress and logos, and the goodwill associated with any of the foregoing; (vi) computer software and programs (both source code and object code form), all proprietary rights in the computer software and programs and all documentation and other materials related to the computer software and programs; (vii) any other intellectual property and industrial property and moral rights, title and interest therein, anywhere in the world and whether registered or unregistered, registrable or unregistrable, or protected or protectable under intellectual property laws, or (viii) any derivatives of or improvements on any of the foregoing,

 

which Consultant may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time Consultant is engaged by the Company, including the copyright thereon.

 

In the context of any action taken by Consultant, the words “directly or indirectly” include any action taken by Consultant for Consultant’s own benefit or the benefit of any person competing with the Company, whether taken individually or in partnership or jointly or in conjunction with any person as principal, agent, trustee, employee or shareholder (other than holding of shares listed on a Canadian or United States stock exchange that does not exceed 5% of the outstanding shares so listed).

 

5.02Confidential Information

 

(a)Consultant acknowledges that, by reason of Consultant’s involvement with the Company, Consultant will have access to Confidential Information. Consultant agrees that, during and after Consultant’s engagement with the Company, Consultant will not disclose to any person, except in the proper course of Consultant’s engagement with the Company, or use for Consultant’s own purposes or for any purposes other than those of the Company, any Confidential Information acquired, created or contributed to by Consultant.

 

(b)Any breach of Section 5.02(a) by Consultant will result in material and irreparable harm to the Company although it may be difficult for the Company to establish the monetary value flowing from such harm. Consultant therefore agrees that the Company, in addition to being entitled to the monetary damages which flow from the breach, will be entitled to injunctive relief in a court of appropriate jurisdiction in the event of any breach by Consultant of Section 5.02(a).

 

5.03Intellectual Property

 

Consultant hereby irrevocably and unconditionally waives all moral rights arising under the Copyright Act (Canada) as amended (or any successor legislation of similar effect), or similar legislation in any applicable jurisdiction, or at common law, that Consultant may have now or in the future with respect to Intellectual Property, including, without limitation, any right Consultant may have to have Consultant’s name associated with the Intellectual Property or to have Consultant’s name not associated with the Intellectual Property, any right Consultant may have to prevent the alteration, translation or destruction of the Intellectual Property, and any rights Consultant may have to control the use of the Intellectual Property in association with any product, service, cause, or institution. Consultant agrees that this waiver may be invoked by the Company, and by any of its authorized agents or assignees, in respect of any or all of the Intellectual Property. Consultant agrees that all Intellectual Property is and shall be owned by the Company and not Consultant and hereby assigns all such Intellectual Property to the extent not already owned by the Company by operation of law. Consultant further agrees to, promptly, at the request of the Company, take all such steps and execute all such assignments and other documents as the Company may reasonably require or consider helpful to effect or evidence the assignment and transfer of the Intellectual Property and to protect, obtain or maintain any patents, copyrights, trade-marks or other proprietary rights in the Intellectual Property.

 

 

 

 

5.04Non-Solicitation

 

d)Except in the proper fulfillment of the Consultant’s duties and responsibilities on behalf of the ‎Company, during the Consultant’s engagement with the Company and for twelve (12) months after the ‎cessation of the Consultant’s engagement with the Company for any reason, the Consultant will not‎, directly or indirectly:

 

(i)other than for the benefit of the Company or any of its affiliates solicit any customer of the Company (who was a customer in the twelve (12) months preceding the date of the termination of the Consultant’s engagement)‎ for the purpose of selling or providing any products or services similar to those sold or provided by the Company;

 

(ii)refer any customer of the Company (who was a customer in the twelve (12) months preceding the date of the termination of the Consultant’s engagement)‎ to any business that is in competition with the Company’s Business;

 

(iii)solicit for business of any person or entity who is, or was at any time within the 12-month period prior to termination, a customer of the Business conducted by the Company (or a potential customer with whom Consultant had Business-related dealings in the prior 12-month period prior to termination);

 

(iv)otherwise attempt to interfere with or damage the business relationship between the Company, on the one hand, and any customer of the Company who was a customer in the twelve (12) months preceding the date of the termination of the Consultant’s engagement;

 

(v)solicit the employment or engagement of (whether as an employee, independent contractor or otherwise) any personnel of the Company (other than any personnel who at the time of the solicitation has not worked for the Company or any of its affiliates for a period of at least six (6) months); or

 

(vi)otherwise attempt to interfere with or damage the business relationship between the Company, on the one hand, and any personnel of the Company, on the other hand. Notwithstanding the foregoing, the Consultant shall not be prohibited from conducting general solicitations of employment or engagement that are not targeted to personnel of the Company.

 

5.05Acknowledgements

 

Consultant acknowledges that:

 

a)the business of the Company is carried on throughout Canada and that the Company is interested in and solicits or canvasses opportunities throughout Canada;

 

b)the reputation of the Company in the industry and its relationships with its customers is the result of hard work, diligence and perseverance on behalf of the Company over an extended period of time;

 

c)the nature of the business of the Company is such that the on-going relationship between the Company and its customers is material and has a significant effect on the ability of the Company to continue to obtain business from its customers with respect to both long term and new contracts; and

 

d)in light of the foregoing, the restrictions in this Article 5 are reasonable and valid and Consultant hereby waives all defences to the strict enforcement thereof.

 

 

 

 

5.06Equitable Remedies

 

Consultant further acknowledges and agrees that: (i) the Company would suffer irreparable and ongoing damages (including a significant loss of the value and goodwill of the Business) in the event that any provision of this Article 5 (or Section 6.03) were not performed in accordance with its terms or otherwise were breached; and (ii) monetary damages, even if available, alone would not be an adequate remedy for any such non-performance or breach. Accordingly, such Consultant agrees that in the event of any breach or threatened breach of any provision of this Article 5, or Section 6.03, the Company shall be entitled, in addition to all other rights and remedies that it may have existing in its favor at law, in equity or otherwise to seek injunctive or other equitable relief (including a temporary restraining order, a preliminary injunction and a final injunction) to prevent any such breach or threatened breach and to enforce such provisions specifically, without the necessity of posting a bond or other security or of proving actual damages. The prevailing party in any action commenced under this Section 5.06 (whether through a monetary judgment, injunctive relief or otherwise) also shall be entitled to recover reasonable legal fees and court costs incurred in connection with such action.

 

TERMINATION OF CONSULTING AGREEMENT

 

6.01Termination of Agreement Without Notice

 

‎Either party may terminate this Agreement effective immediately for Cause, ‎without advance notice or payment in lieu of such notice. Without restricting the generality of the foregoing, “Cause” includes: (i) Consultant’s conviction of or admission to the commission of an indictable offence or Consultant’s conviction of or admission to a violation of another criminal law involving the affairs of the Company; (ii) any intentional act of fraud, theft, embezzlement or other illegal conduct by Consultant involving the Company; (iii) a material breach of the provisions of this Agreement, where such breach is incapable of ‎cure, or with respect to a material breach capable of cure, where the breaching party does ‎not cure such breach within fifteen (15) days after receipt of written notice of such breach‎; (iv) willful or substantial neglect by Consultant of Consultant’s Duties and responsibilities under this Agreement for a period of ten (10) business days after receiving written notice of the same; (v) Consultant’s material breach of the Company’s policies or procedures that is not reasonably curable in the Company’s sole discretion (acting reasonably) or any other willful misconduct which causes material harm to the Company or its business reputation, including due to any adverse publicity; and/or (vi) any conduct that constitutes cause at common law.

 

6.02Termination of Agreement With Notice

 

Except in the event of termination without notice as set out in Section 6.01 ‎of this Agreement, the Company and Consultant agree that this Agreement and the ‎engagement of the Consultant by the Company may be terminated in the ‎following circumstances only:‎ ‎

 

a)At any time by the Consultant, upon giving the Company sixty (60) days of advance notice ‎in ‎writing;‎

 

b)At any time by the Company within four (4) months of the Effective Date, upon (i) giving the Consultant two (2) weeks of advance ‎notice ‎in writing, or (ii) payment to the Consultant of two (2) weeks of Basic Fees in lieu ‎of notice (to be calculated based on the average ‎weekly ‎Basic Fees over the immediately preceding month);

 

c)At any time by the Company following the four (4) month anniversary of the Effective Date, upon (i) giving the Consultant four (4) months of advance ‎notice ‎in writing, or (ii) payment to the Consultant of four (4) months of Basic Fees in lieu ‎of notice (to be calculated based on the average ‎monthly ‎Basic Fees over the four (4) immediately preceding months); ‎or

 

d)At any time, by mutual written agreement.‎

 

 

 

 

6.03Return of Property

 

Upon the termination of this Agreement for any reason, or at any other time upon the Company’s ‎written request, and as a condition of the Company paying Consultant any termination payments required hereunder, Consultant shall promptly:

 

a)deliver or cause to be delivered to the Company all books, documents, effects, money, securities or other property belonging to the Company or for which the Company is liable to others, which are in the possession, charge, control or custody of Consultant; and

 

b)‎permanently erase all of the Company’s Confidential Information from the ‎Consultant’s personal electronic systems.

 

6.04Expense Reimbursement

 

Upon termination for any reason, any expenses properly and legally incurred under this Agreement shall be promptly repaid to Consultant.

 

DIRECTORS AND OFFICERS

 

7.01Indemnity

 

Subject to the provisions of the Canada Business Corporations Act, the Company agrees to indemnify and save Consultant harmless from and against all demands, claims, costs, charges and expenses, including any amount paid to settle an action or satisfy a judgment, reasonably incurred by Consultant in respect of any civil, criminal or administrative action or proceeding to which Consultant is made a party by reason of being or having been a director or officer of the Company or of any affiliated Company whether before or after any cessation of engagement if:

 

a)Consultant acted honestly and in good faith with a view to the best interests of the Company; and

 

b)in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, Consultant had reasonable grounds for believing that Consultant’s conduct was lawful.

 

7.02Insurance

 

If Consultant is a director or officer at the relevant time, Consultant shall be covered by comprehensive directors’ and officers’ liability insurance, which shall be established and maintained by the Company at its expense. The insurance policies to be maintained by the Company hereunder may contain exclusions from coverage in respect of negligence or mala fides acts on the part of Consultant.

 

CONTRACT PROVISIONS

 

8.01No Breach of Obligations to Others

 

Consultant acknowledges and represents to the Company that in carrying out Consultant’s Duties and functions for the Company, Consultant will not disclose to the Company any confidential information of any third party. Consultant acknowledges and represents to the Company that Consultant has not brought to the Company nor will Consultant use in the performance of Consultant’s Duties and functions with the Company any confidential materials or property of any third party. Consultant further acknowledges and represents that Consultant is not a party to any agreement with or under any legal obligation to any third party that conflicts with any of Consultant’s obligations to the Company under this Agreement.

 

 

 

 

8.02Headings

 

The headings of the Articles and paragraphs herein are inserted for convenience of reference only and shall not affect the meaning or construction hereof.

 

8.03Independent Advice

 

Consultant confirms having had the reasonable opportunity to obtain independent legal advice regarding this Agreement that Consultant is signing this Agreement freely and voluntarily with full understanding of its contents.

 

8.04Governing Law

 

This Agreement shall be governed by the laws in force in the Province of British Columbia and the laws of Canada applicable therein.

 

8.05Entire Agreement

 

This Agreement constitutes and expresses the whole agreement of the parties hereto with reference to any of the matters or things herein provided for or herein before discussed or mentioned with reference to Consultant’s engagement, and it cancels and replaces any and all prior understandings and agreements between Consultant and the Company. All promises, representations, collateral agreements and understandings not expressly incorporated in this Agreement are hereby superseded by the within Agreement.

 

8.06Severability

 

If any provision contained herein is determined to be void or unenforceable in whole or in part, it shall not be deemed to affect or impair the validity of any other provision herein and each such provision is deemed to be separate and distinct.

 

8.07Survival

 

‎All terms and conditions under the Sections respecting the Independent ‎Contractor Relationship, Conflict of Interest, Confidential Information, Intellectual Property, Non-Solicitation, Equitable Remedies, Termination of Consulting Agreement, and Governing Law shall survive the termination of this Agreement whether the termination is ‎initiated by the Consultant, by the Company, on a with or without Cause basis, or by mutual ‎agreement, or whether the termination is lawful or unlawful‎

 

8.08Notice

 

Any notice required or permitted to be given under this Agreement shall be in writing and shall be properly given if personally delivered, delivered by facsimile transmission or email (with confirmation of receipt) or mailed by prepaid registered mail addressed as follows:

 

in the case of the Company:

 

Cameron Chell

Chief Executive Officer, President

Draganfly Inc.

2108 St. George Avenue,

Saskatoon, SK, S7M0K7

Canada

 

in the case of Consultant:

 

Scott Larson

[Redacted]

 

 

 

 

8.09Amendments and Waiver

 

No modification of or amendment to this Agreement shall be valid or binding unless set forth in writing and duly executed by both of the parties hereto and no waiver of any breach of any term or provision of this Agreement shall be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, shall be limited to the specific breach waived.

 

8.10Successors

 

This Agreement and all rights of Consultant hereunder shall enure to the benefit of and be enforceable by Consultant and Consultant’s personal or legal representatives, heirs, executors, administrators and successors and shall enure to the benefit of and be binding upon the Company, its successors and assigns.

 

8.11Taxes and Deductions

 

All payments under this Agreement shall be subject to withholding of such amounts, if any, relating to tax or other deductions as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation.

 

8.12Currency

 

All dollar amounts set forth or referred to in this Agreement refer to the currency of Canada.

 

8.13Counterparts

 

This Agreement may be executed in counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

 

8.14Copy of Agreement

 

Consultant hereby acknowledges receipt of a copy of this Agreement duly executed by the Company.

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

  Draganfly Inc.
     
    “/s/ Cameron Chell”
  Name: Cameron Chell
  Title: Director
     
    “/s/ Scott Larson”
    Scott Larson

 

 

  

EX-4.8 4 ex4-8.htm

 

Exhibit 4.8

 

EMPLOYMENT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of April 1, 2022 (‎the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

PAUL SUN,

 

an individual residing at [Redacted]

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Company ‎and the Employee entered into an Employment Agreement dated November 2020 and an Employment Agreement Amendment Agreement dated September 30, 2021 (together, the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;

 

B.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Employment Agreement Amending Agreement hereinafter set forth;

 

 

 

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Employment Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Employee’s base salary, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.Provision 3.1 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay the Employee a salary in the amount of CDN$250,000.00 (the “Annual Salary”) payable by semi-monthly instalments. The Company will review the Annual Salary annually during the term of this Agreement and may, in its sole discretion, adjust the Annual Salary. Any such adjustments may be made without requiring a written amendment to this Agreement, ‎and without causing ‎termination or breach of this ‎Agreement.‎ ‎

 

2.Provision 3.3 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

In addition to the above Annual Salary, the Employee shall be eligible to earn a discretionary annual performance bonus (“Performance Bonus”). The Performance Bonus will be determined following the completion of the ‎Company’s financial year each year, based on performance metrics to be ‎determined by the Company’s compensation committee in its sole discretion‎. The Company shall pay the Employee the Performance Bonus, if any, within the thirty (30) days following the financial year to which the Performance Bonus relates. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year. To be eligible for a Performance Bonus, the Employee must also be Actively Employed on the date of payment of any such ‎bonus. For purposes of this Agreement, the last day that the Employee is “Actively Employed” ‎shall be the later of:‎ (i) the ‎last day that‎ the Employee actually performs their ‎duties prior to the termination ‎of the Employee’s employment with the ‎Company for ‎any reason; or (ii) the ‎end of ‎the minimum ‎period of statutory notice of termination prescribed by the Ontario Employment Standards Act, 2000 (the “ESA”)‎. This is because a Performance Bonus is not earned until the payment date. For clarity, ‎except to the extent required by the ESA: ‎‎‎(i) the last day that the Employee is Actively ‎Employed ‎shall not be extended by any ‎‎‎‎contractual or ‎‎common law notice of ‎‎termination period in ‎respect ‎of which the Employee ‎receives ‎‎or may ‎‎receive pay ‎in ‎lieu of notice ‎of termination or damages ‎in ‎lieu of such ‎notice ‎of ‎‎termination; and ‎(ii) entitlement to any ‎Performance Bonus‎ shall not ‎be included ‎in any ‎entitlement which the Employee ‎may ‎have to pay in lieu or damages in lieu ‎‎of ‎notice ‎‎of ‎termination. ‎

 

The performance metrics and target Performance Bonus of the ‎Employee for any given year are attached hereto as ‎Schedule “B”. Schedule “B” will be reviewed from time-to-‎time and may be amended by the Company without ‎requiring a written amendment to this Agreement, and ‎without causing ‎termination or breach of this Agreement. ‎

 

 

 

 

3.Provision 3.6 entitled “Consideration for Services” will be added into the ‎Employment Agreement as follows:

 

The Company will grant the Employee 120,000 restricted share units of the Company (“RSUs”) ‎to purchase up to 120,000 common shares of the Company. The grant of RSUs to the Employee shall be made in accordance with the terms and conditions ‎of the Company’s Amended and Restated Share Compensation Plan (the “Plan”) and applicable ‎rules and requirements of the Canadian Securities Exchange and NASDAQ. The RSUs shall vest ‎in accordance with the following vesting schedule:‎

 

a)‎40,000 RSUs granted on the ‎date that is ‎the 6-month ‎anniversary of ‎the Effective Date‎ of the Employment Agreement Amending Agreement‎;‎

 

b)‎40,000 RSUs granted on the ‎date that is ‎the 12-month ‎anniversary of ‎the Effective Date‎ of the Employment Agreement Amending Agreement‎; and‎

 

c)‎40,000 RSUs granted on the ‎date that is ‎the 18-month ‎anniversary of ‎the Effective Date‎ of the Employment Agreement Amending Agreement‎.‎

 

d)Schedule “B” entitled “Performance Bonus Program” will be added into the ‎Employment Agreement as follows:‎

 

For the calendar year of 2022, the Employee’s target ‎annual Performance Bonus is ‎CDN$270,000.00, based on the ‎following milestones and achievements:

   % Bonus 
ERP set up and operational   15%
Min US$20 mill in bank on Dec 31.   25%
Net Income as per budget   20%
Improved SOX and internal controls   10%
Acquisition of $5 mill rev or $10 million in value   30%
    100%

 

To clarify, the Performance Bonus remains discretionary as solely determined and approved by the Board. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year.

 

4.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.

 

5.The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Amending Agreement or the changes to his employment as set out herein, which specifically includes any claims under any applicable human rights, workers’ compensation, occupational health and ‎safety, and employment standards legislation including but not limited to the Employment Standards Act, 2000, the Human Rights Code, the Workplace Safety and Insurance Act, 1997 and the Pay Equity Act.

 

6.This Amending Agreement amends the Employment Agreement. This Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.

 

7.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

8.If there is a conflict between any provision of this Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Amending Agreement are to prevail.

 

9.This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of Ontario. The Parties irrevocably attorn to the jurisdiction to the Ontario Superior Court of Justice in Toronto.

 

‎[signature page follows]‎

 

 

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this 1st day of April 2022:

 

“/s/ Cameron Chell”   “/s/ Paul Sun”
DRAGANFLY INC.   PAUL SUN
     
Cameron Chell    
Director    

 

 

 

EX-4.9 5 ex4-9.htm

 

Exhibit 4.9

 

THIRD EMPLOYMENT AGREEMENT AMENDMENT

 

THIS THIRD EMPLOYMENT AGREEMENT AMENDMENT, effective as of April 1, 2023 (‎the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

PAUL SUN,

 

an individual residing at [Redacted]

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

(Company and Employee/You are together referred to herein as the “Parties”)

 

WHEREAS:

 

10.The Company ‎and the Employee entered into an Employment Agreement dated November 2020, an Employment Amendment Agreement dated September 30, 2021, and an Employment Agreement Amendment dated April 1, 2022 (Collectively, the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;

 

11.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Third Amending Agreement hereinafter set forth;

 

 

 

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Third Amending Agreement, including the increase to the Employee’s base salary, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.Provision 3.1 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay the Employee a salary in the amount of CDN$267,000.00 (the “Annual Salary”) payable by bi-weekly installments.

 

2.Provision 3.3 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

In addition to the above Annual Salary, the Employee shall be eligible to earn a discretionary annual performance bonus (“Performance Bonus”). The Performance Bonus will be determined following the completion of the ‎Company’s financial year each year, based on performance metrics to be ‎determined by the Company’s compensation committee in its sole discretion‎. The Company shall pay the Employee the Performance Bonus, if any, following the approval of performance bonus by the Board of Directors during the March board meeting. . The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year. To be eligible for a Performance Bonus, the Employee must also be Actively Employed on the date of payment of any such ‎bonus. For purposes of this Agreement, the last day that the Employee is “Actively Employed” ‎shall be the later of:‎ (i) the ‎last day that‎ the Employee actually performs their ‎duties prior to the termination ‎of the Employee’s employment with the ‎Company for ‎any reason; or (ii) the ‎end of ‎the minimum ‎period of statutory notice of termination prescribed by the Ontario Employment Standards Act, 2000 (the “ESA”)‎. This is because a Performance Bonus is not earned until the payment date. For clarity, ‎except to the extent required by the ESA: ‎‎‎(i) the last day that the Employee is Actively ‎Employed ‎shall not be extended by any ‎‎‎‎contractual or ‎‎common law notice of ‎‎termination period in ‎respect ‎of which the Employee ‎receives ‎‎or may ‎‎receive pay ‎in ‎lieu of notice ‎of termination or damages ‎in ‎lieu of such ‎notice ‎of ‎‎termination; and ‎(ii) entitlement to any ‎Performance Bonus‎ shall not ‎be included ‎in any ‎entitlement which the Employee ‎may ‎have to pay in lieu or damages in lieu ‎‎of ‎notice ‎‎of ‎termination. ‎

 

The performance metrics and target Performance Bonus of the ‎Employee for any given year are attached hereto as ‎Schedule “B”. Schedule “B” will be reviewed from time-to-‎time and may be amended by the Company without ‎requiring a written amendment to this Agreement, and ‎without causing ‎termination or breach of this Agreement. ‎

 

3.Provision 3.6 entitled “Consideration for Services” will be added into the ‎Employment Agreement as follows:

 

The Company will grant the Employee 128,000 restricted share units of the Company (“RSUs”) ‎to purchase up to 128,000 common shares of the Company. The grant of RSUs to the Employee shall be made in accordance with the terms and conditions ‎of the Company’s Amended and Restated Share Compensation Plan (the “Plan”) and applicable ‎rules and requirements of the Canadian Securities Exchange and NASDAQ. The RSUs shall vest ‎in accordance with the following vesting schedule:‎

 

 

 

 

e)‎42,666 RSUs granted on October 30, 2023‎;‎

 

f)‎42,667 RSUs granted on September 3, 2024; and‎

 

g)‎42,667 RSUs granted on March 20, 2025‎.‎

 

4.Schedule “B” entitled “Performance Bonus Program” will be added into the ‎Employment Agreement as follows:‎

 

For the calendar year of 2023, the Employee’s target ‎annual Performance Bonus is ‎CDN$267,000.00, based on the ‎following milestones and achievements:

   % Bonus 
Revenue of $12 million with sliding pro-rated scale <$10 million is 0%, $11M is 50%, $12M is 100%   20%

175% Payroll Efficiency Target” calculated as “Total Revenue/Wages & Salaries”; with sliding scale noted as <105% is 0, 140% is 50%

   20%
ENPS of 20   10%
All filings on time    10%
Complete ERP implementation with dashboard / analysis    10%
Complete Functional Test of Internal Controls and Process    20%
1 acquisition completed   10%
    100%

 

To clarify, the Performance Bonus remains discretionary as solely determined and approved by the Board. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year.

 

5.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.

 

6.The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Third Amending Agreement or the changes to his employment as set out herein, which specifically includes any claims under any applicable human rights, workers’ compensation, occupational health and ‎safety, and employment standards legislation including but not limited to the Employment Standards Act, 2000, the Human Rights Code, the Workplace Safety and Insurance Act, 1997 and the Pay Equity Act.

 

7.This Third Amending Agreement amends the Employment Agreement. This Third Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Third Amending Agreement will be effective on the Effective Date.

 

8.This Third Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

9.If there is a conflict between any provision of this Third Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Third Amending Agreement are to prevail.

 

10.This Third Amending Agreement is governed by and is to be construed and interpreted in accordance with the laws of Ontario. The Parties irrevocably attorn to the jurisdiction to the Ontario Superior Court of Justice in Toronto.

 

‎[signature page follows]‎

 

 

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Third Amending Agreement this _______ day of _____________ 2023

 

“/s/ Cameron Chell”   “/s/ Paul Sun”

DRAGANFLY INC.

 

Authorized Signatory

I have authority to bind the Corporation

 

PAUL SUN

 

 

 

 

 

EX-4.10 6 ex4-10.htm

 

Exhibit 4.10

 

EMPLOYMENT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of April 1, 2022 ‎(the “Effective Date”) is between:

 

DRAGANFLY INNOVATIONS INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

PAUL MULLEN,

 

an individual residing at [Redacted]

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Company ‎and the Employee entered into an Employment Agreement dated April 12, 2021 and an Employment Agreement Amendment Agreement dated ‎November 1, 2021 (together, the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;

 

B.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Employment Agreement Amending Agreement hereinafter set forth;

 

 

 

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Employment Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Employee’s base salary, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.Provision 3.1 in the Employment Agreement is replaced with the following:

 

As compensation for carrying out the Services during the ‎term of this Agreement, the Company agrees to pay the ‎Employee a salary in the amount of CDN$210,000.00 (the ‎‎”Annual Salary”) payable by semi-monthly instalments. The ‎Company will review the Annual Salary annually during the ‎term of this Agreement and may, in its sole discretion, adjust ‎the Annual Salary. Any such adjustments may be made ‎without requiring a written amendment to this Agreement, ‎‎and without causing ‎termination or breach of this ‎‎Agreement.

 

2.Provision 3.2 in the Employment Agreement is replaced with the following:

 

In addition to the above Annual Salary, the Employee shall ‎be eligible to earn a discretionary annual performance ‎bonus (“Performance Bonus”). The Performance Bonus will ‎be determined following the completion of the ‎Company’s ‎financial year each year, based on performance metrics to be ‎‎determined by the Company’s compensation committee in its ‎sole discretion‎. The Company shall pay the Employee the ‎Performance Bonus, if any, within the thirty (30) days ‎following the financial year to which the Performance Bonus ‎relates. The Employee understands and agrees that payment ‎of a Performance Bonus should not be considered to be ‎expected compensation and the payment of a Performance ‎Bonus in any one or successive years shall not create an ‎entitlement to a Performance Bonus in any subsequent year. ‎To be eligible for a Performance Bonus, the Employee must ‎also be Actively Employed on the date of payment of any ‎such ‎bonus. For purposes of this Agreement, the last day ‎that the Employee is “Actively Employed” ‎shall be the later of:‎ ‎‎(i) the ‎last day that‎ the Employee actually performs their ‎‎duties prior to the termination ‎of the Employee’s employment ‎with the ‎Company for ‎any reason; or (ii) the ‎end of ‎the ‎minimum ‎period of statutory notice of termination prescribed ‎by the Ontario Employment Standards Act, 2000 (the “ESA”)‎. ‎This is because a Performance Bonus is not earned until the ‎payment date. For clarity, ‎except to the extent required by the ‎ESA: ‎‎‎(i) the last day that the Employee is Actively ‎Employed ‎‎shall not be extended by any ‎‎‎‎contractual or ‎‎common law ‎notice of ‎‎termination period in ‎respect ‎of which the ‎Employee ‎receives ‎‎or may ‎‎receive pay ‎in ‎lieu of notice ‎of ‎termination or damages ‎in ‎lieu of such ‎notice ‎of ‎‎termination; ‎and ‎(ii) entitlement to any ‎Performance Bonus‎ shall not ‎be ‎included ‎in any ‎entitlement which the Employee ‎may ‎have ‎to pay in lieu or damages in lieu ‎‎of ‎notice ‎‎of ‎termination. ‎

 

 

 

 

The performance metrics and target Performance Bonus of ‎the ‎Employee for any given year are attached hereto as ‎‎Schedule “B”. Schedule “B” will be reviewed from time-to-‎‎time and may be amended by the Company without ‎‎requiring a written amendment to this Agreement, and ‎‎without causing ‎termination or breach of this Agreement. ‎

 

The Employee shall be entitled to participate in the Company’s benefit programs as may be amended from time to time (the “Benefits”). All Benefits are subject to the terms and conditions of the applicable policies. The Employee agrees that the Company may substitute or modify the Benefits or their terms and conditions without notice.

 

3.Provision 3.4 will be added into the ‎‎Employment Agreement as follows:

 

The Company will grant the Employee 120,000 restricted ‎share units of the Company (“RSUs”) ‎to purchase up to ‎‎120,000 common shares of the Company. The grant of ‎RSUs to the Employee shall be made in accordance with the ‎terms and conditions ‎of the Company’s Amended and ‎Restated Share Compensation Plan (the “Plan”) and ‎applicable ‎rules and requirements of the Canadian ‎Securities Exchange and NASDAQ. The RSUs shall vest ‎in ‎accordance with the following vesting schedule:‎

 

a)‎40,000 RSUs granted on the ‎date that is ‎the 6-month ‎‎anniversary of ‎the Effective Date‎ of the Employment ‎Agreement Amending Agreement‎;‎

 

b)‎40,000 RSUs granted on the ‎date that is ‎the 12-month ‎‎anniversary of ‎the Effective Date‎ of the Employment ‎Agreement Amending Agreement‎; and‎

 

c)‎40,000 RSUs granted on the ‎date that is ‎the 18-month ‎‎anniversary of ‎the Effective Date‎ of the Employment ‎Agreement Amending Agreement‎.‎

 

4.Schedule “B” entitled “Performance Bonus Program” will be added into the ‎‎Employment Agreement as follows:

 

For the calendar year of 2022, the Employee’s target ‎annual ‎Performance Bonus is ‎CDN$210,000.00, based on the ‎‎following milestones and achievements:

 

   % Bonus 
Revenue of $13 million (min revenue of $8M)   20%
US office established and staffed   20%
$500k revenue from new product or international   25%
Company-wide aligned and integrated   15%
Net Income as per budget   20%
    100%

 

 

 

 

To clarify, the Performance Bonus remains discretionary as ‎solely determined and approved by the Board. The Employee ‎understands and agrees that payment of a Performance ‎Bonus should not be considered to be expected ‎compensation and the payment of a Performance Bonus in ‎any one or successive years shall not create an entitlement ‎to a Performance Bonus in any subsequent year.‎

 

5.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.

 

6.The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Amending Agreement or the changes to his employment as set out herein, which specifically includes any claims under any applicable human rights, workers’ compensation, occupational health and ‎safety, and employment standards legislation including but not limited to the Employment Standards Act, the Human Rights Code and the Workers’ Compensation Act.

 

7.This Amending Agreement amends the Employment Agreement. This Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.

 

8.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

9.If there is a conflict between any provision of this Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Amending Agreement are to prevail.

 

10.This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of British Columbia and the laws of Canada applicable therein. The Parties irrevocably attorn to the jurisdiction of the courts of the Province of British Columbia in relation to enforcement of this Amending Agreement.

 

 

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this 1st day of April 2022:

 

“/s/ Paul Mullen”  
Paul Mullen  
(Employee Signature)  
   
By:  
DRAGANFLY INNOVATIONS INC.  
   
“/s/ Cameron Chell”  
Cameron Chell  
Director  

 

 

 

EX-4.11 7 ex4-11.htm

 

Exhibit 4.11

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (“Agreement”) is dated as of April 12th, 2021 the “Effective Date”).

 

BETWEEN:

 

DRAGANFLY INNOVATIONS INC., a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M OK7

 

(“Company”)

 

AND:

 

PAUL MULLEN, [Redacted]

 

(the “Employee”)

 

WHEREAS the Company carries on the worldwide business of manufacturing search and navigation equipment within the commercial UAV space;

 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Employee covenant and agree as follows:

 

1. SERVICES TO BE PROVIDED

 

1.1‎ Commencing on the Effective Date, the Employee shall provide executive services to the Company and, in this regard, the Employee shall hold the position of Vice President, Telehealth at the Company. Furthermore, commencing on the Effective Date the Employee shall provide such services to the Company as are described in Schedule “A” to this Agreement (the “Services”). The Employee shall also provide any other services not specifically mentioned in Schedule “A”, but which, by reason of the Employee’s capability, the Employee knows or ought to know are necessary to ensure that the best interests of the Company are maintained.

 

1.2 The Employee shall perform the Services to the level of competence and skill one would reasonably expect from an Employee with the skills and experience similar to that of the Employee. The Employee shall devote sufficient working time, attention and ability in a timely manner to the Business of the Company (as hereinafter defined), and to any associated company, as is reasonably necessary for the proper performance of the Services pursuant to this Agreement.

 

1.3 The Employee will faithfully, honestly and diligently serve the Employee, use its best efforts to promote the best interests of the Company and co-operate with the Company, and utilize maximum professional skill and care to ensure that the Services are rendered to the satisfaction of the Company.

 

1.4 The Employee will comply with all applicable rules, laws and regulations, and all ‎applicable Company policies (to the extent they have been provided to the Employee by ‎the Company), having application to the carrying out and performance of its obligations ‎under this Agreement.‎

 

 
 

 

1.5 At all times while on the Company’s premises or representing the Company in ‎any other location in connection with the provision of the Services, the ‎Employee will observe the Company’s rules and regulations with respect to ‎conduct, health, safety and protection of persons and property.‎

 

2. LOCATION AND PERFORMANCE OF WORK

 

2.1 The Employee shall work from either their own residence or at any other ‎Company site as long as the location is in the Lower Mainland, BC. The ‎Employee shall also be expected to regularly travel to, and perform the duties ‎at, such other locations as may be determined by Company from time to time. ‎The Employee warrants and represents that the Employee shall maintain a ‎valid passport and that the Employee is not disqualified, to the Employee’s ‎knowledge, from receiving permission to enter the U.S., the European Union, ‎China or any other country or region of the world as a business visitor.‎

 

3. CONSIDERATION FOR SERVICES

 

3.1‎ As compensation for carrying out the Services during the term of this ‎Agreement, the Company agrees to pay the Employee a salary in the amount of ‎CDN$130,000 (the “Annual Salary”) payable by semi-monthly instalments. ‎The Company will review the Annual Salary annually during the term of this ‎Agreement and may, in its sole discretion, adjust the Annual Salary.‎

 

3.2‎ In addition to the above Annual Salary, the Employee shall be eligible to earn ‎a discretionary annual performance bonus of up to 50% of the Annual Salary ‎‎(“Performance Bonus”), pursuant to the terms and conditions that to be ‎determined and approved by the CEO. The Company shall pay the Employee ‎the Performance Bonus within the thirty (30) days following the Employee’s ‎completion of each Year, beginning from the Effective Date. The Employee ‎understands and agrees that payment of a Performance Bonus should not be ‎considered to be expected compensation and the payment of a Performance ‎Bonus in any one or successive years shall not create an entitlement to a ‎Performance Bonus in any subsequent year. Further, the Employee shall be ‎eligible to earn a Performance Bonus on a pro-rated basis, and the Employee ‎shall be entitled to receive a pro rata portion of the Performance Bonus for ‎any period of employment predating the payment of the Performance Bonus. ‎Without limiting the generality of the foregoing, a Performance Bonus shall ‎only continue to vest, accrue or be payable up to the date designated by the ‎Company as the effective date on which the period of employment ends.‎

 

The Employee shall be entitled to participate in the Company’s benefit programs as ‎may be amended from time to time (the “Benefits”). All Benefits are subject ‎to the terms and conditions of the applicable policies. The Employee agrees ‎that the Company may substitute or modify the Benefits or their terms and ‎conditions without notice.‎

 

3.3‎ Upon Board approval, the Employee will receive 50,000 Restricted Share Unit’s of ‎Draganfly shares, along with 50,000 Options, both of which will be subject to ‎the terms and conditions of the the Companys’ Employee Stock Option Plan.‎

 

For greater clarity, the Compensation will be:‎

 

  Annual Salary of $130,000‎
  Annual Bonus of up to 50% of Annual Salary
  ‎50,000 Restricted Share Units ofDFLY‎
  ‎50,000 Options DFLY‎

 

 
 

 

4. VACATION

 

‎4.1‎ The Employee shall be entitled to take vacation during each calendar year at ‎such time or times as shall be agreed between the Employee and the ‎Company, in the amount of four (4) weeks, pro-rated for part years. The ‎Employee shall be entitled to carry over vacation entitlement from one (1) ‎year to the next without written approval of the Company, without any excess ‎being forfeited subject to any applicable statutory minimums being honoured.‎

 

5. EXPENSES

 

‎5.1‎ The Employee shall be reimbursed by the Company for all out-of-pocket ‎expenses actually, necessarily and properly incurred by the Employee in the ‎discharge of duties for the Company. The Employee agrees that such ‎reimbursements shall be due only after the Employee has rendered an ‎itemized expense account, together with receipts where applicable, showing ‎all monies actually expended on behalf of the Company and such other ‎information as may be required and requested by the Company.‎

 

6. STATUTORY DEDUCTIONS AND TAXES

 

‎6.1‎ The Company shall be entitled to withhold from any compensation, benefits ‎or amounts payable under this Agreement all applicable federal or provincial ‎taxes and other statutory deductions as may be required from time to time ‎pursuant to any law or governmental regulation or ruling.‎

 

7. TERM AND TERMINATION

 

‎7.1‎ This Agreement will commence on the Effective Date and will continue until terminated in ‎accordance with the provisions of this Agreement (“Term”).‎

 

‎7.2‎ The Employee may resign employment by giving the Company thirty (30) ‎days’ written notice, in which event the Employee shall not be entitled to any ‎severance payment but shall be entitled to receive all Annual Salary earned to ‎the date of cessation of employment, all earned but unpaid bonus payment, ‎any outstanding earned but untaken vacation pay and reimbursement of any ‎final expenses (collectively, “Final Wages”). The Company may, at its option, ‎terminate the Employee’s employment prior to the end of such resignation ‎notice period, in which case, the Company shall only be liable to pay the ‎Employee his Annual Salary on regular paydays through to the end of the resignation period, to pay all earned but unpaid bonus payment, to pay out any ‎outstanding earned but untaken vacation pay, to reimburse any final expenses and to ‎continue Benefits other than disability and other coverages which cannot be extended to ‎former employees over such period.‎

 

‎7.3‎ At any time, the Company may terminate the employment of the Employee without just ‎cause by notice in writing stating the last day of employment (the “Termination Date”), in ‎which case the Company shall be obligated to provide the Employee with the ‎compensation set out below (the “Severance”). The unconditional lump sum portions of the ‎Severance shall be payable within fourteen (14) business days following the Termination ‎Date. The Severance shall consist of the following:‎

 

a)the Final Wages;‎
   
b)An additional lump sum payment equal to three (3) months salary (the “SeverancePeriod”); and
   
 c)the Company shall continue at its cost the Benefits then in effect for the Employee, other ‎than disability insurance and other coverages which cannot be extended to former ‎employees, until the earlier of the end of the Severance Period or the Employee ‎obtaining alternate coverage (of which prompt written notice must be given to the ‎Company).‎

 

 
 

 

It is intended that the Severance exceeds the minimum requirements of the Employment ‎Standards Act (British Columbia), as amended. To the extent that the Severance falls below ‎a minimum requirement of this statute, or its regulations, as may be amended from time to ‎time, then the Company shall be required to pay an amount to the Employee that meets, ‎but does not exceed, such minimum requirement, in lieu of the Severance.‎

 

‎7.4‎ At any time, the Company may terminate the engagement of the Employee and this ‎Agreement for cause. In such event, the Employee shall not be entitled to any ‎compensation or advance notice, but shall be entitled to receive Final Wages. For purposes ‎of this Agreement, “cause” includes but is not limited to: (i) the Employee commits a crime ‎involving dishonesty, breach of trust, or physical harm to any person; (ii) the Employee ‎willfully engages in conduct that is in bad faith and injurious to the Company, including ‎but not limited to, misappropriation or disclosure of trade secrets or any other kind of ‎Company assets including intellectual property or Confidential Information, dishonesty, ‎fraud, embezzlement, diverting or misusing Company resources for Employee’s own or a ‎third party’s benefit; (iii) the Employee commits a material breach of this Agreement or ‎known Company policy, including policy against bullying, sexual harassment or racial ‎discrimination, which breach is not cured within twenty (20) days after written notice to ‎Employee from the Company; (iv) the Employee willfully refuses to implement or follow a ‎lawful policy or directive of the Company, which breach is not cured within twenty (20) ‎days after written notice to Employee from the Company; (v) the Employee has ‎demonstrated a clear inability to satisfactorily perform the duties of the position despite an ‎opportunity to improve his performance; or (vi) any other conduct that constitutes cause ‎for termination of employment under the common law.‎

 

8.‎ CHANGE OF CONTROL

 

‎8.1‎ “Change of Control” means:‎

 

  a) the acquisition, beneficially, directly or indirectly, by any person or group of ‎persons acting jointly or in concert, within the meaning of National ‎Instrument 62104, Takeover Bids and Issuer Bids, or any successor ‎instrument thereto, of common shares of the Company which, when ‎added to all other common shares of the Company at the time held ‎directly or indirectly by such person or persons acting jointly or in ‎concert, totals for the first time more than 50% of the outstanding ‎common shares of the Company;‎
     
  b) during any period of not more than six (6) consecutive months, the removal, ‎by extraordinary resolution of the shareholders of the Company, of ‎more than fifty one (51%) percent of the incumbent directors on the ‎Company’s Board at the beginning of the period;‎
     
  c) the consummation of a sale of all or substantially all of the assets of the ‎Company; or
     
  d) the consummation of a reorganization, plan of arrangement, merger or other ‎transaction which has substantially the same effect as to (a) to (c) above.‎

 

If at any time during the term of this Agreement there is a Change of Control, and within ‎twelve (12) months of such Change of Control there is a termination by the Company ‎without cause or termination by the Employee due to the following (“Good Reason”):‎

 

  a) the failure of the Company to pay any amount due to the Employee ‎hereunder, which failure persists for fifteen (15) days after the ‎Company receives the Employee’s notice of failure;‎
     
  b) any unilateral material reduction in the Employee’s title or a material reduction in his ‎duties or responsibilities;‎

 

 
 

 

  c) any unilateral material adverse change in the Employee’s Annual Salary, or
     
  d) the Company’s material breach of this Agreement, which breach has not been cured by the ‎Company within fifteen (15) days after receipt of notice from the Employee ‎specifying, in reasonable detail, the nature of the breach or failure,‎

 

the Employee shall then be entitled to receive from the Company only a lump ‎sum payment equal to twelve (12) months of Annual Salary and average ‎Performance Bonus. The Employee acknowledges and agrees that the terms of ‎this clause set out the entire obligation of the Company to give the Employee ‎notice or pay in lieu of notice in the event that the Employee’s employment is ‎terminated for a reason as described in this clause.‎

 

2.‎ CONFIDENTIALITY

 

‎2.1 For the purposes of this Agreement, “Confidential Information” means ‎information, whether or not originated by the Employee, that relates to the ‎business or affairs of the Company, its affiliates, clients, sales personnel or ‎suppliers and is confidential or proprietary to, about or created by the ‎Company, its affiliates, clients or suppliers (whether or not reduced to writing ‎or designated or marked as confidential), including, but not limited to, the ‎following:‎

 

  a) any technical and non-technical information related to the Company’s business ‎and current, future and proposed products and services of the ‎Company, including, without limitation, Company Innovations (as ‎defined herein), Company Property (as defined herein) and the ‎Company’s information concerning research, development, design and ‎product details and specifications, financial information, procurement ‎requirements, engineering and manufacturing information, and business ‎plans;‎
     
  b) information relating to strategies, research, communications, business plans and financial ‎data of the Company;‎
     
  c) any information of or regarding the Company and its business which is not readily publicly ‎available;‎
     
  d) work product resulting from or related to work or projects performed, ‎or to be performed, for the Company or its affiliates, including, but not ‎limited to, the methods, processes, procedures, analysis, techniques ‎and audits used in connection therewith;‎
     
  e) ‎any intellectual property contributed to the Company, and any other ‎technical and business information of the Company and its affiliates ‎which is of a confidential, trade secret and/or proprietary character;‎
     
  f) marketing and development plans, price and cost data, price and fee ‎amounts, pricing and billing policies, quoting procedures, marketing ‎techniques, methods of obtaining business, forecasts and forecast ‎assumptions and volumes, current and prospective client lists, and ‎future plans and potential strategies of the Company that have been or ‎are being discussed;‎
     
  g) information belonging to third parties or which is claimed by third parties to ‎be confidential or proprietary and which the Company has agreed to ‎keep confidential; and
     
  h) any other information that becomes known to the Employee as a result of this ‎Agreement or the services performed hereunder, including information ‎received by the Company from others, that the Employee, acting ‎reasonably, believes is confidential information or that the Company ‎takes measures to protect.‎

 

 
 

 

‎2.2‎ The Employee’s obligations under this Section 9 do not apply to any ‎Confidential Information that the Employee can demonstrate: (a) was in the ‎public domain at or subsequent to the time the Confidential Information was communicated to the ‎Employee by the Company through no fault of the Employee; (b) was rightfully ‎in the Employee’s possession free of any obligation of confidence at or ‎subsequent to the time the Confidential Information was communicated to the ‎Employee by the Company; or (c) was independently developed by the ‎Employee without use of, or reference to, any Confidential Information ‎communicated to the Employee by the Company. A disclosure of any ‎Confidential Information by Employee in response to a valid order by a court ‎or other governmental body or as otherwise required by law will not be ‎considered to be a breach of this Agreement or a waiver of confidentiality for ‎other purposes, provided, however, that the Employee provides prompt prior ‎written notice thereof to the Company to enable the Company to seek a ‎protective order or otherwise prevent the disclosure.‎

 

‎2.3‎ The Employee acknowledges that the Confidential Information is a valuable ‎and unique asset of the Company and that the Confidential Information is and ‎will remain the exclusive property of the Company. The Employee agrees to ‎maintain securely and hold in strict confidence all Confidential Information ‎received, acquired or developed by the Employee or disclosed to the Employee ‎as a result of or in connection with the Services. The Employee agrees that, ‎both during and after the termination of this Agreement, the Employee will not, ‎directly or indirectly, divulge, communicate, use, copy or disclose or permit ‎others to use, copy or disclose, any Confidential Information to any person, ‎except as such disclosure may be consented to by prior written authorization of ‎the Board.‎

 

‎2.4‎ The Employee may use the Confidential Information solely to perform the ‎Services for the benefit of Company. The Employee shall treat all Confidential ‎Information with the same degree of care as the Employee accords to the ‎Employee’s own confidential information, but in no case shall the Employee ‎use less than reasonable care. The Employee shall immediately give notice to ‎the Company of any unauthorized use or disclosure of the Confidential ‎Information. The Employee shall assist the Company in remedying any ‎unauthorized use or disclosure of the Confidential Information.‎

 

‎2.5‎ All Confidential Information and any materials and items (including, without ‎limitation, software, equipment, tools, artwork, documents, drawings, papers, ‎diskettes, tapes, models, apparatus, sketches, designs and lists) that the ‎Company furnishes to the Employee, whether delivered to the Employee by the ‎Company or made by the Employee in the performance of the Services, and ‎whether or not they contain or disclose Confidential Information (collectively, ‎the “Company Property”), are the sole and exclusive property of the Company ‎or the Company’s affiliates, suppliers or customers. The Employee agrees to ‎treat the Company Property with the same degree of care as the Employee treats ‎its own property, but in no case shall the Employee use less than reasonable ‎care. Within five (5) days after any request by the Company, the Employee ‎shall destroy or deliver to the Company, at the Company’s option: (a) all ‎Company Property and (b) all materials and items in the Employee’s possession ‎or control that contain or disclose any Confidential Information. The Employee ‎will provide the Company a written certification of the Employee’s compliance ‎with the Employee’s obligations under this Section 9.5.‎

 

‎2.6‎ During the term of this Agreement, the Employee will not accept work, enter into a contract ‎or accept an obligation in breach of the Employee’s obligations under Section 11 of this ‎Agreement, or the scope of the Services to be rendered for the Company under this ‎Agreement. The Employee warrants that, to the best of the Employee’s knowledge, there is ‎no other existing contract or duty on the Employee’s part that conflicts with or is ‎inconsistent with this Agreement.‎

 

 
 

 

‎2.7‎ The Employee represents and warrants that the Employee has not used and will ‎not use, while performing the Services, any materials or documents of another ‎company which the Employee is under a duty not to disclose. The Employee ‎understands that, while performing the Services, the Employee shall not breach ‎any obligation or confidence or duty the Employee may have to any current or ‎former client or employer. The Employee represents and warrants that it will ‎not, to the best of its knowledge and belief, use or cause to be incorporated in ‎any of the Employee’s work product, any data software, information, designs, ‎techniques or know-how which the Employee or the Company does not have ‎the right to use.‎

 

‎2.8‎ The Employee will indemnify and hold harmless the Company from and against ‎any and all third party claims, suits, actions, demands and proceedings against ‎the Company and all losses, costs, damages, expenses, fees and liabilities ‎related thereto arising out of or related to: (a) an allegation that any item, ‎material or other deliverable delivered by the Employee under this Agreement ‎infringes any intellectual property rights or publicity rights of a third party; (b) ‎an alleged breach by the Employee of any agreement between the Employee ‎and any third party; or (c) any negligence by the Employee or any other act or ‎omission of the Employee, including, without limitation, any breach of this ‎Agreement by the Employee.‎

 

3.‎ DISCLOSURE AND ASSIGNMENT OF WORK RESULTING FROM PROVISION OF ‎SERVICES

 

‎3.1‎ In this Agreement, “Innovations” means all discoveries, designs, ‎developments, improvements, inventions (whether or not protectable under ‎patent laws), works of authorship, information fixed in any tangible medium of ‎expression (whether or not protectable under copyright laws), trade secrets, ‎know-how, ideas (whether or not protectable under trade secret laws), mask ‎works, trademarks, service marks, trade names and trade dress. “CompanyInnovations” means Innovations that: (a) result or derive from the provision of ‎the Services or from the Employee’s knowledge or use of Confidential ‎Information; (b) are conceived or made by the Employee (individually or in ‎collaboration with others) in the course of provision of the Services; (c) result ‎from or derive from the use or application of the resources of the Company, its ‎affiliates or suppliers; (d) relate to the Business of the Company or to actual or ‎demonstrably anticipated research and development by the Company or its ‎affiliates; or (e) the Employee, solely or jointly with others, creates, derives, ‎conceives, develops, makes or reduces to practice during the Term.‎

 

‎3.2‎ All Company Innovations shall be the exclusive property of the Company and ‎the Company shall have sole discretion to deal with Company Innovations. The ‎Employee agrees that no intellectual property rights in the Company ‎Innovations are or shall be retained by the Employee. For greater certainty, all ‎work done during the Term by the Employee for the Company or its affiliates is the sole property of the Company ‎or its affiliates, as the case may be, as the first author for copyright purposes ‎and in respect of which all copyright shall vest in the Company or the relevant ‎affiliate, as the case may be.‎

 

‎3.3‎ The Employee agrees to maintain adequate and current records of all Company ‎Innovations, which records shall be and remain the property of the Company. ‎The Employee agrees to promptly disclose and describe to the Company all ‎Company Innovations. The Employee hereby does and will irrevocably assign ‎to the Company or the Company’s designee all of the Employee’s right, title and ‎interest in and to any and all Company Innovations and all associated records.‎

 

‎3.4‎ In consideration of the benefits to be received by the Employee under the terms ‎of this Agreement, the Employee hereby irrevocably sells, assigns and ‎transfers, and agrees in the future to sell, assign and transfer all right, title and ‎interest in and to the Company Innovations and intellectual property rights ‎therein, including, without limitation, all patents, copyright, industrial design, ‎circuit topography and trademarks, and any goodwill associated therewith in ‎Canada, the United States and worldwide to the Company and the Employee ‎shall hold all the benefits of the rights, title and interest mentioned above in ‎trust for the Company prior to the assignment to the Company, save and except ‎for any moral rights which the Employee shall waive. To the extent any of the ‎rights, title and interest in and to Company Innovations cannot be assigned by ‎the Employee to the Company, the Employee hereby grants to the Company an ‎exclusive, royalty-free, transferable, irrevocable, worldwide, fully paid-up ‎license (with rights to sublicense through multiple tiers of sublicensees) to fully ‎use, practice and exploit those non-assignable rights, title and interest, ‎including, but not limited to, the right to make, use, sell, offer for sale, import, ‎have made, and have sold, the Company Innovations. To the extent any of the ‎rights, title and interest in and to the Company Innovations can neither be ‎assigned nor licensed by the Employee to the Company, the Employee hereby ‎irrevocably waives and agrees never to assert the non-assignable and non-‎licensable rights, title and interest against the Company, any of the Company’s ‎successors in interest, or any of the Company’s customers.‎

 

 
 

 

‎3.5‎ The Employee agrees to perform, during and after the Term, all acts that the ‎Company deems necessary or desirable to permit and assist the Company, at its ‎expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, ‎rights and title throughout the world in the Company Innovations as provided to ‎the Company under this Agreement. If the Company is unable for any reason to ‎secure the Employee’s signature to any document required to file, prosecute, ‎register or memorialize the assignment of any rights under any Company ‎Innovations as provided under this Agreement, the Employee hereby ‎irrevocably designates and appoints the Company and the Company’s duly ‎authorized officers and agents as the Employee’s agents and attorneys-in-fact to ‎act for and on the Employee’s behalf and instead of the Employee to take all ‎lawfully permitted acts to further the filing, prosecution, registration, ‎memorialization of assignment, issuance and enforcement of rights in, to and ‎under the Company Innovations, all with the same legal force and effect as if ‎executed by the Employee. The foregoing is deemed a power coupled with an ‎interest and is irrevocable.‎

 

‎3.6‎ If the Employee incorporates or permits to be incorporated any Innovations relating in ‎any way, at the time of conception, reduction to practice, creation, derivation, ‎development or making of the Innovation, to the Company’s business or actual or ‎demonstrably anticipated research or development but which were conceived, reduced to ‎practice, created, derived, developed or made by the Employee (solely or jointly) either ‎unrelated to the Employee’s work for Company under this Agreement or prior to the ‎Effective Date (collectively, the “Out-of-Scope Innovations”) into any of the Company ‎Innovations, then the Employee hereby grants to the Company and the Company’s ‎designees a royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with ‎rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit ‎all patent, copyright, moral right, mask work, trade secret and other intellectual property ‎rights relating to the Out-of-Scope Innovations. Notwithstanding the foregoing, the ‎Employee agrees that the Employee shall not incorporate, or permit to be incorporated, ‎any Innovations conceived, reduced to practice, created, derived, developed or made by ‎others or any Out-of-Scope Innovations into any Company Innovations without the ‎Company’s prior written consent.‎

 

4.‎ NON-INTERFERENCE WITH BUSINESS

 

‎4.1‎ In this Agreement, “Business of the Company” means the business of manufacturing ‎search and navigation equipment within the commercial UAV space.‎

 

‎4.2‎ The Employee agrees that, during the Term, the Employee will not, on its own behalf or ‎on behalf of or in connection with any third party, directly or indirectly, in any capacity ‎whatsoever, including, without limitation, as an employer, employee, principal, agent, ‎director, officer, joint venturer, partner, shareholder or other equity holder, lender or other ‎debt holder, independent contractor, licensor, licensee, franchisor, franchisee, distributor, ‎consultant, financier, supplier or trustee, or by or through any company, cooperative, ‎partnership, trust, unincorporated association or otherwise, anywhere in North America:‎

 

  a) carry on, be engaged in, have any financial or other interest in or be otherwise ‎commercially involved in any endeavour, activity or business which is in ‎competition with the Business of the Company;‎

 

 
 

 

  b) canvass or solicit the business of (or procure or assist the canvassing or soliciting of the ‎business of) any customer, prospective customer or supplier of the Company to ‎supply or purchase any goods or services that are substantially the same as or in ‎competition with goods or services supplied in the Business of the Company;‎
     
  c) accept (or procure or assist the acceptance of) any business from any customer, ‎prospective customer, sales personnel or supplier that is substantially the same as ‎or in competition with the Business of the Company; or
     
  d) ‎supply (or procure or assist the supply of) any goods or services to any customer, ‎prospective customer, sales personnel or supplier that are substantially the same ‎as or in competition with the goods or services supplied in the Business of the ‎Company.‎

 

‎4.3‎ During the Term, and for a period of twelve (12) months immediately ‎following the termination or expiration of this Agreement, the Employee ‎agrees not to solicit or induce any customer, prospective customer, supplier, ‎sales personnel, employee or independent contractor involved with the ‎Company to terminate or breach any employment, contractual or other ‎relationship with the Company, or to otherwise discontinue or alter such third ‎party’s relationship with the Company.‎

 

‎4.4‎ During the Term, and for a period of twelve (12) months immediately ‎following the termination or expiration of this Agreement, the Employee ‎agrees not to, on its own behalf or on behalf of or in connection with any ‎third party, directly or indirectly, in any capacity whatsoever, engage in any ‎pattern of conduct that involves the making or publishing of written or oral ‎statements or remarks (including without limitation the repetition or ‎distribution of derogatory rumours, allegations, negative reports or comments) ‎which are disparaging, deleterious or damaging to the integrity, reputation or ‎goodwill of the Company or any of its affiliates, officers, directors, ‎employees, consultants or advisors.‎

 

5. FULL SATISFACTION AND RELEASE

 

‎5.1‎ The Employee agrees to accept the Severance, as applicable, in full ‎satisfaction of any and all claims the Employee has or may have against the ‎Company arising out of such termination, including: under applicable ‎employment standards legislation and entitlement to reasonable notice under ‎common law. The Employee agrees to sign and deliver a full and final release ‎of the Company of all such claims arising upon such termination in return for ‎payment of the lump sum components of the Severance in excess of ‎employment standards minimum payments.‎

 

6. RIGHT TO DEDUCT

 

‎6.1‎ The Company shall have the right to offset any money properly due by the Employee to ‎the Company against any amounts payable by the Company to the Employee under this ‎Agreement.‎

 

 
 

 

7.‎ GENERAL

 

‎7.1‎ This Agreement contains the entire Agreement and obligation between the parties with ‎respect to its subject matter. No amendment to this Agreement will be valid or effective ‎unless in writing and signed by all of the parties.‎

 

‎7.2‎ The Employee undertakes to fulfill all of its obligations under this Agreement, and not to ‎do anything which would impair or prejudice the Employee’s ability to do so. The ‎Employee agrees that he is bound under his obligations in Sections 9, 10 and 11 of this ‎Agreement.‎

 

‎7.3‎ The Employee’s obligations under this Agreement are of a unique character ‎that gives them particular value, and that the breach of any of these ‎obligations will cause irreparable and continuing damage to the Company for ‎which money damages are insufficient. The Company is entitled to injunctive ‎relief, a decree for specific performance, and all other relief as may be proper (including money damages if ‎appropriate), without the need to post a bond.‎

 

‎7.4‎ It is intended that this Agreement shall be in compliance with the minimum ‎requirements of British Columbia’s Employment Standards Act, as may be ‎amended from time to time. To the extent that a term or condition of this ‎Agreement falls below a minimum requirement of this statute or its regulations, ‎as may be amended from time to time, such minimum requirement, and no ‎greater requirement, shall replace the term or condition of this Agreement, and ‎shall be incorporated into the Agreement.‎

 

‎7.5‎ The Employee acknowledges that the restrictions contained in Section s 9, 10 ‎and 11 are, in view of the nature of the Business of the Company, reasonable ‎and necessary to protect the legitimate interests of the Company, that the ‎Company would not have entered into this Agreement in the absence of such ‎restrictions and that any violation of any provision of those Sections could ‎result in irreparable injury to the Company. The Employee agrees that, in the ‎event it violates any of the restrictions referred to in Section 9, 10 and 11, the ‎Company shall be entitled to such injunctive relief or other remedies at law or ‎in equity which the Court deems fit.‎

 

‎7.6‎ The Employee expressly acknowledges that this Agreement is reasonable and ‎valid in all respects and irrevocably waives (and irrevocably agrees not to ‎raise) as a defence any issue of reasonableness in any proceeding to enforce ‎any provision of this Agreement, the intention of the parties being to provide ‎for the legitimate and reasonable protection of the interests of the Company by ‎providing, without limitation, for the broadest scope, the longest duration and ‎the widest territory allowable by law.‎

 

‎7.7‎ The Employee agrees to indemnify the Company from all losses, claims, ‎actions, damages, assessments or demands (including reasonable legal fees and ‎expenses) which result from negligent acts or omissions of the Employee in ‎providing the Services. Notwithstanding the foregoing, the Company agrees that ‎the Employee will be covered by the Company’s Directors & Officers and ‎Employment Practices Liability Insurance, once such insurance is obtained by ‎the Company.‎

 

‎7.8‎ Any notice, request, demand or other communication hereunder shall be in writing and shall ‎be delivered as follows, with notice deemed given as indicated: (a) by personal delivery, ‎when actually delivered; (b) by overnight courier, upon written verification of receipt; (c) by ‎facsimile or email, when sent, if sent during normal business hours of the recipient, and if ‎not sent during normal business hours, then on the recipient’s next business day; or (d) by ‎certified or registered mail, return receipt requested, upon verification of receipt. Notice ‎shall be sent to the addresses set forth on the first page of this Agreement or to such other ‎address as the parties may advise each other in writing from time to time in accordance with ‎this Section 14.8.‎

 

 
 

 

‎7.9‎ The Company and the Employee will be responsible for all of their own ‎expenses, legal and other professional fees, disbursements, and all other costs ‎incurred in connection with the negotiation, preparation, execution and delivery ‎of this Agreement and all documents and instruments relating hereto. The ‎parties agree that they have had adequate opportunity to seek independent legal ‎advice with respect to the subject matter of this Agreement, and have either obtained such advice or consciously chosen not to do so with full knowledge of the risks associated with not obtaining such legal advice.‎

 

‎7.10‎ If any provision of this Agreement, including as to term or geographical area, is ‎held to be illegal, invalid or unenforceable under present or future laws by any ‎court of competent jurisdiction, such illegality, invalidity or unenforceability ‎shall not affect the legality, enforceability or validity of any other provisions ‎of this Agreement or of the same provision as applied to any other fact or ‎circumstance, and such illegal, unenforceable or invalid provision shall be ‎modified to the minimum extent necessary to make such provision legal, valid ‎or enforceable.‎

 

‎7.11‎ Time shall be of the essence of this Agreement.‎

 

‎7.12‎ Except as specifically permitted herein, the Employee will not sell, assign or ‎transfer any rights or interests created under this Agreement or delegate any of ‎the Employee’s duties without the prior written consent of the Company.‎

 

‎7.13‎ The headings in this Agreement are inserted for convenience of reference only and shall not ‎affect the construction or interpretation of this Agreement. Wherever the singular or ‎masculine or neuter is used in this Agreement, the same shall be construed as meaning the ‎plural or feminine or a body politic or corporate and vice versa where the context so ‎requires.‎

 

‎7.14‎ The parties agree that this Agreement is effective as of the Effective Date, and ‎the parties agree that there is fresh, sufficient consideration for this Agreement. ‎The parties waive the ability to claim that: (i) this Agreement is void for lack of ‎fresh, sufficient consideration, and (ii) this Agreement is not effective as of the ‎Effective Date.‎

 

‎7.15‎ This Agreement will be governed by and construed in accordance with the laws ‎of the Province of British Columbia, and the federal laws of Canada applicable ‎therein, and each of the parties irrevocably submit to the exclusive jurisdiction ‎of courts of competent jurisdiction in the Province of British Columbia, without ‎reference to its conflicts of law jurisprudence, in respect of any dispute or ‎claim arising out of this Agreement or any legal obligation between the parties. ‎Notwithstanding the foregoing, the Company may enforce any post-employment ‎obligation of the Employee under this Agreement in any court of competent ‎jurisdiction anywhere in the world.‎

 

‎7.16‎ This Agreement may be executed in any number of counterparts, each of which ‎shall be deemed to be an original and all of which taken together shall be ‎deemed to constitute one and the same instrument. Counterparts may be ‎executed either in original or electronic form and each of the parties to this ‎Agreement agree that any signature delivered by electronic transmission will be ‎deemed to be the original signature of the delivering party.‎

 

‎7.17‎ Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful ‎money of Canadian.‎

 

 
 

 

IN WITNESS WHEREOF, the parties have signed this Agreement as of the day and year first written above.

 

“/s/ Cameron Chell”   “/s/ Paul Mullen”
         
Name: Cameron Chell   Name: Paul Mullen
Title: Chief Executive Officer   Date: March 5, 2021
Date:        

 

 

 

EX-4.12 8 ex4-12.htm

 

Exhibit 4.12

 

THIRD EMPLOYMENT AGREEMENT AMENDMENT

 

THIS THIRD EMPLOYMENT AGREEMENT AMENDMENT (the “Third Amending Agreement”) , effective as of April 1, 2023 ‎(the “Effective Date”) is between:

 

DRAGANFLY INNOVATIONS INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

PAUL MULLEN,

 

an individual residing at [Redacted]

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

11.The Company ‎and the Employee entered into an Employment Agreement dated April 12, 2021, an Employment Agreement Amendment dated ‎November 1, 2021, and an Employment Agreement Amendment dated April 1, 2022 (together, the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;

 

12.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Third Amending Agreement hereinafter set forth;

 

 

 

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Third Amending Agreement, including the increase to the Employee’s base salary, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.Provision 3.1 in the Employment Agreement is replaced with the following:

 

As compensation for carrying out the Services during the ‎term of this Agreement, the Company agrees to pay the ‎Employee a salary in the amount of CDN$250,000.00 (the ‎‎”Annual Salary”) payable by bi-weekly instalments. The ‎Company will review the Annual Salary annually during the ‎term of this Agreement and may, in its sole discretion, adjust ‎the Annual Salary. Any such adjustments may be made ‎without requiring a written amendment to this Agreement, ‎‎and without causing ‎termination or breach of this ‎‎Agreement. Provision 3.2 in the Employment Agreement is replaced with the following:

 

In addition to the above Annual Salary, the Employee shall ‎be eligible to earn a discretionary annual performance ‎bonus (“Performance Bonus”). The Performance Bonus will ‎be determined following the completion of the ‎Company’s ‎financial year each year, based on performance metrics to be ‎‎determined by the Company’s compensation committee in its ‎sole discretion‎. The Company shall pay the Employee the ‎Performance Bonus, if any, following the approval of performance bonus by the Board of Directors during the March board meeting. The Employee understands and agrees that payment ‎of a Performance Bonus should not be considered to be ‎expected compensation and the payment of a Performance ‎Bonus in any one or successive years shall not create an ‎entitlement to a Performance Bonus in any subsequent year. ‎To be eligible for a Performance Bonus, the Employee must ‎also be Actively Employed on the date of payment of any ‎such ‎bonus. For purposes of this Agreement, the last day ‎that the Employee is “Actively Employed” ‎shall be the later of:‎ ‎‎(i) the ‎last day that‎ the Employee actually performs their ‎‎duties prior to the termination ‎of the Employee’s employment ‎with the ‎Company for ‎any reason; or (ii) the ‎end of ‎the ‎minimum ‎period of statutory notice of termination prescribed ‎by the Ontario Employment Standards Act, 2000 (the “ESA”)‎. ‎This is because a Performance Bonus is not earned until the ‎payment date. For clarity, ‎except to the extent required by the ‎ESA: ‎‎‎(i) the last day that the Employee is Actively ‎Employed ‎‎shall not be extended by any ‎‎‎‎contractual or ‎‎common law ‎notice of ‎‎termination period in ‎respect ‎of which the ‎Employee ‎receives ‎‎or may ‎‎receive pay ‎in ‎lieu of notice ‎of ‎termination or damages ‎in ‎lieu of such ‎notice ‎of ‎‎termination; ‎and ‎(ii) entitlement to any ‎Performance Bonus‎ shall not ‎be ‎included ‎in any ‎entitlement which the Employee ‎may ‎have ‎to pay in lieu or damages in lieu ‎‎of ‎notice ‎‎of ‎termination. ‎

 

The performance metrics and target Performance Bonus of ‎the ‎Employee for any given year are attached hereto as ‎‎Schedule “B”. Schedule “B” will be reviewed from time-to-‎‎time and may be amended by the Company without ‎‎requiring a written amendment to this Agreement, and ‎‎without causing ‎termination or breach of this Agreement. ‎

 

The Employee shall be entitled to participate in the Company’s benefit programs as may be amended from time to time (the “Benefits”). All Benefits are subject to the terms and conditions of the applicable policies. The Employee agrees that the Company may substitute or modify the Benefits or their terms and conditions without notice.

 

2.Provision 3.4 will be added into the ‎‎Employment Agreement as follows:

 

The Company will grant the Employee 120,000 restricted ‎share units of the Company (“RSUs”) ‎to purchase up to ‎‎120,000 common shares of the Company. The grant of ‎RSUs to the Employee shall be made in accordance with the ‎terms and conditions ‎of the Company’s Amended and ‎Restated Share Compensation Plan (the “Plan”) and ‎applicable ‎rules and requirements of the Canadian ‎Securities Exchange and NASDAQ. The RSUs shall vest ‎in ‎accordance with the following vesting schedule:‎

 

d)‎40,000 RSUs granted October 30, 2023‎;‎

 

 

 

 

e)‎40,000 RSUs granted on September 3, 2024‎; and‎

 

f)‎40,000 RSUs granted on March 20, 2025‎.‎

 

3.Schedule “B” entitled “Performance Bonus Program” will be added into the ‎‎Employment Agreement as follows:

 

For the calendar year of 2023, the Employee’s target ‎annual ‎Performance Bonus is ‎CDN$250,000.00, based on the ‎‎following milestones and achievements:

   % Bonus 
Revenue of $12 million with sliding pro-rated scale <$10 million is 0%, $11M is 50%, $12M is 100%   20%
“175% Payroll Efficiency Target” calculated as “Total Revenue”/”Wages & Salaries; with sliding scale noted as <105% is 0, 140% is 50%   30%
ENPS of 20   10%
Launch and revenue from 2 new UAV platforms and 2 new integrated systems   20%
Global production capacity of 100 3 XL’s and 10 Heavy Lifts per month   20%
    100%

 

To clarify, the Performance Bonus remains discretionary as ‎solely determined and approved by the Board. The Employee ‎understands and agrees that payment of a Performance ‎Bonus should not be considered to be expected ‎compensation and the payment of a Performance Bonus in ‎any one or successive years shall not create an entitlement ‎to a Performance Bonus in any subsequent year.‎

 

4.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.

 

5.The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Amending Agreement or the changes to his employment as set out herein, which specifically includes any claims under any applicable human rights, workers’ compensation, occupational health and ‎safety, and employment standards legislation including but not limited to the Employment Standards Act, the Human Rights Code and the Workers’ Compensation Act.

 

6.This Amending Agreement amends the Employment Agreement. This Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.

 

7.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

8.If there is a conflict between any provision of this Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Amending Agreement are to prevail.

 

9.This Amending Agreement is governed by,and is to be construed and interpreted in accordance with the laws of British Columbia and the laws of Canada applicable therein. The Parties irrevocably attorn to the jurisdiction of the courts of the Province of British Columbia in relation to enforcement of this Amending Agreement.

 

 

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this _______ day of _____________ 2023:

 

“/s/ Paul Mullen”  
Paul Mullen  
(Employee Signature)  
   
By:  
   
DRAGANFLY INNOVATIONS INC.  
   
“/s/ Cameron Chell”  
Authorized Signatory  
I have authority to bind the corporation.  

 

 

EX-4.13 9 ex4-13.htm

 

Exhibit 4.13

 

June 3, 2022

 

Deborah R. Greenberg

 

Via email: [Redacted]

 

Dear Deborah

 

Re: Employment Agreement

 

We are pleased to offer you full time-permanent employment with, Draganfly Innovations Inc. (the “Company”) on the terms set out in this letter agreement (the “Agreement”).

 

The specific terms of your employment under this Agreement are as follows:

 

Employment and Duties

 

The term of your employment shall commence no later than July 4th 2022 and shall continue indefinitely until your employment is terminated in accordance with the terms of this Agreement.

 

You will be employed as the Chief Legal Officer. You shall be expected to carry out all duties and responsibilities assigned to you by management of the Company which are reasonably associated with your position.

 

You shall perform your work for the Company from your home in [Redacted] or at another location that may be mutually agreed to between you and the Company. It is acknowledged and agreed that you will not be required to relocate without your consent.

 

Base Salary

 

Your base salary will be $275,000 per annum, less deductions and withholdings required or authorized by law, payable bi-weekly. Payment from the Company will be made by direct deposit to your designated bank account.

 

It is acknowledged that the Company is currently undergoing a salary review process and that your salary will be subject to the review and will be adjusted, if required, in the fall of 2022, along with any other positive changes that may be made to the compensation for the executive team.

 

In addition to the above annual salary, you shall be eligible to earn a discretionary annual performance bonus targeted at 85% of your base salary that is in effect at the time of the payment of the bonus (the “Performance Bonus”).

 

The Performance Bonus shall be based upon the achievement of certain financial and/or operating

 

objectives that will developed in consultation with the CEO within [30] days of your Start Date and

 

then annually thereafter at the outset of each year, or as soon as practicable thereafter.

 

For greater certainty, you shall be eligible to receive a pro-rated Performance Bonus for the remainder of the 2022 calendar year, based on the agreed upon criterion.

 

The Company shall pay you the Performance Bonus, if any, within the thirty (30) days following the end of the calendar year period to which it applies. You understand and agree that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year.

 

For clarity, in the event that your employment ends due to a termination for Just Cause or a Resignation Without Good Reason, you have no entitlement to any further Performance Bonus and no entitlement to claim damages in lieu of any further Performance Bonus.‎

 

RSU Options

 

Upon Board approval, which is expected to occur no later than 60 days post execution hereof, you will receive a grant of Restricted Share Units (RSUs) equal to 75% of your base salary.

 

Thereafter, on an annual basis and in accordance with the Company’s Employee Stock Option Plan will be eligible to receive further grants of RSUs equal to no less than 75% of your base salary in effect on the date of the future grants.

 

The RSUs will be subject to the terms and conditions of the Company’s Employee Stock Option Plan. For greater certainty and notwithstanding anything to the contrary, the RSUs will vest over a period of 18 months, with one third (33%) of the RSUs vesting every 6 months’ time, from the date of each grant.

 

 

 

 

Benefits and Perquisites

 

You will be entitled to participate in the Company’s group benefit plan from the commencement of your employment. The Company reserves the right to alter or vary the terms of the Company’s group benefit plan in its sole discretion, so long as you are not left with materially less valuable benefits.

 

The Company will pay for or reimburse the costs of your annual professional fees and legal insurance fees required to be procured in the course of your employment duties with the Company.

 

The Company will provide you with a reasonable annual allowance to attend legal industry conferences and/or have memberships in relevant legal industry groups, subject to approval from the Company’s CEO.

 

You will be provided with a Laptop computer and/or Tablet to allow you to conduct the Company’s business.

 

You will also be entitled to participate in any other form of executive benefit and/or perquisite that other executives of the Company are currently entitled to or may become eligible for or entitled to.

 

Vacation

 

You will be entitled to 5 weeks’ paid vacation per calendar year which may be taken at times acceptable to and approved by the Company in advance. Vacation should be taken during the calendar year in which it is ‎earned. A maximum of five (5) unused vacation days may be ‎carried over into the subsequent year and must then be used by ‎March 31st of that year, ‎Upon the cessation of your employment, however caused and ‎regardless of the reasons therefore, you will be paid all accrued but ‎unpaid vacation pay. ‎‎

 

Expenses

 

The Company will pay for or reimburse you for all reasonable and approved business expenses associated with the performance of your responsibilities, upon presentation of expense statements, invoices and receipts or such other supporting documentation as the Company may reasonably require.

 

Duties and Responsibilities

 

Chief Legal Officer

 

Provide expert and strategic legal advice to management
Set internal governance policies and manage the impact of external factors
Evaluate and weigh multiple inputs and impacts of any decision or course of action
Anticipate issues and estimate risks strategically
Identify proactive solutions that will eliminate or mitigate risks
Base your decision-making process on ethics and integrity
Create associations of trust and respect with key stakeholders
Deal with external parties (regulators, external counsel, politicians, clients)
Attract, develop, direct, motivate and drive performance from team
Draft agreements that minimize risks and maximize legal rights
Assist with the preparation or review of continuous disclosure documents required by applicable securities laws
Advise on debt and equity financing terms and structure
Manage stock exchange reporting and compliance requirements
Manage correspondence with regulatory agencies
Deal with complex, significant matters that cut across legal and related areas
Keep abreast of legislative changes

 

Termination of Employment

 

Just Cause

 

The Company may terminate your employment at any time for just cause, as contemplated by applicable law without payment of any compensation, except for payment of accrued wages and accrued vacation, through the date of termination of employment.

 

 

 

 

Termination Without Cause

 

The Company may terminate your employment Without Cause upon the provision of the following payments and terms:

 

a.A payment on account of any accrued and unpaid wages, vacation pay and reimbursable expenses up to and including the date of termination;

 

b.A retiring allowance payment equal to:

 

i.4 months of your base salary in effect as of the date of termination if you are terminated within less than 6 months from your start date;

 

ii.9 months of your base salary if you are terminated between 6 months and less than 12 months from your start date;

 

iii.12 months of your base salary if you are terminated as of 12 months from your start date, which allowance shall increase by one additional month’s pay for each full year of employment following your first 12 months of service, up to a maximum of 24 months’ pay.

 

c.A payment on account of your Performance Bonus pro-rated for the number of months set out in paragraph (b) above, which shall be calculated based upon the greater of (a) your targeted annual Performance Bonus; or (b) the annual average of the actual Performance Bonuses paid to you in the two-year period prior to the termination date;

 

d.A payment on account of your Performance Bonus, from the outset of the calendar year of your termination to the date of your termination, which shall be calculated based upon your targeted Performance Bonus in effect at the time;

 

e.A payment in the amount of 10% of the retiring allowance set out at item (b) above, in lieu of all other benefits and perquisites that you receive pursuant to this Agreement; and

 

f.With respect to any unvested RSUs held by you as of the date of a termination Without Cause, and notwithstanding anything to the contrary in any other plan or agreement, your unvested RSUs will continue to vest for the period of time represented in item (b) above.

 

Resignation For Good Reason

 

If there is an event or series of events that constitute Good Reason pursuant to this section, you shall have the right to terminate this Agreement and resign from your employment with the Company. In order to resign for Good Reason, you must provide written notice to the ‎Company’s Chief Executive Officer, within 30 days after the first occurrence of the ‎event giving rise to Good Reason setting forth the basis for your resignation, allow ‎the Company at least 30 days from receipt of such written notice to cure such event ‎‎(“Cure Period”), and if such event is not reasonably cured within such period, you ‎must resign from all positions that you then hold with the Company not later than 30 ‎days after the expiration of the Cure Period.‎

 

For the purposes of this section, “Good Reason” shall mean any of the following, unless you have given your express written consent thereto:

 

a.Changed Duties or Status. The assignment to you of any duties materially inconsistent with your role as Chief Legal Officer of the Company or a material diminution in the nature or status of your responsibilities or duties;

 

b.Changed Reporting Relationships. The material diminution of your duties, responsibilities, powers or authorities, including the assignment of ‎any duties and responsibilities materially inconsistent with your position of Chief Legal Officer, provided that Good ‎Reason shall not exist under this clause if such diminution of authority, duties and responsibilities is a result of ‎the hiring of additional subordinates to assume some of your duties and responsibilities which are in fact, in ‎the aggregate from time to time, not a material diminution of such authority, duties and responsibilities as Chief ‎Legal Officer;

 

 

 

 

c.Reduced Compensation. Any reduction in your base salary or any other form of material reduction to any other term of your compensation or perquisites, excluding any variations in the Performance Bonus that are based that are based upon yours or the Company’s performance, but shall include the Company’s failure to award or assess your Performance Bonus through an objectively fair and identifiable process

 

d.Breach of Contract. Any material breach by the Company of its duties or obligations to you under this ‎Agreement that resulted or may result in material harm to you‎; or

 

e.Relocation. The Company’s requiring you to be based anywhere other than in ‎Montreal, Quebec without your consent, except for required travel on the Company’s business to an extent substantially consistent with your business travel obligations in the ordinary course of business.

 

For greater certainty, these provisions shall prevail over any conflicting language found elsewhere in the Agreement.

 

In the event that you terminate your employment for Good Reason, the Company shall provide you with the compensation and benefits required in the event of a termination Without Cause.

 

Termination Without Cause or Resignation for Good Reason Following a Change of Control

 

If your employment is terminated Without Cause or for Good Reason, in either case, in the twelve (12) month period following a Change of Control, as defined below, the Severance Payment shall become 18 months of your base salary and the greater of (a) your targeted annual Performance Bonus multiplied by 1.5; or (b) the average of the actual Performance Bonuses paid to you in the two year period prior to the termination date, multiplied by 1.5.

 

For the purposes of this Agreement a “Change of Control” means:

 

a.the sale by the Company of all or substantially all of its assets;

 

b.the acceptance by the shareholders of the Company, representing in the aggregate fifty percent (50%) or more of all of the issued Common Shares in the capital of the Company (collectively, the “Shares”), of any offer, whether by way of a takeover bid or otherwise, for all or any of the outstanding Shares; provided that no Change of Control shall be deemed to have occurred if upon completion of any such transaction individuals who were members of the Board immediately prior to the effective date of such transaction constitute a majority of the board of directors of the resulting issuer following such effective date;

 

c.the acquisition, by whatever means, by a person (or two or more persons who, in such acquisition, have acted jointly or in concert or intend to exercise jointly or in concert any voting rights attaching to the Shares acquired), directly or indirectly, of beneficial ownership of such number of Shares or rights to Shares, which together with such person’s then-owned Shares and rights to Shares, if any, represent (assuming the full exercise of such rights) fifty percent (50%) or more of the combined voting rights attached to the then-outstanding Shares;

 

d.the entering into of any agreement by the Company to merge, consolidate, restructure, amalgamate, initiate an arrangement or be absorbed by, into or with another company; provided that no Change of Control shall be deemed to have occurred if upon completion of any such transaction individuals who were members of the Board immediately prior to the effective date of such transaction constitute a majority of the board of directors of the resulting issuer following such effective date;

 

e.the passing of a resolution by the Board or shareholders of the Company to substantially liquidate the assets of the Company or wind up the Company’s business or significantly rearrange its affairs in one or more transactions or series of transactions or the commencement of proceedings for such a liquidation, winding-up or re-arrangement (except where such rearrangement is part of a bona fide reorganization of the Company in circumstances where the business of the Company is continued and the shareholdings remain substantially the same following the re-arrangement); or

 

 

 

 

f.the circumstance in which individuals who were members of the Board immediately prior to a meeting of the shareholders of the Company involving a contest for the election of directors no longer constitute a majority of the Board following such election.

 

Full and Final Entitlement upon Termination of this Agreement

 

The payments and terms set forth above are inclusive of the minimum notice of termination or pay in lieu thereof (along with, in either case, the continuation of benefits in accordance with applicable law), and notice of termination (if applicable), all in accordance with applicable law.

 

For greater certainty, you will not be entitled to any further notice or payments on termination than that which is set out in the aforementioned paragraphs and you explicitly waive your right to any civil law entitlements.

 

The termination entitlements described above shall continue to be in effect for the duration of your employment unless otherwise amended in writing and signed by both you and the Company. You acknowledge and agree that the termination provisions in this Agreement are reasonable and constitute full and adequate notice and/or compensation to you with respect to the termination of your employment. You therefore understand and agree that upon lawful termination of your employment in compliance with the above termination provisions, you will have no right to claim further notice, pay in lieu of notice, damages, severance pay, reinstatement, benefits, or any other compensation from the Company, whether under contract, statute, common law or otherwise.

 

Resignation Without Good Reason

 

You may resign from your employment at any time by providing the Company with four weeks’ written notice. The Company may, at its sole discretion, require that you not attend at work for the balance of the resignation ‎notice period, provided that the Company continues to pay any amounts that you would ‎have earned and maintains your participation in the benefit plans and programs in which you then participate for this notice of ‎resignation period.

 

Employee Personal Information

 

By accepting employment with the Company, you consent to the collection of your personal information from such sources as your application, resume and any subsequent information provided by you in the employment context and you agree to the use of this information for purposes related to your employment. You certify that this personal information provided is true and complete. You also agree that we may disclose your personal information either within the Company or externally as required to process benefits, payroll, maintain required compliance activities and licensing.

 

Professionalism

 

During your employment with the Company, you agree that you will act at all times in a professional and honest manner. You will not work, directly or indirectly, on your own behalf or for any other individual, corporation, partnership, unincorporated organization, governmental agency or other entity which, in the reasonable opinion of the Company, may give rise to a conflict of interest.

 

Confidential Information

 

In this Agreement, “Confidential Information” includes, without limitation, confidential information of the Company, including information developed or contributed by you while in the employment of the Company, relating to such things as business operations, computer programs and associated procedures and systems, parts information, accounting and statistical data and records, pricing and discount practices, other financial information, market studies, sources of supply, special programs relating to sales, training, products and equipment, and any other matters related to the business of the Company which are not commonly known in the public domain.

 

 

 

 

Except as authorized in writing by the Company, you agree to treat all Confidential Information which you receive or acquire during the course of your employment with the Company on a strictly confidential basis and hold the same solely for the benefit of the Company both during and subsequent to your employment and you will not declare or use, give, loan, sell or otherwise dispose of or make available to any person, firm or corporation, directly or indirectly, any such Confidential Information either during or subsequent to your employment with the Company except as required in the performance of your duties under this Agreement.

 

Employee Policies and Procedures

 

You will be required to comply with the Company policies, as they are amended from time to time, which may be communicated by way of manuals, memoranda or via electronic means.

 

Directors and Officers Liability Insurance and Indemnification over Claims

 

During and after the term of your employment, the Company shall:

 

a.in addition to any protection under the organizational documents of the Company, maintain for your benefit directors and officer’s liability insurance at levels equivalent to that provided to other senior executives; and

 

a.indemnify and hold you harmless to the fullest extent permitted by applicable law with regard to any action or inaction you may take as an officer, director or employee of the Company or its affiliates or as a fiduciary of any benefit plan of the Company or any affiliate, subject to any limitations on such indemnification imposed by applicable law.

 

This Article shall survive any termination of your employment.

 

Additional Terms

 

This Agreement constitutes the entire agreement between you and the Company relating to your employment relationship and supersedes any prior, contemporaneous, or subsequent statements, representations, warranties, understandings, or inducements of any kind, whether oral or written.

 

The terms of this Agreement shall remain in effect throughout your employment with the Company, notwithstanding any changes to your title, position, duties, responsibilities, salary or compensation.

 

You represent that, except as disclosed in writing to the Company, ‎you are not bound by the terms of any agreement with any previous employer ‎or other party to refrain from competing, directly or indirectly, with the ‎business of such previous employer or any other party. You further ‎represent that your performance of all the terms of this Agreement as an ‎employee of the Company does not and will not breach any agreement to ‎keep in confidence proprietary information, knowledge or data ‎acquired by you in confidence or in trust prior to your employment with ‎the Company. You will not disclose to the Company or induce the Company to use any ‎confidential or proprietary information or material belonging to any ‎previous employer or others. ‎

 

You agree that all restrictions contained in this Agreement are reasonable and valid and you hereby waive any and all defenses to their strict enforcement by the Company.

 

You agree that you have been afforded the opportunity to read this Agreement, and to obtain independent legal advice prior to signing it.

 

Nothing in this Agreement is intended to contract out of your minimum entitlements under applicable law. In the event that applicable law provides you with superior entitlements than provided for in this Agreement, the Company shall provide you with your minimum legal entitlements in substitution for your rights under this Agreement.

 

 

 

 

All paragraphs and covenants contained in this Agreement are severable, and in the event that any of them shall be held to be invalid, unenforceable or void by a court of a competent jurisdiction, such paragraphs or covenants shall be severed, and the remainder of this Agreement shall remain in full force and effect.

 

This Agreement is personal to you and may not be assigned in any way by you without the prior written consent of the Company. The Company may assign its rights and obligations under this Agreement to any successor or affiliated entity.

 

This Agreement shall be governed by and construed and interpreted in accordance with the laws of the Province of Quebec and the laws of Canada applicable therein.

 

If you have any questions respecting any of these terms, please contact the undersigned immediately.

 

Please acknowledge your receipt and review of this Agreement and your acceptance of the terms and conditions of your employment with the Company by signing one copy below and returning it to Cameron Chell via HelloSign on or before 4:00 pm PST Pacific time prior to June 6th, 2022.

 

We are pleased to offer you this opportunity and we look forward to receiving your acceptance of our offer. We look forward to having you join the team.

 

Sincerely,

 

Cameron Chell

 

CEO

 

Draganfly Innovations Inc.

 

I have read, understood and hereby accept the foregoing offer. I acknowledge that I have been provided with an opportunity to seek independent legal advice before indicating my acceptance of this offer by my signature below.

 

In signing below, I further acknowledge having requested that this Agreement and all ancillary documents be drafted solely in English. En signant ci-dessous, je reconnais également avoir demandé que la présente entente ainsi que tout document y afférent soient rédigés en anglais seulement.

 

“/s/ Deborah Greenberg”  
Deborah R. Greenberg   Date

 

 

 

EX-4.14 10 ex4-14.htm

 

Exhibit 4.14

 

THIS FIRST EMPLOYMENT AGREEMENT AMENDMENT (the “First Amending Agreement”), is made and effective as of April 1, 2023 ‎(the “Effective Date”) between:

 

DRAGANFLY INNOVATIONS INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

DEBORAH R. GREENBERG,

 

an individual residing at [Redacted]

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

(Company and Employee/You are together referred to herein as the “Parties”)

 

WHEREAS:

 

A.The Company ‎and the Employee entered into an Employment Agreement dated June 3, 2022 (the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;

 

B.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this First Amendment hereinafter set forth;

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this First Amending Agreement, including the increase to the Employee’s base salary, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.The second paragraph of the provision entitled “Employment and Duties” shall be amended by changing the title “Chief Legal Officer” to Chief Legal and Corporate Services Officer”.

 

2.The provision entitled “Base Salary” in the Employment Agreement is replaced with the following:

 

Your base salary will be $300,000 per annum, less deductions and withholdings required or authorized by law, payable bi-weekly. Payment from the Company will be made by direct deposit to your designated bank account.

 

In addition to the above annual salary, you shall be eligible to earn a discretionary annual performance bonus targeted at 100% of your base salary that is in effect at the time of the payment of the bonus (the “Performance Bonus”).

 

The Performance Bonus will ‎be determined following the completion of the ‎Company’s ‎financial year each year, based on performance metrics to be ‎‎determined by the Company’s compensation committee in its ‎sole discretion‎. The Company shall pay the Employee the ‎Performance Bonus, if any, following the approval of performance bonus by the Board of Directors during the March board meeting. The Employee understands and agrees that payment ‎of a Performance Bonus should not be considered to be ‎expected compensation and the payment of a Performance ‎Bonus in any one or successive years shall not create an ‎entitlement to a Performance Bonus in any subsequent year. ‎

 

The performance metrics and target Performance Bonus of ‎the ‎Employee for 2023 are attached hereto as ‎‎Schedule “A”.

 

 

 

 

3.The third paragraph of the provision entitled “RSU Options” in the Employment Agreement is replaced with the following:

 

The Company hereby grants the Employee 144,000 restricted ‎share units of the Company (“RSUs”) ‎to purchase up to ‎‎144,000 common shares of the Company. Subject to the terms of this Agreement, the grant of ‎RSUs to the Employee shall be made in accordance with the ‎terms and conditions ‎of the Company’s Amended and ‎Restated Share Compensation Plan (the “Plan”) and ‎applicable ‎rules and requirements of the Canadian ‎Securities Exchange and NASDAQ. The RSUs shall vest ‎in ‎accordance with the following vesting schedule:‎

 

a)‎48,000 RSUs granted September 3, 2023‎;‎

 

b)‎48,000 RSUs granted on March 3, 2024‎; and‎

 

c)‎48,000 RSUs granted on September 3, 2024‎.‎

 

4.Schedule “A” entitled “Performance Bonus Program” will be added to the ‎‎Employment Agreement as follows:

 

For the calendar year of 2023, the Employee’s target ‎annual ‎Performance Bonus is ‎CDN$300,000.00, based on the ‎‎following milestones and achievements:

   % Bonus 
Revenue of $12 million with sliding pro-rated scale < $10 million is 0%, $11M is 50%, $12M is 100%   20%
175% Payroll Efficiency Target” calculated as “Total Revenue/Wages & Salaries”; with sliding scale noted as < 105% is 0, 140% is 50%   20%
ENPS of 20   15%
IT, cybersecurity, Intranet policies and platforms defined, developed, and adopted   15%
1 acquisition completed    10%
Complete set of contracts, LOI, MOU, Joint Collaboration, NDAs templated and with 2 - 5 business day turnaround for drafts   20%
    100%

 

5.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect unamended

 

6.The Employee hereby releases the Company from any and all claims she has or may have arising in any way out of the terms of this First Amending Agreement or the changes to her employment as set out herein.

 

7.This First Amending Agreement amends the Employment Agreement. This First Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the First Amending Agreement will be effective on the Effective Date.

 

8.This First Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

9.If there is a conflict between any provision of this First Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this First Amending Agreement are to prevail.

 

10.This First Amending Agreement is governed by, and is to be construed and interpreted in accordance with, the laws of Quebec and the laws of Canada applicable therein. The Parties irrevocably attorn to the jurisdiction of the courts of the Province of Quebec in relation to enforcement of this First Amending Agreement.

 

 

 

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the First Amending Agreement this _______ day of _____________ 2023:

 

“/s/ Deborah Greenberg”  
Deborah R. Greenberg (Employee Signature)  
   
By:  
DRAGANFLY INNOVATIONS INC.  
   
“/s/ Cameron Chell”  
Authorized Signatory  
I have authority to bind the corporation.  

 

 

 

EX-8.1 11 ex8-1.htm

 

Exhibit 8.1

 

List of Significant Subsidiaries

 

Draganfly Innovations Inc., a company incorporated under the laws of the Province of British Columbia, all of the shares of which are beneficially owned by the Company.

 

Dronelogics Systems Inc., a company incorporated under the laws of the Province of British Columbia, all of the shares of which are beneficially owned by the Company.

 

Draganfly Innovations USA Inc., a company incorporated under the laws of Delaware, all of the shares of which are beneficially owned by the Company.

 

 

EX-12.1 12 ex12-1.htm

 

Exhibit 12.1

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Cameron Chell, certify that:

 

1.I have reviewed this annual report on Form 20-F of Draganfly Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

 

4.The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting.

 

5.The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

 

Date: March 27, 2024  
     
  /s/ Cameron Chell  
Name: Cameron Chell  
Title: Chief Executive Officer  
  (principal executive officer)  

 

 

 

EX-12.2 13 ex12-2.htm

 

Exhibit 12.2

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Paul Sun, certify that:

 

1.I have reviewed this annual report on Form 20-F of Draganfly Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

 

4.The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be ‎designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and ‎the preparation of financial statements for external purposes in accordance with generally accepted accounting ‎principles;‎

 

(c)Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting.

 

5.The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

 

Date: March 27, 2024  
     
  /s/ Paul Sun  
Name: Paul Sun  
Title: Chief Financial Officer  
  (principal financial officer)  

 

 

 

EX-13.1 14 ex13-1.htm

 

Exhibit 13.1

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, as the Chief Executive Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 20-F for the fiscal year ended December 31, 2023, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 20-F for the fiscal year ended December 31, 2023 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

 

Date: March 27, 2024  
   
/s/ Cameron Chell  
Cameron Chell  
Chief Executive Officer  
(principal executive officer)  

 

 

 

EX-13.2 15 ex13-2.htm

 

Exhibit 13.2

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, as the Chief Financial Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 20-F for the fiscal year ended December 31, 2023, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 20-F for the fiscal year ended December 31, 2023 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

 

Date: March 27, 2024  
   
/s/ Paul Sun  
Paul Sun  
Chief Financial Officer  
(principal executive officer)  

 

 

 

EX-15.1 16 ex15-1.htm

 

Exhibit 15.1

 

 

Management Discussion and Analysis

For the year ended December 31, 2023

 

 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

This Management’s Discussion and Analysis (“MD&A”) is presented and dated as of March 27, 2024, and should be read in conjunction the annual consolidated financial statements and related notes for the year ended December 31, 2023. The Company’s audited consolidated financial statements have been prepared on a “going concern” basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

 

The operations of the Company have been primarily funded through its Regulation A+ Offering of units, its Nasdaq prospectus financing, internally generated cashflow and private placements of equity and convertible debentures. The continued operations of the Company are dependent on the Company’s ability to generate profitable operations in the future, develop and execute a sufficient financing plan for future operations and receive continued financial support from shareholders and other providers of finance.

 

The consolidated financial statements do not reflect the adjustments, if any, or changes in presentation that may be necessary should the Company not be able to continue on a going concern basis.

 

All currency amounts in the accompanying financial statements and this management discussion and analysis are in Canadian dollars unless otherwise noted.

 

Special Note Regarding Forward Looking Information

 

This Management Discussion & Analysis (“MD&A”) is intended to provide readers with the information that management believes is required to gain an understanding of the current results of Draganfly Inc. (the “Company” or “Draganfly”) and to assess the Company’s future prospects. Accordingly, certain sections of this report, other than statements of historical fact, may contain forward-looking statements that are based on current plans and expectations and are subject to certain risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions.

 

The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

 

the intentions, plans and future actions of the Company;
statements relating to the business and future activities of the Company;
anticipated developments in operations of the Company;
market position, ability to compete and future financial or operating performance of the Company;
the timing and amount of funding required to execute the Company’s business plans;
capital expenditures;
the effect on the Company of any changes to existing or new legislation or policy or government regulation;
the availability of labor;
requirements for additional capital;
goals, strategies and future growth;
the adequacy of financial resources;
expectations regarding revenues, expenses and anticipated cash needs;
general market conditions and macroeconomic trends driven by geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors.

 

2

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions, and expectations of future performance, taking into account the information currently available to us. Furthermore, unless otherwise stated, the forward-looking statements contained in this Annual Report are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether because of new information, future events, changes or otherwise, except as required by law.

 

These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. These include, without limitation, the Company’s current and planned operations and the expected results of new operations and new clients. These risks and uncertainties include, but are not restricted to:

 

The Company’s history of losses;
The dilution of holdings in the Company’s securities;
Research and development costs;
The failure of new business models to produce financial returns;
Operational risks for which the Company may not be adequately insured;
The Company operates in an evolving market that makes it difficult to evaluate business and future prospects;
Competitive market conditions and challenges from competitors;
The pace of technological change and the Company’s ability to stay on top of market and technology changes;
The failure to obtain necessary regulatory approvals and permits or limitations placed on the development, operation, and sale of unmanned aerial vehicles (“UAVs”) by governments;
Risks associated with any particular future acquisitions that would allow the company to provide additional product or service offerings;
The Company’s ability to retain key employees and personnel and the Company’s ability to manage growth;
Adverse economic changes;
Negative macroeconomic and geopolitical trends that could restrict the Company’s ability to access capital;
Uncertainties associated with operations in foreign countries;
Adverse tax policies;
An inability to access critical components or raw materials used to manufacture the Company’s products and supply chain disruptions;
Weather and other natural outdoor conditions that can imperil the use of UAVs;
The Company’s products may be subject to recalls or returns or defective products or services that could negatively affect the Company’s operating results;
An inability to secure adequate funding for research and development;
Export controls or restrictions on the Company’s ability to deliver its product outside of Canada;
Consumer perception regarding the use and safety of UAVs;
A failure to successfully market the Company’s products;
Security risks associated with electronic communications and IT infrastructure;
Inadequate consumer protection and data privacy practices;
An inability of our business partners to fulfill their obligations to us or to secure company information;
A failure to protect the Company’s intellectual property, proprietary rights, and trade secrets, including through a failure to adequately apply for or seek such protections;
Failure to adhere to financial reporting obligations and mandates associated with being a public company;
The Company’s limited experience operating as publicly traded corporation;
Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters;
Write-downs of goodwill or other intangible assets;
Legal proceedings in which the Company may become involved;
Conflicts of interests among our directors and officers;

 

3

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Volatility related to our share price;
A failure to maintain an active trading market for our common shares;
The Company may never pay dividends, and a return on an investment in the Company will depend upon an appreciation in the price of our shares after purchase;
The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes;
United States investors may not be able to obtain an enforcement of civil liabilities against the Company
The Company’s status as an “emerging growth company”;
Increased costs and compliance matters related to our status as a public company in the United States; and
The Company’s status as a “foreign private issuer.”

 

Readers are cautioned to read more about the potential risks the Company faces under the heading “Business Risks” at the end of this MD&A.

 

Non-GAAP Measures and Additional GAAP Measures

 

In this MD&A we describe certain income and expense items that are unusual or non-recurring. There are terms not defined by International Financial Reporting Standards (IFRS). Our usage of these terms may vary from the usage adopted by other companies. Specifically, Gross profit, Gross margin and Cash flow from operations are undefined terms by IFRS that may be referenced herein. We provide this detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results.

 

Throughout this document, reference is made to “gross profit,” “gross margin,” and “working capital”, which are non-IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Corporation’s liquidity and its ability to meet its current obligations. Readers are cautioned that these non-IFRS measures may not be comparable to similar measures used by other companies. Readers are also cautioned not to view these non-IFRS financial measures as an alternative to financial measures calculated in accordance with International Financial Reporting Standards (“IFRS”).

 

Core Business and Strategy

 

Draganfly creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company is incorporated under the British Columbia Business Corporations Act and has its registered office located at suite 2700 - 1133 Melville Street, Vancouver, BC, V6E 4E5 with a head office at 35 103rd St. E, Saskatoon, SK, S7N 1Y8.

 

Recognized as being at the forefront of UAV (“unmanned aerial vehicle”) technology for over two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, agriculture, industrial inspections, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

 

Founded in 1998, Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. The company has sold products and services to over 50 countries.

 

4

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Draganfly can provide its customers with an entire suite of products and services that include quad-copters, fixed-wing aircrafts, ground based robots, handheld controllers, flight training, and software used for tracking, live streaming, data collection, and health monitoring. The integrated UAV system is equipped for automated take-offs and landings with altitude and return to home functions as well as in-house created survey software. Draganfly’s standard features combined with custom fit camera payloads ranging from multi-spectral, hyper-spectral, LIDAR, thermal, and infrared allows Draganfly to offer a truly unique solution to clients.

 

With 23 issued and one pending fundamental UAV patents in the portfolio, Draganfly will continue to expand and grow its intellectual property portfolio.

 

Historically, the main business of the Company was as a manufacturing company offering commercial UAVs directly to its customer base across various industry verticals. The Company has evolved to offer drone solutions, including continuing to sell and develop its own OEM products, providing engineering procurement, drone services, and reselling third party products.

 

Draganfly works with its customers to customize a product or platform from idea to research and development (R&D) to completion and testing. A work plan is created with timelines and budgets which includes materials, travel, testing, and engineering time. The work plan is approved by the customer before work begins. To date, the majority of this work is considered proprietary in nature and is protected by trade secrets and other intellectual property protections.

 

The Company’s scope includes providing custom built parts, accessories, drone services, and the ability to sell third-party manufactured UAVs along with support services.

 

On February 26, 2024, the Company completed an underwritten share placement of 11,200,000 units with each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. Each unit was sold at a price of $0.27 USD for gross proceeds of $3,617,780 million ($4,075,946 million CAD). Net proceeds of $3,289,520 million USD ($4,433,831 million CAD) was received after share issue costs of $328,260 USD ($442,450 thousand CAD). The pre-funded warrants have an exercise price of $0.0001 USD and were exercised on the date of issue bringing the total gross proceeds to $3,618,000 USD. The remaining warrants have an exercise price of $0.36 USD and are exercisable immediately with a term of 5 years. As part of this transaction 670,000 warrants were issued to the underwriter with an exercise price of $0.3375 USD and will have a term of 3 years.

 

On October 30, 2023, the Company completed a public offering and issued 6,400,000 share units at an offering price of USD $0.55 per unit for gross proceeds of USD $3,520,000. The units were issued as follows: 4,800,000 units comprised of one share and one warrant and 1,600,000 units comprised of one pre-funded warrant with an exercise price of $0.0001 USD and have no expiry date and one warrant. The warrants had an exercise price of USD $0.61 per share, are exercisable immediately and expire five years from the date of issuance.

 

March 31, 2023 the Company closed an underwritten public offering of 8,000,000 common shares at a price of $1.00 USD per share for total gross proceeds of $8,000,000 USD ($10,856,166 million CAD) with share issue costs of $1,443,163 USD ($1,953,032 million CAD) for net proceeds of $6,556,837 ($8,903,134 million CAD).

 

On January 31, 2023, the Company entered into an equity distribution agreement. The agreement will allow the Company from time to time, to distribute in an at-the-market offering (“ATM”) up to $15,000,000 (USD) in common shares. Draganfly intends to use the net proceeds from the ATM for general corporate purposes, including to fund ongoing operations, growth initiatives and/or for working capital requirements including the continuing development and marketing of the Company’s core products, potential acquisitions and research and development.

 

From February 1, 2023 to February 17, 2023, the Company distributed 650,759 ATM shares under the ATM offering at an average price of $2.69 per share for net proceeds of $1,526,810.

 

5

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

On July 30, 2021, the Company’s shares began trading on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO”. The Company’s shares continue to trade on the Canadian Stock Exchange (the “CSE”), however, as of July 30, 2021 they now trade under the symbol “DPRO” on that exchange as well. The Company’s shares also trade on the Frankfurt Stock Exchange under the Symbol “3UB”.

 

In order to become compliant with Nasdaq regulations, the company also underwent a stock consolidation. Effective July 29, 2021, the Company consolidated its issued and outstanding common shares on a 5 to 1 basis, which resulted in 27,045,909 common shares outstanding post-consolidation.

 

Additional information relating to the Company may be found at the Company’s website, www.draganfly.com.

 

2023 Highlights

 

2023 Total Revenues of $6,554,842 with Product Sales of $5,287,093

 

2023 revenues decreased by $1,050,217 from $7,605,059 in 2022 to $6,554,842 with the bulk of this decrease coming from provision of services. Service revenue decreased by $786,878 from $2,054,627 in 2022 to $1,267,749 in 2023.

 

Gross Profit was $2,064,114 with a Gross Margin increase of 21.1% in 2023 compared to 2022.

 

In 2023, the Company’s total gross margin was 31.5% compared to 10.4% in 2022. Gross margin excluding the non-cash write down of inventory of $331,671 (2022 - $1,976,514) would have been 36.5% (2022 - 36.4%). The non-cash write down of inventory for 2022 was primarily related to a product line that is no longer a focus for the Company.

 

Continued Diversification of its Product and Services Offering

 

Given the Company’s deep engineering talent, the Company continues to expand its product and services available to its customers. Doing this leverages the Company’s core skill set of innovation that tends to lead to future projects, bringing in more consistent revenue. The Company continues to increase its scope of products and service to include the sale of third-party manufactured UAVs and drone-as-a-service type work. Having a larger breadth of products and services, in part, mitigates some risk for the Company given its offering covers a broader market.

 

Functional Reorganization

 

The Company has undertaken an effort to reorganize its functions into departments such as Finance, Sales and Marketing, Operations, Human Resources, etc. with the key goal of obtaining efficiencies by streamlining processes and procedures at a corporate shared service level as opposed to segmenting departments at the subsidiary level.

 

Risks Related to Operations

 

The Company’s UAVs are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company’s business and prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company’s ability to do the following:

 

generate sufficient revenue to maintain profitability;
acquire and maintain market share;
achieve or manage growth in operations;
develop and renew contracts;
attract and retain additional engineers and other highly qualified personnel;
successfully develop and commercially market new products;
adapt to new or changing policies and spending priorities of governments and government agencies; and
access additional capital when required and on reasonable terms.

 

For further and more detailed risk disclosure, please reference “Business Risks” at the end of this MD&A.

 

6

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Outlook and Guidance

 

General

 

The Company believes that drone regulations are gradually evolving in favor of additional use cases, which could lead to more revenue opportunities from a greater pool of customers. The Company is positioned properly to take advantage of this dynamic given its legacy and ongoing innovative product development coupled with being publicly traded providing greater market awareness than its private competitors. The Company will increasingly focus on some of its growth initiatives beyond Canada and into the United States and abroad. All else being equal, accessing more capital will help the Company expand and diversify its engineering and drone services businesses. The Company has already built the infrastructure including human resources from an oversight, sales and engineering perspective. Further, the Company will continue to focus on innovation, product development, and expanding its hardware offerings opportunistically into niche segments of the UAV and related sectors. Finally, the Company has considered providing various other non-engineering services and it may make more sense to buy an existing industry player than to build out this offering. The Company expects to be active in this regard reviewing partnerships and acquisitions in the current fiscal year and the near future.

 

Selected Financial Information

 

The following selected financial data has been extracted from the unaudited condensed consolidated interim financial statements, prepared in accordance with International Financial Reporting Standards, for the fiscal years indicated and should be read in conjunction with the unaudited condensed consolidated interim financial statements. All earnings per share calculations are shown post-consolidation.

 

For the year ended December 31,  2023   2022   2021 
Total revenues  $6,554,842   $7,605,059   $7,053,965 
Gross Profit (as a % of revenues) (1)   31.5%   10.4%   37.5%
Net (loss) income   (23,611,810)   (27,654,364)   (16,202,972)
Net (loss) income per share ($)               
-  Basic   (0.56)   (0.82)   (0.58)
-  Diluted   (0.56)   (0.82)   (0.58)
Comprehensive (loss) income   (23,709,851)   (27,305,305)   (16,399,137)
Comprehensive (loss) income per share ($)               
-  Basic   (0.56)   (0.81)   (0.59)
-  Diluted   (0.56)   (0.81)   (0.59)
Change in cash and cash equivalents  $(4,801,169)  $(15,180,932)  $21,093,297 

 

(1)Gross Profit (as a % of revenues) would have been 36.5% (2022 – 36.4%; 2021 – 37.5%) not including a non-cash write down of inventory for $331,671 (2022 - $1,976,514; 2021 - $nil)).

 

The net loss and comprehensive loss for the year ended December 31, 2023, includes non-cash changes comprised of a change in fair value of derivative liability of $211,110 (2022 - $5,502,688; 2021 - $8,149,812), an expense for impairment of notes receivable of $101,351 (2022 - $309,385;2021 - $891,471), a write down of inventory of $331,671 (2022 - $1,976,514; 2021 - $nil)), and an expense for goodwill and intangibles impairment of $87,415 (2022 - $6,454,914; 2021 - $4,579,763) and would otherwise have been a net loss of $23,302,483 (2022 - $24,416,239; 2021 – $18,881,550), and comprehensive loss of $23,400,524 (2022 - $24,067,180; 2021 - $19,077,715).

 

7

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

As at 

December 31,

2023

   December 31,
2022
 
Total assets  $8,330,292   $14,638,533 
Working capital   (717,017)   10,168,800 
Total non-current liabilities   523,584    249,740 
Shareholders’ equity  $407,716   $11,040,881 
           
Number of shares outstanding   49,229,563    34,270,579 

 

Shareholders’ equity and working capital as at December 31, 2023, includes a fair value of derivative liability of $4,196,125 ($57,314 – 2022) and would otherwise be $4,603,841 ($11,098,195 – 2022) and $3,479,108 ($10,226,114 - 2022) respectively.

 

Results of Operations

 

Revenue

 

For the year ended December 31,  2023   2022   2021 
Product sales  $5,287,093   $5,550,432   $5,103,399 
Provision of services   1,267,749    2,054,627    1,950,466 
Total revenue  $6,554,842   $7,605,059   $7,053,865 

 

Total revenue for the year ended December 31, 2023, decreased by $1,050,217 or 13.8% as compared to 2022. The decrease in revenue is largely due to a decrease in services in Dronelogics.

 

Product sales decreased $263,339 or 4.7% in 2023 as compared to 2022. The small decrease in revenue is largely due to decreased product sales from Dronelogics.

 

Services revenue decreased by $786,878 or 38.3% in 2023 as compared to 2022. The decrease was due primarily to fewer arrangements for services in Dronelogics.

 

Costs of Goods Sold/Gross Margin

 

For the year ended December 31,  2023   2022   2021 
Cost of goods sold(1)  $(4,490,728)  $(6,814,384)  $(4,410,777)
Gross profit  $2,064,114   $790,675   $2,643,088 
Gross margin (%)   31.5%   10.4%   37.5%

 

(1)Cost of goods sold would have been $4,159,057 (2022 - $4,837,870; 2021 - $4,410,777) not including a non-cash write down of inventory for $331,671 (2022 - $1,976,514; 2021 - $nil).

 

Gross profit is the difference between the revenue received and the direct cost of that revenue. Gross margin is gross profit divided by revenue and is often presented as a percent.

 

For the year ended December 31, 2023, the Company’s Gross Profit increased by $1,273,439 or 161.1% compared to 2022. As a percentage of sales, gross margin increased from 10.4% in 2022 to 31.5% in 2023.

 

8

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

For the year ended December 31, 2023, not including the non-cash write down of inventory of $331,671 (2022 - $1,976,514) the Company’s Gross Profit decreased by $371,404 (2022 - $124,101) or 18.5% (2022 – increased 4.7%) compared to 2022. As a percentage of sales, adjusted gross margin increased from 36.4% in 2022 to 36.5% in 2023 (2022 – decrease from 37.5% in 2021 to 36.4% in 2022).

 

Selling, General and Administrative

 

For the year ended December 31,  2023   2022   2021 
Insurance  $1,825,137   $3,722,237   $2,962,767 
Office and Miscellaneous   6,303,879    5,397,961    6,455,998 
Professional Fees   4,145,586    6,821,583    4,445,949 
Research and development   1,554,823    651,302    510,895 
Share-based payments   2,021,664    3,311,024    3,952,595 
Travel   704,994    396,388    143,904 
Wages and salaries   6,976,792    6,105,020    2,768,010 
Total  $23,532,875   $26,405,515   $21,240,118 

 

For the year ended December 31, 2023, SG&A expenses decreased by 10.9%, from $26,405,515 in 2022 to $23,532,875 in 2023. The largest contributors to the decrease are insurance cost, professional fees expense and share-based payments.

 

Net and Comprehensive Income (Loss)

 

For the year ended December 31,  2023   2022   2021 
Loss from operations  $(22,616,331)  $(26,909,948)  $(19,278,188)
Change in fair value of derivative liability   211,110   5,502,688    8,149,812 
Finance and other costs   83,280    44,345    5,074 
Foreign exchange (loss) gain   (249,563)   745,102    362,448 
Gain (loss) on disposal of assets   (944)   (10,755)   - 
Impairment of notes receivable   (101,351)   (309,385)   (891,471)
Impairment of goodwill   -    (6,454,914)   (4,579,763)
Income from government assistance   5,232    2,446    24,148 
Write down of deposit   -    (228,572)   - 
Other (loss) income   (943,243)   (35,371)   4,968 
Net loss   (23,611,810)   (27,654,364)   (16,202,972)
Cumulative translation differences   (94,861)   447,542    136,475 
Unrealized gain on investments available for sale   (3,180)   (98,483)   (332,640)
Comprehensive loss  $(23,709,851)  $(27,305,305)  $(16,399,137)

 

For the year ended December 31, 2023, the Company recorded a comprehensive loss of $23,709,851 compared to $27,305,305 in 2022.

 

9

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The net and comprehensive loss for the year ended December 31, 2023, includes non-cash changes comprised of a gain in fair value of derivative liability of $211,110, an expense on impairment for notes receivable of $101,351, a write down of inventory of $331,671, and an expense for goodwill and intangibles impairment of $87,415 and would otherwise be losses of $23,302,483 and $23,400,524 respectively. The net and comprehensive loss the for the same period last year, includes non-cash changes comprised of a gain in fair value of derivative liability of $5,502,688, an expense on impairment for notes receivable of $309,385, a write down of inventory of $1,976,514, and an expense for goodwill and intangibles impairment of $6,454,914 and would otherwise be losses of $24,416,239 and $24,067,180 respectively.

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2023,

 

The Company issued 1,508,255 common shares for the vesting of restricted share units.
The Company issued 8,000,000 common shares in a financing for $10,856,166 with share issuance costs of $1,786,980 for net proceeds of $9,069,186.
The Company issued 650,729 common shares in an ATM (“At - the - market”) financing for $1,748,946 with share issuance costs of $222,136 for net proceeds of $1,526,810.
The Company issued 4,800,000 common shares in a financing for proceeds of $4,858,995 with share issuance costs of $889,623 for net proceeds of $3,969,372. Of the total share issuance costs $793,979 were expensed in other income (expense).

 

During the year ended December 31, 2022:

 

The Company issued 16,538 common shares for the exercise of warrants for $87,170.
The Company issued 12,500 common shares for the exercise of stock options for $26,875.
The Company issued 1,072,595 common shares for the vesting of Restricted Share Units.

 

Summary of Quarterly Results

 

The following selected quarterly financial data has been extracted from the financial statements, prepared in accordance with International Financial Reporting Standards.

 

Total revenue for the three months ended December 31, 2023, decreased by $397,863 or 30.2% as compared to the same period in 2022. The decrease was due to lower product sales.

 

SG&A expenses decreased 52.5% compared to the same period in 2022 due to lower professional fees, wage costs, and lower share based compensation charges. These are partially offset by an increase in travel costs. The other income (expense) and comprehensive loss for the fourth quarter of 2023 includes non-cash changes comprised of a fair value derivative liability gain of $153,798, and would otherwise be an other expense of $1,122,810 and comprehensive loss of $4,345,594, respectively.

 

Total revenue for the three months ended December 31, 2023, decreased by $1,221,718 or 57.1% as compared to the three months ended September 30, 2023. The primary decrease in revenue is due to the decrease in product revenue as well as service sales. Product sales decreased by $981,303 or 59.4% in the fourth quarter of 2023 as compared to the third quarter of 2023 primarily due to delayed timing of certain product orders as well as increased competition. Service revenue decreased by $240,415 or 49.6% in the fourth quarter or 2023 as compared to the third quarter of 2023 primarily due to fewer service arrangements.

 

SG&A expenses decreased by $2,884,538 or 47.6% compared to the third quarter of 2023 due to decreased office and miscellaneous costs, professional fees, salaries and wages and share-based payments, partially offset by an increase in research and development.

 

10

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The table below summarizes the quarterly results over the past eight fiscal quarters. All earnings per share calculations are shown post-consolidation.

 

   2023 Q4   2023 Q3   2023 Q2   2023 Q1 
Revenue  $916,299   $2,138,018   $1,899,039   $1,601,486 
Cost of goods sold(2)  $(657,420)  $(1,243,334)  $(1,431,922)  $(1,158,052)
Gross profit(3)  $258,879   $894,683   $467,117   $443,434 
Gross margin – percentage   28.3%   41.8%   24.6%   27.7%
Operating expenses  $(3,482,141)  $(6,356,138)  $(7,234,034)  $(7,608,132)
Operating income (loss)  $(3,223,262)  $(5,461,456)  $(6,766,917)  $(7,164,697)
Operating loss per share - basic  $(0.08)  $(0.13)  $(0.15)  $(0.20)
Operating loss per share - diluted  $(0.08)  $(0.13)  $(0.15)  $(0.20)
Other income (expense)  $(965,072)  $14,569   $(142,046)  $97,073 
Change in fair value of derivative liability (1)  $153,798  $-   $-   $57,312 
Other comprehensive income (loss)  $(3,461)  $(83,363)  $18,152   $(29,369)
Comprehensive income (loss)  $(4,191,796)  $(5,530,248)  $(6,890,812)  $(7,096,995)
Comprehensive income (loss) per share - basic  $(0.10)  $(0.13)  $(0.15)  $(0.18)
Comprehensive income (loss) per share - diluted  $(0.10)  $(0.13)  $(0.15)  $(0.18)

 

   2022 Q4   2022 Q3   2022 Q2   2022 Q1 
Revenue  $1,314,162   $1,876,221   $2,370,115   $2,044,562 
Cost of goods sold(4)  $(2,980,133)  $(1,249,313)  $(1,356,526)  $(1,228,412)
Gross profit(5)  $(1,665,971)  $626,908   $1,013,589   $816,150 
Gross margin – percentage   -126.8%   33.4%   42.8%   39.9%
Operating expenses  $(7,342,669)  $(7,007,691)  $(7,176,445)  $(6,173,819)
Operating loss  $(9,008,640)  $(6,380,783)  $(6,162,856)  $(5,357,669)
Operating loss per share - basic  $(0.26)  $(0.19)  $(0.19)  $(0.16)
Operating loss per share - diluted  $(0.26)  $(0.19)  $(0.19)  $(0.16)
Other income (expense)  $(7,575,889)  $1,039,968   $6,638,171   $(846,666)
Change in fair value of derivative liability (1)  $334,016   $305,094   $6,094,438   $(1,230,860)
Other comprehensive income (loss)  $(76,073)  $348,282   $165,009   $(88,159)
Comprehensive income (loss)  $(16,660,602)  $(4,992,533)  $640,324   $(6,292,494)
Comprehensive income (loss) per share - basic  $(0.49)  $(0.15)  $0.02   $(0.19)
Comprehensive income (loss) per share - diluted  $(0.49)  $(0.15)  $0.02   $(0.19)

 

(1)Included in other income (expense).
(2)Cost of goods sold includes non-cash inventory write downs of $77,047 in Q1 2023, $122,600 in Q2 2023, $8,600 in Q3 2023 and $123,424 in Q4 2023 and would have been $1,081,005 in Q1 2023, $1,309,322 in Q2, $1,234,734 in Q3, and $533,996 in Q4 2023 before these write downs.
(3)Gross profit would have been $520,481 in Q1 2023, $589,717 in Q2 2023, $903,283 in Q3 2023 and $382,303 in Q4 2023 without the write downs. Gross profit would have been $310,543 in Q4 of 2022 without the write downs.
(4)Cost of goods sold in Q4 2022 would have been $1,003,619 not including a non-cash write down of inventory for $1,976,514.
(5)Gross profit for Q4 2022 would have been $310,543 not including a non-cash write down of inventory for $1,976,514.

 

11

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Liquidity and Capital Resources

 

The Company’s liquidity risk is derived from its loans, accounts payable, and accrued liabilities, as it may encounter difficulty discharging those obligations, but the Company endeavors to mitigate that risk through the careful management of its debt holders and the assertive pursuit of capital inflow for its operations. The Company’s working capital shortfall of $(717,017) as at December 31, 2023, would be increased to an excess of $3,479,108, if the non-cash derivative liability was excluded. The Company’s working capital as at December 31, 2022 was $10,168,800.

 

The Company considers the items included in capital to include shareholders’ equity. The Company manages its capital structure and adjusts it in light of changes in economic and business conditions, financing environment, and the risk characteristics of the underlying assets. The Company does not have any contracted or committed capital expenditures as of the date of this MD&A. The Company utilizes its credit card facilities from time to time to make various purchases for their operations.

 

The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. Based on the Company’s existing operations, the Company will need to raise additional capital during the next twelve months and beyond to support its business plan.

 

Subsequent to December 31, 2023, the Company closed an underwritten public offering and issued 13,400,000 share units at an offering price of $0.27 per unit for gross proceeds of $3,618,000 USD. Gross proceeds in local currency resulted in $4,876,282 with share issue costs of $442,450, netting $4,433,831.

 

Subsequent to December 31, 2023, 1,600,000 pre-funded warrants were exercised for proceeds of $160 USD ($216 CAD) and an equal number of shares were issued at a value of $578,200 USD ($773,624 CAD).

 

On October 30, 2023 the Company entered into a public offering and issued 6,400,000 share units at an offering price of $0.55 per unit for gross proceeds of USD $3,520,000. Gross proceeds in local currency resulted in $4,858,995 with share issuance costs of $493,109, netting $4,365,886.

 

On March 31, 2023, the Company closed an underwritten public offering of its common shares in the United States for gross proceeds of USD $8,000,000. Gross proceeds in local currency resulted in $10,856,166 with share issuance costs of $1,953,032, netting $8,903,134.

 

On January 31, 2023, the Company entered into an equity distribution agreement. The agreement allowed the Company, from time to time, to distribute in an at-the-market offering for up to USD $15,000,000 in common shares. From February 1, 2023 to February 17, 2023, the Company distributed 650,729 ATM shares under the ATM offering at an average price of 2.69 per share for gross proceeds in local currency of $1,748,976 with share issuance costs of $222,136, netting $1,526,810.

 

Draganfly intends to use the net proceeds for general corporate purposes, including to fund operations, growth initiative and/or for capital requirements including the continuing development and marketing of the Company’s core products, potential acquisitions and research and development.

 

Further, in order to maintain or adjust its capital structure, the Company may issue new shares, new debt, or scale back the size and nature of its operations. The Company is not subject to externally imposed capital requirements. As at December 31, 2023, shareholders’ equity was $407,716 and at December 31, 2022, shareholder’s equity was $11,040,881. The Company’s shareholder’s equity at December 31, 2023 would be $4,603,841 ($11,098,195 – 2022) if the non-cash derivative liability was considered equity.

 

12

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

We expect, from time to time, to evaluate the acquisition of businesses, intellectual property, products and technologies for which a portion of the net proceeds may be used. There is always the potential that any acquisition or investment in a company or product has a negative impact on future cash flows of the Company.

 

Our plan of operations for the next year includes the following: (i) ensure production capacity is adequate to meet demand for products; (ii) continuing to hone existing product offerings; (iii) streamline workflow efficiencies; (iv) diversifying and expanding business lines organically and by potential acquisitions; (v) continuing to patent innovative ideas for new products; and (vi) developing and increasing current product offering to various niche industries that are not currently being served.

 

AS of the date of the MD&A, we cannot predict with certainty all of the particular uses for the net proceeds received from the closing of past financings. The amounts and timing of our actual expenditures may very significantly depending on numerous factors.

 

Off-Balance Sheet Arrangements

 

The Company has no material undisclosed off-balance sheet arrangements that have or are reasonably likely to have, a current or future effect on our results of operations, financial condition, revenues or expenses, liquidity, capital expenditures or capital resources.

 

Contractual Obligations

 

As of December 31, 2023, and as of the date of this MD&A, and in the normal course of business, the following is a summary of the Company’s material obligations to make future payments, representing contracts, and other commitments that are known and committed.

 

Right of Use Asset

 

   Total 
Cost     
Balance at December 31, 2021 and 2022  $683,117 
Additions   740,355 
Lease adjustment   - 
Balance at December 31, 2023  $1,423,472 
      
Accumulated depreciation     
Balance at December 31, 2021  $215,011 
Charge for the year   123,360 
Balance at December 31, 2022  $338,371 
Charge for the year   363,086 
Foreign exchange   328 
Balance at December 31, 2023  $701,785 
      
Net book value:     
December 31, 2022  $344,746 
December 31, 2023  $721,687 

 

The statement of financial position shows the following amounts related to leases:

 

   2023   2022 
Buildings  $721,687   $342,361 
Vehicles   -    2,385 
   $721,687   $344,746 

 

Additions to the right of the assets during the 2023 financial year were $740,355 (2022 - $nil).

 

Lease Liability

 

   Total 
Balance at December 31, 2021  $489,123 
Interest expense   39,795 
Lease payments   (150,275)
Balance at December 31, 2022  $378,643 
Additions   734,903 
Interest expense   96,423 
Lease payments   (423,410)
Foreign exchange   3,464 
Balance at December 31, 2023  $790,023 
      

 

13

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Which consists of:

 

   December 31, 2023   December 31, 2022 
Current lease liability  $362,001   $133,962 
Non-current lease liability   428,022    244,681 
Balance at December 31, 2023  $790,023   $378,643 

 

Maturity analysis  December 31, 2023   December 31, 2022 
Less than one year  $429,948   $147,340 
One to three years   355,879    209,078 
Four to five years   141,519    83,850 
Total undiscounted lease liabilities   927,346    440,268 
Amount representing interest   (137,323)   (61,625)
   $790,023   $378,643 

 

Variable lease payments of $43,542 (2022 - $22,539) have been recognized in profit and loss.

 

Related Party Transactions

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2023, the company incurred fees of $429,766 (December 31, 2022 - $442,485) which are included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $3,780 (December 31, 2022 - $30,804).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2023, the Company incurred fees of $592,500 (December 31, 2022 - $566,487) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $35,417 (December 31, 2022 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2023, the Company incurred fees of $215,019 (December 31, 2022 - $383,288) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $9,287 (December 31, 2022 - $20,745).

 

Trade receivables/payables and accrued receivables/payables:

 

As at December 31, 2023, the Company had $nil (December 31, 2022 - $nil) receivable from related parties outstanding that were included in accounts receivable and $190,664 (December 31, 2022 - $51,549) payable from related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

14

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023, 2022 included:

 

For the years ended December 31,  2023   2022   2021 
Director fees  $600,933   $522,349   $370,094 
Salaries   979,154    843,917    722,068 
Share-based payments   1,109,232    2,106,906    2,475,949 
   $2,689,319   $3,473,172   $3,568,111 

 

Other related parties

 

For the years ended December 31,  2023   2022   2021 
Management fees paid to a company controlled by CEO and director  $592,500   $466,487   $290,225 
Management fees paid to a company that the CEO holds an economic interest in   429,766    442,485    315,643 
Management fees paid to a company controlled by a director   215,019    383,288    205,691 
   $1,237,285   $1,392,260   $811,559 

 

Share Capital

 

Common shares issued

 

   Number of
Common Shares
   Share Capital 
Balance, December 31, 2021   33,168,946   $81,038,365 
Shares issued for exercise of warrants   16,538    87,170 
Share issue costs   -    (5,122)
Shares issued for exercise of RSUs   1,072,595    2,427,801 
Shares issued for exercise of stock options   12,500    51,875 
Balance, December 31, 2022   34,270,579   $83,600,089 
Shares issued for financing   13,450,729    13,125,176 
Share issue costs       (2,295,022)
Shares issued for exercise of RSU’s   1,508,255    2,640,733 
Balance, December 31, 2023   49,229,563   $

97,070,976

 

 

15

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Stock options

 

The following is the summary of the Company’s stock option activity. Number of options and weighted average exercise prices in the table below are shown as they were outstanding, forfeited, granted, and exercised:

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2021   1,035,991   $4.60 
Exercised   (12,500)   2.15 
Forfeited   (146,334)   4.77 
Outstanding, December 31, 2022   877,157   $4.60 
Exercised   (9,999)   3.77 
Forfeited   30,000    0.63 
Outstanding, December 31, 2023   897,158   $4.48 

 

Restricted Share Units (RSUs)

 

The following is the summary of the Company’s RSU activity. Number of RSUs in the table below are shown as they were outstanding, exercised, forfeited, and granted:

 

   Number of RSUs 
Outstanding, December 31, 2021   514,832 
Exercised   (1,072,595)
Issued   1,820,972 
Forfeited   (64,334)
Outstanding, December 31, 2022   1,198,875 
Exercised   (1,508,255)
Issued   1,685,316 
Forfeited   (262,969)
Outstanding, December 31, 2023   1,112,967 

 

Warrants

 

During the year ended December 31, 2023, the Company issued 1,600,000 pre-funded warrants for a purchase price of $0.5499USD with an exercise price of $0.0001USD per unit. The Company also issued 6,400,000 warrants at an exercise price $0.6123USD. Being in a currency that is not the Company’s functional currency these warrants are required to be recorded as a financial liability. As a financial liability, the portion of the warrants related to the future exercise price will be revalued on every reporting period to fair market value with the change in fair value being recorded in profit or loss. All of the above warrants have a 5 year term, expiring October 30, 2028 and vest immediately. 320,000 underwriter warrants were issued as part of the transaction with an exercise price of $0.6875USD and a term of 3 years. These warrants were treated as share issue costs.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period At the date of issue the warrants were valued with a risk free rate of 4.8%, volatility of 115.35%, expected life of 5 years and an expected dividend yield rate of 0%. The broker warrants were valued with a risk free rate of 4.87%, volatility of 138.83%, expected life of 3 years and an expected dividend yield of 0%.

 

16

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Warrant Derivative Liability

 

Balance at December 31, 2021  $4,865,772 
Change in fair value of warrants outstanding   (4,865,772)
Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110
Balance at December 31, 2023  $4,196,125 

 

Derivative liability balance at  December 31, 2023   December 31, 2022 
Warrants  $4,196,125   $- 
Contingent consideration   -    57,314 
Ending balance  $4,196,125   $57,314 

 

The derivative financial liability consists of the fair value of the non-compensatory share purchase warrants that have exercise prices that differ from the functional currency of the Company and are within the scope of IAS 32 “Financial Instruments: Presentation”. Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price  Number of Warrants Outstanding at December 31, 2023   Fair Value at December 31, 2023   Number of Warrants Outstanding at December 31, 2022   Fair Value at December 31, 2022 
February 5, 2021 (1)  USD$ 3.55   -   $-    1,319,675   $- 
March 5, 2021 (2)  USD$ 3.55   -    -    5,142,324          - 
October 30, 2023 (3)  USD$ 0.6123   6,400,000    3,180,543    -    - 
October 30, 2023 (4)  USD$ 0.0001   1,600,000    1,015,582    -    - 
         8,000,000   $4,196,125    6,461,999   $- 

 

1)The warrants expired on February 5, 2023.
2)The warrants expired on March 5, 2023.
3)The warrants expire October 30, 2028
4)The warrants have no expiry date

 

The following is the summary of the Company’s warrant activity. Number of warrants and weighted average exercise prices in the table below are shown as they were outstanding, exercised, forfeited, and granted:

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2021   8,414,819   $4.99 
Exercised   (16,538)   4.51 
Expired   (481,484)   4.61 
Outstanding, December 31, 2022   7,917,797   $5.08 
Issued   8,320,000    0.50 
Expired   (7,661,999)   5.89 
Outstanding, December 31, 2023   8,574,798   $0.63 

 

17

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

As at December 31, 2023, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price  Number of warrants outstanding 
July 29, 2021  July 29, 2024  US$ 5.00   250,000 
September 14, 2021  September 14, 2024  US$ 5.00   4,798 
October 30, 2023  October 30, 2026  US$ 0.6875   320,000 
October 30, 2023  October 30, 2028  US$ 0.6123   6,400,000 
October 30, 2023  No expiry date  US$ 0.0001   1,600,000 
            8,574,798 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2023, was 4.63 years (December 31, 2022 – 0.47 years).

 

There were 1,200,000 warrants issued on March 22, 2021 to acquire Vital. At December 31, 2022 900,000 of the warrants are currently held in escrow, to be released upon completion of the milestones. The milestones were related to the recognition of revenue on the related acquisition in range of $2,000,000 to $6,000,000 which was not met. The warrants expired on March 25, 2023.

 

Critical Accounting Policies and Estimates

 

Significant estimates and assumptions

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.

 

18

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

 

Investments in Private companies

 

Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.

 

Expected credit losses on trade receivables and notes receivable

 

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment and forward-looking information.

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Other Significant judgements

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company’s consolidated financial statements include:

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
the classification of financial instruments;
the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;
the determination of whether a set of assets acquired and liabilities assumed constitute a business; and
the determination of the functional currency of each entity in the group.

 

19

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Foreign currency translation

 

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 

The functional currencies of the parent company and each subsidiary are as follows:

 

Draganfly Inc. Canadian Dollar
Draganfly Innovations Inc.  Canadian Dollar
Draganfly Innovations USA, Inc.  US Dollar
Dronelogics Systems Inc.  Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

 

Share-based payments

 

The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

 

The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

 

20

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

a)If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.
b)If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.
c)If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

 

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 8,574,798 warrants, 897,158 options and 1,112,967 RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 

Financial Instruments

 

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial assets/liabilities   Classification
Cash and cash equivalents   Fair value through profit or loss

Receivables

  Amortized cost
Notes receivable   Fair value through profit or loss
Investments   Fair value through other comprehensive income
Trade payables   Amortized cost
Customer deposits   Amortized cost
Loans payable   Amortized cost
Derivative liability   Fair value through profit or loss

 

21

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

 

22

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 

Impairment of non-financial assets

 

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life; and
an intangible asset not yet available for use;

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

23 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

 

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

24 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

 

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 

Deferred Income

 

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Class of intangible asset   Useful live
Customer relationship   5 years
Brand   5 years
Software   5 years
Patents   5 years

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

25 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

Class of equipment   Depreciation rate
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Expected lease term
Vehicles   30%

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

 

(i)the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)its intention to complete the intangible asset and use or sell it;
(iii)its ability to use or sell the intangible asset;
(iv)how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Government assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

26 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

Business Risks

 

The Company does engage in significant transactions and activities in currencies other than its functional currency. Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company.

 

An investment in the Company’s Common Shares is highly speculative and involves significant risks. In addition to the other information contained in this MD&A and the documents incorporated by reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently consider immaterial, may also materially and adversely affect our business, operations and condition, financial or otherwise.

 

Risks Related to the Company, its Business and Industry

 

The Company has a history of losses.

 

The Company has incurred net losses since its inception. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will be any earnings or revenues in any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research, development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

 

27 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

A shareholder’s holding in the Company may be diluted if the Company issues additional Common Shares or other securities in the future.

 

The Company may issue additional Common Shares or other securities in the future, which may dilute a shareholder’s holding in the Company. The Company’s articles permit the issuance of an unlimited number of Common Shares, and shareholders have no pre-emptive rights in connection with further issuances of any securities. The directors of the Company have the discretion to determine if an issuance of Common Shares or other securities is warranted, the price at which any such securities are issued and the other terms of issue of Common Shares or securities. In addition, the Company may issue additional Common Shares upon the exercise of incentive stock options to acquire Common Shares under its share compensation plan or upon the exercise or conversion of other outstanding convertible securities of the Company, which will result in further dilution to shareholders. In addition, the issuance of Common Shares or other securities in any potential future acquisitions, if any, may also result in further dilution to shareholder interests.

 

The Company expects to incur substantial research and development costs and devote significant resources to identifying and commercializing new products and services, which could significantly reduce its profitability and may never result in revenue to the Company.

 

The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, and introducing new products and services that achieve market acceptance. The Company plans to incur substantial research and development costs as part of its efforts to design, develop and commercialize new products and services and enhance its existing products. The Company believes that there are significant opportunities in a number of business areas. Because the Company accounts for research and development costs as operating expenses, these expenditures will adversely affect its earnings in the future. Further, the Company’s research and development programs may not produce successful results, and its new products and services may not achieve market acceptance, create any additional revenue or become profitable, which could materially harm the Company’s business, prospects, financial results and liquidity.

 

Shortfalls in available external research and development funding could adversely affect the Company.

 

The Company depends on its research and development activities to develop the core technologies used in its UAV products and for the development of the Company’s future products. A portion of the Company’s research and development activities can depend on funding by commercial companies and the Canadian government. Canadian government and commercial spending levels can be impacted by a number of variables, including general economic conditions, specific companies’ financial performance and competition for Canadian government funding with other Canadian government-sponsored programs in the budget formulation and appropriation processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to commercial companies, which directly impact the amount of research and development that companies appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, company funding for research and development could be reduced. Any reductions in available research and development funding could harm the Company’s business, financial condition and operating results.

 

The Company’s adoption of new business models could fail to produce any financial returns.

 

Forecasting the Company’s revenues and profitability for new business models is inherently uncertain and volatile. The Company’s actual revenues and profits for its business models may be significantly less than the Company’s forecasts. Additionally, the new business models could fail for one or more of the Company’s products and/or services, resulting in the loss of Company’s investment in the development and infrastructure needed to support the new business models, and the opportunity cost of diverting management and financial resources away from more successful businesses.

 

The Company will be affected by operational risks and may not be adequately insured for certain risks.

 

The Company will be affected by a number of operational risks and the Company may not be adequately insured for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, potential legal liability and adverse governmental action, any of which could have an adverse impact on the Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse impact on the Company’s future cash flows, earnings, results of operations and financial condition.

 

28 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and future prospects.

 

The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company’s ability to do the following:

 

generate sufficient revenue to reach and maintain profitability;
acquire and maintain market share;
achieve or manage growth in operations;
develop and renew contracts;
attract and retain additional engineers and other highly-qualified personnel;
successfully develop and commercially market new products;
adapt to new or changing policies and spending priorities of governments and government agencies; and
access additional capital when required and on reasonable terms.

 

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results of operations and financial condition would be materially harmed.

 

The Company operates in a competitive market.

 

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify.

 

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

 

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

 

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

 

The markets in which the Company competes are characterized by rapid technological change, which requires the Company to develop new products and product enhancements and could render the Company’s existing products obsolete.

 

Continuing technological changes in the market for the Company’s products could make its products less competitive or obsolete, either generally or for particular applications. The Company’s future success will depend upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the markets in which it offers products.

 

29 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Delays in introducing new products and enhancements, the failure to choose correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive prices may cause existing and potential customers to purchase the Company’s competitors’ products.

 

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully develop new products or enhancements that meet customer requirements on a timely basis, its products could lose market share, its revenue and profits could decline, and the Company could experience operating losses.

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from expanding sales of its small UAV to non-military customers in Canada.

 

Transport Canada is responsible for establishing, managing, and developing safety and security standards and regulations for civil aviation in Canada, and includes unmanned civil aviation (drones). Civil operations include law enforcement, scientific research, or use by private sector companies for commercial purposes. The Canadian Aviation Regulations (“CARs”) govern civil aviation safety and security in Canada, and by extension govern operation of drones in Canada to an acceptable level of safety.

 

While Transport Canada has been a leader in the development of regulations for the commercial use of remotely piloted aircraft systems (“RPAS”) and continues to move forward rapidly with its regulatory development, it has acknowledged the challenge of regulations keeping pace with the rapid development in technology and the growing demand for commercial RPAS use, particularly in the beyond visual line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS working group released its Phase 2 report which outlined a proposed set of revision to the CARs to permit beyond visual line of sight operations. This report was the basis for the recently released Notice of Proposed Amendment (“NPA”) by Transport Canada on lower risk beyond visual line-of-sight.

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, including the granting of certain Special Flight Operations Certificates (“SFOCs”), or limitations put on the use of RPAS in response to public safety concerns, may prevent the Company from testing or operating its aircraft and/or expanding its sales which could have an adverse impact on the Company’s business, prospects, results of operations and financial condition.

 

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.

 

A significant portion of the Company’s business is based on the operation of RPAS. The operation of RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As the RPAS industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the Company could find itself to be in non-compliance with these new regulations. While the Company endeavours to take all necessary action to reduce the risks associated with the operations of RPAS and to remain well-informed and up-to-date on any addendums and changes to the applicable regulations, there is no assurance that an incident involving an RPAS or the Company’s non-compliance would not create a significant current or future liability for the company.

 

The regulation of RPAS operations within the Canadian Domestic Airspace (“CDA”) is still evolving and is expected to continue to change with the proliferation of RPAS, advancements in technology, and standardization within the industry. Changes to the regulatory regime may be disruptive and result in the Company needing to adopt significant changes in its operations and policies, which may be costly and time-consuming, and may materially adversely affect the Company’s ability to manufacture and make delivery of its products and services in a timely fashion.

 

30 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company’s business and research and development activities are subject to oversight by Transport Canada, the federal institution responsible for transportation policies and programs, including the rules in the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a SFOC. The Company’s ability to develop, test, demonstrate, and sell products and services depends on its ability to acquire and maintain a valid SFOC.

 

In addition, there exists public concern regarding the privacy implications of Canadian commercial and law enforcement use of small UAV. This concern has included calls to develop explicit written policies and procedures establishing UAV usage limitations. There is no assurance that the response from regulatory agencies, customers and privacy advocates to these concerns will not delay or restrict the adoption of small UAV by prospective non-military customers.

 

The Company may be subject to the risks associated with future acquisitions.

 

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if completed, may expose the Company to additional potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

 

The Company’s inability to retain management and key employees could impair the future success of the Company.

 

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose experience, know-how, key professionals and staff members as well as business partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

 

The Company faces uncertainty and adverse changes in the economy.

 

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may result in a decrease in demand for the Company’s products, which could have a material adverse impact on the Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also increase costs associated with developing and publishing products, increase the cost and decrease the availability of sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could have a material adverse impact on the financial condition and operating results of the Company.

 

31 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company is subject to certain market-based financial risks associated with its operations.

 

The Company could be subject to interest rate risks, which is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities, however market fluctuations could increase the costs at which the Company can access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate of interest. In addition, the Company engages in transactions in currencies other than its functional currency. Depending on the timing of these transactions and the applicable currency exchange rates, conversions to the Company’s functional currency may positively or negatively impact the Company.

 

Negative macroeconomic and geopolitical trends could affect demand for the Company’s products and its ability to access sources of capital.

 

There can be no assurance that the Company’s business and corresponding financial performance will not be adversely affected by general negative economic or consumer trends or events, including pandemics, public health crises, weather catastrophes, acts of terrorism, war, and political instability. In particular, global economic markets have seen extensive volatility over the past few years owing to the outbreak of the COVID-19 pandemic, the war between Russia and Ukraine, and the war between Israel and Hamas, the closing of certain financial institutions by regulators in March 2023, and political instability. These events have created, and may continue to create, significant disruption of the global economy, supply chains and distribution channels, and financial and labor markets. If such conditions continue, recur or worsen, this may have a material adverse effect on the Company’s business, financial condition and results of operations as consumer demand and its ability to access capital on favorable terms, or at all, could be negatively impacted as a result of such conditions and consequences. Furthermore, such economic conditions have produced downward pressure on share prices and on the availability of credit for financial institutions and corporations while also driving up interest rates, further complicating borrowing and lending activities. If current levels of market disruption and volatility continue or increase, the Company might experience reductions in business activity, increases in funding costs, decreases in asset values, additional write-downs and impairment charges and lower profitability.

 

The Company may be subject to the risks associated with foreign operations in other countries.

 

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. As a result of such expansion, the Company may be subject to the legal, political, social and regulatory requirements and economic conditions of foreign jurisdictions. The Company cannot predict government positions on such matters as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

 

If the Company expands its business to foreign markets, it will need to respond to rapid changes in market conditions, including differing legal, regulatory, economic, social and political conditions in these countries. If the Company is not able to develop and implement policies and strategies that are effective in each location in which it does business, then the Company’s business, prospects, results of operations and financial condition could be materially and adversely affected.

 

There are tax risks the Company may be subject to in carrying on business in Canada.

 

The Company is a resident of Canada for purposes of the Income Tax Act (Canada) (the “Tax Act”). Since the Company is operating in a new and developing industry there is a risk that foreign governments may look to increase their tax revenues or levy additional taxes to level the playing field for perceived disadvantages to traditional brick and mortar businesses. There is no guarantee that governments will not impose such additional adverse taxes in the future.

 

If critical components or raw materials used to manufacture the Company’s products become scarce or unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could damage its business.

 

The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of required components, subsystems, or systems of sufficient quality, will increase prices for the components, subsystems or systems and will perform their obligations on a timely basis.

 

32 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The global supply chain has experienced significant disruptions recently, caused by the COVID-19 pandemic and by geopolitical conflict, including the wars in Ukraine and Gaza, and the possibility of widening conflict in the Middle East. These disruptions have impacted a variety of products and goods and have had various downstream effects, making it more difficult to reliably and timely source and supply goods and has also resulted in shortages of labor and equipment. The macroeconomic impacts of the COVID-19 pandemic and global conflicts, including the disruption of global shipping lanes in the Middle East, have contributed to inflationary pressure, rising interest rates, and increased market volatility, adding additional pricing uncertainty. These conditions, if not mitigated or remedied in a timely manner, could delay or preclude delivery of raw materials needed to manufacture the Company’s products or delivery of its products to customers, particularly in international markets. If the Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or cost-effective basis to its customers, or at all, which could cause customers to terminate their contracts with the Company, increase the Company’s costs and seriously harm its business, results of operations and financial condition. Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to accommodate components from different suppliers. The Company may experience significant delays in manufacturing and shipping its products to customers and incur additional development, manufacturing and other costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign its products. The Company cannot predict if it will be able to obtain replacement components within the time frames that it requires at an affordable cost, if at all.

 

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the use and effectiveness of the Company’s products.

 

The Company’s business will involve the operation and flying of UAVs, a technology-based product used outside. As such, the business is subject to various risks inherent in a technology-based businesses operated in outdoor conditions, including faulty parts, breakdowns and crashes. Although the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural outdoor elements, which could be exacerbated due to risks associated with climate change, will not have a material adverse effect on the use and effectiveness of its products.

 

The Company’s products may be subject to recall or return.

 

Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate or inaccurate labeling disclosure. If any of the Company’s equipment were to be recalled due to an alleged product defect, safety concern or for any other reason, the Company could be required to incur unexpected expenses of the recall and any legal proceedings that might arise in connection with the recall. The Company may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management time and attention. Additionally, product recalls may lead to increased scrutiny of the Company’s operations by Transport Canada or other regulatory agencies, requiring further management time and attention and potential legal fees, costs and other expenses.

 

If the Company releases defective products or services, its operating results could suffer.

 

Products and services designed and released by the Company involve extremely complex software programs and are difficult to develop and distribute. While the Company has quality controls in place to detect and prevent defects in its products and services before they are released, these quality controls are subject to human error, overriding, and reasonable resource constraints. Therefore, these quality controls and preventative measures may not be effective in detecting and preventing defects in the Company’s products and services before they have been released into the marketplace. In such an event, the Company could be required, or decide voluntarily, to suspend the availability of the product or services, which could significantly harm its business and operating results.

 

33 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company’s products and services are complex and could have unknown defects or errors, which may give rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.

 

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained defects and errors and may in the future contain defects, errors or performance problems when first introduced, when new versions or enhancements are released, or even after these products have been used by the Company’s customers for a period of time. These problems could result in expensive and time-consuming design modifications or warranty charges, delays in the introduction of new products or enhancements, significant increases in the Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial and could significantly reduce the Company’s operating margins.

 

The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s products could also lead to product returns, recalls, or liability claims or lawsuits against it. A defect, error or failure in one of the Company’s UAV could result in injury, death or property damage and significantly damage the Company’s reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly due to unknown defects or errors.

 

Although the Company maintains insurance policies, it cannot provide any assurance that this insurance will be adequate to protect the Company from all material judgments and expenses related to potential future claims or that these levels of insurance will be available in the future at economical prices or at all. A successful product liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a particular claim, the claim could nevertheless diminish the Company’s brand and divert management’s attention and resources, which could have a negative impact on the Company’s business, financial condition and results of operations.

 

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain Canadian government authorization regarding the export of its products, or if current or future export laws limit or otherwise restrict the Company’s business.

 

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In some cases, explicit authorization from the Canadian government is needed to export its products. The export regulations and the governing policies applicable to the Company’s business are subject to change. The Company cannot provide assurance that such export authorizations will be available for its products in the future. Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but could significantly limit them in the future. Non-compliance with applicable export regulations could potentially expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government approvals under applicable regulations, the Company may not be able to sell its products in certain international jurisdictions, which could adversely affect the Company’s financial condition and results of operations.

 

34 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Negative consumer perception regarding the Company’s products could have a material adverse effect on the demand for the Company’s products and the business, results of operations, financial condition and cash flows of the Company.

 

The Company believes the UAV industry is highly dependent upon consumer perception regarding the safety, efficacy, and quality of the UAV used. Consumer perception of these products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, and other publicity regarding the use of UAV. There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention, or other research findings or publicity will be favourable to the UAV market. Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favourable than, or that question, earlier research reports, findings or publicity could have a material adverse effect on the demand for the Company’s products and the business, results of operations, financial condition and cash flows of the Company. The dependence upon consumer perceptions means that adverse scientific research reports, findings, regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, could have a material adverse effect on the Company, the demand for the Company’s products, and the business, results of operations, financial condition and cash flows of the Company. Further, adverse publicity reports or other media attention regarding the safety, the efficacy, and quality of UAV based surveys in general, or the Company’s products specifically, could have a material adverse effect.

 

If the Company fails to successfully promote its product brand, this could have a material adverse effect on the Company’s business, prospects, financial condition and results of operations.

 

The Company believes that brand recognition is an important factor to its success. If the Company fails to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, financial condition and results of operations. This will depend largely on the Company’s ability to maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, products and services. Any negative publicity about the Company or its industry, the quality and reliability of the Company’s technologies, products and services, the Company’s risk management processes, changes to the Company’s technologies, products and services, its ability to effectively manage and resolve customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of sellers and buyers with the Company’s products or services, could adversely affect the Company’s reputation and the confidence in and use of the Company’s technologies, products and services. Harm to the Company’s brand can arise from many sources, including; failure by the Company or its partners to satisfy expectations of service and quality; inadequate protection of sensitive information; compliance failures and claims; litigation and other claims; employee misconduct; and misconduct by the Company’s partners, service providers, or other counterparties. If the Company does not successfully maintain a strong and trusted brand, its business could be materially and adversely affected.

 

The Company may be subject to electronic communication security risks.

 

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Cyberattacks could result in unauthorized access to the Company’s computer systems or its third-party IT service provider’s systems and, if successful, misappropriate personal or confidential information. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

 

The last few years have seen an increase in the volume and sophistication of targeted cyber-attacks. A failure of the Company’s IT infrastructure could severely limit the Company’s ability to conduct ordinary operations or expose the Company to liability. To date, the Company’s systems have functioned capably, and it has not experienced a material impact to its operations as a result of an IT infrastructure issue. Data security breaches suffered by well-known companies and institutions have attracted a substantial amount of media attention, prompting new foreign, federal, provincial and state laws and legislative proposals addressing data privacy and security. As a result, the Company may become subject to more extensive requirements to protect the customer information that it processes in connection with the purchase of its products, resulting in increased compliance costs.

 

35 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

While the Company has taken measures to protect against cyberattacks, even the most well-protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted security breaches are continually evolving and generally are not recognized until launched against a target or, in some cases, are designed not to be detected and, in fact, may not be detected. Any such compromise of the Company’s or its third party’s IT service providers’ data security and access, public disclosure, or loss of personal or confidential business information, could result in legal claims and proceedings, liability under laws to protect privacy of personal information, and regulatory penalties, and could disrupt the Company’s operations, require significant management attention and resources to remedy any damages that result, and damage its reputation and customers willingness to transact business with us, any of which could adversely affect our business.

 

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.

 

The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government or court-imposed fines, judgments or orders requiring that the Company change its practices, which could have an adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur substantial costs or require it to change its business practices in a manner adverse to its business.

 

The Company relies on its business partners, and they may be given access to sensitive and proprietary information in order to provide services and support to the Company’s teams.

 

The Company relies on various business partners, including third-party service providers, vendors, licensing partners, development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these third parties are given access to sensitive and proprietary information in order to provide services and support to the Company’s teams. These third parties may misappropriate the Company’s information and engage in unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure of the third parties to adequately maintain or update their services and technologies, could result in a disruption to the Company’s business operations. Further, disruptions in the financial markets and economic downturns may adversely affect the Company’s business partners and they may not be able to continue honoring their obligations to the Company. Alternative arrangements and services may not be available to the Company on commercially reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner or vendor. If the Company loses one or more significant business partners, the Company’s business could be harmed.

 

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other proprietary rights, the Company’s business, financial condition, and results of operations could be materially harmed.

 

The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only limited protection, may not provide the Company with any competitive advantages, and may be challenged by third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise obtain and use the Company’s intellectual property.

 

36 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Moreover, many of the Company’s employees have access to the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result damage the Company’s competitive position. If the Company fails to protect its intellectual property and other proprietary rights, then the Company’s business, results of operations or financial condition could be materially harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the Company’s results of operations.

 

In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the Company is pursuing a product or service development that may violate the rights of others may entail significant expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the proceedings could result in significant expense to the Company and divert the attention and efforts of the Company’s management and technical employees, even if the Company prevails.

 

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent protection could be reduced or eliminated for non-compliance with these requirements.

 

The Canadian Intellectual Property Office (“CIPO”), the United States Patent and Trademark Office (“USPTO”) and various foreign national or international patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and various foreign national or international patent agencies in several stages over the lifetime of the patent. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file national and regional stage patent applications based on the Company’s international patent application, failure to respond to official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its competitors might be able to enter the market, which would have a material adverse effect on the Company’s business.

 

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may include re-examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.

 

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction to jurisdiction.

 

The grant of a patent does not have any bearing on whether the invention described in the patent application would infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still infringe the rights of an earlier granted patent.

 

37 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be costly, time-consuming and limit the Company’s ability to use certain technologies in the future.

 

The Company may become subject to claims that its technologies infringe upon the intellectual property or other proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and could divert the Company’s management’s attention away from the execution of its business plan. Moreover, any settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of the technology.

 

The Company cannot assure that it would be able to obtain a license from the third party asserting the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable alternative technology to permit the Company to continue offering, and the Company’s customers to continue using, the Company’s affected product. An adverse determination also could prevent the Company from offering its products to others. Infringement claims asserted against the Company may have a material adverse effect on its business, results of operations or financial condition.

 

The Company may not be able to protect its intellectual property rights throughout the world.

 

Filing, prosecuting, and defending patents on all of the Company’s product candidates throughout the world would be prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not obtained patent protection to develop their own products and their products may compete with products of the Company.

 

If the Company is required to write down goodwill and other intangible assets, the Company’s financial condition and results could be negatively affected.

 

Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate cash flows, and the fair value of the goodwill dips below its book value. The Company is required to review its goodwill for impairment at least annually. Events that may trigger goodwill impairment include deterioration in economic conditions, increased competition, loss of key personnel, and regulatory action. Should any of these occur, an impairment of goodwill relating to the acquisition of Dronelogics Systems Inc. could have a negative effect on the assets of the Company.

 

From time to time, the Company may become involved in legal proceedings, which could adversely affect the Company.

 

The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be difficult to predict and could have a material adverse effect on the Company’s business, operating results, or financial condition.

 

The Company’s directors and officers may have conflicts of interest in conducting their duties.

 

Because directors and officers of the Company are or may become directors or officers of other reporting companies or have significant shareholdings in other technology companies, the directors and officers of the Company may have conflicts of interest in conducting their duties. The Company and its directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from voting for or against a particular matter in which the director has the conflict. In appropriate cases, the Company will establish a special committee of independent directors to review a particular matter in which several directors, or officers, may have a conflict. In determining whether or not the Company will participate in a particular program and the interest therein to be acquired by it, the directors will primarily consider the potential benefits to the Company, the degree of risk to which the Company may be exposed and its financial position at that time. Other than as indicated, the Company has no other procedures or mechanisms to deal with conflicts of interest.

 

The Company’s Articles provide that the Company must indemnify a director or former director against all judgments, penalties or fines to which such person is or may be liable by reason of such person being or having been a director of the Company and the executive officers and directors may also have rights to indemnification from the Company, including pursuant to directors’ and officers’ liability insurance policies, that will survive termination of their agreements.

 

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect the Company’s reported financial results or financial condition.

 

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect the Company’s reported financial results or financial condition.

Generally accepted accounting principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to the Company’s business, including but not limited to revenue recognition, impairment of goodwill and intangible assets, inventory, income taxes and litigation, are highly complex and involve many subjective assumptions, estimates and judgments. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments could significantly change the Company’s reported financial performance or financial condition in accordance with generally accepted accounting principles.

 

38 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Risks Related to Our Common Shares

 

The market price of the Common Shares may be highly volatile.

 

The market price of the Common Shares is highly volatile and has been subject to wide fluctuations in response to a number of factors that are beyond the Company’s control, including but not limited to

 

  revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of the investment community;
  actual or anticipated changes or fluctuations in its results of operations;
  announcements by us or the Company’s competitors of new products or new or terminated significant contracts, commercial relationships or capital commitments;
  rumors and market speculation involving it or other companies in its industry;
  changes in its executive management team or the composition of the board of directors of the Company (the “Board”);
  fluctuations in the share prices of other companies in the technology and emerging growth sectors;
  general market conditions and macroeconomic trends driven by factors outside the Company’s control, such as pandemics, geopolitical conflicts, supply chain disruptions, market volatility, inflation, rising interest rate, political instability, and labor challenges, among other factors;
  actual or anticipated developments in its business or its competitors’ businesses or the competitive landscape generally;
  litigation involving us, the Company’s industry or both, or investigations by regulators into its operations or those of competitors;
  announced or completed acquisitions of businesses or technologies by the Company or its competitors;
  new laws or regulations or new interpretations of existing laws or regulations applicable to its business;
  shareholder activism and related publicity;
  foreign exchange rates; and
  other risk factors as set out in this Annual Report and in the documents incorporated by reference into this Annual Report.

 

If the market price of the Company’s Common Shares drops significantly, shareholders could institute securities class action lawsuits against it, regardless of the merits of such claims. Such a lawsuit could cause it to incur substantial costs and could divert the time and attention of management and other resources from the Company’s business, which could harm its business, results of operations and financial condition.

 

There is no guarantee that an active trading market for the Company’s Common Shares will be maintained on the CSE and/or Nasdaq. Investors may not be able to sell their Common Shares quickly or at the latest market price if the trading in our Common Shares is not active.

 

The Company’s Common Shares are currently listed on the Canadian Stock Exchange (“CSE”), the Nasdaq Stock Market, LLC (“Nasdaq”), and the Frankfurt Stock Exchange, however, it shareholders may be unable to sell significant quantities of Common Shares into the public trading markets without a significant reduction in the price of their Common Shares, or at all and there can be no guarantee that an active trading market for the Common Shares may be maintained. There can be no assurance that there will be sufficient liquidity of its Common Shares on the trading market, and that we will continue to meet the listing requirements of the CSE, Nasdaq or any other public listing exchange.

 

39 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

Failure to meet Nasdaq’s continued listing requirements could result in the delisting of the Company’s Common Shares, negatively impact the price of the Company’s Common Shares and negatively impact its ability to raise additional capital.

 

If the Company fails to satisfy the continued listing requirements of the Nasdaq, such as corporate governance requirements or the minimum closing bid price requirement, the exchange may take steps to delist the Company’s Common Shares. Such a delisting would likely have a negative effect on the price of the Company’s Common Shares and would impair shareholders’ ability to sell or purchase its Common Shares when they wish to do so.

 

As previously disclosed, on September 22, 2023, the Company received a letter from the Listing Qualifications ‎Department of Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the Bid ‎Price Rule ) by failing to maintain a minimum bid price for the Company s common shares of at least $1.00 per ‎share for 30 consecutive business days. The Company was allowed an initial 180-day grace period, or until March ‎‎20, 2024, (the Bid Price Compliance Period ), to regain compliance with the Bid Price Rule. To regain compliance ‎with the Bid Price Rule the closing bid price of the Company s common shares needed to be at least $1.00 per share ‎for a minimum of ten consecutive business days during the Bid Price Compliance Period.‎

 

On March 21, 2024, the Company received notification that it had failed to regain compliance with the Bid Price ‎Rule and is not eligible for a second 180 day compliance period because of its failure to comply with the $5 million ‎minimum stockholders equity initial listing requirement for the period ended September 30, 2023. Unless the ‎Company timely requests a hearing before an independent Nasdaq Hearings Panel (the Nasdaq Panel ), the ‎Company s securities will be subject to delisting. Accordingly, the Company will request a hearing before the ‎Nasdaq Panel. The hearing request will automatically stay any suspension or delisting action pending the hearing ‎and the expiration of any additional extension period granted by the Nasdaq Panel following the hearing. In that ‎regard, pursuant to the Nasdaq Listing Bid Price Rules, the Nasdaq Panel has the discretion to grant an additional ‎extension period that can expire as late as September 17, 2024. At the hearing, the Company will be asked to ‎provide a plan to regain compliance to the Nasdaq Panel. The Company intends to present a plan to regain ‎compliance with the Bid Price Rule and request the continued listing of its common shares on Nasdaq pending such ‎compliance. However, there can be no assurance that the Nasdaq Panel will grant the Company s request or that ‎the Company will ultimately regain compliance with all applicable requirements for continued listing on Nasdaq.‎

 

Future issuances of equity securities by us or sales by the Company’s existing shareholders may cause the price of its Common Shares to fall.

 

The market price of the Company’s Common Shares could decline as a result of issuances of securities or sales by its existing shareholders in the market, including by its directors, executive officers and significant shareholders, or the perception that these sales could occur. Sales of the Company’s Common Shares by shareholders might also make it more difficult for it to sell Common Shares at a time and price that it deems appropriate. The Company also expects to issue Common Shares in the future. Future issuances of Common Shares, or the perception that such issuances are likely to occur, could affect the prevailing trading prices of the Common Shares.

 

We may never pay dividends over the foreseeable future.

 

Investors should not rely on an investment in the Company’s Common Shares to provide dividend income. The Company does not anticipate that it will pay any cash dividends to holders of its Common Shares in the foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand its operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors must rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase the Company’s Common Shares.

 

 

40 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

United States investors may not be able to obtain enforcement of civil liabilities against us.

 

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this Annual Report reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons.

 

Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this Annual Report.

 

We are an emerging growth company and intend to take advantage of reduced disclosure requirements applicable to emerging growth companies, which could make the Company’s Common Shares less attractive to investors.

 

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross revenue of $1.07 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth anniversary of the date of the completion of the first sales of its common equity pursuant to an effective registration statement under the Securities Act); (iii) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the market value of the Company’s Common Shares held by non-affiliates exceeds $700 million as of the last business day of its most recently completed second fiscal quarter after we have been a reporting company in the United States for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to rely upon exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).

 

We may take advantage of some, but not all, of the available exemptions available to emerging growth companies. We cannot predict whether investors will find the Company’s Common Shares less attractive if it relies on these exemptions. If some investors find the Company’s Common Shares less attractive as a result, there may be a less active trading market for its Common Shares and the price of its Common Shares may be more volatile.

 

41 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

We will incur increased costs as a result of operating as a public company in the United States and the Company’s management will be required to devote substantial time to new compliance initiatives.

 

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as ‎defined ‎‎under the JOBS Act, we incur significant legal, accounting and other expenses, in addition to ‎those we ‎incur as a ‎Canadian public company, that we did not incur prior to being listed on Nasdaq. In ‎‎addition, the Sarbanes-Oxley ‎Act, and rules implemented by the SEC and Nasdaq impose various other ‎‎requirements on public companies, and ‎the Company spends time and resources to ensure compliance with its ‎‎reporting obligations in both Canada and the ‎United States.‎

 

For example, pursuant to Section 404, we are required to furnish a report by our management on our internal control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth company, must be accompanied by an attestation report on ICFR issued by our independent registered public accounting firm. To achieve compliance with Section 404, we must document and evaluate our ICFR, which is both costly and challenging. In this regard, we must dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for ICFR. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude that our ICFR is effective as required by Section 404. This could result in a determination that there are one or more material weaknesses in our ICFR, which could cause an adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated financial statements.

 

In addition, becoming a public company in the United States has increased legal and financial compliance as well as regulatory costs, such as additional Nasdaq fees, and has made some of our public company obligations more time consuming. We invest resources to comply with evolving laws, regulations and standards in both Canada and the United States, and this investment results in increased general and administrative expenses and increased diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with public company laws, regulations and standards in the United States are insufficient, regulatory authorities may initiate legal proceedings against us and our business may be harmed.

 

Being a public company in the United States and complying with applicable rules and regulations also makes it more expensive for us to obtain sufficient levels of director and officer liability insurance coverage. This factor may also make it more difficult for us to attract and retain qualified executive officers and members of our Board of Directors.

 

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. issuer, which may limit the information publicly available to the Company’s U.S. shareholders.

 

We currently qualify as a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do not file the same reports that a U.S. domestic issuer would file with the SEC, although we are required to file with or furnish to the SEC the continuous disclosure documents that we are required to file in Canada under Canadian securities laws. In addition, the Company’s officers, directors and principal shareholders are exempt from the reporting and “short swing” profit recovery provisions of Section 16 of the Exchange Act. Therefore, the Company’s shareholders may not know on as timely a basis when its officers, directors and principal shareholders purchase or sell our securities as the reporting periods under the corresponding Canadian insider reporting requirements are longer. In addition, as a foreign private issuer, the Company is exempt from the proxy rules under the Exchange Act. The Company is also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material non-public information. While the Company expects to comply with the corresponding requirements relating to proxy statements and disclosure of material non-public information under Canadian securities laws, these requirements differ from those under the Exchange Act and Regulation FD and shareholders should not expect to receive in every case the same information at the same time as such information is provided by U.S. domestic issuers.

 

42 

 

 

Draganfly Inc.
Management Discussion and Analysis
For the year ended December 31, 2023

 

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate governance practices, except to the extent that such laws would be contrary to U.S. federal securities laws and Nasdaq listing rules and provided that we disclose the requirements we are not following and describe the Canadian practices we follow instead. We rely on this exemption in part. As a result, the Company’s shareholders may not have the same protections afforded to shareholders of U.S. domestic issuers that are subject to all U.S. corporate governance requirements.

 

At some point in the future, we may cease to be a foreign private issuer. If we cease to qualify, we will be subject to the same reporting requirements and corporate governance requirements as a U.S. domestic issuer, which may increase the Company’s costs of being a public company in the United States.

 

REGULATORY POLICIES

 

Disclosure Controls and Procedures

 

Disclosure Controls and Procedures (“DC&P”) are designed to provide reasonable assurance that all material information is gathered and reported on a timely basis to senior management so that appropriate decisions can be made regarding public disclosure and that information required to be disclosed by the issuer under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation. The Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), along with other members of management, have designed, or caused to be designed under the CEO and CFO’s supervision, DC&P and established processes to ensure that they are provided with sufficient knowledge to support the representations made in the interim certificates required to be filed under National Instrument 52-109.

 

Internal Controls over Financial Reporting

 

The CEO and CFO, along with participation from other members of management, are responsible for establishing and maintaining adequate Internal Control over Financial Reporting (“ICFR”) to provide reasonable assurance regarding the reliability of financial statements prepared in accordance with IFRS. During the year ended December 31, 2023, there has been no change in the Company’s ICFR that has materially affected, or is reasonably likely to materially affect, the Company’s ICFR.

 

Limitations of Controls and Procedures

 

The Company’s management, including its CEO and CFO, believe that any DC&P or ICFR, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, they cannot provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been prevented or detected. These inherent limitations include the realities that judgements in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Accordingly, because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Other Information

 

Additional information about the Company is available at www.draganfly.com

 

Approval

 

This MD&A is authorized for issue by the Board on March 27, 2024

 

43 

 

 

 

EX-15.3 17 ex15-3.htm

 

Exhibit 15.3

 

CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Annual Report on Form 20-F of our report dated March 27, 2024, with respect to the consolidated financial statements of Draganfly Inc. as at and for the years ended December 31, 2023 and 2022 included in this Annual Report on Form 20-F of Draganfly Inc.

 

We also consent to the incorporation by reference in the Registration Statements on Form F-10 (No. 333-271498), as amended, and Form S-8 (No. 333-259459) of Draganfly Inc. of our report dated March 27, 2024 referred to above.

 

/s/ DMCL LLP

 

Chartered Professional Accountants

Vancouver, Canada

 

March 27, 2024

 

 

EX-97.1 18 ex97.htm

 

Exhibit 97

 

DRAGANFLY INC.

 

DODD-FRANK CLAWBACK POLICY

 

Upon the recommendation of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Draganfly Inc. (the “Company”), the Board has adopted the following Dodd-Frank Clawback Policy (this “Policy”) on November 9, 2023, effective as of October 2, 2023 (the “Effective Date”).

 

1. Purpose. The purpose of this Policy is to provide for the recoupment of certain incentive compensation pursuant to Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, in the manner required by Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated thereunder, and the Applicable Listing Standards (as defined below) (collectively, the “Dodd-Frank Rules”).

 

2. Administration. This Policy shall be administered by the Committee. Any determinations made by the Committee shall be final and binding on all affected individuals.

 

3. Definitions. For purposes of this Policy, the following capitalized terms shall have the meanings set forth below.

 

(a) “Accounting Restatement” shall mean an accounting restatement of the Company’s financial statements due to the material adverse noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement (i) to correct an error in previously issued financial statements that is material and adverse to the previously issued financial statements (i.e., a “Big R” restatement), or (ii) that corrects an error that is not material and adverse to previously issued financial statements, but that would result in a materially adverse misstatement if the error were corrected in the current period or left uncorrected in the current period (i.e., a “little r” restatement).

 

(b) “Affiliate” shall mean each entity that directly or indirectly controls, is controlled by, or is under common control with the Company.

 

(c) “Applicable Listing Standards” shall mean Nasdaq Listing Rule 5608.

 

(d) “Clawback Eligible Incentive Compensation” shall mean Incentive-Based Compensation Received by a Covered Executive (i) on or after the Effective Date, (ii) after beginning service as a Covered Executive, (iii) if such individual served as a Covered Executive at any time during the performance period for such Incentive-Based Compensation (irrespective of whether such individual continued to serve as a Covered Executive upon or following the Restatement Trigger Date), (iv) while the Company has a class of securities listed on a senior securities exchange in the United States or a national securities association in the United States, and (v) during the applicable Clawback Period. For the avoidance of doubt, Incentive-Based Compensation Received by a Covered Executive on or after the Effective Date could, by the terms of this Policy, include amounts approved, awarded, or granted prior to such Effective Date.

 

(e) “Clawback Period” shall mean, with respect to any Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Restatement Trigger Date and any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of at least nine months shall count as a completed fiscal year).

 

(f) “Company Group” shall mean the Company and its Affiliates.

 

(g) “Covered Executive” shall mean any “executive officer” of the Company as defined under Applicable Listing Standards.

 

 
 

 

(h) “Erroneously Awarded Compensation” shall mean the amount of Clawback Eligible Incentive Compensation that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received had it been determined based on the restated amounts, computed without regard to any taxes paid. With respect to any compensation plan or program that takes into account Incentive-Based Compensation, the amount contributed to a notional account that exceeds the amount that otherwise would have been contributed had it been determined based on the restated amount, computed without regard to any taxes paid, shall be considered Erroneously Awarded Compensation, along with earnings accrued on that notional amount.

 

(i) “Exchangeshall mean The Nasdaq Stock Market.

 

(j) “Financial Reporting Measures” shall mean measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and all other measures that are derived wholly or in part from such measures. Share price and total shareholder return (and any measures that are derived wholly or in part from share price or total shareholder return) shall for purposes of this Policy be considered Financial Reporting Measures. For the avoidance of doubt, a measure need not be presented in the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission (the “SEC”) in order to be considered a Financial Reporting Measure.

 

(k) “Incentive-Based Compensation” shall mean any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.

 

(l) “Received” shall mean the deemed receipt of Incentive-Based Compensation. Incentive-Based Compensation shall be deemed received for this purpose in the Company’s fiscal period during which the Financial Reporting Measure specified in the applicable Incentive-Based Compensation award is attained, even if payment or grant of the Incentive-Based Compensation occurs after the end of that period.

 

(m) “Restatement Trigger Date” shall mean the earlier to occur of (i) the date the Board, a committee of the Board, or the officer(s) of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

 

4. Recoupment of Erroneously Awarded Compensation. Upon the occurrence of a Restatement Trigger Date, the Company shall recoup Erroneously Awarded Compensation reasonably promptly, in the manner described below. For the avoidance of doubt, the Company’s obligation to recover Erroneously Awarded Compensation under this Policy is not dependent on if or when restated financial statements are filed following the Restatement Trigger Date.

 

  (a) Process. The Committee shall use the following process for recoupment:

 

(i) First, the Committee will determine the amount of any Erroneously Awarded Compensation for each Covered Executive in connection with an Accounting Restatement. For Incentive-Based Compensation based on (or derived from) share price or total shareholder return where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the applicable Accounting Restatement, the amount shall be determined by the Committee based on a reasonable estimate of the effect of the Accounting Restatement on the share price or total shareholder return upon which the Incentive-Based Compensation was Received (in which case, the Company shall maintain documentation of such determination of that reasonable estimate and provide such documentation to the Exchange).

 

(ii) Second, the Committee will provide each affected Covered Executive with a written notice stating the amount of the Erroneously Awarded Compensation, a demand for recoupment, and the means of recoupment that the Company will accept.

 

 
 

 

  (b) Means of Recoupment. The Committee shall have the discretion to determine the appropriate means of recoupment of Erroneously Awarded Compensation, which may include without limitation: (i) recoupment of cash or Company shares, (ii) forfeiture of unvested cash or equity awards (including those subject to service-based and/or performance-based vesting conditions), (iii) cancellation of outstanding vested cash or equity awards (including those for which service-based and/or performance-based vesting conditions have been satisfied), (iv) to the extent consistent with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), offset of other amounts owed to the Covered Executive or forfeiture of deferred compensation, (v) reduction of future compensation, and (vi) any other remedial or recovery action permitted by law. Notwithstanding the foregoing, the Company Group makes no guarantee as to the treatment of such amounts under Section 409A, and shall have no liability with respect thereto. For the avoidance of doubt, appropriate means of recoupment may include amounts approved, awarded, or granted prior to the Effective Date. Except as set forth in Section 4(d) below, in no event may the Company Group accept an amount that is less than the amount of Erroneously Awarded Compensation in satisfaction of a Covered Executive’s obligations hereunder.

 

  (c) Failure to Repay. To the extent that a Covered Executive fails to repay all Erroneously Awarded Compensation to the Company Group when due (as determined in accordance with Section 4(a) above), the Company shall, or shall cause one or more other members of the Company Group to, take all actions reasonable and appropriate to recoup such Erroneously Awarded Compensation from the applicable Covered Executive. The applicable Covered Executive shall be required to reimburse the Company Group for any and all expenses reasonably incurred (including legal fees) by the Company Group in recouping such Erroneously Awarded Compensation if the Company Group can prove that the Covered Executive did not behave in good faith, acted recklessly or frivolously in respect of their failure to repay the Erroneously Awarded Compensation.

 

  (d) Exceptions. Notwithstanding anything herein to the contrary, the Company shall not be required to recoup Erroneously Awarded Compensation if one of the following conditions is met and the Committee determines that recoupment would be impracticable:

 

(i) The direct expense paid to a third party to assist in enforcing this Policy against a Covered Executive would exceed the amount to be recouped, after the Company has made a reasonable attempt to recoup the applicable Erroneously Awarded Compensation, documented such attempts, and provided such documentation to the Exchange;

 

(ii) Recoupment would violate home country law where that law was adopted prior to November 28, 2022, provided that, before determining that it would be impracticable to recoup any amount of Erroneously Awarded Compensation based on violation of home country law, the Company has obtained an opinion of home country counsel, acceptable to the Exchange, that recoupment would result in such a violation and a copy of the opinion is provided to the Exchange; or

 

(iii) Recoupment would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.

 

5. Reporting and Disclosure. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the Dodd-Frank Rules.

 

6. Indemnification Prohibition. No member of the Company Group shall be permitted to indemnify any current or former Covered Executive against (i) the loss of any Erroneously Awarded Compensation that is recouped pursuant to the terms of this Policy, or (ii) any claims relating to the Company Group’s enforcement of its rights under this Policy. The Company may not pay or reimburse any Covered Executive for the cost of third-party insurance purchased by a Covered Executive to fund potential recoupment obligations under this Policy.

 

 
 

 

7. Acknowledgment. To the extent required by the Committee, each Covered Executive shall be required to sign and return to the Company the acknowledgement form attached hereto as Exhibit A pursuant to which such Covered Executive will agree to be bound by the terms of, and comply with, this Policy. For the avoidance of doubt, each Covered Executive will be fully bound by, and must comply with, the Policy, whether or not such Covered Executive has executed and returned such acknowledgment form to the Company.

 

8. Interpretation. The Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. The Board intends that this Policy be interpreted consistent with the Dodd-Frank Rules.

 

9. Amendment; Termination. The Board may amend or terminate this Policy from time to time in its discretion, including as and when it determines that it is legally required to do so by any federal securities laws, SEC rule or the rules of any national securities exchange or national securities association on which the Company’s securities are listed.

 

10. Other Recoupment Rights. The Board intends that this Policy be applied to the fullest extent of the law. The Board and/or Committee may require that any employment agreement, equity award, cash incentive award, or any other agreement entered into be conditioned upon the Covered Executive’s agreement to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company Group, whether arising under applicable law, regulation or rule, pursuant to the terms of any other policy of the Company Group, pursuant to any employment agreement, equity award, cash incentive award, or other agreement applicable to a Covered Executive, or otherwise (the “Separate Clawback Rights”). Notwithstanding the foregoing, there shall be no duplication of recovery of the same Erroneously Awarded Compensation under this Policy and the Separate Clawback Rights, unless required by applicable law.

 

11. Successors. This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.

 

Approved November 9, 2023

 

 
 

 

Exhibit A

 

DRAGANFLY INC. DODD-FRANK CLAWBACK POLICY

 

ACKNOWLEDGEMENT FORM

 

By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of the Draganfly Inc. Dodd-Frank Clawback Policy (the “Policy”). Capitalized terms used but not otherwise defined in this Acknowledgement Form (this “Acknowledgement Form”) shall have the meanings ascribed to such terms in the Policy.

 

By signing this Acknowledgement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned’s employment with the Company Group. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by returning any Erroneously Awarded Compensation to the Company Group reasonably promptly to the extent required by, and in a manner permitted by, the Policy, as determined by the Committee of the Company’s Board of Directors in its sole discretion.

 

  Sign:  
  Name: [Employee]
     
  Date:  

 

 

 

 

 

GRAPHIC 19 mda_001.jpg begin 644 mda_001.jpg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end GRAPHIC 20 form20-f_004.jpg begin 644 form20-f_004.jpg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end GRAPHIC 21 form20-f_001.jpg begin 644 form20-f_001.jpg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end GRAPHIC 22 form20-f_002.jpg begin 644 form20-f_002.jpg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mdaaud_001.jpg begin 644 mdaaud_001.jpg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dpro-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995511 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - MANAGEMENT JUDGEMENT AND ASSUMPTIONS link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - NOTES RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - PREPAIDS link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - INTANGIBLE ASSETS AND GOODWILL link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - RIGHT OF USE ASSETS link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - LEASE LIABILITES link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - DEFERRED INCOME link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - OFFICE AND MISCELLANEOUS link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - NOTES RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - PREPAIDS (Tables) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - RIGHT OF USE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - LEASE LIABILITES (Tables) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - DEFERRED INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - LOANS PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - SEGMENTED INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995551 - Disclosure - OFFICE AND MISCELLANEOUS (Tables) link:presentationLink link:calculationLink link:definitionLink 995552 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995554 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995556 - Disclosure - SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details) link:presentationLink link:calculationLink link:definitionLink 995557 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 995558 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995559 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995560 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 995561 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995562 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995563 - Disclosure - RECEIVABLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995564 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - SCHEDULE OF COST OF SALES (Details) link:presentationLink link:calculationLink link:definitionLink 995566 - Disclosure - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995567 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995568 - Disclosure - NOTES RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995569 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 995570 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995571 - Disclosure - SCHEDULE OF INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 995572 - Disclosure - SCHEDULE OF FAIR VALUE OF INVESTMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995573 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995574 - Disclosure - INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995576 - Disclosure - EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995577 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details) link:presentationLink link:calculationLink link:definitionLink 995578 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995579 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995580 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 995581 - Disclosure - RIGHT OF USE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995582 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995583 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) link:presentationLink link:calculationLink link:definitionLink 995584 - Disclosure - LEASE LIABILITES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995586 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 995587 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995588 - Disclosure - SCHEDULE OF LOANS (Details) link:presentationLink link:calculationLink link:definitionLink 995589 - Disclosure - DEFERRED INCOME (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995590 - Disclosure - LOANS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995591 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995592 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995593 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995594 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 995596 - Disclosure - SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995597 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995598 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995599 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995600 - Disclosure - SHARE CAPITAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995601 - Disclosure - SCHEDULE OF SEGMENTED INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 995602 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 995603 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995604 - Disclosure - SCHEDULE OF KEY COMPENSATION AWARDS (Details) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995606 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995607 - Disclosure - SCHEDULE OF AGING OF RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 995608 - Disclosure - SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995609 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 995610 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 995611 - Disclosure - SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 995612 - Disclosure - SCHEDULE OF INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 995613 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 995614 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 25 dpro-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 26 dpro-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 27 dpro-20231231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Issued capital [member] Reserve of share-based payments [member] Retained earnings [member] Reserve of gains and losses from investments in equity instruments [member] Reserve of exchange differences on translation [member] Legal Entity [Axis] Draganfly innovations inc [member] Dragonfly Innovations USA Inc [member] Dronelogics Systems Inc [member] Types of antidilutive instruments [axis] Warrants [member] Share options [member] Restricted share units [member] Classes of intangible assets and goodwill [axis] Customer relationship intangible assets [member] Brand names [member] Computer software [member] Patent [member] Classes of property, plant and equipment [axis] Computer equipment [member] Furniture and equipment [member] Leasehold improvements [member] Vehicles [member] Types of contracts [axis] Guaranteed investment certificate [member] Guaranteed investment certificate one [member] Products and services [axis] Inventory [member] Types of share-based payment arrangements [axis] Note one [member] Note two [member] Note three [member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Accumulated impairment [member] Types of investment property [axis] Public company shares [member] Private company shares [member] Classes of share capital [axis] Rental services [member] Gross carrying amount [member] Customer-related intangible assets [member] Goodwill [member] Accumulated depreciation and amortisation [member] Counterparties [axis] Vital and dronelogics [member] Dronelogics [member] Vital [member] Classes of intangible assets other than goodwill [axis] Brand and software [member] Buildings [member] Range [axis] Bottom of range [member] Top of range [member] Maturity [axis] Not later than one year [member] Later than one year and not later than three years [member] Later than four years and not later than five years [member] Borrowings by name [axis] CEBA [member] CEBA [member] Vehicle loan [member] Common stock 1 [member] Common shares [member] Stock options [member] Restricted stock units [member] USD Warrants [Member] Broker Warrants [Member] Ranges of exercise prices for outstanding share options [axis] Exercise price one [member] Plan names [axis] Incentive share compensation plan [member] Exercise price two [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Exercise price six [member] Exercise price seven [member] Exercise price eight [member] Exercise price nine [member] Exercise price ten [member] Exercise price eleven [member] Restricted stock units rsu [member] Range 1 [member] Range 2 [member] Range 6 [member] Range 7 [member] Warrant one [member] Warrant two [member] Warrant three [member] Warrant four [member] Warrant five [member] Segments [axis] Drones [member] Corporates [member] Geographical areas [axis] CA [member] US country [member] Service concession arrangements [axis] Business services agreement [member] Categories of related parties [axis] Business instincts group [member] Independent consultant agreement [member] Alberta lltd [member] Executive consultant agreement [member] Scottlarson [member] CEO and director [member] CEO [member] Directors [member] Other related parties [member] Past due status [axis] Current [member] Later than one month and not later than two months [member] Later than two months and not later than three months [member] Later than three months [member] Classes of financial instruments [axis] Trade payables and accrued liabilities [member] Types of risks [axis] Liquidity risk [member] Later than one year and not later than five years [member] Customer deposits [member] Deferred income [member] Loan payable [member] Derivative liability [member] Lease liabilities [member] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Unobservable inputs [axis] Historical volatility for shares, measurement input [member] Expiring in 2030 to 2043 [Member] Expiring in 2040 to 2043 [Member] Pre-funded Warrants [Member] Non-adjusting events after reporting period [axis] Non Adjustment Events [Member] Underwritten Share Placement [Member] Ordinary shares [member] Ranges of Exercise Prices of Warrants Two [member] Ranges of Exercise Prices of Warrants One [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Name Auditor Location Auditor Firm ID Statement of financial position [abstract] ASSETS Current Assets Cash and cash equivalents Receivables Inventory Notes receivable Prepaids Total current assets Non-current Assets Equipment Intangible assets Investments Right of use assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Trade payables and accrued liabilities Customer deposits Deferred income Loans payable Derivative liability Lease liabilities Total current liabilities Non-current Liabilities Loans payable Deferred income Lease liabilities TOTAL LIABILITIES SHAREHOLDERS’ EQUITY Share capital Reserves – share-based payments Accumulated deficit Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS’ EQUITY TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Profit or loss [abstract] REVENUE Sales of goods Provision of services TOTAL REVENUE COST OF SALES GROSS PROFIT OPERATING EXPENSES Amortization Depreciation Director fees Insurance Office and miscellaneous Professional fees Research and development Share-based payments Travel Wages and salaries Total operating expenses OTHER INCOME (EXPENSE) Change in fair value of derivative liability Finance and other costs Foreign exchange gain Loss on disposal of assets Loss on write-off of notes receivable Government income Write down of deposit Loss on impairment of goodwill and intangibles Other income (expense) NET LOSS FOR THE YEAR OTHER COMPREHENSIVE INCOME (LOSS) Items that may be reclassified to profit or loss Foreign exchange translation Items that will not be reclassified to profit or loss Change in fair value of equity investments at FVOCI COMPREHENSIVE LOSS FOR THE YEAR Net Income (Loss) per share - Diluted Net Income (Loss) per share - Diluted Weighted average number of common shares outstanding - Basic Weighted average number of common shares outstanding - Diluted Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Balance Balance, shares Shares issued in the acquisitions of Vital Shares issued in the acquisitions of Vital, shares Shares issued for financing Shares issued for financing, shares Share issue costs Shares issued for the exercise of RSUs Shares issued for the exercise of RSUs, shares Shares issued for the exercise of warrants Shares issued for exercise of warrants, shares Shares issued for the exercise of stock options Shares issued for the exercise of stock options, shares Shares issued in lieu of cash Shares issued in lieu of cash, shares Share-based payments Net loss Change in fair value of equity investments at FVOCI Translation of foreign operations Shares issued for the exercise of warrants, shares Shares issued for financing – ATM (“At-the-market”) Shares issued for financing ATM ("At-the-market"), shares Share issue costs Balance Balance, shares Statement of cash flows [abstract] OPERATING ACTIVITIES Net loss for the year Adjustments for: Amortization Depreciation Bad debt Change in fair value of derivative liability Write down of inventory Impairment of notes receivable Impairment of goodwill and intangibles Write down of deposit Finance and other costs (Gain) loss on sale of assets  Adjustments for profit loss Net changes in non-cash working capital items: Receivables Inventory Prepaids Trade payables and accrued liabilities Customer deposits Deferred income Cash used in operating activities INVESTING ACTIVITIES Cash paid for acquisition, net of cash received Purchase of equipment Disposal of equipment Purchase of intangible assets Purchase of investments Repayment (Issuance) of notes receivable Cash provided by (used in) investing activities FINANCING ACTIVITIES Proceeds from issuance of common shares for financing Share issue costs Proceeds from issuance of common shares for warrants exercised Proceeds from issuance of common shares for stock options exercised Proceeds from issuance of loans Repayment of loans Repayment of lease liabilities Cash provided by (used in) financing activities Effects of exchange rate changes on cash Change in cash Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year The following are included in cash flow from operating activities: Interest paid in cash Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Nature And Continuance Of Operations And Going Concern NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN Notes and other explanatory information [abstract] MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION Management Judgement And Assumptions MANAGEMENT JUDGEMENT AND ASSUMPTIONS Cash And Cash Equivalents CASH AND CASH EQUIVALENTS Receivables RECEIVABLES Inventory INVENTORY Notes Receivable NOTES RECEIVABLE Prepaids PREPAIDS Investments INVESTMENTS Equipment EQUIPMENT Intangible Assets And Goodwill INTANGIBLE ASSETS AND GOODWILL Right Of Use Assets RIGHT OF USE ASSETS Lease Liabilites LEASE LIABILITES Trade Payables And Accrued Liabilities TRADE PAYABLES AND ACCRUED LIABILITIES DEFERRED INCOME LOANS PAYABLE Disclosure of share capital, reserves and other equity interest [text block] SHARE CAPITAL SEGMENTED INFORMATION OFFICE AND MISCELLANEOUS RELATED PARTY TRANSACTIONS Disclosure of financial instruments [text block] FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT INCOME TAXES SUBSEQUENT EVENTS Statement of Compliance Basis of consolidation Foreign currency translation Share-based payments Loss per share Financial Instruments Impairment of non-financial assets Income taxes Inventory Revenue recognition Deferred Income Cost of Goods Sold Intangible Assets and Goodwill Equipment Research and development expenditures Government Assistance Leases New accounting standards issued not yet effective SCHEDULE OF WHOLLY OWNED SUBSIDIARIES SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES SCHEDULE OF CLASS OF EQUIPMENT SCHEDULE OF CASH AND CASH EQUIVALENTS SCHEDULE OF AMOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF COST OF SALES DISCLOSURE OF NOTES RECEIVABLE SCHEDULE OF PREPAID EXPENSES AND DEPOSITS SCHEDULE OF INVESTMENTS SCHEDULE OF FAIR VALUE OF INVESTMENT SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF INTELLECTUAL PROPERTY SCHEDULE OF RIGHT OF USE ASSETS SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES SCHEDULE OF OPERATING LEASE LIABILITIES SCHEDULE OF OPERATING MATURITY ANALYSIS SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF DEFERRED INCOME SCHEDULE OF LOANS PAYABLE SCHEDULE OF LOANS SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SCHEDULE OF STOCK OPTIONS OUTSTANDING SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS SCHEDULE OF WARRANT DERIVATIVE LIABILITY SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS SUMMARY OF CHANGES IN WARRANTS SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF SEGMENTED INFORMATION SCHEDULE OF GEOGRAPHIC REVENUE SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES SCHEDULE OF KEY COMPENSATION AWARDS SCHEDULE OF KEY MANAGEMENT TRANSACTIONS SCHEDULE OF AGING OF RECEIVABLES SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY SCHEDULE OF INCOME TAX SCHEDULE OF DEFERRED TAXES Accumulated deficit DisclosureMaterialAccountingPoliciesAndBasisOfPreparationTable [Table] DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems [Line Items] Name of subsidiary Country of incorporation of subsidiary Proportion of ownership interest in subsidiary Disclosure of reconciliation of changes in intangible assets and goodwill [table] Intangible assets, useful life Disclosure of detailed information about property, plant and equipment [table] Depreciation rate Depreciation rate, description Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] Aggregate sale price Potentially dilutive loss per share Schedule Of Cash And Cash Equivalents Cash held in banks Guaranteed investment certificates Cash and cash equivalents Disclosure of disaggregation of revenue from contracts with customers [table] Purchase of financial instrument Financial instrument term Average effective Instrument rate Schedule Of Amounts Receivable Trade accounts receivable Taxes receivable Trade and other receivables Provision for doubtful account Schedule Of Inventories Finished goods Parts Inventories Schedule Of Cost Of Sales Inventory Consulting and services Other Cost of sales Cost of sales Reserve inventory write down Disclosure of terms and conditions of share-based payment arrangement [table] Maturity date Rate Principal Interest Accretion Impairment loss Repayments Note receivable Maturity date Impairment loss Note receivable interest rate Impairment Loans written down Repayments of current borrowings Schedule Of Prepaid Expenses And Deposits Insurance Prepaid interest Prepaid marketing services Prepaid rent Prepaid subscriptions Deposits  Prepaid expenses and deposits  Schedule Of Prepaid Expenses And Deposits Details Purchase of inventory Schedule Of Investments Balance Change in fair value Balance Disclosure of detailed information about investment property [table] Fair value of investments Risk free interest rate Expected volatility Expected life Expected dividend yield Number of shares purchased Quoted exercise price Quoted price per share [custom:WarrantExpiration] Number of shares purchased value Property, plant and equipment, beginning balance Additions Disposals Property, plant and equipment, ending balance Accumulated depreciation Property, plant and equipment, beginning balance Charge for the year Disposals Accumulated depreciation Property, plant and equipment, ending balance Property, plant and equipment Non - cash transfer of equipment from inventory Disclosure of reconciliation of changes in goodwill [table] Balance at December 31, 2022 Additions Foreign exchange translation Impairment Cost, ending balance Balance at December 31, 2022 Charge for the year Foreign exchange translation Impairment Balance at December 31, 2023 Net book value Disclosure of offsetting of financial assets [table] Percentage of cash flow projection Weighted average revenue Percentage of weighted average cost of capital Impairment of goodwill Impairment of goodwill Assumption discount rates Reduction in value Schedule Of Right Of Use Assets Right of use assets, Cost, Balance Right of use assets, Cost, Additions Right of use assets, Cost, Lease adjustment Right of use assets, Cost, Balance Right of use assets, Accumulated depreciation, Balance Right of use assets, Accumulated depreciation, Charge for the year Right of use assets, Accumulated depreciation, Balance Additional right of the assets Schedule Of Operating Lease Liabilities Balance - Beginning of period Interest expense Lease Payments Additions Foreign exchange Balance - Ending of period Current lease liabilities Non-current lease liabilities Lease liabilities Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Total undiscounted lease liabilities Amount representing interest Lease liability Disclosure of detailed information about borrowings [table] Depreciation lease liability Weighted average lessee's incremental borrowing rate applied to lease Variable lease payments Schedule Of Trade Payables And Accrued Liabilities Trade accounts payable Accrued liabilities Government grant payable Trade payables and accrued liabilities Deferred, revenue beginning Revenue recognized Unearned revenues received  Deferred income gross Current portion Long term portion  Deferred Income net Opening balance Issuance of loans payable Fair value adjustment Repayment of loans payable Accretion expense Ending balance Start Date Maturity Date Rate Total Carrying Value Deferred revenue Loan received Interest rate Loans forgivable amount Proceeds from loan Loan forgiveness Unsecured loan received Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Grant Date Expiry Date Exercise Price Remaining Contractual Life (years) Number of Options Outstanding Number of Options Exercisable Number of options outstanding, Beginning Balance Weighted average exercise price, Beginning Balance Number of options outstanding, Exercised Weighted average exercise price, Exercised Number of options outstanding, forfeited Weighted average exercise price, Granted Weighted average exercise price, forfeited Number of options outstanding, issued Weighted average exercise price, Issued Number of options outstanding, Ending Balance Weighted average exercise price, Ending Balance Exercise price Number of RSUs outstanding, Beginning of the period Number of RSUs,Vested Number of RSUs,Issued Number of RSUs ,Forfeited Number of RSUs,Issued Number of RSUs outstanding, Ending of the period Beginning of the period Change in fair value of warrants outstanding Warrants issued Ending of the period Warrants Contingent consideration Derivative liability Issue date Exercise price Number of Warrants Outstanding Fair Value of warrants Disclosure of classes of share capital [table] Weighted Average Exercise Price, Outstanding, Beginning Balance Warrants, Excercised Weighted Average Exercise Price, Exercised Warrants, Issued Weighted Average Exercise Price, Issued Warrants, Issued Warrants, Expired Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Outstanding, Ending Balance Date issued Expiry date Exercise price Number of warrants outstanding Restricted share units Number of shares issued [custom:SharesIssuedForFinancingCost] [custom:IssuedCapitalCost-0] Proceeds from issuing shares Shares issued for financing - ATM, shares Shares issued for financing - ATM Share issue costs Proceeds from issue of shares Share issue related cost Other income (expense) Number of shares exercise Exercise of warrants Number of stock issued for exercise of options Stock issued during period value exercise of options Number of options outstanding, Granted Stock option exercisable year Adjustments for share-based payments Number of accelerated vesting shares Number of accelerated issued shares Number of accelerated Forfeited shares Expense from share-based payment transactions with employees Warrants issued Warrant exercise price share Exercise price Warrants exercise price Warrants term Warrants expiration date Underwriter warrants issued Volatility rate Warrants held in escrow Revenue on acquisition Weighted average remaining contractual life of outstanding share options Total revenue Segment loss Finance and other costs Impairment of goodwill and intangibles Change in fair value of derivative liability Loss on write-off of notes receivable Loss on write down of inventory Net loss for the year Non-current assets Revenue Revenue Advertising, Marketing, and Investor Relations Compliance fees Impairment of accounts receivable Contract Work Other Office and Miscellaneous Expenses Director fees Salaries Share-based payments Total Disclosure of transactions between related parties [table] Management fees paid to a company, total  Disclosure of detailed information about service concession arrangements [table] Incurred fees Indebted amount Disclosure of provision matrix [table]  Total receivables Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]  Financial liabilities Foreign exchange rate Disclosure of fair value measurement of assets [table] Equity securities in investee companies Notes receivable Derivative liability Total Disclosure of significant unobservable inputs used in fair value measurement of assets [table] [custom:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage] Impact on comprehensive loss Loss before income taxes Canadian statutory rates Expected income tax recovery Impact of different foreign statutory tax rates Non-deductible items Share issue costs Adjustments to prior years provision versus statutory tax returns Differences between prior year provision and final tax return Change in deferred tax asset not recognized Income tax Share issuance costs Non-capital losses Property and equipment Capital gain reserve Scientific Research and Experimental Development Total deferred income tax assets Deferred income tax not recognized Net deferred tax assets Non-capital loss carry forward Number of warrants exercised Proceeds from exercise of warrants Number of shares issued, value Description of shares issuance Share price Proceeds from issue of ordinary shares Net proceeds from issue of ordinary shares Proceeds from issue of ordinary shares Warrant exercise price Description of exercisable term of warrants Notes receivables current. Disclosure of nature and continuance of operations and going concern explanatory. Current loans payable. Non current loans payable. Dragonfly Innovations USA Inc [member] Dronelogics Systems Inc [member] Shares issued for exercise of stock options. Shares issued for exercise of stock options, shares. Deferred income including contract liabilities non current. Stock issued during period value exercise of warrants. Number of stock issued for exercise of warrants. Shares issued for exercise of restricted stock units. Shares issued for exercise of restricted stock units, shares. Shares issued for financing ATM. Shares issued for financing ATM shares. Operating expense abstract. Share based payments expenses. Other income expense abstract. Shares issued for financing. Shares issued for financing shares. Other income loss. Components of other comprehensive income that may be reclassified to profit or loss net of tax abstract. Loss on write-off of notes receivable. Write down of deposit. Loss on impairment of goodwill and intangibles. Description of accounting policy share based payments explanatory. Aggregate sale price description. Description of accounting policy loss per share explanatory. Description of accounting policy inventory explanatory. Warrants outstanding. Description of accounting policy for cost of goods sold explanatory. Operating expenses total. Options outstanding. Loss for adjustments. Change in fair value of derivative liability. Finance and other costs. Gain loss on sale of assets. Write down of inventory. Changes in items of working capital abstract. Increase decrease in deferred income. Repayment of notes receivable. Proceed from issuance of common stock. Proceeds from issuance of common shares for stock options exercised. Repayment of loans. Repayment of lease liability. Supplementary cash flow disclosure. Interest paid in cash. Bad debt. Disclosure of investment explanatory. Disclosure of fair value of investment explanatory. Disclosure of class of equipment explanatory. Depreciation percentage. Furniture and equipment [member] Depreciation description. Number of shares purchased. Number of shares purchased, value. Disclosure of fair value of warrants for weighted average assumptions explanatory. Disclosure of management judgement and assumptions explanatory. Disclosure of detailed information about cash and cash equivalents explanatory. Property plant and equipment cost. Purchase of financial instruments. Average effective instrument rate. Quoted exercise price. Quoted exercise price per share. Taxes receivable. Provision for doubtful account. Disclosure of inventories information explanatory. Non cash transfer of equipment from inventory. Rental services [member] Inventory [member] Reserve inventory write down. Patent [member] Loans payable amount. Fair value adjustment on loans. Repayment of loans payable. Accretion expenses. Intangible assets other-than goodwill gross. Issuance of loans payable. Consulting and services. Other cost of sales. Disclosure of notes receivable explanatory. Impairment loss recognised in profit or loss additions. Impairment loss recognised in profit or loss foreign exchange translation. Disclosure of notes receivables explanatory. Note receivable interest amount. Note receivable accretion amount. Note receivable. Note receivable start date. Accumulated amortization intellectual properties and goodwill. Accumulated amortization foreign exchange translation. Intangible assets including goodwill. Percentage of weighted average revenue growth rate earnings before interest taxes depreciation and amortization. Percentage of weighted average cost of capital. Borrowings maturity start day. Brand and software [member] Loans forgivable amount. Loan forgiveness. Number of stock issued for restrcited share units. Common shares [member] Impairment loss recognised in profit or loss goodwill dronelogics. Loans written down. Disclosure of loans payable explanatory. Disclosure of detailed information about of right of use assets. Common shares one [member] Current insurance expenses. Current prepaid interest. Current prepaid marketing services. Current prepaid rent. Current prepaid subscriptions. Current deposits. Common stock 1 [member] Number of stock issued for exercise of options. Value of stock issued for exercise of options. Disclosure of sharebased payment arrangements options outstanding and exercisable explanatory. Stock options grant date. Exercise price one [member] Plan names [axis] Incentive share compensation plan [member] Disclosure of prepaid expenses and deposits explanatory. Expiry date for stock options. Disclosure of detailed information about operating lease liabilities explanatory. Additions lease liabilities. Foreign exchange translation. Repayments of notes receivable. Lease implicit interest. Disclosure of trader payables and accrued liabilities explanatory. Schedule of deferred income explanatory. Exercise price two [member] Guaranteed investment certificate one [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Exercise price six [member] Exercise price seven [member] Exercise price eight [member] Exercise price nine [member] Exercise price ten [member] Exercise price eleven [member] Depreciation lease liability. Number of share options issued in share based payment arrangement. Weighted average remaining contractual life of exercisable share options. Guaranteed investment certificate [member] Note one [member] Note two [member] Note three [member] Vital and dronelogics [member] Dronelogics [member] Vital [member] CEBA [member] CEBA [member] Vehicle loan [member] Common stock 2 [member] Note 4[member] Deferred revenues. Advisor [member] Disclosure of measurement inputs and validation techniques for weighted average assumptions explanatory. Customer relationship intangible assets [member] Disclosure of number and weighted average exercise prices of restricted stock units explanatory. Restricted stock units rsu [member] Number of instruments other equity instruments vested. Business services agreement [member] Business instincts group [member] Number of instruments other equity instruments issued. Deferred revenue beginning. Revenue recognized. Unearned revenues received. Disclosure of warrant derivative liability explanatory. Business acquisition derivative liability. Warrants. Shares issued for pre funded warrants issued. Underwriter warrants issued. Deferred income gross. Disclosure of detailed information about intangible assets and goodwill explanatory. Shares issued for financing cost. Additional right of use assets. Issued capital cost. Variable lease payments. Range 4 [member] Drones [member] Corporates [member] Segment gain income loss. Impairment of goodwill and intangibles. Disclosure of other and miscellaneous explanatory. Compliance fees. Contract work. Key management personnel compensation salaries. CEO and director [member] CEO [member] Impairment of accounts receivable. Current financial assets at fair value through profit or loss of equity. Tax effect rates share issue costs. Tax effect of adjustments to prior years provision versus statutory tax returns. Tax effect of differences between prior year provision and final tax return. Deferred tax assets share issuance costs. Deferred tax assets non capital losses. Deferred tax assets property and equipment. Deferred tax assets capital gain reserve. Deferred tax assets scientific research and experimental development. Deferred tax assets deferred income tax not recognized. Number of warrants issued. Disclosure of detailed information about income tax. Disclosure of detailed information about deferred taxes explanatory. Deferred income [member] Loan payable [member] Derivative liability [member] Disclosure of amounts receivable explanatory. Shares issued for financing at the market value. Shares issued for financing at the market shares. Payments for acquisitions. US country [member] Draganfly Innovations Inc [member] Public company shares [member] Private company shares [member] Disclosure of maturity analysis for financial liabilities held for managing liquidity risk explanatory. Expiring in two thousand thirty to two thousand forty three [member] Expiring in two thousand thirty to two thousand forty three [member] Stock options [member] Number of other equity instruments vesting in share-based payment arrangement. Gains losses on change in fair value of derivative. Change in fair value of warrant of derivatives outstanding. Shares issued for exercise of warrants of derivatives. Share issue related cost one. Expected life of options. Accumulated depreciation property, plant and equipment. Accumulated depreciation of disposal of property plant and equipment. Financial instrument term. Warrant exercise price. Note receivable maturity date. Note receivable interest rate. Note receivable face amount. Employee [member] Restricted stock units [member] Independent consultant agreement [member] Alberta lltd [member] Warrants issued. Executive consultant agreement [member] Scottlarson [member] Warrants held in escrow. Warrants issuance date. Range 1 [member] Range 2 [member] Range 3 [member] Range 5 [member] Range 6 [member] Range 7 [member] Current warrants fair value. Disclosure of number and weighted average exercise prices of warrants and their fair values explanatory. Disclosure of measurement inputs and validation techniques for weighted average assumptions explanatory. Disclosure of change in warrants explanatory. Number of instruments other equity instruments exercised. Disclosure of sharebased payment arrangements for warrants outstanding explanatory. Compensation warrants issued date. Warrant one [member] Warrant two [member] Warrant three [member] Warrant four [member] Warrant five [member] Warrant expiry date. Compensation warrants, exercise price. Compensation warrants number of warrants. CA [member] US [member] Disclosure of information about key compensation awards explanatory. Key management personnel compensation director fees. Current financial assets at fair value through profit or loss of derivative liability. Current financial assets at fair value through profit or loss of notes receivable. Directors [member] Trade payables and accrued liabilities [member] Customer deposits [member] Shares issued for exercise of stock options one. Warrant expiration. Shares issued in the acquisitions. Shares issued in the acquisition shares. Stock issued during period share exercise of warrants. Shares issued in lieu of cash value. Shares issued in lieu of cash shares. Number of warrants exercised. Pre-funded Warrants [Member] Non-deductible items. Proceeds from issuance of loans. Description of shares issuance. Net proceeds from issue of ordinary shares. Proceeds from issue of ordinary shares after issue costs. Description of exercisable term of warrants. Ranges of Exercise Prices of Warrants One [member] Ranges of Exercise Prices of Warrants Two [member] Non Adjustment Events [Member] Underwritten Share Placement [Member] Broker Warrants [Member] Gain loss on fair value of derivative liabilities. Right of use assets lease adjustment. Right of use assets accumulated amortization. Warrants term. Warrants maturity date. USD Warrants [Member] CEBA [member] [Default Label] Current assets Assets Current liabilities NoncurrentLoansPayable Non-current deferred income including non-current contract liabilities Liabilities Equity attributable to owners of parent Equity and liabilities Gross profit Operating expense LossOnImpairmentOfGoodwillAndIntangibles Comprehensive income Diluted earnings (loss) per share Equity Number of shares outstanding Increase (decrease) through share-based payment transactions, equity Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income ShareIssueRelatedCostOne Adjustments for amortisation expense Adjustments for depreciation expense BadDebt GainLossOnFairValueOfDerivativeLiabilities FinanceAndOtherCosts GainLossOnSaleOfAssets Adjustments to reconcile profit (loss) Adjustments for decrease (increase) in trade accounts receivable Adjustments for decrease (increase) in inventories Adjustments for decrease (increase) in prepaid expenses Adjustments for increase (decrease) in trade accounts payable Adjustments for increase (decrease) in deposits from customers IncreaseDecreaseInDeferredIncome Cash flows from (used in) operating activities PaymentsForAcquisitions Purchase of property, plant and equipment, classified as investing activities Purchase of intangible assets, classified as investing activities Purchase of investment property RepaymentOfNotesReceivable Cash flows from (used in) investing activities Payments for share issue costs RepaymentOfLoans RepaymentOfLeaseLiability Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Description of accounting policy for share-based payment transactions [text block] Description of accounting policy for measuring inventories [text block] Description of accounting policy for property, plant and equipment [text block] Trade and other receivables Cost of inventories recognised as expense during period RepaymentsOfNotesReceivable NoteReceivableStartDate CurrentInsuranceExpenses Losses on change in fair value of derivatives PropertyPlantAndEquipmentCost Disposals, property, plant and equipment AccumulateddepreciationPropertyPlantAndEquipment AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment Additions other than through business combinations, intangible assets other than goodwill ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation Impairment loss recognised in profit or loss, intangible assets other than goodwill AccumulatedAmortizationIntellectualPropertiesAndGoodwill Amortisation, intangible assets other than goodwill AccumulatedAmortizationForeignExchangeTranslation AccumulatedAmortizationImpairment Right-of-use assets, revalued assets, at cost RightofuseAssetsAccumulatedAmortization Payments of lease liabilities, classified as financing activities AdditionsLeaseLiabilities DeferredIncomeGross Accruals and deferred income including contract liabilities LoansPayableAmount Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options exercised in share-based payment arrangement Number of share options forfeited in share-based payment arrangement NumberOfInstrumentsOtherEquityInstrumentsVested GainsLossesOnChangeInFairValueOfDerivative ChangeInFairValueOfWarrantOfDerivativesOutstanding Consideration transferred, acquisition-date fair value BusinessAcquisitionDerivativeLiability NumberOfInstrumentsOtherEquityInstrumentsExercised CompensationWarrantsExercisePrice Other operating income (expense) WarrantsIssued Exercise price, share options granted SegmentGainIncomeLoss ImpairmentOfGoodwillAndIntangibles Gains (losses) on loans and receivables Other expense, by function KeyManagementPersonnelCompensationDirectorFees Key management personnel compensation, share-based payment CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability TaxEffectRatesShareIssueCosts Deferred tax assets Net deferred tax assets EX-101.PRE 28 dpro-20231231_pre.xml XBRL PRESENTATION FILE XML 30 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
12 Months Ended
Dec. 31, 2023
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2023
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-40688
Entity Registrant Name Draganfly Inc.
Entity Central Index Key 0001786286
Entity Incorporation, State or Country Code A1
Entity Address, Address Line One 235 103rd St E.
Entity Address, City or Town Saskatoon
Entity Address, State or Province SK
Entity Address, Country CA
Entity Address, Postal Zip Code S7N 1Y8
Title of 12(b) Security Common Shares
Trading Symbol DPRO
Security Exchange Name NASDAQ
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Bankruptcy Proceedings, Reporting Current true
Entity Common Stock, Shares Outstanding 49,229,563
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] false
Auditor Name DALE MATHESON CARR-HILTON LABONTE LLP
Auditor Location Vancouver, Canada
Auditor Firm ID 1173
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 235 103rd St E
Entity Address, City or Town Saskatoon
Entity Address, State or Province SK
Entity Address, Country CA
Entity Address, Postal Zip Code S7N 1Y8
City Area Code 800
Local Phone Number 979.9794
Contact Personnel Name Paul Sun
XML 31 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Financial Position - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 3,093,612 $ 7,894,781
Receivables 649,612 2,088,965
Inventory 1,596,536 1,055,942
Notes receivable 169,300
Prepaids 1,342,215 2,307,724
Total current assets 6,681,975 13,516,712
Non-current Assets    
Equipment 680,801 404,691
Intangible assets 56,426 179,801
Investments 189,403 192,583
Right of use assets 721,687 344,746
TOTAL ASSETS 8,330,292 14,638,533
Current Liabilities    
Trade payables and accrued liabilities 2,638,981 2,816,676
Customer deposits 104,715 194,758
Deferred income 12,112 63,690
Loans payable 85,058 81,512
Derivative liability 4,196,125 57,314
Lease liabilities 362,001 133,962
Total current liabilities 7,398,992 3,347,912
Non-current Liabilities    
Loans payable 5,059
Deferred income 95,562
Lease liabilities 428,022 244,681
TOTAL LIABILITIES 7,922,576 3,597,652
SHAREHOLDERS’ EQUITY    
Share capital 97,070,976 83,600,089
Reserves – share-based payments 6,870,139 7,264,340
Accumulated deficit (103,588,356) (79,976,546)
Accumulated other comprehensive income (loss) 54,957 152,998
TOTAL SHAREHOLDERS’ EQUITY 407,716 11,040,881
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 8,330,292 $ 14,638,533
XML 32 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Comprehensive Loss - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
REVENUE      
Sales of goods $ 5,287,093 $ 5,550,432 $ 5,103,399
Provision of services 1,267,749 2,054,627 1,950,466
TOTAL REVENUE 6,554,842 7,605,059 7,053,865
COST OF SALES (4,490,728) (6,814,384) (4,410,777)
GROSS PROFIT 2,064,114 790,675 2,643,088
OPERATING EXPENSES      
Amortization 35,960 179,482 135,966
Depreciation 510,677 593,277 175,098
Director fees 600,933 522,349 370,094
Insurance 1,825,137 3,722,237 2,962,767
Office and miscellaneous 6,303,879 5,397,961 6,455,998
Professional fees 4,145,586 6,821,583 4,445,949
Research and development 1,554,823 651,302 510,895
Share-based payments 2,021,664 3,311,024 3,952,595
Travel 704,994 396,388 143,904
Wages and salaries 6,976,792 6,105,020 2,768,010
Total operating expenses (24,680,445) (27,700,623) (21,921,276)
OTHER INCOME (EXPENSE)      
Change in fair value of derivative liability 211,110 5,502,688 8,149,812
Finance and other costs 83,280 44,345 5,074
Foreign exchange gain (249,563) 745,102 362,448
Loss on disposal of assets (944) (10,755)
Loss on write-off of notes receivable (101,351) (309,385) (891,471)
Government income 5,232 2,446 24,148
Write down of deposit (228,572)
Loss on impairment of goodwill and intangibles (6,454,914) (4,579,763)
Other income (expense) (943,243) (35,371) 4,968
NET LOSS FOR THE YEAR (23,611,810) (27,654,364) (16,202,972)
Items that may be reclassified to profit or loss      
Foreign exchange translation (94,861) 447,542 136,475
Items that will not be reclassified to profit or loss      
Change in fair value of equity investments at FVOCI (3,180) (98,483) (332,640)
COMPREHENSIVE LOSS FOR THE YEAR $ (23,709,851) $ (27,305,305) $ (16,399,137)
Net Income (Loss) per share - Diluted $ 0.56 $ 0.82 $ 0.59
Net Income (Loss) per share - Diluted $ 0.56 $ 0.82 $ 0.59
Weighted average number of common shares outstanding - Basic 42,192,384 33,556,969 27,787,348
Weighted average number of common shares outstanding - Diluted 42,192,384 33,556,969 27,787,348
XML 33 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Shareholders' Equity - CAD ($)
Issued capital [member]
Reserve of share-based payments [member]
Retained earnings [member]
Reserve of gains and losses from investments in equity instruments [member]
Reserve of exchange differences on translation [member]
Total
Balance at Dec. 31, 2020 $ 36,943,304 $ 3,024,007 $ (36,119,210) $ 104 $ 3,848,205
Balance, shares at Dec. 31, 2020 17,218,695          
IfrsStatementLineItems [Line Items]            
Shares issued in the acquisitions of Vital $ 2,303,999 1,241,250 3,545,249
Shares issued in the acquisitions of Vital, shares 1,200,000          
Shares issued for financing $ 36,092,187 36,092,187
Shares issued for financing, shares 11,584,657          
Share issue costs $ (4,678,821) 864,060 (3,814,761)
Shares issued for the exercise of RSUs $ 1,752,052 (1,752,052)
Shares issued for the exercise of RSUs, shares 448,660          
Shares issued for the exercise of warrants $ 4,929,790 4,929,790
Shares issued for exercise of warrants, shares 1,939,534          
Shares issued for the exercise of stock options $ 1,937,866 (923,743) 1,014,123
Shares issued for the exercise of stock options, shares 405,499          
Shares issued in lieu of cash $ 1,757,988 1,757,988
Shares issued in lieu of cash, shares 371,901          
Share-based payments 3,952,595 3,952,595
Net loss (16,202,972) (16,202,972)
Change in fair value of equity investments at FVOCI (332,640) (332,640)
Translation of foreign operations 136,475 136,475
Balance at Dec. 31, 2021 $ 81,038,365 6,406,117 (52,322,182) (332,640) 136,579 34,926,239
Balance, shares at Dec. 31, 2021 33,168,946          
IfrsStatementLineItems [Line Items]            
Share issue costs $ (5,122) (5,122)
Shares issued for the exercise of RSUs $ 2,427,801 (2,427,801)
Shares issued for the exercise of RSUs, shares 1,072,595          
Shares issued for the exercise of warrants $ 87,170 87,170
Shares issued for the exercise of stock options $ 51,875 (25,000) 26,875
Shares issued for the exercise of stock options, shares 12,500          
Share-based payments 3,311,024 3,311,024
Net loss (27,654,364) (27,654,364)
Change in fair value of equity investments at FVOCI (98,483) (98,483)
Translation of foreign operations 447,542 447,542
Shares issued for the exercise of warrants, shares 16,538          
Balance at Dec. 31, 2022 $ 83,600,089 7,264,340 (79,976,546) (431,123) 584,121 11,040,881
Balance, shares at Dec. 31, 2022 34,270,579          
IfrsStatementLineItems [Line Items]            
Shares issued for financing $ 11,376,230 11,376,230
Shares issued for financing, shares 12,800,000          
Share issue costs $ (222,136) (222,136)
Shares issued for the exercise of RSUs $ 2,640,733 (2,640,733)
Shares issued for the exercise of RSUs, shares 1,508,255          
Share-based payments 2,021,664 2,021,664
Net loss (23,611,810) (23,611,810)
Change in fair value of equity investments at FVOCI (3,180) (3,180)
Translation of foreign operations (94,861) (94,861)
Shares issued for financing – ATM (“At-the-market”) $ 1,748,946 1,748,946
Shares issued for financing ATM ("At-the-market"), shares 650,729          
Share issue costs $ (2,072,886) 224,868 (1,848,018)
Balance at Dec. 31, 2023 $ 97,070,976 $ 6,870,139 $ (103,588,356) $ (434,303) $ 489,260 $ 407,716
Balance, shares at Dec. 31, 2023 49,229,563          
XML 34 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
OPERATING ACTIVITIES      
Net loss for the year $ (23,611,810) $ (27,654,364) $ (16,202,972)
Adjustments for:      
Amortization 35,960 179,482 135,966
Depreciation 510,677 593,277 175,098
Bad debt 216,238
Change in fair value of derivative liability (211,110) (5,502,688) (8,149,812)
Write down of inventory 331,671 1,976,514
Impairment of notes receivable 101,351 309,385 891,471
Impairment of goodwill and intangibles 87,415 6,454,914 4,579,763
Write down of deposit 228,572
Finance and other costs 4,355,156 (34,427) (926)
(Gain) loss on sale of assets 18,426 (24,148)
Share-based payments 2,021,664 3,311,024 3,952,595
 Adjustments for profit loss (16,144,362) (20,138,311) (14,642,965)
Net changes in non-cash working capital items:      
Receivables 1,223,112 (681,838) (596,336)
Inventory (872,265) (150,241) (2,157,203)
Prepaids 965,509 2,958,581 (3,401,868)
Trade payables and accrued liabilities (170,782) 1,661,697 (1,044,133)
Customer deposits (90,043) 22,624 (213,315)
Deferred income 43,984 (21,543) 51,186
Cash used in operating activities (15,044,847) (16,349,031) (22,004,634)
INVESTING ACTIVITIES      
Cash paid for acquisition, net of cash received (466,643)
Purchase of equipment (490,391) (79,713) (212,579)
Disposal of equipment 46,976 10,755
Purchase of intangible assets (4,684)
Purchase of investments (623,706)
Repayment (Issuance) of notes receivable 63,838 842,297 (2,002,678)
Cash provided by (used in) investing activities (379,577) 768,655 (3,305,606)
FINANCING ACTIVITIES      
Proceeds from issuance of common shares for financing 13,125,176 44,255,651
Share issue costs (2,070,154) (5,122) (3,814,762)
Proceeds from issuance of common shares for warrants exercised 87,170 4,929,790
Proceeds from issuance of common shares for stock options exercised 26,875 1,014,123
Proceeds from issuance of loans 60,000
Repayment of loans (6,747) (6,746) (48,747)
Repayment of lease liabilities (330,159) (150,275) (128,996)
Cash provided by (used in) financing activities 10,718,116 (48,098) 46,267,059
Effects of exchange rate changes on cash (94,861) 447,542 136,478
Change in cash (4,706,308) (15,628,474) 20,956,819
Cash and cash equivalents, beginning of year 7,894,781 23,075,713 1,982,416
Cash and cash equivalents, end of year 3,093,612 7,894,781 23,075,713
Interest paid in cash $ 57,041 $ 51,338 $ 31,010
XML 35 R6.htm IDEA: XBRL DOCUMENT v3.24.1
NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN
12 Months Ended
Dec. 31, 2023
Nature And Continuance Of Operations And Going Concern  
NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN

1. NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $103,588,356. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These consolidated financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

XML 36 R7.htm IDEA: XBRL DOCUMENT v3.24.1
MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.

 

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2024.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (DII)  Canada   100%
Draganfly Innovations USA, Inc. (DI USA)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Foreign currency translation

 

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 

The functional currencies of the parent company and each subsidiary are as follows:

 

Draganfly Inc.   Canadian Dollar
Draganfly Innovations Inc.   Canadian Dollar
Draganfly Innovations USA, Inc.   US Dollar
Dronelogics Systems Inc.   Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

 

Share-based payments

 

The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

 

The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

 

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.
b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.
c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

 

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 8,574,798 warrants, 897,158 options and 1,112,967 RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 

Financial Instruments

 

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial assets/liabilities   Classification
Cash and cash equivalents   Fair value through profit or loss
Receivables   Amortized cost
Notes receivable   Fair value through profit or loss
Investments   Fair value through other comprehensive income

Trade payables

  Amortized cost
Customer deposits   Amortized cost
Loans payable   Amortized cost
Derivative liability   Fair value through profit or loss

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 

Impairment of non-financial assets

 

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life; and
an intangible asset not yet available for use;

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Deferred income tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

 

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

 

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 

Deferred Income

 

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Class of intangible asset   Useful live
Customer relationship   5 years
Brand   5 years
Software   5 years
Patents   5 years

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

Class of equipment   Depreciation rate
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Expected lease term
Vehicles   30%

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

 

(i)the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)its intention to complete the intangible asset and use or sell it;
(iii)its ability to use or sell the intangible asset;
(iv)how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

New accounting standards issued not yet effective

 

Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.

 

XML 37 R8.htm IDEA: XBRL DOCUMENT v3.24.1
MANAGEMENT JUDGEMENT AND ASSUMPTIONS
12 Months Ended
Dec. 31, 2023
Management Judgement And Assumptions  
MANAGEMENT JUDGEMENT AND ASSUMPTIONS

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS

 

Significant estimates and assumptions

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D)

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.

 

Investments in Private companies

 

Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.

 

Expected credit losses on trade receivables and notes receivable

 

When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment and forward-looking information.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D)

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company’s consolidated financial statements include:

 

  The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
  the classification of financial instruments;
  the assessment of revenue recognition using the five-step approach under IFRS 15; and
  the determination of the functional currency of each entity in the group.

 

XML 38 R9.htm IDEA: XBRL DOCUMENT v3.24.1
CASH AND CASH EQUIVALENTS
12 Months Ended
Dec. 31, 2023
Cash And Cash Equivalents  
CASH AND CASH EQUIVALENTS

4. CASH AND CASH EQUIVALENTS

 

   December 31, 2023   December 31, 2022 
Cash held in banks  $3,093,612   $7,500,607 
Guaranteed investment certificates   -    394,174 
Cash and cash equivalents  $3,093,612   $7,894,781 

 

On March 27, 2022 the Company renewed a GIC for $142,852 for 1 year at a rate of 1.00% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $143,436 and purchased a new GIC for $143,436 for 1 year at a rate of 4.5% per annum.

 

On May 30, 2022 the Company renewed the GIC for $140,493 for 1 year at a rate of 0.75% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $140,738 and purchased a new GIC for $140,738 for 1 year at a rate of 4.5% per annum.

 

All GIC’s were required to be maintained and renewed upon maturity until such time as the associated credit cards were cancelled. These credit cards were cancelled and all related GIC’s were not renewed during the year ended December 31, 2023.

 

XML 39 R10.htm IDEA: XBRL DOCUMENT v3.24.1
RECEIVABLES
12 Months Ended
Dec. 31, 2023
Schedule Of Amounts Receivable  
RECEIVABLES

5. RECEIVABLES

 

   December 31, 2023   December 31, 2022 
Trade accounts receivable  $610,443   $1,343,795 
Taxes receivable   39,169    745,170 
Trade and other receivables  $649,612   $2,088,965 

 

During the year ended December 31, 2023 the Company recorded a provision for doubtful accounts of $216,238 (2022 - $nil).

 

The Company applies a direct customer analysis approach to measure expected credit losses. The Company assesses collectability of receivables of each customer on an individual basis using quantitative and qualitative information available to management. The historical loss rates are adjusted to reflect the current and forward-looking information on economic factors affecting the ability of the customers to make regular monthly payments on the receivables.

 

Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include business closure and/or the failure to make monthly contractual payments.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 40 R11.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY
12 Months Ended
Dec. 31, 2023
Schedule Of Inventories  
INVENTORY

6. INVENTORY

 

  

December 31,

2023

  

December 31,

2022

 
Finished goods  $904,858   $542,934 
Parts   691,678    513,008 
Inventories  $1,596,536   $1,055,942 

 

During the year ended December 31, 2023, $3,738,980 (2022 - $6,048,348; 2021 – $3,420,713) of inventory was recognized in cost of sales including an allowance for obsolete and slow-moving inventory of $331,671 (2022 - $1,976,514; 2021 - $nil).

 

Cost of sales consist of the following:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Inventory  $3,738,980   $6,048,348    $ 3,420,713  
Consulting and services   549,448    730,170      679,345  
Other   202,300    35,866      310,719  
Cost of sales  $4,490,728   $6,814,384    $ 4,410,777  

 

XML 41 R12.htm IDEA: XBRL DOCUMENT v3.24.1
NOTES RECEIVABLE
12 Months Ended
Dec. 31, 2023
Notes Receivable  
NOTES RECEIVABLE

7. NOTES RECEIVABLE

  

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2023

 
Note 1(1)  2023-12-15   0%  $190,396   $      -   $       -   $(101,351)  $(63,838)  $        - 
Note 2(1)  2024-09-22   5%   1,003,682    -    -    -    -    - 
Total          $1,194,078   $-   $-   $(101,351)  $(63,838)  $- 

 

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2022

 
Note 1(1)  2023-03-31   0%  $190,396   $-   $12,764   $-   $(33,860)  $169,300 
Note 2(1)  2024-09-22   5%   1,003,682    48,992    27,971    (1,080,645)   -    - 
Note 3  2022-04-26   8%   -    37,177    -    771,260    (808,437)   - 
Total          $1,194,078   $86,169   $40,735   $(309,385)  $(842,297)  $169,300 

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss with an initial maturity date of October 31, 2022. During the year ended December 31, 2022 the parties agreed on an amended maturity date of January 31, 2023. During the year ended December 31, 2023 the parties agreed to extend the maturity date to December 15, 2023. As the borrower has not repaid the loan it was impaired to $nil.

 

Note 2 was issued on September 9, 2021, bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. Management has determined that it is unlikely that the loan will be repaid and the loan was impaired to $nil during the year ended December 31, 2022.

 

Note 3 was issued on November 17, 2021 bearing interest at 8% and was due April 26, 2022. At December 31, 2021, management determined that it was unlikely that the loan would be repaid and the loan was written down to $nil. During the year ended December 31, 2022, the parties agreed on a repayment plan, with the loan and interest being repaid in the amount of $808,437.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 42 R13.htm IDEA: XBRL DOCUMENT v3.24.1
PREPAIDS
12 Months Ended
Dec. 31, 2023
Schedule Of Prepaid Expenses And Deposits  
PREPAIDS

8. PREPAIDS

 

   December 31, 2023   December 31, 2022 
Insurance  $838,445   $1,148,455 
Prepaid interest   810    1,889 
Prepaid marketing services   71,539    733,417 
Prepaid rent   21,768    12,485 
Prepaid subscriptions   48,007    29,194 
Deposits(1)   361,646    382,284 
 Prepaid expenses and deposits   $1,342,215   $2,307,724 

 

(1) A deposit in the amount of $228,572 related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.

 

XML 43 R14.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS
12 Months Ended
Dec. 31, 2023
Schedule Of Investments  
INVESTMENTS

9. INVESTMENTS

 

Balance at December 30, 2021   291,066 
Change in fair value   (98,483)
Balance at December 31, 2022   192,583 
Change in fair value   (3,180)
Balance at December 31, 2023  $189,403 

 

Fair value of investments is comprised of:

 

Public company shares  $57,143 
Private company shares   132,260 
Balance at December 31, 2023  $189,403 
      
Public company shares  $57,143 
Private company shares   135,440 
Balance at December 31, 2022  $192,583 

 

The Company holds 1,428,571 common shares (2022 – 1,428,571) and nil (2022 – 1,428,571) warrants of Windfall Geotek Inc. a publicly traded company. At December 31, 2023 the fair value of the shares was based on the quoted price of $0.04 (2022 - $0.04). As of the issue date of these consolidated financial statements the quoted price of the shares was $0.03. The warrants expired on March 17, 2023. The fair values of the warrants as of December 31, 2022 were estimated using the Black-Scholes Option Pricing Model with the following assumptions:

   December 31, 2022 
Risk free interest rate   4.07%
Expected volatility   116.00%
Expected life   0.21 years 
Expected dividend yield   0%

 

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. In determining the fair value of the investment (classified at level 3 in the fair value hierarchy), the Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 44 R15.htm IDEA: XBRL DOCUMENT v3.24.1
EQUIPMENT
12 Months Ended
Dec. 31, 2023
Disclosure Equipment Abstract  
EQUIPMENT

10. EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
Cost                        
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
Additions   60,240    528,080    -    -    -    588,320 
Disposals   (18,688)   (36,099)   (4,352)   (29,967)   -    (89,106)
Balance at December 31, 2022  $95,662   $834,453   $-   $-   $36,033   $966,148 
Additions   58,611    320,941    86,530    -    24,310    490,394 
Disposals   (21,000)   (115,204)   -    -    -    (136,204)
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $-   $60,343   $1,320,338 
                               
Accumulated depreciation                              
Balance at December 31, 2021  $25,291   $102,277   $4,352   $24,737   $13,234   $169,891 
Charge for the year   32,627    433,855    -    -    3,435    469,917 
Disposals   (15,920)   (33,342)   (4,352)   (24,737)   -    (78,351)
Balance at December 31, 2022  $41,998   $502,790   $-   $-   $16,669   $561,457 
Charge for the year   22,762    112,361    6,790    -    12,497    154,410 
Disposals   (6,582)   (69,748)   -    -    -    (76,330)
Balance at December 31, 2023  $58,178   $545,403   $6,790   $-   $29,166   $639,537 
                               
Net book value:                              
December 31, 2022  $53,664   $331,663   $-   $-   $19,364   $404,691 
December 31, 2023  $75,095   $494,789   $79,740   $-   $31,177   $680,801 

 

During the year ended December 31, 2022 $508,607 of inventory that was used for rental services was transferred to equipment.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 45 R16.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS AND GOODWILL
12 Months Ended
Dec. 31, 2023
Intangible Assets And Goodwill  
INTANGIBLE ASSETS AND GOODWILL

11. INTANGIBLE ASSETS AND GOODWILL

SCHEDULE OF INTELLECTUAL PROPERTY 

   Patents   Customer Relationships   Brand  

 

Software

   Goodwill   Total 
Cost                        
Balance at December 31, 2021  $41,931   $197,000   $23,000   $552,000   $5,940,409   $6,754,340 
Additions   -    -    -    4,684    -    4,684 
Foreign exchange translation   -    -    1,571    29,576    257,782    288,929 
Impairment   -    -    (24,571)   (462,577)   (6,198,191)   (6,685,339)
Balance at December 31, 2022  $41,931   $197,000   $-   $123,683   $-   $362,614 
Impairment   -    (87,415)   -    -    -    (87,415)
Balance at December 31, 2023  $41,931   $109,585   $-   $123,683   $-   $275,199 
                               
Accumulated amortization                              
Balance at December 31, 2021  $41,931   $60,414   $3,450   $114,235   $-   $220,030 
Charge for the year   -    27,317    4,719    147,446    -    179,482 
Foreign exchange translation   -    -    431    13,295    -    13,726 
Impairment   -    -    (8,600)   (221,825)   -    (230,425)
Balance at December 31, 2022   41,931    87,731    -    53,151    -    182,813 
Charge for the year   -    21,854    -    14,106    -    35,960 
Balance at December 31, 2023  $41,931   $109,585   $-   $67,257   $-   $218,773 
                               

Net book value:

                              
December 31, 2022  $-   $109,269   $-   $70,532   $-   $179,801 
December 31, 2023  $-   $-   $-   $56,426   $-   $56,426 

 

Goodwill

 

On December 31, 2022 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

 

  5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2% (2021 – 2%).
  Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 6.5% (2021 – 14%) for Dronelogics and 0% (2021 – 42%) for Vital Intelligence Inc. (“Vital”) respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.
  Cash flows were discounted at the weighted average cost of capital of 19% (2021 – 17%) for Dronelogics and 29% (2021 – 24%) for Vital based on peer group averages and adjusted for the Company’s risk factors.

 

Based on the annual goodwill impairment test, the Company determined that the goodwill for Dronelogics and Vital required impairment, as such the Company recorded an impairment charge of $2,166,563 (2021 – nil) for Dronelogics and $4,031,628 (2021 - $4,579,763) for Vital. In addition to the goodwill, the Company deemed that the brand and software for Vital required impairment, as such the Company recorded an impairment charge of $15,971 and $240,752 respectively.

 

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

 

  A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $104,248 for Dronelogics (2021 – $597,100) and $Nil for Vital (2021 - $570,133).

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 46 R17.htm IDEA: XBRL DOCUMENT v3.24.1
RIGHT OF USE ASSETS
12 Months Ended
Dec. 31, 2023
Right Of Use Assets  
RIGHT OF USE ASSETS

12. RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2021 and 2022  $683,117 
Additions   740,355 
Lease adjustment   - 
Balance at December 31, 2023  $1,423,472 
      
Accumulated depreciation     
Balance at December 31, 2021  $215,011 
Charge for the year   123,360 
Balance at December 31, 2022  $338,371 
Charge for the year   363,086 
Foreign exchange   328 
Balance at December 31, 2023  $701,785 
      
Net book value:     
December 31, 2022  $344,746 
December 31, 2023  $721,687 

 

The consolidated statement of financial position shows the following amounts related to leases:

   December 31, 2023   December 31, 2022 
Buildings  $721,687   $342,361 
Vehicles   -    2,385 
Right of use assets  $721,687   $344,746 

 

Additions to the right of the assets during the 2023 financial year were $740,355 (2022 - $nil).

 

XML 47 R18.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE LIABILITES
12 Months Ended
Dec. 31, 2023
Lease Liabilites  
LEASE LIABILITES

13. LEASE LIABILITES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

 

   Total 
Balance at December 31, 2021  $489,123 
Interest expense   39,795 
Lease payments   (150,275)
Balance at December 31, 2022   378,643 
Interest expense   96,423 
Additions   734,903 
Lease payments   (423,410)
Foreign exchange   3,464 
Balance at December 31, 2023  $790,023 

 

Which consists of:        
         
   December 31, 2023   December 31, 2022 
Current lease liability  $362,001   $133,962 
Non-current lease liability   428,022    244,681 
Ending balance  $790,023   $378,643 

 

Maturity analysis  December 31, 2023   December 31, 2022 
Less than one year  $429,948   $147,340 
One to three years   355,879    209,078 
Four to five years   141,519    83,850 
Total undiscounted lease liabilities   927,346    440,268 
Amount representing interest   (137,323)   (61,625)
Lease liability  $790,023   $378,643 

 

Variable lease payments of $43,542 (2022 - $22,539) have been recognized in profit and loss.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 48 R19.htm IDEA: XBRL DOCUMENT v3.24.1
TRADE PAYABLES AND ACCRUED LIABILITIES
12 Months Ended
Dec. 31, 2023
Trade Payables And Accrued Liabilities  
TRADE PAYABLES AND ACCRUED LIABILITIES

14. TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2023   December 31, 2022 
Trade accounts payable  $1,259,623   $751,422 
Accrued liabilities   1,345,649    2,031,545 
Government grant payable   33,709    33,709 
Trade payables and accrued liabilities  $2,638,981   $2,816,676 

 

XML 49 R20.htm IDEA: XBRL DOCUMENT v3.24.1
DEFERRED INCOME
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
DEFERRED INCOME

15. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   December 31, 2023   December 31, 2022 
Deferred, revenue beginning  $63,690   $5,233 
Revenue recognized   (64,816)   (4,939)
Unearned revenues received   108,800    63,396 
 Deferred income gross   $107,674   $63,690 
Current portion  $12,112   $63,690 
Long term portion   95,562    - 
 Deferred Income net  $107,674   $63,690 

 

Deferred revenue of $12,112 as of December 31, 2023 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangement and will be recognized according to the terms of that arrangement over the next 5 years.

 

XML 50 R21.htm IDEA: XBRL DOCUMENT v3.24.1
LOANS PAYABLE
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
LOANS PAYABLE

16. LOANS PAYABLE

 

   December 31, 2023   December 31, 2022 
Opening balance  $86,571   $93,317 
Issuance of loans payable   -    - 
Fair value adjustment   -    (4,891)
Repayment of loans payable   (6,747)   (6,746)
Accretion expense   5,234    4,891 
Ending balance  $85,058   $86,571 

 

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2023   Carrying Value December 31, 2022 
CEBA  2020-05-19  2024-03-28   0%  $40,000   $37,383 
CEBA  2021-04-23  2024-03-28   0%   40,000    37,383 
Vehicle loan  2019-08-30  2024-09-11   6.99%   5,058    11,805 
Total             $85,058   $86,571 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

16. LOANS PAYABLE (CONT’D)

 

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before January 18, 2024. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%. On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the entire loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.

 

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.

 

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.

 

XML 51 R22.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE CAPITAL
12 Months Ended
Dec. 31, 2023
SHARE CAPITAL

17. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2023,

 

  The Company issued 1,508,255 common shares for the vesting of restricted share units.
  The Company issued 8,000,000 common shares in a financing for $10,856,166 with share issuance costs of $1,953,032 for net proceeds of $8,903,134.
  The Company issued 650,729 common shares in an ATM (“At – the - market”) financing for $1,748,946 with share issuance costs of $222,136 for net proceeds of $1,526,810.
  The Company issued 4,800,000 common shares in a financing for proceeds of $4,858,995 with share issuance costs of $889,623 for net proceeds of $3,969,372. Of the total share issuance costs $793,979 were expensed in other income (expense).

 

During the year ended December 31, 2022,

 

  The Company issued 16,538 common shares for the exercise of warrants for $87,170.
  The Company issued 12,500 common shares for the exercise of stock options for $26,875.
  The Company issued 1,072,595 common shares for the vesting of restricted share units.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

As at December 31, 2023, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $2.50    5.84    278,332    278,332 
November 19, 2019  November 19, 2029  $2.50    5.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    6.33    85,000    85,000 
April 30, 2020  April 30, 2030  $3.85    6.33    110,000    110,000 
July 3, 2020  July 3, 2025  $3.20    1.51    100,000    100,000 
November 24, 2020  November 24, 2030  $2.50    6.90    32,000    32,000 
February 2, 2021  February 2, 2031  $13.20    7.10    30,000    30,000 
March 8, 2021  March 8, 2026  $13.90    2.19    10,000    10,000 
April 27, 2021  April 27, 2031  $10.15    7.33    146,000    97,326 
September 9, 2021  September 9, 2026  $4.84    2.69    25,826    17,217 
November 9, 2023  November 9, 2033  $0.626    9.87    30,000    10,000 
                 897,158    819,875 

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2021   1,035,991   $4.60 
Exercised   (12,500)   2.15 
Forfeited   (146,334)   4.77 
Outstanding, December 31, 2022   877,157   $4.60 
Forfeited   (9,999)   3.77 
Issued   30,000    0.63 
Outstanding, December 31, 2023   897,158   $4.48 

 

During the year ended December 31, 2023,

 

  The Company granted 30,000 options to an advisor to the board. Each option is exercisable at $0.626 per share for 10 years.

 

No options were granted by the Company for the year ended December 31, 2022

 

During the year ended December 31, 2023, the Company recorded $151,174 (2022- $502,837) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

Year ended December 31,  December 31, 2023   December 31, 2022 
Risk free interest rate   4.58%   - 
Expected volatility   115.1%   - 
Expected life   10    - 
Expected dividend yield   0%   - 
Exercise price  $0.63   $- 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company in its discretion and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at December 31, 2023, the Company had the following RSUs outstanding:

 

   Number of RSU’s 
Outstanding, December 31, 2021   514,832 
Vested   (1,072,595)
Issued    1,820,972 
Forfeited   (64,334)
Outstanding, December 31, 2022   1,198,875 
Vested   (1,508,255)
Issued    1,685,316 
Forfeited   (262,969)
Outstanding, December 31, 2023   1,112,967 

 

During the year ended December 31, 2023, 1,508,255 RSU’s fully vested according to the terms and the Company granted 1,687,014 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 264,668 RSU’s were forfeited by employees who have left the Company.

 

During the year ended December 31, 2022, 1,072,595 RSU’s fully vested according to the terms and the Company granted 1,820,972 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, 64,334 RSU’s were forfeited by employees who have left the Company.

 

During the year ended December 31, 2023, the Company recorded share-based payment expense of $1,866,490 (2022: $2,808,187) for RSU’s, based on the fair values of RSU’s granted which are calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the year ended December 31, 2023, the Company issued 1,600,000 warrants for a purchase price of $0.5499USD with an exercise price of $0.0001USD per unit. The Company also issued 6,400,000 warrants at an exercise price $0.6123USD. Being in a currency that is not the Company’s functional currency these warrants are required to be recorded as a financial liability. As a financial liability, the portion of the warrants related to the future exercise price will be revalued at every reporting period to fair market value with the change in fair value being recorded in profit or loss. All of the above warrants have a 5 year term, expiring October 30, 2028 and vest immediately. 320,000 underwriter warrants were issued as part of the transaction with an exercise price of $0.6875USD and a term of 3 years. These warrants were treated as share issue costs.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period. At the date of issue the warrants were valued with a risk free rate of 4.8%, volatility of 115.35%, expected life of 5 years and an expected dividend yield rate of 0%. The broker warrants were valued with a risk free rate of 4.87%, volatility of 138.83%, expected life of 3 years and an expected dividend yield of 0%.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

Warrant Derivative Liability

 

Balance at December 31, 2021  $4,865,772 
Change in fair value of warrants outstanding   (4,865,772)
Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110
Balance at December 31, 2023  $4,196,125 

 

Derivative liability balance at  December 31, 2023   December 31, 2022 
Warrants  $4,196,125   $- 
Contingent consideration   -    57,314 
Ending balance  $4,196,125   $57,314 

 

The contingent liability is related to an acquisition on March 22, 2021, whereby 1,200,000 warrants were issued and 900,000 were held in escrow and classified as a contingent liability that were to be released upon completion of certain milestones. The milestones were related to the recognition of revenue on the related acquisition in range of $2,000,000 to $6,000,000 which was not met. The warrants expired on March 25, 2023.

 

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price   Number of Warrants Outstanding at December 31, 2023   Fair Value at December 31, 2023   Number of Warrants Outstanding at December 31, 2022   Fair Value at December 31, 2022 
February 5, 2021 (1)  US$ 3.55    -   $-    1,319,675   $- 
March 5, 2021 (2)  US$  3.55    -    -    5,142,324    - 
October 30, 2023 (3)  US$ 0.6123    6,400,000    3,180,543    -    - 
October 30, 2023 (4)  US$0.0001    1,600,000    1,015,582    -    - 
         8,000,000   $4,196,125    6,461,999   $- 

 

  1) The warrants expired on February 5, 2023.
  2) The warrants expired on March 5, 2023.
  3) The warrants expire October 30, 2028.
  4) The warrants have no expiry date.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

17. SHARE CAPITAL (CONT’D)

 

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   December 31, 2023   December 31, 2022 
Risk free interest rate   3.84%   4.07%
Expected volatility   113.78%   91.66%-93.48% 
Expected life   4.8 years    0.10-0.18 years 
Expected dividend yield   0%   0%

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2021   8,414,819   $4.99 
Exercised   (16,538)   4.51 
Issued   (481,484)   4.61 
Outstanding, December 31, 2022   7,916,797   $5.08 
Issued   8,320,000    0.50 
Expired   (7,661,999)   5.89 
Outstanding December 31, 2023   8,574,798   $0.63 

 

As at December 31, 2023, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of warrants outstanding 
July 29, 2021  July 29, 2024  US$ 5.00    250,000 
September 14, 2021  September 14, 2024  US$5.00    4,798 
October 30, 2023  October 30, 2026  US$0.6875    320,000 
October 30, 2023  October 30, 2028  US$0.6123    6,400,000 
October 30, 2023  No expiry date  US$0.0001    1,600,000 
            8,574,798 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2023, was 4.63 years (December 31, 2022 – 0.47 years).

 

XML 52 R23.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENTED INFORMATION
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SEGMENTED INFORMATION

18. SEGMENTED INFORMATION

 

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

18. SEGMENTED INFORMATION (CONT’D)

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, lead director, chief operating officer and chief financial officer.

 

December 31, 2023  Drones   Vital   Corporate   Total 
Sales of goods  $4,905,417   $381,676   $-   $5,287,093 
Provision of services   1,267,749    -    -    1,267,749 
Total revenue  $6,173,166   $381,676   $-   $6,554,842 
Segment loss  $14,743,176   $(140,366)  $8,323,731   $22,926,541 
Finance and other costs   (80,211)   -    (3,069)   (83,280)
Depreciation   499,530    -    11,148    510,677 
Amortization   35,960    -    -    35,960 
Change in fair value of derivative liability   -    -    (211,110)   (211,110)
Loss (recovery) on write-off of notes receivable   -    -    101,351    101,351 
Loss on write down of inventory   331,671    -    -    331,671 
Net loss for the year  $15,530,126   $(140,366)  $8,222,051   $23,611,810 

 

December 31, 2022  Drones   Vital   Corporate   Total 
Sales of goods  $5,388,262   $162,170   $-   $5,550,432 
Provision of services   2,054,627    -    -    2,054,627 
Total revenue  $7,442,889   $162,170   $-   $7,605,059 
Segment loss  $9,929,789   $602,580   $12,926,884   $23,459,253 
Finance and other costs   (3,529)   -    (40,186)   (44,345)
Depreciation   586,185    -    -    593,277 
Amortization   179,482    -    -    179,482 
Impairment of goodwill and intangibles   2,166,563    4,288,351    -    6,454,914 
Change in fair value of derivative liability   -    -    (5,502,688)   (5,502,688)
Loss on write-off of notes receivable   1,080,645    -    (771,260)   309,385 
Loss on write down of inventory   251,754    1,724,760    -    1,976,514 
Write down of deposit   -    228,572    -    228,572 
Net loss for the year  $14,190,889   $6,844,263   $6,619,212   $27,654,364 

 

December 31, 2021  Drones   Vital   Corporate   Total 
Sales of goods   4,957,134    146,265    -    5,103,399 
Provision of services   1,950,466    -    -    1,950,466 
Total revenue  $6,907,600   $146,265   $-   $7,053,865 
Segment loss  $7,819,739   $257,656   $10,498,164   $18,575,560 
Finance and other costs   16,272    -    (21,346)   (5,074)
Depreciation   175,098    -    -    175,098 
Amortization   135,966    -    -    135,966 
Impairment of goodwill and intangibles   -    4,579,763    -    4,579,763 
Change in fair value of derivative liability   -    -    (8,149,812)   (8,149,812)
Loss on write-off of notes receivable   -    -    891,471    891,471 
Net loss for the year  $8,147,075   $4,837,419   $3,218,477   $16,202,972 

 

 

   2023   2022      2021  
Geographic segmentation is as follows:  For the years ended December 31,  
   2023   2022    2021  
Non-current assets                  
Canada  $1,441,701   $1,121,821    $ 3,441,872  
United States   206,616    -      5,112,659  
   $1,648,317   $1,121,821    $ 8,554,531  
Revenue                  
Canada  $6,162,672   $6,919,038    $ 4,982,373  
United States   392,170    686,021      2,071,492  
Revenue  $6,554,842   $7,605,059    $ 7,053,865  

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 53 R24.htm IDEA: XBRL DOCUMENT v3.24.1
OFFICE AND MISCELLANEOUS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
OFFICE AND MISCELLANEOUS

19. OFFICE AND MISCELLANEOUS

 

     2023      2022   2021 
     For the years ended December 31, 
   2023     2022   2021 
Advertising, Marketing, and Investor Relations  $ 4,243,432     $4,431,818   $5,165,791 
Compliance fees    193,250      152,826    432,874 
Impairment of accounts receivable    216,238      -    - 
Contract Work    772,003      441,798    300,975 
Other    878,956      371,519    556,358 
Office and Miscellaneous Expenses  $ 6,303,879     $5,397,961   $6,455,998 

 

XML 54 R25.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
RELATED PARTY TRANSACTIONS

20. RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2023, the Company incurred fees of $429,766 (December 31, 2022 - $442,485) which are included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $3,780 (December 31, 2022 - $30,804).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2023, the Company incurred fees of $592,500 (December 31, 2022 - $566,487) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $35,417 (December 31, 2022 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2023, the Company incurred fees of $215,019 (December 31, 2022 - $383,288) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $9,287 (December 31, 2022 - $20,745).

 

Trade receivables/payables and accrued receivables/payables:

 

As at December 31, 2023, the Company had $190,664 (December 31, 2022 - $51,549) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

20. RELATED PARTY TRANSACTIONS (CONT’D)

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023 and 2022 included:

 

      For the years ended December 31, 
    2023    2022   2021 
Director fees   $ 600,933     $522,349   $370,094 
Salaries     979,154      843,917    722,068 
Share-based payments     1,109,232      2,106,906    2,475,949 
Total   $ 2,689,319    $3,473,172   $3,568,111 

 

Other related party transactions

 

    For the years ended December 31,
    2023    2022   2021 
Management fees paid to a company controlled by CEO and director   $ 592,500    $566,487   $290,225 
Management fees paid to a company that the CEO holds an economic interest in     429,766     442,485    315,643 
Management fees paid to a company controlled by a director     215,019     383,288    205,691 
Management fees paid to a company, total    $ 1,237,285    $1,392,260   $811,559 

 

XML 55 R26.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
12 Months Ended
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers.

 

Receivables

 

Receivables primarily consist of trade receivables, accrued receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date abut past events, current conditions and forecasts of future economic conditions. Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

The Company’s aging of receivables was as follows:

 SCHEDULE OF AGING OF RECEIVABLES

   December 31, 2023   December 31, 2022 
0 – 30 days  $271,622   $1,020,091 
31 – 60 days   109,928    116,378 
61 – 90 days   64,259    343,364 
91 + days   203,803    609,132 
 Total receivables  $649,612   $2,088,965 

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2023:

 

 SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES

   1 year   1 – 5 years   Total 
Trade payables and accrued liabilities  $2,638,981   $-   $2,638,981 
Customer deposits   104,715    -    104,715 
Deferred income   12,112    95,562    107,674 
Loans payable   85,058    -    85,058 
Derivative liability   4,196,125    -    4,196,125 
Lease liability   429,948    497,398    927,346 
 Financial liabilities  $7,466,939   $592,960   $8,059,899 

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

 

   December 31, 2023   December 31, 2022 
Foreign exchange rate  $530,758   $969,977 

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the consolidated statements of financial position. These financial assets are measured at fair value through profit and loss.

 

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2023  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $       -   $132,260   $189,403 
Derivative liability   -    -    4,196,125    4,196,125 
Total  $57,413   $-   $4,328,385   $4,385,528 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $    -   $

135,440

   $192,583 
Notes receivable   -    -    169,300    169,300 
Derivative liability   -    -    57,314    57,314 
Total  $57,143   $-   $362,054   $419,197 

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

 

Type

 

 

Valuation technique

 

 

Key inputs

  Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

 

●    Share price

●    Risk free interest rate

●    Dividend yield

Key unobservable inputs

●    Expected volatility

 

The estimated fair value would increase (decrease) if:

 

     The price was higher (lower)

●     The risk-free rate was higher (lower)

●     The dividend yield was lower (higher)

●     The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
      

Year ended

December 31, 2023

  

Year ended

December 31, 2022

 
Volatility   20%  $291,149   $- 

 

Capital Management

 

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity.

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2022.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

XML 56 R27.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
INCOME TAXES

22. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2023 and 2022:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Loss before income taxes  $23,611,810  $27,654,364    $ 16,202,972  
Canadian statutory rates   27%   27%     27 %
Expected income tax recovery   6,330,400   7,338,900      4,196,600  
Impact of different foreign statutory tax rates   -    -      34,900  
Non-deductible items   (509,800)   (1,214,400)     116,400  
Share issue costs   773,400   1,400      887,600  
Adjustments to prior years provision versus statutory tax returns   (87,600)   (742,400)     376,500  
Differences between prior year provision and final tax return   (153,400)   867,500      (206,000 )
Change in deferred tax asset not recognized   (6,353,000)   (6,251,000)     (5,406,000 )
Income tax  $-   $-    $ -  

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Deferred income tax assets (liabilities):                  
Share issuance costs  $995,000   $568,000    $ 728,000  
Non-capital losses   20,377,000    14,602,000      7,043,000  
Property and equipment   1,115,000    962,000      449,000  
Capital gain reserve   -    -      74,000  
Scientific Research and Experimental Development   365,000    367,000      291,000  
Total deferred income tax assets  $22,852,000   $16,499,000      8,585,000  
Deferred income tax not recognized   (22,852,000)   (16,499,000)     (8,585,000 )
Net deferred tax assets  $-   $-    $ -  

 

The Company has non-capital loss carry forward of approximately $67,701,122 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2030 to 2043. The Company has non-capital loss carry forward of $8,241,878 CAD ($6,231,434 USD) which may be carried forward to apply against future year income tax for tax purposes in the United States, subject to the final determination by the tax authorities, expiring in the years 2040 to 2043.

 

XML 57 R28.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SUBSEQUENT EVENTS

23. SUBSEQUENT EVENTS

 

Warrant exercise

 

On February 6, 2024 1,600,000 pre-funded warrants were exercised for proceeds of $160 USD ($216 CAD) and an equal number of shares were issued at a value of $578,200 USD ($773,624 CAD).

 

Share issuance

 

On February 26, 2024, the Company announced that it completed an underwritten share placement of 11,200,000 units with each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. Each unit was sold at a price of $0.27 USD for gross proceeds of $3.6 million ($4.8 million CAD). Net proceeds of $3.3 million USD ($4.4 million CAD) was received after share issue costs of $329,000 USD ($442,000 CAD). The pre-funded warrants have an exercise price of $0.0001 USD and were exercised on the date of issue. The remaining warrants have an exercise price of $0.36 USD and are exercisable immediately with a term of 5 years. As part of this transaction 670,000 warrants were issued to the underwriter with an exercise price of $0.3375 USD and will have a term of 3 years.

XML 58 R29.htm IDEA: XBRL DOCUMENT v3.24.1
MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Statement of Compliance

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.

 

These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2024.

 

Basis of consolidation

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (DII)  Canada   100%
Draganfly Innovations USA, Inc. (DI USA)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Foreign currency translation

Foreign currency translation

 

Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.

 

The functional currencies of the parent company and each subsidiary are as follows:

 

Draganfly Inc.   Canadian Dollar
Draganfly Innovations Inc.   Canadian Dollar
Draganfly Innovations USA, Inc.   US Dollar
Dronelogics Systems Inc.   Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.

 

Share-based payments

Share-based payments

 

The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.

 

The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.

 

The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

a) If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.
b) If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.
c) If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.

 

Loss per share

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.

 

Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had 8,574,798 warrants, 897,158 options and 1,112,967 RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.

 

Financial Instruments

Financial Instruments

 

Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial assets/liabilities   Classification
Cash and cash equivalents   Fair value through profit or loss
Receivables   Amortized cost
Notes receivable   Fair value through profit or loss
Investments   Fair value through other comprehensive income

Trade payables

  Amortized cost
Customer deposits   Amortized cost
Loans payable   Amortized cost
Derivative liability   Fair value through profit or loss

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.

 

Impairment of non-financial assets

Impairment of non-financial assets

 

The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life; and
an intangible asset not yet available for use;

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

Income taxes

 

Current income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Deferred income tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

Inventory

 

Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.

 

The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.

 

Deferred Income

Deferred Income

 

A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.

 

Cost of Goods Sold

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets and Goodwill

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Class of intangible asset   Useful live
Customer relationship   5 years
Brand   5 years
Software   5 years
Patents   5 years

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Equipment

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

Class of equipment   Depreciation rate
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Expected lease term
Vehicles   30%

 

Research and development expenditures

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:

 

(i)the technical feasibility of completing the intangible asset so that it will be available for use or sale;
(ii)its intention to complete the intangible asset and use or sell it;
(iii)its ability to use or sell the intangible asset;
(iv)how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;
(v)the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
(vi)its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For the Year Ended December 31, 2023

Expressed in Canadian Dollars

 

 

2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)

 

Government Assistance

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

Leases

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

New accounting standards issued not yet effective New accounting standards issued not yet effective   Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.
XML 59 R30.htm IDEA: XBRL DOCUMENT v3.24.1
MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF WHOLLY OWNED SUBSIDIARIES

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (DII)  Canada   100%
Draganfly Innovations USA, Inc. (DI USA)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%
SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES

 

Class of intangible asset   Useful live
Customer relationship   5 years
Brand   5 years
Software   5 years
Patents   5 years
SCHEDULE OF CLASS OF EQUIPMENT

 

Class of equipment   Depreciation rate
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Expected lease term
Vehicles   30%
XML 60 R31.htm IDEA: XBRL DOCUMENT v3.24.1
CASH AND CASH EQUIVALENTS (Tables)
12 Months Ended
Dec. 31, 2023
Cash And Cash Equivalents  
SCHEDULE OF CASH AND CASH EQUIVALENTS

 

   December 31, 2023   December 31, 2022 
Cash held in banks  $3,093,612   $7,500,607 
Guaranteed investment certificates   -    394,174 
Cash and cash equivalents  $3,093,612   $7,894,781 
XML 61 R32.htm IDEA: XBRL DOCUMENT v3.24.1
RECEIVABLES (Tables)
12 Months Ended
Dec. 31, 2023
Schedule Of Amounts Receivable  
SCHEDULE OF AMOUNTS RECEIVABLE

 

   December 31, 2023   December 31, 2022 
Trade accounts receivable  $610,443   $1,343,795 
Taxes receivable   39,169    745,170 
Trade and other receivables  $649,612   $2,088,965 
XML 62 R33.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY (Tables)
12 Months Ended
Dec. 31, 2023
Schedule Of Inventories  
SCHEDULE OF INVENTORIES

 

  

December 31,

2023

  

December 31,

2022

 
Finished goods  $904,858   $542,934 
Parts   691,678    513,008 
Inventories  $1,596,536   $1,055,942 
SCHEDULE OF COST OF SALES

Cost of sales consist of the following:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Inventory  $3,738,980   $6,048,348    $ 3,420,713  
Consulting and services   549,448    730,170      679,345  
Other   202,300    35,866      310,719  
Cost of sales  $4,490,728   $6,814,384    $ 4,410,777  
XML 63 R34.htm IDEA: XBRL DOCUMENT v3.24.1
NOTES RECEIVABLE (Tables)
12 Months Ended
Dec. 31, 2023
Notes Receivable  
DISCLOSURE OF NOTES RECEIVABLE

  

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2023

 
Note 1(1)  2023-12-15   0%  $190,396   $      -   $       -   $(101,351)  $(63,838)  $        - 
Note 2(1)  2024-09-22   5%   1,003,682    -    -    -    -    - 
Total          $1,194,078   $-   $-   $(101,351)  $(63,838)  $- 

 

   Maturity Date  Rate   Principal   Interest   Accretion   (Impairment)/Recovery   Repayments  

Balance December

31, 2022

 
Note 1(1)  2023-03-31   0%  $190,396   $-   $12,764   $-   $(33,860)  $169,300 
Note 2(1)  2024-09-22   5%   1,003,682    48,992    27,971    (1,080,645)   -    - 
Note 3  2022-04-26   8%   -    37,177    -    771,260    (808,437)   - 
Total          $1,194,078   $86,169   $40,735   $(309,385)  $(842,297)  $169,300 

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 64 R35.htm IDEA: XBRL DOCUMENT v3.24.1
PREPAIDS (Tables)
12 Months Ended
Dec. 31, 2023
Schedule Of Prepaid Expenses And Deposits  
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS

 

   December 31, 2023   December 31, 2022 
Insurance  $838,445   $1,148,455 
Prepaid interest   810    1,889 
Prepaid marketing services   71,539    733,417 
Prepaid rent   21,768    12,485 
Prepaid subscriptions   48,007    29,194 
Deposits(1)   361,646    382,284 
 Prepaid expenses and deposits   $1,342,215   $2,307,724 

 

(1) A deposit in the amount of $228,572 related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.

 

XML 65 R36.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Schedule Of Investments  
SCHEDULE OF INVESTMENTS

Balance at December 30, 2021   291,066 
Change in fair value   (98,483)
Balance at December 31, 2022   192,583 
Change in fair value   (3,180)
Balance at December 31, 2023  $189,403 
SCHEDULE OF FAIR VALUE OF INVESTMENT

Fair value of investments is comprised of:

 

Public company shares  $57,143 
Private company shares   132,260 
Balance at December 31, 2023  $189,403 
      
Public company shares  $57,143 
Private company shares   135,440 
Balance at December 31, 2022  $192,583 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

   December 31, 2022 
Risk free interest rate   4.07%
Expected volatility   116.00%
Expected life   0.21 years 
Expected dividend yield   0%
XML 66 R37.htm IDEA: XBRL DOCUMENT v3.24.1
EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure Equipment Abstract  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Software   Vehicles   Total 
Cost                        
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
Additions   60,240    528,080    -    -    -    588,320 
Disposals   (18,688)   (36,099)   (4,352)   (29,967)   -    (89,106)
Balance at December 31, 2022  $95,662   $834,453   $-   $-   $36,033   $966,148 
Additions   58,611    320,941    86,530    -    24,310    490,394 
Disposals   (21,000)   (115,204)   -    -    -    (136,204)
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $-   $60,343   $1,320,338 
                               
Accumulated depreciation                              
Balance at December 31, 2021  $25,291   $102,277   $4,352   $24,737   $13,234   $169,891 
Charge for the year   32,627    433,855    -    -    3,435    469,917 
Disposals   (15,920)   (33,342)   (4,352)   (24,737)   -    (78,351)
Balance at December 31, 2022  $41,998   $502,790   $-   $-   $16,669   $561,457 
Charge for the year   22,762    112,361    6,790    -    12,497    154,410 
Disposals   (6,582)   (69,748)   -    -    -    (76,330)
Balance at December 31, 2023  $58,178   $545,403   $6,790   $-   $29,166   $639,537 
                               
Net book value:                              
December 31, 2022  $53,664   $331,663   $-   $-   $19,364   $404,691 
December 31, 2023  $75,095   $494,789   $79,740   $-   $31,177   $680,801 
XML 67 R38.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS AND GOODWILL (Tables)
12 Months Ended
Dec. 31, 2023
Intangible Assets And Goodwill  
SCHEDULE OF INTELLECTUAL PROPERTY

SCHEDULE OF INTELLECTUAL PROPERTY 

   Patents   Customer Relationships   Brand  

 

Software

   Goodwill   Total 
Cost                        
Balance at December 31, 2021  $41,931   $197,000   $23,000   $552,000   $5,940,409   $6,754,340 
Additions   -    -    -    4,684    -    4,684 
Foreign exchange translation   -    -    1,571    29,576    257,782    288,929 
Impairment   -    -    (24,571)   (462,577)   (6,198,191)   (6,685,339)
Balance at December 31, 2022  $41,931   $197,000   $-   $123,683   $-   $362,614 
Impairment   -    (87,415)   -    -    -    (87,415)
Balance at December 31, 2023  $41,931   $109,585   $-   $123,683   $-   $275,199 
                               
Accumulated amortization                              
Balance at December 31, 2021  $41,931   $60,414   $3,450   $114,235   $-   $220,030 
Charge for the year   -    27,317    4,719    147,446    -    179,482 
Foreign exchange translation   -    -    431    13,295    -    13,726 
Impairment   -    -    (8,600)   (221,825)   -    (230,425)
Balance at December 31, 2022   41,931    87,731    -    53,151    -    182,813 
Charge for the year   -    21,854    -    14,106    -    35,960 
Balance at December 31, 2023  $41,931   $109,585   $-   $67,257   $-   $218,773 
                               

Net book value:

                              
December 31, 2022  $-   $109,269   $-   $70,532   $-   $179,801 
December 31, 2023  $-   $-   $-   $56,426   $-   $56,426 
XML 68 R39.htm IDEA: XBRL DOCUMENT v3.24.1
RIGHT OF USE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Right Of Use Assets  
SCHEDULE OF RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2021 and 2022  $683,117 
Additions   740,355 
Lease adjustment   - 
Balance at December 31, 2023  $1,423,472 
      
Accumulated depreciation     
Balance at December 31, 2021  $215,011 
Charge for the year   123,360 
Balance at December 31, 2022  $338,371 
Charge for the year   363,086 
Foreign exchange   328 
Balance at December 31, 2023  $701,785 
      
Net book value:     
December 31, 2022  $344,746 
December 31, 2023  $721,687 
SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES

The consolidated statement of financial position shows the following amounts related to leases:

   December 31, 2023   December 31, 2022 
Buildings  $721,687   $342,361 
Vehicles   -    2,385 
Right of use assets  $721,687   $344,746 
XML 69 R40.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE LIABILITES (Tables)
12 Months Ended
Dec. 31, 2023
Lease Liabilites  
SCHEDULE OF OPERATING LEASE LIABILITIES

   Total 
Balance at December 31, 2021  $489,123 
Interest expense   39,795 
Lease payments   (150,275)
Balance at December 31, 2022   378,643 
Interest expense   96,423 
Additions   734,903 
Lease payments   (423,410)
Foreign exchange   3,464 
Balance at December 31, 2023  $790,023 

 

Which consists of:        
         
   December 31, 2023   December 31, 2022 
Current lease liability  $362,001   $133,962 
Non-current lease liability   428,022    244,681 
Ending balance  $790,023   $378,643 

SCHEDULE OF OPERATING MATURITY ANALYSIS

Maturity analysis  December 31, 2023   December 31, 2022 
Less than one year  $429,948   $147,340 
One to three years   355,879    209,078 
Four to five years   141,519    83,850 
Total undiscounted lease liabilities   927,346    440,268 
Amount representing interest   (137,323)   (61,625)
Lease liability  $790,023   $378,643 
XML 70 R41.htm IDEA: XBRL DOCUMENT v3.24.1
TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2023
Trade Payables And Accrued Liabilities  
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2023   December 31, 2022 
Trade accounts payable  $1,259,623   $751,422 
Accrued liabilities   1,345,649    2,031,545 
Government grant payable   33,709    33,709 
Trade payables and accrued liabilities  $2,638,981   $2,816,676 
XML 71 R42.htm IDEA: XBRL DOCUMENT v3.24.1
DEFERRED INCOME (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF DEFERRED INCOME

 

   December 31, 2023   December 31, 2022 
Deferred, revenue beginning  $63,690   $5,233 
Revenue recognized   (64,816)   (4,939)
Unearned revenues received   108,800    63,396 
 Deferred income gross   $107,674   $63,690 
Current portion  $12,112   $63,690 
Long term portion   95,562    - 
 Deferred Income net  $107,674   $63,690 
XML 72 R43.htm IDEA: XBRL DOCUMENT v3.24.1
LOANS PAYABLE (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF LOANS PAYABLE

 

   December 31, 2023   December 31, 2022 
Opening balance  $86,571   $93,317 
Issuance of loans payable   -    - 
Fair value adjustment   -    (4,891)
Repayment of loans payable   (6,747)   (6,746)
Accretion expense   5,234    4,891 
Ending balance  $85,058   $86,571 
SCHEDULE OF LOANS

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2023   Carrying Value December 31, 2022 
CEBA  2020-05-19  2024-03-28   0%  $40,000   $37,383 
CEBA  2021-04-23  2024-03-28   0%   40,000    37,383 
Vehicle loan  2019-08-30  2024-09-11   6.99%   5,058    11,805 
Total             $85,058   $86,571 
XML 73 R44.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2023
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

As at December 31, 2023, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $2.50    5.84    278,332    278,332 
November 19, 2019  November 19, 2029  $2.50    5.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    6.33    85,000    85,000 
April 30, 2020  April 30, 2030  $3.85    6.33    110,000    110,000 
July 3, 2020  July 3, 2025  $3.20    1.51    100,000    100,000 
November 24, 2020  November 24, 2030  $2.50    6.90    32,000    32,000 
February 2, 2021  February 2, 2031  $13.20    7.10    30,000    30,000 
March 8, 2021  March 8, 2026  $13.90    2.19    10,000    10,000 
April 27, 2021  April 27, 2031  $10.15    7.33    146,000    97,326 
September 9, 2021  September 9, 2026  $4.84    2.69    25,826    17,217 
November 9, 2023  November 9, 2033  $0.626    9.87    30,000    10,000 
                 897,158    819,875 
SCHEDULE OF STOCK OPTIONS OUTSTANDING

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2021   1,035,991   $4.60 
Exercised   (12,500)   2.15 
Forfeited   (146,334)   4.77 
Outstanding, December 31, 2022   877,157   $4.60 
Forfeited   (9,999)   3.77 
Issued   30,000    0.63 
Outstanding, December 31, 2023   897,158   $4.48 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS

 

Year ended December 31,  December 31, 2023   December 31, 2022 
Risk free interest rate   4.58%   - 
Expected volatility   115.1%   - 
Expected life   10    - 
Expected dividend yield   0%   - 
Exercise price  $0.63   $- 
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS

As at December 31, 2023, the Company had the following RSUs outstanding:

 

   Number of RSU’s 
Outstanding, December 31, 2021   514,832 
Vested   (1,072,595)
Issued    1,820,972 
Forfeited   (64,334)
Outstanding, December 31, 2022   1,198,875 
Vested   (1,508,255)
Issued    1,685,316 
Forfeited   (262,969)
Outstanding, December 31, 2023   1,112,967 
SCHEDULE OF WARRANT DERIVATIVE LIABILITY

Warrant Derivative Liability

 

Balance at December 31, 2021  $4,865,772 
Change in fair value of warrants outstanding   (4,865,772)
Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110
Balance at December 31, 2023  $4,196,125 

 

Derivative liability balance at  December 31, 2023   December 31, 2022 
Warrants  $4,196,125   $- 
Contingent consideration   -    57,314 
Ending balance  $4,196,125   $57,314 
SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price   Number of Warrants Outstanding at December 31, 2023   Fair Value at December 31, 2023   Number of Warrants Outstanding at December 31, 2022   Fair Value at December 31, 2022 
February 5, 2021 (1)  US$ 3.55    -   $-    1,319,675   $- 
March 5, 2021 (2)  US$  3.55    -    -    5,142,324    - 
October 30, 2023 (3)  US$ 0.6123    6,400,000    3,180,543    -    - 
October 30, 2023 (4)  US$0.0001    1,600,000    1,015,582    -    - 
         8,000,000   $4,196,125    6,461,999   $- 

 

  1) The warrants expired on February 5, 2023.
  2) The warrants expired on March 5, 2023.
  3) The warrants expire October 30, 2028.
  4) The warrants have no expiry date.

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   December 31, 2023   December 31, 2022 
Risk free interest rate   3.84%   4.07%
Expected volatility   113.78%   91.66%-93.48% 
Expected life   4.8 years    0.10-0.18 years 
Expected dividend yield   0%   0%
SUMMARY OF CHANGES IN WARRANTS

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2021   8,414,819   $4.99 
Exercised   (16,538)   4.51 
Issued   (481,484)   4.61 
Outstanding, December 31, 2022   7,916,797   $5.08 
Issued   8,320,000    0.50 
Expired   (7,661,999)   5.89 
Outstanding December 31, 2023   8,574,798   $0.63 
SCHEDULE OF WARRANTS OUTSTANDING

As at December 31, 2023, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of warrants outstanding 
July 29, 2021  July 29, 2024  US$ 5.00    250,000 
September 14, 2021  September 14, 2024  US$5.00    4,798 
October 30, 2023  October 30, 2026  US$0.6875    320,000 
October 30, 2023  October 30, 2028  US$0.6123    6,400,000 
October 30, 2023  No expiry date  US$0.0001    1,600,000 
            8,574,798 
XML 74 R45.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENTED INFORMATION (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF SEGMENTED INFORMATION

December 31, 2023  Drones   Vital   Corporate   Total 
Sales of goods  $4,905,417   $381,676   $-   $5,287,093 
Provision of services   1,267,749    -    -    1,267,749 
Total revenue  $6,173,166   $381,676   $-   $6,554,842 
Segment loss  $14,743,176   $(140,366)  $8,323,731   $22,926,541 
Finance and other costs   (80,211)   -    (3,069)   (83,280)
Depreciation   499,530    -    11,148    510,677 
Amortization   35,960    -    -    35,960 
Change in fair value of derivative liability   -    -    (211,110)   (211,110)
Loss (recovery) on write-off of notes receivable   -    -    101,351    101,351 
Loss on write down of inventory   331,671    -    -    331,671 
Net loss for the year  $15,530,126   $(140,366)  $8,222,051   $23,611,810 

 

December 31, 2022  Drones   Vital   Corporate   Total 
Sales of goods  $5,388,262   $162,170   $-   $5,550,432 
Provision of services   2,054,627    -    -    2,054,627 
Total revenue  $7,442,889   $162,170   $-   $7,605,059 
Segment loss  $9,929,789   $602,580   $12,926,884   $23,459,253 
Finance and other costs   (3,529)   -    (40,186)   (44,345)
Depreciation   586,185    -    -    593,277 
Amortization   179,482    -    -    179,482 
Impairment of goodwill and intangibles   2,166,563    4,288,351    -    6,454,914 
Change in fair value of derivative liability   -    -    (5,502,688)   (5,502,688)
Loss on write-off of notes receivable   1,080,645    -    (771,260)   309,385 
Loss on write down of inventory   251,754    1,724,760    -    1,976,514 
Write down of deposit   -    228,572    -    228,572 
Net loss for the year  $14,190,889   $6,844,263   $6,619,212   $27,654,364 

 

December 31, 2021  Drones   Vital   Corporate   Total 
Sales of goods   4,957,134    146,265    -    5,103,399 
Provision of services   1,950,466    -    -    1,950,466 
Total revenue  $6,907,600   $146,265   $-   $7,053,865 
Segment loss  $7,819,739   $257,656   $10,498,164   $18,575,560 
Finance and other costs   16,272    -    (21,346)   (5,074)
Depreciation   175,098    -    -    175,098 
Amortization   135,966    -    -    135,966 
Impairment of goodwill and intangibles   -    4,579,763    -    4,579,763 
Change in fair value of derivative liability   -    -    (8,149,812)   (8,149,812)
Loss on write-off of notes receivable   -    -    891,471    891,471 
Net loss for the year  $8,147,075   $4,837,419   $3,218,477   $16,202,972 
SCHEDULE OF GEOGRAPHIC REVENUE

 

   2023   2022      2021  
Geographic segmentation is as follows:  For the years ended December 31,  
   2023   2022    2021  
Non-current assets                  
Canada  $1,441,701   $1,121,821    $ 3,441,872  
United States   206,616    -      5,112,659  
   $1,648,317   $1,121,821    $ 8,554,531  
Revenue                  
Canada  $6,162,672   $6,919,038    $ 4,982,373  
United States   392,170    686,021      2,071,492  
Revenue  $6,554,842   $7,605,059    $ 7,053,865  
XML 75 R46.htm IDEA: XBRL DOCUMENT v3.24.1
OFFICE AND MISCELLANEOUS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES

     2023      2022   2021 
     For the years ended December 31, 
   2023     2022   2021 
Advertising, Marketing, and Investor Relations  $ 4,243,432     $4,431,818   $5,165,791 
Compliance fees    193,250      152,826    432,874 
Impairment of accounts receivable    216,238      -    - 
Contract Work    772,003      441,798    300,975 
Other    878,956      371,519    556,358 
Office and Miscellaneous Expenses  $ 6,303,879     $5,397,961   $6,455,998 
XML 76 R47.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF KEY COMPENSATION AWARDS

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023 and 2022 included:

 

      For the years ended December 31, 
    2023    2022   2021 
Director fees   $ 600,933     $522,349   $370,094 
Salaries     979,154      843,917    722,068 
Share-based payments     1,109,232      2,106,906    2,475,949 
Total   $ 2,689,319    $3,473,172   $3,568,111 
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS

Other related party transactions

 

    For the years ended December 31,
    2023    2022   2021 
Management fees paid to a company controlled by CEO and director   $ 592,500    $566,487   $290,225 
Management fees paid to a company that the CEO holds an economic interest in     429,766     442,485    315,643 
Management fees paid to a company controlled by a director     215,019     383,288    205,691 
Management fees paid to a company, total    $ 1,237,285    $1,392,260   $811,559 
XML 77 R48.htm IDEA: XBRL DOCUMENT v3.24.1
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2023
SCHEDULE OF AGING OF RECEIVABLES

The Company’s aging of receivables was as follows:

 SCHEDULE OF AGING OF RECEIVABLES

   December 31, 2023   December 31, 2022 
0 – 30 days  $271,622   $1,020,091 
31 – 60 days   109,928    116,378 
61 – 90 days   64,259    343,364 
91 + days   203,803    609,132 
 Total receivables  $649,612   $2,088,965 
SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES

The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2023:

 

 SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES

   1 year   1 – 5 years   Total 
Trade payables and accrued liabilities  $2,638,981   $-   $2,638,981 
Customer deposits   104,715    -    104,715 
Deferred income   12,112    95,562    107,674 
Loans payable   85,058    -    85,058 
Derivative liability   4,196,125    -    4,196,125 
Lease liability   429,948    497,398    927,346 
 Financial liabilities  $7,466,939   $592,960   $8,059,899 
SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

 

   December 31, 2023   December 31, 2022 
Foreign exchange rate  $530,758   $969,977 
SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2023  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $       -   $132,260   $189,403 
Derivative liability   -    -    4,196,125    4,196,125 
Total  $57,413   $-   $4,328,385   $4,385,528 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $57,143   $    -   $

135,440

   $192,583 
Notes receivable   -    -    169,300    169,300 
Derivative liability   -    -    57,314    57,314 
Total  $57,143   $-   $362,054   $419,197 
SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
      

Year ended

December 31, 2023

  

Year ended

December 31, 2022

 
Volatility   20%  $291,149   $- 
XML 78 R49.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF INCOME TAX

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2023 and 2022:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Loss before income taxes  $23,611,810  $27,654,364    $ 16,202,972  
Canadian statutory rates   27%   27%     27 %
Expected income tax recovery   6,330,400   7,338,900      4,196,600  
Impact of different foreign statutory tax rates   -    -      34,900  
Non-deductible items   (509,800)   (1,214,400)     116,400  
Share issue costs   773,400   1,400      887,600  
Adjustments to prior years provision versus statutory tax returns   (87,600)   (742,400)     376,500  
Differences between prior year provision and final tax return   (153,400)   867,500      (206,000 )
Change in deferred tax asset not recognized   (6,353,000)   (6,251,000)     (5,406,000 )
Income tax  $-   $-    $ -  
SCHEDULE OF DEFERRED TAXES

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

   December 31, 2023   December 31, 2022    December 31, 2021  
Deferred income tax assets (liabilities):                  
Share issuance costs  $995,000   $568,000    $ 728,000  
Non-capital losses   20,377,000    14,602,000      7,043,000  
Property and equipment   1,115,000    962,000      449,000  
Capital gain reserve   -    -      74,000  
Scientific Research and Experimental Development   365,000    367,000      291,000  
Total deferred income tax assets  $22,852,000   $16,499,000      8,585,000  
Deferred income tax not recognized   (22,852,000)   (16,499,000)     (8,585,000 )
Net deferred tax assets  $-   $-    $ -  
XML 79 R50.htm IDEA: XBRL DOCUMENT v3.24.1
NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Nature And Continuance Of Operations And Going Concern    
Accumulated deficit $ 103,588,356 $ 79,976,546
XML 80 R51.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details)
12 Months Ended
Dec. 31, 2023
Draganfly innovations inc [member]  
DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems [Line Items]  
Name of subsidiary Draganfly Innovations Inc. (DII)
Country of incorporation of subsidiary Canada
Proportion of ownership interest in subsidiary 100.00%
Dragonfly Innovations USA Inc [member]  
DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems [Line Items]  
Name of subsidiary Draganfly Innovations USA, Inc. (DI USA)
Country of incorporation of subsidiary US
Proportion of ownership interest in subsidiary 100.00%
Dronelogics Systems Inc [member]  
DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems [Line Items]  
Name of subsidiary Dronelogics Systems Inc. (“Dronelogics”)
Country of incorporation of subsidiary Canada
Proportion of ownership interest in subsidiary 100.00%
XML 81 R52.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details)
12 Months Ended
Dec. 31, 2023
Customer relationship intangible assets [member]  
IfrsStatementLineItems [Line Items]  
Intangible assets, useful life 5 years
Brand names [member]  
IfrsStatementLineItems [Line Items]  
Intangible assets, useful life 5 years
Computer software [member]  
IfrsStatementLineItems [Line Items]  
Intangible assets, useful life 5 years
Patent [member]  
IfrsStatementLineItems [Line Items]  
Intangible assets, useful life 5 years
XML 82 R53.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF CLASS OF EQUIPMENT (Details)
12 Months Ended
Dec. 31, 2023
Computer equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 30.00%
Furniture and equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 20.00%
Leasehold improvements [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, description Expected lease term
Vehicles [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 30.00%
XML 83 R54.htm IDEA: XBRL DOCUMENT v3.24.1
MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative)
12 Months Ended
Dec. 31, 2023
shares
IfrsStatementLineItems [Line Items]  
Aggregate sale price (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date
Warrants [member]  
IfrsStatementLineItems [Line Items]  
Potentially dilutive loss per share 8,574,798
Share options [member]  
IfrsStatementLineItems [Line Items]  
Potentially dilutive loss per share 897,158
Restricted share units [member]  
IfrsStatementLineItems [Line Items]  
Potentially dilutive loss per share 1,112,967
XML 84 R55.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash And Cash Equivalents        
Cash held in banks $ 3,093,612 $ 7,500,607    
Guaranteed investment certificates 394,174    
Cash and cash equivalents $ 3,093,612 $ 7,894,781 $ 23,075,713 $ 1,982,416
XML 85 R56.htm IDEA: XBRL DOCUMENT v3.24.1
CASH AND CASH EQUIVALENTS (Details Narrative) - CAD ($)
Aug. 23, 2022
May 30, 2022
Mar. 27, 2022
Guaranteed investment certificate [member]      
IfrsStatementLineItems [Line Items]      
Purchase of financial instrument $ 143,436 $ 140,493 $ 142,852
Financial instrument term 1 year 1 year 1 year
Average effective Instrument rate 4.50% 0.75% 1.00%
Guaranteed investment certificate one [member]      
IfrsStatementLineItems [Line Items]      
Purchase of financial instrument $ 140,738    
Financial instrument term 1 year    
Average effective Instrument rate 4.50%    
XML 86 R57.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF AMOUNTS RECEIVABLE (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Amounts Receivable    
Trade accounts receivable $ 610,443 $ 1,343,795
Taxes receivable 39,169 745,170
Trade and other receivables $ 649,612 $ 2,088,965
XML 87 R58.htm IDEA: XBRL DOCUMENT v3.24.1
RECEIVABLES (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Amounts Receivable    
Provision for doubtful account $ 216,238
XML 88 R59.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INVENTORIES (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Inventories    
Finished goods $ 904,858 $ 542,934
Parts 691,678 513,008
Inventories $ 1,596,536 $ 1,055,942
XML 89 R60.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF COST OF SALES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Inventories      
Inventory $ 3,738,980 $ 6,048,348 $ 3,420,713
Consulting and services 549,448 730,170 679,345
Other 202,300 35,866 310,719
Cost of sales $ 4,490,728 $ 6,814,384 $ 4,410,777
XML 90 R61.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Cost of sales $ 4,490,728 $ 6,814,384 $ 4,410,777
Reserve inventory write down 331,671 1,976,514
Inventory [member]      
IfrsStatementLineItems [Line Items]      
Cost of sales $ 3,738,980 $ 6,048,348 $ 3,420,713
XML 91 R62.htm IDEA: XBRL DOCUMENT v3.24.1
DISCLOSURE OF NOTES RECEIVABLE (Details) - CAD ($)
12 Months Ended
Nov. 17, 2021
Sep. 09, 2021
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]        
Principal     $ 1,194,078 $ 1,194,078
Interest     86,169
Accretion     40,735
Impairment loss     (101,351) (309,385)
Repayments     (63,838) (842,297)
Note receivable     169,300
Impairment loss     $ 101,351 $ 309,385
Note one [member]        
IfrsStatementLineItems [Line Items]        
Maturity date [1]     Dec. 15, 2023 Mar. 31, 2023
Rate [1]     0.00% 0.00%
Principal [1]     $ 190,396 $ 190,396
Interest [1]    
Accretion [1]     12,764
Impairment loss [1]     (101,351)
Repayments [1]     (63,838) (33,860)
Note receivable [1]     169,300
Impairment loss [1]     $ 101,351
Note two [member]        
IfrsStatementLineItems [Line Items]        
Rate   5.00% 5.00% [1] 5.00% [1]
Principal [1]     $ 1,003,682 $ 1,003,682
Interest [1]     48,992
Accretion [1]     27,971
Impairment loss [1]     (1,080,645)
Repayments [1]    
Note receivable [1]    
Maturity date [1]     Sep. 22, 2024 Sep. 22, 2024
Impairment loss [1]     $ 1,080,645
Note three [member]        
IfrsStatementLineItems [Line Items]        
Rate 8.00%     8.00%
Principal      
Interest       37,177
Accretion      
Impairment loss       (771,260)
Repayments       (808,437)
Note receivable      
Maturity date       Apr. 26, 2022
Impairment loss       $ 771,260
[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 92 R63.htm IDEA: XBRL DOCUMENT v3.24.1
NOTES RECEIVABLE (Details Narrative) - CAD ($)
12 Months Ended
Nov. 17, 2021
Sep. 09, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]          
Impairment     $ 101,351 $ 309,385  
Repayments of current borrowings       $ 808,437  
Note two [member]          
IfrsStatementLineItems [Line Items]          
Note receivable interest rate   5.00% 5.00% [1] 5.00% [1]  
Impairment [1]     $ 1,080,645  
Note two [member] | Accumulated impairment [member]          
IfrsStatementLineItems [Line Items]          
Impairment        
Note three [member]          
IfrsStatementLineItems [Line Items]          
Note receivable interest rate 8.00%     8.00%  
Impairment       $ 771,260  
Loans written down        
[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 93 R64.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Prepaid Expenses And Deposits    
Insurance $ 838,445 $ 1,148,455
Prepaid interest 810 1,889
Prepaid marketing services 71,539 733,417
Prepaid rent 21,768 12,485
Prepaid subscriptions 48,007 29,194
Deposits [1] 361,646 382,284
 Prepaid expenses and deposits  $ 1,342,215 $ 2,307,724
[1] A deposit in the amount of $228,572 related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.
XML 94 R65.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Prepaid Expenses And Deposits      
Purchase of inventory $ 228,572
XML 95 R66.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INVESTMENTS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Investments    
Balance $ 192,583 $ 291,066
Change in fair value (3,180) (98,483)
Balance $ 189,403 $ 192,583
XML 96 R67.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FAIR VALUE OF INVESTMENT (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Fair value of investments $ 189,403 $ 192,583 $ 291,066
Public company shares [member]      
IfrsStatementLineItems [Line Items]      
Fair value of investments 57,143 57,143  
Private company shares [member]      
IfrsStatementLineItems [Line Items]      
Fair value of investments $ 132,260 $ 135,440  
XML 97 R68.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Risk free interest rate 4.58%
Expected volatility 115.10%
Expected life 10 years
Expected dividend yield 0.00%
Warrants [member]    
IfrsStatementLineItems [Line Items]    
Risk free interest rate 3.84% 4.07%
Expected volatility 113.78% 116.00%
Expected life 4 years 9 months 18 days 2 months 15 days
Expected dividend yield 0.00% 0.00%
XML 98 R69.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS (Details Narrative)
12 Months Ended
Oct. 27, 2021
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
IfrsStatementLineItems [Line Items]      
Number of shares purchased | shares 50,000 1,428,571 1,428,571
Quoted exercise price | $ / shares   $ 0.04 $ 0.04
Quoted price per share | $ / shares   $ 0.03  
[custom:WarrantExpiration]   Mar. 17, 2023  
Number of shares purchased value | $ $ 100,000    
Warrants [member]      
IfrsStatementLineItems [Line Items]      
Number of shares purchased | shares     1,428,571
XML 99 R70.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance $ 966,148 $ 466,934
Additions 490,394 588,320
Disposals (136,204) (89,106)
Property, plant and equipment, ending balance 1,320,338 966,148
Accumulated depreciation Property, plant and equipment, beginning balance 561,457 169,891
Charge for the year 154,410 469,917
Disposals (76,330) (78,351)
Accumulated depreciation Property, plant and equipment, ending balance 639,537 561,457
Property, plant and equipment 680,801 404,691
Computer equipment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 95,662 54,110
Additions 58,611 60,240
Disposals (21,000) (18,688)
Property, plant and equipment, ending balance 133,273 95,662
Accumulated depreciation Property, plant and equipment, beginning balance 41,998 25,291
Charge for the year 22,762 32,627
Disposals (6,582) (15,920)
Accumulated depreciation Property, plant and equipment, ending balance 58,178 41,998
Property, plant and equipment 75,095 53,664
Furniture and equipment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 834,453 342,472
Additions 320,941 528,080
Disposals (115,204) (36,099)
Property, plant and equipment, ending balance 1,040,192 834,453
Accumulated depreciation Property, plant and equipment, beginning balance 502,790 102,277
Charge for the year 112,361 433,855
Disposals (69,748) (33,342)
Accumulated depreciation Property, plant and equipment, ending balance 545,403 502,790
Property, plant and equipment 494,789 331,663
Leasehold improvements [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 4,352
Additions 86,530
Disposals (4,352)
Property, plant and equipment, ending balance 86,530
Accumulated depreciation Property, plant and equipment, beginning balance 4,352
Charge for the year 6,790
Disposals (4,352)
Accumulated depreciation Property, plant and equipment, ending balance 6,790
Property, plant and equipment 79,740
Computer software [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 29,967
Additions
Disposals (29,967)
Property, plant and equipment, ending balance
Accumulated depreciation Property, plant and equipment, beginning balance 24,737
Charge for the year
Disposals (24,737)
Accumulated depreciation Property, plant and equipment, ending balance
Property, plant and equipment
Vehicles [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 36,033 36,033
Additions 24,310
Disposals
Property, plant and equipment, ending balance 60,343 36,033
Accumulated depreciation Property, plant and equipment, beginning balance 16,669 13,234
Charge for the year 12,497 3,435
Disposals
Accumulated depreciation Property, plant and equipment, ending balance 29,166 16,669
Property, plant and equipment $ 31,177 $ 19,364
XML 100 R71.htm IDEA: XBRL DOCUMENT v3.24.1
EQUIPMENT (Details Narrative)
12 Months Ended
Dec. 31, 2022
CAD ($)
Rental services [member]  
IfrsStatementLineItems [Line Items]  
Non - cash transfer of equipment from inventory $ 508,607
XML 101 R72.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INTELLECTUAL PROPERTY (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 $ 179,801  
Cost, ending balance 56,426 $ 179,801
Net book value 56,426 179,801
Patent [member]    
IfrsStatementLineItems [Line Items]    
Net book value
Customer-related intangible assets [member]    
IfrsStatementLineItems [Line Items]    
Net book value 109,269
Brand names [member]    
IfrsStatementLineItems [Line Items]    
Net book value
Computer software [member]    
IfrsStatementLineItems [Line Items]    
Net book value 56,426 70,532
Goodwill [member]    
IfrsStatementLineItems [Line Items]    
Net book value
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 362,614 6,754,340
Additions   4,684
Foreign exchange translation   288,929
Impairment (87,415) (6,685,339)
Cost, ending balance 275,199 362,614
Gross carrying amount [member] | Patent [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 41,931 41,931
Additions  
Foreign exchange translation  
Impairment
Cost, ending balance 41,931 41,931
Gross carrying amount [member] | Customer-related intangible assets [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 197,000 197,000
Additions  
Foreign exchange translation  
Impairment (87,415)
Cost, ending balance 109,585 197,000
Gross carrying amount [member] | Brand names [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 23,000
Additions  
Foreign exchange translation   1,571
Impairment (24,571)
Cost, ending balance
Gross carrying amount [member] | Computer software [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 123,683 552,000
Additions   4,684
Foreign exchange translation   29,576
Impairment (462,577)
Cost, ending balance 123,683 123,683
Gross carrying amount [member] | Goodwill [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 5,940,409
Additions  
Foreign exchange translation   257,782
Impairment (6,198,191)
Cost, ending balance
Accumulated depreciation and amortisation [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 182,813 220,030
Charge for the year 35,960 179,482
Foreign exchange translation   13,726
Impairment   (230,425)
Balance at December 31, 2023 218,773 182,813
Accumulated depreciation and amortisation [member] | Patent [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 41,931 41,931
Charge for the year
Foreign exchange translation  
Impairment  
Balance at December 31, 2023 41,931 41,931
Accumulated depreciation and amortisation [member] | Customer-related intangible assets [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 87,731 60,414
Charge for the year 21,854 27,317
Foreign exchange translation  
Impairment  
Balance at December 31, 2023 109,585 87,731
Accumulated depreciation and amortisation [member] | Brand names [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 3,450
Charge for the year 4,719
Foreign exchange translation   431
Impairment   (8,600)
Balance at December 31, 2023
Accumulated depreciation and amortisation [member] | Computer software [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022 53,151 114,235
Charge for the year 14,106 147,446
Foreign exchange translation   13,295
Impairment   (221,825)
Balance at December 31, 2023 67,257 53,151
Accumulated depreciation and amortisation [member] | Goodwill [member]    
IfrsStatementLineItems [Line Items]    
Balance at December 31, 2022
Charge for the year
Foreign exchange translation  
Impairment  
Balance at December 31, 2023
XML 102 R73.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Impairment of goodwill $ 87,415 $ 6,454,914 $ 4,579,763
Assumption discount rates   10.00%  
Brand and software [member]      
IfrsStatementLineItems [Line Items]      
Impairment of goodwill   $ 15,971 $ 240,752
Vital and dronelogics [member]      
IfrsStatementLineItems [Line Items]      
Percentage of cash flow projection   2.00% 2.00%
Dronelogics [member]      
IfrsStatementLineItems [Line Items]      
Weighted average revenue   6.50% 14.00%
Percentage of weighted average cost of capital   19.00% 17.00%
Impairment of goodwill   $ 2,166,563  
Reduction in value   $ 104,248 $ 597,100
Vital [member]      
IfrsStatementLineItems [Line Items]      
Weighted average revenue   0.00% 42.00%
Percentage of weighted average cost of capital   29.00% 24.00%
Impairment of goodwill   $ 4,031,628 $ 4,579,763
Reduction in value   $ 570,133
XML 103 R74.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF RIGHT OF USE ASSETS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Right Of Use Assets    
Right of use assets, Cost, Balance $ 683,117  
Right of use assets, Cost, Additions 740,355
Right of use assets, Cost, Lease adjustment  
Right of use assets, Cost, Balance 1,423,472 683,117
Right of use assets, Accumulated depreciation, Balance 338,371 215,011
Right of use assets, Accumulated depreciation, Charge for the year 363,086 123,360
Right of use assets, Accumulated depreciation, Balance 701,785 338,371
Right of use assets $ 721,687 $ 344,746
XML 104 R75.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Right of use assets $ 721,687 $ 344,746
Buildings [member]    
IfrsStatementLineItems [Line Items]    
Right of use assets 721,687 342,361
Vehicles [member]    
IfrsStatementLineItems [Line Items]    
Right of use assets $ 2,385
XML 105 R76.htm IDEA: XBRL DOCUMENT v3.24.1
RIGHT OF USE ASSETS (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Right Of Use Assets    
Additional right of the assets $ 740,355
XML 106 R77.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Lease Liabilites    
Balance - Beginning of period $ 378,643 $ 489,123
Interest expense 96,423 39,795
Lease Payments (423,410) (150,275)
Additions 734,903  
Foreign exchange 3,464  
Balance - Ending of period 790,023 378,643
Current lease liabilities 362,001 133,962
Non-current lease liabilities 428,022 244,681
Lease liabilities $ 790,023 $ 378,643
XML 107 R78.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Total undiscounted lease liabilities $ 927,346 $ 440,268  
Amount representing interest (137,323) (61,625)  
Lease liability 790,023 378,643 $ 489,123
Not later than one year [member]      
IfrsStatementLineItems [Line Items]      
Total undiscounted lease liabilities 429,948 147,340  
Later than one year and not later than three years [member]      
IfrsStatementLineItems [Line Items]      
Total undiscounted lease liabilities 355,879 209,078  
Later than four years and not later than five years [member]      
IfrsStatementLineItems [Line Items]      
Total undiscounted lease liabilities $ 141,519 $ 83,850  
XML 108 R79.htm IDEA: XBRL DOCUMENT v3.24.1
LEASE LIABILITES (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Depreciation lease liability The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years  
Variable lease payments $ 43,542 $ 22,539
Bottom of range [member]    
IfrsStatementLineItems [Line Items]    
Weighted average lessee's incremental borrowing rate applied to lease 11.70%  
Top of range [member]    
IfrsStatementLineItems [Line Items]    
Weighted average lessee's incremental borrowing rate applied to lease 13.30%  
XML 109 R80.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Trade Payables And Accrued Liabilities    
Trade accounts payable $ 1,259,623 $ 751,422
Accrued liabilities 1,345,649 2,031,545
Government grant payable 33,709 33,709
Trade payables and accrued liabilities $ 2,638,981 $ 2,816,676
XML 110 R81.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF DEFERRED INCOME (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Deferred, revenue beginning $ 63,690 $ 5,233
Revenue recognized (64,816) (4,939)
Unearned revenues received 108,800 63,396
 Deferred income gross 107,674 63,690
Current portion 12,112 63,690
Long term portion 95,562
 Deferred Income net $ 107,674 $ 63,690
XML 111 R82.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF LOANS PAYABLE (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Opening balance $ 86,571 $ 93,317
Issuance of loans payable
Fair value adjustment (4,891)
Repayment of loans payable (6,747) (6,746)
Accretion expense 5,234 4,891
Ending balance $ 85,058 $ 86,571
XML 112 R83.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF LOANS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
May 19, 2020
IfrsStatementLineItems [Line Items]      
Rate     25.00%
Total Carrying Value $ 85,058 $ 86,571  
CEBA [member]      
IfrsStatementLineItems [Line Items]      
Start Date May 19, 2020    
Maturity Date Mar. 28, 2024    
Rate 0.00%   5.00%
Total Carrying Value $ 40,000 37,383  
CEBA [member]      
IfrsStatementLineItems [Line Items]      
Start Date Apr. 23, 2021    
Maturity Date Mar. 28, 2024    
Rate 0.00%    
Total Carrying Value $ 40,000 37,383  
Vehicle loan [member]      
IfrsStatementLineItems [Line Items]      
Start Date Aug. 30, 2019    
Maturity Date Sep. 11, 2024    
Rate 6.99%    
Total Carrying Value $ 5,058 $ 11,805  
XML 113 R84.htm IDEA: XBRL DOCUMENT v3.24.1
DEFERRED INCOME (Details Narrative)
Dec. 31, 2023
CAD ($)
Notes and other explanatory information [abstract]  
Deferred revenue $ 12,112
XML 114 R85.htm IDEA: XBRL DOCUMENT v3.24.1
LOANS PAYABLE (Details Narrative) - CAD ($)
Apr. 23, 2021
Dec. 04, 2020
May 19, 2020
Dec. 31, 2023
IfrsStatementLineItems [Line Items]        
Interest rate     25.00%  
CEBA [member]        
IfrsStatementLineItems [Line Items]        
Loan received     $ 40,000  
Interest rate     5.00% 0.00%
Loans forgivable amount $ 20,000   $ 10,000  
Proceeds from loan   $ 20,000    
Loan forgiveness   $ 10,000    
Unsecured loan received $ 60,000      
XML 115 R86.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]        
Exercise Price | $ / shares $ 0.6123      
Remaining Contractual Life (years) 4 years 7 months 17 days 5 months 19 days    
Number of Options Outstanding 897,158 877,157 897,158 1,035,991
Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Number of Options Outstanding 897,158   897,158  
Number of Options Exercisable 819,875   819,875  
Exercise price one [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Oct. 30, 2019      
Expiry Date Oct. 30, 2029      
Exercise Price | $ / shares     $ 2.50  
Remaining Contractual Life (years) 5 years 10 months 2 days      
Number of Options Outstanding 278,332   278,332  
Number of Options Exercisable 278,332   278,332  
Exercise price two [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Nov. 19, 2019      
Expiry Date Nov. 19, 2029      
Exercise Price | $ / shares     $ 2.50  
Remaining Contractual Life (years) 5 years 10 months 20 days      
Number of Options Outstanding 50,000   50,000  
Number of Options Exercisable 50,000   50,000  
Exercise price three [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Apr. 30, 2020      
Expiry Date Apr. 30, 2030      
Exercise Price | $ / shares     $ 2.50  
Remaining Contractual Life (years) 6 years 3 months 29 days      
Number of Options Outstanding 85,000   85,000  
Number of Options Exercisable 85,000   85,000  
Exercise price four [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Apr. 30, 2020      
Expiry Date Apr. 30, 2030      
Exercise Price | $ / shares     $ 3.85  
Remaining Contractual Life (years) 6 years 3 months 29 days      
Number of Options Outstanding 110,000   110,000  
Number of Options Exercisable 110,000   110,000  
Exercise price five [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Jul. 03, 2020      
Expiry Date Jul. 03, 2025      
Exercise Price | $ / shares     $ 3.20  
Remaining Contractual Life (years) 1 year 6 months 3 days      
Number of Options Outstanding 100,000   100,000  
Number of Options Exercisable 100,000   100,000  
Exercise price six [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Nov. 24, 2020      
Expiry Date Nov. 24, 2030      
Exercise Price | $ / shares     $ 2.50  
Remaining Contractual Life (years) 6 years 10 months 24 days      
Number of Options Outstanding 32,000   32,000  
Number of Options Exercisable 32,000   32,000  
Exercise price seven [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Feb. 02, 2021      
Expiry Date Feb. 02, 2031      
Exercise Price | $ / shares     $ 13.20  
Remaining Contractual Life (years) 7 years 1 month 6 days      
Number of Options Outstanding 30,000   30,000  
Number of Options Exercisable 30,000   30,000  
Exercise price eight [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Mar. 08, 2021      
Expiry Date Mar. 08, 2026      
Exercise Price | $ / shares     $ 13.90  
Remaining Contractual Life (years) 2 years 2 months 8 days      
Number of Options Outstanding 10,000   10,000  
Number of Options Exercisable 10,000   10,000  
Exercise price nine [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Apr. 27, 2021      
Expiry Date Apr. 27, 2031      
Exercise Price | $ / shares     $ 10.15  
Remaining Contractual Life (years) 7 years 3 months 29 days      
Number of Options Outstanding 146,000   146,000  
Number of Options Exercisable 97,326   97,326  
Exercise price ten [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Sep. 09, 2021      
Expiry Date Sep. 09, 2026      
Exercise Price | $ / shares     $ 4.84  
Remaining Contractual Life (years) 2 years 8 months 8 days      
Number of Options Outstanding 25,826   25,826  
Number of Options Exercisable 17,217   17,217  
Exercise price eleven [member] | Incentive share compensation plan [member]        
IfrsStatementLineItems [Line Items]        
Grant Date Nov. 09, 2023      
Expiry Date Nov. 09, 2033      
Exercise Price | $ / shares     $ 0.626  
Remaining Contractual Life (years) 9 years 10 months 13 days      
Number of Options Outstanding 30,000   30,000  
Number of Options Exercisable 10,000   10,000  
XML 116 R87.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Number of options outstanding, Beginning Balance | shares 877,157 1,035,991
Weighted average exercise price, Beginning Balance $ 4.60 $ 4.60
Number of options outstanding, Exercised | shares   (12,500)
Weighted average exercise price, Exercised   $ 2.15
Number of options outstanding, forfeited | shares (9,999) (146,334)
Weighted average exercise price, Granted $ 0.626 $ 4.77
Weighted average exercise price, forfeited $ 3.77  
Number of options outstanding, issued | shares 30,000  
Weighted average exercise price, Issued $ 0.63  
Number of options outstanding, Ending Balance | shares 897,158 877,157
Weighted average exercise price, Ending Balance $ 4.48 $ 4.60
XML 117 R88.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Risk free interest rate 4.58%
Expected volatility 115.10%
Expected life 10 years
Expected dividend yield 0.00%
Exercise price $ 0.63
XML 118 R89.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 6,461,999  
Number of RSUs outstanding, Ending of the period 8,000,000 6,461,999
Restricted stock units rsu [member]    
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 1,198,875 514,832
Number of RSUs,Vested (1,508,255) (1,072,595)
Number of RSUs,Issued (1,685,316) 1,820,972
Number of RSUs ,Forfeited (262,969) (64,334)
Number of RSUs,Issued 1,685,316 (1,820,972)
Number of RSUs outstanding, Ending of the period 1,112,967 1,198,875
XML 119 R90.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) - Warrants [member] - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Beginning of the period $ 4,865,772
Change in fair value of warrants outstanding 211,110 (4,865,772)
Warrants issued 3,985,015  
Ending of the period 4,196,125
Warrants 4,196,125
Contingent consideration 57,314
Derivative liability $ 4,196,125 $ 57,314
XML 120 R91.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
shares
$ / shares
Dec. 31, 2022
USD ($)
shares
IfrsStatementLineItems [Line Items]    
Exercise price | $ / shares $ 0.6123  
Number of Warrants Outstanding | shares 8,000,000 6,461,999
Fair Value of warrants | $ $ 4,196,125
Range 1 [member]    
IfrsStatementLineItems [Line Items]    
Issue date [1] Feb. 05, 2021  
Exercise price | $ / shares [1] $ 3.55  
Number of Warrants Outstanding | shares [1] 1,319,675
Fair Value of warrants | $ [1]
Range 2 [member]    
IfrsStatementLineItems [Line Items]    
Issue date [2] Mar. 05, 2021  
Exercise price | $ / shares [2] $ 3.55  
Number of Warrants Outstanding | shares [2] 5,142,324
Fair Value of warrants | $ [2]
Range 6 [member]    
IfrsStatementLineItems [Line Items]    
Issue date Oct. 30, 2023  
Exercise price | $ / shares [3] $ 0.6123  
Number of Warrants Outstanding | shares [3] 6,400,000
Fair Value of warrants | $ [3] $ 3,180,543
Range 7 [member]    
IfrsStatementLineItems [Line Items]    
Issue date Oct. 30, 2023  
Exercise price | $ / shares [4] $ 0.0001  
Number of Warrants Outstanding | shares [4] 1,600,000
Fair Value of warrants | $ [4] $ 1,015,582
[1] The warrants expired on February 5, 2023.
[2] The warrants expired on March 5, 2023.
[3] The warrants expire October 30, 2028.
[4] The warrants have no expiry date.
XML 121 R92.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Risk free interest rate 4.58%
Expected volatility 115.10%
Expected life 10 years
Expected dividend yield 0.00%
Warrants [member]    
IfrsStatementLineItems [Line Items]    
Risk free interest rate 3.84% 4.07%
Expected volatility 113.78% 116.00%
Expected life 4 years 9 months 18 days 2 months 15 days
Expected dividend yield 0.00% 0.00%
Warrants [member] | Bottom of range [member]    
IfrsStatementLineItems [Line Items]    
Expected volatility   91.66%
Expected life   1 month 6 days
Warrants [member] | Top of range [member]    
IfrsStatementLineItems [Line Items]    
Expected volatility   93.48%
Expected life   2 months 4 days
XML 122 R93.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF CHANGES IN WARRANTS (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period | shares 6,461,999  
Weighted Average Exercise Price, Outstanding, Beginning Balance  
Number of RSUs outstanding, Ending of the period | shares 8,000,000 6,461,999
Weighted Average Exercise Price, Outstanding, Ending Balance $ 0.63
Warrants [member]    
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 7,916,797 8,414,819
Weighted Average Exercise Price, Outstanding, Beginning Balance $ 5.08 $ 4.99
Warrants, Excercised   (16,538)
Weighted Average Exercise Price, Exercised   $ 4.51
Warrants, Issued (8,320,000) (481,484)
Weighted Average Exercise Price, Issued $ 0.50 $ 4.61
Warrants, Issued 8,320,000 481,484
Warrants, Expired (7,661,999)  
Weighted Average Exercise Price, Expired $ 5.89  
Number of RSUs outstanding, Ending of the period 8,574,798 7,916,797
Weighted Average Exercise Price, Outstanding, Ending Balance $ 0.63 $ 5.08
XML 123 R94.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WARRANTS OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Warrant one [member]  
IfrsStatementLineItems [Line Items]  
Date issued Jul. 29, 2021
Expiry date Jul. 29, 2024
Exercise price | $ / shares $ 5.00
Number of warrants outstanding 250,000
Warrant two [member]  
IfrsStatementLineItems [Line Items]  
Date issued Sep. 14, 2021
Expiry date Sep. 14, 2024
Exercise price | $ / shares $ 5.00
Number of warrants outstanding 4,798
Warrant three [member]  
IfrsStatementLineItems [Line Items]  
Date issued Oct. 30, 2023
Expiry date Oct. 30, 2026
Exercise price | $ / shares $ 0.6875
Number of warrants outstanding 320,000
Warrant four [member]  
IfrsStatementLineItems [Line Items]  
Date issued Oct. 30, 2023
Expiry date Oct. 30, 2028
Exercise price | $ / shares $ 0.6123
Number of warrants outstanding 6,400,000
Warrant five [member]  
IfrsStatementLineItems [Line Items]  
Date issued Oct. 30, 2023
Exercise price | $ / shares $ 0.0001
Number of warrants outstanding 1,600,000
Warrants [member]  
IfrsStatementLineItems [Line Items]  
Number of warrants outstanding 8,574,798
XML 124 R95.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE CAPITAL (Details Narrative)
12 Months Ended
Mar. 22, 2021
CAD ($)
shares
Dec. 31, 2023
$ / shares
Dec. 31, 2023
CAD ($)
shares
$ / shares
Dec. 31, 2022
CAD ($)
shares
$ / shares
Dec. 31, 2021
CAD ($)
Dec. 31, 2023
CAD ($)
shares
IfrsStatementLineItems [Line Items]            
Number of shares issued | shares           8,000,000
[custom:SharesIssuedForFinancingCost]     $ 10,856,166      
[custom:IssuedCapitalCost-0]           $ 1,953,032
Proceeds from issuing shares     8,903,134      
Shares issued for financing - ATM     1,748,946      
Share issue costs     222,136      
Proceeds from issue of shares     1,526,810      
Shares issued for financing     11,376,230   $ 36,092,187  
Share issue related cost     $ 222,136 $ 5,122 3,814,761  
Exercise of warrants       $ 87,170 4,929,790  
Number of options outstanding, Granted | shares     30,000      
Weighted average exercise price, Granted | $ / shares     $ 0.626 $ 4.77    
Stock option exercisable year     10 years      
Adjustments for share-based payments     $ 2,021,664 $ 3,311,024 $ 3,952,595  
Warrants issued | shares 1,200,000   1,600,000      
Warrant exercise price share | $ / shares   $ 0.5499        
Exercise price | $ / shares   0.0001        
Warrants exercise price | $ / shares   0.6123        
Warrants term           5 years
Warrants expiration date Mar. 25, 2023         Oct. 30, 2028
Risk free interest rate     4.58%    
Volatility rate     115.10%    
Expected life     10 years    
Expected dividend yield     0.00%    
Warrants held in escrow | shares 900,000          
Weighted average remaining contractual life of outstanding share options     4 years 7 months 17 days 5 months 19 days    
Bottom of range [member]            
IfrsStatementLineItems [Line Items]            
Revenue on acquisition $ 2,000,000          
Top of range [member]            
IfrsStatementLineItems [Line Items]            
Revenue on acquisition $ 6,000,000          
USD Warrants [Member]            
IfrsStatementLineItems [Line Items]            
Risk free interest rate     4.80%      
Volatility rate     115.35%      
Expected life     5 years      
Expected dividend yield     0.00%      
Broker Warrants [Member]            
IfrsStatementLineItems [Line Items]            
Risk free interest rate     4.87%      
Volatility rate     138.83%      
Expected life     3 years      
Expected dividend yield     0.00%      
Warrants [member]            
IfrsStatementLineItems [Line Items]            
Warrants issued | shares     6,400,000      
Warrants exercise price | $ / shares   $ 0.6875        
Warrants term           3 years
Underwriter warrants issued | shares     320,000      
Stock options [member]            
IfrsStatementLineItems [Line Items]            
Adjustments for share-based payments     $ 151,174 $ 502,837    
Restricted stock units [member]            
IfrsStatementLineItems [Line Items]            
Number of accelerated vesting shares | shares     1,508,255 1,072,595    
Number of accelerated issued shares | shares     1,687,014 1,820,972    
Number of accelerated Forfeited shares | shares     264,668 64,334    
Expense from share-based payment transactions with employees     $ 1,866,490 $ 2,808,187    
Common stock 1 [member]            
IfrsStatementLineItems [Line Items]            
Restricted share units | shares     1,508,255 1,072,595    
Number of shares exercise | shares       16,538    
Number of stock issued for exercise of options | shares       12,500    
Stock issued during period value exercise of options       $ 26,875    
Common shares [member]            
IfrsStatementLineItems [Line Items]            
Number of shares issued | shares           4,800,000
Proceeds from issuing shares     $ 3,969,372      
Shares issued for financing - ATM, shares | shares     650,729      
Shares issued for financing     $ 4,858,995      
Share issue related cost     889,623      
Other income (expense)     $ 793,979      
XML 125 R96.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF SEGMENTED INFORMATION (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Sales of goods $ 5,287,093 $ 5,550,432 $ 5,103,399
Provision of services 1,267,749 2,054,627 1,950,466
Total revenue 6,554,842 7,605,059 7,053,865
Segment loss 22,926,541 23,459,253 18,575,560
Finance and other costs (83,280) (44,345) (5,074)
Depreciation 510,677 593,277 175,098
Amortization 35,960 179,482 135,966
Impairment of goodwill and intangibles   6,454,914 4,579,763
Change in fair value of derivative liability (211,110) (5,502,688) (8,149,812)
Loss on write-off of notes receivable 101,351 309,385 891,471
Loss on write down of inventory 331,671 1,976,514  
Write down of deposit 228,572
Net loss for the year 23,611,810 27,654,364 16,202,972
Drones [member]      
IfrsStatementLineItems [Line Items]      
Sales of goods 4,905,417 5,388,262 4,957,134
Provision of services 1,267,749 2,054,627 1,950,466
Total revenue 6,173,166 7,442,889 6,907,600
Segment loss 14,743,176 9,929,789 7,819,739
Finance and other costs (80,211) (3,529) 16,272
Depreciation 499,530 586,185 175,098
Amortization 35,960 179,482 135,966
Impairment of goodwill and intangibles   2,166,563
Change in fair value of derivative liability
Loss on write-off of notes receivable 1,080,645
Loss on write down of inventory 331,671 251,754  
Write down of deposit    
Net loss for the year 15,530,126 14,190,889 8,147,075
Vital [member]      
IfrsStatementLineItems [Line Items]      
Sales of goods 381,676 162,170 146,265
Provision of services
Total revenue 381,676 162,170 146,265
Segment loss (140,366) 602,580 257,656
Finance and other costs
Depreciation
Amortization
Impairment of goodwill and intangibles   4,288,351 4,579,763
Change in fair value of derivative liability
Loss on write-off of notes receivable
Loss on write down of inventory 1,724,760  
Write down of deposit   228,572  
Net loss for the year (140,366) 6,844,263 4,837,419
Corporates [member]      
IfrsStatementLineItems [Line Items]      
Sales of goods
Provision of services
Total revenue
Segment loss 8,323,731 12,926,884 10,498,164
Finance and other costs (3,069) (40,186) (21,346)
Depreciation 11,148
Amortization
Impairment of goodwill and intangibles  
Change in fair value of derivative liability (211,110) (5,502,688) (8,149,812)
Loss on write-off of notes receivable 101,351 (771,260) 891,471
Loss on write down of inventory  
Write down of deposit    
Net loss for the year $ 8,222,051 $ 6,619,212 $ 3,218,477
XML 126 R97.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF GEOGRAPHIC REVENUE (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Non-current assets $ 1,648,317 $ 1,121,821 $ 8,554,531
Revenue      
Revenue 6,554,842 7,605,059 7,053,865
CA [member]      
IfrsStatementLineItems [Line Items]      
Non-current assets 1,441,701 1,121,821 3,441,872
Revenue      
Revenue 6,162,672 6,919,038 4,982,373
US country [member]      
IfrsStatementLineItems [Line Items]      
Non-current assets 206,616 5,112,659
Revenue      
Revenue $ 392,170 $ 686,021 $ 2,071,492
XML 127 R98.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Advertising, Marketing, and Investor Relations $ 4,243,432 $ 4,431,818 $ 5,165,791
Compliance fees 193,250 152,826 432,874
Impairment of accounts receivable 216,238
Contract Work 772,003 441,798 300,975
Other 878,956 371,519 556,358
Office and Miscellaneous Expenses $ 6,303,879 $ 5,397,961 $ 6,455,998
XML 128 R99.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF KEY COMPENSATION AWARDS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Director fees $ 600,933 $ 522,349 $ 370,094
Salaries 979,154 843,917 722,068
Share-based payments 1,109,232 2,106,906 2,475,949
Total $ 2,689,319 $ 3,473,172 $ 3,568,111
XML 129 R100.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Management fees paid to a company, total  $ 2,689,319 $ 3,473,172 $ 3,568,111
CEO and director [member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company, total  592,500 566,487 290,225
CEO [member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company, total  429,766 442,485 315,643
Directors [member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company, total  215,019 383,288 205,691
Other related parties [member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company, total  $ 1,237,285 $ 1,392,260 $ 811,559
XML 130 R101.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Incurred fees $ 4,145,586 $ 6,821,583 $ 4,445,949
Indebted amount 190,664 51,549  
Business services agreement [member] | Business instincts group [member]      
IfrsStatementLineItems [Line Items]      
Incurred fees 429,766 442,485  
Indebted amount 3,780 30,804  
Independent consultant agreement [member] | Alberta lltd [member]      
IfrsStatementLineItems [Line Items]      
Incurred fees 592,500 566,487  
Indebted amount 35,417  
Executive consultant agreement [member] | Scottlarson [member]      
IfrsStatementLineItems [Line Items]      
Incurred fees 215,019 383,288  
Indebted amount $ 9,287 $ 20,745  
XML 131 R102.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF AGING OF RECEIVABLES (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
 Total receivables $ 649,612 $ 2,088,965
Current [member]    
IfrsStatementLineItems [Line Items]    
 Total receivables 271,622 1,020,091
Later than one month and not later than two months [member]    
IfrsStatementLineItems [Line Items]    
 Total receivables 109,928 116,378
Later than two months and not later than three months [member]    
IfrsStatementLineItems [Line Items]    
 Total receivables 64,259 343,364
Later than three months [member]    
IfrsStatementLineItems [Line Items]    
 Total receivables $ 203,803 $ 609,132
XML 132 R103.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details)
Dec. 31, 2023
CAD ($)
IfrsStatementLineItems [Line Items]  
 Financial liabilities $ 8,059,899
Trade payables and accrued liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 2,638,981
Customer deposits [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 104,715
Deferred income [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 107,674
Loan payable [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 85,058
Derivative liability [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 4,196,125
Lease liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 927,346
Not later than one year [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 7,466,939
Not later than one year [member] | Trade payables and accrued liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 2,638,981
Not later than one year [member] | Customer deposits [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 104,715
Not later than one year [member] | Deferred income [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 12,112
Not later than one year [member] | Loan payable [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 85,058
Not later than one year [member] | Derivative liability [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 4,196,125
Not later than one year [member] | Lease liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 429,948
Later than one year and not later than five years [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 592,960
Later than one year and not later than five years [member] | Trade payables and accrued liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities
Later than one year and not later than five years [member] | Customer deposits [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities
Later than one year and not later than five years [member] | Deferred income [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities 95,562
Later than one year and not later than five years [member] | Loan payable [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities
Later than one year and not later than five years [member] | Derivative liability [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities
Later than one year and not later than five years [member] | Lease liabilities [member] | Liquidity risk [member]  
IfrsStatementLineItems [Line Items]  
 Financial liabilities $ 497,398
XML 133 R104.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Foreign exchange rate $ 530,758 $ 969,977
XML 134 R105.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies $ 189,403 $ 192,583
Notes receivable   169,300
Derivative liability 4,196,125 57,314
Total 4,385,528 419,197
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies 57,143 57,143
Notes receivable  
Derivative liability
Total 57,413 57,143
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies
Notes receivable  
Derivative liability
Total
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies 132,260 135,440
Notes receivable   169,300
Derivative liability 4,196,125 57,314
Total $ 4,328,385 $ 362,054
XML 135 R106.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details) - Historical volatility for shares, measurement input [member] - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
[custom:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage] 20.00%  
Impact on comprehensive loss $ 291,149
XML 136 R107.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INCOME TAX (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Loss before income taxes $ 23,611,810 $ 27,654,364 $ 16,202,972
Canadian statutory rates 27.00% 27.00% 27.00%
Expected income tax recovery $ 6,330,400 $ 7,338,900 $ 4,196,600
Impact of different foreign statutory tax rates 34,900
Non-deductible items (509,800) (1,214,400) 116,400
Share issue costs 773,400 1,400 887,600
Adjustments to prior years provision versus statutory tax returns (87,600) (742,400) 376,500
Differences between prior year provision and final tax return (153,400) 867,500 (206,000)
Change in deferred tax asset not recognized (6,353,000) (6,251,000) (5,406,000)
Income tax
XML 137 R108.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF DEFERRED TAXES (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Share issuance costs $ 995,000 $ 568,000 $ 728,000
Non-capital losses 20,377,000 14,602,000 7,043,000
Property and equipment 1,115,000 962,000 449,000
Capital gain reserve 74,000
Scientific Research and Experimental Development 365,000 367,000 291,000
Total deferred income tax assets 22,852,000 16,499,000 8,585,000
Deferred income tax not recognized (22,852,000) (16,499,000) (8,585,000)
Net deferred tax assets
XML 138 R109.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details Narrative) - 12 months ended Dec. 31, 2023
USD ($)
CAD ($)
Expiring in 2030 to 2043 [Member]    
IfrsStatementLineItems [Line Items]    
Non-capital loss carry forward   $ 67,701,122
Expiring in 2040 to 2043 [Member]    
IfrsStatementLineItems [Line Items]    
Non-capital loss carry forward $ 6,231,434 $ 8,241,878
XML 139 R110.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS (Details Narrative)
12 Months Ended
Feb. 26, 2024
USD ($)
$ / shares
shares
Feb. 26, 2024
CAD ($)
Feb. 06, 2024
USD ($)
shares
Feb. 06, 2024
CAD ($)
shares
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Feb. 26, 2024
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
IfrsStatementLineItems [Line Items]                  
Proceeds from exercise of warrants | $         $ 87,170 $ 4,929,790    
Number of shares issued | shares                 8,000,000
Proceeds from issue of ordinary shares | $         $ 1,526,810        
Warrant exercise price | $ / shares                 $ 0.5499
Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ordinary shares [member]                  
IfrsStatementLineItems [Line Items]                  
Number of shares issued | shares 11,200,000             11,200,000  
Description of shares issuance each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share.              
Share price | $ / shares               $ 0.27  
Proceeds from issue of ordinary shares $ 3,600,000 $ 4,800,000              
Net proceeds from issue of ordinary shares 3,300,000 4,400,000              
Proceeds from issue of ordinary shares $ 329,000 $ 442,000              
Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ordinary shares [member] | Ranges of Exercise Prices of Warrants Two [member]                  
IfrsStatementLineItems [Line Items]                  
Description of exercisable term of warrants 3 years 3 years              
Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ordinary shares [member] | Ranges of Exercise Prices of Warrants One [member]                  
IfrsStatementLineItems [Line Items]                  
Description of exercisable term of warrants 5 years 5 years              
Pre-funded Warrants [Member]                  
IfrsStatementLineItems [Line Items]                  
Number of warrants exercised | shares     1,600,000 1,600,000          
Proceeds from exercise of warrants     $ 160 $ 216          
Number of shares issued, value     $ 578,200 $ 773,624          
Pre-funded Warrants [Member] | Non Adjustment Events [Member] | Underwritten Share Placement [Member]                  
IfrsStatementLineItems [Line Items]                  
Number of warrants exercised | shares     670,000 670,000          
Warrant exercise price | $ / shares               0.0001  
Pre-funded Warrants [Member] | Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ranges of Exercise Prices of Warrants Two [member]                  
IfrsStatementLineItems [Line Items]                  
Warrant exercise price | $ / shares               $ 0.3375  
Pre-funded Warrants [Member] | Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ordinary shares [member]                  
IfrsStatementLineItems [Line Items]                  
Number of warrants exercised | shares 2,200,000             2,200,000  
Warrants [member] | Non Adjustment Events [Member] | Underwritten Share Placement [Member] | Ranges of Exercise Prices of Warrants Two [member]                  
IfrsStatementLineItems [Line Items]                  
Warrant exercise price | $ / shares $ 0.36                
EXCEL 140 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 141 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 142 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 144 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 376 463 1 true 120 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://draganfly.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Statements of Financial Position Sheet http://draganfly.com/role/StatementsOfFinancialPosition Consolidated Statements of Financial Position Statements 2 false false R3.htm 00000003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://draganfly.com/role/StatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://draganfly.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://draganfly.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 995511 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN Sheet http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcern NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN Notes 6 false false R7.htm 995512 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION Sheet http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparation MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION Notes 7 false false R8.htm 995513 - Disclosure - MANAGEMENT JUDGEMENT AND ASSUMPTIONS Sheet http://draganfly.com/role/ManagementJudgementAndAssumptions MANAGEMENT JUDGEMENT AND ASSUMPTIONS Notes 8 false false R9.htm 995514 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://draganfly.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 9 false false R10.htm 995515 - Disclosure - RECEIVABLES Sheet http://draganfly.com/role/Receivables RECEIVABLES Notes 10 false false R11.htm 995516 - Disclosure - INVENTORY Sheet http://draganfly.com/role/Inventory INVENTORY Notes 11 false false R12.htm 995517 - Disclosure - NOTES RECEIVABLE Notes http://draganfly.com/role/NotesReceivable NOTES RECEIVABLE Notes 12 false false R13.htm 995518 - Disclosure - PREPAIDS Sheet http://draganfly.com/role/Prepaids PREPAIDS Notes 13 false false R14.htm 995519 - Disclosure - INVESTMENTS Sheet http://draganfly.com/role/Investments INVESTMENTS Notes 14 false false R15.htm 995520 - Disclosure - EQUIPMENT Sheet http://draganfly.com/role/Equipment EQUIPMENT Notes 15 false false R16.htm 995521 - Disclosure - INTANGIBLE ASSETS AND GOODWILL Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwill INTANGIBLE ASSETS AND GOODWILL Notes 16 false false R17.htm 995522 - Disclosure - RIGHT OF USE ASSETS Sheet http://draganfly.com/role/RightOfUseAssets RIGHT OF USE ASSETS Notes 17 false false R18.htm 995523 - Disclosure - LEASE LIABILITES Sheet http://draganfly.com/role/LeaseLiabilites LEASE LIABILITES Notes 18 false false R19.htm 995524 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES Sheet http://draganfly.com/role/TradePayablesAndAccruedLiabilities TRADE PAYABLES AND ACCRUED LIABILITIES Notes 19 false false R20.htm 995525 - Disclosure - DEFERRED INCOME Sheet http://draganfly.com/role/DeferredIncome DEFERRED INCOME Notes 20 false false R21.htm 995526 - Disclosure - LOANS PAYABLE Sheet http://draganfly.com/role/LoansPayable LOANS PAYABLE Notes 21 false false R22.htm 995527 - Disclosure - SHARE CAPITAL Sheet http://draganfly.com/role/ShareCapital SHARE CAPITAL Notes 22 false false R23.htm 995528 - Disclosure - SEGMENTED INFORMATION Sheet http://draganfly.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 23 false false R24.htm 995529 - Disclosure - OFFICE AND MISCELLANEOUS Sheet http://draganfly.com/role/OfficeAndMiscellaneous OFFICE AND MISCELLANEOUS Notes 24 false false R25.htm 995530 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://draganfly.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 25 false false R26.htm 995531 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT Sheet http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT Notes 26 false false R27.htm 995532 - Disclosure - INCOME TAXES Sheet http://draganfly.com/role/IncomeTaxes INCOME TAXES Notes 27 false false R28.htm 995533 - Disclosure - SUBSEQUENT EVENTS Sheet http://draganfly.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 28 false false R29.htm 995534 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies) Sheet http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies) Policies 29 false false R30.htm 995535 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables) Sheet http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables) Tables http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparation 30 false false R31.htm 995536 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Sheet http://draganfly.com/role/CashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS (Tables) Tables http://draganfly.com/role/CashAndCashEquivalents 31 false false R32.htm 995537 - Disclosure - RECEIVABLES (Tables) Sheet http://draganfly.com/role/ReceivablesTables RECEIVABLES (Tables) Tables http://draganfly.com/role/Receivables 32 false false R33.htm 995538 - Disclosure - INVENTORY (Tables) Sheet http://draganfly.com/role/InventoryTables INVENTORY (Tables) Tables http://draganfly.com/role/Inventory 33 false false R34.htm 995539 - Disclosure - NOTES RECEIVABLE (Tables) Notes http://draganfly.com/role/NotesReceivableTables NOTES RECEIVABLE (Tables) Tables http://draganfly.com/role/NotesReceivable 34 false false R35.htm 995540 - Disclosure - PREPAIDS (Tables) Sheet http://draganfly.com/role/PrepaidsTables PREPAIDS (Tables) Tables http://draganfly.com/role/Prepaids 35 false false R36.htm 995541 - Disclosure - INVESTMENTS (Tables) Sheet http://draganfly.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://draganfly.com/role/Investments 36 false false R37.htm 995542 - Disclosure - EQUIPMENT (Tables) Sheet http://draganfly.com/role/EquipmentTables EQUIPMENT (Tables) Tables http://draganfly.com/role/Equipment 37 false false R38.htm 995543 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwillTables INTANGIBLE ASSETS AND GOODWILL (Tables) Tables http://draganfly.com/role/IntangibleAssetsAndGoodwill 38 false false R39.htm 995544 - Disclosure - RIGHT OF USE ASSETS (Tables) Sheet http://draganfly.com/role/RightOfUseAssetsTables RIGHT OF USE ASSETS (Tables) Tables http://draganfly.com/role/RightOfUseAssets 39 false false R40.htm 995545 - Disclosure - LEASE LIABILITES (Tables) Sheet http://draganfly.com/role/LeaseLiabilitesTables LEASE LIABILITES (Tables) Tables http://draganfly.com/role/LeaseLiabilites 40 false false R41.htm 995546 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://draganfly.com/role/TradePayablesAndAccruedLiabilities 41 false false R42.htm 995547 - Disclosure - DEFERRED INCOME (Tables) Sheet http://draganfly.com/role/DeferredIncomeTables DEFERRED INCOME (Tables) Tables http://draganfly.com/role/DeferredIncome 42 false false R43.htm 995548 - Disclosure - LOANS PAYABLE (Tables) Sheet http://draganfly.com/role/LoansPayableTables LOANS PAYABLE (Tables) Tables http://draganfly.com/role/LoansPayable 43 false false R44.htm 995549 - Disclosure - SHARE CAPITAL (Tables) Sheet http://draganfly.com/role/ShareCapitalTables SHARE CAPITAL (Tables) Tables http://draganfly.com/role/ShareCapital 44 false false R45.htm 995550 - Disclosure - SEGMENTED INFORMATION (Tables) Sheet http://draganfly.com/role/SegmentedInformationTables SEGMENTED INFORMATION (Tables) Tables http://draganfly.com/role/SegmentedInformation 45 false false R46.htm 995551 - Disclosure - OFFICE AND MISCELLANEOUS (Tables) Sheet http://draganfly.com/role/OfficeAndMiscellaneousTables OFFICE AND MISCELLANEOUS (Tables) Tables http://draganfly.com/role/OfficeAndMiscellaneous 46 false false R47.htm 995552 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://draganfly.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://draganfly.com/role/RelatedPartyTransactions 47 false false R48.htm 995553 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) Sheet http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) Tables http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement 48 false false R49.htm 995554 - Disclosure - INCOME TAXES (Tables) Sheet http://draganfly.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://draganfly.com/role/IncomeTaxes 49 false false R50.htm 995555 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative) Sheet http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcernDetailsNarrative NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative) Details http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcern 50 false false R51.htm 995556 - Disclosure - SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details) Sheet http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details) Details 51 false false R52.htm 995557 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details) Sheet http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details) Details 52 false false R53.htm 995558 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details) Sheet http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails SCHEDULE OF CLASS OF EQUIPMENT (Details) Details 53 false false R54.htm 995559 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative) Sheet http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative) Details http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables 54 false false R55.htm 995560 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Sheet http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Details 55 false false R56.htm 995561 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) Sheet http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative CASH AND CASH EQUIVALENTS (Details Narrative) Details http://draganfly.com/role/CashAndCashEquivalentsTables 56 false false R57.htm 995562 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details) Sheet http://draganfly.com/role/ScheduleOfAmountsReceivableDetails SCHEDULE OF AMOUNTS RECEIVABLE (Details) Details 57 false false R58.htm 995563 - Disclosure - RECEIVABLES (Details Narrative) Sheet http://draganfly.com/role/ReceivablesDetailsNarrative RECEIVABLES (Details Narrative) Details http://draganfly.com/role/ReceivablesTables 58 false false R59.htm 995564 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://draganfly.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 59 false false R60.htm 995565 - Disclosure - SCHEDULE OF COST OF SALES (Details) Sheet http://draganfly.com/role/ScheduleOfCostOfSalesDetails SCHEDULE OF COST OF SALES (Details) Details 60 false false R61.htm 995566 - Disclosure - INVENTORY (Details Narrative) Sheet http://draganfly.com/role/InventoryDetailsNarrative INVENTORY (Details Narrative) Details http://draganfly.com/role/InventoryTables 61 false false R62.htm 995567 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details) Notes http://draganfly.com/role/DisclosureOfNotesReceivableDetails DISCLOSURE OF NOTES RECEIVABLE (Details) Details 62 false false R63.htm 995568 - Disclosure - NOTES RECEIVABLE (Details Narrative) Notes http://draganfly.com/role/NotesReceivableDetailsNarrative NOTES RECEIVABLE (Details Narrative) Details http://draganfly.com/role/NotesReceivableTables 63 false false R64.htm 995569 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Details 64 false false R65.htm 995570 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical) Sheet http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetailsParenthetical SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical) Details 65 false false R66.htm 995571 - Disclosure - SCHEDULE OF INVESTMENTS (Details) Sheet http://draganfly.com/role/ScheduleOfInvestmentsDetails SCHEDULE OF INVESTMENTS (Details) Details 66 false false R67.htm 995572 - Disclosure - SCHEDULE OF FAIR VALUE OF INVESTMENT (Details) Sheet http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails SCHEDULE OF FAIR VALUE OF INVESTMENT (Details) Details 67 false false R68.htm 995573 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) Details 68 false false R69.htm 995574 - Disclosure - INVESTMENTS (Details Narrative) Sheet http://draganfly.com/role/InvestmentsDetailsNarrative INVESTMENTS (Details Narrative) Details http://draganfly.com/role/InvestmentsTables 69 false false R70.htm 995575 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 70 false false R71.htm 995576 - Disclosure - EQUIPMENT (Details Narrative) Sheet http://draganfly.com/role/EquipmentDetailsNarrative EQUIPMENT (Details Narrative) Details http://draganfly.com/role/EquipmentTables 71 false false R72.htm 995577 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details) Sheet http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails SCHEDULE OF INTELLECTUAL PROPERTY (Details) Details 72 false false R73.htm 995578 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Details http://draganfly.com/role/IntangibleAssetsAndGoodwillTables 73 false false R74.htm 995579 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) Sheet http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails SCHEDULE OF RIGHT OF USE ASSETS (Details) Details 74 false false R75.htm 995580 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details) Sheet http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details) Details 75 false false R76.htm 995581 - Disclosure - RIGHT OF USE ASSETS (Details Narrative) Sheet http://draganfly.com/role/RightOfUseAssetsDetailsNarrative RIGHT OF USE ASSETS (Details Narrative) Details http://draganfly.com/role/RightOfUseAssetsTables 76 false false R77.htm 995582 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Sheet http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Details 77 false false R78.htm 995583 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) Sheet http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) Details 78 false false R79.htm 995584 - Disclosure - LEASE LIABILITES (Details Narrative) Sheet http://draganfly.com/role/LeaseLiabilitesDetailsNarrative LEASE LIABILITES (Details Narrative) Details http://draganfly.com/role/LeaseLiabilitesTables 79 false false R80.htm 995585 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) Details 80 false false R81.htm 995586 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details) Sheet http://draganfly.com/role/ScheduleOfDeferredIncomeDetails SCHEDULE OF DEFERRED INCOME (Details) Details 81 false false R82.htm 995587 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details) Sheet http://draganfly.com/role/ScheduleOfLoansPayableDetails SCHEDULE OF LOANS PAYABLE (Details) Details 82 false false R83.htm 995588 - Disclosure - SCHEDULE OF LOANS (Details) Sheet http://draganfly.com/role/ScheduleOfLoansDetails SCHEDULE OF LOANS (Details) Details 83 false false R84.htm 995589 - Disclosure - DEFERRED INCOME (Details Narrative) Sheet http://draganfly.com/role/DeferredIncomeDetailsNarrative DEFERRED INCOME (Details Narrative) Details http://draganfly.com/role/DeferredIncomeTables 84 false false R85.htm 995590 - Disclosure - LOANS PAYABLE (Details Narrative) Sheet http://draganfly.com/role/LoansPayableDetailsNarrative LOANS PAYABLE (Details Narrative) Details http://draganfly.com/role/LoansPayableTables 85 false false R86.htm 995591 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Sheet http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Details 86 false false R87.htm 995592 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details) Sheet http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details) Details 87 false false R88.htm 995593 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Details 88 false false R89.htm 995594 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) Sheet http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) Details 89 false false R90.htm 995595 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) Details 90 false false R91.htm 995596 - Disclosure - SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details) Details 91 false false R92.htm 995597 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) Details 92 false false R93.htm 995598 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details) Sheet http://draganfly.com/role/SummaryOfChangesInWarrantsDetails SUMMARY OF CHANGES IN WARRANTS (Details) Details 93 false false R94.htm 995599 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails SCHEDULE OF WARRANTS OUTSTANDING (Details) Details 94 false false R95.htm 995600 - Disclosure - SHARE CAPITAL (Details Narrative) Sheet http://draganfly.com/role/ShareCapitalDetailsNarrative SHARE CAPITAL (Details Narrative) Details http://draganfly.com/role/ShareCapitalTables 95 false false R96.htm 995601 - Disclosure - SCHEDULE OF SEGMENTED INFORMATION (Details) Sheet http://draganfly.com/role/ScheduleOfSegmentedInformationDetails SCHEDULE OF SEGMENTED INFORMATION (Details) Details 96 false false R97.htm 995602 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details) Sheet http://draganfly.com/role/ScheduleOfGeographicRevenueDetails SCHEDULE OF GEOGRAPHIC REVENUE (Details) Details 97 false false R98.htm 995603 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) Sheet http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) Details 98 false false R99.htm 995604 - Disclosure - SCHEDULE OF KEY COMPENSATION AWARDS (Details) Sheet http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails SCHEDULE OF KEY COMPENSATION AWARDS (Details) Details 99 false false R100.htm 995605 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) Sheet http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) Details 100 false false R101.htm 995606 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://draganfly.com/role/RelatedPartyTransactionsTables 101 false false R102.htm 995607 - Disclosure - SCHEDULE OF AGING OF RECEIVABLES (Details) Sheet http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails SCHEDULE OF AGING OF RECEIVABLES (Details) Details 102 false false R103.htm 995608 - Disclosure - SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details) Sheet http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details) Details 103 false false R104.htm 995609 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) Sheet http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) Details 104 false false R105.htm 995610 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) Sheet http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) Details 105 false false R106.htm 995611 - Disclosure - SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details) Sheet http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details) Details 106 false false R107.htm 995612 - Disclosure - SCHEDULE OF INCOME TAX (Details) Sheet http://draganfly.com/role/ScheduleOfIncomeTaxDetails SCHEDULE OF INCOME TAX (Details) Details 107 false false R108.htm 995613 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details) Sheet http://draganfly.com/role/ScheduleOfDeferredTaxesDetails SCHEDULE OF DEFERRED TAXES (Details) Details 108 false false R109.htm 995614 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://draganfly.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://draganfly.com/role/IncomeTaxesTables 109 false false R110.htm 995615 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://draganfly.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://draganfly.com/role/SubsequentEvents 110 false false All Reports Book All Reports dpro-20231231.xsd dpro-20231231_cal.xml dpro-20231231_def.xml dpro-20231231_lab.xml dpro-20231231_pre.xml form20-f.htm form20-f_001.jpg form20-f_002.jpg form20-f_004.jpg mdaaud_001.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 146 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form20-f.htm": { "nsprefix": "DPRO", "nsuri": "http://draganfly.com/20231231", "dts": { "schema": { "local": [ "dpro-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "dpro-20231231_cal.xml" ] }, "definitionLink": { "local": [ "dpro-20231231_def.xml" ] }, "labelLink": { "local": [ "dpro-20231231_lab.xml" ] }, "presentationLink": { "local": [ "dpro-20231231_pre.xml" ] }, "inline": { "local": [ "form20-f.htm" ] } }, "keyStandard": 270, "keyCustom": 193, "axisStandard": 28, "axisCustom": 1, "memberStandard": 38, "memberCustom": 75, "hidden": { "total": 336, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 174, "http://draganfly.com/20231231": 159, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 376, "entityCount": 1, "segmentCount": 120, "elementCount": 811, "unitCount": 6, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1032, "http://xbrl.sec.gov/dei/2023": 46 }, "report": { "R1": { "role": "http://draganfly.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R2": { "role": "http://draganfly.com/role/StatementsOfFinancialPosition", "longName": "00000002 - Statement - Consolidated Statements of Financial Position", "shortName": "Consolidated Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeAndOtherCurrentReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R3": { "role": "http://draganfly.com/role/StatementsOfComprehensiveLoss", "longName": "00000003 - Statement - Consolidated Statements of Comprehensive Loss", "shortName": "Consolidated Statements of Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:GrossProfit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R4": { "role": "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "longName": "00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R5": { "role": "http://draganfly.com/role/StatementsOfCashFlows", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:LossForAdjustments", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:LossForAdjustments", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R6": { "role": "http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcern", "longName": "995511 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN", "shortName": "NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNatureAndContinuanceOfOperationsAndGoingConcernExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNatureAndContinuanceOfOperationsAndGoingConcernExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R7": { "role": "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparation", "longName": "995512 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R8": { "role": "http://draganfly.com/role/ManagementJudgementAndAssumptions", "longName": "995513 - Disclosure - MANAGEMENT JUDGEMENT AND ASSUMPTIONS", "shortName": "MANAGEMENT JUDGEMENT AND ASSUMPTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfManagementJudgementAndAssumptionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfManagementJudgementAndAssumptionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R9": { "role": "http://draganfly.com/role/CashAndCashEquivalents", "longName": "995514 - Disclosure - CASH AND CASH EQUIVALENTS", "shortName": "CASH AND CASH EQUIVALENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R10": { "role": "http://draganfly.com/role/Receivables", "longName": "995515 - Disclosure - RECEIVABLES", "shortName": "RECEIVABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfAmountsReceivableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfAmountsReceivableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R11": { "role": "http://draganfly.com/role/Inventory", "longName": "995516 - Disclosure - INVENTORY", "shortName": "INVENTORY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R12": { "role": "http://draganfly.com/role/NotesReceivable", "longName": "995517 - Disclosure - NOTES RECEIVABLE", "shortName": "NOTES RECEIVABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNotesReceivableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNotesReceivableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R13": { "role": "http://draganfly.com/role/Prepaids", "longName": "995518 - Disclosure - PREPAIDS", "shortName": "PREPAIDS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R14": { "role": "http://draganfly.com/role/Investments", "longName": "995519 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R15": { "role": "http://draganfly.com/role/Equipment", "longName": "995520 - Disclosure - EQUIPMENT", "shortName": "EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R16": { "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwill", "longName": "995521 - Disclosure - INTANGIBLE ASSETS AND GOODWILL", "shortName": "INTANGIBLE ASSETS AND GOODWILL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R17": { "role": "http://draganfly.com/role/RightOfUseAssets", "longName": "995522 - Disclosure - RIGHT OF USE ASSETS", "shortName": "RIGHT OF USE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R18": { "role": "http://draganfly.com/role/LeaseLiabilites", "longName": "995523 - Disclosure - LEASE LIABILITES", "shortName": "LEASE LIABILITES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R19": { "role": "http://draganfly.com/role/TradePayablesAndAccruedLiabilities", "longName": "995524 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES", "shortName": "TRADE PAYABLES AND ACCRUED LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R20": { "role": "http://draganfly.com/role/DeferredIncome", "longName": "995525 - Disclosure - DEFERRED INCOME", "shortName": "DEFERRED INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R21": { "role": "http://draganfly.com/role/LoansPayable", "longName": "995526 - Disclosure - LOANS PAYABLE", "shortName": "LOANS PAYABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R22": { "role": "http://draganfly.com/role/ShareCapital", "longName": "995527 - Disclosure - SHARE CAPITAL", "shortName": "SHARE CAPITAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R23": { "role": "http://draganfly.com/role/SegmentedInformation", "longName": "995528 - Disclosure - SEGMENTED INFORMATION", "shortName": "SEGMENTED INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R24": { "role": "http://draganfly.com/role/OfficeAndMiscellaneous", "longName": "995529 - Disclosure - OFFICE AND MISCELLANEOUS", "shortName": "OFFICE AND MISCELLANEOUS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R25": { "role": "http://draganfly.com/role/RelatedPartyTransactions", "longName": "995530 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R26": { "role": "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement", "longName": "995531 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R27": { "role": "http://draganfly.com/role/IncomeTaxes", "longName": "995532 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R28": { "role": "http://draganfly.com/role/SubsequentEvents", "longName": "995533 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R29": { "role": "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies", "longName": "995534 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:StatementOfIFRSCompliance", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:StatementOfIFRSCompliance", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R30": { "role": "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables", "longName": "995535 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R31": { "role": "http://draganfly.com/role/CashAndCashEquivalentsTables", "longName": "995536 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)", "shortName": "CASH AND CASH EQUIVALENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R32": { "role": "http://draganfly.com/role/ReceivablesTables", "longName": "995537 - Disclosure - RECEIVABLES (Tables)", "shortName": "RECEIVABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R33": { "role": "http://draganfly.com/role/InventoryTables", "longName": "995538 - Disclosure - INVENTORY (Tables)", "shortName": "INVENTORY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfInventoriesInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfInventoriesInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R34": { "role": "http://draganfly.com/role/NotesReceivableTables", "longName": "995539 - Disclosure - NOTES RECEIVABLE (Tables)", "shortName": "NOTES RECEIVABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNotesReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfNotesReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R35": { "role": "http://draganfly.com/role/PrepaidsTables", "longName": "995540 - Disclosure - PREPAIDS (Tables)", "shortName": "PREPAIDS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R36": { "role": "http://draganfly.com/role/InvestmentsTables", "longName": "995541 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfInvestmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfInvestmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R37": { "role": "http://draganfly.com/role/EquipmentTables", "longName": "995542 - Disclosure - EQUIPMENT (Tables)", "shortName": "EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R38": { "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwillTables", "longName": "995543 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R39": { "role": "http://draganfly.com/role/RightOfUseAssetsTables", "longName": "995544 - Disclosure - RIGHT OF USE ASSETS (Tables)", "shortName": "RIGHT OF USE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R40": { "role": "http://draganfly.com/role/LeaseLiabilitesTables", "longName": "995545 - Disclosure - LEASE LIABILITES (Tables)", "shortName": "LEASE LIABILITES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R41": { "role": "http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables", "longName": "995546 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)", "shortName": "TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R42": { "role": "http://draganfly.com/role/DeferredIncomeTables", "longName": "995547 - Disclosure - DEFERRED INCOME (Tables)", "shortName": "DEFERRED INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:ScheduleOfDeferredIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:ScheduleOfDeferredIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R43": { "role": "http://draganfly.com/role/LoansPayableTables", "longName": "995548 - Disclosure - LOANS PAYABLE (Tables)", "shortName": "LOANS PAYABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfLoansPayableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfLoansPayableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R44": { "role": "http://draganfly.com/role/ShareCapitalTables", "longName": "995549 - Disclosure - SHARE CAPITAL (Tables)", "shortName": "SHARE CAPITAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R45": { "role": "http://draganfly.com/role/SegmentedInformationTables", "longName": "995550 - Disclosure - SEGMENTED INFORMATION (Tables)", "shortName": "SEGMENTED INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R46": { "role": "http://draganfly.com/role/OfficeAndMiscellaneousTables", "longName": "995551 - Disclosure - OFFICE AND MISCELLANEOUS (Tables)", "shortName": "OFFICE AND MISCELLANEOUS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R47": { "role": "http://draganfly.com/role/RelatedPartyTransactionsTables", "longName": "995552 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R48": { "role": "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables", "longName": "995553 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R49": { "role": "http://draganfly.com/role/IncomeTaxesTables", "longName": "995554 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R50": { "role": "http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcernDetailsNarrative", "longName": "995555 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative)", "shortName": "NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:RetainedEarnings", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R51": { "role": "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails", "longName": "995556 - Disclosure - SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details)", "shortName": "SCHEDULE OF WHOLLY OWNED SUBSIDIARIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DragonflyInnovationsIncMember", "name": "ifrs-full:NameOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DragonflyInnovationsIncMember", "name": "ifrs-full:NameOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R52": { "role": "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails", "longName": "995557 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_CustomerRelationshipIntangibleAssetsMember", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_CustomerRelationshipIntangibleAssetsMember", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R53": { "role": "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "longName": "995558 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details)", "shortName": "SCHEDULE OF CLASS OF EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember", "name": "DPRO:DepreciationPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfClassOfEquipmentExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember", "name": "DPRO:DepreciationPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfClassOfEquipmentExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R54": { "role": "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative", "longName": "995559 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:AggregateSalePriceDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:AggregateSalePriceDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R55": { "role": "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails", "longName": "995560 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:BalancesWithBanks", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:BalancesWithBanks", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R56": { "role": "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "longName": "995561 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)", "shortName": "CASH AND CASH EQUIVALENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2022-08-232022-08-23_custom_GuaranteedInvestmentCertificateMember", "name": "DPRO:PurchaseOfFinancialInstruments", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-08-232022-08-23_custom_GuaranteedInvestmentCertificateMember", "name": "DPRO:PurchaseOfFinancialInstruments", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R57": { "role": "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails", "longName": "995562 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details)", "shortName": "SCHEDULE OF AMOUNTS RECEIVABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R58": { "role": "http://draganfly.com/role/ReceivablesDetailsNarrative", "longName": "995563 - Disclosure - RECEIVABLES (Details Narrative)", "shortName": "RECEIVABLES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:ProvisionForDoubtfulAccount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:ProvisionForDoubtfulAccount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfAmountsReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R59": { "role": "http://draganfly.com/role/ScheduleOfInventoriesDetails", "longName": "995564 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "shortName": "SCHEDULE OF INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinishedGoods", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfInventoriesInformationExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinishedGoods", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfInventoriesInformationExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R60": { "role": "http://draganfly.com/role/ScheduleOfCostOfSalesDetails", "longName": "995565 - Disclosure - SCHEDULE OF COST OF SALES (Details)", "shortName": "SCHEDULE OF COST OF SALES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R61": { "role": "http://draganfly.com/role/InventoryDetailsNarrative", "longName": "995566 - Disclosure - INVENTORY (Details Narrative)", "shortName": "INVENTORY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CostOfSales", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ReversalOfInventoryWritedown", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R62": { "role": "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "longName": "995567 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details)", "shortName": "DISCLOSURE OF NOTES RECEIVABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:NoteReceivableFaceAmount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:NoteReceivableFaceAmount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R63": { "role": "http://draganfly.com/role/NotesReceivableDetailsNarrative", "longName": "995568 - Disclosure - NOTES RECEIVABLE (Details Narrative)", "shortName": "NOTES RECEIVABLE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ImpairmentLoss", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "ifrs-full:RepaymentsOfCurrentBorrowings", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfNotesReceivableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R64": { "role": "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "longName": "995569 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:CurrentInsuranceExpenses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:CurrentInsuranceExpenses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R65": { "role": "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetailsParenthetical", "longName": "995570 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical)", "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "DPRO:WriteDownOfDeposit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R66": { "role": "http://draganfly.com/role/ScheduleOfInvestmentsDetails", "longName": "995571 - Disclosure - SCHEDULE OF INVESTMENTS (Details)", "shortName": "SCHEDULE OF INVESTMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:InvestmentProperty", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:LossesOnChangeInFairValueOfDerivatives", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfInvestmentExplanatory", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R67": { "role": "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails", "longName": "995572 - Disclosure - SCHEDULE OF FAIR VALUE OF INVESTMENT (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF INVESTMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:InvestmentProperty", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_PublicCompanySharesMember", "name": "ifrs-full:InvestmentProperty", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfFairValueOfInvestmentExplanatory", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R68": { "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "longName": "995573 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://draganfly.com/role/InvestmentsDetailsNarrative", "longName": "995574 - Disclosure - INVESTMENTS (Details Narrative)", "shortName": "INVESTMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2021-10-252021-10-27", "name": "DPRO:NumberOfSharesPurchased", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2021-10-252021-10-27", "name": "DPRO:NumberOfSharesPurchased", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R70": { "role": "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "995575 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "DPRO:PropertyPlantAndEquipmentCost", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "DPRO:PropertyPlantAndEquipmentCost", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R71": { "role": "http://draganfly.com/role/EquipmentDetailsNarrative", "longName": "995576 - Disclosure - EQUIPMENT (Details Narrative)", "shortName": "EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_RentalServicesMember", "name": "DPRO:NonCashTransferOfEquipmentFromInventory", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_RentalServicesMember", "name": "DPRO:NonCashTransferOfEquipmentFromInventory", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R72": { "role": "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "longName": "995577 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details)", "shortName": "SCHEDULE OF INTELLECTUAL PROPERTY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:IntangibleAssetsIncludingGoodwill", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R73": { "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "longName": "995578 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R74": { "role": "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails", "longName": "995579 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details)", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R75": { "role": "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails", "longName": "995580 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details)", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_BuildingsMember", "name": "ifrs-full:RightofuseAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssetsRelatedToLeases", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R76": { "role": "http://draganfly.com/role/RightOfUseAssetsDetailsNarrative", "longName": "995581 - Disclosure - RIGHT OF USE ASSETS (Details Narrative)", "shortName": "RIGHT OF USE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "longName": "995582 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:LeaseLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R78": { "role": "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails", "longName": "995583 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details)", "shortName": "SCHEDULE OF OPERATING MATURITY ANALYSIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R79": { "role": "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "longName": "995584 - Disclosure - LEASE LIABILITES (Details Narrative)", "shortName": "LEASE LIABILITES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DepreciationLeaseLiability", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:DepreciationLeaseLiability", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R80": { "role": "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails", "longName": "995585 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details)", "shortName": "SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R81": { "role": "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "longName": "995586 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details)", "shortName": "SCHEDULE OF DEFERRED INCOME (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredRevenueBeginning", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:ScheduleOfDeferredIncomeExplanatory", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredRevenueBeginning", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:ScheduleOfDeferredIncomeExplanatory", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R82": { "role": "http://draganfly.com/role/ScheduleOfLoansPayableDetails", "longName": "995587 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details)", "shortName": "SCHEDULE OF LOANS PAYABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "DPRO:LoansPayableAmount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfLoansPayableExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "DPRO:LoansPayableAmount", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfLoansPayableExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R83": { "role": "http://draganfly.com/role/ScheduleOfLoansDetails", "longName": "995588 - Disclosure - SCHEDULE OF LOANS (Details)", "shortName": "SCHEDULE OF LOANS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "AsOf2020-05-19", "name": "ifrs-full:BorrowingsInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:LoansAndAdvancesToBanks", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R84": { "role": "http://draganfly.com/role/DeferredIncomeDetailsNarrative", "longName": "995589 - Disclosure - DEFERRED INCOME (Details Narrative)", "shortName": "DEFERRED INCOME (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredRevenues", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredRevenues", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R85": { "role": "http://draganfly.com/role/LoansPayableDetailsNarrative", "longName": "995590 - Disclosure - LOANS PAYABLE (Details Narrative)", "shortName": "LOANS PAYABLE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2020-05-19", "name": "ifrs-full:BorrowingsInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-05-19_custom_CanadaEmergencyBusinessAccountMember", "name": "ifrs-full:LoansReceived", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R86": { "role": "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "longName": "995591 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "shortName": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ExercisePriceOneMember_custom_IncentiveShareCompensationPlanMember", "name": "DPRO:StockOptionsGrantDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R87": { "role": "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails", "longName": "995592 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details)", "shortName": "SCHEDULE OF STOCK OPTIONS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "unitRef": "CADPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R88": { "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "longName": "995593 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R89": { "role": "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "longName": "995594 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details)", "shortName": "SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_custom_IfrsRestrictedStockUnitsRsuMember", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R90": { "role": "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "longName": "995595 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)", "shortName": "SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_WarrantsMember", "name": "DPRO:GainsLossesOnChangeInFairValueOfDerivative", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfWarrantDerivativeLiabilityExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_WarrantsMember", "name": "DPRO:GainsLossesOnChangeInFairValueOfDerivative", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfWarrantDerivativeLiabilityExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R91": { "role": "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "longName": "995596 - Disclosure - SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details)", "shortName": "SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:CurrentWarrantFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R92": { "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "longName": "995597 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_ifrs-full_WarrantsMember_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R93": { "role": "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails", "longName": "995598 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details)", "shortName": "SUMMARY OF CHANGES IN WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_WarrantsMember66932625", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "CADPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfChangeInWarrantsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R94": { "role": "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "995599 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_WarrantOneMember", "name": "DPRO:CompensationWarrantsIssuedDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_WarrantOneMember", "name": "DPRO:CompensationWarrantsIssuedDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R95": { "role": "http://draganfly.com/role/ShareCapitalDetailsNarrative", "longName": "995600 - Disclosure - SHARE CAPITAL (Details Narrative)", "shortName": "SHARE CAPITAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:SharesIssuedForFinancingCost", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R96": { "role": "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "longName": "995601 - Disclosure - SCHEDULE OF SEGMENTED INFORMATION (Details)", "shortName": "SCHEDULE OF SEGMENTED INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:SegmentGainIncomeLoss", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R97": { "role": "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "longName": "995602 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details)", "shortName": "SCHEDULE OF GEOGRAPHIC REVENUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:GeographicNoncurrentAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:GeographicNoncurrentAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R98": { "role": "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails", "longName": "995603 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details)", "shortName": "SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdvertisingExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdvertisingExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R99": { "role": "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails", "longName": "995604 - Disclosure - SCHEDULE OF KEY COMPENSATION AWARDS (Details)", "shortName": "SCHEDULE OF KEY COMPENSATION AWARDS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:KeyManagementPersonnelCompensationDirectorFees", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "DPRO:KeyManagementPersonnelCompensationDirectorFees", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R100": { "role": "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails", "longName": "995605 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details)", "shortName": "SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:KeyManagementPersonnelCompensation", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_CEOAndDirectorMember", "name": "ifrs-full:KeyManagementPersonnelCompensation", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R101": { "role": "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "995606 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfessionalFeesExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R102": { "role": "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails", "longName": "995607 - Disclosure - SCHEDULE OF AGING OF RECEIVABLES (Details)", "shortName": "SCHEDULE OF AGING OF RECEIVABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R103": { "role": "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails", "longName": "995608 - Disclosure - SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details)", "shortName": "SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R104": { "role": "http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails", "longName": "995609 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details)", "shortName": "SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ForeignExchangeGain", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ForeignExchangeGain", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R105": { "role": "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails", "longName": "995610 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details)", "shortName": "SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R106": { "role": "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails", "longName": "995611 - Disclosure - SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details)", "shortName": "SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember", "name": "DPRO:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember", "name": "DPRO:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R107": { "role": "http://draganfly.com/role/ScheduleOfIncomeTaxDetails", "longName": "995612 - Disclosure - SCHEDULE OF INCOME TAX (Details)", "shortName": "SCHEDULE OF INCOME TAX (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R108": { "role": "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails", "longName": "995613 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details)", "shortName": "SCHEDULE OF DEFERRED TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredTaxAssetsShareIssuanceCosts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "DPRO:DeferredTaxAssetsShareIssuanceCosts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R109": { "role": "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "longName": "995614 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember", "name": "ifrs-full:TaxEffectOfTaxLosses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember", "name": "ifrs-full:TaxEffectOfTaxLosses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R110": { "role": "http://draganfly.com/role/SubsequentEventsDetailsNarrative", "longName": "995615 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "ifrs-full:ProceedsFromExerciseOfWarrants", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-26_custom_NonadjustmentEventsMember_custom_UnderwrittenSharePlacementMember_ifrs-full_OrdinarySharesMember", "name": "ifrs-full:ParValuePerShare", "unitRef": "CADPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } } }, "tag": { "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Loss before income taxes" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r39", "r40" ] }, "DPRO_AccretionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccretionExpenses", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "lang": { "en-us": { "role": { "label": "Accretion expense", "documentation": "Accretion expenses." } } }, "auth_ref": [] }, "ifrs-full_AccrualsAndDeferredIncomeIncludingContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccrualsAndDeferredIncomeIncludingContractLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Income net", "label": "Accruals and deferred income including contract liabilities" } }, "en": { "role": { "documentation": "The amount of accruals and deferred income, including contract liabilities. [Refer: Accruals; Deferred income including contract liabilities]" } } }, "auth_ref": [ "r349", "r351" ] }, "DPRO_AccumulatedAmortizationForeignExchangeTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccumulatedAmortizationForeignExchangeTranslation", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange translation", "documentation": "Accumulated amortization foreign exchange translation.", "label": "AccumulatedAmortizationForeignExchangeTranslation" } } }, "auth_ref": [] }, "DPRO_AccumulatedAmortizationImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccumulatedAmortizationImpairment", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment", "label": "AccumulatedAmortizationImpairment" } } }, "auth_ref": [] }, "DPRO_AccumulatedAmortizationIntellectualPropertiesAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccumulatedAmortizationIntellectualPropertiesAndGoodwill", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at December 31, 2022", "periodEndLabel": "Balance at December 31, 2023", "documentation": "Accumulated amortization intellectual properties and goodwill.", "label": "AccumulatedAmortizationIntellectualPropertiesAndGoodwill" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAndAmortisationMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r48", "r356", "r362", "r366", "r367" ] }, "ifrs-full_AccumulatedImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedImpairmentMember", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated impairment [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]" } } }, "auth_ref": [ "r170", "r180", "r247", "r356", "r362", "r366", "r367" ] }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedOtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income (loss)" } }, "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } } }, "auth_ref": [ "r349" ] }, "DPRO_AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Disposals", "documentation": "Accumulated depreciation of disposal of property plant and equipment.", "label": "AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment" } } }, "auth_ref": [] }, "DPRO_AccumulateddepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AccumulateddepreciationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated depreciation Property, plant and equipment, beginning balance", "periodEndLabel": "Accumulated depreciation Property, plant and equipment, ending balance", "documentation": "Accumulated depreciation property, plant and equipment.", "label": "AccumulateddepreciationPropertyPlantAndEquipment" } } }, "auth_ref": [] }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Contingent consideration", "label": "Consideration transferred, acquisition-date fair value" } }, "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r167" ] }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfDiscountRates", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Assumption discount rates" } }, "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r357" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r302" ] }, "DPRO_AdditionsLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AdditionsLeaseLiabilities", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "documentation": "Additions lease liabilities.", "label": "AdditionsLeaseLiabilities" } } }, "auth_ref": [] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "label": "Additions other than through business combinations, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r88" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r44" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://draganfly.com/role/RightOfUseAssetsDetailsNarrative", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Right of use assets, Cost, Additions", "verboseLabel": "Additional right of the assets" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r137" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r308" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r308" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r308" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r308" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - Diluted" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r80" ] }, "ifrs-full_AdjustmentsForAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForAmortisationExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization", "label": "Adjustments for amortisation expense" } }, "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Adjustments for decrease (increase) in inventories" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaids", "label": "Adjustments for decrease (increase) in prepaid expenses" } }, "en": { "role": { "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Receivables", "label": "Adjustments for decrease (increase) in trade accounts receivable" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation", "label": "Adjustments for depreciation expense" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDepositsFromCustomers", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Customer deposits", "label": "Adjustments for increase (decrease) in deposits from customers" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in deposits from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deposits from customers; Profit (loss)]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade payables and accrued liabilities", "label": "Adjustments for increase (decrease) in trade accounts payable" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForReconcileProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLoss", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Adjustments for profit loss", "label": "Adjustments to reconcile profit (loss)" } }, "en": { "role": { "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for:" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 8.0 }, "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share-based payments", "verboseLabel": "Adjustments for share-based payments" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdvertisingExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising, Marketing, and Investor Relations" } }, "en": { "role": { "documentation": "The amount of expense arising from advertising." } } }, "auth_ref": [ "r347" ] }, "DPRO_AggregateSalePriceDescription": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AggregateSalePriceDescription", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate sale price", "documentation": "Aggregate sale price description." } } }, "auth_ref": [] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r19", "r132", "r141", "r142", "r146", "r147", "r148", "r153", "r175", "r221", "r249", "r251" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r272", "r284", "r294", "r320" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r275", "r287", "r297", "r323" ] }, "DPRO_AlbertaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AlbertaLtdMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Alberta lltd [member]", "documentation": "Alberta lltd [member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r308" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r315" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r279", "r288", "r298", "r315", "r324", "r328", "r336" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r50", "r125" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r334" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Amortization" } }, "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } } }, "auth_ref": [ "r347" ] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Charge for the year", "label": "Amortisation, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r90" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Indebted amount" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r62", "r66" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r280" ] }, "ifrs-full_AntidilutiveInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AntidilutiveInstrumentsMember", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r81" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Canadian statutory rates" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r40" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r16", "r124", "r125", "r127", "r192", "r195" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r280" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r265", "r267", "r280" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r265", "r267", "r280" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r265", "r267", "r280" ] }, "DPRO_AverageEffectiveInstrumentRate": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "AverageEffectiveInstrumentRate", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Average effective Instrument rate", "documentation": "Average effective instrument rate." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r331" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r332" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r327" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r327" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r327" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r327" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r327" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r327" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r330" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r329" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r328" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r328" ] }, "DPRO_BadDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BadDebt", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Bad debt", "documentation": "Bad debt.", "label": "BadDebt" } } }, "auth_ref": [] }, "ifrs-full_BalancesWithBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BalancesWithBanks", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash held in banks" } }, "en": { "role": { "documentation": "The amount of cash balances held at banks." } } }, "auth_ref": [ "r373" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) per share - Diluted" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r78", "r79" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r377" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Rate", "label": "Interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Maturity Date" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r377" ] }, "DPRO_BorrowingsMaturityStartDay": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BorrowingsMaturityStartDay", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Start Date", "documentation": "Borrowings maturity start day." } } }, "auth_ref": [] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r129", "r148", "r163", "r235", "r237", "r377" ] }, "DPRO_BrandAndSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BrandAndSoftwareMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Brand and software [member]", "documentation": "Brand and software [member]" } } }, "auth_ref": [] }, "ifrs-full_BrandNamesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BrandNamesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Brand names [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r223" ] }, "DPRO_BrokerWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BrokerWarrantsMember", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Broker Warrants [Member]", "documentation": "Broker Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_BuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BuildingsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Buildings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r355" ] }, "DPRO_BusinessAcquisitionDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BusinessAcquisitionDerivativeLiability", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability", "documentation": "Business acquisition derivative liability.", "label": "BusinessAcquisitionDerivativeLiability" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r267", "r280" ] }, "DPRO_BusinessInstinctsGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BusinessInstinctsGroupMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business instincts group [member]", "documentation": "Business instincts group [member]" } } }, "auth_ref": [] }, "DPRO_BusinessServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "BusinessServicesAgreementMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business services agreement [member]", "documentation": "Business services agreement [member]" } } }, "auth_ref": [] }, "DPRO_CAMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CAMember", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en-us": { "role": { "label": "CA [member]", "documentation": "CA [member]" } } }, "auth_ref": [] }, "DPRO_CEOAndDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CEOAndDirectorMember", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "CEO and director [member]", "documentation": "CEO and director [member]" } } }, "auth_ref": [] }, "DPRO_CEOMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CEOMember", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "CEO [member]", "documentation": "CEO [member]" } } }, "auth_ref": [] }, "DPRO_CanadaEmergencyBusinessAccountLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CanadaEmergencyBusinessAccountLoanMember", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "CEBA [member]", "documentation": "CEBA [member]", "label": "CEBA [member] [Default Label]" } } }, "auth_ref": [] }, "DPRO_CanadaEmergencyBusinessAccountMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CanadaEmergencyBusinessAccountMember", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "CEBA [member]", "documentation": "CEBA [member]" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r43", "r46", "r87", "r91", "r95", "r96", "r97", "r99", "r100", "r170", "r180", "r181" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r46", "r91", "r95", "r97", "r99", "r170", "r180", "r181" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 }, "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails", "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents, beginning of year", "periodEndLabel": "Cash and cash equivalents, end of year", "totalLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r12", "r106", "r121" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash provided by (used in) financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r101", "r107" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash provided by (used in) investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r101", "r107" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "INVESTING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash used in operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r101", "r107" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r65" ] }, "DPRO_ChangeInFairValueOfWarrantOfDerivativesOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ChangeInFairValueOfWarrantOfDerivativesOutstanding", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of warrants outstanding", "documentation": "Change in fair value of warrant of derivatives outstanding.", "label": "ChangeInFairValueOfWarrantOfDerivativesOutstanding" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r306" ] }, "DPRO_ChangesInItemsOfWorkingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ChangesInItemsOfWorkingCapitalAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net changes in non-cash working capital items:", "documentation": "Changes in items of working capital abstract." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r180", "r182", "r183", "r184" ] }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r180", "r182", "r183", "r184" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r364" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r92" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r47" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r27" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r307" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r307" ] }, "DPRO_CommonSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CommonSharesMember", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common shares [member]", "documentation": "Common shares [member]" } } }, "auth_ref": [] }, "DPRO_CommonStock1Member": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CommonStock1Member", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock 1 [member]", "documentation": "Common stock 1 [member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r312" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r311" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r313" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r310" ] }, "DPRO_CompensationWarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CompensationWarrantsExercisePrice", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "documentation": "Compensation warrants, exercise price.", "label": "CompensationWarrantsExercisePrice" } } }, "auth_ref": [] }, "DPRO_CompensationWarrantsIssuedDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CompensationWarrantsIssuedDate", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Date issued", "documentation": "Compensation warrants issued date." } } }, "auth_ref": [] }, "DPRO_CompensationWarrantsNumberOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CompensationWarrantsNumberOfWarrants", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Number of warrants outstanding", "documentation": "Compensation warrants number of warrants." } } }, "auth_ref": [] }, "DPRO_ComplianceFees": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ComplianceFees", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Compliance fees", "documentation": "Compliance fees." } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r4" ] }, "DPRO_ComponentsOfOtherComprehensiveIncomeThatMayBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ComponentsOfOtherComprehensiveIncomeThatMayBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that may be reclassified to profit or loss", "documentation": "Components of other comprehensive income that may be reclassified to profit or loss net of tax abstract." } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will not be reclassified to profit or loss" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "COMPREHENSIVE LOSS FOR THE YEAR", "label": "Comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r30", "r109", "r111", "r119", "r232" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r355" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer software [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r224" ] }, "DPRO_ConsultingAndServices": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ConsultingAndServices", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "lang": { "en-us": { "role": { "label": "Consulting and services", "documentation": "Consulting and services." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "DPRO_ContractWork": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ContractWork", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Contract Work", "documentation": "Contract work." } } }, "auth_ref": [] }, "DPRO_CorporatesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CorporatesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Corporates [member]", "documentation": "Corporates [member]" } } }, "auth_ref": [] }, "ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfInventoriesRecognisedAsExpenseDuringPeriod", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Cost of inventories recognised as expense during period" } }, "en": { "role": { "documentation": "The amount of inventories recognised as an expense during the period. [Refer: Inventories]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/ScheduleOfCostOfSalesDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "COST OF SALES", "totalLabel": "Cost of sales", "label": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r35" ] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r188" ] }, "ifrs-full_CounterpartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r188" ] }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Country of incorporation of subsidiary" } }, "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r71", "r75", "r113", "r115" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r20", "r117", "r232" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "DPRO_CurrentDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentDeposits", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Current deposits." } } }, "auth_ref": [] }, "ifrs-full_CurrentDepositsFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDepositsFromCustomers", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Customer deposits" } }, "en": { "role": { "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Derivative liability" } }, "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLoss", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Total" } }, "en": { "role": { "documentation": "The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]" } } }, "auth_ref": [ "r187" ] }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative liability", "documentation": "Current financial assets at fair value through profit or loss of derivative liability.", "label": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability" } } }, "auth_ref": [] }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Equity securities in investee companies", "documentation": "Current financial assets at fair value through profit or loss of equity." } } }, "auth_ref": [] }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Notes receivable", "documentation": "Current financial assets at fair value through profit or loss of notes receivable.", "label": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "DPRO_CurrentInsuranceExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentInsuranceExpenses", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Insurance", "documentation": "Current insurance expenses.", "label": "CurrentInsuranceExpenses" } } }, "auth_ref": [] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "verboseLabel": "Current lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r134" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r21", "r118", "r232" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "DPRO_CurrentLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentLoansPayable", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Loans payable", "documentation": "Current loans payable." } } }, "auth_ref": [] }, "ifrs-full_CurrentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentMember", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current [member]" } }, "en": { "role": { "documentation": "This member stands for a current time band." } } }, "auth_ref": [ "r247", "r252" ] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 }, "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Prepaids", "totalLabel": "Prepaid expenses and deposits" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r347" ] }, "DPRO_CurrentPrepaidInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentPrepaidInterest", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid interest", "documentation": "Current prepaid interest." } } }, "auth_ref": [] }, "DPRO_CurrentPrepaidMarketingServices": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentPrepaidMarketingServices", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid marketing services", "documentation": "Current prepaid marketing services." } } }, "auth_ref": [] }, "DPRO_CurrentPrepaidRent": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentPrepaidRent", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid rent", "documentation": "Current prepaid rent." } } }, "auth_ref": [] }, "DPRO_CurrentPrepaidSubscriptions": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentPrepaidSubscriptions", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid subscriptions", "documentation": "Current prepaid subscriptions." } } }, "auth_ref": [] }, "DPRO_CurrentWarrantFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CurrentWarrantFairValue", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value of warrants", "documentation": "Current warrants fair value." } } }, "auth_ref": [] }, "DPRO_CustomerDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CustomerDepositsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Customer deposits [member]", "documentation": "Customer deposits [member]" } } }, "auth_ref": [] }, "DPRO_CustomerRelationshipIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "CustomerRelationshipIntangibleAssetsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Customer relationship intangible assets [member]", "documentation": "Customer relationship intangible assets [member]" } } }, "auth_ref": [] }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CustomerrelatedIntangibleAssetsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Customer-related intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } } }, "auth_ref": [ "r365" ] }, "DPRO_DeferredIncomeGross": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredIncomeGross", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income gross", "documentation": "Deferred income gross.", "label": "DeferredIncomeGross" } } }, "auth_ref": [] }, "ifrs-full_DeferredIncomeIncludingContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredIncomeIncludingContractLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": "ifrs-full_AccrualsAndDeferredIncomeIncludingContractLiabilities", "weight": 1.0, "order": 1.0 }, "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred income", "verboseLabel": "Current portion" } }, "en": { "role": { "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, including contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r349", "r351" ] }, "DPRO_DeferredIncomeIncludingContractLiabilitiesNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredIncomeIncludingContractLiabilitiesNonCurrent", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": "ifrs-full_AccrualsAndDeferredIncomeIncludingContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Long term portion", "documentation": "Deferred income including contract liabilities non current." } } }, "auth_ref": [] }, "DPRO_DeferredIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredIncomeMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income [member]", "documentation": "Deferred income [member]" } } }, "auth_ref": [] }, "DPRO_DeferredRevenueBeginning": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredRevenueBeginning", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": "DPRO_DeferredIncomeGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred, revenue beginning", "documentation": "Deferred revenue beginning." } } }, "auth_ref": [] }, "DPRO_DeferredRevenues": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredRevenues", "crdr": "credit", "presentation": [ "http://draganfly.com/role/DeferredIncomeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Deferred revenues." } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred income tax assets", "label": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r14", "r17", "r41" ] }, "DPRO_DeferredTaxAssetsCapitalGainReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsCapitalGainReserve", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Capital gain reserve", "documentation": "Deferred tax assets capital gain reserve." } } }, "auth_ref": [] }, "DPRO_DeferredTaxAssetsDeferredIncomeTaxNotRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsDeferredIncomeTaxNotRecognized", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income tax not recognized", "documentation": "Deferred tax assets deferred income tax not recognized." } } }, "auth_ref": [] }, "DPRO_DeferredTaxAssetsNoncapitalLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsNoncapitalLosses", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Non-capital losses", "documentation": "Deferred tax assets non capital losses." } } }, "auth_ref": [] }, "DPRO_DeferredTaxAssetsPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsPropertyAndEquipment", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment", "documentation": "Deferred tax assets property and equipment." } } }, "auth_ref": [] }, "DPRO_DeferredTaxAssetsScientificResearchAndExperimentalDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsScientificResearchAndExperimentalDevelopment", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Scientific Research and Experimental Development", "documentation": "Deferred tax assets scientific research and experimental development." } } }, "auth_ref": [] }, "DPRO_DeferredTaxAssetsShareIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DeferredTaxAssetsShareIssuanceCosts", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Share issuance costs", "documentation": "Deferred tax assets share issuance costs." } } }, "auth_ref": [] }, "DPRO_DepreciationDescription": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DepreciationDescription", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation rate, description", "documentation": "Depreciation description." } } }, "auth_ref": [] }, "ifrs-full_DepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Depreciation" } }, "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } } }, "auth_ref": [ "r347" ] }, "DPRO_DepreciationLeaseLiability": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DepreciationLeaseLiability", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation lease liability", "documentation": "Depreciation lease liability." } } }, "auth_ref": [] }, "DPRO_DepreciationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DepreciationPercentage", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation rate", "documentation": "Depreciation percentage." } } }, "auth_ref": [] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Right of use assets, Accumulated depreciation, Charge for the year" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r135" ] }, "DPRO_DerivativeLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DerivativeLiabilityMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability [member]", "documentation": "Derivative liability [member]" } } }, "auth_ref": [] }, "DPRO_DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Goods Sold", "documentation": "Description of accounting policy for cost of goods sold explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Income" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for deferred income tax. [Refer: Deferred tax expense (income)]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Loss per share" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Government Assistance" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of non-financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Income taxes" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets and Goodwill" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Leases" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForMeasuringInventories", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Description of accounting policy for measuring inventories [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r51" ] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Equipment", "label": "Description of accounting policy for property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue recognition" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Research and development expenditures" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r348" ] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payments", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r348" ] }, "DPRO_DescriptionOfExercisableTermOfWarrants": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DescriptionOfExercisableTermOfWarrants", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of exercisable term of warrants", "documentation": "Description of exercisable term of warrants." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "verboseLabel": "Volatility rate" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of cash flow projection" } }, "en": { "role": { "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } } }, "auth_ref": [ "r84", "r85" ] }, "ifrs-full_DescriptionOfNatureOfImpendingChangeInAccountingPolicy": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfNatureOfImpendingChangeInAccountingPolicy", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "New accounting standards issued not yet effective" } }, "en": { "role": { "documentation": "The description of the nature of the impending change or changes in accounting policy due to a new IFRS that has been issued but is not yet effective." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r165" ] }, "DPRO_DescriptionOfSharesIssuance": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DescriptionOfSharesIssuance", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of shares issuance", "documentation": "Description of shares issuance." } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Net Income (Loss) per share - Diluted", "label": "Diluted earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r78", "r79" ] }, "ifrs-full_DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Potentially dilutive loss per share" } }, "en": { "role": { "documentation": "The potential dilutive effect on the weighted average number of ordinary shares that relates to the assumed conversion of the entity\u2019s instruments. It represents the aggregate of the reconciliation amounts for all classes of instruments that reflect dilutive effect on weighted average number of ordinary shares." } } }, "auth_ref": [ "r80" ] }, "DPRO_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DirectorsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Directors [member]", "documentation": "Directors [member]" } } }, "auth_ref": [] }, "ifrs-full_DirectorsRemunerationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DirectorsRemunerationExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Director fees" } }, "en": { "role": { "documentation": "The amount of remuneration paid or payable to the entity's directors." } } }, "auth_ref": [ "r347" ] }, "DPRO_DisclosureCashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureCashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash And Cash Equivalents", "verboseLabel": "Schedule Of Cash And Cash Equivalents" } } }, "auth_ref": [] }, "DPRO_DisclosureEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureEquipmentAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Equipment" } } }, "auth_ref": [] }, "DPRO_DisclosureIntangibleAssetsAndGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureIntangibleAssetsAndGoodwillAbstract", "lang": { "en-us": { "role": { "label": "Intangible Assets And Goodwill" } } }, "auth_ref": [] }, "DPRO_DisclosureInventoryAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureInventoryAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Schedule Of Inventories", "terseLabel": "Schedule Of Cost Of Sales" } } }, "auth_ref": [] }, "DPRO_DisclosureInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureInvestmentsAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Investments", "label": "Schedule Of Investments" } } }, "auth_ref": [] }, "DPRO_DisclosureLeaseLiabilitesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureLeaseLiabilitesAbstract", "lang": { "en-us": { "role": { "label": "Lease Liabilites", "verboseLabel": "Schedule Of Operating Lease Liabilities" } } }, "auth_ref": [] }, "DPRO_DisclosureManagementJudgementAndAssumptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureManagementJudgementAndAssumptionsAbstract", "lang": { "en-us": { "role": { "label": "Management Judgement And Assumptions" } } }, "auth_ref": [] }, "DPRO_DisclosureMaterialAccountingPoliciesAndBasisOfPreparationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureMaterialAccountingPoliciesAndBasisOfPreparationAbstract", "auth_ref": [] }, "DPRO_DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "DisclosureMaterialAccountingPoliciesAndBasisOfPreparationLineItems [Line Items]" } } }, "auth_ref": [] }, "DPRO_DisclosureMaterialAccountingPoliciesAndBasisOfPreparationTable": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureMaterialAccountingPoliciesAndBasisOfPreparationTable", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "DisclosureMaterialAccountingPoliciesAndBasisOfPreparationTable [Table]" } } }, "auth_ref": [] }, "DPRO_DisclosureNatureAndContinuanceOfOperationsAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureNatureAndContinuanceOfOperationsAndGoingConcernAbstract", "lang": { "en-us": { "role": { "label": "Nature And Continuance Of Operations And Going Concern" } } }, "auth_ref": [] }, "DPRO_DisclosureNotesReceivableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureNotesReceivableAbstract", "lang": { "en-us": { "role": { "label": "Notes Receivable" } } }, "auth_ref": [] }, "DPRO_DisclosureOfAmountsReceivableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfAmountsReceivableExplanatory", "presentation": [ "http://draganfly.com/role/Receivables" ], "lang": { "en-us": { "role": { "label": "RECEIVABLES", "documentation": "Disclosure of amounts receivable explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r19" ] }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfConsolidationExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of consolidation" } }, "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparation" ], "lang": { "en-us": { "role": { "label": "MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalents" ], "lang": { "en-us": { "role": { "label": "CASH AND CASH EQUIVALENTS" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r345" ] }, "DPRO_DisclosureOfChangeInWarrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfChangeInWarrantsExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF CHANGES IN WARRANTS", "documentation": "Disclosure of change in warrants explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfClassOfEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfClassOfEquipmentExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CLASS OF EQUIPMENT", "documentation": "Disclosure of class of equipment explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapital" ], "lang": { "en-us": { "role": { "label": "SHARE CAPITAL" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCostOfSalesExplanatory", "presentation": [ "http://draganfly.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COST OF SALES" } }, "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfDeferredIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDeferredIncomeExplanatory", "presentation": [ "http://draganfly.com/role/DeferredIncome" ], "lang": { "en-us": { "role": { "label": "DEFERRED INCOME" } }, "en": { "role": { "documentation": "The disclosure of deferred income. [Refer: Deferred income including contract liabilities]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://draganfly.com/role/LoansPayableTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOANS" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r377" ] }, "DPRO_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CASH AND CASH EQUIVALENTS", "documentation": "Disclosure of detailed information about cash and cash equivalents explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "presentation": [ "http://draganfly.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAXES", "documentation": "Disclosure of detailed information about deferred taxes explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT" } }, "en": { "role": { "documentation": "The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r177", "r182", "r186" ] }, "DPRO_DisclosureOfDetailedInformationAboutIncomeTax": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutIncomeTax", "presentation": [ "http://draganfly.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCOME TAX", "documentation": "Disclosure of detailed information about income tax." } } }, "auth_ref": [] }, "DPRO_DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES", "documentation": "Disclosure of detailed information about intangible assets and goodwill explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTELLECTUAL PROPERTY" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r92" ] }, "DPRO_DisclosureOfDetailedInformationAboutOfRightOfUseAssets": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "presentation": [ "http://draganfly.com/role/RightOfUseAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE ASSETS", "documentation": "Disclosure of detailed information about of right of use assets." } } }, "auth_ref": [] }, "DPRO_DisclosureOfDetailedInformationAboutOfRightOfUseAssetsRelatedToLeases": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutOfRightOfUseAssetsRelatedToLeases", "presentation": [ "http://draganfly.com/role/RightOfUseAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES" } } }, "auth_ref": [] }, "DPRO_DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE LIABILITIES", "documentation": "Disclosure of detailed information about operating lease liabilities explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://draganfly.com/role/EquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r47" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/EquipmentDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES" } }, "en": { "role": { "documentation": "The entire disclosure for the effect of changes in foreign exchange rates." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://draganfly.com/role/SegmentedInformation" ], "lang": { "en-us": { "role": { "label": "SEGMENTED INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r202" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://draganfly.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r37" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r128" ] }, "DPRO_DisclosureOfFairValueOfInvestmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfFairValueOfInvestmentExplanatory", "presentation": [ "http://draganfly.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE OF INVESTMENT", "documentation": "Disclosure of fair value of investment explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory", "presentation": [ "http://draganfly.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS", "documentation": "Disclosure of fair value of warrants for weighted average assumptions explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF AGING OF RECEIVABLES" } }, "en": { "role": { "documentation": "The disclosure of financial assets that are either past due or impaired. [Refer: Financial assets]" } } }, "auth_ref": [ "r209" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS" } }, "en": { "role": { "documentation": "The disclosure of financial instruments designated at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of financial instruments [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasExplanatory", "presentation": [ "http://draganfly.com/role/SegmentedInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GEOGRAPHIC REVENUE" } }, "en": { "role": { "documentation": "The disclosure of geographical information." } } }, "auth_ref": [ "r200" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://draganfly.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r42" ] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF KEY COMPENSATION AWARDS" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the terms and conditions of hedging instruments and how they affect future cash flows." } } }, "auth_ref": [ "r174" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]" } } }, "auth_ref": [ "r361" ] }, "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwill" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS AND GOODWILL" } }, "en": { "role": { "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInventoriesExplanatory", "presentation": [ "http://draganfly.com/role/Inventory" ], "lang": { "en-us": { "role": { "label": "INVENTORY" } }, "en": { "role": { "documentation": "The entire disclosure for inventories." } } }, "auth_ref": [ "r55" ] }, "DPRO_DisclosureOfInventoriesInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfInventoriesInformationExplanatory", "presentation": [ "http://draganfly.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVENTORIES", "documentation": "Disclosure of inventories information explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfInvestmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfInvestmentExplanatory", "presentation": [ "http://draganfly.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVESTMENTS", "documentation": "Disclosure of investment explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInvestmentPropertyExplanatory", "presentation": [ "http://draganfly.com/role/Investments" ], "lang": { "en-us": { "role": { "label": "INVESTMENTS" } }, "en": { "role": { "documentation": "The entire disclosure for investment property." } } }, "auth_ref": [ "r98" ] }, "ifrs-full_DisclosureOfInvestmentPropertyTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInvestmentPropertyTable", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about investment property [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of investment property." } } }, "auth_ref": [ "r94" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://draganfly.com/role/LeaseLiabilites" ], "lang": { "en-us": { "role": { "label": "LEASE LIABILITES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r144", "r145" ] }, "ifrs-full_DisclosureOfLoansAndAdvancesToCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLoansAndAdvancesToCustomersExplanatory", "presentation": [ "http://draganfly.com/role/LoansPayable" ], "lang": { "en-us": { "role": { "label": "LOANS PAYABLE" } }, "en": { "role": { "documentation": "The disclosure of loans and advances to customers. [Refer: Loans and advances to customers]" } } }, "auth_ref": [ "r345" ] }, "DPRO_DisclosureOfLoansPayableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfLoansPayableExplanatory", "presentation": [ "http://draganfly.com/role/LoansPayableTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOANS PAYABLE", "documentation": "Disclosure of loans payable explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfManagementJudgementAndAssumptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfManagementJudgementAndAssumptionsExplanatory", "presentation": [ "http://draganfly.com/role/ManagementJudgementAndAssumptions" ], "lang": { "en-us": { "role": { "label": "MANAGEMENT JUDGEMENT AND ASSUMPTIONS", "documentation": "Disclosure of management judgement and assumptions explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES", "documentation": "Disclosure of maturity analysis for financial liabilities held for managing liquidity risk explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING MATURITY ANALYSIS" } }, "en": { "role": { "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r142" ] }, "DPRO_DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS", "documentation": "Disclosure of measurement inputs and validation techniques for weighted average assumptions explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfNatureAndContinuanceOfOperationsAndGoingConcernExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfNatureAndContinuanceOfOperationsAndGoingConcernExplanatory", "presentation": [ "http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcern" ], "lang": { "en-us": { "role": { "label": "NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN", "documentation": "Disclosure of nature and continuance of operations and going concern explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfNotesReceivableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfNotesReceivableExplanatory", "presentation": [ "http://draganfly.com/role/NotesReceivable" ], "lang": { "en-us": { "role": { "label": "NOTES RECEIVABLE", "documentation": "Disclosure of notes receivable explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfNotesReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfNotesReceivablesExplanatory", "presentation": [ "http://draganfly.com/role/NotesReceivableTables" ], "lang": { "en-us": { "role": { "label": "DISCLOSURE OF NOTES RECEIVABLE", "documentation": "Disclosure of notes receivables explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS", "documentation": "Disclosure of number and weighted average exercise prices of restricted stock units explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTIONS OUTSTANDING" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r162" ] }, "DPRO_DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING", "documentation": "Disclosure of number and weighted average exercise prices of warrants and their fair values explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [ "r163" ] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r172" ] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://draganfly.com/role/SegmentedInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SEGMENTED INFORMATION" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r192" ] }, "DPRO_DisclosureOfOtherAndMiscellaneousExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfOtherAndMiscellaneousExplanatory", "presentation": [ "http://draganfly.com/role/OfficeAndMiscellaneousTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES", "documentation": "Disclosure of other and miscellaneous explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherOperatingExpenseExplanatory", "presentation": [ "http://draganfly.com/role/OfficeAndMiscellaneous" ], "lang": { "en-us": { "role": { "label": "OFFICE AND MISCELLANEOUS" } }, "en": { "role": { "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r345" ] }, "DPRO_DisclosureOfPrepaidExpensesAndDepositsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfPrepaidExpensesAndDepositsExplanatory", "presentation": [ "http://draganfly.com/role/PrepaidsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS", "documentation": "Disclosure of prepaid expenses and deposits explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "presentation": [ "http://draganfly.com/role/Prepaids" ], "lang": { "en-us": { "role": { "label": "PREPAIDS" } }, "en": { "role": { "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://draganfly.com/role/Equipment" ], "lang": { "en-us": { "role": { "label": "EQUIPMENT" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r49" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r47" ] }, "ifrs-full_DisclosureOfProvisionMatrixTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionMatrixTable", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of provision matrix [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the provision matrix." } } }, "auth_ref": [ "r247" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "presentation": [ "http://draganfly.com/role/RightOfUseAssets" ], "lang": { "en-us": { "role": { "label": "RIGHT OF USE ASSETS" } }, "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r139" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r170" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill." } } }, "auth_ref": [ "r364" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_DisclosureOfServiceConcessionArrangementsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfServiceConcessionArrangementsTable", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about service concession arrangements [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of service concession arrangements." } } }, "auth_ref": [ "r204" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r28" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r154" ] }, "DPRO_DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANTS OUTSTANDING", "documentation": "Disclosure of sharebased payment arrangements for warrants outstanding explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE", "documentation": "Disclosure of sharebased payment arrangements options outstanding and exercisable explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WHOLLY OWNED SUBSIDIARIES" } }, "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r73", "r77", "r123" ] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY" } }, "en": { "role": { "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of assets." } } }, "auth_ref": [ "r126" ] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of significant unobservable inputs used in fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to significant unobservable inputs used in the fair value measurement of assets." } } }, "auth_ref": [ "r126" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://draganfly.com/role/TradePayablesAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "TRADE PAYABLES AND ACCRUED LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "presentation": [ "http://draganfly.com/role/ReceivablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF AMOUNTS RECEIVABLE" } }, "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r345" ] }, "DPRO_DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "presentation": [ "http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES", "documentation": "Disclosure of trader payables and accrued liabilities explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF KEY MANAGEMENT TRANSACTIONS" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r63" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r65" ] }, "DPRO_DisclosureOfWarrantDerivativeLiabilityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureOfWarrantDerivativeLiabilityExplanatory", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT DERIVATIVE LIABILITY", "documentation": "Disclosure of warrant derivative liability explanatory." } } }, "auth_ref": [] }, "DPRO_DisclosurePrepaidsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosurePrepaidsAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Prepaids", "label": "Schedule Of Prepaid Expenses And Deposits", "terseLabel": "Schedule Of Prepaid Expenses And Deposits Details" } } }, "auth_ref": [] }, "DPRO_DisclosureReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureReceivablesAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Receivables", "label": "Schedule Of Amounts Receivable" } } }, "auth_ref": [] }, "DPRO_DisclosureRightOfUseAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureRightOfUseAssetsAbstract", "lang": { "en-us": { "role": { "label": "Right Of Use Assets", "verboseLabel": "Schedule Of Right Of Use Assets" } } }, "auth_ref": [] }, "DPRO_DisclosureTradePayablesAndAccruedLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DisclosureTradePayablesAndAccruedLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Trade Payables And Accrued Liabilities", "verboseLabel": "Schedule Of Trade Payables And Accrued Liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Disposals", "label": "Disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r45" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r267" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r265", "r267", "r280" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r265", "r267", "r280", "r316" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r266" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r254" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r267" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r267" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r301" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r257" ] }, "DPRO_DragonflyInnovationsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DragonflyInnovationsIncMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Draganfly innovations inc [member]", "documentation": "Draganfly Innovations Inc [member]" } } }, "auth_ref": [] }, "DPRO_DragonflyInnovationsUSAIncMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DragonflyInnovationsUSAIncMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Dragonfly Innovations USA Inc [member]", "documentation": "Dragonfly Innovations USA Inc [member]" } } }, "auth_ref": [] }, "DPRO_DronelogicsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DronelogicsMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dronelogics [member]", "documentation": "Dronelogics [member]" } } }, "auth_ref": [] }, "DPRO_DronelogicsSystemsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DronelogicsSystemsIncMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Dronelogics Systems Inc [member]", "documentation": "Dronelogics Systems Inc [member]" } } }, "auth_ref": [] }, "DPRO_DronesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "DronesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Drones [member]", "documentation": "Drones [member]" } } }, "auth_ref": [] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effects of exchange rate changes on cash" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r104", "r105" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r256" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r260" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r256" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r256" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r344" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r256" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r341" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r280" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r256" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r256" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r256" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r256" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r342" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r65" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r16", "r24", "r108", "r110", "r124", "r125", "r127" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r15" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r4" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r309" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r272", "r284", "r294", "r320" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r269", "r281", "r291", "r317" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r315" ] }, "DPRO_ExecutiveConsultantAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExecutiveConsultantAgreementMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Executive consultant agreement [member]", "documentation": "Executive consultant agreement [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceEightMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceEightMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price eight [member]", "documentation": "Exercise price eight [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceElevenMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price eleven [member]", "documentation": "Exercise price eleven [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceFiveMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price five [member]", "documentation": "Exercise price five [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceFourMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceFourMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price four [member]", "documentation": "Exercise price four [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceNineMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceNineMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price nine [member]", "documentation": "Exercise price nine [member]" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise Price", "verboseLabel": "Exercise price", "terseLabel": "Warrants exercise price" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r163" ] }, "DPRO_ExercisePriceOneMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceOneMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price one [member]", "documentation": "Exercise price one [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceSevenMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price seven [member]", "documentation": "Exercise price seven [member]" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "label": "Exercise price, share options granted" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r165" ] }, "DPRO_ExercisePriceSixMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceSixMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price six [member]", "documentation": "Exercise price six [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceTenMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceTenMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price ten [member]", "documentation": "Exercise price ten [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceThreeMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price three [member]", "documentation": "Exercise price three [member]" } } }, "auth_ref": [] }, "DPRO_ExercisePriceTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExercisePriceTwoMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price two [member]", "documentation": "Exercise price two [member]" } } }, "auth_ref": [] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r165" ] }, "DPRO_ExpectedLifeOfOptions": { "xbrltype": "durationItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExpectedLifeOfOptions", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected life", "documentation": "Expected life of options." } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expense from share-based payment transactions with employees" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r347" ] }, "DPRO_ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expiring in 2040 to 2043 [Member]", "documentation": "Expiring in two thousand thirty to two thousand forty three [member]" } } }, "auth_ref": [] }, "DPRO_ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expiring in 2030 to 2043 [Member]", "documentation": "Expiring in two thousand thirty to two thousand forty three [member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "DPRO_FairValueAdjustmentOnLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "FairValueAdjustmentOnLoans", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "lang": { "en-us": { "role": { "label": "Fair value adjustment", "documentation": "Fair value adjustment on loans." } } }, "auth_ref": [] }, "ifrs-full_FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsNotRecognisedInOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsNotRecognisedInOtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of equity investments at FVOCI" } }, "en": { "role": { "documentation": "The fair value gains (losses) that would have been recognised in other comprehensive income if financial assets had not been reclassified out of the available-for-sale category. [Refer: Financial assets available-for-sale; Other comprehensive income]" } } }, "auth_ref": [ "r206" ] }, "ifrs-full_FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsRecognisedInOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsRecognisedInOtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value of equity investments at FVOCI", "label": "Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income" } }, "en": { "role": { "documentation": "The fair value gains (losses) recognised in other comprehensive income on financial assets reclassified out of the available-for-sale category. [Refer: Financial assets available-for-sale; Other comprehensive income]" } } }, "auth_ref": [ "r205" ] }, "DPRO_FinanceAndOtherCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "FinanceAndOtherCosts", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance and other costs", "documentation": "Finance and other costs.", "label": "FinanceAndOtherCosts" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance and other costs", "negatedLabel": "Finance and other costs" } }, "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Total receivables" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r176", "r180", "r181", "r183", "r247" ] }, "DPRO_FinancialInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://draganfly.com/20231231", "localname": "FinancialInstrumentTerm", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Financial instrument term", "documentation": "Financial instrument term." } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r176" ] }, "ifrs-full_FinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinishedGoods", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } } }, "auth_ref": [ "r216", "r359" ] }, "ifrs-full_ForeignExchangeGain": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ForeignExchangeGain", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Foreign exchange rate" } }, "en": { "role": { "documentation": "The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]" } } }, "auth_ref": [ "r6", "r57" ] }, "DPRO_ForeignExchangeTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ForeignExchangeTranslation", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Foreign exchange", "documentation": "Foreign exchange translation." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r276", "r288", "r298", "r324" ] }, "DPRO_FurnitureAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "FurnitureAndEquipmentMember", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and equipment [member]", "documentation": "Furniture and equipment [member]" } } }, "auth_ref": [] }, "DPRO_GainLossOnFairValueOfDerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GainLossOnFairValueOfDerivativeLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of derivative liability", "documentation": "Gain loss on fair value of derivative liabilities.", "label": "GainLossOnFairValueOfDerivativeLiabilities" } } }, "auth_ref": [] }, "DPRO_GainLossOnSaleOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GainLossOnSaleOfAssets", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on sale of assets", "documentation": "Gain loss on sale of assets.", "label": "GainLossOnSaleOfAssets" } } }, "auth_ref": [] }, "DPRO_GainsLossesOnChangeInFairValueOfDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GainsLossesOnChangeInFairValueOfDerivative", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of the period", "periodEndLabel": "Ending of the period", "documentation": "Gains losses on change in fair value of derivative.", "label": "GainsLossesOnChangeInFairValueOfDerivative" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of derivative liability", "negatedLabel": "Change in fair value of derivative liability" } }, "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r353" ] }, "ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnDisposalsOfNoncurrentAssets", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss on disposal of assets" } }, "en": { "role": { "documentation": "The gains (losses) on disposals of non-current assets. [Refer: Non-current assets]" } } }, "auth_ref": [ "r347" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign exchange gain" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r6", "r57" ] }, "ifrs-full_GainsLossesOnLoansAndReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnLoansAndReceivables", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on write-off of notes receivable", "label": "Gains (losses) on loans and receivables" } }, "en": { "role": { "documentation": "The gains (losses) on loans and receivables. [Refer: Loans and receivables]" } } }, "auth_ref": [ "r207" ] }, "DPRO_GeographicNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GeographicNoncurrentAssets", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r200", "r219", "r239", "r244" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r200", "r219", "r239", "r244" ] }, "ifrs-full_GoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GoodwillMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill [member]" } }, "en": { "role": { "documentation": "This member stands for goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r222" ] }, "ifrs-full_GovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GovernmentGrants", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Government grant payable" } }, "en": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r43", "r87", "r96", "r100", "r170", "r181", "r183", "r247" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "GROSS PROFIT", "label": "Gross profit" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r211" ] }, "DPRO_GuaranteedInvestmentCertificateMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GuaranteedInvestmentCertificateMember", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Guaranteed investment certificate [member]", "documentation": "Guaranteed investment certificate [member]" } } }, "auth_ref": [] }, "DPRO_GuaranteedInvestmentCertificateOneMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "GuaranteedInvestmentCertificateOneMember", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Guaranteed investment certificate one [member]", "documentation": "Guaranteed investment certificate one [member]" } } }, "auth_ref": [] }, "ifrs-full_HistoricalVolatilityForSharesMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HistoricalVolatilityForSharesMeasurementInputMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Historical volatility for shares, measurement input [member]" } }, "en": { "role": { "documentation": "This member stands for the historical volatility for shares used as a measurement input." } } }, "auth_ref": [ "r234" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r265", "r267", "r280" ] }, "DPRO_IfrsRestrictedStockUnitsRsuMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IfrsRestrictedStockUnitsRsuMember", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted stock units rsu [member]", "documentation": "Restricted stock units rsu [member]" } } }, "auth_ref": [] }, "DPRO_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IfrsStatementLineItems", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/EquipmentDetailsNarrative", "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/InvestmentsDetailsNarrative", "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails", "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails", "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails", "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails", "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails", "http://draganfly.com/role/ScheduleOfLoansDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails", "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SubsequentEventsDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLoss", "crdr": "debit", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment loss", "label": "Impairment loss", "verboseLabel": "Impairment" } }, "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r82", "r83" ] }, "ifrs-full_ImpairmentLossOnFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLossOnFinancialAssets", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment of notes receivable" } }, "en": { "role": { "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]" } } }, "auth_ref": [ "r208" ] }, "DPRO_ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange translation", "documentation": "Impairment loss recognised in profit or loss foreign exchange translation.", "label": "ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment of goodwill and intangibles", "verboseLabel": "Impairment of goodwill" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]" } } }, "auth_ref": [ "r169" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment of goodwill" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]" } } }, "auth_ref": [ "r363" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment", "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r89" ] }, "DPRO_ImpairmentOfAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ImpairmentOfAccountsReceivable", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of accounts receivable", "documentation": "Impairment of accounts receivable." } } }, "auth_ref": [] }, "DPRO_ImpairmentOfGoodwillAndIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ImpairmentOfGoodwillAndIntangibles", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of goodwill and intangibles", "documentation": "Impairment of goodwill and intangibles.", "label": "ImpairmentOfGoodwillAndIntangibles" } } }, "auth_ref": [] }, "DPRO_IncentiveShareCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IncentiveShareCompensationPlanMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Incentive share compensation plan [member]", "documentation": "Incentive share compensation plan [member]" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Income tax" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r32", "r38", "r39", "r40", "r69", "r122", "r191" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Change in cash", "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r106" ] }, "DPRO_IncreaseDecreaseInDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IncreaseDecreaseInDeferredIncome", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred income", "documentation": "Increase decrease in deferred income.", "label": "IncreaseDecreaseInDeferredIncome" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Impact on comprehensive loss" } }, "en": { "role": { "documentation": "The amount of increase (decrease) in the fair value measurement of liabilities, recognised in other comprehensive income after tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]" } } }, "auth_ref": [ "r374" ] }, "DPRO_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "[custom:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage]" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payments", "label": "Increase (decrease) through share-based payment transactions, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r3" ] }, "DPRO_IndependentConsultantAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IndependentConsultantAgreementMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Independent consultant agreement [member]", "documentation": "Independent consultant agreement [member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r279", "r288", "r298", "r315", "r324", "r328", "r336" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r334" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r268", "r340" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r268", "r340" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r268", "r340" ] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r347" ] }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsAndGoodwillMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r364" ] }, "DPRO_IntangibleAssetsIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IntangibleAssetsIncludingGoodwill", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Net book value", "documentation": "Intangible assets including goodwill." } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "periodStartLabel": "Balance at December 31, 2022", "periodEndLabel": "Cost, ending balance" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r9", "r91" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r92", "r222", "r241" ] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r136" ] }, "DPRO_InterestPaidInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "InterestPaidInCash", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid in cash", "documentation": "Interest paid in cash." } } }, "auth_ref": [] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Inventory", "totalLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r10", "r52", "r213" ] }, "DPRO_InventoryMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "InventoryMember", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory [member]", "documentation": "Inventory [member]" } } }, "auth_ref": [] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails", "http://draganfly.com/role/ScheduleOfInvestmentsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investments", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "verboseLabel": "Fair value of investments" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r8", "r95", "r97" ] }, "ifrs-full_InvestmentPropertyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentPropertyMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for investment property. It also represents the standard value for the 'Types of investment property' axis if no other member is used. [Refer: Investment property]" } } }, "auth_ref": [ "r233", "r236", "r347" ] }, "DPRO_IssuanceOfLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IssuanceOfLoansPayable", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of loans payable", "documentation": "Issuance of loans payable." } } }, "auth_ref": [] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued, value" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Share capital" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r217" ] }, "DPRO_IssuedCapitalCost": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "IssuedCapitalCost", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:IssuedCapitalCost-0]", "documentation": "Issued capital cost." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Management fees paid to a company, total" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r61" ] }, "DPRO_KeyManagementPersonnelCompensationDirectorFees": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "KeyManagementPersonnelCompensationDirectorFees", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Director fees", "documentation": "Key management personnel compensation director fees.", "label": "KeyManagementPersonnelCompensationDirectorFees" } } }, "auth_ref": [] }, "DPRO_KeyManagementPersonnelCompensationSalaries": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "KeyManagementPersonnelCompensationSalaries", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Salaries", "documentation": "Key management personnel compensation salaries." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfKeyCompensationAwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payments", "label": "Key management personnel compensation, share-based payment" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r60" ] }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } } }, "auth_ref": [ "r141", "r142", "r153", "r249", "r253", "r347" ] }, "ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneMonthAndNotLaterThanTwoMonthsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one month and not later than two months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than two months." } } }, "auth_ref": [ "r247", "r252", "r347" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than five years." } } }, "auth_ref": [ "r248", "r253" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than three years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than three years." } } }, "auth_ref": [ "r249", "r250", "r253" ] }, "ifrs-full_LaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanThreeMonthsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later than three months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three months." } } }, "auth_ref": [ "r247", "r252" ] }, "ifrs-full_LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later than two months and not later than three months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two months and not later than three months." } } }, "auth_ref": [ "r247", "r252", "r347" ] }, "DPRO_LeaseImplicitInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LeaseImplicitInterest", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Amount representing interest", "documentation": "Lease implicit interest." } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance - Beginning of period", "periodEndLabel": "Balance - Ending of period", "verboseLabel": "Lease liabilities", "label": "Lease liability" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r134" ] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r229", "r230" ] }, "ifrs-full_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } } }, "auth_ref": [ "r355" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r50", "r125" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r125" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r125" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r50", "r125" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r16", "r124", "r125", "r127", "r192", "r196" ] }, "ifrs-full_LiquidityRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiquidityRiskMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liquidity risk [member]" } }, "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r149", "r150", "r151", "r246" ] }, "DPRO_LoanForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LoanForgiveness", "crdr": "debit", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan forgiveness", "documentation": "Loan forgiveness." } } }, "auth_ref": [] }, "DPRO_LoanPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LoanPayableMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Loan payable [member]", "documentation": "Loan payable [member]" } } }, "auth_ref": [] }, "ifrs-full_LoansAndAdvancesToBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LoansAndAdvancesToBanks", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Total Carrying Value" } }, "en": { "role": { "documentation": "The amount of loans and advances the entity has made to banks." } } }, "auth_ref": [ "r349" ] }, "DPRO_LoansForgivableAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LoansForgivableAmount", "crdr": "debit", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loans forgivable amount", "documentation": "Loans forgivable amount." } } }, "auth_ref": [] }, "DPRO_LoansPayableAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LoansPayableAmount", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Ending balance", "documentation": "Loans payable amount.", "label": "LoansPayableAmount" } } }, "auth_ref": [] }, "ifrs-full_LoansReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LoansReceived", "crdr": "credit", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan received" } }, "en": { "role": { "documentation": "The amount of loans received." } } }, "auth_ref": [ "r347" ] }, "DPRO_LoansWrittenDown": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LoansWrittenDown", "crdr": "debit", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loans written down", "documentation": "Loans written down." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "DPRO_LossForAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LossForAdjustments", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net loss for the year", "documentation": "Loss for adjustments." } } }, "auth_ref": [] }, "DPRO_LossOnImpairmentOfGoodwillAndIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LossOnImpairmentOfGoodwillAndIntangibles", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on impairment of goodwill and intangibles", "documentation": "Loss on impairment of goodwill and intangibles.", "label": "LossOnImpairmentOfGoodwillAndIntangibles" } } }, "auth_ref": [] }, "DPRO_LossOnWriteoffOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "LossOnWriteoffOfNotesReceivable", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss on write-off of notes receivable", "documentation": "Loss on write-off of notes receivable." } } }, "auth_ref": [] }, "ifrs-full_LossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LossesOnChangeInFairValueOfDerivatives", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value", "label": "Losses on change in fair value of derivatives" } }, "en": { "role": { "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r353" ] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r19", "r132", "r141", "r142", "r146", "r147", "r148", "r153", "r175", "r185", "r221", "r249" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r307" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r307" ] }, "ifrs-full_MiscellaneousOtherOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MiscellaneousOtherOperatingExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 5.0 }, "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Office and miscellaneous", "totalLabel": "Office and Miscellaneous Expenses" } }, "en": { "role": { "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r347" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r327" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r335" ] }, "ifrs-full_NameOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NameOfSubsidiary", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Name of subsidiary" } }, "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r70", "r74", "r112", "r114" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r308" ] }, "ifrs-full_NetDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDeferredTaxAssets", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Net deferred tax assets" } }, "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r354" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent" } } }, "auth_ref": [] }, "DPRO_NetProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NetProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from issue of ordinary shares", "documentation": "Net proceeds from issue of ordinary shares." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "DPRO_NonCashTransferOfEquipmentFromInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NonCashTransferOfEquipmentFromInventory", "crdr": "credit", "presentation": [ "http://draganfly.com/role/EquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non - cash transfer of equipment from inventory", "documentation": "Non cash transfer of equipment from inventory." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r307" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r305" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r304" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r335" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r335" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r36" ] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r36" ] }, "DPRO_NonadjustmentEventsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NonadjustmentEventsMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Adjustment Events [Member]", "documentation": "Non Adjustment Events [Member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current Assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred income", "label": "Non-current deferred income including non-current contract liabilities" } }, "en": { "role": { "documentation": "The amount of non-current deferred income including non-current contract liabilities. [Refer: Deferred income including contract liabilities]" } } }, "auth_ref": [ "r349", "r351" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Non-current lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r134" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current Liabilities" } } }, "auth_ref": [] }, "DPRO_NoncurrentLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoncurrentLoansPayable", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Loans payable", "documentation": "Non current loans payable.", "label": "NoncurrentLoansPayable" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r18", "r141", "r142", "r153", "r249", "r253" ] }, "DPRO_NoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteOneMember", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Note one [member]", "documentation": "Note one [member]" } } }, "auth_ref": [] }, "DPRO_NoteReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivable", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Note receivable", "documentation": "Note receivable." } } }, "auth_ref": [] }, "DPRO_NoteReceivableAccretionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableAccretionAmount", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Accretion", "documentation": "Note receivable accretion amount." } } }, "auth_ref": [] }, "DPRO_NoteReceivableFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableFaceAmount", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Principal", "documentation": "Note receivable face amount." } } }, "auth_ref": [] }, "DPRO_NoteReceivableInterestAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableInterestAmount", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Note receivable interest amount." } } }, "auth_ref": [] }, "DPRO_NoteReceivableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableInterestRate", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rate", "verboseLabel": "Note receivable interest rate", "documentation": "Note receivable interest rate." } } }, "auth_ref": [] }, "DPRO_NoteReceivableMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableMaturityDate", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Maturity date", "documentation": "Note receivable maturity date." } } }, "auth_ref": [] }, "DPRO_NoteReceivableStartDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteReceivableStartDate", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Maturity date", "documentation": "Note receivable start date.", "label": "NoteReceivableStartDate" } } }, "auth_ref": [] }, "DPRO_NoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteThreeMember", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Note three [member]", "documentation": "Note three [member]" } } }, "auth_ref": [] }, "DPRO_NoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NoteTwoMember", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Note two [member]", "documentation": "Note two [member]" } } }, "auth_ref": [] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "DPRO_NotesReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NotesReceivablesCurrent", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Notes receivable", "documentation": "Notes receivables current." } } }, "auth_ref": [] }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsExercised": { "xbrltype": "decimalItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfInstrumentsOtherEquityInstrumentsExercised", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants, Excercised", "documentation": "Number of instruments other equity instruments exercised.", "label": "NumberOfInstrumentsOtherEquityInstrumentsExercised" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants, Issued", "label": "Warrants, Issued" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r166", "r376" ] }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsIssued": { "xbrltype": "decimalItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfInstrumentsOtherEquityInstrumentsIssued", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs,Issued", "label": "Number of RSUs,Issued", "verboseLabel": "Number of accelerated issued shares", "documentation": "Number of instruments other equity instruments issued." } } }, "auth_ref": [] }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsVested": { "xbrltype": "decimalItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfInstrumentsOtherEquityInstrumentsVested", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs,Vested", "documentation": "Number of instruments other equity instruments vested.", "label": "NumberOfInstrumentsOtherEquityInstrumentsVested" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs ,Forfeited", "negatedTerseLabel": "Warrants, Expired", "label": "Number of accelerated Forfeited shares" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r376" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of RSUs outstanding, Beginning of the period", "periodEndLabel": "Number of RSUs outstanding, Ending of the period", "label": "Number of Warrants Outstanding" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r376" ] }, "DPRO_NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of accelerated vesting shares", "documentation": "Number of other equity instruments vesting in share-based payment arrangement." } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options Outstanding", "periodStartLabel": "Number of options outstanding, Beginning Balance", "periodEndLabel": "Number of options outstanding, Ending Balance" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r155", "r160", "r163" ] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options Exercisable" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r161" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options outstanding, Exercised", "label": "Number of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options outstanding, forfeited", "label": "Number of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r157" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options outstanding, Granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r156" ] }, "DPRO_NumberOfShareOptionsIssuedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfShareOptionsIssuedInSharebasedPaymentArrangement", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Number of options outstanding, issued", "documentation": "Number of share options issued in share based payment arrangement." } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r346" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r26" ] }, "DPRO_NumberOfSharesPurchased": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfSharesPurchased", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares purchased", "documentation": "Number of shares purchased." } } }, "auth_ref": [] }, "DPRO_NumberOfSharesPurchasedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfSharesPurchasedValue", "crdr": "credit", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares purchased value", "documentation": "Number of shares purchased, value." } } }, "auth_ref": [] }, "DPRO_NumberOfWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "NumberOfWarrantsExercised", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants exercised", "documentation": "Number of warrants exercised." } } }, "auth_ref": [] }, "ifrs-full_OperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OperatingExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total operating expenses", "label": "Operating expense" } }, "en": { "role": { "documentation": "The amount of all operating expenses." } } }, "auth_ref": [ "r353" ] }, "DPRO_OperatingExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "OperatingExpenseAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES", "documentation": "Operating expense abstract." } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r78", "r352" ] }, "ifrs-full_OtherCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Guaranteed investment certificates" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r373" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign exchange translation", "verboseLabel": "Translation of foreign operations" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r22", "r33" ] }, "DPRO_OtherCostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "OtherCostOfSales", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Other cost of sales." } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities" } }, "en": { "role": { "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_OtherExpenseByFunction": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherExpenseByFunction", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other expense, by function" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses." } } }, "auth_ref": [ "r35", "r68", "r211" ] }, "DPRO_OtherIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "OtherIncomeExpenseAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)", "documentation": "Other income expense abstract." } } }, "auth_ref": [] }, "DPRO_OtherIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "OtherIncomeLoss", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income (expense)", "documentation": "Other income loss." } } }, "auth_ref": [] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Other income (expense)", "label": "Other operating income (expense)" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r353" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r307" ] }, "ifrs-full_OtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherRelatedPartiesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Other related parties [member]" } }, "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r64" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r267" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r274", "r286", "r296", "r322" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r277", "r289", "r299", "r325" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r277", "r289", "r299", "r325" ] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r25" ] }, "ifrs-full_PastDueStatusAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Past due status [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r247" ] }, "ifrs-full_PastDueStatusMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusMember", "presentation": [ "http://draganfly.com/role/ScheduleOfAgingOfReceivablesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used." } } }, "auth_ref": [ "r247" ] }, "DPRO_PatentMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PatentMember", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "lang": { "en-us": { "role": { "label": "Patent [member]", "documentation": "Patent [member]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r303" ] }, "DPRO_PaymentsForAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PaymentsForAcquisitions", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash paid for acquisition, net of cash received", "documentation": "Payments for acquisitions.", "label": "PaymentsForAcquisitions" } } }, "auth_ref": [] }, "ifrs-full_PaymentsForShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForShareIssueCosts", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issue costs", "label": "Payments for share issue costs" } }, "en": { "role": { "documentation": "The cash outflow for share issue costs." } } }, "auth_ref": [ "r369" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Lease Payments", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r228" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r306" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r306" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r305" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r308" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r304" ] }, "DPRO_PercentageOfWeightedAverageCostOfCapital": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PercentageOfWeightedAverageCostOfCapital", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of weighted average cost of capital", "documentation": "Percentage of weighted average cost of capital." } } }, "auth_ref": [] }, "DPRO_PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "percentItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average revenue", "documentation": "Percentage of weighted average revenue growth rate earnings before interest taxes depreciation and amortization." } } }, "auth_ref": [] }, "DPRO_PlanNamesAxis": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PlanNamesAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Plan names [axis]", "documentation": "Plan names [axis]" } } }, "auth_ref": [] }, "DPRO_PlanNamesDomain": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PlanNamesDomain", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r261" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r262" ] }, "DPRO_PrefundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PrefundedWarrantsMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Pre-funded Warrants [Member]", "documentation": "Pre-funded Warrants [Member]" } } }, "auth_ref": [] }, "DPRO_PrivateCompanySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PrivateCompanySharesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Private company shares [member]", "documentation": "Private company shares [member]" } } }, "auth_ref": [] }, "DPRO_ProceedFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ProceedFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common shares for financing", "documentation": "Proceed from issuance of common stock." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common shares for warrants exercised", "verboseLabel": "Proceeds from exercise of warrants" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r369" ] }, "DPRO_ProceedsFromIssuanceOfCommonSharesForStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ProceedsFromIssuanceOfCommonSharesForStockOptionsExercised", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common shares for stock options exercised", "documentation": "Proceeds from issuance of common shares for stock options exercised." } } }, "auth_ref": [] }, "DPRO_ProceedsFromIssuanceOfLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ProceedsFromIssuanceOfLoans", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of loans", "documentation": "Proceeds from issuance of loans." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfBondsNotesAndDebentures", "crdr": "debit", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from loan" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of bonds, notes and debentures." } } }, "auth_ref": [ "r369" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issue of shares", "verboseLabel": "Proceeds from issue of ordinary shares" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r369" ] }, "DPRO_ProceedsFromIssueOfOrdinarySharesAfterIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ProceedsFromIssueOfOrdinarySharesAfterIssueCosts", "crdr": "debit", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issue of ordinary shares", "documentation": "Proceeds from issue of ordinary shares after issue costs." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssuingShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingShares", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuing shares" } }, "en": { "role": { "documentation": "The cash inflow from issuing shares." } } }, "auth_ref": [ "r227" ] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Disposal of equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r226" ] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://draganfly.com/role/EquipmentDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r198", "r238" ] }, "ifrs-full_ProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesMember", "presentation": [ "http://draganfly.com/role/EquipmentDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r198", "r238" ] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Professional fees", "verboseLabel": "Incurred fees" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r347" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "NET LOSS FOR THE YEAR", "label": "Net loss", "negatedLabel": "Net loss for the year" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r2", "r29", "r102", "r109", "r111", "r192", "r194", "r232", "r242" ] }, "ifrs-full_ProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAbstract", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "REVENUE" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equipment", "periodEndLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r7", "r46" ] }, "DPRO_PropertyPlantAndEquipmentCost": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PropertyPlantAndEquipmentCost", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Property, plant and equipment, beginning balance", "periodEndLabel": "Property, plant and equipment, ending balance", "documentation": "Property plant and equipment cost.", "label": "PropertyPlantAndEquipmentCost" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r47", "r222", "r241" ] }, "ifrs-full_PropertyServiceChargeIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyServiceChargeIncomeExpense", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Charge for the year" } }, "en": { "role": { "documentation": "The amount of income or expense arising from property service charge. [Refer: Property service charge expense; Property service charge income]" } } }, "auth_ref": [ "r347" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://draganfly.com/role/ScheduleOfWhollyOwnedSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r72", "r76", "r116" ] }, "DPRO_ProvisionForDoubtfulAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ProvisionForDoubtfulAccount", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful account", "documentation": "Provision for doubtful account." } } }, "auth_ref": [] }, "DPRO_PublicCompanySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PublicCompanySharesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Public company shares [member]", "documentation": "Public company shares [member]" } } }, "auth_ref": [] }, "DPRO_PurchaseOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "PurchaseOfFinancialInstruments", "crdr": "credit", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase of financial instrument", "documentation": "Purchase of financial instruments." } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of intangible assets", "label": "Purchase of intangible assets, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r225" ] }, "ifrs-full_PurchaseOfInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfInvestmentProperty", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments", "label": "Purchase of investment property" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of investment property. [Refer: Investment property]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r225" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r303" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r303" ] }, "DPRO_QuotedExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://draganfly.com/20231231", "localname": "QuotedExercisePrice", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Quoted exercise price", "documentation": "Quoted exercise price." } } }, "auth_ref": [] }, "DPRO_QuotedExercisePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://draganfly.com/20231231", "localname": "QuotedExercisePricePerShare", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Quoted price per share", "documentation": "Quoted exercise price per share." } } }, "auth_ref": [] }, "DPRO_Range1Member": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "Range1Member", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Range 1 [member]", "documentation": "Range 1 [member]" } } }, "auth_ref": [] }, "DPRO_Range2Member": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "Range2Member", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Range 2 [member]", "documentation": "Range 2 [member]" } } }, "auth_ref": [] }, "DPRO_Range6Member": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "Range6Member", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Range 6 [member]", "documentation": "Range 6 [member]" } } }, "auth_ref": [] }, "DPRO_Range7Member": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "Range7Member", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Range 7 [member]", "documentation": "Range 7 [member]" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r129", "r148", "r163", "r235", "r237", "r377" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r129", "r148", "r163", "r235", "r237", "r377" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r163" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "auth_ref": [ "r163" ] }, "DPRO_RangesOfExercisePricesOfWarrantsOneMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RangesOfExercisePricesOfWarrantsOneMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ranges of Exercise Prices of Warrants One [member]", "documentation": "Ranges of Exercise Prices of Warrants One [member]" } } }, "auth_ref": [] }, "DPRO_RangesOfExercisePricesOfWarrantsTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RangesOfExercisePricesOfWarrantsTwoMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ranges of Exercise Prices of Warrants Two [member]", "documentation": "Ranges of Exercise Prices of Warrants Two [member]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r269", "r281", "r291", "r317" ] }, "DPRO_RentalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RentalServicesMember", "presentation": [ "http://draganfly.com/role/EquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rental services [member]", "documentation": "Rental services [member]" } } }, "auth_ref": [] }, "DPRO_RepaymentOfLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RepaymentOfLeaseLiability", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of lease liabilities", "documentation": "Repayment of lease liability.", "label": "RepaymentOfLeaseLiability" } } }, "auth_ref": [] }, "DPRO_RepaymentOfLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RepaymentOfLoans", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of loans", "documentation": "Repayment of loans.", "label": "RepaymentOfLoans" } } }, "auth_ref": [] }, "DPRO_RepaymentOfLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RepaymentOfLoansPayable", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "lang": { "en-us": { "role": { "label": "Repayment of loans payable", "documentation": "Repayment of loans payable." } } }, "auth_ref": [] }, "DPRO_RepaymentOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RepaymentOfNotesReceivable", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment (Issuance) of notes receivable", "documentation": "Repayment of notes receivable.", "label": "RepaymentOfNotesReceivable" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfCurrentBorrowings", "crdr": "credit", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayments of current borrowings" } }, "en": { "role": { "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]" } } }, "auth_ref": [ "r369" ] }, "DPRO_RepaymentsOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RepaymentsOfNotesReceivable", "crdr": "credit", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments", "documentation": "Repayments of notes receivable.", "label": "RepaymentsOfNotesReceivable" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Research and development" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r93" ] }, "DPRO_ReserveInventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ReserveInventoryWriteDown", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Loss on write down of inventory", "documentation": "Reserve inventory write down." } } }, "auth_ref": [] }, "ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfChangeInValueOfTimeValueOfOptions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reduction in value" } }, "en": { "role": { "documentation": "A component of equity representing the accumulated change in the value of the time value of options when separating the intrinsic value and time value of an option contract and designating as the hedging instrument only the changes in the intrinsic value." } } }, "auth_ref": [ "r203", "r350" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of exchange differences on translation [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r58", "r212" ] }, "ifrs-full_ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of gains and losses from investments in equity instruments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated gains and losses from investments in equity instruments that the entity has designated at fair value through other comprehensive income." } } }, "auth_ref": [ "r212" ] }, "ifrs-full_ReserveOfSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPayments", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Reserves \u2013 share-based payments" } }, "en": { "role": { "documentation": "A component of equity resulting from share-based payments." } } }, "auth_ref": [ "r350" ] }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPaymentsMember", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of share-based payments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } } }, "auth_ref": [ "r212" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r270", "r282", "r292", "r318" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r271", "r283", "r293", "r319" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r278", "r290", "r300", "r326" ] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing restricted share units." } } }, "auth_ref": [ "r361" ] }, "DPRO_RestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RestrictedStockUnitsMember", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock units [member]", "documentation": "Restricted stock units [member]" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/NatureAndContinuanceOfOperationsAndGoingConcernDetailsNarrative", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r217", "r218" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r4", "r212" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL REVENUE", "label": "Total revenue", "verboseLabel": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r31", "r120", "r171", "r190", "r193", "r198", "r199", "r201", "r210", "r211", "r232" ] }, "ifrs-full_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueAbstract", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "auth_ref": [] }, "ifrs-full_RevenueFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromGovernmentGrants", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Government income" } }, "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } } }, "auth_ref": [ "r360" ] }, "ifrs-full_RevenueFromRenderingOfServices": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromRenderingOfServices", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_Revenue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Provision of services" } }, "en": { "role": { "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]" } } }, "auth_ref": [ "r347" ] }, "ifrs-full_RevenueFromSaleOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromSaleOfGoods", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_Revenue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Sales of goods" } }, "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]" } } }, "auth_ref": [ "r347" ] }, "ifrs-full_RevenueOfAcquiree": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueOfAcquiree", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue on acquisition" } }, "en": { "role": { "documentation": "The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]" } } }, "auth_ref": [ "r168" ] }, "DPRO_RevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RevenueRecognized", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": "DPRO_DeferredIncomeGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Revenue recognized", "documentation": "Revenue recognized." } } }, "auth_ref": [] }, "ifrs-full_ReversalOfInventoryWritedown": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReversalOfInventoryWritedown", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reserve inventory write down" } }, "en": { "role": { "documentation": "The amount recognised as a reduction in the amount of inventories recognised as an expense due to the reversal of any write-down of inventories resulting from an increase in net realisable value. [Refer: Inventories; Inventory write-down]" } } }, "auth_ref": [ "r34", "r54" ] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right of use assets" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r133", "r138" ] }, "DPRO_RightofuseAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RightofuseAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Right of use assets, Accumulated depreciation, Balance", "periodEndLabel": "Right of use assets, Accumulated depreciation, Balance", "documentation": "Right of use assets accumulated amortization.", "label": "RightofuseAssetsAccumulatedAmortization" } } }, "auth_ref": [] }, "DPRO_RightofuseAssetsLeaseAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "RightofuseAssetsLeaseAdjustment", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Right of use assets, Cost, Lease adjustment", "documentation": "Right of use assets lease adjustment." } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssetsRevaluedAssetsAtCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssetsRevaluedAssetsAtCost", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Right of use assets, Cost, Balance", "periodEndLabel": "Right of use assets, Cost, Balance", "label": "Right-of-use assets, revalued assets, at cost" } }, "en": { "role": { "documentation": "The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r140" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r335" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r335" ] }, "DPRO_ScheduleOfDeferredIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ScheduleOfDeferredIncomeExplanatory", "presentation": [ "http://draganfly.com/role/DeferredIncomeTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED INCOME", "documentation": "Schedule of deferred income explanatory." } } }, "auth_ref": [] }, "DPRO_ScottLarsonMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ScottLarsonMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Scottlarson [member]", "documentation": "Scottlarson [member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r255" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r259" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r258" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r263" ] }, "DPRO_SegmentGainIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SegmentGainIncomeLoss", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Segment loss", "documentation": "Segment gain income loss.", "label": "SegmentGainIncomeLoss" } } }, "auth_ref": [] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r83", "r131", "r192", "r220", "r245" ] }, "ifrs-full_SegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r83", "r131", "r197", "r220", "r245" ] }, "ifrs-full_ServiceConcessionArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ServiceConcessionArrangementsAxis", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Service concession arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r204" ] }, "ifrs-full_ServiceConcessionArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ServiceConcessionArrangementsMember", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for arrangements in which an entity (the operator) may enter into an arrangement with another entity (the grantor) to provide services that give the public access to major economic and social facilities. The grantor may be a public or private sector entity, including a governmental body. Examples of service concession arrangements involve water treatment and supply facilities, motorways, car parks, tunnels, bridges, airports and telecommunication networks. Examples of arrangements that are not service concession arrangements include an entity outsourcing the operation of its internal services (for example, employee cafeteria, building maintenance, and accounting or information technology functions). It also represents the standard value for the 'Service concession arrangements' axis if no other member is used. [Refer: Government [member]]" } } }, "auth_ref": [ "r204" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "auth_ref": [] }, "ifrs-full_ShareIssueRelatedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareIssueRelatedCost", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issue costs", "label": "Share issue related cost" } }, "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } } }, "auth_ref": [ "r346" ] }, "DPRO_ShareIssueRelatedCostATM": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ShareIssueRelatedCostATM", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share issue costs" } } }, "auth_ref": [] }, "DPRO_ShareIssueRelatedCostOne": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "ShareIssueRelatedCostOne", "crdr": "debit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issue costs", "documentation": "Share issue related cost one.", "label": "ShareIssueRelatedCostOne" } } }, "auth_ref": [] }, "ifrs-full_ShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOptionsMember", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share options [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing share options." } } }, "auth_ref": [ "r361" ] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r164" ] }, "DPRO_SharesIssuedForExerciseOfRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForExerciseOfRestrictedStockUnits", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of RSUs", "documentation": "Shares issued for exercise of restricted stock units." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForExerciseOfRestrictedStockUnitsShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForExerciseOfRestrictedStockUnitsShares", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of RSUs, shares", "documentation": "Shares issued for exercise of restricted stock units, shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForExerciseOfStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForExerciseOfStockOptions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of stock options", "documentation": "Shares issued for exercise of stock options." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForExerciseOfStockOptionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForExerciseOfStockOptionsShares", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of stock options, shares", "documentation": "Shares issued for exercise of stock options, shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForExerciseOfWarrantsOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForExerciseOfWarrantsOfDerivatives", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants issued", "documentation": "Shares issued for exercise of warrants of derivatives." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancing", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing", "documentation": "Shares issued for financing." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingATM": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingATM", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing - ATM", "documentation": "Shares issued for financing ATM." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingATMShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingATMShares", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing - ATM, shares", "documentation": "Shares issued for financing ATM shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingAtTheMarketShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingAtTheMarketShares", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing ATM (\"At-the-market\"), shares", "documentation": "Shares issued for financing at the market shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingAtTheMarketValue": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingAtTheMarketValue", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing \u2013 ATM (\u201cAt-the-market\u201d)", "documentation": "Shares issued for financing at the market value." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingCost", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:SharesIssuedForFinancingCost]", "documentation": "Shares issued for financing cost." } } }, "auth_ref": [] }, "DPRO_SharesIssuedForFinancingShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedForFinancingShares", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for financing, shares", "documentation": "Shares issued for financing shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedInLieuOfCashShare": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedInLieuOfCashShare", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued in lieu of cash, shares", "documentation": "Shares issued in lieu of cash shares." } } }, "auth_ref": [] }, "DPRO_SharesIssuedInLieuOfCashValue": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedInLieuOfCashValue", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued in lieu of cash", "documentation": "Shares issued in lieu of cash value." } } }, "auth_ref": [] }, "DPRO_SharesIssuedInTheAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedInTheAcquisitions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued in the acquisitions of Vital", "documentation": "Shares issued in the acquisitions." } } }, "auth_ref": [] }, "DPRO_SharesIssuedInTheAcquisitionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SharesIssuedInTheAcquisitionsShares", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued in the acquisitions of Vital, shares" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r264" ] }, "ifrs-full_SpareParts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SpareParts", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Parts" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of interchangeable parts that are kept in an inventory and are used for the repair or replacement of failed parts. [Refer: Inventories]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfIFRSCompliance": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfIFRSCompliance", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Statement of Compliance" } }, "en": { "role": { "documentation": "An explicit and unreserved statement of compliance with all the requirements of IFRSs." } } }, "auth_ref": [ "r5" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r273", "r285", "r295", "r321" ] }, "DPRO_StockIssuedDuringPeriodShareExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodShareExerciseOfWarrants", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for exercise of warrants, shares", "documentation": "Stock issued during period share exercise of warrants." } } }, "auth_ref": [] }, "DPRO_StockIssuedDuringPeriodSharesExerciseOfOptions": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodSharesExerciseOfOptions", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock issued for exercise of options", "documentation": "Number of stock issued for exercise of options." } } }, "auth_ref": [] }, "DPRO_StockIssuedDuringPeriodSharesExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of warrants, shares", "verboseLabel": "Number of shares exercise", "documentation": "Number of stock issued for exercise of warrants." } } }, "auth_ref": [] }, "DPRO_StockIssuedDuringPeriodSharesRestrcitedShareUnits": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodSharesRestrcitedShareUnits", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted share units", "documentation": "Number of stock issued for restrcited share units." } } }, "auth_ref": [] }, "DPRO_StockIssuedDuringPeriodValueExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodValueExerciseOfOptions", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period value exercise of options", "documentation": "Value of stock issued for exercise of options." } } }, "auth_ref": [] }, "DPRO_StockIssuedDuringPeriodValueExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for the exercise of warrants", "verboseLabel": "Exercise of warrants", "documentation": "Stock issued during period value exercise of warrants." } } }, "auth_ref": [] }, "DPRO_StockOptionsExpiryDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockOptionsExpiryDate", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Expiry Date", "documentation": "Expiry date for stock options." } } }, "auth_ref": [] }, "DPRO_StockOptionsGrantDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockOptionsGrantDate", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Grant Date", "documentation": "Stock options grant date." } } }, "auth_ref": [] }, "DPRO_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "StockOptionsMember", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock options [member]", "documentation": "Stock options [member]" } } }, "auth_ref": [] }, "DPRO_SupplementaryCashFlowDisclosure": { "xbrltype": "stringItemType", "nsuri": "http://draganfly.com/20231231", "localname": "SupplementaryCashFlowDisclosure", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "The following are included in cash flow from operating activities:", "documentation": "Supplementary cash flow disclosure." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r314" ] }, "ifrs-full_TaxEffectFromChangeInTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectFromChangeInTaxRate", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Change in deferred tax asset not recognized" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "DPRO_TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Adjustments to prior years provision versus statutory tax returns", "documentation": "Tax effect of adjustments to prior years provision versus statutory tax returns." } } }, "auth_ref": [] }, "DPRO_TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Differences between prior year provision and final tax return", "documentation": "Tax effect of differences between prior year provision and final tax return." } } }, "auth_ref": [] }, "DPRO_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLosses", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Non-deductible items", "documentation": "Non-deductible items." } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Impact of different foreign statutory tax rates" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "crdr": "credit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Expected income tax recovery" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_TaxEffectOfTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfTaxLosses", "crdr": "debit", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-capital loss carry forward" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } } }, "auth_ref": [ "r39" ] }, "DPRO_TaxEffectRatesShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TaxEffectRatesShareIssueCosts", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share issue costs", "documentation": "Tax effect rates share issue costs.", "label": "TaxEffectRatesShareIssueCosts" } } }, "auth_ref": [] }, "DPRO_TaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TaxesReceivable", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Taxes receivable", "documentation": "Taxes receivable." } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r129", "r148", "r163", "r235", "r237", "r377" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r306" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade payables and accrued liabilities", "totalLabel": "Trade payables and accrued liabilities" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r13" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade accounts payable" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r214", "r351" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r11", "r23" ] }, "ifrs-full_TradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Trade and other receivables", "label": "Trade and other receivables" } }, "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } } }, "auth_ref": [ "r11", "r23" ] }, "DPRO_TradePayablesAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "TradePayablesAndAccruedLiabilitiesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade payables and accrued liabilities [member]", "documentation": "Trade payables and accrued liabilities [member]" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivables", "crdr": "debit", "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Trade accounts receivable" } }, "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } } }, "auth_ref": [ "r215" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r334" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r336" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Travel" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r347" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r337" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r338" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r336" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r336" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r339" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r337" ] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r81" ] }, "ifrs-full_TypesOfContractsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsAxis", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of contracts [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r240", "r243" ] }, "ifrs-full_TypesOfContractsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsMember", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "auth_ref": [ "r240", "r243" ] }, "ifrs-full_TypesOfInvestmentPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfInvestmentPropertyAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueOfInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Types of investment property [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r347" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r173", "r178", "r179" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://draganfly.com/role/ScheduleOfContractualMaturitiesOfFinancialLiabilitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r173", "r178", "r179" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r164" ] }, "DPRO_USCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "USCountryMember", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "lang": { "en-us": { "role": { "label": "US country [member]", "documentation": "US country [member]" } } }, "auth_ref": [] }, "DPRO_USDWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "USDWarrantsMember", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "USD Warrants [Member]", "documentation": "USD Warrants [Member]" } } }, "auth_ref": [] }, "DPRO_UnderwriterWarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "UnderwriterWarrantsIssued", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter warrants issued", "documentation": "Underwriter warrants issued." } } }, "auth_ref": [] }, "DPRO_UnderwrittenSharePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "UnderwrittenSharePlacementMember", "presentation": [ "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwritten Share Placement [Member]", "documentation": "Underwritten Share Placement [Member]" } } }, "auth_ref": [] }, "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UndiscountedOperatingLeasePaymentsToBeReceived", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "lang": { "en-us": { "role": { "label": "Total undiscounted lease liabilities" } }, "en": { "role": { "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r142" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r333" ] }, "DPRO_UnearnedRevenuesReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "UnearnedRevenuesReceived", "crdr": "credit", "calculation": { "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails": { "parentTag": "DPRO_DeferredIncomeGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Unearned revenues received", "documentation": "Unearned revenues received." } } }, "auth_ref": [] }, "ifrs-full_UnobservableInputsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsAxis", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Unobservable inputs [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r126", "r375" ] }, "ifrs-full_UnobservableInputsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsMember", "presentation": [ "http://draganfly.com/role/ScheduleOfFairValueForDerivativeLiabilityDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used." } } }, "auth_ref": [ "r126", "r375" ] }, "ifrs-full_UnsecuredBankLoansReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnsecuredBankLoansReceived", "crdr": "credit", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unsecured loan received" } }, "en": { "role": { "documentation": "The amount of loans received from banks that have not been secured by collateral. [Refer: Loans received]" } } }, "auth_ref": [ "r347" ] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://draganfly.com/role/ScheduleOfIntangibleAssetsWithFiniteUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, useful life" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r86" ] }, "DPRO_VariableLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "VariableLeasePayments", "crdr": "credit", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Variable lease payments", "documentation": "Variable lease payments." } } }, "auth_ref": [] }, "DPRO_VehicleLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "VehicleLoanMember", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "lang": { "en-us": { "role": { "label": "Vehicle loan [member]", "documentation": "Vehicle loan [member]" } } }, "auth_ref": [] }, "ifrs-full_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "VehiclesMember", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r355" ] }, "DPRO_VitalAndDronelogicsMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "VitalAndDronelogicsMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vital and dronelogics [member]", "documentation": "Vital and dronelogics [member]" } } }, "auth_ref": [] }, "DPRO_VitalMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "VitalMember", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Vital [member]", "documentation": "Vital [member]" } } }, "auth_ref": [] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Wages and salaries" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r358" ] }, "DPRO_WarrantExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantExercisePrice", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise price share", "verboseLabel": "Warrant exercise price", "documentation": "Warrant exercise price." } } }, "auth_ref": [] }, "DPRO_WarrantExpiration": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantExpiration", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:WarrantExpiration]", "documentation": "Warrant expiration." } } }, "auth_ref": [] }, "DPRO_WarrantExpiryDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantExpiryDate", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Expiry date", "documentation": "Warrant expiry date." } } }, "auth_ref": [] }, "DPRO_WarrantFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantFiveMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant five [member]", "documentation": "Warrant five [member]" } } }, "auth_ref": [] }, "DPRO_WarrantFourMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantFourMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant four [member]", "documentation": "Warrant four [member]" } } }, "auth_ref": [] }, "DPRO_WarrantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantOneMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant one [member]", "documentation": "Warrant one [member]" } } }, "auth_ref": [] }, "DPRO_WarrantThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantThreeMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant three [member]", "documentation": "Warrant three [member]" } } }, "auth_ref": [] }, "DPRO_WarrantTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantTwoMember", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant two [member]", "documentation": "Warrant two [member]" } } }, "auth_ref": [] }, "DPRO_Warrants": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "Warrants", "crdr": "debit", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants", "documentation": "Warrants." } } }, "auth_ref": [] }, "DPRO_WarrantsHeldInEscrow": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantsHeldInEscrow", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants held in escrow", "documentation": "Warrants held in escrow." } } }, "auth_ref": [] }, "DPRO_WarrantsIssuanceDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantsIssuanceDate", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantAndFairValueOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Issue date", "documentation": "Warrants issuance date." } } }, "auth_ref": [] }, "DPRO_WarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantsIssued", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants issued", "documentation": "Warrants issued.", "label": "WarrantsIssued" } } }, "auth_ref": [] }, "DPRO_WarrantsMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantsMaturityDate", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants expiration date", "documentation": "Warrants maturity date." } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative", "http://draganfly.com/role/MaterialAccountingPolicyInformationAndBasisOfPreparationDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SubsequentEventsDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing warrants." } } }, "auth_ref": [ "r361" ] }, "DPRO_WarrantsTerm": { "xbrltype": "durationItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WarrantsTerm", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants term", "documentation": "Warrants term." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Expired" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Issued" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price", "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning Balance", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending Balance" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Exercised" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r158" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Issued" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r159" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, forfeited" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Granted" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r156" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, Beginning Balance", "periodEndLabel": "Weighted average exercise price, Ending Balance", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r155", "r160" ] }, "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "presentation": [ "http://draganfly.com/role/LeaseLiabilitesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average lessee's incremental borrowing rate applied to lease" } }, "en": { "role": { "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment." } } }, "auth_ref": [ "r143" ] }, "DPRO_WeightedAverageRemainingContractualLifeOfExercisableShareOptions": { "xbrltype": "durationItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option exercisable year", "documentation": "Weighted average remaining contractual life of exercisable share options." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remaining Contractual Life (years)", "verboseLabel": "Weighted average remaining contractual life of outstanding share options" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r163" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - Basic" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r80" ] }, "DPRO_WriteDownOfDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WriteDownOfDeposit", "crdr": "credit", "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 9.0 }, "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetailsParenthetical", "http://draganfly.com/role/ScheduleOfSegmentedInformationDetails", "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Write down of deposit", "negatedLabel": "Write down of deposit", "negatedTerseLabel": "Purchase of inventory", "documentation": "Write down of deposit." } } }, "auth_ref": [] }, "DPRO_WriteDownOfInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://draganfly.com/20231231", "localname": "WriteDownOfInventory", "crdr": "debit", "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Write down of inventory", "documentation": "Write down of inventory." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://draganfly.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r343" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "98", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_a&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_d&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_f&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "d", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_d_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_e_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "57", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_57&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "C12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "q", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23A&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.15", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.15&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "SIC", "Number": "29", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=SIC&num=29&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "12A", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_12A_d&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "12A", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_12A_e&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_a_iv&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_a&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "31", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_31_b&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B36_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG20D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r255": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r256": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r310": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r314": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r315": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r316": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r317": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r318": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r319": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r320": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r321": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r322": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r323": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r324": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r325": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r326": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r327": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r328": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r329": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r330": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r331": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r332": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r333": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r334": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r335": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r336": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r337": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r338": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r339": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r340": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r341": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r342": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r343": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r344": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "144", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_144&doctype=Standard", "URIDate": "2023-03-23" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2023-03-23" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "h", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h&doctype=Standard", "URIDate": "2023-03-23" }, "r376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 147 0001493152-24-011503-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-011503-xbrl.zip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�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�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

3 8.YV(U7_/Y:J@#V.*A]6_1A M5;QP,_LQS2$PH"T,D!]2W]L8V?E$7AAI@OC$*;:4@?FC,5,^\&QIZT< MV.U+(3NS^LRJZY!;)Y8\@2T -R&24#A M\4J#RS:X&=FP7DC;#&^/;0]8OS[!\U2:L&$YS*XG"3?+ MHH/[Z%,8?K_@?; M"*%S/ JI/U*2BKEC[K7K!^B@%!/(W"T\E4]85%G,J($7U8*4@J*,.]!$;U@,@;:3^_11 H'IJZ7W\ MMW7$OZ<=P'3!T6A=*Z 'D[XJ_VAL^4>E&R1&;A%C/,VEGHW+3)+Z2I8L8ZFK MX[.2:O+"D"=6CW%?-W!'=0,O>,@>NH&/5#?P _$OU0U\J\>M$8RJ&_@A-T1U M ]_+-JINX*W4.;[.>+<3\I1P?8WN-;V[)D_JR8?UDRH N,APP&RC3U>) 5]4'7 #[ZV-Q4;R0HVU=!,] M/'0Q?K9UG?5-N]N)>;+@$]R$X%:4,=]Q+G@F^=DDH,-@4W,_\K3 35(ZK-T/ MI=NYO^Z&7J(H('G(L*\;6)N_"IJ,P<6 (=4@):.IQ;EH(Q)!F,(J+3$=&'),D4 34( M_'=93+,\[U6T6ON&1VUNH6;S'F V[\__>^0,1B^7++?'FO.'LF>T'?[)7= ^ M,47- -V6T@!6!%BN:V,L'PVGJ# MH<-&8&>1V0A6[R*.)IQ[XN<1F&$C,,,<15N*MMI%6TY?9P-SM(:R0NWBZT?M M[.? PT%X%ZEV3O+E'!'J.T]_CNG[%R4![@:'H%8VL(=L9*\EU@K]F:;)#,M9 M3WT@$4T'\XD5]2GJ:SCUM?N?%=YAL^&VS88P?6#D7;#X4?IDD87M&P(Y,O6 MD_*78JRGMH%KMMR";PWX6[I8S%];^X;*Q;(5R%:_9U,2Y*/%LFF 7%[L-8[^ M5.7RJI/%87UKN,'#PO_A\02C<\";;]PX=K%P@M39X8 9 Z6&*H1O'\*;K%_3 MX]8A?))&D^]:M* &L +KT?@:]!76*ZQO'=8S?4"#P.[WI7\I?>DT)T[[MH4O MO>6J66O ?_7F]64VAV??=CMP5O^=N7'*X^ 63RT+TD2%CD^-@B"Z05)* M>,")BOXN#DEZ"L"@]=S4U69NHHTYQW2J-';I6FHM10EEQ:5)ZJ:4$YO@2 PN MZBW0\3#!0@VRA\FY\"&$AX1N2O,RNIWWQ0)?^"**B;HO4S?TW-A3@S).AB/H MSL#\PFL>9F7:8#J+.=> +Z>S9'-JY]),EFD]\[GF)DOU.*OI MB'E-#J4SYDMU.S=PFY>AHT4#Q.7DP/*R24HET?M&E%:BQR:@CX1\^6R>;F?- M<)Z^V>L_W^;8:V>\/%J'@7UW)1UK(LM37"@<;V+*#CX%GD\P;52,DP^US>2LIO.OR=[L=T98 XSI]BPU&0[8I,];- M79I%@B\%@Y:V;^,.&*8I6M (Y^>&E\85MUO/WO*Y%LXQQX&J]%RVE+>@&X77_L3+F6D]KDJ,LNWZ7;P=49# M'%%.FW 2,>1>K"?)7 MH2*FI/HF.7.6[#WUD;OW\)CI!?-W7SXA' ^(11;P2O:HYVQ\I;CV2L7DMRW? M:I$>DX]S%K*TG/*\9EP@VT9C ;'%W7@RHU4\((<@ M6N#=3PS_[JMM'ZC:]GW6MH,^IHK;57'[%IYW.A95W*Z*VU5QNRIN;Z_62,[Q ME$J/QZ!"W6@)A3'@"E% 73K)8Q')T'"^ OVTP#IJ:CBF38%FW""_&"RO"[!B M =",'@2]'AI>2%=,,E$<]*$7%/)#$N;%Z V M,.":GIUX-I<:U-)SKT..*U M>+9U1]<&3176_GO;YL6UIS9L1B^\RG9=+IL'=RMG(@/<#1Z+;#G/-TB#+\(9 MM IZJX8AC["KQ&BT::%M(5F/3Z<8*(SE(D.F&[N-$VX._ 8;CD9,M^XZDF;# M[^@&LX>UL45;PW_PWNV2@#=*S_UI*F]!PY X5&]'N,L7,,0_BIX'16P>D./P>C=@3;\2$3-GPXJ,G;!^@].PZ> MJ,&[!KCAR&9.O>G^"2"QL=^84>M_?0I(@$?:=1[9#*TB)P+A!=%^#CTWF;U$ M7\R$AZE[U?B9F.:P][!)Z,\?>.3;CX,Q>EN,GSPX&*;=VV(FY^'!&/2V(,;G M)Y,&FPIK@W5>X#VF"?\Z#YM^_=#);]MH=V=] M9CM@!_:W$+('A<-A \=AHVU4WH/" 6JW T; :'LX#B7M*XA.2=)E@/$<<^+] M29,Q7N_I-:%R>F37>\86QMVA0=ABIN&!0:B[ 8_#U^]":<\/LI1["JD54C<; MJ1_JKONTMB]0D_%]Y/2QTH]/R M>.KZ'N-[5.E6FQJR?CZ%<(@;.X;^3D=LL@KO0;1V0-PZ;P"5-0&&_H!9QHZS ML1OE!B3ALUQZN9OY_&2]@O5Y[#^P1W!H,XO@WX$=@L.1 MSH;;"-T#.P3UD8-==!MI78H'WT$%;7,;&C4K_O0DH3PL$H3M><+!)0 ^;:-* MNBT];.MS?)JZ[SIB^X%5WW54_H,HOFO9RP_T[H_.?SAH=:>JYGOBU7SFTZGF M,UM:S6>VM)K/?*+5?$>MH;(,L,?KR3FMJ0$;#ASL6M92^$UF#71FU!60UL"O MVQB0?#C^_ U>/;=@;AV:8PFCBADAO7#F@M8.3<"MOD#;P F3O?-FO_VQ]D MTQPRN^Z=;47EW/[X7;T&K[^>TQTD^X0Y3I^-!C7)?US/H&,Z;%3/C#M!E-Y@ MNF&Q_K )N4%#PV%&?XN$P'),-3U[&U@?#<+". M;S?+ -JVM.Q E1JG/B6]5^Q M/^BSX3;^C8/67V''1#9RFN#R<9@#QV9LXP,[?#G8T 9PG"8RU29681W@!"SL MYK$-WS@X+EAZG^FC'=MF'8A" YFUYN\G()"#."R.ALZC:[5W5\55;LL[H&S MKI#T!_$W6#:@R/"'KOXQL-Y;?[B_Y0ELP=D0:\!:Y'+:H@#J('P<%1V=.?JI MRW-L-AJ9K%_/Q3AR#-36F64V0=R?88MYD]G;Z!ZGM)X>5+-T&$/3;H"M>^+J M'KVW#24?'GEWQI$;5!VU( ML6]IT=#2J,OJ0%&:@[XRZ'5UONJC9Q-6SGAGD/6>V??#G]9V&7K80GL[07+! M;6R!M!UP!T:R#^$DR#PX#X^M\& M30AEVC/#-,&"UNE+,_]R6'QER0'VH8>76LPV;?K>+K^_B3* 8^9>XV!+'L)U M3!_"OWI_Y4G,TD=@H)KB6?0-=KX>6&))N(8> W8TV-..>,QN6T,PB7'0.#@S MX=4MZ"DR;#\96HV7(934O!O:BM3].B'U39W90V.9C/K#$1L8@V6"'>D6,X=6 MC62MH0E49U5)]L9/9U&6TF!9HH[=8!6DI%5K#NJ 6X;.^G;^6& ]5"6ZYLDY M82HQ^43HTVX\?3Y>X$I2,M=*/B!$QQB!-$ZE:,8D(K>4SJ5 PG4+6;T;1"#@ M\&&C@?Z2 0WK;2/2YL-N5Y'>CXG8[:N %_M?Y MN?;>YX'WJ_;9O>(O88&_,QY.\$9C^%+[%R;Q_*J9VOEY[GI[]^%?.4@K_,19 M;-6<8C?>MUVKF#6O?(?O']C5VF[)=T0@5AK35#M"S\NK5X%":,59M[1-416#5C'L<=)T(R+6VA0]6H[2L=2\TW2^ M&YJZ[2Z$I!-[?R?SZLWK=[%[Y8;30"I.'\()\,\WKVL\],#[U9P-^>B&0%!S M$"T"R'=^,LF2Q(]"L@0O0C>X3?SD%)NT7;/ 9FSC^R@6\*.1>LO=6..AQSWM M'9_P^9C'FF4PLJ,W;^33D=KM 1].[@__[\SW_!0X B+\6W?AIVZ@?>%)E,43 MOHSY;7N_EA_/UQGO=C!1P0UO?XZ3O[/H9:(%^8$!(2??-3\1Z=M ;-,XFFM^ M"I=$;@C+NI-)E(7P>>'>NN. "TZ>TC!&X"-\);W@+=TDU LIX_ MG?J3+( G>< 59[0%5]U..HL2KD5C>&TW!48)MX^E>TK"2L3O7D=Q JQ-F\,S MX$IT+;NI #J=Q5%V-:-[)F[,IUD #\\Y,:G[*;[7.-5F40#OEQ#H>+F;),@] MKV%G%EF<9#Y=/I%HZX-LBV[(1, 5(E&/%*'K[6L)7[&7-U'\':V._/9D%L7I MU T"\ON?#8P!TXW!"]P> +W&S%BW(\R:,660@.*7P,;"*[NAQO\!XA'Q XO9 M@Q$S]"'3_"F]1&'CK,V\OX''P>T44ML*;B#=M0":M-0S,+0,9\B&NMYK+2D\ M(4H&M31,?$)JQ 4P52X2J0VY722IX6408_,!3\D+\?A8T!-'C#!"E5/LA#ED-_ XO\ M^.YG=[YX>;'\K"P%@OL?GG0[M%\QAU60'P$K=2>2-PJNFL+QXGGD_Y^[W[EV M[<9^E %[!4$Y ])/B._ L_VXRGE:B[1/B.8*SIGS6#A#Q"L_S#AQ=^TJ(H8: M@;T?AT*J(EJA.,H68 T@AE1NCL:I"Z2"N41XRH"&)4T@&0 BN).9SP&'A3,, M!7"W4Z(%$AJBZ31#Q"6\!*D*>)>BV/0!H2="9G) <" A5F,JY"$!-S0TAL>P ;. ;"9T #& M_#8*:94D6RQ 6-.Y%#QJ$;BAHK<3@7^9C1/RF($I#0=4UY:64&(21(A1H"F1 M1$!G+^ X\%+0*R> Z%,>Y[3D)PDJK ;H4;K.=%V7R;E92$29XB+%#8O8%X3R M3.^9 U 2 0*\D'CS51Y^G0 NYLJ98PQIT6^7[RH!6G$%2LAH@CB:Q3&0("C= M/ &56 CJ9[;HWSH405H)%H$+E(-"%I]@VR:S^SHHBR%/B4R>84V?Q8:6H9"U ML9S@E3X8-+= ZQ-,*M=9OP'FP1*7*6BBR0;!"A@(Z$"2]2$H:.C8$8H9CG,/ M#AILU+>8;ID%%F(>)B9V&9:MD/"$2/A?;IBY\>T&-%SFCZ'T9J"G,8W]<992 M!.8JYN01%&9[\5%S@R"ZX5YU058WU.&!$1@5^8K4^ *>Y*;G<-\Y;,QWGI8( MCVB<+?!>8IY&/T==?CF%[0R-E_5/ENL.:EJ\ WP>=<&". MM(NO'W/Z(HJD._#+4EB0+'"OP;BZXJ4H,'O.J%*KMH8.ZT0F2&9@#S%_ I2. M.VG+-$V@(J="608VSF9#0WD23P5^)8(+I,-#CWSL6<*EV9R6IT\(P4/ &D" M* 9S&3T*BPS^2O 19=8-K( *[I+]#JATDV):/)CIPD,-.LLOL"0NF_O>8B3; MF(@2O6CE@NC8%_X$_.CQ:QY$"T&[\!Q!>U+,K/,H3# 5'5[$RR8IP+*(X$U3 M]'FX$WA@(OR0M!20#2=IAQ\JSU$(>B+PWV-0MC"80K8ZM(WFO! MK_=1+PL)=&@)AOC TQ7"P!]L:I1ICN1$@(%4*77-[15#AW-T2" MT-&'SN8D&_^;3U*$%':'QR%(&/AQOB!=:1VV][2+#4&A.YSUP' Q(&/K S8 MLY LPC5AFZ4E2B^;D) BI&,PW085:6BL#Q#=<;\+%F\-:*V(8X$&[X#R-+0- M,#7Q,:,A,\ 2R/N,(WPOMH]CY;$.V$49KV@M8C\H0V^D,O3VFJ%GJ@P]E:&G M,O14AI[*T%,9>C^ -OT7[W8PP6&2;G!P:!SC!'FHN&(>H6F5!T:%M9?R(("% M,/P IA4HQ.DM*XPLD;S!)[,P"J(K7_KU;F8^FE8:AEIAS6Y'VFM+=B9JZ: Y M@@TJTI7(F:"YP8U[*U)<2O.-PM2H=R\!&E-U1Y*2?8A.&NK3B)>)L H"J,TH M+!WR*U=D?X%R[DXHL"U"Z!HIHIC^E:Q8E4],Y6P/^)\RX#D8D\<#J:0^R#09 M$>0G7E24XU-*1(3N/3^\^E4[\U\ GTJRTAN " /VF#M!"P/1S,. 6BJRYT2U["P_$F,$VY.P^ CBCM MCO(+.69&^J!Y IW@== J@)TQ2'B4+F!B M4E+#[08'!RQ]O0KUPDT%E821-+C O'+%GJ)A7+PS+7UV#6\@O2(2,'+38*HB MY7>07S"MO3T^*4]O E Q32WT,O1=TADA$<><+&>Y0H L &],>'P-?*"U.-MR MDKNX+'ATF0#'B_PWIMT@HPSQY!:8[P9G3C[@,I-(9K\2WW91"\H"(-"LDMZV MS/UC4"#*]&-R_ 510M% 6&:!Z4A%:I1TOKASD9=,(L>?2S]@E&'.%(FGI90^ M%"] 6[?5K"9 -Y&?1?>&&$[G,2*K3*!2^'>ZBH)/T^GY&S? 6$*W(BF1\21O&' KN= M@D%52HZ*''S)4!;N+7$FY \+# F&J4Q?)C1+!'A1/@-@[J<51H8,['N(?0;P MHJ+ 0/&'T_&'+^@!(W3\!AAT@74B^V<-AW^1HX"[I_,U>GJ_/.9C''*.IO5S M/5AT:YMMJ<4BUC>FKOB#-_3*I7>^X8C*>%/@;6Q&O;9][MM/^+9__L=/YD]W MK+@FRG9_^/!K!)K0EHUQ:\_VT+C/ ( F%(?A5F.4"YO.[>S'G!/%\JZ;+^=7.\[7Q"6=H,<,8;+IK[3.. M@3JK"(U/+I0<67;TT FO6Z/6 *=*]+<8#7!PW*IO0_U@-G*F/["F66;LH,IT MHG[@Z[?]04W!S_?2$?W0N+N][+B#7=0&JSQ2(NT4]KQ#3CVXQ_LV\@]G'-K8 MP;>_[K: ]&)D^;C)'N"4ZF+4QNHU !64-'-0:&.@&&PRW'0&F;('& MH_B?/(4+HN^B0<*O[=?7=A)])Y1)*SNZ44\[\DGL:X:TS0;VMLI"6VA%R0 A M TR#.<.:IWKO,F"/&?+;A>-:$@@]1$#Z.,E2"?:XR)N2E@E)BTCFKBSQ 1SBX-)6(YNC/-["4-YD?()#)*O!%T/6^C;\K#OLPR5@-S3Y* M!NX*R7IT.D7XV;)-9CDUW]UQPL_[&$'^+S[S)P&OH56C=++#^F2V#<;NVX78 M:'L0T'IK?\5I#9%=L/T@4E?9'\KD5D7*IP:_2*JB7JJB [QL*Y^/;,!Q#F5W M9VHY4UI35 )*_4^?R;0I[8S&%YQKST(_4%U.3SD?!BW7;N>/O*O/(2LTE!FK M$HN/;?;=FW+;!%/''HZ847<"G-;4V2;QYJ?7'ZC/9Y+FQ7J'CFU9(S88'3/M M]M I2B(#-R]P:K]U#(7/L&F$W#UW7,.M:*OU& M87(W/C["W-G2^K)L; B]X\W-3OC9S%B;>@HC!].R3WL(ATN^NX]/-^TTSBA% MWJ@EB6[UX$-PX$?NOTJ VR(!CMF.W<@\*)4"=UCWXTAGCX@AJA2X)^MCO*=] ML:FK]L45_\?CVQ=;JGWQP3U[JGVQ:E_;9YI!MRUC:D%.V MSP1*VV;.L$;3C4RA5'[-QOHUVYI6N3ZFW+RT2J6[;ZA:>C1]%#;=1YR"2%/_ M"C_#H>V"?1%WT^V"!]%F&^R">^NA_N )=4X.-9R@LJZ=3*LL -LH\C(7 B-0XWV@XIGJZ59]@&ZQLU?&NMBKM'*V]HL6&_P5WNUG(\2I"7 MHU:P2P#W5EP:_A;UH*?.Y#-1OM3JMAK$ VU;9Z;38AYX02TDEH=9^#+A\P?F MAF>&!:BW7XO_1?LYX9EC,,=L5D;]0[#^ARX15KZL-ONR6ID(<$3P_^7&H. $ MO-L)EO+DL4;XF6VQOFV6-;^FR?K6Z(68,#?F/,0AD]%5".O1C*E%'$W]E/)G M@BA1@]Q..:A)]+CJ=CZ[<7JK?8W=,'$G:I;;J2.D2WIBV'8^G8UF]_H3>)![%7/1]>P,[_HY\' 6VT7^[<\Q?7XA1L>^R6__ M$.(H99PE_CNH!@OM3-[WYL/O^1VLVRF'>]/PM;_O;)Z)K MSP>23Z-8COTN9L#E2K 8-8=3*'$R-+_&2<7!K1CX%@4!]V@V.C"*:]\C!WV\ MB&(<7">'(8N$/'S2501*#G8BX QG/<,U5_X$Y\BB-4:3!@B@>9''Q[0K'O(8 M@*EM',/!F3[.S%RXN%[YV.+2RO,UA"VB/*F4UKWAXP2T*.!V'L=AM[4'TQ"[ MD&917_N)+V+@E2LP-CCE' %*M2A+\X%\Q5+N K.73=3CGRC^;XRG." M,\7HNR>6)H9MCMC <;2SFC\;V;=MF\P>]E_DT^-Q'KR8[UUP;TX9D+"%N&1/ MNTBJ4XK=\/1= M";;/;&.P#%FWHQK!- !\I-?_RD# 6G3.^MW$6J.#]:3Z6W'9!DJ]G(!]I_WA MQ@E.?G8+HBM&W$L MB="AG-L/X,"X7LD4)=ILJ=]"K6/[JTV$A3!EB#0)FBY M$"*/>;G(*C!$V*L[4K[\OMB%5N$6Y>V@TNR778B1/Z--8G1H,7,X?+%1OG<[ MAV,7(WCT8 -@@*$#NZ_XQ0DM0S %/1!J0+'"9 MU ,NYR6H@R"6Y,VTB[40>YX9(YTYCKU)CS%8WQZ]T"1"K7^\>"0QG9)[%0^4 MM_:ZG:_PVF.1?+D,,[+A+$R B\=H<(91>%[8IV-@NG0-*HL9![,-3#_8_J4O(P,CM!575?NS*F#5Y+_?;"E4_6++F:-M3*]_ M,IB'OL=#*E].#O1V):4G*=?IFVOK.M[E<73TPS:P3&?ML]1IBHQ>7[J!&[-]/W,0VKW3MB#/AO516-S:KM4 <.:4W.&(V8]H5K%/94P M #9;S!ALR_2>Z";TG2$SC#WWY%$.V9,X9#^E,\S278FGJ\E@RB&F'&+*(=9L MA]C'BLV@VU4:N!OE0 O=+"*U?\]F::.<'8=U9\KJAR?C[]@G;NG %48- MZ,"[%P=>JUPM!C#& >#EP]O!M("P#^;%-)@%RK7I;-M7K/E4O1^L&AH&Z_?W M[)%7[KN3N.\H*MGMO'47/DUK5QF4)SR,M]%\'H7=3H*'DFA^DF3<4Z[4$[A2 MU_C JB]L;M8/-MUYY+[:VX#QT^L_,W+S1E/MU1ODPP(!-6(*M>2$-4L^UKW: MJLVB7=$*3GF@S3E>1^]BB@2K)3=O&H'S*(_8G;ZV3?VK+8L9SI"-ZBU&FY8; MM^$%A@;3X30LIR&N/8'&N7"A3'?^#X\G?L*1#]RX<>Q6,I,.Y2HR'-:W=DSE M.F"BVX 9@YJ:?UJ_57U,4LZ"Z.A XB6'/Z;SIIS069\9];!8?<%#M"^]AV2^ M7'X[/+DP?6"R_JC&1$YU'B:SS0$;UH>E-8UH[L['W'BH21J!EA M9/?"MOO@ MC+5!PG9D'>UQ&_H&&P[VXPP[B"=R>^5WH^I6XY&-\M4=V D/O&&@LWY])L?^ M/7:-VM:#N4"'%L-:&WUXL!T]=OAO'>.?^MCS$][FX&+<8G9?9P.SMIVGDN, MD6&";C78,4Q^ 7KF'KMSW//369W7GE4[=9DYJB_;H3G833<'32IG;0F4(5_ MCA/LVO<4="90F6A[?GBUR62.#5RK7G#YI#2G9@]./:SF9(^8:8Y8WSG"T(E& M;>O!-*='Q6CV'%<:#9@.>O$(A?Q2,.G@2ETKH[JM#2&N#<'=UY3/5$WY*D&; MQS?EZZNF? >/):NF?*HI7W,V1#7EV\LVJJ9\K50Z,(D,@R7=3A$M44EDIP+_ MZXQW.U,06=$-C0E-B)B2; [@W&K+C?%R3\U2K"MOI'?;T\KD('FPQ,V$&0!D MZ0('0CVB\/\L8II5()KS=SLI-=L>8]H5IB#@'S0^0:ZO.NR=/@ON0";] 8N"2R3^M$,L=X<4MN:^^E\YI5Y( M2OTMI]3/2*G[V8ACIJM]JK*+YJ:L8<)7GXWJ%2\MR5BS>_6*AQ/EJN48ZQT\ M +,^06)C].6 B34]8\TZ-+O->V#W!K5J M^M.'=^[F^>:AB7$X&#"C?^@&B#4&O253/BU;6*,8U-CU'=>>M)3^; 3RN9:# ML=5C:Z3>M'>SUA#R<;-R'A^CW2A;&A4[/' RF\[TK5,VGTHX]K!;JO<.%]\^ M.KO=>$QWBLP?.#8W:TX-E.-@]^V![J3SZI_7H?^%)&ON3%"W.W+)0^<3O_Z@VSB<=@W-MC0 MQ 3/+>H'#F[F_P#^8L?>A[OX8#AW6J>IP8S1<%V=91-<3FUR4FXL0-G%47D" M-_ RRVOJ]AK,&?:99=0*WY2SM'VNG3/3,=G(V6N5ZJD(2#GV=F_4:!AX_-L& M,)4[JDW@OWKS^J^B*Y%R/)T*_'=9#*34[=P_%[DZ?%D6"ANBC8"N:XN8GT\S MNC7O-45EQ*ZVR.+)S,T32=$W\$SO]>W1Z-OE.^W&3V?41UYJ;]U.]2I8V,"K M%@!'%OII3_M:'0 =)%$.B,-L"4CQ=#>M+BR?#HLZAFG!HCWM#2=/6XB=P+,X MYN%$=KGWDVXGC-*U+C=XQPDF'+I!]28.#R@?'',MYG]G?BR&4(_QXR2BF=0T MM%KV)8 E M\50[%[VL6&7Y@XFD444QZO] 06#\L'],!S\/MIEF;Q:O(N['(0 M"#"NL23,TV A#M+N%KZAA6$?8(_]B-:9NGZ,R/B=IQI=3ZTT86[P@_+N)HZJ<:G'\0)0F\'#Q?0NZ.H^L*_#,7/KE:7^!>RN,YNB 7 M/B*E]FF21H2#.N'@$+V0W6*\2^^B4%IBLLGD(M3 MHHF;T"2C')84KDA<.L\:)BZAJP-F#R(B>D%=@I+&D5MBO ZA914#Z)%IS.ED MX)G):A^$7FO914X]<"A#-@Q4BX9+_TTT\]^]>MX/<;/D9 ASD M=Q589#0@U.99D/J+P!>#"G"IL$SF+[7("BL"?-UP)]8@PBX#O@N:AGV!M]#D MD \0 OFF2,9P(7[P\"+X12#S$BLBK)<,1E 3*'+)=VT:U7].A,\Q. 7<;\J)POIR@!417EA>X/G7OH= WF+M8[&Z_ER( MB'$RT^=E3Q M\<$C@JKX6!4?-V=#5/'Q7K91%1^W4NF0BF^W\PXNN 9U#(S$/W*+6*6?'#+] M9 ]9%+(5%]H21\FAV+D2C@V=/AO4H^K-FLJXT;'_=IT3IM+DO6H+/H&H_,;C M:DQ@_@Z$?VA8?IOBH1V[N!\KGEF'(O>I%*-OFAU"MMAHB',3'S^3\P1!QJ-P MD1\H"&D:&(;<:\%.(](+[N!9S8XY'Z[P@1DC!]LFMS+C4&N6OE;%-I[6:-K#'EO0_J6G+ M;;'V !WA:YQ?/HG"Q >LIQAD^RV[VHG\J7"O28)3DB^!)T2(BFEGKL31B%PL_F"AXF; M1O&M3+HJL@\+MP:E^%':V6J+2_P%(/&G4U :IW$TEREU]8R_Y7I2G%4.3UP!Z4&R$2#UU,N\0JXD25Z1[;TGP KY-5-=H[-]VWI-S/ MR&2*HJYVF'Q3FS!Q"EBW$QQE27+AA:X47&SE_FJ>B;ROS7F/W(,RM7[PC=@= M2_;D36C#YMR-)>URJUBKYGZAT+SGXSC#9AM]$:G6SHQ:4[C"9;"5WP+=&]\N MWSV[V[FAKW=7:%:O7B&ZZ_-W[SBP 9J'.T^.Y/1I.-P/VG0#3)X1<^H5UT]^ M\P_N<2NH_J,+]D%)\N;=C8#O(.>U+1M+"CY457YC)KDW!I ^,VR366;-67 J M@,2%=__WF*D<.T[7+4AEI1K+TLZL?5*+J,P[]&$4A8)-P0Z+&4.=]>V:LOW# M$W(3TIO6$,+F.OX:?=B/:2"^"_5LA$G4T+8_4%(4&O_P(2,#$]-8?_CP;,BG MLA,J?+B?'3B!,K&-:^.!7'-;870WWVQ!J.VP:8]#9+8_8*?RIQ 1;A\C ZW< M,=;-;F@'2W\ TAR>FS^A4/:!XH%+1;K54F@=MWFE1'VU,OS1594K'' GD/6> MV??#G]:&X1ZVT-Y.$)WFE3+*A\!VC'P#;8=_BK [-:81[7-6H@56;TWQJ,*6 M>\_"_#&PI>IE5JCRL(.PGCRJU/I=*41YR#'8[4"4Y19H8220X)8Z+-4._BEI M_T: M*I\VM+&I DI8?NWWRY[90X/9PQ]\@K:S70#]N/1_VF$P S8R!FPP:L(,[7Y/ MWX([G;16LBW#4X9,MM+>\?:=GGSB=]1[_<>_WHF;MVP0,(V*I!XV/GTV8,Y. M(<.M8+Y_"OS3W=%^;[C7O6QF<;H:MK.1]?<'-DAT-4>[35/IGXY;^+Z6\K9J M*5]Q<3V^I?Q M90_N.-:M917+>6;LR&JI?Q>ME&UE&]EEYF+I-M9U^-@>:[= MS/7D=*0\%+RN':Z*JK:BM0HV5=FVY?2Q3!#IN\G3/ X=,'U0=+3:\671YHXO M#VZ(WY38KF5OZE;Q7UEPJYFC.^.[V[:)&&SSD%H,Z"&],.YIA;$AZJKU>W6/ M]&Z/WV,,V^RO]9 WL+?!)5^D0M@9]C*B;!V%V;R6?>=:F\_ZOO,]6/!XG6^K M<85Q]2KBAQ_9RDK._@Y,#$0]](EM"$4UA;H.=E##O1Y4=P$FJK%5)]8DB;,J_=.HNQK5$_YC/ M73]$/]($;HC=29I17^/IQE%+F.T//ZWQ4]W +W;/R<=.G]62OK2?0\]-9B^[ M';UG#\1E+Y[8Y.GV@ \($1-*Q%PSF"E$47GDPB]5%@>:INQ!ET::._D[PWJP M?_FI&_1P]'K]K$=R05F;4M:;P'VB3W4*QOL,)Y#[8;?#DTD0]K(:7QWP2785^OD+, MKWF(G;E#^:NXF-XJH:NZ'3_48IH_!M<_,_-F$[C@,Z?X=#/S86<0[\,HU>8\ M%=!LKK T:R66;<.:EB/]JS>OW\8^:47=SL5D DH0#B_1/H.@G/A#2W#V03:A_=?+H$?DW1) ME@)?P'CG[G>N;<0!S1V#EM+M !113.Q\CL2=8$MH7 @!R<7'_;#AXK+H<9JE M63(".%#*^;B-D,I)H)@#44)&S>6$R>XGP1NW94I"_IE[N[8 MK*TK5'3*\&1EBF;=[V#KK7&W_DB3:OFY])U@2FCDD$.0L'YUD^R;NL4@BFM# ME[HN'$9?\S+R/8F1F,%#L&@TV_DZ/)62)0V+-B07+'1TAK,#R[\HU#.=U)GO M"2O3==UV.,NMWYU$-RCAVU' M![Z'.;HZT,';F(95BYK(XX8UT,+= 9:P:P1S:4TCJ)W@&U !=X[4J?7<=*;9 MB=?)QCSFFNU)A^R; EH:#Y5[9%?GIDRM_BCPW3W0+/1L-=[Q*)DL*?6\<$H0 M?^,:3U9 M3=/JP+M.D^N:O YN'I0F3=&^N]@T!@^D\=!8R?GH3.J_H]7ST.OX"XV"!IL7 MUP6M19X< $BCIE.CKBGQ4VI4N^\7,RO.$P_^AJ=5B 5U&@R-(&Y/POH@2 MS'*R=UI[*%^,L2_ZWIVG [+I&5ZO6M"WK/'I& M5I8NF^#H^2FH&7/ MZ.=UIV0ET>H-C=+E0J(W\AR]!D1[%RV+R67R-6Y)W)@\7]KCSIJM'$_Z-_WE M9FLJ76O[$'Q^JYME]YO^7!;O8!QWM?^Z]$B#S[*N:=,.?@VN3&6\+T6O9SM= MY.*9*?J["BN^F LK'K6PXJ]S8<5<6#$75LR%%7-AQ5Q8\0&X!.R>(19:-X?9 M-3O=\-TF<""' T>Y]6E*\EH:R1H@%D1*J3((J=-H_LV6+W_\DMXV_NW ].: MV"B\95V\/&E-6;+#A,*!Y:(DOXW?RE$<_#%VU'R\.OJB.H*DK2H2#$6>QY-PRV4X1$U[VAN/H8EH] 'Z92###@[B;*>R%KNL@-< M5/%^),*G7^W,>EO597U%[F6C.01YV462-^2[5LEZBT2W;2^-1Y'+TZ_=VZ.) MM\_,^SB?X:L>:[N=Y'7(H?V!>Y(;!DAD53&'GDXY_/\1/,TXF%[X74,48C_< M-!?4L#'M*#WIDI*\^5"@C6-:PC=:4*TK)KB=S99 =T*:!O&HH)+IVS%<@S/T^D[[[1 M".QRL::=+CJR$Q!HY7/2()!+NV4*EAS) ='^RGG2W\[Z\*3ZL%HNP@2;"ZC' MN_G1'\L<<(IO7OUW^\>&__EQ7/4,A5CDB!CCMW2D8?:L!X\1+2+&3_#EE&PO M^OR.O$Q % F)DFT'CKQO!,K8>RU0>Z*<*]J>&MB.((E-RX\7&9UMI<2SJY-C:!( ./*'M M]T@.:.!X4S<[U>N(3;,"E0P%/KQ<."W+!C2,V+[*>R,&.5F.9D-/L,E426S2 MFI/?OD4BA"Q:FPFA-X>9D?#-8OQ*L"' N4Q0ER\7=I-I:3P.)M7'>1$*$B]X M.OWQ)FORB[*N.8\;O'W6XZ?3XV];L^G)RRE)(C@[C[M[[W:MJ#KR0 H67$ZR MS&K[=,-WX%B8^&9(%DY@8!A:KJ.5/(RH;^TN_%CBXV,5!.4H>2<=OCZW7?!MX^=!^- M9K\E9<5@X1L$_-BDI'^D:AU#/9%R)%-^!SX"_+0BT]VT:U%7^'QIKN13XGR7 MQ0Y)5%T:FH@U0;T^YH6Y3%[[Q&P:!C$8GWYD;R8>9(,#;DL88X(DK9^#\68_ M7X4>>2C1%$LO5(!@UM7W^>,G+ MK0'A*AGB 3,0R 0?J>KJPH6;9,/.5AF=N2[]S[__W^]QZ)>+ ,?.7JQ1F.6, M6?\ ,.LV;$&CR>AU#NI22Q2W+J])'060\91?L]\K8-Q7J>RU2D6+GF":MP/! M4O@Z?;GP]4]#V/J=\X1?PB;^;\8D-7?J?"I]TIYJF[0__L=7?_GRJQ=1(O6I M]DI+'O!?C!6<.IX6@4>G%U6Y!6H5,_IU(G4B]+LU&7 V3&##$AIMN%@-%[!@6_ LH746*!H>@R@R\B0/+P8);JC)/=\WN;S]KCGK7OH>5N7 M=.)8^(=5]T79F+X4UP(I+D1]; MJY]^H%H8P20!0/P8+CFCZ70]JBB2%4X?'= 7#SS553Z?F/G$G->)D;KX M:JU%0Q)NE HFKDM"!+9SA>#@&MN/N\H_(S3L734L?YEK6!ZUAN6KN89EKF&Y MSSW#VS+7L,PU+',-RUS#\I,E1^V'FH/_^_8]??_-C:&T_ M-&)S?[M#(C*W.7G6,G^<8(;S!SYG#_#1UMM9S6HP>_/E-QG]EX\[^E=DXI+\ M5\G7<(>:">LKVJ5',&.?8G JW,.JOLXD)XW]')RF1][5>2=_GYU\^^9EBA&? MUXZ^??.A[R59?F5]5:S;Y,VA[]GO2[!I]I0X.3O*;2UG"%+L[!@C&/N5&(J%P8 M1M 'KH[4(I2ER]E;C'W5FN") (]GJ&&E,7@L)OF2?-K&+[0]'&*WBE?*CD6 MHMZM"N(%R=70^[+,9HPOSUK_W(!E;;F0VDOW%,!IU$T+0/[DCTFU ZS\QFQI MIL"2G;=G=K8#/W,%H4SPQWF*YZ#72;U]"W=GR"@H=TEYU>MWI ^4C;>!!NJ: M@NMGF"] @G"^*NTY MB%\@/")^J(X"_H#KH)VLI$Z4N!9/9(G)(PI7T(V>-US8P;4@NQWM-(N.(*1Q M-UO%@W\(=?X>U7@@^.#J MV))!.6),WJWE M0F?^&[6EBC;\*->;,B^W[HYRY)ZMN+\7].3+&7KRF-"3SSZ9H2JT 7-X)P$U_IR? =F<9)#3P!F!$:R#^:5H4>=- MEO41DUK:ZNBS\JFV.:WC+E&25.^,BO,L#*0(X37<84+,Y[?@(O5#_#"SYA]2 M&<0CE$!\]NGEY_M'5?39QT^]^N'UYF'%#R&C@T&M7'O,G0XC!.R##\^^(JWZ M9DVJ[($U&"A+JJSV<&VB/BHNZ>BS7LP=S0R#I^23'Z.'U-KL007#[(CL07^T M_AC= .N;.XHRYC-W%F=N]6&=N=6! W6X$\6*2%WW-38T^.Z-6P:YX-'#A@$[ MIP$UDP26M)!;KP[Y:<0^Y$ M:V.T*5] OLWN@R\V_\:8V]0=W7;0IOM43/5\QJSS?CP]?#Y[KI M['8WQE3AU5[DKG ^YOA6=T9:EC%M&^>_;T">LLVN'[@D*[P6.@Z-SG2*1P8V M[MNI0['CU&9VR&C0'!ZZ($>F(R/$>FAS3G:?"B6>6B,S\O&S+O@\G^&S_YY= M737F"BFC-H/GJQYD$TI'E.\2X4OROI'.J,(S;-8]JX)//T,E *D#RY*(UGL MW^ <2A:*?%,#.(HC.1)L#3WM;\O%1\7'R=LW7R?_WZ?I)Y]\@O][0>>5?OGI M%W^PG^_JSO(HMP.BI#09YIQ&?;E!C09."IK;*BLYI]=NC3#+FQ>8.;U/7NBX M-.N^0^2!&[;Z=9&80)0+?-3!7"8O-6\QR>X[S@ZDT'.'4FDUJY=PH%N$* M;BKBR3A,\E'V\1UI32&B:W@"![@,8 7EFI3EHNHY*F<-*GT?ZZ./5A^3PQ&Y M.^%W$_]5?(M6AI^P PA)>.DT(\K*2RG_G0[+HC&FRP49%^M>44]R0ZW+NO6M M6*8W27FEWWSC+@E0QLN*D0&YVYD<+7S)0-QCO?@O',VQ,_*20G91XB &?XF:QH^5"3:V95$YUI'NI[)@>7^U^0IH#^.]!PE9YP.-KC( M65])7&; H,XN+SHTN..[3:8SQ_.NJXI5KVT:>CJZ!;3 VEORQN# MK!QN007^^FLVNOO(@ @L&>5@833PV2[OF4O'UT79Q]7PFQ2*=[R$A< M7'F[Q+"%.3"7 HE1H]^E:?=EWSY( $._<67OBZ"Y%7V[M88N8/'BWI;B6^SK M#N@](/MCCZ0:S'S047V;YP'&C7F(OI6;DK>NWW M6)[$\<%8$N:S>5IJ!5^$\MIS@LZWZI,I#0J86N]G1C/1Y5>)>T02[.O?DEAS9+-[]E72MY/BFGD ;^9II@1?O?-<4C6Y#?&8^FL_OS5'WX/'1@<-H/I--B[78;PM /"KS3R;] M]0M"ER!8DH?:J!C?WWU#X%E2L3/NUCNSUVW_]],-_6YK7U'YWN;AOAB-\T/>O7CO"6%0S M=BC)M[,\ MU:>M3ALVG)]NMRLNB0$GQ9MDC=<8:X@>]OW.=F! M"YC%: ?9\*W8AQLOE=E%XV"D*)UTU.\TBFV&W]) :9;K]I*,SL$@@( -RTYC MJ;)UV,#(48.K0[-AQ7,)?TFC(@)=:2CJD MQ1Z3K7)'4\/TM:Z,WG\)R/E;OY@*Q:W73CG=)&W"*N0RP/;:(PK@+\SS'*9Z M[D*;\C9;M"?L'+(#@-0VQI:YV8/,5+[:%%QW:FJVGH<<2W9DZF=[(,[\/'_# M2.H8.,YH;>S?UI0"'+OH]%FCP;C)7(E!^I6.WQ MZU-[XZ F>LYZ3-:+!(6E:RSBM;L';-7%TUCKFLF5' %XLE'[,N'!WAUN A_ MRLC!!X,ZJ*%;6F 4GM ;=LK3(1?G+)FGLI'90 Z<'F\0L!AYV_A,)WCF^S/> MF776-(7AQ!.Q?RP7;W??63\'[X\8. MQWU^]N.E7)I)=^WH E8^&VB"NO,O& UJI'&#D ;;9B9PQFU5=>'@K+-6>GI: M*79^9^WTU+33.#YQ3^V$8]N&FBC0L57I_@]YZN-DNK',\),HL>W%+*N'- M3P,JGNC]$Z%;F!_1*RK+$QBQWY7%QG2T$L>F8#LC\"^7"[*2WMG(T/"%Z'A@ MF;U(%]+&L*7#RI!LJ[693"$@VJI M6;P;4P*'*MR2TZMWF7RK83L3E+.U40"-24CU=RU="*5J_CU9?A !L0&59^>X MK,&P92>7YR:/ZUOE*!QOLK"_X+GMG,:R3C@>- MY>7ZXS&--WS3]Z]><__.K*@L#VA&NF>G9'3/KX'W>U4D?#57)#QJ1<)G(B^6G+#.J\-P=Q5@LXP!'VM\J/ M;C(G_7*/W2T/+F9MZP*X/UE9(B!'?W'M.SVW_G)1X38&=%ARCH(/]0'&(*7) M2(G[8"$&'O[9[M29"]KW"((L%]/B,Q:_JD7[9XA,^+GCL6;?V=EL-A(5]KU= MI?,+B10G.RRC%1HB*1&1XR#2L%-6M?9C$YB^8*2S.#WEJ'%D1GQK>/T&^;Y;F@8:.ZZ1+BU+[?%H?MD7C8E[6C""-GA)&Q+' M^^$$PR7@V^'Z93"U(;9O'EA;N3(QF@;QI\@=>6*9<,* M.X'V,GZORL/"68_F6RY>;^Q?ZZ8E?5FTTBY8- B/PO7%?DUU&9GM!'XYRB!X05%4]E&'J)L; PN[H_%@% MDTY"Y\&5S?&;_+DYE7.D;ABIN_SLBZ)ZA'"=>]#C[>!_?/67+[]Z\=2#=&AX M^9"XG#^ZBC]C-YQ+*'.S ;"-D5V;OF19F\EO>W'(X* MGR (7VMN^,2V<17F:!+HR_/:BRWZ!PRA?21HI M3L]0R[5!A;NOS]#.X#(RQ[/ 3BNMM"]OW=65.3C I<"WVKU9 \%L0=F\O+/; M=RI0[H9)=:P9/+*"T?.](4\!LB '86 4!X;^M&GOW H/.J>SPKVN;:&R?X<: M\/2"LJZNYFC J8;_$HW+/;19*LVCT(^ME8@=T:'*A(K#;IM?UL;DDM;S.FLL M,*3PXK>B0BVJLVA:;KY.XMROS9%Y@2GM MD%S5=7Y3E&7P==5C].#4JKKJ]J48)DZV!R"4DDD#K@B,'(1PZ5R^KX=!("V U?!%&-B[# M<$%O\/G02QB2S7>+O,Q*^A&+"Z;(=5'W;7EPMXS7*'0\!N/2YNZLGG1<=87J M>#F7)!P8FIM['(X:GO.\-BW;ZZ*Q)G5!T(W:0\[]-9NCJM,:P3#@KY7"DGZ?25NSA@NH'!A!Y' M.M098O3F3).-?;>M&WZIY!4P*+@96@1(/Y49>&.N<*78*H\6O_S_/_E4:B?.1ZC>IR[H/Z& M5[T1;CY?+/3Y7"WT"-5"GQ^M%K*;-M<,S35#<\W0XZS7TUF0N69HKAF:K=S MRN5@32D9(;(AB\[LHO!-7M /(&NYE4>/@8;";5P,HS_'O[5<^*_A] E7S"@\ MZL^LVMHX2S!8D:AA^Y+1RA(CRMX!+5E94YK&TO5-I13>-@Z&_%31]1)7"EA' MF>!%2)'ENU>H67<@2[*7?]:O,YB:)M1)= 2C-V1+K\JBW9J KL4:R3KU,[WUT:8%6;O^^D,?VI/8D62!B4-2O44N.4'K6D0)G2S0S:N.206/+PV M[31OE:,279GNQABMNL'+ 2)N@WCY, @0]%H8)D<0'_ @1O=";1DR3CCE.OG$ MS]T! 24J[*"/'!"F-].W!D%S&X2H\E#['@LD2_,#TD@KT77X7=MO-L6ZX,^( MN[YP M^&%XQ<=#?'0C"+5 F[OILY%R$X$Z9765%5N#.EZBD"F@#W6,H_>80[79^1;7\G-69&0 MK@UO)9N'FC(1X 9VEO;2JC?H)B(&>$ =NK+KKAH:GH>:/R+=;VG1R"[6^4T](81^5"7 MR761&](3AQ:^0IJLBVLZ^%F5M#M2+LM%7]&S@9?)> 3V@U"%UX;,;-0:TANR MD@SR75T5]$(, 7[ ?L>5/ACR#?D=C"B+W@9$FH3NFK29 O=N1DTJ/E4/.8Z$I^2&[DRR_2[R^H:1/9,2?[9*\,QUN%RI/X*BLU<8KU8;SK?K:8?O]L2K M[G$''-O[372#$ >+V>])A%W&N,U*_I(_L/@Z[ETZQ5:!V>!5W>3D1'+U?]^ MYE7=!%42#@)DF_&APP\/&$>^W>*L*XY'0F">25F=!P5*S\B\T\:CWI!0M+R[ M+!9S*.H)%%/8B]@;R7IH4-6 8OD&1"OWMIK%#AZ8S7S\(],YL98SF4E'3>?+ MA 4F&:"*&>N^K\FV@%W:T1PEV,&< 75I8PS[ILY[E$( V!C1S(K5Q!\FEUO_ MPIKKZZ:N3%E?%>LV>:,#0B+1U8X$'W U))B=2S[2QZOZ6@/I;]^\3.7[1>L# M,FY@-"^RW+?%?N^QR8Z71 ,#KF%/7VWZ8)N&9EZ6_RNEG>/7 9< M&WCO/\E"WB8O:6#%.I,%L=-G+\9_2;ETXR\P1P%PN,U!DQCZ,DFD_%+L$%%! M7 W*@W7B(@+T(@/@,Z3V^1,&Z,]JHU*AKQ5D8,&.RYV;(E MWX?/DHFDUDJ(Z[&<=: A94ZBT;'P/,[+!6*MY'%J;P:+0K//X"]*.P1O 4T^ M-HSMN_BM6%@VK"^?=F++<6T_83JJQV+MY8)BQGY\16O9]MA+VNAG=C;O LM].N/B M'A<7]^<9%S?CXF9_+[D_-=UC._$5 M/?5>*M'VP**#T;;-FOR&BQRYS^2>4R:<<@-J#(:AN4S^A]W8Z;\N%W \Y94" M%<@J29H 9R'Y<5?I9\?*%8J=N=)0I(83U0PF5U=Y%+BP$B&,UM##8*=/SPV9 M-G6!UYGE:P@[^HI?X: A83TQ8U.F'^M]$V BI>^; M\/CN# #8Z%=+CVJ9SCH[)B1G>^+/7&%IZ%A3!G/,^ G%C%4[M$%N)]78(QD# M-#IC&OY=CK!I:Y4Q[V2J-?CH"LY'#$!!7")UR9E>2ZP %/+%ZG"A_Q2&A:0G M4X,YI7\Q^87HBRA'+;]RMYS7 QQ.\ITK?28JT@](<0M!CKWO[.?8YC(1(@;^\P1@01OH"(0:":;5UE2DW1-WP7.5X$&QVT!@E\ M7HXDS@)Y4F2#AW8+$<&,:C@Q-1+9K]F!]8!#*Q3.X^$6C@ZVZ\X4SF&0.KPV MS =(I^Q(HHYO-9M3DP//0&?EY!5.I.GDG<4'NV?:0=C1BCELN4Q<0;TU8B5' M)AV?$V[X;+NJV!0#W/(+@]0:EP 4PPZ6"FZ>]<9)]08 F)Q*^0>#9=[493ZK MCA-7#]HMT9RCJ(S6Y>VJU@3P1Q1@ +_9N$P@\XG%F$8\*=4GB6O/2D9@F"D9 MIH:K$_1'.IQTKD$,KDZX5-AM&&T%8\)$VL,^K-V2P?TNNS*IU!3>!P&<9#E6 M4"P<[HS-4YFMB5.7'GBN])CKQ8;C6)*R)(C?(AB"B:3G=>@-0H7%7.ADT3X6^3OK[(FYVH" M.O>^/0!X<>0S0I1C\5""Z&[\^Q(+N/!$-XV2]_"C[$.JR))!:X$1G9X-UR*D MR!X*NKF@-M@TW<'F^<-JCGW&R7X-#>8&"7];J*Q!Z!4-7 &E;;WI$'N>]=3) M:G+&W1SD&LP9GM)47*\R+&?DRX@E-&R5'C+N26AHR+0859PD67)%GOO^6%<) M.XZB'?-_@FCQNL@AC6,.R!!05#1*&' =8J$' QD_PKX.$:[2>_*Z8!;JINBX.$ )C?58N,/0 M^KM+.N78/I(C-O_?3)IF5,U] 1""T;*]914B$X(>^6V!-T?E[OV0-;\)1CH2&?#*+ M\T8]TH?O[].>US/<]!\XU-">>(N^L&LZ#8L\'R_AS)VC+(P>VEABVP7"N?HM/LP7-SK.^JHOELKJ)YW"J:+^8JFMG?GZMHYBJ: MN8KF?99QKJ(Y2]M#4O3?6)SIG)D_[?#=1C 2M^TDH]@EVZ(%4QRR[]-9QZCO M%V?A@C^.,Y!GNT!GOK]O7)H2I6NMIA =D+,(F&Z/]HL3GBI'(A/5A?$W&705 MD)>G 3([9A%&L1A)ES;RI8=6]:Y8)RORMC8%@ZC:&D*E($U).G=F)XAM]/QU MK2@58V%I8,.<%G]CG56 ?;K\.7EME2P]$#%FCW(XAE\M+ M&H6B.0Q$7/S/L/8+R[O>TEX'#B7YN[@]I12+SQ@?#8:7A83WW!PO[QM/(6D) MHA4?ZSCH78+.YJ/G W:J C(CH6R4MM:@FRG:/=URZR1:%#MZ4%7 F?P6 0Z M&-(UUHG[4#!9MXZZPSY8KF8!.1EMO;\H^9*5T!(C6[)RK3/$=1/9#!H_S?728/)>1C#@%#< M%9"_4362=(-5C'[[MQF$<.J@Q+,'(1COH#QR!(?TV- M3012=+:)Z\\_^<.'O*'?]DU5P%V1(7(3IV>PJY]]V+OZW]:^D2&&1LX9;^HW M:H,I)(P;T<,<^Y!W^E_*B7O&VWI4 \]XAU,Q\0OB7OS^$'+/?E'.]\5<=7;J MV':P%\L%,^_;0HG&> \V\U4=8?W'NBNNI5.5K<8"\X2V>DQITT'MFMK^DC8* MCI!=":HJZ0B#Q3%M"D7IW*M?"I!(,2.TI#,NW7-2KX^(F!' MYY'T%0?LPT IXJ&YV=45"@LZ(TW9-@C(&E_[_IMYUB>2U0=A2][3W0Z1%I_ M\QO@8(;PDU^=M'VO*TJ'_,GE9U\4U?_1B^17/4B>\V@;^%'Q<73)/<%[F!L_ M)@_XKS/K;<5)M W98H4V#=3X;&DZWYEI4!O;UHZ?>MQ7<6,SW_?]KV^E4C4K MS8N1(1%EP>?SD?F*)K'R:IG$<36&AM#XF9/B*X;:U@@^^AZ&;9?D:R M_0R%VS:-)=$.!7=*NF=1?CZB?/WD)7E;WSS0KIE2R&RHV.IUWTSC&-8C[F8( M[R0KV_IAXPC]&[."H4^+\FBPW_]OS M:;2>3QJ@F'Q?U\:T==^ U7-HYP7!M <.I-'3Z$D(<+(C\NAF4TCA@P<2G,7+VX_,F8<)SV;XDG[X!T!7E:A(D)(*.=J< M;CAU*:S?E:LFJ[I1_\V'4%7S$USPS['P,AJ4?D?G/ENCS;GKU-[:#TLOXK)0 M##7WJZB"9VKY*G-O5C9]P)CI5 W6&.U=,"6SDA+Y;N<#1B)%*-OQHQY8D(V6 MI9,N95=!6P2T6VH T" 8.1ZF-.X8NF+/)_&0W(.C,6 3=2TX8J2W/-'"Q^6G M8W,O*F ^8,'LI#'A&/7H\)0;6[*LK$_/#'A[5YGPYW.9\..6"?]E+A.>$;ES MF?!<)CR7";_/,LYEPF=I>XBCPRC-&4=UXN&_]%T/R4)F6FW\C,(WLM<59EHX M;A_Y(/WCVAP$@L3G6@Q][A1O0]\<,:S"+G2>FC>S'@6,Z8)M<+ "K[=9=25L MI!&-T&7RLM,!['8PD!@L)9VY72&2(PHZ#"W]3HOQI/EV1#RD^0MY@'9%T8(_ MVZB,:/W[_]8\/_^CC,RL3M3W2VL3LT M6*!4>QM8EN'J8/>9UK9B"%OLE(+4M@"QNC Q#^B2+Y/OK<HQ!;HI\^4"=9\H+\+$N0-;*26>S]!!/)_A3UD=9W(NS8VD3^#8.S:-+81:U+O(15TCN4;( .OV':3 M/T!=NO@/F;QKLKNR(NZLR2?7_&*:==%*;D2_BU))/(].U2MHV:8UR"?>-A . M#7,1,D,_(PJ 3?A6.K^V9ZSV/\7;-$@BH[X!N"MTB\%]2K:GG"- MGVKM8P1'"XT>^FJMIHE^Z,#T#T;<"E5\=*^S4E*--WH;^P^.O<$]*7$.FA \ M<./[M=@H_-U==D ]3 &=6G*#I,J@$1+_!-8H50ZZ K-2.&G#+G289C\ZMDS= M'4,_DS67O"'/RC WR);,+MK(E@S'7KO_:*_JNH3'&$IP U5SF9#Z>4U&6RY) M3 MA$*$M*FXG+P0#&G*P]#?TMN^^_F.VV[]XZ20RK]>]\I30E=/L:^FC0X9P M@VZEG#=!]K6H[%?P[S0YU'W2;NN^Y&ZF!:T2W\\T*R$[L9$&*9;B@:/^:]T4 M*WJ\/(6CU0QIG/X[6[$P-GAZH,?"YY(-27S=M/A?YAK6!ETR&'Q\Y?F2I2_2 M-L-V7^,:UT7C)F9X)T/B*_4E6!7@"=JJE-[XKJIO*@%)I6(WD E_8X)/V%?1 M6;3V56J_.19&PH)77?.,9E>L->@S.MVCN:J0XA8;9G]$WQ M&_:6F4_[G28 7_QT_\=M=?7 IWQS6"N!-_-UE=,XFL-L*YPZ1AY9#%LVPH6\ MD0&9CGYQ#J$_&;-N&U;JPD%2XK@6L57M2;PEK#T#R[*ZVZE=*@: 0';*+ MM6_J3='9SI39=5U$+Y!K?+G0D+:] 021Y/QO>I')&M"0M4+]R*VU^=OXFW[Y M?_NLZ1"S<2KVM .O2]0,6+GYXK!Q>0Z<_-"F\D99__D;Q M/8 5 TG_TN:@"#X'L&+;[A>UW&E4H2^$C2@,H&_3)8I8/C[:E^"QA-5M=!ST MB)STX0$S#_H!N 59J\6 K^(S]GKT4WR>[*=W08#^/$. 'A<"].4, 9HA0#,$ M:(8 S1"@&0+TP=C,XMZ\7"Y:Q)? U68:%WK"CUS3$N=,$:H@&S8ORKX;Y3:3 M@@QG&D+FXR9Q!,M9LJTAZ]P%4ST*9/:CGH1,V%V(O"IL/6_PK]C?5$L4\"R1 M(>0&;Q4_B0G:>'7H^K@/9U"HI4 %=H5$ #'2S!8J5^!K*NA/\ =[5DGTZVCL MJ<8%W5!H#-DU3;^J 5NZ,+L]AUM9?TH*H*XJ):&2MM-](T%5?7,KKSX$BZ%$ MS0S@05"RCH\/7BAQ5KJ'&J/Q6G1)5WYSG#>D&8*YW6,#R/W+&I1?F#Q5&!9W M=N]T,WB,2"0$7V($ S8[ETBDCQEC*#QRD86I(803#F+/Z4B3W"%._;[6[7Y>K "II.UJNA0%@"$U*]*:;OB8B@.NM&N\O;X:!NN[+S/.I^)=2?RJAF/B MFEK!FV4!ZKZ#/\SB*7_ON!0P6+UX7ZW0:]K:>K-67O@<:&@^E+]X[60='KCS M$E#8U\SY I(D"2WP,K52U)2*3!V"*/1HB,"<38[1Y<^?FP=^/L.?B%&ZB% M M4;!A!$?Y]P;$BMJ\1'Y+$A/GDL)R M4EOJET:'R"3'!\_TV-4VLY'LT?)$XU\N5J;$/-LP$HU+,#S=]7Y/0T,;5GMK M!%:2:_":(6A[F?S=K+->\9*N1Y! RN*H\'!=7'^D($1M488MVP:MB=DW^<(< MY4!YUC9^'GL/R;=R8466AA/"YBBI+*W=59/M!#Z!#( LIH%9!.)0%)Z*XK&2 M1F,XOD?V*4=EC&YSA, [208$]H_5:;2,HXQ#K#P#=![=Q[O)"?NX/CVEY4LA M2 VC?)>GI"U^R2:@<_!WW+$)>7E(V.LW&W:,(?.7&;3"T:T+\&-\!8CJEXJ:1OE\ZK*^ MP@>4RHH?^/;EOV(U8]FV(M4:>QS#>]??#2\3J'KU9VY3DK>-7YB.,6W,VLKD MZL#$"'J+21NNJC >S_8JJ[*\H.]>.2*'RZE?#NY#H)WD#26&T]K&^C+Y MCIZ"YZ;1BI/6-RCD*N7J0RN&0F;E!]'*KW-20[125S#(5])$2HHQ;%&2T$F, M=MG>3A+YI@OOD'B49$BOTN?8Z#@^?=XR;W ND$ M6&B_]CY]SK?Z?(\_&8_68CSL:_39$X/=YH/C1\H+C@=#)G8NN>P:5]@3;(-IV0WMP*:I M=[(>@;=I7_KLL$WG,_R)R*J#\+&[)::G V%'*'$; L"'E;(3-E$EK9*YNE[/ MML#T9VW^=**6D]L<>AC36SY,;CU@^P/@Y=^6"[(9@?-'C^.>;-@7:-D*357O MR<)&%(D#\"V$MRP&1?5SWQSD*33!-%Q.^K.\*+41&W6.6EL--GR)$[!4@Z8IJKI-E]$K M!/&:!EF]TESA_T>UK_9%WK]3,4 :%A)*.QN&$SGU#,J_:(!)74VO@L85R!+8 M+(\"Q.3EN9 M9)8 2-<="WQ;W"987_)5=8&M&=1&JNCXNI^M3GXO;/07,S;Z<;'1?YVQT3,V M>L9&S]CH&1L]8Z,_&']PPOD74TM\)X-Z>[@9#J]B<:WO#!?7Y<5F4ZSA9H#> M25J8FEM#^V*_N7R=I.OGN, 3B@NX+>LK^BJ($C(I1[S6#MB)90DDZ7G[\E^L M&SU;( )\=/18VP3I02+G(?XJP>P 61&>KI==K_M&0AS[QN2%IOULB2E4!IZ()0UGJVFSIGP8AC/0H)\.F82,5P6PR59GK2NG: M?'[QEDU0A\WG+R?R.+Z!2%YKX&%N\/O>YNF'VJOGLT=NUO/'__CJ+U]^%3X+]>FP+NX?URFE[Z*/",!K9(7])36A:?8?CCV!0E&J;N[O-TOW[2K?6H#R\ MMYH38+WONA;B68A_7R%6L,?# ME7!C /FP)/NSY,Z2^WNKWXXE[WTD5Z!BOIB$W&1R\U')[/O""H'D!7JM24,( MR6!7IIQ%?1;UWU?4/=S-9EWN^]]TX5QYL*9S6)HUR_4LU[^S"D?IZL,$6DM: M 6D!0(OK.6MPT2N2UY7 [)NB]B0#8?4&XZ6"&IHKH:=^\>";9#XO\WGYG3W. M-7/C/TA.O9FSSO8%T&W<_!>A_Z+1EDEU%?8 9N*2N9_0GD@'Q*:3D#D!F4Y55-W8\JY!F;7)GQF<[GR&?T=& M/O,%F:[B?LZ>/Z'L.1CX31N5S>+T2;A%?@=*+,[_(OY2:(;'D'4/C/:VJ?NK M;=U+;OFF;LK\$B^6M'&]V=@D[U3&.W@#\NGTH>P=J,=*M*QKE!<*V732"CVR MZ<[@XDHH,'ZLB[W4B8:P:8$#VWR436SE4M-S6VV3J!Y/25(G( 0@C8/N7$+@ M(SKJ,GG-J7_7!]T5RMI5%"A_:US^6E/HW!!M,_,YG/*."R5[0/86^K#JM@Z+ MP!Q"(BJ"8U&/M-W4YT#O1K($UG"PO2T7^YI$HN5"AP%KHVM(9PM.N4E%VPF$ M A$CB1=I:<&-*CL M*<"+"%[0NJUT&Z>,$"D*_M'J2!LC2='"M#8LN"L+*I4B@B,RXKE2,UTNK.B% M6"?]<,P[KS75 4'2$>D4\C#F7. ;QCU6 $JM[68J?K@K^$&1JX<;!,-JLU+' MG=.I:8J54.7A"14J8*77C3@IKO;SDA?#ZG"Y34J3<05JYHD$7*$6DP5I/4ML M.Y/)+&1$=AXX:YYD7Q^ +3Y6MWUX;!\N+ MR4^TEY)0BZVDR.DF:Z2AJW?32SIZE3;)^+DG'PXX04N5X6JP)HW[62I.[W-9 MXS+;ZU"M,:U1FS9Z:,"2%,;S M'84-?K*:WH= ;<\0YGR=4G9C/L%ZU=8E#7]V%T\\_%?B]@FCQH2XN"M#+RS+ MA'640,)2Y;TS,>*8.2Y""QJ%TRH%:6(*(;U5RBCIP(-W@MYGQD(C'7, 84XH@#=\#R6*)#,]-9&3$T^)+/]O(MFQJ(3@!*52=((4/S M1_P'LS_ E_/6MJ#PN@ZY7#+*N#*0.;%P!@1I3%E]G92O1[I^:K&J9 M2))9F#-/SA9S( LJ$^ O)1WE35Z;]^#)Y MQ7\(^,STNR ;) U.+Q,-GB8M5P$S7[OO0 U#%N=D=9!CT'%#KJX.$TX;^9V7+AIC:UF(/E61V$)('] M%GV,6P&FD^75\5_CN%ME.XE@=YD37[*0>-U\5YQH^/^S+4JZ(T9:'[WH5\; MJ$!ZEWNFC?B(F1D_/EA=3 2B5P 9*;7P;!1EC3QK5C3K)MMTEAE_N0@D]<6$FI*\>V 0"18&LP2ZY,& M\7D$2FP'!7.H09]=M#UG(2MS46]HZ\B9#DDZN=O>9Y]\^EG<.6%*&R0OR %2DF58B%_8,?E,UH2%@T)AM=]A]$@VXY> M!S4^W!H5!GJ!MMOCT9#*X7M>^EN.I\0* %.BE7<:5*DI[4LS"=6S3>M$##@> M;;^FX_UGW4F6(/G!CNHE+5#.^Q,(US]_>!G)%NFR\5545PI" F;WMJV8]=:I M:.Q_)^O6=V*1$PU(I2!_+(GK&S1A08N2;TL^G-][4^ 5 F]@J$>..9#!-]]^ M_RJZB^]A1;.ZF+:?Y0KEKI_WL9]I,#*')G#9.*UGE;(2V'M#F^UK-K;O)M^E MHSQ-#CO9UNM#YH0]G^$[0 5.'#>CD5J&EHFZ<:'[R]&?/?HG/5:""GP#:)^7 M,&HQC>RRHC)[:2<>/KJL!QT7[VC"Y0C:Z*9>\:VLJB!R#J#)Q'<9_3IAQP9 M0MR[I(*$%YNU/&FGENTP4HA-&V( 7"VX?9WPKU\F+\5T4-4I4#UV,]5B]"YD M>@NM_'(!JT,>TC+(N).6(XZ!C48'2Y'-1'XK^.-3KNSBYJ^95$4>% \BAP6* MW+*'!TV0O/%9@YZN%3YW(8_7=7&T\0.L6R$='DVYP4-7C(*RV P4)[=H\,F"R!^5F(V-AQ7_EB\&,W$H MYN25G"4Y[9.7N6/9;)M^SUDQ":_9UA2A^@"H2M4CLWS&!\)#XV!=#JL;;1FY M9ZCE]Z)U0:D>-@WG0@J?7$P0GPI*'V]K-#I5(T!"TF\R;JPDHV (7FY*=$AB:S,(FCF DY"B[MP MZN>X^:W?;U$Z$BY&;KK(35!OSE0C4K783)8^^LITE]%@#&Y7M'I]9WAQ75TQ M9D<_LH?-5'$M/+FD)(@1=!VI@*BVG13F2YH2M\&=$%GN;\.Q;\/40MQX]!?D M;H:5T,%P/3Y^V#MX^JS\+?DH^UB0V" %NO(!3PS7QPO3F(/#$P,G'ZT^3GK< M1S1WNC^03BJ0.G"A=_!,)A^M/Q9@4\$VHKS"P[IQ(4PWDW5+&!FG/NY*C\X_ M#J9=5(&U9#F7CO0'H1UOE1"6&^G2LXPN!G:;"0G 4Q!LR@M,\*.-3";HLJNM MYCF9UNPDUZ)9D6VQEY"VR@1M:'TPMD#73D_R;:Z'_7+!=V3!8>;1O@0-X(%, M\F8'!,+AA:+S,-:?$_B-^<)[,A>>.P"10"N/]\[%+EB(WIE#(%:^0U6A93EQ ML7FL@.>+\2EZXH,ML_X@G5Y.BTOB1?/P-HT5^(^:0S&_F'4O% 90?]:JQI\@ M,J%3[Q0Z74JO28]53'O G&/''T:?./J5!.PXK(/$+$ADM$VK,OLPD';Y+3-86PL: 9#-:PD6:$;WBJL/= MD_'GZ.>ZX#Q9P ^H7 _(B=O?TH0THSPV5+@.R-?NI D@L1?;^B;E5Z$&R'#$ M,5,B*-K L!%^ 1DEO/]A0%7,M_<1^T)$]GE()UN=CW'C4J][R!C)K MH5)X\8W%=RW2<\XGLBF[D!3J)CN,2 V'5\DY'1ZJ03T%6'%1A 6),C"-80IR6P52:'G$*J)F\?)-$Z M+-*VM:,K$\M_%$((ZI[8W^EM[,NYCN);R3/D&FX[C94'O\VNLZ(,&"VMPT/_ MU E95$7TL+$71!>CE%:#;4O74RI 1?6N,KQYA6'I/??PG9@BNV:6[>&.< G' M+V$P_CIC,!X7@_'IC,&8,1@S!F/&8,P8C!F#\<'8]Q-^6M&&$5I; M_";>]H44>W@C;3KY%>-\9R?N"87WU!B/P_ ([R-A+2S>FK511LS6)3E]$OT: MEB>G)0)1 )RFZ3D")Y$R1,D&N&Q#3M3J@,B58-T=+CUXO^036F/>::1N5U3% M#NS@/MLJB8EHU)N2'*(^\T4@01@,&CYT8*15QW(!.:WJ9N> -M;7*.-> ^]L=9QHL=U/,J1 )97(5Z7F-8 ::/UKL%H8FH>WSXD M:[?D?I7 .N"G!@D5&F"M+A,6"&%'7;%!7#)XXG)AJJO,NJU +&6>!%M*6QB9 M8:GS,T$';?IJ;;M=R8<.EZ3Z;8\2]>VZ8JI8+^RS:.A48 M%I 4OJ'F\%PYT#A\/1J29&XYNLNQBKJY/7+Q_%S*LYF W$O_U-VA0:R;VH6+ MN).@J0$38BN*!(E3$QI:D0H0B19)2=^M',P3YTZ/9A HT5,Z7V6GO\I0L@/] MN3)'(%ZW0DJ931 0,%9,_O8B]8^LBM9."IQK^@8#;DN9M\$^K1+JA).Y/[1) MD\HE*NROA>+00R%0<6_H"ZB2%VS>UF0E&4]KNN*X',IDK&3769-N/<+Z;3(C ,3_RG:9WO+KDA1Z3-3@ M=A4<*P[CVS+5OP4<\(7V'8.+X96DR2WKIUDNWD)9):G\S'TM6E3'QW],PR*X MY<+6T?F:ZF@;#O3QGFX^KAPNJENZM:0#S@3!8ZYJ:Y; ?-H(H,=%4%LW/FX1 M0_-[YB9^GQKZJW;T<4., H75DMZH98UX@I,NTC*/M1J[(\3%0W.('+0J:RI M.S7!]WC=M#<5[5I]4S%=$?+);&]R#Q)D*9575%M_#F/S'-$FX:''N5)7+N3FCD#<%EYKV^X%-39LC4Q$T%X-\ 6@B;2CGE\5(S#7:&6?T MLC#9DF:F\N)M5 LX$&I\/U 6[CR@FY<:Q0.K7 B./*ND:RG$1]-*E1O,P>^XQ089\%74&N='-L7[*@ M%=@SLP7/9_B_%H=+1Y>&%O/VN4Y/?44*ULP1BE,/?Q* 1-IR)R1/TJJ/2WV" MZGDVS];;PJ#-GV<@M*;#VS>7R7^)QSZ&Q0CCD92"B_5#ADM;Y,(,]\^:="58 MQ4A?RP-7I/=W,721Q4VB![ .!W*'ZP'J+$2-3@@>.$2&=Y(,#L[M$( T*?V2^9)-I?:M2( MF?..O5(B"P5=O YS="]R@("(Z$S/T)FK@"$9MYS0-FJ3S6UH58;TW#+9HSAL MQBC!#+MW_$_F;PR &&JW>($//;*\4/3]U)V6Z'AYAR$X0Z[?;7#, M7\>-1 OI9QIPC?O>2@#;2SHJJH.R-086*3]B=N\ 1ZR^UF6O[20Q_F,ACTT+XKFPY9R:=XI1:V@8C2"!>5VSB_$3"\'+=82>3C^0; M'RZ\A]QO,=729O"HG"Q2,(B"3A M,M]2EUGFL29SSUJ1>?A.0D H%&\\1%HYNUTAZE6?@5#4:)0RG(P+-I+BKZ5C MQ#8L MUI^26I>D,**.37[#_6R=Z*7<&;/NI4I'"-?%>-1_<]X\)LJM7M"Y(0!==5'=# M_V;^B7#X?MBI&W/=!!05<;)WF@"C,JTR0[!['RMO5]E:^6Y &\[G E-WN_.@\4?YKI[H)JT2U@WLJ;[$7 M'<#?'$4.R23'SPT?BYG)2"7)I?5.NC'6'4G\UP MZAE./<.I9SCU#*=^GV6Q(>>0_LG]G'KJSK^G8^ZK# M&X2A)&$OC[2QC.^*/"]-\DT&7*I ;<+Q,[C"0SC8PS'RR C"=U77N5:&\U>V M6>Z\(4[X=V1'[#1DWH+*YITT/!&& 03_ 9!26A(0QP3TT_1/ 0.*-R4;P6], MY(6MX"\D5@Z48(3'"^Q0-#!(V!@$3 %T3^#(-6?"&M%80H4;-A5Y0\5W8GL_\J297B?>A)4 M+_A](<6$'BD/PJP4QL8>VM@H^8ZT3-H'#WC$UTT M4#> SR]RI(5R?05QG=?R$6;2: TSG9'FJ[JM1,.9VS#LJ.V_2Y);^#@&[X6T M 3&X=&X_'0+@JW>[&HT]1G(K*5<$.XY$H!2KH==#XL;4$@40RZ&F.D3)>.8\;UZNBB(]T*"-O=S%N'DSLG1X@@-,G-XG#?2]^SBNZP\*,K^[(QK)NLW3(8/06;XP$KIKU_(F'_YUW72U7GJLDTDX" M/G("AD>RASM^QQ!1/]A9O>(+GY#E)&04DX$_%:M>3W2<&XV]:.=YW\9VGZW? M95=LKPMR5XQSIS*YBB1#FT3\5&8K4PIBLT7Y%Z P\)IO\Z97Z#99=ZJ(/@ MNX4&G[NLJ4TN]3,9B@49F(<;8NT:O@4/&D"W'2EDW+8PVP&LRBX+M_^UA6U' MZ2X9JR0?%8_ QP9$[-F]G^3!S-SJZE2%]DVZ2H2#"CAFV2>1, 03'C,@W/EM M"&_&SVP%%8.6]B%,C#S#==-WQ5%)"7WXB0XBOHWT9.L F81P)VN]U:US4!"Q MHW#FK=X8*7&WT0=YGY62^78\.>@K/./:EKY515&X2D )#5HZW#3D1 EH!45% M /1AFOGB//'P?SC6"0-F!1VAGFVJ4:O360?>E;4_KG'!I>LH%XTV1.W9)N2*U8:^F4];2 MD*@@M\3V;MEPL>VQ]_DI2:QM1P_EYC#!91651%TG0G%301L9TDFL\[(GPV''RII(I\0+GB:B:B&&MNT*D8N1.ZF.F> MQQT'S%S?@E9EDMFSVSKM$RN?T.$++E@-:(O[%=$DC#35,[MV[L"#_?F3&0_V MN'BPSV<\V(P'F_%@,QYLQH/->+ /QJ.X3T0U,B]M/0<P>CDFQ"5N"">LRZR TW&%JI$N\EY3>J8=.O MD0Y9'?\N[H^EL0A;/3A[K$\QI<DB,EIK^^:H3LBIO=D108I'\8'BBNL=3E,,YCSV ("1+O"M;S M+9@@VWT!1([A1F/I9.#-'0B'0I/TEY5W3ARQP+O@9%0-R51.C'!P<6;]N%1T M.GHW>A'YH#L0)QF0A34M,HV=\C>E\FN@9QS%)(Y:M<67E3TC*YQK-A)[$?APT\ULC!4B2B#L1+G;-/1Q)@X7!NY*(6?*<,"0[B[#/""]^Y M$&XM\709/[*K<_;[.CNGFZQ!5>K!U @:L^\% M^C#9KB+@+Y"G3#[B&/3+47KQP6".&DL^H8'R2@,#07LH%Z..6EVC>,MM% >% M0PI?VXLKN"TB!Q^Y!\CU;;%N$A%17\_-RS^?X;,BYT:,[!;7DLP:*#)6-9NL M*#G@=>1@A0>4 U%%JWB%6S_-HD.'!BAFFS3Q&15D_SB]P:D5'H<_E6I@X'?9 M3=LS?Y\8&V1!@+;'YM!X%L$<&+51'1O;*3H= = =0O<90Q-C5$@AX!5!1%PU]0V05HH0 MH:.*PZ5)Q[X-Z*K07#LG[=4"-9+15;3/5"GVS2JKF)\C:Z?K7/%DW*B^SA.; M)QC0J#,H8(\,E+US\6RO(@X92UMZ%PL60>(FL*4E5[:;R?!"P>+H,['NDE0] M:K?.RN943;T4Y#1D%RLJJ2RG_U-4D64@8I8E!S*UYF4Y$ ?CA17>%=SGRX<#3K9W]!98_3L M /-/SV;S&U90+LI$IR^HZH#25]YHZ7#]RRO O.F7)??OM)[>)/-3PW:CI)[8 M]_-I:_>A.&OM',/)?FN.%_GV/FL3W+$!(^MQ\MA9=3R9@(:W1NDD;(L5$TOP M@3Z.P5>>9L>/IH#UJ4H7=TL&A']93_JK*?Z=28E30[+6N.(G> [2XCWF.,&5 M[JEL<6]I$T+Y/$P7X<5P$(\;A%%0W-04=Y,&SG&0DYO/[B*CYTO-?'][QE*<7XHHFW M4Y>K6M->!<0D5OQ.96RQT#70>6Y8\0@S'F'& M(\QXA _&3XK;JG&H1?KO,..M='*)W>G;$P;WK/O3[CY'6K'Y$F'GX-S!KG"\ MU1 W0MR4]Z1LUP=!G5L(N8B#I'20QX#?.7ZBXV/PD M9;Y._!7B:KBIF/1OXGJML(^ MKZPO)OI7KTV M\:HE#X&-D10Y^F[Q4-W#&@/?6L[]^P_3C](/R/92("7D2+^S-N&0>3C(;2:S MY,^3L]#*&VAX8"VY9:3Q_&_5FLO%0]1F\EMH3<<.%#'LVJ-(DG3L++:HQ*AL M;PJ]!:8.QJU;R5?!^^YE:EEZN;%KS4@+*1@%U@71&C3TZ=*';8*#RCU@1])? MM25*27#T)K-=Z5*WSJ%RX-7UJS-Y!2V%$_VS;41@)#F MQ-/D+NE$(Q'6G%RE>1^SX9G%=LYG^-,ECDCPMU)Z9+.>)2O=7=V9,#@H:41M M*/D0^_!H6I#U@7:B>7!\<+;WGJ*]EZF8(!I?DTTEW8IPB7$'C 8Y\@3T!4(S M)GSK+'>C,+@3S% 6^>%M)*LIEZ)KBCVLML]K*,*VUFK,%M 5&@'BV9T2 AP" M6%YE.BUY1\)'4'T"C;AYCQOEUK9+#Q1VNJ4+S;W(79V40'0RQ][T2X,.JQ;X MD71-SYD1$['N,!R,;QMIC^K8^VUR"/;ZA;TN!,V^9NBF?00 ) ,GSP+>+Y.7 MM,0.+> OLFQ5]U&:(-$LDO44THC$4$MSBT$QY,C3C,8TC<&?1B4I]E2(==;UT)J_!96F ;0!>H,G:85\Y'2WMZ :[['+E\O%?]T"#A85!5=*XG[N#&#K4BR,X M>>'PC(.:<)OWS)JN4G;*EF;5;@[ >N*@VTSE)L)#JU"_"!E0%#>E/BHP_(56 M.#.N'7]XD03920<3Y7DP-.I%8$]';(;Z5T-?K@^&D7[:OO*%X+/=S\?@ZW:* MJ9N'*@<%K09M+TW#P"5IBA<;&J[=2&1H./64H0=>K87\4O#U%*6S7 MUK%F:*W+8 C\+]-E'*\,5KEQ.'):#,?0KI0BL3DZZB-I42I<$L-&..Y7L(^6 M09C3EQL&6&%;3<"P(S<'Y-W76T'FPE0G ^7:#E^KI!SA/7_3?F$.+YS2)2PS MVLD-?0=90RV/:XVI'KUK GN4MCND0KE IK(SRN]3[\EIZNR- G4#GPE&Q1IZ MXT(5!_#>UL [8F_2V:=STM#,FEXHXQ59!@"V"4%EXS,9&/W6R*H1H,/AB\%L MT] QY_/0J:L3L&Q/.S!6!?&"V_H-PV<0K0Y2692BYD3JL_7A9F][M,OLZZ;.(@"PT65 0=V1OR."ZD;>:Y;7TT6T:K35R#]@Z!O\&5B<],L]X%ROML!N4]+BCO MBQF4-X/R9E#>#,J;07DS*.^#<8N8X#..A,(&1Z>>RGOJ$_[P.@AOI%RT_>A. ME QKAWI5-LAU""149-S;0$L:=1K>9&OX(P67ZR)XFX3U+S8@5((41:()> -' M[ O@:EQ]/*QULM&-MYW)+["N@O D<2Y*RFK OFI)/A6:4$K=.GP9S34BTD,> M08&2+_* MO 8="TS]?X2,)<6<9$79PWFPEZV1 ML@E);O(F'>^F/>P0;G,'R_B1$F=A/B2X=EI9%+HPA:5P M'D?P@RPM+4UEXXV(<<*C#CJQD$/6MY.L-*-"*AI@6(9ZIBKPS#7X+31OXZ34 M. LEY<]M *OSR3X1JR"8X)*Y3KE%P$6;,&3(0\> 4'S.!TOE5>-(<(V>!,S# M!)/!JPKW%3M-C_J3W,VC,;O5N%PN7F_(:HG0=R%MD@4Q M!1B H%Z8']\WW04P6/B85B1['A9F;H*]X9M!"TU]C9E$"27GBM#"I966MN(15 $M?#Q4+S$ MA?MHQZ^!\/D.?G)W, /"3#L2+0]647"1RU&"/;4*9J.,$9-I4;"8X60$ MF#BD6BVC:\ K=A0AENUF#,.IAW]$=*R.F1"?L.MVT']YC( BJ#HN[4LNZVK[U*-W)I-"\@[=B]YC=(!B]3L@'G% MXRV]43IJR=+4J])6SPUFR]T[71-FIDR],IY$SNU<^#;+4C-XE#(GD[&E_;9] M[QI@B!O+,W>L4748.@FA,EP]E8G/7]@-XZYS?N"Z/'B!Z(TA[GVYD/[13)W9 M2((XC&=,:*I;]\-YIN"Y-?ELP3S-ZANU^H7)#/9L&^VZ&+3*?EU)UR7!RW? M;J^[7KH("M]G4%@::'5.2DR+"_DW8ZX^7YM@PW13?,A3<%PG:K/-\U1L'H\4 M$G"B5I*(M<'E)*Q04FM/!\ E&\M]/WD;-*A4TXL^M..N5W@?6';9=T>$P.!& MXHMP?W 2B]\CJM78JZJOZ.1(@83I1-?"34RY SI8K5#E*_85>?Z-D9M"+EP+ M5Z\85Z03N2Y:I6VQQ !ZJ:2*N"OTZB.;\EU LBA/".(*0MK&D03_OLOD.[IJ:AXG4U7#CG7\ M=I(&@'^=9TVN5*UL&\O->DU2G'.%B8&QMC96?OAN7B-()(UIW1"8M'5J+675 MZ.,;7)-5P CGO^[3,-:$"Q=&N-NJ@Q>/:P[,DB(5KM<,"KPJF;U9NBG@ MM)G-1JJICV\[BZME= YM4:YI 4"/GHN-8N.D;F)[FRVOX^" MJ4.!>AM:Y_'H, D00K MN#]P/!O3X)@1!FS,'87'*+R7L]0.(6WQN/44V**B MNPXU)[AX^L_,5+H+[_;YC'=[7+S;7V:\VXQWF_%N,]YMQKO->+/Y0 181 M6Y_#_8?>/R;A?:X?^H8>)D1)K6LO H\8@_+=U7R#$ILH&4*U;,G4)-/!\^>V M/I_AOP98S_5CRS:;@@\GLW"XL.H#@CX:J! LB^/] X9!B;WN65C:?J6D"ZB(1=C_@-^GH7T0 ME:%:T!CI (\IPPF4(5E@G02HA1)G.%9G"TB[2FY#;!#6K5B);)C2,>R_0>:2 M!X*%HYF32D\BJ63S J]#E?R#5:/?@VS2)!_]L9M/+27T=7NZ[1 "6*[>F&29&C0'+M91X]R- M$;R2F!)MCVR(/@/E*T+9M@+/;5;D[IJA1=>%QIHEOVZ9<*4A0B]Y(%1(,"\+ M'E\6&\-VNMK*N$; 3_BV3 ;^J@MIZ3'[82!XV[X=38,AUYCMH:KJ51 M:9"UBKKOC%H5$LK8$9V>4"#[>2 M6-Z3L?4R.=MKZ\QO7:TBS:S46$@S&H>+QLR2X_$'1L<(( *9HM90.,?TEJ\ZG]L*';NV)/!E>#5M^=5[NX7WA,%B:S$?Q# M07-3$DX=LQP,TUPF/SIN=Q795[4+*I+!;#+$.8(9ICB4M2*\ZSVYEG$[U7@ M:E3JRU]'-_$;YO;'=UX*GJ,+V#R]1J%)US>9;7 ?V :!E9O3_*]!+N1::-YK M,H+$X=L1T7(^?[;R:L*6GNSJ85U/T06AG/]+D[,L\W MJ/S*-KAL\55,FXP ?A1KCU$UF8\_2:QYN;"*E^-\"#3QFH1J$G(2F7YG>Q3/ M7).PT\O[%5UV[A!HV1LT2L;V&YBW@B@PXL.5'@!KD48F822^8JK9*R2(_3)J MSC8E@0%N;^W6RIX7.[K R%$ZB@%DC<,NF!T9)/\ #O0.1.,3;V?OCKYB!Q ; M#L],-N]"2_UY1DL]+EKJRQDM-:.E9K34C)::T5(S6NJ#,2QOX\F?11C$'#T<4TM"=D:%@)FRM*#1 3O8B@+N@@MHD/RU==?2DW M^)M3=4_!:[F=?UAQ3\HBW YW4WT %\.[O4QD&C4!3SLJJ@$L1=Z;2J)-&_BA M)5#4PP\1N)&(>C163!$&E7X'3B*@Y?9 BYM,'>^.V^*8=6]#>3&M1)E588D4 M-XLQ75<:FUJQH71+JA+D?NSS'= ,Y,J"%I'48Y@ZX-C088+J6NI:M)K%5;>% MU=1Z-/$T]+OJ.7OC"G+2J"Z&DT1=4P@(B79N6ZR.G/R@%T]0WG.VQ^(YG>IU M5B'^P+U@C3W&&D (LD(CJ7$2'_ 0XBFPBS1'+4'N.TOEN>,%NH*693JB#!J/ M1%%N44U\4/0H!?2285QE9/=%C[<=6B,$V=V3U6,!^OBBXT\=>3N.'N!CW?! MNA/&58E>\#RLQ)..ZMF<-07Z8V!WT_L/"L3)Z6 M_3F@Z[@;;:VWO:)!;7,_YE>;S< 3#__; HRDVFV5[1NKOSSJV0(36,>4QR"G M8T3"Y(Y[K6_-"@992UL\-MVTFSDB=#'P']3($MB.DG6:WQ7-[J/>4AY.NOX= MEV,(DTW(VS2 F E 2VJVA73.X2A(Z(]5!P\]G# CTR;">1AT5AD,,HRY(V-L M+T#QUM 9=CI6YPX^17&)7@/!:7Y&N>X;?392N>9'ZYI6I?"H0H9H'33H*(? MK$K)55WGW,DUJF+*JBO.VN 6/D+1N$17NXV2)UY&"7*MTB<1 R(07O3-!;WEO MI3);RC425IQ#9-R/E<2\V ,A0U\0$ZZNW\E'XTYO YE6M *^X9Z$Z%0XO0YU M=J!?KX3(_3+YYEIX6%R!"WF@5U=()MIG!-^W^*#1BCBB,G<2F,?&DJ &K#"I M UCBBA *\LJ4"M4=M,@%SN#-5LJ[7.D,?-_UNF>7/QP<_=6->^D^V/=)F^42Q^!?QL%4-/:]4F.P7BZP[.^?Q+#%WW_+3M:C"D]6K^H MP;:B0O,"R?>/*IS2V^G?XPV?%?B3";O0_J8:0PED( Y_IQ/AU@D!L)'00??F M@+TY*"XD12?=[BLF:1ZR+Z],&!T%K*W;:M-ORP(I-;65X)1[<]D_QT(,V$.-)I(-A)^&H;8XC+X#?!%)=:(Q@5 =!W=M##K00=]4K MZ[1(,:N1E,[QAZH!D]^0])QYF#7K:X?]=.@*1"SR]L[&%(VT$FO J]=]#+"#XFBU:9$(P MVG;?4I0^*#UH@V+<=DN/WM8EZR[N<*"$;CX0[!Z0:C+E/@-^?\F,*1)M&>61 MMXKW*.V3N(5H414[U*=H R)]-RMRSFE=NXIR_D3F/A,.#P!E=D80:T]VQO H M=8;!PD=33IF>6/[&W:H1 QF^1,:+9!8Z/N#.O*XE*\9-!VS 68H; ,OH@;+> M88:-+] *AR$-M+9^H>72"EBD/15V0 I(PZ")9JNR:#' =F_T$MCM"GJ944Y" M*5U@>*>;MO=W;AVDK8]S7TQ#24W#.'HT=!OD9["ZQ8UR36PWGH.\OT!TR0*@ MW8!H!:Z:;.?N]Q16Y=-Y!QE-[B-8ZADSM9Y(ID]_ MF"$BER-."/#V,))8U3XQS>6;HA%V!HT@BG;72D:*WL2Q-7=V'#LEUFZV#9Z MQ6VM@L?O(_X2AZK$DRI=$VR?[*M9RC,^3Z MJZ2^L9E:H*;UAX(UIL0F$&5QEQYW5T.B=67SKCA0X:>Y08Y>61W^GWXG?E.<.'BD-E' MZT9&5YK]G6\F1RO8-\(#L*_I2.I-G.EM0G^\EM2M3XTZ )2G^WUF)S><9 M!M4P["W=QN7!RZ;PCR'(+&P:1Z1_N3@B_I>)'BJ-7[;*F:%-4(IFV%$0_!7^ M&]SX59JW'3EL]'GW,IOSB,^--F:[Y[DAXX<)&+C4=)I\<,P+$O8-5N%D,1U+ MY_#@/0?#X=9:MB_F6K;'K67[ZUS+-M>RS;5L.KR!D13A('(!2V$O>E/TZI$44>CTIG@F) M,#>9)HF<%[TRAWJZ%D9ZK-7E[?[SV>[$7;;I/7R>][1-0P_@$_AB _^,A_=D MK"X=^B>7GWU15+_A!I !\"1'^1]?_>7+KQYKF+^Q3&LL2P;(G&1315R%$-'^ M;Y\UR'^#[%+1KP .:(II3^HETUC0ON>LNQ _NQ+4U+.Q RHFY6BDQ?JJZ XO MGJH;\40E^(,5V4Q)_%5B43(MZ(C<12D1)!S<;P N3 KW+'>SW-U/[JH@5R'# M7*&(;- [?*J+$"2NHA>%#2OQ,[ZI*6V3#_H_2[=:8&U=.;;6'9#0;HM]ZT[ M.ML7G0,V\?!FH9Z%^G[W?[]CZQ[CD[84[&@ *]>+K&FN2>K+/?6'AURJ@$4MC;G4NI792B JPNP.Z O;,[L: M8%D^BCK1^6C-1^O7!AF"OHW.^/6%E(6(H8@T"# !*UO[Z[:\O,P,0E.3$CD0=O"2. P)SZ>GI MR]=?FZ_&#;9(0Q7(4RUL-UM>O.X7)@;OH(F_6G;(*3KDN MQD3J*%>WCF9)2U@9H/NH-1GPMANNUQSE:)2CVPR6(RPR/"[^MZ 2N"%:#\4+*! O7^.00=QYH?(&],%K-DU-A,]&7Z%>9QP;I3ZZ( MI^]VV/K17D.I9G>:$[2T8"SGH0,!5R;ZY%:@!:5EJ+8U$@C](ON! L68!8Q6 M:3V==-BX]^"XN.7QR(9U;X8O5%AH3CG8K1=\)U+7V=9I)L7(?+"6>R GW3/% M]:=H7ZD=J:-&W*>OC&+YGVF3I;_/IY,W'/XQ,HBR2PC>.'J5U(9VOT%>^N)# MP5ZWLFC &FW:K@K(M9F$S@(,3/TR >E7#%8@GK'6V1_HOAZX6/XU1"S=[4?^ ME!0KW?2H#R[(HT9OGWA?R$/A!\94\IK.G\?EMN:!+'[K5FRJBX=MX+)V^[-I(43V[)S6F(T MU^^@1?%X^^P U+N#;;Z'9JYQ54LP4Q3([KL,A)HUB3<5QI MG2]Y@>B.R[8/=#'ZUKA%CLF!WYDTEX]^.)>.?MV3\^[%D?"P9_\.ADK%D_$L5+XTEXV/)^*%=WE]\^ =G MXRAK?YH76WC79@2:U1\AVV D9L.6H;5L1"3%QRF=/7J;L-8L:LTBC4"4+.P3 M(F/0"E&#%WT)Q[="@]8ZS='P3FG<$=N1FI OQH%]^#+]V8.>OBD?21US9S:T M9\WRRIB+KQ,UE021SX"T])%P;0_ #E3WA^*/,2?T=CV=+(J*P9-G>:9"%CT^ MTTI-]9ZY'4OZ@?ROUFV4&A>CNUDH?9@T' =I 5;D'UC4K^]P\HG2+Z\6@K6. MY^VY1<-!8-<;_4VW-15]N&]%A&=D\!'N@9I.(4_&Q\;Q\?R[W=)7>NZ5K/T50E)?>,.;A]C/RM M"N#_;&GXQE/;)'\KZO4/+QVXLJU]CYRNZ:2L,#UK&.=Q0Q)O**N244AY()+3 MJ(!]Z/VV<,FS9\^.'J6/'QT_ENH2OS/OKU^U%S3(LSJ?)3^ZXL+!**,52\OF MR=Z-U[*56[[_4W?E>9Y-)[Q6/_.AQ.2^W%SJ+SJ7QTR<'!>G:T *!/>B(".] MV(NA?\%)-U]RTDRPR-JM$>U6+4,?KJ^>SH^.0)\HQT&J5##QKX^8Y=V*K3Q\ M.4NOFFX7L$NZAM*BJ"Z9L9W,H)QS7D__?O2$'D[.ZY36DKZ05]F,6]6 7K% MS)4N"/XJ_^/XB(_U-[,'<%SDI+P(6N)GGO[!'IL9&\C(D'++BJ[RPV[1K).@ M'D@^AI[F;=[S$S&!=DR3K@7P8$Y@Z5PF9%C(H.V>13F&O%XXBT$Y83U[VB[XZ?FI8; M-%[8\# F?>O=ODHSOK.,6_@6IY"WE\\5(VBD#2U9XDPQ+$F:%/@(T#21HH;L MQ&\4;8TF.PQK4,-G*2,292<$Q+Y7O*Y]SB'B]U M#7SW9.726EHX(' O=VMH1:,VYX_R4)/\G):N..R[T\QOGLI!7Y:]S3W@BRL" M485DK">*\][]/#EAP< MK*;CTK3H2\(4YPVW.10R\A!U$,P7FJWX!N#V7OYL:("RR;6=K'8UC&)E=$'H MN^U\GW,V/+/2DGCPM(RPAGM?T^9;I-'YLX(VFW4ZHD0O,D^R:R0ULYV/(9#2 M:+>F9E$[;2J>\/@X31]FP1_N3T7&A#0\KP (XAF@@W\']?7T.[FV:)O;>%:= MG=8-@DG3?)#+BC]I;7329%.DY? =UIU^) 2^US M-RJ3I2UDP\"X_OOX:XO( MV-EG; HJ7B1R./:F5U[/<2IM@"9.'(;K?7:>_&@XD%:@6]>!'+JBPPLH>_

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

ME9:=U/H9=)UZ'+P3=>5VF2=X#G( IU-&%1U-BO[0.?X#7E<\*1(G*+/F 6\L MEOIBM-1PN)KK -L7&H#]TV(7_PJ@9-5#CS82)PS]S$-OHA;L)%ZR^]NR?V M^N\ENB3?>>V>!]Z4W1]!W(..G2BV6H PCH=7#4$\P6X+R9*N!.&Z:Y M;**&F GPQQ=DJK60^I+6:<)!Z^NC$2JL]*H/.)E,BI-B@K3>DWR_1QX]' M8DGKEMUJV*S';B#MITUJQ50^T$F(J\+L+S-X:CV=72P4@^^?.9Q _VI,50[/ M5%@R"N3BG)_W"J@-.I7L"Y:R%'K [QODIS8W=3 MZ#2XO) [+*[%GXAA63ZOW=Z(^W5[5X=P<1,3QO4%;RZ=8'@PGR6S5%,_L'-K M)QA">QK>W#R\=@EV[PZN'\W0:#).;MX!L)DNBX=V7NV$>751KV-,K=XCR)0X ML+[D&K1F-&8G-D'/-=.X6HS=''_C8O-:VV=3SL$J+Z M,A[O-.\:#L0MV*%=3SNW2&KGI?]4'#R,7U+/%J%<3E^VB"%H$\[M3*^OF8;. MMSM^+ Q$7N]T/GP=0/!K)^&M[,/'->%MEP'JX^B->N*+[Q@;MS.[]C87,](A MO%:4.2G2)W@Q7*;M>Q /D;BKZT$W\D)L$<*,OKP?).#3;B$=IAC&>65.4/0+ MT,W>>U:2S>(RR3O"'F1;&C7IR6?C[N(OOC>/=QLQ!^WHW>+:DJ<,$]*[39[J M_-*U7[Q):IL;4$O>:?8@_LK=U0/&5LG>G;C-.TY#-U: M6AK-NMQ$(IO.!YGHL9,U[=+I,51OY5,^4FU(;V"E:E0;>C%[&BDE[*P\X(BO M8P>[6"/$^GI?UOAJHT28YP5S]D&(C89&G3&9F4;A,4I$GR7"?\+=NOP?^\[) M&W;$_P9/>I_R@&Y^(0SYVU +X&'ZWDF=F3EA%ISNMVV=)'5Y$VH^1+"I#U[C M-/S]&G ^3VK;5.?G&C+1.'&L[S2!^!OIS2?@!&6%[0L#:X\G!'1+AB#%F_[S ;<'3"VB'D3 M8.S@A' V0&FC^!BGGB0]\R?&CZN"@#?5X0":[%(#'NI1%\)^'I1YX#C-;B@+ MS?_:A:'C1C'@R;0EOILLW3SI*J:WX,1I:EHVMVCJ",+GZ+!:2FR!(ORB-A /?;#WAA M!M?2(__97&"C^X@=\^-./[=8)% F]B[!\O#A_4(]I]O,JF8!'F)YYH!^K75F M3V_6'(@1N:6/*H;901"IY!B!76UZK> ITAL+JOY'!/Q_,%44P-#B'!',THR3 MH<+S""MQB!N7Y?!E)P96%_191:3ONS3S=U5;;GT+4>*N(3'QX8)Q3*4BF&\R M[0=5;>.F MMT55&9Z-YEWVC-J?%-B!PH)6O&^1&/X"XQ1I2RO?IF3I5D@+9S) OV2MLS(. MC["B*'\ D@"G@ICG/\%35 @F4_ LA3PDKC7)XRR.#,*7/5E-AK(,B0W!2 M_7;;R23XY7S$%(H9M;7>H[$%$,06ULLY@Z MC_& N#<0$2!8RHP5\#AW^- M NI.W6.(;![>P&6+)8+^**RW'L'-0GRP:I ,&@\C)LL9"B5#TR MN='_PAU"_U92@010> ZFYC8X8VBQA.&Q"P!211?O]<7CW[O5L+KEB0S*#^Z6 M^5_%9\N[/KEA![D08GF4GUP@X_+1D*6/YN-EE(-[&1#7F*[3D\&Z]H:=U>@G MO#G:EY=AX!J+!>LQ>!F;U7<<3L86-8"$50-'N1I(Q>$!7H^60D%%6(#\J27V M"CK[0]3-;)V@$(&60#6Q;O[Z*R'073 1\Y(2"B4W+RFIBJRJ\D"Q=,< )U5V M(FBLZ+N7Q#6W),R#GA<4T;\GW]JWLBK&5?QQ2@A2H!"__LFX _S4Z9%KP0A6 M?5Z_^F>ESMUI%J^:?;*5TO,9S;P#VYM$7&6[_"O\*<\U<:R M G[,':F08)&!0;& (3..(' Y"T>9OLJM) IO@@80!"P5&%0"BGX@O[T! T+' MF(I\" "'4PV9L HR@U56654,7PAKQE7T0%7.62F]2FVJP#43T**"87B$]RY, M*63T>EYF5K Z/:/<)-HJ+4<%W[:B3?V<1YO+^GR79!1/L5V,&9\BVA\ MO+,?5[,FI='+V$-KJ1A5^%GK/C"GHBS/9FA+W9'?'),.?==-J\L]1IBM7\1^T0!3U$49^T0E 94[S 8+)\"H!D4DC"$8=:L+ !;53 M.[$:1>]!67>O3)H5K@S$A,YHKT'IIG.I&D1J)7JGQ@_MW5K$)_8Q5%L,Q3+; MPZ]>SP[Y:2W+1 M!%E 23(Q+$!?Q90ID.!A6Q&XI*JI4.QLPH !(3.>HH/=JSVQH^'S_O#]Y:VR M$>AK#PM.YQ@:0S*QP!!XH8ACB8$9TK/$ Y?0RK1[09?>6#T :- N4-ST_4(. MV\3\[?I2Q!/L0/,]5$36")'Q<76A%8 H+J!X:=4>6Z>E-3SE:%D5U3Z:SLTI7J.4' V0JF7HJD*I9WBV2( MV@[O8I90FY+6-#I)% L4YCN#"W'K8T!# *G@+L@_L#8<*_XN:XA>)8[^UNW3 M$^@]OO*:_EOT]\]MZAL+1!7>TJU-H:@\F6)/]U1P)$9%7D19%F)ZJUO]4"4@ MSTKK6M["33@M3;@ K5^RPXNP60DJ5U\H/Y[-T#ES2-] M$4$:HK++E1#&,* <_ $:2!_7MU7SM14.D(TRWZ27BP^-N\&=T!G\I7WJ[0S8 M0F=YH\C96'KG/$DT:./1[=0"@9$%&O7-P.=:^ !:N+:#I[JKTGUK3:?]Q7"D M3%Z\HD)VR1V_(QQ4H>*A^A76%&JI0/NXR'Z1'0\G=Z, :FS7F(F83-VSVT^! M$=YZ"]\PQ48=&J_=@P==KK'>L /<9Z!8F4VQM]"JU09;3VUG=X)CQLM=19,> MT;<[>?:ZG6L\#QKJ#K[SKFAY^)08Y:S=DIK# M#2H>(6%8?"F!&0I7_^<\)+*)\AC[:=YN7W--N^ZHR4R]9, Z0U/@/S#&V?X MN1V-&VX0,R)C:(&@&(!4RM\__. !!LV[N#5%B M968&OT"Z.#.'#Y;*Q_)4?I[*CSN5[XFNU.?VJ8"Y_?HGKPP$%;C\]ZRBL)*V M'D#%EAIQ?3ATE S_].;M_N%":^)]U-^7X\US1<_DK]_,4T=B2QWIWKFT)8]? M"AK>\,GCDP4"]YT(Z9O$M^ "0?5AWLL[/(IOI0!]8IL' 7@A?3&C\0K_]_KO M-;KRP.L>AXF",)^#!,.7"RO1,T!4 :7RB%.:(DY,:"'6GNA-=HG+L.O^^WV7 MF)SC,AV'A#*/';. "K5$=%U 805B0P_4FG@"M.(64$:UEFQ<;GL2)Y!PL#"< M!%;5*CKCZ/,1=CFP;0>S59QQ^KF0B7XPHQ;;<6'SJC'(P&0H(L1V E?^@RS0 ME&_8*Q>.!Q".U5VK-Y.4CXLZ>?+L,6T8(R-@;F+F<"!U^KSJ*#( MJ,BLPD&!41,4?J#)BKH<,62^ZXV=&]D##9P/:.$C^/\"C+P"@8)P@CI0>/@B MHTT9YA8' UGA] "[GM72']:M Y$$M(!BS*4M("/HJ\&)!ISUX@)X\U 8\/!/ M_-M$E.<\A(?>_,P/QA(T!J"<5J>B!OV\U1!<_: %!(C*$PT\5AWRBAX%2NQ -X# M_Z3?3X,#'B 2X*-$41\,QG_"O J"%7\@_P"(Z6WYHY'"CUB-_VDAP%3@\,'R M5%/!G6$XSVU!6YC1H0'^;UQF=0WK]BSPM#GS<5,@_111W\IAJ0P 5V.:D-%\ MSO%P^)@@K9K+/0AEC01.C^R\E2%IEX203JT6"CZ>G\K'\WO9Z7&.YR_EX_GS M\?Q[LAH-.SM5\]/S*?WYE/Y\2G\^I3^C(C6:C9>"(\0)8SCHQS'(9U^3_ ]_ M=3_RBGM,58DYML?JFV9H+PE\S,KK.R>L1J'I- '/&2,6L,:QO*<(:S M'HXU77"[%P_=<'X%FE][WR6R]@XTK5"/O5[*D1&A*_7GA7C#D_W1H%L;KHB1 M$U1 KN M@)/YXS_=ZGF]=GM5/VHWD&ZO7;U$VC>]9KO51=JWO6ZOW*HU6V<( M^!]2?ZAWJLTNW&GB:MN-4*@5F@Z"N6G'@?9PKQ=FA5M$N93%.B9BVK![!L-M M^KEJP'[VV?>XM@XS?5M^$P<4$+>",D\OI !API_^WS&6GJW 5B9=/^0-4-ZI M 5N.,I_C=O@W5I!@F2\\)?"U-9@NG0('^TH8\L@_L/!7_9D64.9H]#FN4(J8IB=ALR;1 ,<=@* S:[/^T0'&YF'F;_0.L*0#$D2)/)0Y:5+("3CCJ M_X,52P4,U\=I_?0M7D>)'_&:QM87/;=\Z*EZ$^:ZA015_C.W?=A:![IOL$3' MU'RZTH/3UVVLIWM]YL.=13R.;[4EWBSD6?[^!CA\,.?A^EK32E@;TY!MZ6KX M!:L:"/U[]?)WK%1>FN*R&DB_FV[/' >?!KW>R>1S;O.W08[G+/&!L=TW\/XQ MQ\ZAPN$EIP-/H,=K!4IN;!W_:0\T67!8J@G\AV=F M,NI[_^.^TY+.:>?0>"?FACYD"J4#')LPK99K-QO')J28 6X;Y[6+3& MB%+$J7(CDVBBH=S5N1,+=9'^H2Y;*+*KW#Q)1W5UC^D=422;!B&K(_&?.^8&B)_741DKC9CS\>BR4!?I*QKR6'FZ* ME&8Y.AJ#RJ9VBWH0&^?MYVP;B6TW;#1,== S;J:>/6H7EU=GPHW7F---,<^O M&^>,@^-WFVJ8)HY/MGHUV2B1>S3GH<.<8X6/.65QHY7HTDL;G9:2#73:3IY8 MG(CRCQ/90IWEB2*(5DE?,5TQHF\0YXR=A =UG)U]/UV66IS7V74&=4=G.P4[2ZDCS8F09A^JF=PN!T$1Z0B!?AG4K60UZQL[8?>9#G-^+;_=,V%K/ M+QSWC(7MHS6)I9'M,U?5V4A7N+,A3Y58F?9:';5QIMT5R5&BT4[;P1,+%-'^ M@:)O&^SHM3;%/GJV^-!8)-^#OA7R9/,Z9_8+.V&F\W+E<].4WBB^A MWR3,&979[,S$1*L/L4#\+[>_QL]X376U+:!>7^6\4XHQ%;>\6ZD#1%%5Y?1G. MS6J(,WYW<]8=/MW7.^/Z((]PQLGU.ZY;31/79[FVLYRR8">@H7CGTO0G']+[ MQ0 E7I,-=JX.GEBTB/&/%MF"G1=3<8[@WR/4N;VN,\NT6WQ2J\S5C">&;,*A MSN2)ER[Z#].UASIMU$NDBWJ3"W0RF0ETQDWA],/PLU=NU(EJ_[L$.B.RFH.5 MHM6$. .=6$J,I\PP<%[.F1ZY,>XRQ:OK4J5W>Y@XY^[ZTC?.21>)I.**]?O-M(W55R?N4K.E#6N=X7/6'GVCAV]O>$DRE%##Q#?C)M_%S6A\A3\1W;MALN'-?=!OL%5* M+@+^/K6(_:V6LQ_NC%UT<'5J2CZP MPOB%.4S ,P;-Z1_RQ!+;1T2=HGG(,XG8"97>D&?LS*?.NECKGJV/Q;"[VS,= M](Q#=^,[QD!25-WU95C7>[)N!L*>L3/VY\<%VW^7_/ 9ZQLO]M4WC2Q M?>:*.O%TQ3OKD#MBY5JE/RO?5EK:O$(E&O"TGSRQ:!$>:!O1-:L,Q@C]/:*= ME31%.^,G7^R^.B_*XQNY32<;[=P/_0;;1&0G8#)=!)P/Z$R R#L7XG!\?3?@ M9]\EU!F9VQS-E_Y6:S_^R@X.$.N-0 MF_ZASE)BFXBP4S1?O9Y$O"2]J]?C9[[Y1+B\*_-O+U+_&X4Z8]'=I=UB'FD: MV/=E6+>%+%]EJL\4[:4J"5(\\!8W_BZ[UZ,RFYV9B-V7$J'%4S3? M2I21B&<]\Q'/V 7'U?BNSS,O//[!'23@&8/.](]W$HEM):+RK43)!$U*J8UW MQLYZ[S<>R)<,MHG(3;_?IJRS MGI409]PT_CA\HV;33_RS\UUF=4;D-@8_M%-,K%=1-@IF5=S[J\D+ W1S;@9CQN/RY.' MRNW3Y7=J6X]#9>\6Y<"( IV6*,>78=M:1D.;<3/U8"I*XT<9I\F\CC-.EM]Q M#1%5P% J'2R?;!7GA.4@]9\8S_B%H*?$1/N-)!LYHM(5^JR+L4^BF G"ZW30 MPID%F6Q/N[B/$8A4N&U%1OPH9#+?DQ!CY:14D#Z6IJ!I H3_<(/?/ZGSXG21 M=#?\?B@_Y)XCG?3#UK&DDO3SW4A)L$>O-/H06E#.7?)\LS'0^14%1?@+Q\P#+@5=S'S -P&Q]7JG7C3>B*?+^LMA M>OCC4/;^85\JL15-S"E-Q6 ,?&41TY<5CE>6+ZR(P(LU7HNHLBAP>[A[%C8_ M)<#5Y6%K-L)Z<^Z!"AE0#H>SK(6<8[)-=MP0%:J1.)<:AY0:WA7VZ0]F)R!3 MVO)[^?'L528_PHY@3:=,V=/D@E@D#KW;<.9PHPL.(G$2*/+=2Q0P9<(SOW,Z M-&2\(FW7]W\M R&-%_[F^/Z-Z,__T#UK**I%[L VXMIY]FHV,C$XF[$8;7_/ MN]5V[UJZ?^5B=P2W@#@#OF$$0VRWT7$T0Q50@M[1$CL$;>? #88&5Y0ESI4!<<:;W%PS 03-:K("/48;LACG M3O88W_.\>)?FO8IZ61PW^U^&"-+P,'=.E*Y@P$1LWFH"5<&NF]02V)R@ G2 MQP'ZA V$U?-Z[?:J?M1N(-U>NWJ)M&]ZS7:KB[1O>]U>N55KML[% 3+@1=&44_]W7#S6_PX^-;#^'AKQIEH:R*+(3E0 +^M/OY$/@=/&\"G% M'\>!XDS?/)P$( =_^G_'6'J4OB%6]".N[),TV:F'?G^JL6?I OV0ID) G 52 M:8)EPL79ICPBBS_BE2 >ZL+F'Q?T8]3X@5'2B*/6. -/N)MGQ'XD;"3ZP 9- M^KT>KR1_)%N"Y.T9^L:%N@[?#UL6&6&Z%[@H2:_OLVNY/,3''@Z<;#IPL@W_ M2(4'II%>VE-A@;TUX).)LZ"6L>HP3W?LW"@4<:+ ,*B_#[01M_LG)^Q'!OED M0WDONJF SE51:B<1&^5L]KR-6N"N-[77WQKHHSA^:HU&2VJWSH"PID+A+84R M@7M(]66T18O! ME>V*O!-A]M@4:PCH1&*EW5M7L-3,2<]\C[*'WFW(RI '"M]/[QZBPB*%5;"' MJ=YTJ71ZJTI?8G-WE3YMUZ:/[U>+C[X05*4/K;='5.D!3Q])#NTV' 4.?L;Q M#>/,#L0[;E6?5ZKKIL+&<68;E*'>YK^#H?#WZJ**2:W9[2"XH6"^,Z4%X@G M+A+[[KYANG1*!1YU\E6JOO<837=$TO5S0%SFSGP\FK^Z2ZS]?9FJ#B&^P:/>J=7;6YWRK<4 B2@5/_MVWWROA]0]UV] M&!(P22K:I.MI7;IW^S;NZ%[WFEAK-P;5%Z%T-9E[U2&GSNOV+,ITB)K=*GV9 M L,P(35WLI3IYW'OM^K_L#7]9$3-'Y#2E@[V&G=,QI^/K' W:[WAP97^BC_V M)4!BT_\A !:1/:.%Q>R6 !["KSY8R7WRG=0',12:JCK=:"6DI/4A&TU+::D. M]9C5934S>>EO@PBVF!X;C8[98C'XQ/]6B:G7- M/HT/07^HGZ_0IDE'/&E&2 M)3N')LW<=>CRX&QP]\I\J48N))@(2G3C!1W4ZZ1:N>O?AXA8& R3GLKU. L/ M D(SFCQ =Z_L*YZ2>%9[#/=:HG 0VV=K*3^>VT5?VRX*N?&[OMD(^IS?E-[P M]_E3UVM%A7<)H_[_9#,BWL(MX:9W-H)G*&)&J<)F:&I>S,4WB%;YTRW M=6G;H+:];-+)4NF1/2G*Z7B+A-T++4NGI)\_T]P 9P0@XKS9&143&'>"S/V9)P#%1K]SP1N,TF+_? /(V8 M-C?J](.:O%:U8J2I0X&.'='=WZV^=W/X#U"(!0Q-1@"N6&XFJ+("_P;E6E]F M%>X4J;.#L?E!1% MTT:7!:R&_,>-YN2+5'4"<*^2<1/!M',Y:S[VFI[7IO.+K99\F$?AGU=-TR M7-F%&33Z"LJ^%* WGRQGI?EH"-?T1_LJN^6:G\7M M0X5[P&6ZM%V!;3OS)FVT/BIQ_3@ND8D%U%)%IXX"LI% "RCEVZ&$6/08&Z7\ MHU>7QH)R=R--_"@OX7C]]OJE>:4DA/&U_I7 & \:REW#.%'$"C2^M:X]-H3_ M/!+@@\!U3G1X #"L)GTBX'<*+QI_-LWB&0_$DS2"OH1JLT+44P1Z04-64) 9 M*T[!(=R?6&H-787 QP#X@+].54LXZ1' D^Y@+(O@^P9\]<%9\(77,L>+P(?4 MQOHYAK(HRA_P%Q]NNY95U>F;\BHI=>T09G2E 4?MR(/>^8OVV:*#C(2\KS?/SGOU&E*^ MJW?*9W6DW.W>7AL3(MWYE>S.?]PY'K_[=,A'8)[HQUHW45*9+DIP#J'#/(M\ M=B-EGA[(96C89Y(X\>NA3!XF&1W[>/RG(ZBOR%#A>6"5:,""4#5$ ?;#]M&. M^\T-%S+@;U/EFTU=%+71$#,*+]1C"X?")\GHP%CN/!K<%9 M,>&SKXB 39CC/R=NQ<%;?YM.]P.TU]*^7.> MA9R[)6["ZL"[[M]%N2P\7,]6(VD\4!Y2_P4Z5S3MAX>JV_;7?BA*G(:=CGP8 MG9?SU=XU6G"^\M1GG3.M4>NU1^<*OH6I NHR' ^JRS*EP+;[@ GI,E$8^GE[ M.;A8'SL?M%\^I/,F2:^SF1/GVWV=D >+ MZ.B$*DCT=W3"-JWG3LY7XBAL9X[RU%J+=P%;S$;SZP\T #L%U%\E]$OJKU1, M=E\M4#%*M-.4R$U]QV3,Z?C8F#O,A,VV-N:5^OM4T.9-2=64J5[G$[*3L^G= M,F!.MZZ)KVAV;0>(X0[!&R9+NP_!W#P@8B<&S)NHW+%*RKJ+Q*"6@=$4.L@+3P4KO>X^+R@[PCYZJ7Z\'3+9J?0 M,IM]#!D]MD?OB%Z*S'\.Q"G'__GW_YV<( UH=O]";@#'_P9/>I_RT@ \@:%_ M(W>PGAH\##DY,64L,-:#"[-MG<2D#MI0%:O!ZE"],+BQ7]F3M[V#1]#_X157 MV6OCQ Y*"XB_$=AN\ LI*VQ?&/Q&6L!\,0#=DB%(,<+^K?]:7X._6HD$2Q[\ M^U\ >P\L*#S[>M+G@>T!GCW1D6B'.^G7P9T%N#M@;!'S)L#8P0GA;(#21O$Q M0T8&ZPT%.> XRZZA9#3_:Q>-CAO% M@"?3LOC>DM7/FHOU+3AQ6O*+]ID_% !WPE>?^ ?R%:"7FJW1XX*<+,,I^I'O;R*TD0$WS!:[V M);#4&_-'5M?[F%41EI,G>C\I;("%CH8PX\TI(([N6-AM64 ^QL)@C$P4&>9/ M5&!EL)IN:E3@_!C8!%L3%'Z@R8K>$6OOL <:$- !P@GJ0.'A$X]8B8,_90>P M]1[.REOUN]8_!V,8Q$$4X)^ )^K62L'HJ86]N9SUE@)XS5 8\/!/_-M$E.<\ M.!9\LL8/QA(T_6$X59V*&OBJBBPM(_U0!4194:O1O@NCI"KR3Z=[J_X\1>#_ MP*E$$8 *@(5%\!-]IH#5%SP!0)8Y6WLN?#C[ 6$!K2ZC35B3-7 *:3F5"(#U M#0!4A[$*3\ K,QT!L*F7%43H81S!Z1+&=74PJ>I4A]!DJL _:<9%!-5$BWYA MCU>MF!&Q,:.!MC=VCO3-TX+?>S_Y")P2W%Z2-02X,SSX'%;\@?P#T*;?=#12 M^!&XZ$\+V\90=?T\MJ%+KBL/%?D-T0"9ZN\"_S_-*"]YSK?7KEXBMZUF;ZU/W0[V3+:K[R4! MG^D.YH336(;\TX\(%6OWUO0^U#0E)??3[TS1,?<[;UG,ZSD;']W>?[G7P?>V M%KT]+@)I> ^0WRUMZMZ^&^]PHR;XLI>1T%&GUJRCEQ'?UV^\ MD?(B;@\Y=P=PQOL5<7^M)>,KJ>6Q#LS.%Y[<8@#*8P'IWJ43^_9V,:^)]]=W MV%(Z&:=+9!>SST94QX*R@- +-_ M&-NVD&\F4.@( L6 5!H$2KG1^EOD*\K3S,_<*;B6J"5OQ(03+];QDA0OH8I= M50":_SL^\90S-%8L,%1@XR5S%LL>0@4>@L>V\3V,/YRRY61[E%E$"-#C_N+R_N.G7V%AB M4E\E#K6C6-MMZ0U:0!FZ0%.' M52[5VOU,05N^I12%*.&YP]B$^XC8Q29KHTWGL&0M1F(%AF12O",#117K1C^%=TCQX%+[D''('87U M;ND5M("B4%QO6&682B$0<@ ,]KSHG_4(Y6S0Z;P0F>G>^![K;-USEO!UW]X_ M=+9=4B8G)KW8U)*/[PM1^SS#;^^KC(=\9 <#7N05?;Z!U9*GFBP9P"/? 1SA M+$?_&[JDT*[9D"T11GO; @+1-=?!!AOV]"9,O8/1Z)#4>.5-7?856BU.UE)3 MCP4@Z8LC;:(KI43SKU/J[.QIO(6NS([&$&252* G, GM&J0F::I01/VW,.LV MB28?.;MM[3VVKL9?O:F79P=C^%6$-]H%]18L00+$)DN\HSW4_?7I1)8KIAF:0NM+^^QA=P/ZH8'Y01JMU@G1I8*).F[?LXA M2O4=S\,E\/IS6R_ZQU@VFL>A\09)T.J^_TI-SYDY?#!K"EL7!TQRUE2\)7J; M)(%*H(,;[7+"??+IMZ9\*^<""X#= G!;&Q(2LZ:J\5A3^Z.KZX=> WE9M^CG>3(I3HI[=K_*["Z'HIR:U70)$NE9"_A,=D..+R]T^ M1>>6 5T!DF2AQ*QO^#ERC6:)C2C_@3+NUSKY5&,EG_WI&T&\'6-$GCX_CQ4'4U&W!::J-1T.#M321\?!>5DN\VSY+&,6G?E.CIW#3X-S M 0-/?TNN[0XT"G5?DR;O62@K\K&9Z;E*)%O']';=JJBV\N\M1)ONN[7-;&TY MH-9JU'NC7O-=$H"X%EE5-1XV&0-'J',F+AZQS]D OYL_=_LQNJQW1.ZL,>F?7X]Z;XWYX*U19!^>Q,N_Y>>-?KCSA-$6!=+% M79,2Q6*A6/3=$XA\F(>T/->I,ABSU@(7/VO2A0/'($.X-69ZV_5:(M7"9H]* MFQ&PIU7_A/D(RQ^W7JR;N$&@ZWAW\ 50-!8)KJM[P0501(GQK3(#GS0B#@!V MKKO)PZ,UH.(N&\MV*8_=??IVGC4@NRG_9BS=C/OEBP4ZC+RS*\A)(E)V*08, M ,I&-V%@ @0,_*HQ3M82+N"QLI^$07TE3$#?IRQI B>(4S@-V!:",,Q6^_HF M\^F6M7I'7/>NJ:?SR_/TRBF;2[2\R;/S(BXD[]A[72@%%5^LYL%I6SUAY\JL M5165G=*M55@^0JU;O,*J+/[R@*%NH::ZSA.2W3:>*(2HBQ9_&)0NJ/@/9%G&R1?XE_4%PTO3J.SP UPJMRG*2 M-0>-^#Z_"H/ $=S(<+F<0Q38OB *VOP4*?O\1K1E#[26C^%[LMPD/#X&:_ \(S^X-5L:_ D!9M*/!0T!"AGX/VHX&K@]>;!V;X\LQW?G+.]75VK M/5YY@Q3-:8]V2G[C<17_:,TJE_UU2H9YF"7]>LUH=I.@C>3@XK=?W%2!YI^+ M-IEC+TG4TU]&K%74F4ROFY'P0 48]A*@>;EV[>+ZM:]9@%! !36 9?WZG/WV M5+.COG ,S[YZL3%X"ZL3#8S8)RB?0T+V%SR.GEH KBX$"R\Y SW$\ACY2-&+#UB[O6?* M1L@L%LX+X!-&_TEW,)9%\!(K& Z%!K"FIRK/%>P1IJ D343!RRO!)JSTI]ETE M*ZO=*-?Q^B;BZ ;P$^YA4_=H59JO#I0!%W MH<=\.4&^&X3;@X%UDX' M/,(C\J%''+G)\_0&> E;[9DJM$&6N:TJ.Q$T5G2FL@#DW2**PC!9+5W,2A\K MB[RSO)M@'E"_Y';]$N62X?*C:S=P";E0!=9F9NL$LZD?".KC/Z53W]K2'P5D M)D-6@=Z>%]XQ?[S##"!,SMTM'W @K"LH/:P]SK07;(7UU:&B8#O0U6+$-0;0 M'0^N490XQ7V-C!^Z ZA?#3CY0_[( ^.VDD +#%?@H\# ,FYO8!0:' FB%+\M MJWWEG5(9(H*M$0$7 :P.@"3<875X@F>+&V[(>MV4-_' "7#!&?CA'*ZO]!7 MS%I1 ?QVS?QR6;T!QC PX]C1H61OYYTF[L3N#35C;-%S_TL&*S$(<_/C[[^X \CQ-Y7Y-O2[C( M)%2L>*.*]FWHW:JCZ;3I:&_DSS_DF_O)&.T67]*KI@.@/":K#,7I4]HW1_"C M<.30U#XV^9XUM3=B/\\OM&OELMVX?5V7_/#P.REK;XP$TM+XT*K:&V==1;EI$-2=TAYOT]8'5M3;.1(--Z\_BJ[.:!#%(P*DKPWE/P?B ME.,=:]/APO3?X$GO4UX:@",_RA73-*ZY-BXT3.R@M(/Y& M8,CU%U)6V+XP^(VT -\8@&[)$*08Z=A;;WT-_FHU,\,:F&$LNE_'PO_/WKMV M)ZIT:\/?\RO8O=?:8_5X219GH7L]/8;QD)B#)FJ.7QRHJ'0(&$"-_OJWJ@!% M!$4$Q33W,YZUTXE"'>;AJEES7E.7Q+?3M@3C1#^P(=I$][IS/NM.',NZ+ZVQ M(\SK%L:]G'"=K:5T27R,VGLLH5HK,]7W<06P\&U=QK%+21E+<'/ HT35./4^ M+^94S:(N]D6UITS1KH7]7T7MG(7+ZSS4O*J:*1DG\\[?*K*#5H76/+FB8<(K M: FEW*9Y+F5-1SFH+S!YH.2?@YKN&0!8 HZ"AM0]D54P"%7LRN#A16BX=)_% M=]F.^DB13N?VPV5MW0HFCDS-XP9\W",RPD'\6/: XVQN"VVA_5^W,5R:40S[ M9&.)/\V6?IW4?S)W=M*XS-=+6"%_5VGF;[!_"K5JT\XU*WX_X@1Z/P$(>_Y< MSK^5P&%A"/&?/I(\9PYVZ6CI;E]O'U6*X$UC$5ZRWSCI=*[F]-^6Z,X$5Q;M MUH]JS<12GM%R+/M^,3@:IC1[:B>+N6'SR1VIW"7=NYYMS=2J-GF\OR-KM;? MWO6%RU+QX::$USU>;6+%4KSSFFY7'$G93R9]7;BK-ER/O6[]K6_$= M/.ZY"%2O@R[AMVX5GBBQ:C+-C_\*9DIU4=50L]A?Z7X"UM7 ER?[:L;,W=^H^?F :YT->]&CB/\LJUMS1TFB0VL=]C; MBI7R6 ;G.1;/A6]E>TM70E1/IH MCJT(;A5R\_[:C/G)&Z)TX>26O)-:BFM NJB9?MQ6M,B.9[ MGI5>Y.?"(#2JB17)N+\(+UY/Y<_3@=SM2N#A8/4H^;.M*Q"8?/MUZCU:?.W^ MB#O.89[=9E6#A.UR](4[AKD.%U99@U7S4]9TI_)C[G:,);^S!STL7%[TQ#N5 MNM.[J_F)GXD:REFMV3YQU1D+5ZXL>/G0U=3.>*G8U= MV-Q?& ,%4P-(:(5.C(1]6OP2BE+0G"4M;0SC#<&B42PNIC.[%N'DPT4[^93V M8<=J5R;9$6]'+K*%_;2H2BQX&\HZL03AL4X[!'%)@<-):C,42V_/J*.Y#/2[ MA#Z":[55:QY!CW80 M=U\)R%!HVH/;?XJ;3M8,GA;__?-RH]/?)2[QD/_?ZC MVSUOK/6PNY?L^=DV71RQRYWY@MWT3[J6IU>90B!+R%I6D%V"TO?2T_-3X5&Y MSJT$PU;NUKF N_7-='MQ8J@=;H["8JB]W8!_>7&F@L4YB0O;+MT6QU?L;7W: MBR[.25^PT)LO6+(4C+614O!9\ ;8"@+VP)&[DD58EZ5:^*G@^5))8[[S,9(- MU'\'5C>X3KQ-S125@GL]42^ GJ3K4G<_@0)9UYL?$\$<3A;\HD&;?:#H!1FG6B3AR^3ZA_KQ(=#](95:9=A07!QQ57W1XJ8\HV64 M2&]Q#[",$MD<3@P<8QD&"Y] M\ZD[V8,#?QF\YKH7>OM*6>0X^84%]QGI#[DOG)=1QE3KF2ZV91HRD9^7A M33X_FG+%+]1?J@F;*2S. '.UA/2UKI8.X&WB0FD@)>ZMJ'<&&&Q9#A-\<6PR MD("IF*YCD/1AL2<)FK)L$/R) F;C^8HL";./.S5)[GEO=N:.#5Z 9:!/*7+^ M$[6L^\Q6=)X^;:BHL'U2TJVH):.C:Q/_+2F>/S2F%975 M:^0^MF0 B;1D%99;@R&%VAKW'")MT&YD_\*F[8&[8D_KQ)J6U6X;KJ7!J[-X)1?_ MMIYD*[;#30([IO15V7F*+HTE%>8 JO9?+2O@UG_P#H0#0C0=J%M/J_60T]4E MR5?(W-BC#I^\0D!_COQ:K8?^.K]LZE+Y>K-L78U\RN,V[JK5)G8B6HVEWB6[N]OHH2 !<*ZC_M[3-G=:R0=7>?:M1]3H2M415%FQ@_OI"H M'\W@O:0Q9&LV>?J<-FG6I*_I3:0Q)R[2F'RUB)7SE3KVF+]Y*&&UAV:C"7Y7 MJ5X<*V=,E.16G^V*-PR)#IEH7-"+1+\B0K&P/SICTC',:)#(.J=\-5,XI%1O ML.61':*4.:QTU8/Y$11LF?*<24'*I0#B*S1 !+*R'?_Z.QY-[[=,EL^D(.52 ML%GO4[_C>ZF8H-F_XSUE> \5 I'WO^&!B3@H+-3=W+ 81<(,V,/%?9HN:WI M']?EJV?T;=(.'?:NBZ5A:]:VNC0-M:CCA?O9V42*6\HT2N9<& MB+'4UD>B/L58AS'2O_O(/^3W '%.09K_0^.O@%$)L2;$^QQP5V*49*(=C^.7 MTR?AYO[I?O"N//QVM5XY2.]C7XE?DFAFY[;']!D;V(_PT)4+J=*IQ+*4EWMX M6F *R(PYD/32QT@VIZXNT"Y)JJCKXGB7W(S MR5@T/H2CL;&LBWLG-1++9Q*[7S/-[<-,K^9]QBWLU\4'(/ ?T]) +HM2H==/ MBZG> *EB6O"U=2<;\19'[)@W1I,"SN76 *Y,A9-Q.N?;.9WD]; U&PB")KTU M;JH5Z4B<#D>EQ^DD4-6<;%"FF(J@#+60P0J00;I=_Z1G?/=ZS.\>E*&B!&4X M.D10QDK=V121H;P1F?UR7<.@2R(F.=%XS58M_HXNMN,1]RN6$DJ7ST3AEDY3 M;(?RQ1I;M;B/*[:3-,PX$OKY[2K+CREFX]&(\[>+]F_SX>+U@]_V(' 0!)([ M,'']EY%@-@51&(\L#A[YZ?NDQ/7J3%A ?! 9%#(9/"(KFLA1;DERK9 **\O" MQ[:9N@@R2%\0FXS%51ZPR&;4U>2C8SD4A$9X1:"!\VY6/JH%KD'-?];F L> MR@6W:J-V#I9P48(E.39$L*36,364=46LK73"_J$/&R^)_#*4W;+_2,DN@9)R MV@,E+NF_!=)_.[@R;^K#EPG!I"E0POF"B;"UF<&!$N*,(Q>*DH5*X@05Y:,- ME7ATXN&AJ'?&-[=:N_.G OSP.AF67,+3JYDUN<$7Z MIG_Q=A" OZ;=E?\*[:88?-B3+['LJF"G/I(G<)99XZ8RG4AK^F4B1V6/)KV4 M^,F8HA_H/',,H7S^T$?F+R/!3 K"-AY9;'?Y-ZTDLO?W@S2';7CVB,,VT;GY MOVIR2VXAA"] "#6U702CR#>)7B(AG%R4$ Z?BR^$@[;^'R:H$&G_[._)4V4' MQW["5A&N"N]YVH,S+KF^!W)]\5FEN=Q3G6?$;]NOH1\IR?XC.3E?<,S'$,D! MIT8RU=3N67L&WZXEQQ09\BCDA!\\-JKG=\5I=UODG:YF#ON.'?E: 6'7)'MN MN]C1'V<$#C7AA>;S*8A#>72X-!0; V[(*&3H.%0:=#>62)6_&E)1(U4D3I L MSO)4IH''X(:)HPV >52X0C_6WHF9)C?9E+OAD.$)@[ZKYTB[>NCC:8X,Q"9/ I2# X#G%1 LI.L$$?A-[?UJ;/J5,OP^R M+&OH "(EPMB9P5QU^/+X6BD:)!4?PCJ(7D8-'BRI&$F$C=>M! K6=4 \9NWZ MDFAIBOOO(H9]@H7F B)D?B@B!DH;PT MQ"/"=1P-'XJPU4N_'8UNIS)S\4(?=L09Y7JY MH\MEHMR:W3WU/TVQ.;CDY7AR/);IBC>.<650)!C4VQ7]=O&4+\Z>8TP\Z6F: MJ6JF9+DM^Q_(=;'?L,]WY8M64VXN+_^>.G?50;QK#NUJS"0K=FP*#4IG>IU[[H1 M!K5I[[DM]M[-#O5EMKW8FIEW'?%Q.,XS8DS;3N^Z[41K1@PZE>'%$WFIOB6P M[;EPVXYY$B3YK[+K0*^FO?;@4GF[,$9L/+O.[+KK0!3?M%E]EJ\2XF4G@5WG M-^WZ0!Q+F*I9NS]%Z;N;=WP.MN)#6Q K!/0<0[^458!(P0M.YYX]WO9TV?NS M]T=YOS=]W-5>,P_PA5H3E?)]@[]N*T?3^]+G7((ZGDJ?'674!0;A?TY/L;(L M*=T?V)W8EWZ")WV,)+6#G@#&A\ZVX&?L]-2V_EUY'/YXN^E0PB%\NU77Q7"] M%/U@]%KGYGNX]79T"$:0U\6VW/F)5<5WR5KI MJ@:7E,JYO_6O\S7XIX61=FST?_^"M??9!5T2WT[;4D_3P;.':!?=Z\X%'0:/ M8=V7UMB1YG4+XUY.N,[64KI$/D9#DW0$(<9Q@@?Z/JX %KZMRSAV*2EC"6X. M>)2H&J?>Y\4YU__:OXJZV!?5GC+=BEFUHG8 HFG_VKQ,AYI7%< LX\348%]A MK*"IR X"(-8%0JF*:D<6%:QAPNHG&,I.]US*FGX"I_$BB3I6 DZSZ]>D,,TS M*'T.=-^#C M'I$1#KK,M <<9_@=VD+[OVYCN#2C&/8I=A-U%*8T"+$=6X/M]B\R=W;2N,S7 M2U@A?U=IYF^P?PJU:O/__I>GR-S/XO=PFIW*V?D)0-@J5E-SW^!+1D<<0OBG MP[M^]Y4A22Q5J!9EHZ-HQDB7:KU;280_0 M?48=W5^_2N+1'&:: ^FD M!R_#%<$9"+I$M@S4WY'+G=DP*ZJT(4A\WO:Z PT!7S12A-& MW;7A!VZUKJ0 ,VX.T&=[P#UH$_@'*UD"/$@$P!5:3M$P1N]6CO&/+Z0;1S/X MY9@;?PY.Y=0+4;X"[OQF*LP%N2L;0-3!\X'&2]]^-0J7I>+#30FKE;&G4N7B MLEDJ8OG'4CU_4<+RC<;#[5VS4JMBY5H=>\K7Z_EJL^&]'MWB1F_KM0QWLOH6 M*I_Z:'*E_^@NP Z,1H.,UN\[V=4[3+)(I*U*>E^VZL=\3$44MFUAN=@[+==E MXPWKZ9*$R3!2!APRI@.''+"0\UY:^TZW=75A.F!NI#,*?O,P I@YEC,-BP"S MZC("*;4>W(DRV(B*O0]UL WN2JD+B)ND;FLH=UO=X4;VF8("$!"LQ$+/*(A# MV125Y6HK!VW:]5:SBGY%771?[VH"%5,V1'MC_F"4)?@6CMEF_I+6\D0Y3J I MFJ$]AX2M&-S!60-E;E&N%,,[ /)ABQK>C\7==4 +["^6K&3;[_\[4*?WI<"' MT-;X<_>6V+YCU&EJKM.KQ941=+K],;D;/-\1C<:B'4Z S=^<[!N;LE)S9:4V M*RM<"-:CK'0\RLJ<$;E4] K_.VD2M7A10^ES*'7@:7NL*:(I*[(Y#5BN_<*$ M V*#:'B@$&P[G#5^G"_Q?M' >>VB@)TZ MR_';H(%D!?AOSUN/FB[4YSVQ=TA8W_5@-W6-U]&O<#!8GW;]]ARY#."WX5\= M);\MO)@$-7UXGDFNM@@KQGU+:!!=<\,# ]HV8T&>,G]5?!RM7S>7? MQQ.>2@A<*G(O*!"5PS196+KQ]5T#>/KCO8FD)_8VP$<:^P5G7X_0 M_1 (C0TK^>L<:G@ M6MT1KR\[RKL;^6"676JT/R%T:+X,%,HW:+(,+I%G)%$ M ,GW"DZBD]NS%1BSXX;Q+],'XII@C7YOSQNV"EW"[18='>":FW:K4:!]-GO ^TK\I(3#]NS" @+JB;L[MYOQS MN]<\H#4;3Z]%8=KI\!>#H]D0;]HNV9KU;JNC.E^>/+RP@6F[#[>W^?H+S-HM M7.:K%Z4&5JEF";I_8(IGPNC:HIM#0W3QY*7IM'3H]Z=Z^Y[L*@TTR+Q=J3%O MPXZXXM.TEOO)ZN6(F+-Z?2FS-^$\7QA\P73)P(M-$:%?)+ M7?7B!OF-YQ%;(LS'R:*3NQ^)*(Z=2P!4J+!BRBK)PH9@9;0%X96S[MY,\V/F M$27#Q!,X[SF#WBHA>'ZX6&PT)-MF2 ;GR=!DHX?+DCW*]-\U[*'+F3J.W[%= MCK?]XVXR9W7.;* S? *Z7=5FRD@E!9/E%KKM5#OZ^U \2.?/107V9#VXMB>^ M'W':@:URC7WM ',6GF]X;R8@Y4G&/B#&$9.@VY&] I0]HI+<(O;@N$FW7OAJ MRWRM6G*UU963!B D__O='+XHBME> 2 XL$X=>S2)-$?_9TTS@.T7+)&@);W5 MY82O$2$YG*77I)4EI@O>;MQ?1*O.=T8(!V%8^WT@*H( _+$:W B[ MHLG8+&%WF\63..-;WGP@/?-"DS\Z#6*IB^N.T,86Q,,!FJ?.N'#S.27N"F_A M "?T-B1B,9C=(Z#,&1<:Y1Q=\]O#1$&60GON:QPTCC4L.%\U/%+< MUZ5-S!F8N0_ZI5,JOKY<*SM>VGR5BYH09HJF.!@'7S)3NP=H<[A D^2-^IPP/U2W*"HWB#>NLUQM^V?P8+D)3V9]*'OG'9:^D1,)[M[6#F'(Z;>]ASF\C&B5=H]W$^<*X]EOG/%Z$3%[_)L7'+L,'<,NL$UMWKTR7EP?0S!7_ZF=W>T9J]#N6; M\\O2Q!SVTKB#>>-$-%>1.VYW['X'[YEB ['K[07J8#=M,>V$>H F+:]I'*>7 M(HAIS9XOF>EMKS P+]\"*8+5$T M)4R.4.Z2>GBY&ZNJK$^Q;G GPXR;9W7-+$B&!CE,'15/MG5A6;'\W%^:EG(_ MK$J4M^W?[L1L7LI/80'*(!B15$.$.-\!75:*!;3/K6Z#];J6]VW+9R)H6M_!TP9=<0I9OR5U&1ASRRSQZ]?GVZ^K MD3+%*,&AHO)E(D\#@*6=;N3>3;Z^U(C <:*'%*1E ON5 M)5F6'2;%LD/[4KH\-/X*HH#QDJ[%WCP#\R$K7V?1EJ(V+;F"PF2CA\9R<#X> MB;QJ?S(/OS_>BO=O+HFT(V,(G@0%G0(-SM+PU\:+ B5W23*C!:\7RX5RU+>E M(8%DMSL:WG%OEY=24NAV_K8M M08FP%;IM2$/3"F&2S#80=U]5@/$+#[,W$.N2%_KJMY#/-W1I(B0%8B/*2X[< M!&)71"0DDMUOH:@/6-UK=S?JP/C4+6R5=M74FF.E(Q\:G[J$MRPDET31.0 MB%]\\OO#FFZ)N1A=42+5.>>UY-!F9(D1-N%-CY!PZ1*2=*#-0T=#E\3MY3=1 M?KDFZI=EX>!XTRV6;K'CHU5VN1$G<<;Q.3;#G$E@3OH F-,MPA7NIO+&&WRU M(?TAJ#-04:(=S1PEV9)*(KW(\R"!S0TA_Z3@9ED;Z8XF7#,F]?*J-2[[N:30 MYN)UVT$'GLW YAKA*>T-;+KEY57I2J_]TEWEG$\*:T:6E]R64#.HT?P?#36Y M T--M["5\Y^?5]7+7*/X^]!(TRV42T(7C7W% S1):DV-1@8T=VJCMV^@Z19@ MHM:\O7PO=^]N^G\&S@Q2$R':>'XH^SW3 M?A?)^^>G2F*!S\7KMH,6 KT'*+IV_Q-->-J+Q%4U3(I6#''HN0<"LQ#?31RO M;?!PR>,UEP;?OGR\/EY_U.I/A\=K+DU?TN3=4R6),^"(UO02V*:^X:"%_0 ?J(H^;9:?/K:&@6GH')((4 S2S]UR+DF/J\ M]!>?WL%I7^*T++N^/V.].3"EUH:$QR1G655P8F_\\"!U- M/"YU.S(9(5JH\NCIK;9CD^%:LYMN;793'U?&YTQ<7"2)\PPF2=F1^."; ^ED MXI!/B3;YE"Z]BS)J50,U ,K:2%0P1>Y)04J/B0;\DP]+RP3\Q5F;Q$[B:\G! MZLYL"HO)W("YU'HN1ARD:K4A5"H#\7]US1??8-OL,M_./S+>]3(C/K\KU?;ZU1:1MF9W(95U.#:GSHSO2831MR0Q1!/%M$R=7 MI,5"+?Z"0FT8'(>!_>.5#0K[O__E*9+\:1>@QKZ4RR'6I.3#V_)RUKYG/U_X MNU?Z\2W,;J[T9PR[EV12>TF<,3GO7IYX0BRQ:3(2CN]G;NOYW_^+[W2<#(8D5=4^&P'N&Q M"_L'_9^3"M!S!<1X'#@BZ/[>'JTEA21Q+6 Q;" M&:.!GF%(^ECN2/ CB@BQG:DA@CQ#5!"(&ZE@H52(^<#CP##&TD#N*.#S_SSD M'[];+[;&N?&][L?.QV .1!-[ET1H'K Q?) !AS"0E"%XDBF!M32F[T-P.C&L MIRA $J03&' ;(B@YE+2A8K]!Q+HR]%<=>T56EAR3U8XRZL*M =O2T0PP E4# M8Y9U\"9E"G;*T#HR6HB); [0F-&ZHL5:FJAQ=M)T,0N*_;XN]<$W#?0E6;6\ M,SQ/@I^LR<_%!7Q<%97I#")B^!=GG0Q3$M_1J\#XM [X.OB -3A[M&A[P)*! M\]X0_!:L],F2./E,V5B,K0M?#79ZBHBI5?1N"9EDZZGSY>G,'V.]]I\B JB MV@-+5%$[9]^/5*&/VAK5A@"M08DX6;(6.O*E8&ME%2@ TE8=P@(#J +<_[D< MR\""Z$#L[&] $0!J.):["ZWO#&2IAVG.BU# P8 B_"Z^2?K9D2Z0O -X^"=XTL<(&EKX!'#P>!25$?P9H4D4%.S*X_#A*VO6IZ8V1#.? M_\+Y"H=@PE;TE>%(*?W02/"%!AB?;YS'/V6G(T%Q\G!@ED^70+F]BC^QYG0( M1I#7Q;;<<= Y7.FJ!I>4XMW?^M?Y&OS3(CSDQ(;^^Q>LO<\NZ)+X=MJ6@*T% MSQZB772O.^>S[L2QK/O2&CO2O&YAW,L)U]E:2I?(IY0M-F%66_! W\<5P,*W M=1G'+B5E+,'- 8\25>/4^[R8SP5SIXIV+>S_H ,.=R(XU+RJ&H!!)[9/*0!7 M!.T@@A]E607P# !)K&'"A"[HQ=(]E[*FG\!IO$BB#@GUP236=X=)W0S T1J@ M17! .0$(H0" 9U<&#R]"PZ7[++[+=M1'BG0ZMQ\N:^M6,'%D:AXWX.,>D1$. MNMJQ!QSG#2ZTA?9_W<9P:48Q[),-)OXT6QH$V8X,&-JA&=_0"_9/H59MHM!S M[F?Q>Q:".5P(IJV)>M?IH^2S(,H,!?.0?^]0RTWWHE4#V9J5!**HUX=\NTG[MVJP]R7J'CI] M'DYJ96Q] #SK\!"RPX.-3=$H%O@TA4E5;FY\1^@8H=C:4+CB*,ER.I(5^W:2 MD>X_#.$R=\69$R4]64;6$-.T%8=^_P91X*.) @K2.Y(P&C6-?KXB"2J;'DE M(TS31ASZ_1L$08@F"/.KD+E=J)_SOXG'"GLUX](C#?-AIFE'#OW^#1+!^$G$ MC+L:E4O$_7OG.D7M5II:VI3=5=HP7U%/RD;=NH^$H+DA*@"C7FA:UVC-RF^% MX>43>]TQ%ZV[$FC'PA"[L,?#$:.#4Q\.^@O2U*]T/_6\S?NZI-MU^DM+R$[L M=LV1&\!YSF!ARXV(Y?::D'%3(%B<(7.IXW?/Y#"M:=CMW<+(<= MW=:%)*):%Q:G^!Q."*$[2!^BBX=3*(R[.L#)Y\R-76K*2CRCS22/6JOC^C%!5Y)*JI>DSC% MY? <(Z2Z3#Z3[ -(=D@$0M(;$4@F,YG,+,L,D\E,)C-)>] U.#@L]].1^DM? M3)SWP\2MV4M1NAL]BI-H(/X).O >_U AI M&F)#T9%#P!Q.YFBA,#3(U2.1\L3DJGHE> M)GI[ML#!YQ$JPUF6P7F&.C:3ZWM$<7&/V\E6%Z*L5M2.]B[=:(;1DJNM MKMR:$97[@=XV)^\7,0;L8YRO/7A, 6,^SG8*07JX)T(\W]V/"^=36T3+#3!3 MX&I6P@ ,GF, X@\/=;(V'7N3JW^2%:Q V$R%[:"V&E5B")P.?WJ,<3^^9V)T M&//D31OVB!*SLXGB<9JB\1R]AI\^LU!?0+36H,HMHMP!0D11N$ !C,FD1(I" M!+:MVG_)6KR"9I@.:.S=,8.B.;@=4&PB@>X89V[/ =53:N8 ,>T8YI%"R;6' MWCWX_<49;44T8D.4D2/'/(%3Y"&4ZT@=_]Z$*6RHB>(WAIHRQ_JU[, &Z!:6 M7'TU>(X37.A[Y,U.G(4D*=QBC]$2\3OF]%9:0F=Y;N0" "5498U MO2@-=0D288+1ECYA"P2I-6M?7[#UFVJA*$=)2/ $]W8I<5^,+5.0G6+C&S<] M+AQ&1\Z#900!9^F4=!7-)"PJ&J,W)Z-F6_>EC<-Z<$9O$5?SA&A)G&1"=[S) MA.P+"=D:Q!8YCY0E"9S+A2X9/D!4K; &M^7?(;.SL8S;'M7G%^6.>^BQ0JSQ MM>A3M88YRR!;)80 B3RT#( ML6Y=!OW3MG4;KSZW,-IQQG&9R)?L% SDDH>_*\UD[5"R%GQL82,?6](B5=O" MK!M-5 UP9JE+'0FL'3JSV-AJF./*;T^-DG!!ISU=$LX&^T>7.AH8X/0[[-8Q MT0&V.]5Z/0BW5-@H"M/G<\P4,19_S5*9OS[6K\8G_W>0^T%>ID$KFD.PA=7E4PT#LB?!ETE:DX^E41].T>W,LB,.C&- MU(D+H8XK"L%M$84(BC.RL!X4)ZF,S#93BT348F.^0U2]""2HXR+S.F])4'<0 M5?#FUV1:< Q:D)02K+_@Y+;('PODUZ,H"B?"7T5E_B'3C/UK1G 8*K=%&"J( M'I#&.9+$^?"9;VE1 N>L]:\)K[-_G9S\-W0_&0R, !N]]KD_L7=1[\M@>/"C M\_^_/')87B7WII$';R^-(<\D:TPKLQG"P:-98!U)4>P%1KL&_PT^U7'^O?4$ M;1T AT5%'!I@!,Y//S&GOR-^K8(! AL"PZ8( FRA7XB*>#L6J[8@,T<:N0_9:/5?6E:6O\ ?#FHE;BK&WMKEKNO-J;3<:YTSB42 MAK?A%@/15N0IPQ$;3IEWD,.UWT3O\J+-I[YDVL,'G>7F8/7O_1[1_*7%][A& MS0,95-@H=RXRVR&+TSR0-"YTUZ!DMFNM=I^W9L++>64Z>)"'4I3DCVU2Y':8^IVNC64#R@= GH8]]BS=-97IKKZZ MZR-ZL4'8R.4B\.J-P3DJ-(5JELC]ITAV6/R1%8QD,K.MS&0%(YG,[-&#+GM+ M/CH_S5%XRQ#=_>Q%;GZJ7OYOO-PVM]W7RGE%('(U$M^:9IO!XEK@3KV&( M"T/SD5QLJ@%:>&>Z")\=S\VM+][::. "Y2 Y\+#_HR<[XN(U6;HO$6%8(!T<02% MLP=I1IS)UB%E:WW!';][P1U) ;O%X3S/9++UA\C6L@P)L12L,:R 4RR=#AD* M$?%>:2[OX,C76V)8I:[[XUH4!M&]$K3;AHBK(A& M7"!3B!Q2IG&6.@2NS)IKQ!-Z$C)B^+1M7=)F8#UP$R)W3&<(G.1#4X9DMN#H M!)QC+&B(>[=9EO=!3MW7[L>M+-IPF M(J=LL@*-4[G0"9L'B%,5UF AGU;RK5E^-,C?M*_Z#_UXN6JC3]4:YBR#17&K MC\_^QP2+:")R<(K,"3C#AZX$S QT*GTK360QJJ/=NLV9;=G6?4F[[K'AD8-# MJ;+AOK"(6>2!5=Z'HJS#M;-JWR>RHN35;D4U1;4OHV[+L\OZ?4E1FR6F,DAE M.MAB#@YS$)P%NLJ3%_/(E"SJ]?AF&8D-..U0;$UR',YR*;DUS^3K@/*U*8>, M)B*SS(.S'<^GI[MK)F:185X6_4K=UB5O(9;- !DY\L7A#,O@ IF2/#]?D$B=)].W*<8U ML28$T![6 U/"QG!.5F\[9U:8(HMM69%-;_/G3 NC&5"2R@SHL6Y=%IU*V]9M M3'C9PG['F%M%DY%SJUB<)2B)"MQ1=C(&/I.X@1/X-Q!\A\S,!$G#LR2M]*V==MYYIWMQ ;P MMT5%I(("ML,^J7!#RW+$;5[521-"#B=EG1A7^A77-RIUB5#TL< M,8\EU=3TZ1/$345MHK9F$W[ZNWY.E@M"ZF-J2Z@/ZX+A0]@G.Y/*]"QJ,#M0 M/.+">%3D]#.*)?$JC5>G5'3F.CQ',7CN(*@@DZX8CPU4EB&7 MNJU+S#!XM#]Z4APNY#B<3?N-J0/AYJL$8YU#S9#GG!:U5R+7Z>6Y63'&8%WR M7-9/2RBN:\TI8.DS@O:4D?K35"XC]<]D9J.M7[5:<:._WZUI---TDP.7GCV[W:_8T> MA20XI>U-JI*)Q@&9A>'.8^9 PJ:2J&^W72N#/+#Z)[MH1TLIOA#JN$*O]!:A MUZ#K=08G!2+K>9*IQ;&IQ<;C [U%\#B(NQGG&> UPM=Y9#=CB:B'HJ)7#.9;!:2[T)4-:5, Y@/UK MPB2;7RMZ,H%^0M+*#K#E&DS@&1)OT2IB/* 7$AYR%=)LD,$&X MKO_O&_5M<3(7SEOP303X?RWT$TD!-]-R'=9M/GLC_RD;K99SI^4^M;1F@X?? M[;*@D1^_%Z0.<9D8ZTW1K;MK*1)>RG*TI70AW=:L<"],"]6>_J%RL:\D>M$Q M+"07;2&]J*@UDWZS)O?YK):>XY?+^=N.845]M7SV>G,Q>IH)HE2L#.^CT!%OCBO:KH*!G@*^V'!( M8U8,EOU)^F__;5O^%/FW'TCP%Y>YM_K;'Z&%;]OM6CE?T$7.01<9.H05F8.% MP04VAY.T'_SR7X#MU^Q+;H8W<"+ /5C:D\B$)23#X13GESA]O#L2\J:07KHI M/-[I)BB RU+&1&>"Q4F"QFG!+V0=<>&W\R!U285<#VJ_U@.'A;'<@;QEM-$T M":9,OFI)IVI]^P4.OV/9@/L#O(EA#R'DS? :<8IRL^LO9=%N9L/+GL\.Q.61 MF.ATJL C$3C#^?7XB'COZK^ZQ[>S(8TH0P<;T6S- M:,R=9LGQ;$8RUVR5%. MTEJ$]V@PN>*]UGW\ ' PF3JQ$!'.P",L.B9BNC74>$_"\8;@_THLA+Y#J_(H M_B_RB8S#!0*V,/>KN8DO$IY$3.1/EH2-QT$F\>-@)@Z[WZVM0PAKCJ;9TA]> M$Y?5C8U\+L[A!$OC_!X5+J@-BA-P]VUU[*1TCCLF^WCY\/EPSR9)1&2/ 259 MSBOZUHA>""D*+1!;]GN.X*W9W5, 0*;0?Y76]OU&4CL[AE()#@\"3Q.^N9??,VU]:SA[CDL)*P68''6MTQ^FS7T M=014N+[M]]++N&U>$K7V[SVQE 2V7X\B#OXH* )F"-=E-HJ/B(&%#0!YW[*2 M)!4M_,J&!,(L'PR$#S3TF'H/1S7#D3FW*!*GF2A>[?N1+NCRPG$[7%X1N2@> MZ_L:0UOW:F%;X7OT5CCE& M^.CIA9JB[0_;&?8U:]QV31"9/JN,KP;\>;N;9&PT;"_#5,AWCCH2^=ZEB53T6&4N,ET,T?%N ME27PM2,WZ+8V>A;EU"6R5R73C^AO>:FRY,G-U"X1PMK\[AD0$.3E<"*793,? MF51L#)SQN]-,,SA/YW"&W)Q"F0E'JH1C ^39XJ =U$H,IT@>>,E<)AG'(1G+ M$B#L3LD,4^<("A="I,_%G9:_(/BRWUP=O4NZW/GUWW .JO@\W9JQ5]2M^F3< MWW2H"$Q9Z:$"6YJEWW;3UG:;&OK9WG#)Z(A#&.308<7&TO:#Y? *5%$V.@#' MC71(?B!I?5T<#B"^S.N2:)0^AXJHBK#US;>E51;R2] U[$-:,YX6\\;UIZ:U MF;ULS7S$YV1KUK[0VC-.KDVZBZ![5S; \,"&@966['V)NH>-PF6I^'!3.JF5 ML8M2[:*>O[NL%+!ZZ;%4?2C9>^ML=/K(WCQ+$9;[+7G*_@@V)1F62W^R*092 M3-%SLBG:(IMB&;+P*)]?&%(_=K*IR'.#PTO3RNY5C#9L(PTWCYIO(V5MHTY5 M>_?"[]I V68;8]XSZN!KYH>I?''68CV+OAQLY?KUS<5YYF%"!*AJ8S3RW_[M?"%:"2&52N#,H(PV47>F2_GCR)@SDZS"74C0,"983+FUYUD4VXHNREKY?>3.VQLO!L]_PA)UL M24!>C!T<8-F_=UB4@JB*77$]=RCU][X[4[BX,_?<@L(Y$0E\;I$UOS@9 $MK M&]H\LK.MSCR&X*8 7PFK>;C \PX'>+T[;;_EI+?\U>+2V)E\B-DGV%8P>,[+ ML>R\4>LM IKSNXV\WYV&$#E-G,09AL1SA-^%_R;:VP.V>9DKT+ZT93^JP892 M#;F"M(.*KAWGR@/?U.[?'@7)5SO2J0K>=DC^JK!%1I-7%4B*Q'DJBBKLQ9OZ M"/\:7SH?G7-/MQ*<$OC\-O*VVI AM+P5^)M.Y:ER?B[1P>&N150>CCD^L?'> M#ON+3>0*"QI94#[H)G#-MNSO2)1\2]@'L"92%VN8\-H]3>&)M/7F\G=K"Y7D MME')K0'20Z, ),?4IXYFWHL7HG$_$(?7\7>>28'+\* GS_0])H"+S)M"P,YY M?B6FJ6X9=LB(50KZC2]T[CQ1V+6BLM:V2R818'BX=S;$ . MYIYCS]OU\_B*%V(I 5%KCM#"]OAI5NMS;5,B!MP=@ "F;,+AK(;^OS ^6E)7 MAHC.M8%S#(_3I%]B; :%T@"%UF@.M3T*FEU=W;WF]>FX>2D\6X\9-'I"('+WF<91F< MI0,*]W8#2D'5ZS8A?KYMF/!M+?F\-7O^724_IVVUVJ;C96Z++-IUI\U,=EF< MRLOB;#-2M!F'N;E?&!C&MYG5(,JEP^5=J30L<4+#=N*XM]+Q0+,PU.T-&/AAQ.,E1..=[211ET?Y@(QPD9FF1*6HN4V'N MJQF2W*$S&RG@!.W'V)LRQ_%76)^12#.T@(6/?'QC<'!8QNE< *=>>&?'[^KL M5@+%PW9;N9OUC?<[)A&NC.PB.34QT+48,:4ARAV]\KI+!H:,?':F!0HGEK$.A 8K!?KR(E)',_A1!9CC(TA+$F(LEX$HB>FX$2.Q!DA M9&Y:K%'!UNQQE)M\B$_=O!9C+\@PMBY.-@/_Z&&&1$*:"JI MQM,[8(=P#%9\:W;[+&B-F?9T?M\]:@:KX;$,WL74H5LR!PDZWB41DEIUL?84 M$_M]7>J+)MAJS! 5\/2V:( _ :F%=!0="\6B9C/PWY)JRN84FPPD74*_@-_! M)B)XJ-B5SHYTF7SV&-&429\=9=25?OWW/Z>G6%F6E.X/[$[L PC:D#Y&DMI! M3Z!^8HC<'OR,G9[:BM25Q^%-B#7K4U,;HIG/?^%\A4.^>"M6K7!<63YKL2:1 M$HS/U\[[1X [0%8DW4/-53YUKZ6SBC^QYG0(1I#7Q;;<^8E5@;VT5KJJP26E M!/>W_G6^!O^TL$2.&?KO7[#V/KN@2^+;:5L"QA,\>XAVT;WNG,^Z$\>R[DMK M[#71?@OC7DZXSM92ND0^/NT]%F/\#3W0]W$%L.YM7<:Q2TD92W!OP*-$U3CU M/B_.N?[7_E74Q;ZH]I0IVK2P_ZNH'6"(V[\V+].AYE6%K29.3 UYD(*F(C,H MPFL"J^^O+"K6A0%J.I?NN90U_01.XT42=:RTPMN$6?0^:9Y!Z7.H2P9P^B>R MBJ'L!AD\O CMENZS^"[341\ITNG;R CW=$-C@HHF /.,X3 M*32%]G_=MG!I1C'LDXTE_C1;&H38K+=X3PDQ$\(RU 9"V!K05[TVE'0$>^TF MEH&DL)ZN:-L\J#4;#6_4S]N;SGV%C^O$<\;*JKV^,C W\%FGZ).<0N[@RW]QYQRL"EE>[M^!W &^*JJ2-UM 7NVIEMGE*:U;H5G^? MSYZ%)T4XFH,YV"$?,N3!>Z=VJXS8X8/B3X:\X#/&:F4L2("QTO-=J=HH!4MR MQG%\3(5N7GWVJU)@A'-?RF/F1F[W?G_2@[Z\@=N5#GY+Z/Q;?Q9?TI?%EW^= ML#/EHE0UTU/+MBV/XM>GLUSL8MZ7._BS0I/36:/:N!DUB5T_?:?[+WB8\=M_UK$(V*Y5TN:J38\^:%8[=BOJ;9*(?X:U@11U+X,BIHZ'4)46$5\I!B=Z'YTE%-O"O M0 .XB<2NO?%N?U4"HJ4C49&3!(& ,#3.T'[I2 '3]B>QB\93&-YB)\&WZ&.[ MU]6Q;3?0>*DT_6(:\0C7AF0A:HM&FU[18@!0Y,G0)4H9NVQ2J6O[I7?=6@0W MI3'MPB#%L7A.2!VKJS\\(!8AV8+V/E1D4>U(94DREG!!G[D"?[P<# ;=^#*K M8YSM8NA83PHLXSK\"7K-J3G(D M_]T8=4G!^6XWV=C@;^G()<$D2^$\%9J(-"LR/SC3QVZ"M,%KTM%+G&D@2#DF M%97E_H[2Q1^*L@YS?VJ]? >EH!IUJ2/)8WCGMN0X+VC]KOO /9=U)9$# M=8P+L9@5IO4PT9X7IL\G]N6\ZOI]C.AE(U<%4[#'LR^Y0N9E]^5EW4\*IBEF M:'8C37'FZ@[OZL+N)K=Q-P_@;VCWP4Q%?'=/FOZVY%W&S[Q8^UTIWCVD]%1F MC1N# _]RWL.]*Q%]1>0@0RY'X03AQP>3^8HTG,@V2,:F\UCD8DG46TL('?W, MG-3AG=0.8K3A-,9$#OC0!($+.;]"S+1X1VKI5A,ED-K1WO-I>:2BX2ZY2O6R M?3_AGHWV511RQHA$53LL!)I2FF[TMR]8WNQSH^:(;+H#\)>':$Z:B1S3X',\ M+K!^P;%#9+=(G"5WI51-VB1Q&8UD.I]G0$/@0;"'^D.9\"=(LU<+XUG&UY&9K."2&1.O=7."< MCT&[V7@K4]3SV_%R8-5Z/;DCH?2MI75 X[*G?]14X:7(261?!BI%E-U-L&F+5+,@R65Q6LCA KK6($KX)26T19 ZVS0S+XD+XP.)!495#][66[:OJE[)^KF-)BE@ AD*0CX?FLVKM4-ZOF1'%Z]'1LY M 46LDA/PK=F#4GJ?U%\+^H3^]JM>NLDW2T7L+E]OOF#->K[:R!>:E5KU"] 3 M'#$KG=^Y:&*=BVKJ27[4!R_$$'$.*> V0] [>/440X1B4A>354S$VB-#5B7# MP Q)'X/3C(&)?5U"C$'8/_!;__>_/$41/_/.;]&_R9_?L8EL#K!SY^L5%

H%C80P6C XH+A0BHC&8T;S$I6K>^#T0UU:2P#/Z1,D071-461NF"ZVLE0 MU\9R%U7^ZT,-^"<).)&QI&A#-#?XHKX&CIR0*$G",=BJS93ZP!+UQ(ZLR*:( MG!_\&-@+L8_FCF-]206^3EE=-AS3K-,@V%[PO)/%6^#DVSC!Y\[$1J M&V#K,+ MD@'D9>6]\-^:JH '@:\:SAZ.O-E?,>;SLSM]N!];@!NJZ;)D M+!EO\&__9\Y%&$FPTSKD:3JH5EFZ>,9OVCR.K)[:L4MCIJCSF0\NCEP3B:.2Q^^Q+'[R?@A\X $W4)FDG(]8@&['V(T4\VYLY2MDADQ7>8^NEKAY?; ^;1!XT[<0I/&&[< MV@1R;%AKYFGV?33RKUU3GS-E6LB]AY#_<"NQK@5XLLH N>)->41>S//7XA"^W@&#\Z=-7!P M@UYNP\$3>#AH)(##&THHO@'%W!@II@B/,HL#J'V(+"S^&' .)5E@L7,4EE? MVTWQY,;LNH^;B[,A)&O?<.Z$QT?,/CYBTJ?4&9GR6')&B!C>G;/RG'O7>@U\ MBJA8CA]"@Q-X&K.]M]\3/[BGM%]G1&"S5E^[/>67B,;62""E:@<)8([,^'_>.5I!#^>0]'ICU* M2Z%:.Q\^YP?Y6FX?TA)X@HI16J(7_',<.#KE@J3E^TD*CC'Y1)^O;J M92;>GW>ZK$LF[26SUF:?YYKX1).+GL?-X@P9*)G+=NPDR(X5(\I.]_-F][/& M'N7G2NYU"7$XD=\#Y>?'C^?B\X\?I^%KRSCJVR]55I9Q>@:B#P2BKT;*%*.1 M?276(^@5=.J/GTOSCP7 YT9',TWL1M0-386XV8'")\!*N]X?'AF#AQC8G2X9 MNQF'I<$!YS M0?C%UT_$9"%\^#AV3!!^+B'QFB^TK=:N.O:K>5>;796?>]>/U$$1?(@9VY]< MF83'[^U02L_B1'!*>T@ +^P;P.]15LXY2A ?!HU/\J#X/3Y9B7S8HWD:I_C MS*;O@;<0)_N#[^RAX/O^)%+JOS[I=6EV^R"F ;W')YB1SY4"$,N0V#W0A!4. M=4>P/\$93=BGN^O+?N.6/XC@)&71;G?M [#J6MZ.(AF$9W^% -5OU M"V7V0GV.._3C]+61-ROEJW*S5'ZH/]SW'TKEQF/YK?]8OCIO*M7S>[)^U238 M9J4P*+T^UP?BT^>L4F(''?5JT+U0J-?&6_Y;X%$F"B@ 0[O4GHD;;GK>WX=S M]1BXZ*R# H%SW.IM:$(W]>LOY/>YY<+.[GPV>?M]^=$M"MU<&"[=G=VB9\LC MYR>Q),XR:VJ48][P[R>VZ85@7;?FC0TM1&*ER%J(?G$RF//EV5\\PYK 1+1% M!6;!&C!SU !8 !9%H.#'"!R5.K#'-0[K)4_G&;AM2=319]3N27?NS,7O%@"9V6[2WIK/VUGY$+#&VMZ:)K+WUOMM; MQ]TW^@^P&8>=8-:;>S_SRGISIVD&66_N8^G-G9GMQ"<(BSZ#BSJQ?PJU:A-> M#Y.YG\7O7W@=OOQ&7TO3$U>)(+S(DLKS>OJ%8, 5Y MM,'!&NS&[7PS[B084%^=)(/AH2 8_X#IV) M.0$- *TT0[)_;V #<8Q"$B/P:QU6Q\)P-?#Z0_!'IV 6K!L&5T5%??>L+!<[ MCC'/$8?_1A>=X$]C&8925C)/8%GR9*#!\$G!I528.!'UKG5U^B8ME>?V0B2) MH%&@J)T3L?EQI/'HHPZF>_@0SL];L[NGEW.B/N7>/A<=.Y>(Q+[]:A0N2\6' MFQ)6*V/7I1>L4+N%G>_ST*=B^:=\O=CP1 &M9=DJ;!!^Z<(%&+[%V3+8E[QL MKR17&_KE"@?JMFJ?H.!XUO>-=GFL4+Q'WA!.PIOY[UZV< T=[Z(#/-7R27V; M&5?EW)O:X\W*KAW@=^[OG!JF/W>OX<7ZT2V?=+#9>6?4K=\_/4TT.FLM?9RT M9?[;78*;3,ZWF[2V._])=B-=[EJ]_'U*#:F<]*=\IH+8R3[A:-V@]LMTO1B$-SD=,V M.=BB@%[M@+*!<=Z_D70:.H"'M_996^J5DT6B4KR!0C07N5LU2U$XO2ZK(>M5 M_15[5<5I>> M-5-+2B0W.&\^\T!A$APH6FW#^!^ ME]D!0JSC0-2E-BQ#OA.G\%-+KGA EJL:3W>4MV3:92?/2X[F=XHF"%.![22D M8$7:OU%J6!25RZ ML0G1L)'K!H%F<+A ^'4LW"G\G_4Q^?-:P<4E[9N@5>0 ,H4S.187PH??TM,I M3M@2<[D[Q;FN4MH=RC"+=W?5(^X4U]1,43D OMI_[[;-VQP12<70'XC".5[ M:5_&E0Q-[1E-??E.E66E=G!:UP)^(>OM$#-'T_< MO -3S'2M2HQ%)L%5[T3 $J2]6.C@,_+FN7.0W:S(Z.)G[9+OA,USO\U7\Q>E MVU*U&:XU8);O'N*(-\_B),F=$YG=]*3!:>=[2B'? 8OL^?#L]^5%0FW.+_]\ M&Z8XUT>1%5W^S+RAS/1M6OJLWK1_9_GL:Q.<\W[Y[/'O1WMHU%_?.O*+"W\= MS7DU2Y#?,D$^?OD9/4R4C\L>\_2>)=P[46)VVRCQ( (A9Z%4RZM=)U71V8X[ M@>N_/HQ%,1\EM'RP+/U;5UDI)! ?BC(J.9VW.T+C\+0\\O0XBC6Y_Z]8L_KC MBB6OLN7Z28'G(!GYOCZX&4^6XA_#8>6O-=611Y/I'W]L> O)CGS?OJ%Q4);^ M'R#_?QTV?3_^,.T6PA;]NEL@<(I:T^ W33G]I3U!%P>O?*KE<[WX^7@^ZL5W M%;Y/8&)QD@)\C 8!,T2%!HGB!U_YW.*R>=$(MWK*D MO*RLX5!@;;W$1V^ 20#()AQ!DMXRCB.WQ7&S\]^4H3T,W]XG4?B@4E+$$ J& MP5:_KEJ'Y%0_">CF?Y&5>M0V?V0K\.[9H[&1X[,D. CD@)?R.]EG(&[_(&[= MO5B&W[SX;7M%B4R:1>*T0.$4YW%@WSID\5U0!/17PK@44GGIZI,3R_-7O@ M: ^G$Z;(A M&YCT.=0,JW'I6-2GL#-'5X)MR@WKS#F&7%?F%--Z6&_>54V>:\"\):HN&V^& MU>KT7!/U+OS"/*2!B<.AKHTEJ[_UNP9<&?@M:G@&O^?NX@$^!UO*PQF@%AV& M/);@L[I:![T0#14\R;0^#=!"1X8?1CU7)=VJD%+D=]D$O_3V'+':E0PU'74D M@7/HF$#GC;,3.&YS.D2O0D-"ZP+^AKX#!SH1IW"1)@.Y,\",$?C/_"-@&:T9 M=.&/<*8R+ $1#;#ZBJ)-C*S)R&$:K?\G_RKH4E L]US%;'FH^S)4<] M%=>F0(V9VP&@?. -(Q5H%C <0(6 3S8PN0=C7RA**ND8JK62=:<8L@=\-3)5 M[Y)D8D#K+84'6&($#)76!G- +MQ(IFURIH/;.!MCU/X--A9N5P>)@+WMJK5Q MHC&P371'DL?PT&![%.<1EEU''YX;W\6SD+" 9Z'GM*>P"Q6L=H0?/T&_F\@F M> $V .?)TP\@'JA=U9)3D\T1%);EMPXE'2)!PWF/-!:5D2544&+1T&WI!.,] MTITZ:C$#IK&^D)DC-HQ'O0NN+3@9ZC(8!'@,-,>&;)A04X!9[DIN[08(K=,! M!\ EE;<0E_@)?EK\UJ.1%L2::R3 9="'J/"\ID HJ!L0R9VT 7Q4)>A"K ] M-88#L>DXP8) M8;O&XA6BJP!8Q6R,8#%]A8217WENA+\J*RBQG7H2\#L:+T> M\$=SU4=.2#:AOY''#!9QD";J)@JF9;#L^=CP-C4.UPA^$89S%36 MT2CMUGA+5K$X0I8/>$(P0!&";'RI?UY;4F0) FZ4#JP")-\%XP%O$)43U]AP M\,&I!N8OOD/\[ *O< RPP%NR8F;0MN+0A,OJ0-+AJ,"2ND=TI#+KHW"(.\/I MONZ.YMRA5O5.SWOX!.8G]@A\ ?P9A710K'6U*_&:...$R.!*5S6XI#2YU%C9^1KJ%#T/,CH1 M1JL3\^HNZ)+X=MJ6@$B#9P_1+KK7G?,GB#B.=5]:8V^W.K^%<2_GO.GVORZ1 MCU%]OWT%>Y#XX,%;4M7)O:B+?5'M*5:1:]C_5=3.6;H[U%:YP*[7<)IO,!FMR7_9K?IGD'I3R0CV=&]C_@UMX9<)P7LM , MV_]UV^&E&<6P3S:.R:QN&BB\X#5*A&L2[)]"K=K\O__E*3+WL_@].]0>9O E M.Q1YX@XR_0.WA2)^E@HWZ"?RYW=PCA.5J0%/2(83,8)W "8FB9V!Z]8!>AP, MGDOA=02FH8 8O.- 5R3PHRB6*:+8UCP.ZGJY#WL,YNUJG:X [.R/%#FSI4D]!H3KK56W1:N]NY\G =XS, M#O@NCMR0"181@V$Q=('RKJF2TQM>-,"9$Z)H8S2$2X!^EA=7J]8!%:R9.!9E M!?W5JE_U+IG8'ID O!LP_@;],PY&KZ.3: <<8-'9UCB![X0POP,^AX)SO9&) M%M(I?5U\]@SS'LLGNFR:D@K/]=AD(*&0@76[ \[/KIE8NV*-'EX7@8<#W#X] M Q"H"\RR?;5ES6*+[SLMZ7&XH6H?ADS@ \!$YV$,&.P&T[&.^O8_4 P!ZTIM MV%04R(ZD]J$C 4Y5/ %+:$=B5;U_?CB8-QW7/8'M,H-)]:#LL!9OK^03& M^=)P+QMGUK@MT,NI&N<\V$I>:U8G9CM79A:TDB>U,H;E+RK5"T@P62\52I7' M_/E-:4$HZ5Z3KT0F&:<0IB>Q8LT<5;7NU?U]\D#8;!;O,YS5-),MMQQ-^)>T\" M0TZ3_(G1!!I&5YP: 1OIHDQ+-'MX/VV@-Y1W."_EXJ:3VERYY!'5Y0STO%'K M^18G+JF?-?-R<:^O6ZR!%P/3L\SM[=3;Q>IB-+!!'X5JV%$>/_D8M<6$>2'$[GTMQGFTG Q?KIJ$2A4[B9Q[$G8XW,+A")G#.0J'$UHXEVT %9GFC@/RZ5M;F[F'%Y&)T]ZI(";/X)!Y5$T@TCO]OG9,Y1%W^ M01DAXB'%.S+_M<%J1&:SHP@:YPD_.M9MKU ROI,_C;YN5P^Y0:8C!YLY<-XG MZ5W;)J?10N!=W*3D#LM6AP>KN(KWE M9(/#;^NA_>)N/&/I=8D>RQ"9%X]C!)PCM[J&RKQ=QNZUA:/S2&KDF#6%$SR/ M"USHW@RIH.=:S\]5;LUR''MW-W[\N'O/'4UBX%'GGEN,'S?RQTCNRN8T(S%) MU526]V6)Q\3)_IZ78T]D10'HRL3:,)%=D98(2Q84%"ZZ$IBE"IX "4[ 5[LC M3P4\JE='6=VJ36QTTAYU^Q+*EWL!'* +F&B/YB& M+J$N4G:.OGOH\W1:N[A>&TJZB-YB?]%.%U=1-8/:U\"?3MJB(7NH.R05YB4; MF"LQ'I7"CWH]R. $"8_1<-P+8PS 8$[AD!C#=%^OIVKLS [3&:A=]'+;( L]!%0-S%A+T WS;6%3@ MV\ZP2]DP-1W"=66*^RX2\&]@3MI([TA6]8$*GPMWZZ0M614%0%",D:A:'X"/ M-Z>8(75&N@Q9(JVZ>_!F'%M0*)@#.K VP=4!0DM:M*Q)ZIVM&=_HS&Z$=_%3ZA\-+H % M U81@*,:59*#5A"L2CAO*GDSRLWZ ]? MO)ABKT?FO9'3^V?=DXM2"ON^WW#>&-56")?K.]5;Y];7T\''W^[+9 M3T\EAG5/-07#3-.F'/K]&X2"V%(HO!+AN5DNRV/TZ_E%Z)-R3=*?+"=V62<."^M^UY/WO6ES@ MU9N14%!$6#KOJHMUL7@O=W=L0I:Z.W&*KBF FN8MBCK7PVT==:LW9+&"72,A M"_*J[KNA\SQ;FY\5)3;_]ON63+)^B/'6#NP82$2K \O$%UQ]#H>?"_=N+A[: MDQZN%@5LT*"$*SF8S2/86T#<)=$A4QJ"D8W=Q"RT[KBNE%>58_GT3$?.JJ)P M#JB'P$>I'4E63/[82B8F[DHF]Q=/#:ES*G^>#N1N5P(/!\Z"DC_;N@*$B/KV MZW3]G7-6LY;NG8[;K"5ILJ*G=.U@L@Z0])(H$"O8[$1%::@9LAD/[!+RYNN- M5G[1BE%@5X@BN1U7WIDT$!)KU@'[OE_\=$!O^(714H" ;V-HHM?5@L-#C@R= MH7 #E_,H 0MVN:#&)6^1(]TDD<.Y7)KK MAXM)@K$;353M$%XL2(R8/M3J_38W5=(9)(+S-9Q+N Q\?5GPM2K7VUB3R$%H MGL4)-C0%3H:\#N_00H:&&"8+#:5MZQ+"(KN9CLAAY>U,QP%P")EL4 A5:(#3 MB/.\:2QX1/NLEQ]>>_>33R[]D2%G">;Y0-,,H7Q9A!(L\=N8F\A!: 8G!0XG MJ>P>ZX@\7EBPPF=@)6U;EUC@) XK$CG2O+45.0!NH9+ +6[<(8F&%'>.\_7P M\87XZ#P1L\%>V=QV#:_ M=@(7PY;8& _;>>*@<,R7GU%9.0R6?XZM85-8R-' MA!E*P 4F]$DLK#!GY#GI4)PCT9(M[^UB51TJLNH(.9P6=E6=3$\R/0FO)[N+ M>^1HOT !<6>X5(O[#LGG,\7H3[0WQ6B3R13:A5' A!D6YW-'8_.KP\L0;/PL M=E\0O'IL2N1K@!S.\,2T(TB._D;E&68'"!8[PD=X4 M.,-,1H\:]GED-/+=!X\3K(#SPJXV-DTLHTQK=C]M=W.?=\_E2?=HV,0.S8RU MT^ M2LZRI@,WJYY(GQU@5OL6D>61,W0>GFSTR!;,$8(.ZN39F6+!S*8]4=:Q ML:B,+$:\WL@<(2K).=6A7[O4DW>+R1..2C*'401D'O9&*+"!XGS.%91;2 MKB89B(=U('6!C$/N3^ESB'@1$5VF/2A$#@I>W5M1"C H(R&JRS-65O>A$C[] M5^ \$.TEF*@RZDJ__ON?TU.L+$M*]P=V)_;!D;4A?8S >J('L3^Q1[CSX&?L M]-3&"%UY'-X_6PMP:FI#M CS7SA?X=!8MZ++"T>"Y[Z+NM@7 MU9XR10(3]G\5M7,6#E<<:E[@N"P9)\"[6:RU*C+!T+EB\Y,+!CNU68S2Z9X+ M "@G* M=#HW72Y#[]8Z<61J'@_DXYF1_0^*:-H#CC.0 ,VP_5^W'5Z:40S[9..8S.J: M&,V>,4'=G^Q?RD!]X"M.[<_&+.@4>7:R8$:N5!O-^L-MJ=IL8/EJT<697*\T MKK';?#5_48)_QOZ!1,LVJW;Q^Q&?/O?!+,_.F>47\2@WU7L)')4Z9JU70,<7 MHZ+:)[R2?:"IP_-,,($\O73#MLN#6[/ZU<>5.DIKSOD26SY?XL!^FP-,!*=D#7;* M ,_2941/=C( AA.*C6&*JGF&E=WG5? NDL"&D@[/(?#TBL;B]P9PY#8GL!W% M0P.39 $ MV7+12"OMR_KG>%JHO/?20R/M8'(THP4N3\]2'^8.S7]?&;B;U'Q?*6M?GR9: M09_U2\R'LL6^)KV)U,$6T3\%2%A. 5K&(!>BK+9FNC%J?$SXZXM&9Y]=5VV+ MQQ'Q$G,Z$7HXB"6?OIUV'8R(>[,('YRJ._P0N120>:^*_+?0YPKW28*+G&G. MT@2>"U_SNUXB#TR]O4E=TJ,;J5.$-$H]94E]4(=7+G**N, )N)#+Q2?S:4K" M .CCDKSB2M3-2W=(Q758_UH7^W%G7XBR?H)"!E]B.E]B9_(GP![ BX6 (([= M;Q0U7 7F$"4HP"A*=QXFFWD+^P#Y&&HST_3-2Q2Y\ MC]3]#GO/=B24%"-:N39@C&]03*'LRO F 1ZH'-D%OW.+[E$O"/7##L.Z)!5. M>C*0.U:4UI9OZQ*QK>-0&IH0Z1I^XNET#$+W+\)M4X"JXNH-K/=FTIJ\9 M1VMT]W%MRC'KKTW]&#.*$K1&JF(E?.5.O:8OWDH8NWAXA*[J]?*E29*6;BI-;[>K5J$ MJZ)#W@OM\5[FO+A,CP,//$!3'4V\='P'8L+Q?I+T^Z3#BO/^WA'XR]?+[@=] MH*L="XG!Z9.'N]!)T5:7=MAJ:MU6,[S2X'\/:Y]*]^!;?<"[NQ1M]?D.6TVO MVVHY]S"CNUJATB,/OM6'LZEIVFJN->L..6-\.;WYR!]H3[9NJ)W\I3E=:G7F M^2/2HMDBK)=Z!#-QFM^\';QQ SJ[;=$^UG'?*%NS0#; M="8-V,*OW,#5^[ID+O6* &'_V$7X0C/LK(=EG@-B=.: '$XR=.JZM_[1(FL- M-\Q_$R>UY7)9'^I4R,0QF[$U.-1CQOC(#85H"J=\"5 RF@0Q>A= M7L 9(GT.%2'KQ' UJMFL2QU)1C=7"B.GC^./^O5!G_2L$?F(I[0F!9@.O M1NSI>-'T?FG6W=7BZVC2__VZ3//9$NQ@2\/2[&>+=QR+YV/)^?@LN4]K V3- M/W)]Y3?1U&_OZ&.BQM^BO<\7)Z=+$S%QR,-GCMMX^,P(#3.969:9S0&+3&;^ M%)F)^QCIXQP3B8/D(L=!MFX-E"E#I@Q[40:/A.^O^55J&@#0.3=,=W>^BK#^ M5HCE4A6928&X?)?V62L<9XK5UA?.Z:L 3FO9[X%+?:-(=2*7HWST4N$KH>FVNLD(<=9%85G]S9)1>AZJ_>6@\OS^]/KR_U(2# M9^IG]3>)UM\HU]WSRP?)J(X/7Y21U=\D6G^CCH5ZQQ@.R]"3'WBKL_H;:ZMG M->.WHA%Y^G[6R0IPYG%K&L6MJ;@+<(3*["*G]04M*\#)LH /G 5,[1ICS@IP MOI#('JSN_UNH"@:Q,(Z5;M_G*/MNZ/6]=W+[08ZD307%"Y.MODA-PF@A=$)U)XY\CC1X1 MBWR1G"H1\\5EY_'ALJ"ZN-'C\^5CUV3IE_^_O3=M3AS) D6_UZ_@];OS8B:H M:K0OTW,[0D@"L0HDL8@O%1+:T8860/KU+P78QBZ\4;;+KO;$1+<;4"K/R;/G M62ZQS2Y.P?TLD?O-L_6?:FA\ELA]TLQS:>:S1.Z39GYU5=!/6\87QS=Q\BL* M8^^Z>NB3$_YYG'"'O"\.G'X \GX\AOH2Q7$)8R_$_C!)#>+5.U9\5L1]9H2_ M84;X3V8K$-#/5,0](UOAO62.?S+0!V&@IWDP!/19$?=)>K^7['ZJXT- %U\) MH 3R%<)_UC3\Y*!/#GH7''2'+2ZOAX/IKS#]L[.1WT$UW$,SDKGO91YU)\.> M)EK*\J5F;7VL\8'?LBC> W#]P=490G=]WE< 17',+X=IL=4$WD/Q7S6<+[U_ MONS5 -K#(+WJL;VJJ*$_#..MEC#.W.-4(VJWIE^-Y=O_YF1 Y9<\/!DU>3+R M]J4&\?U:=)])V+W5?/B/O^_:CW>*,M.3(LR[19K/QLA)Y>4#%9IWBS*?OO[= MN 9 _:6UFT][X1/C1C>0(_^ZK]WS:;+MQZ*Q_^G7 DJ_14=[Q']BX1/$0#)RV>7Y-N[R=0ZI- /PQ0TRMMN0?D6F/^TV@6P3YI]L, U3.+ M/0@'2^LW)=7[[E=>I1;S/)X[P%],OB6FOQ<0J>/&>X!U,]N:9GAK1/O1Z*TF M4)_,ISZ.K:Z&&M\ZI3LW5Z]CHUTF%5Z!8F>'>>;[_9WS+,Z%2!ZBLJ<"]M(N M5[6-D\.-K+T?=#VM_;S35)&&FU7CS(_ST?>>644GX*O"U)*:"?YV@%.E5S0% M#G69^]7H:^! [;T[\(H#'\E+)_+-=+\-,=XO,P+.>?6C0628_BNB\75$Y4N> MSY5(_,$/?2.Q?R,67_L]+^G7T@1)GZE-W0,@.UIBUF) 8>:;X?"M8)/<=%6S M$K,B$B#BS32K)8#G?CLX.7?C&I5\*5S3-SX@>%=L?2; ] &A>?BP^%UL+BO! MOXDJ@^.69HS_H6+]2NT"#G6#O58\4<#;*/>KH.8R 6:66?NW81[^^D_-M?[[ MV\G](_&\=%CS##$"I!_D/K!MTIKCVHZ9U/[M1ULS^<_OQ'4GO%>!G "E\&VO M%"I=\,^"W;BE*/:P[V&N_?N @M\9=O-'N?OPX9^_-/NH\81S]V*W;O]NW9NV MDBC8]Q&%8/#_+#KM*6JF2RT&V\F2W+QSHTK\\<,=+N>F2S^JW&/1DF\\Z'VU.[CQJ47KOA5H6)<4?M^XJ:?I6_N?KO/)[&2^( MK3HB!FCKXMO07TL#K2CY4CF:/WJWYYS:K[5*S4;AWAB+HS1U]Q==CA;:X*U9 MM'_P#%=]W7\11,#:/@V=G-IV7_:VW5&S.QIXZWY;UW>=IF6!5=/__D[WBK\# M*(>5KOFN"7\O9TQ!4C+/MQWG_,S6/_Z668'G)GW^B]BJM9B.5)LR_0E?:XE2 MC>.ESI11.E.^UN\PS4Z_HZB/W++^5JUOSY[7J:"J=8Y>T).*/,[Y"Z>="R_: MU]*LG.<__F;WG/_\G?SDMHF?W'8G 22U:)PWVDO,1TS3/=R#DBT"X#Y,9[[ M5&HX>]8OAZ>;XWW1%_TBHKNGJ=91_/TH_/[X6ST&64WCVGI]R?\]8R=7/:BO M^D^CY_I@?6+^#3"/7(CYIS+YS[49)?YU3U;,'W]/3V)#]S0SN_?9G[JX>[ K MUGGB?/JBV$/-RJZL"AKB;SHO=(Y1'^X8\SEOK7.YJ432E;%:C(ZVZLU#/YC^ MTN&2!MC_(S.I-(5FF]^-^#!M#8(A^/OWZ[EKITV:?_0A]FV<3W\BN&#K244K M-X<(#.]]G#T]V?3^\:O6SLAL)^&!T-EHY(-UA6^)CS\>\ C/SFFY /([_B/Y MQ(S\"^)>RI>07>&@4F8P$33-%V5^6LKIG^,A:3)@:RX\+1:@H27-_9R?T"_C^XM)EA(:_PAA]AMU_GL_/:[OWQNSHNV=V MY)K9D3=C]C$2^%V4#[P6_M;,_L2"1/A6J\:7I=;G%7I W\NQ- M0YLGEVHO-YKIA;/#6"UV,\W_,M!"8!3]D./UGK=^/BOR PW!JNZ%V?U\A +L MH,)_6G.SM+8\G$D5A XT%UBKU4"%*B_OF(X%/J]TF!OF9E7'HM7LJ HK@\^6 M9G)(RP(_B9.HN@ZK)6:6)^$^I)U64L6)?" ##EE^NAF:%ECZ"_@RJ@0?@$M; M7?WDS_W-TM5NTBS)EV"IZZCZU=;!>U,@Q=+J\],W_'__+X7 Y%\U<]\C^:6J M:#YTQ=5[H[";,ZVH(0!'#^C"J#9228(]S;A5[E_-K\1_=N[]=TS=< MX>[W%6W,1 .?_;B_[% +60L![ >"JKEIFE=/@L>2FEX VPE0'2#?BA<.Q%R9 M2YN]JOZB5:F-0+X9AZW%B5M=C^\?.12"Q< ,LRJXW&29!X -JI5O@09>6 LC MH"ESW0,05,@!IP=K7UI-KE07?O>>W+",&7@ GV(Y= M (QD#GBTVLW^!=>K5;E>P;6,!C^I)$,* #C<6!E[1.\A*:[C5;73@-&7RD+Y MC9AP?[]K[I9^;IA__^__^?:MUJIN_?];&P$<_0566N*OVMY&!'_7 MOGT[FJV&NWFZ5?28#4#L5=*S;G&>=C=S3O/='[8#^SN;3GX^2G^X0KAS%=3Z M=HK+*RS^5:M*H/Y;8Q*@@Y9_U8; QSM@>AA5*$71TZ<:5X]57]W8;%<&V_\: M /=G3@%8YZMON@E<);!VO#_%4[P3]R9;? "\W\+Q76/V'&).T5GA^8#*$Y)_ MIW;9:ZK+/PZ)*^>68P'B]<3]6A-,?V-6AP.6TL+TV]WU7M@&Y1+-UD+++YYU M+P \RC^?9K?^*KCVW9._'+,@6*#D*SFX3UV\;E=0DS/PP5Z_O6]8KO)"]AC#N7V'&*"B[>[-TH.P>[/T MSCW\O809'.JMTTEO@[]4^Y%?>G3 N_AR)X,*:7TOHSEA;O4.T6E3?_S=&;+B M@*\IS)R7KP_XP\9OWB+I%,;_.+TA/24KSLPTUZ]BUH?;!>"+,WJ49]?D=B>- M]*3E_[.6^5[N"&41MH+Y0'PQ4OTE[66JXD5@N_AF>CN[T]V#"GZTJ^(?V<'H MN5*S*3!S\HIE3WZV3ZZ_SA+5@BBOO/QC;61Y:%*SCRIQD&CLQ'O:G1[V>N6TLH<95=D]9VC/N+)I2?.T3DUR/QYY(K;]#. M5\B&K]$.'] ^'[+.K.TK/C#K?@+M]Z89W%6"\(7 G>VM#E&W;'5FN:P4.%CH MT&KQ>]GMJ*Q.-3>8I+WF*'8G=7R6P/%<,''L U4+G"]% MVTG A?X>NT:5P)Y7&=#?2U8;4:NU6B*2\^J33%Z0S,Z$%/9QA/=D\+^W[MX_ M.1#I5ROWNX1\F79'GCJ>Y+'*@??=U/M?[\9I^ISY]3/T_(B]@"#OA)I?BW1_ MP@5_XJG_9!K^!54<3SOY1VP/Y*FC.BXY^:B MG+?4PS]'7X_I9^)2ZB(!=5%?Z;/4]2C.7LV'/Z8 M)KX2]W'[.62O7>7:1B%WXQKZ&I 2P6?NN%)NN'? M#_1[^7DBNLQ_0I\Q,K1J\@BDV0]SGR'Z*_7+W:C_?&JD!U_T"XCO$><*?<98 MSGM(#_Z*P-@]/OQK*]/_O*D>?DS57AQB@6'B_@#+TW4M=T;7[@V'?6N0 M3IKF)ANE&5"C/B\UE96[)&7RYUVNRTGC,&JC*LHV ;[3[%,__HJ[Q]LLB_C'E=G$.$$61 M+Q%/1,XZDLQ-YQ$E&B5NE%0EN^FH:F23@K=,S23-4_DJ2E=YTH?>-M]+V\9$ M+EJJ&^P2'?BFKB1SN[]*7,%YK/^)KR"M9N,!4/>[N!.5/$#\J5M?T/>\F.XN M4Z78,Z(X][@ #W'AI_/Y3I3I+Z&^1Y0N]M3 +6]5S<&[U\HI:K/E[5-JP*P!-]_*F.7]75?:(DO8@Z+]3ASP@/ MW1?&PU_>+_[/IV/\ZQSCER3 Q]3XQ2DZ%$'>HQX^M/?\YA+B,?W]C'#9/?(! M@8BOT*.*_#\/Z_!S63L5!(=I1YVKV^COI9A(.=[%/#K&7L6!?H/JFCU(5><- MPP2'G)A&I:#W^]"J:7?[WITW+3H^BVX^:M'-/;Q^)NGB#*5?J.Z?$3"[AYV) MKRA0^.<9^OV4X-SUZ1_)I/\LP7GQ$IR7I^Y'; D<>@':1G#X!6C[M6,%CU#S MNRK(>7DZ>,1DP7\^+(D#A^8)1LLCQ_!TD^:TL5Z5&,!&^Z[X8$TQ-I-]TG7Z MO5PIB\',[Z5.E_Y(U<*=Z^*<3U/E^0T5?KF5\M1D6!Q]-!GVEU@"[Z47U*\P M!RXGJE]"0=BE%/2F+31>0^F>[[+Q\\?T$+;Q.Y.-?J(GU=,F&''?2Z;E]MD. M8H21]V$:<+Y%=U2]E4]8==83LVM/E MASFZD[$QUZ-*\O"DO>E)*GQF!G&4:$EQ75!5W:)4'4OS,$\/09A]KU/ST.UT MZ[A+IQ9&MZ(TQPB->ZN'ZG&NT)?CN*&;9J['?JN?W5#/=T.%OI=1WE2:PJQK M2]ACW5"KL?4?N-&:^_:_/CJ@?MB,J?=('=9PN9'>IVF78Z 6BR?Y\L/T/'W? MN9!79M-I)Y*]*9#6_NW?#%K]SW_O$-3G]?2%+_HL@_Z=#^,%+]0?6>%\=)8_ M<9IN'")FS]#7:>O58,5#Y9+;^1YHG,*4_5C\7IH\/0J3_L3EJ)<+T]XT6OX) M1-]4-NT'53Y4W/394OF7M50^1 >)[O;=R-,*EKWW?KB%Y=)T#3^G.NP-SN\ M!T739U_E7TJ"9R]GB6=.Z^P=*G%Q@PX2N>^X'D;' MHSH9>D G#Z/P.&#XV)+CMD8VB&X?0NU%JWCW+0VK_AQ7LY(/P<;/E.QWHX/O MDMG3-3!Q<1D$ GU%2?(Y$O 7G-6GY_3*1'5>ISZC!<>=E'WL*P$ASR&JC^+N MO3CFSZO'BYMJ $[&[LN>?):+VGI '8Z2* ;JK6!"@U_G;ES5>MU1B1YC2&F: MRKO@?58R78&POX SKX#XU(7O1A>>H[%GZ,.+NW# 7V'X63[IISK\4.KPR71U M7B5>W(N#)O[Q^O#)J#^O$R\.,F$8_1(:$7U ([('/=_6W% R4S/9F'?TH>!) M70@1HV'YWCW$(R@U&\!22P[ ?.K%=Y$"2\*?W7T_@#9ZZFDBOWEWW_-:X$=1 M^70=0%X9SYL;THW/. MDKU:B]L$G^B.^2Z=I1O0:E>P[?VF4^AJ)^!]JHMWXT8]ARJ?[EZ1%\VLTT5>W,0!)9X5V?X=U>U/'\EY17SY&&7ZO@+89VGBVW-0?X#Z MNZL #9M=:=A &U9_=L3D>RFNO:W=Q*E=-5[O?;MB2E0I5N/>W+]_@)Z]+U_A MEZC8FYKB'PCN&;KSXC@&@GRE\&=%D3[5YW/IZOT1T5F52%V<[E(U7:?OBX?] MAEKQN>@^J^ZHB]-5J*\X=9_%^V+1QZL/KLO\AQ'8PE5]V,'9/%& 9>*L!,KN M0?!'*O,_DP*_W\1GMZ+?NEO1>:OV88I_NC*F?G[ S?.U\F?#HL^&1:] X.<- MA1<8H_-LB^&S:]&E78M>C!C.FS$_WXSUB?;,(T?Q4.[":"W3JAL(\6)\E0+#<5QDZQ0HI./6E'U MB9.8YF#?->%[::5")Q^50V@%B"ISLPII=PN#;L/Y>'3M'& /]1"^\:Z!S!9K;AOZ%1U M6?]B'*=W:GOTZ_LI5X>_M3QSHF3? .)KS3QBL>KO73U\&)B%0"A4+0?L7/3/ M&J#QVO-H_ >J;CY.U3G ZDN2]N'<'Z9L8MB#NT-O)9;Z>Z?LQ\&Y0]@7YSX! MMP:#OU(D=1]=U\#/:O^^Z(PG\IN?L99TPE :Y#3J_79G?$E>#3B"?6=I%/Z* MH=B]9PQ^]I_:)0+LRSD!=BJPKD3-!.P(+%=-=KI/BM5^E&+.\4;[42'V!0BO M&R'V0_:E2_=49*^[BAYDE5ZY6E2QW-7^UZRU% :MUS=VJQ>REJND'J6*HX?NB'P$\ + MOEVA_\5(Y7_ZWPCZYY<[70L1&("961#CNNMM=_7'W_*D*?/C"3]4:OP4_/.F M+:'^]R>3O/WF9T"J:F'VQ=R9R=)-S0\*QH<^ S'\TC+U)*^ZK1+[%G%8[:YU M67=8! "A-.I3:,4L9F*%A-FKN'Z>>9NS Y0 MF4F^GWMXV](9)::5 S%A7*U_9B([59P--5C=6#+[O50V]_;XZ]H5)=UK MQ^QO#>X%XNS] /8-0KX!F([6RSU;O"/RGYJYU!FV3NR3?9^0M*JL)"#HH6ND M6IR8WP[;N %^:P(7ZAH#>]L#N-M+TS32LXX)=TN'C(X_K73<%4)N4'1COAX/ M^/6.&A_"=K16Q 6WO#[JJ\W5++"[:QA/C_YQP_5A ,^:L,>COXP(2.@2_WIO MH@)Y\I!Q>L8!(9]UEE?NYJN?I3<5A:3E"Q&N??"SO+QK"$P\Y$S^9U\> L[2 M7.? Z ^O95JZEP5[IOY2]8D#'*UE-:VVT?S!8GRQFX=XABU[@2 MYG*%^;#>R:_$Q'!#@/H#^%?J)5#8V3+O-Z7LG,MV2[T\ MKE?.8?A^;PVY5BKWX^SX@T?1<;V'[^? O*.=?M+M@RM;XD&_KWH&&(5NYOQ MDN1IVGNZ3-RX>O(4995TNDN3_U3JQ+FY&%MTN@QNKD9.T':'1"O,_?&$R/"1 M^GXU'<+P[1E&]Y/#'W^;VM+9D]75)?\U5AY;^>Y0^(8!U!Z/O@8'N M<,A38R*W.02XT:,K+H'^1,@'(R-5B-I.JB2$!P/5S+W!S6.XX38TW^,0#XE; M(:]_LJ4#N3S4QCI,0*[NB<'NC?"]@#HN<#1]GA>'/7L6]X> WH&5]-18TC? M"NE2JQ!'W T HG_>&][] GQ9O\+:CP% ^C**/@D-_I,IFC5-=Z5 \21R/RGZ M%D4_U?^\AZ(//2#_O#_[[8JB]\'26E6*\Z#@AD\L?C/[%-S/(_,ES FKG4B0 MRY/X_"G*+R+U@R'_A--XSX2.//5J]6'1C3Y*Z.?O;YJ7T?6G^-[3M=U275*: MF7&5@/Y)U[?H^JENZ<,"_/Y;KE,!OG<&$W-INILJ"%Z1V='I/.!^/Y3LK%RG M;^C_473OR7?_S6%"6QQ#,?0IXX^\H$S,LI]FS'1R7X+$17SPW%-YUSSQG%+L M TO\<$V/(@]6Y7^Y]YK^9\G\4^0?HNWC+4X%12@-7\IB__W(_!F9#6?(_-B^ M_<'N*D>SO:II.I<_Z&@;^2WB@R\2?N?[ M:VA6I ZVO0D4'G]S!\\/$OHY)+]-R/ Y077DLNO/VR%#0+_P@T'#*B)^)]4U M.M2^&%JV)]>]+#G0>6(&FAM65UJ7D#G]-#*OC)DC!+\_R9_\_ ZQGWXE::%= M+74+7VDK2L0\2S-PA #H_7;$_;7D'78Z__3-O9.RC:X83!0%;(/%&1/#'Y/! M;G3$'70>%W@R+F[S(OI4#_DV+]Y02EJ->V#5PKK]=WITR>>"JK7:/C#JNA]V=;W$O+?_R-'VHU[[FS_;/&I+582_;9 M9YGCIK4,/)<>)=<#]M@%%3JOQS(O84.]* N6E* %@L0R"U7_Q85$CU+U?0AY M(M'?(=++KG.O= %!/ICN<&-=[2VS8[W"L9SY.K<2X/B@$IYD?$&?/L:S^>/- MS"ZN"$4-EA(F-SZFV?4T'KO4^'JJ+_^0(X2B)/ZX(^3Z_M&CN=?.0C[MK'=N M9YTPUK(+4=&J.Y0M_1]K9]W'5?1%=A;ZL)UU6O'P2K4X+]?GX%9UQ@/]T. 6 M$-&[9#D2FM)P^I';H7WYW__S[5NMY9J^\=_:2+/-O\#3Z]P,E_NGR+]J1X[[ M;ZVOI5GMV[=CLSG#W3R]U]T!W&]9%!\/\OC!U2/$'OO[3G2UI>G[Q_YU^Q!L M]=]@P\NK_[[]TF7D^UJ<@LU>_?47$-I&YE2[A_YU[I"SY+[.K&!_9QL2GF_V MOP1\:2:W7O?'WZUOIPB]0N5?M=0U@ ^(HA*1R0B9 M=;LI">G"B&=6L\YDYQ*ET]%#PFNHF^%N@,H,PQKF%[1_9G?)_ MNQO,AT*=*NLCT4S\<)X1 M2EY7Z.D.2]MUGXNH.CF'X '+2244S&>0V:6,32/4B65H*1D=[.H-<]/(2&.C M[XBFD6X0;[UR9A#I!/' [\R1*:J3K;AMTOV\J2X$*D'BH(Z8JT;,(A@&T]8F MQ8>&!UFEA9CAKIB%R'J^"OH02B;++->+NFB%8:O1L/J0:B+MN'H=!'UMO"DM7'+=IC-*R0#=41/GV<+0;]<888JZ5B#!PUNZ2X7[I)%D/%(G;7G77F'*5#+2/4B;"X:$QR/ MARV7["D:FO>I)=+I:'Z3XE$WGPA;KSZCN\-=H\'@AMML1R0=#&5;0D9%NK:X0I&&BG"]*Z/L<\%VDQF*31'7/F]RPXV(Q#@J,)PU=V5-V;B1"@IF4H M\UTNDKM\VMEU\J$]*6U?'6HLF;.00UG#;"3P\YZ0L>.69 FMOL0R!([2S5G1 MZV-1LR7*BZV/-=1T-#7IGK%9XP0J;^-A;YG[LQUI+9*AGT'H/#>Z18OQ!['# M2-F49LN4G]H.PEN-(2=ST_6PA"7;HHMQPQTM0GBPY>2-;&B[528XZ;;=R68Z MO5Y9-F!>NI>VW&RNI$B.:)UE3QQP!8(2FMND5TR,X%V:7BG2-E/X-"&[1KQ; M-O.<@RA_C;AB$8:%A:#4$B62.I+TS&$PZ4IK)\'U==C&^'+2FFS8$:9A_: I M*EV:V^GF=RLEMI*.0Y"ZY+Q)O4B?5Y6LQ@>[%9MST^T7 9]5JIO!X--N5B MQ>IFB,ZG;&F9V)39\C9J"LQ$:H]ZAE-,L38QBKKNKD@;@-RT?#LQR$YS1C/X ME.E/8H+MEKMAVYLQBM$=-IM05>L%LNIJW:$PSK[U(8LX:"-DE0:[IS70S)!X \ABX[ MI-L0"O1FQTO;>G,XCHC.*/%TC_2:1%/K6GZ4BTLR&K>$N#\VF^9D(X2*"1%V M3DQ:G)3&C6U_Q>++34$S1!?ON0KAZ>5\R7A0WUD9XE9OKH,"T69LK]/D]':V M#G"[WA+'JV[859ME#TI;#MHWQZ6M+"=KP]_):&ER*3(GZLLPZI% 6U/@E'C5 M%F!+L+.QH90]JN2*K#6-EX+?[(\Q7B5W)<)[Z(A'1ZUZ6U!)?AZM2(M@C>XF M68>K':5D\WFY8;; 6NBZ:7/$II#5934\:=>AT.++[X8B8\.*4K[-\H+?[]"I?B3UAUI12%TCO=2_?<#C&-HTH M(AJ]-4H-];[)B)Z543(],2;;PEXVO:*Y&DE8I^6[HIXPD! NZ') <4PD0+X] MZ1$+Q$FZJY%LVNNZV9NT<3[I<,.H)[D:LV/52=9N&^TEJB=N3\O8=L'ASG M9BNP1BI8JK>P^2VL=DEF*+K;I+6B 9\*NOVQN.[[#K>-4Z_?H9F R,[3(U'*U[+776KJ= M#.M)SH9KLKZM/PLI2+ >P$ NY@4]V:,@ABJ05% MA./ME(=7J_&L;+6#= '138GJ"K+G+05RJ<14E\?@9*2CGK/CYE%W 2TZ<]+2 M6C,&%T.Z'O$L*NH<8NTV7HK4Q3(Q%TM+ZN;D?.-Y[:T'J'D:CU=6TEZ/VF@K MR[I4MT-P22C&XQKAA*-TFC*J:1RXU06#K77PNZ6@@](!_R@P< M:NUQ2'/MC\(2 EOIN^T)M4R--65O TP=2Z$SR\$):;DJ0DJ43,6GFO93HVJ(3V@A;T.QB4V(M-LF)45_LKYD. MDP!] ?%TDU,]BAN*XT:^[/L&;TY:81-#LE;'=LR)/.M,ERW$G>NPMAXJEIE( MDL)-5@LYC?M#I)\APZXTTJ<+6PY&(S=QYJ.=)J['XTYK/>GWF+&T #RK\:$^ MI^,V:H=3G)2,L3MKS80^EZN$SAB#A9S968".&GE?]Z!L.9TQ'K>6Y9U+J6VE MW,BIO9GBOCH3F,6PN:XWF&B4QC3?'8IILQ?['2BEV27O"$L.5@O$IA NA54[ M9KHC0(K#F"0L73,A6J!MH+NPJ0] M:#2SU[X3K?I]=3RKMYWA#E%%("('F]%L/&0#DXH'I3(*FU9]PT>$Q*^G"]1/ M3"_5MIZX\S8(MNQWJ6;>G_>VF-)L):[<]G4=8RBME;EJWRZ(PM\A1*_.X, 5 MF6VEY2;RPB#.[+;=1I9=-V[LX#XMZVU_.@]&$DI/K9R(\N6$['1='IF)'=:B M"H.3ZA"R+.%>@H0!,C=F++<-M[ 6;\?\+I"&"&MEB >),#GL#A"UIS,X"2V0 MO+V)/;_>87DAE\A(&;>299<0*'D8;UI-J+>K\QTLP]84%UI;8EKT\:&XQ6R/ MT,;Y.K(<>6*)BZVN(UISAW/]81=KCA<;;S!HQKT-/E!]5-B98M=+9V&_X[:R M@2<-M8U23%MJ(J+QPFLHCN?WF,3@M;3!]MF4"+EP(3F[57>7666Q7/?$=-!G MG!9&$GI7<%REY8UG\M 1(9CK3IQ@MQ9M72VR4!K():=-^'RVLQ9A@Y&W9.S& M6W5:5YJYUC0[,#?@YX*[';>;9CYMVRN#W8L5"Y- HU.DN MSA35S)P)O/!F#36TC46C"<#O=QB-G/);IV'7U5+UV!:]X\8!W5!;'60RU ;] M<.K0%)PS0J^Y9';#6"X4=R6IW,"/FEUG8$.K8R7H6;+4%/\X% M7>HT<#/QO404B_DLJ2O)TK;5Y:8Y]+C6>)"@9%=,NL8X*_J&/.@#1VZ)6!13 MM/KR%'9SDU%+PFX[5NGP](Z0![.05UV>15;,Q*1L*'.BN$QP('ZEHD.XC JA M<#2 &B*O!Z,^!.2?"%M!Y'4$?282!),*OJZL5,AT@KI3)F#C')RM'0[T"SS:(Y*PIA8Z'\X&SPIK==<*Q029. M=A2G39UXK=*B%LN0&TGE$AX)(R DZR-OI74[4CR&-X3.;I&-*6Y#=3AVPB%6 M>)"?<)II=XB5N)[Y&EOT6U8K3 -@\T3;Q2:#VT%[5A])Y:2_C=<,XRD%L0V; MW7"V;J_(Q&V+DX+NMSH9+RU8I@ALK.'"Y<1.ZCJ)3Q@5V"14?9*Z=1TF)IT% M%/*=+1Q8C:0]XN=APHN;2.U.K;AC-06<,)WQC*V3?;THF:[HM0L#(Y9+N2X6 MQG1NFRM4$.QP9R?2?*6M-OI00\N&%8X':I$4Y-;3ZUY(;,H!:[F#1H(,F&A1 M6EMMVD<5CHK6;6C@!X(=([!K;2VET^6W%!FJB!".=4_5C-(!)JL=MG*KS((& M:>QPN05\AZ#5I;M![#96^ S6!\/VQFPO#&R'*'J_+V"C%=1>:,#H7:_9#5'@ M4R% #=:3&G)KVBOM .A_/,ZUQBRW1\6T;P199$M.2]ULL1&2%2HSB4R/\HR& MQC8@03>+]1*9D9R1#Y*Y3(7%G-@.-,VCE:Z,FJ36[VN4C.SF3JLG))*;Y;-! MV["($!A'<7O0S;<,HO;[HFX:02NDS7 Q+":ZN=3Q$+!K?\!LYHJFAXS"^*(] MMK6YKR9]")]LFV3?FL% H0K)3DJ-< $'<6[UZ+8YZ82=1>BY76@L;UMI/S+$ M:&4;[95FW4 M:"$#M9&Q&[8'[%T!;:]HQ3=296NK3NXP+:D=>J4@"C.6,G-HZRZM ; M;UFT,VERGK_V%3.U QE"@*Z'.EY4%D#"+?*:(X?ZSEJ]A8JY?O-53","T6S%@0193UDA2TAJ1U8C-/0W4:?-]MZ?<)M MK+IM-D88&1'(?#J:9_WNQG3HCF0DW5A"H11NZ.14&M%; EVA,#(UTU*DE[JX;0XWH:;@ SYL#^3&QA\D$3DUC0#R=* MHVDL['A73]1%.([FFTA6&K:JBB9-CBW$BZC6<#NU864R&_<@1")W6)!TIB@W M$KAA *3;9#-JRCV<&WF-7/;UGJ:%AEC?&3VMA+'17,68Q#-\"8?T0=$:CSU$ M7!H19VRU(8X-T%'2:V_8@:=*0+2[?4*$@>4U1(QV5%)R=V*O-X,X[#5;QF;. M*DC*LVM@X_8!55NBA$'SZ4(B-GF7G@1![! -A*(=W/0V\'RXP'O=#%C'4;IF MY[Y(QK@;Q,B\C2"1;Q6-?#*@D+CGNP,$2=2C"# ";=^M]KTV,!77*6?2F7X\;0F\4HWQ1 MCEL#FA/E.0/6!^CE]7D=5G8-M:Z,6>.9UH?[:LMR%N^4\W;88/UVM=AK66DUBW?2" MMEB'4+H^[%!ZVI2:X8 %_+81\$W71]DB6+&L*;,J,^3Z\PTS=R)5:X\4$2?[ MSIQ8XOI8'Q*6H*OUK6"1P,W9;%79"'?>J"ZM&D@C3%D]9H!V7J[KD1YT24?; MJ?RHLV,2:[P18+$8+WI"M.M*)BN0RES>B1S$D1N' 1IT/6QUU/IRP@J;+@V- M^PPAE;36YKBP,<$364IF78_(@)L\D7NK==QWZ\N!-IX@X]ULF)FMB0CO2LW/ MYK" 0@O'Q>H#+K= MM-6W37N2A![K!Y,(&=<%FY@MYBVM0%&;)#%BRC22WI1LQLB4V?8R(0LB?%(7 M&'?HEAL('88S;NMV%FQWL5.MS5?0 +2&.D>,NTT>J;-]N;[J;\>[_GP\[3,#J3?O^UB"!>($B1LP*UNB M.J6-*3(MYZ3=6BNZ2HA4N-6QAN1/W%TGPIU1I+K P.\%<3AO]HCYSO5:6#OH MQ2RLCI21.)E;19>=9'87,C$[TDQTI+6&D-_+VHLI+!F U17;K+.JV:.U3:&U M1B;+X^-ACTPE&&JP90_G17'*STQCA&;;\:;;+]N<8Y>4\=Y+&SB_"X:TK3/!RG\P7;Q'5O8BM6,H^LZ3CI.X@Q)$53 M@7$*74L\9/F0Z]8U)W6::*3L-HO0-4NQ3\*0BI)IO G-LBY@?:R196Y>1V?S MHN$T!'J4SE%S6UB;H2R->D*V8T>"VV+0$;'08E)M3[#([L[TJ*=CU)BN"ZFO MCO"0BA6H,9(V3F<\;&MPO<=&.+F"1(.IHF7U!@4!X1C+/!=Y MQM?B8@:+"XOE*'H3%!$?CJ U:F1*$:&D/$'E>H@3ELT[@V:+0_$U;H;KB&^C M"VJT$Q0N72]HKK&8L/J.Z$S;F#!@C#J7.:M.8:XCJ=XL66&\]C5.\3#>W78F MC..S[0W5*2P!T^H.S0B"*ZV'/3%TUL*&L63'J5MMF.9'4'.Y59=RE]KTG74I M6\7*6%M<.UQ+2(.%6\HL4.IP']CIFLY@@"MR&C4A>X4!SR&P-\ ? MY')T)&/=Q:I-DTAS3$GC11W;,$"Q]R(!^-!"+V[C4"+0:'O@^\N5VU17U%#P M-J;6YV '\ANF2L8PAFO]GK,:6V7=)3I]/!PD9'N@SU9SB)AB2X2S$A[F-VW( M4"=Q6/?F+;W%MBUUJ0?)EAGTT2 G&4J/O3$\RH?(8(7G]#I&%7=*CDA[-DSF4=7%-; /'5=O@^J G2+,BV?A!X%HRHHWC(NUVHTZ::XJP M&IFB0_!YKS/7Z[X#VQ-=[<'C>2,%OG+".45#3\;H-/C'IISV+ MLGPY99)-":'K-CL)# _%$J >#3H?@L]8N-#1(8^=.ANW:XTTT M0]8%8WO%K"-)V)(HE:8LV6ML*/?TR+%:E(M!!>];DWB6!#0YZ9D^L\6Q(@@@ M 4:$NM84>1+/M7@@6>JD0=69Z7CCZFU9-<2=R&1QL6A*M@*OZX3I)E#=AUM4 MSDQM&S%<.;.X&:W(ZD3W*)WRVGV(+KA%O5^IK:V+M]NPJDUEJUUB&J%9LR*> MH<0(]>9VIZ449D0;IL46;18NF@9'^71GW0];5I$MYLX6D@K;4OA.PVBN(RIE MI]*4J\\Z4%LW5AG2QA"G%0*@W&T57SA9@_UM4P6VO[Q*2@8UZ\4"UUR.DOY2M0,I66MF@&!SMI$/[ M__[?0X9)0X^,HOJWDP7^W_\_4$L#!!0 ( %2">UA67BS42G< "B$ 0 M 9F]R;3(P+69?,# Q+FIP9]2[>3Q4?_PO?DHBTB!+V:9"UFBQA4P;DI#$ M9)TDV4(+&1FF[+L02I;LR3)91\C8%4GV+OO=[O_?^OM_/ M]W=_]W?O'[\?C_$P9\YYG_=K>[Z>S_=Y#VN$-0WP7M4ST -V[=H%W(9_ =8X M<.GON_^MG[^#_.^.L8O5"/!Q L6[M]EV'0-V\^UBX]O%:@60 +"+_;^> /SK MSZ[=;'O8]W)P[N/BAD^HX@5V[V)CV[V'C9U]SQ[X4W_XWD]\L+Y/@X)#0L/"(R(3$E\F M):>\>IV:G9.;EU_PKO!]>45E536QYF-M9[BP@D)\%=%JA[K .A)GS@+>UW5X#ZM\E,X&,;KCWQ%_M+(C M%8)W1\J^_?_=ZY^]B!E)QXMG4GT\&0FDD2X(=EPD:2<.:U69Q[BR T4CR.]) MUOCI8-)ZJ8$L0OE=(F @S0RYX,WA3H1B]=F 6,T"D$IOFD5FDA W8? M-^,9"S"KE&%F3IYJUR)^4-FI*CKP6;H.T*H[>L-7Z9L1QL>:>D9TU?=QEX_:, ML,S=4A:@K,:QD4GCH.!;/(/'N,$"2DHK@IVA0?WA<B2[:>RJH3I]N@OGF(E9T*T)!TP;^RDX"RDP+DL5Z_\^*$CGGX/IU)?6Y5$ M3CW'U=4NLN'76TU,\LT%77^U>^]!9G 7\CWK+#O4L_T2AV/F!Z "!@)4/X$A M] LX:QJI#2]D5W=J0-NZY,>4]4BSY>O[E;9'K4X@+_0?59JZU[=AS9 )#*N H"_@MI_]/!S%S3;H2S:ANY4;$ M'WB4HZT\ MV\1-&@-.@B'OL:53QKW:^GDQQSIN]=:C7/*[%6M_)>8KYB]1OLT):>%57UZV MW P\P\@T-5;)$BI4V,*FPF@'%T6)T\3;H^+ M:]#I#9# Z5!_6-8.5OFR@#Y5T6U^O?+OE>)J)[;&YDF%]>Y"Z;DNWWM\'I$S M[UP0Z-=G',$W760!T_/*8SZ;SP>JIG8%?-X-6^8,:O8\=$!$N4^.SPH5 F^=%.-Z%3FJ;X.F'7@^#\C?$B/^7?V[#+??"'\:Z( MT:Y-;'D""YC)[$"&9'(YQ'[Y(UA-ZXAAH-ZZIJA=>;"E)G)B=>-I>]ZA(]&+ MF^I2\<_V$9Y7X4&E80:_G_[+%N75^&G1!0OY#H/O#)]"/:XT?ADB->?BTM.B M-LF< ^;AA/4%&CJJWGRFY/%U&BH&9TC UK4^K?I*3,WX1'&W8P$V0ZK<']-S M4^=_FPX4?*RKR; \G#Z;;''OT:T$H\>#Y6]KOTQ]D=[^\9^$6O8?X\^HD2U8 MD63T,0 68#K# MC_P(5A!)@P5(FAL;LT)'C!D,38%DC.N&KG;W9T9 B".=/X M?3A]JE*)4-UTCQCH=Y6&#JEZ=R?CD+0UN^0RH69;PC-)LR+E9&=>:I[BL<_;1%- MSB/IZ(#)J?*PE4O(H./,@@;%11)W-AATG( (QESO\V;>=%UWEG,\_KY,*21O MR1,Q*GR]0FF8FY^8D<7->QZ<@I"+<%M*90$Y1.HPQ(_B90';+PFM)%"K SJ/ M+#-AA@8HLX!%1) ;^/)]B&RGO%&5WZI']'_B,[DNV".__WKDC#QQ_> MTY/\8/#[TT_+= 2F#^0.;WN:HO^; RU[@ED U4(9/,X"VB?LQ#G(PZLQ5),; M0Z7'3C?ENP7(2'#5OO*\PJA!MP]!$@:E(OJ78R>%?>?O88Z?99-#O=W7GZ_L &JJ/0]AV@?@%IO4(R?3$KS1DZ5A%M.55L)!;A]B3!6OFG_^U^XV[+TF>^,AV86#PW M_AXA1$<)G* 5M5DT[ ,=IJW]U9;;=&3JB?5UQ#[RX)]/ZBVUC\]59WIZ^VG9 MNFDVI#N*/=E<_WSWXR6B\QV4"IX,95(-"#M:>!X\69*&8 &OKT9!!^ O+P, MC: V.4"C'9P?>$M_&3/79=6?G__&O4C+Q6/R]O\R=KK\6VFP !!?P.!W@V*G M6C#@%<8E%C!_(^X?CI&Z B//!>-3,<^02P8(AC )VJ>N4H1DJ$Z%W/EQ_K<, MM:!5EF+SXO0*[OB#O8^,#P"J&X1F)"BWQ3@X-5-%ZX.$ X:GV.HOO(^3.I[B M-Z.ES+7T^%/+_5!16U0[V_FZ^@P]LONJ?>K]/[&D+R+/KMSNO%J>5K3[DMP? MBT-': .\+GZ<+.#,WRF[WIJ-O=5W*UTZ\J:E9((:.O;*Q"7)G$+YGTN7%.3D M.R_L"3(AK,]%2N=Z(N05_N M3IRK3B]80IOXDQ4*XS,]\LA:J\=FOIWZ@B5^;SWQACX-YXDMW$R=X$1!@')Z M<<@0E&>VO\4E)5L#Y2]&Z9A%#]>+0BJFU'^J/"8V_W M_;S+M>>*BY3R"D[4/[*S,,N3=:O]13+O7V?;U(R4+6[\2Q]H)F,'-\-!%%V! M(3\,J>%\:#&$9]!AK-V";N6PMHFOTSN,]8@)A>=.UX4^23];I:'-S4N^1:YJ M3R)FQPVJYBW\WQT.6T#\4Y1M9!AB,$^336#FH%;.4F$+T(A -T;[LJO7 &7< MWN:A9@ DH-,\5)H21J/!C& K[F(?_I(#Z%7;#@0]QO0RH;T[!R M#5169O _-DVS)JR&3'>=;MUU/(M,"%?[,)L&.'KN$\0\&C$7*P/X=>9!0;H# MU$FJ'"Q61\'1%ZA2++9>C0T!_/ VZIN-X?(VZ:0CD^N4O):+Z3 MSO-5I+)4[G?2,<\W8C!-+9^XPA%]0Z&S/7F0"#'!Q$#!S$3HQ(PSZW M!C'0@.ZUE$IL)P5N^:A9W40*WXN>9%B!WGOZ.(WS2FW>_FXX!C[]JO)H4O\I M(G*U)('B9G0)[4CL1VP53IN(@^H4?!#N# U!7HBH]#R,1;9;J<:%XTY0,A&3 M+>]^CLW'%)XG"EF%A,SN[^W:WZOQ>?MNY'GJU_ANL?C2T\%O5S9_[J"6JZ>] MD]8]5ZWI#P-@("Z3B($3C1?J)PEXL8"0'526VVV:VURO!,/ ME.4N]E3H=6$W'[&J)E3/=R;VS+Q\D9 &H;AHFQUF.K4L8#88ZD!NHG6D\$N' M<_J"?7.S=UA (MN?CG]L'3G_W%#6I[-K_UN5HU@ 8N-OC\#WCH-N+& ?,AS/ MZ#3]QZ/H[0>F^O^:'?HLX!^ ;*P79BYU**H!\Y[I?DPUZME]V]?FQB59X)I1 M3)38_NZ'9-T0 :=Y%RE=TR[>7:K0K0'3%!XK#ZD^FZ^9&2AG0\XJY>9#=]&@TZ' B\0 M-6CP$VC8'J!,W?O1D>*Y&RQJ#=A/DWBC[:,9\(ELZW:#"I4Y/MP?H7)F;,G* MO#MOEK]-Y6&7:,?I\BOA2Y=D)7?@S GT@;/G*ZF2T&AK=A'$T^^69M$-T;NAUI>X?&^:K:,L._:C)H$;DF_";**?=I\B?< MA+MG-_"S+ ! ?4^.I&%&?V^&@>IT,YP"ZAV0L=P6G1W-_6]'NG'_>< M'/OQUM0W9]D*EZ5<:>1W+:FAI_#G6)K0\-#C_0;"R;0KT. MP%17 +#0^TCA MX6@1N;_3$>']2;)E3+=:I_^]6VI21F*!]2R_]O+R=LEJ]F<+25Q1FIB7*LUG MM8#^ "NS:43MM.P0)T;JR"\//3(DXSD4Y^Y4!:=$J*[Q&QS<=W\C?-["VL]+ MSK?(2.S%V*O;D4N;P]O>X!3=@.' S,+I/Z0H1TR>'O@3,\QO5.!\O4>U(-3K MT$27='5$5H=<15FL]-$]37<;TF^JSDU\_?B2!1B#)S;L8%DB]* 2#!*/BMM' M]5J0_=Y=AK6D5.R?&?W27/3E]*@)0J3&V?AT@6+/8;M8]L'@1?),3))F0MAO M5#3)H(&?6B2(#J-J&#S$"/<'.X9W?JAY9_]H)7T@,EUVP?*E?7BZXC6R[$U+ M#ZZ8^UXNQH*G^)OT\C0&H!PH=+Q,L&)7\[J MY$="I&9_#NWC>1=YVQ9L'L:4II#"8UV2;N>H3]C_O#M8V&^;4(0ZJU[(B(_: MN8\E6%4N!'=JR+!?('X)\[5PBGE@>[#USIE457DM3QGC?75C20588"G<8@%<<+&R8Y@Q(R$8(;"X[,@N%L!I47K: MH/'P;>#+C-0SK1<*VUJ%<+^P%F9ZF3 YKT/!.@=&60"1U@,A/R 9Y(,[+F!C M(MYL.N8@?MUD1A/F?S_]9_%8"03-+F:&P 7ZM =(I+K%<+=IJF66+A[\<4&Z M>'UQ++W2YTF"D;LL?Y/D)7GAR//BAY+LX^W8:0N;K>!!NIK;4V18@R(VRJRW MRH3/Y=&RB(V:R-["8JEJWHE/B5^D:G'\N2X[JU'VU)/XG_4HN# M4:3<=IK /#F*)I,80B3HZE;3&EW&*@7*34EBR)$Y0FW.=32H#%*WSA)233^3 MPV^S MWDQ898>]A]HQ&^?^-D=./#]^7? I1_,4**N_TD1+[,A @N[3)L++FF%1VB:J M@PUQCCYDH\?&@11K+='TJUY^744WB<$E>>FMD7>]]YO=UGI] =)6^(4$CV\Q M,HB-!#H/"(OHZYX"PW^VQ/P/:"N2&[@IOXXVWK-QTGZBVW+VU\.@4!GUKO?V M!9%=I^OMU!%BNAIW*PLT3Q==Y"J6O)&6QR%]N*U*FA'7A#%<$Z@)BZXQ.=(Q MQQ 5.^#;^E'(-#I95*:CKU6?^_6]5]>$CMV4-SQ;).*=<[5^0JXS_4J[J]+U M!&-E.@>L6QD=J+[I[$A9MB:=XP$#**"!!PQ%7$E_=_FQS2T[O;>?I2;8$IY?3?[= WK&C; *(KX5T:( MMB(9^806 JA8P$AW"L.O1&%A@GF#@$3/#N*S)@_Y(["BL3CMZ5\GOV)SHDYB M?TE^_C":K\ =:"DS*&M!L$9>O0GSDUM--PDK"=IJP)>C%B[+<&6OVMD<9A59["JLJ. MQKR5]LX%W?C5,/+"JCU="X>FJ1*"8%'^]P:1.!,_]L'NTCC[ R7B7ZF6YX?5 M343M7(:^9Q[?XVMY+2M20= L"'-I>#T$;J-OX$[;1B4R(S/.L(!^[22FW?!O MY;Z#S5_?-!_0:J&6ZK^:]\T_0#PP][JU[&QY4_%50BSA55_A5=2-G(MQY<$/ MO'XHGDV*/VFV:5@UIZ8F4FK\LC90G-/3]V-]RG=:P^IZOBU&C&A.E, M,9PU=2T,9YYEZ'F D&/75/RI.YKXQ&(LI/;J4.U=ZL$327-5S=N/-?:=#CU* ME-TQ)L6M@7(FC(RI#@R="X0[N7E/D-L63!(*@E_+1*_V@AK$PN MUO.^VG#]@PF?MJY8_XG&]A@3@BG!<*06.Y:(*S,_2^8V3'F-:M)Y,:FP$,#[ M(-2LU?* [(Z9KT>[;S"';]=[EDXA/TZ MI=257^2/YKCZ*]CS-RCW=C?,J!Z$ NX.JE&.]@:<'CZZW"8AAE; MRH(W;:-,H_BC4Z9MGMAQTU?SO%XZQ-B2L/KWTXO- 7UI*14OM]UU+$ANT!G< M$]"!RM:2ZA,)R6/#(+YNA,50-I49,O)A0%4HTSRU'2X)0_N]Z>Z/3[. +!=B MQ6%Q(57>I!,?XZV;O3"@+'HEB3 &!FX9@WEL%\CI(D9^YF=^VAVI=NS/J:VN M\*DVV!AP*PQIFZCE/#IQE-^C??!1PS)MJJF!EU;03!*UPG8T0TB:47X2&<^_ M;.5.#/=Z(VXWV6)10=U\5UV;GH:F&B<3-[L4BWAFCVF%)UL*G170," M<>+"#'[B#$>,67.&>%1['(5I?1DOJ!1W.^.8NRRVHGG2+GFGYAGFC>#D1+ITRO;[BK7U7.OQQZYU3&E=KS(W3N0:6 B8H8>$21Q^$"=63)%,XS#]G MAM4[=/#FI3I^G+L_J,/5U(M=$2B[=:T'$>1YLOV>!MK5 M#SO.]A%RAL)/E2SW>&_@7R,9&R;T17P[R;&=*0@>Y @RIS(\XWH#Q7*TTV[<#7M:.15OI;O!HT,'_:-W)DT MN],W3XD)ILQ&)NNVO"J\_NW#:-5^8P5D3#/%SB6VR5I0]^9GVJ'W7I-&INVY M!2'S:32-"!W'/T2&\##$9>]/9X.Z'H#J9(\*B4RZ'O0]J@AKW2C\T/?&!"C3 M;!%_"1$3<"37[I'AWBP'3[QG#FA'SL;.#'OO>J>TV3NY#]\MM+GY^T9]W8 W M=^&:Y]HOI_I/];5)"[5U=1^3\FL^UF18N!S/\$V?2[8\G&%P.#WBCE' -+ZI M%5^I5$;KA[C\:(DMOR>_J(?J[+;\B=Q;+W7O]*X%,EB:_+Z7M-\JXA]IV0Q+:Z01)[$K=(U].]17#SSNZ!K7_,.\[7B_=(U MR[/>E=49]2YZR (M41^K:,Q7NUY)O5E+&UBU=U9^&OC_ZPL5*+_/Q,7R!S8B^ M\HX6@XL93[KG.9K9_-0SL&$O#@%Z4A'L\ MU>I*;;7+#552K*IS?+4,%-*GQ=@UWQ_X8OOG9PJ#%]6Q#/%-\>*_SCAI#N/' HZ@VD7_#PT9YP&GN/_:WXSEZK2 .B6U38K1R>$]T#K=)5 M,6E<6\+$"NLQ:WVIW^TQ/Y,8#K OAY#$$U!B/DZ)&GS!P[\5CEHL6-S4@TL M0'H L7 )XLJ$'7D6K(#_RH%;A6 'IF& @:*:-8N$YN7C^,&;2G;GU%OLQ,[4 MFV*#+"LB+:KJ:3T1)_H4/N%O/M8:WQNE6Y;FDBRTA%=^5UK1F,%.P[>R !&L M-7GJF?:Y0I#0/JDZ[#7%@[5N>7JNSM;5ZANQR%;?R=[>A>M/@LO<>=O.-GZ/ M9*:] ]3/2\6YO.>]K1-B,SLJJD%'Q[!%1!G&P2>ZXNMKK_PGVU[T_2\ (H M:BP8!#W3A$&;P *V)4AC_,O&_6O5_K7MWWYW3LPQWX^)QBD_4;__.W[3HW&" M>+BQYVKA?[#]O:#OL9PN/XSU5L S?+0Z0[+A" MX>Z"*!006P2Q=/P?B6^-] MA/_@77S .HD33_-W(#!T2D3U-] [NS^;U:JQ)"G$.7EU6$YY1_D.\<Y+WPB[/I_>;:-GJ2!7Q&T!YZ82=RXD7.\B9A)ZYJGEPJC693.$!^)EF3 M/[R3A&^ZS *FHU'E,JMSU.56WH*6'DZ&)+C*'C,W_+SA-'BP90S1K:ZJIL%'%+H"4YM=U7XOT?2^>.=/77KHQH_:3L"Y@:@9PBB=,M6* M"<0<]"*M>$HPE&A/JJ9) HM+T/U3KK72L\F)1BXZ@\)JPI$1OO9>[XL>.S[< MT\@#BC1GIZ_F6!/6U]DF2/;*XVA*QPH?71^+W'P.FA7:[%,Q!!5Q[F2UURGZ M8-"T85UX6'B]9/%X,I_FE*5B7![FY)F?8_5/GJ97>#R?26$Z-.QE.%+55WFH M?F1B!R*T-F%IDAW,(_,(MP>(UO,Z MG0JM;*T^XS[?0M"*"1LPH 7=Q#N[.U!0*_8T]+3Q)S_59:B'),C'4!I6-U)) MSC@ OBXP*FW*'6MNV5+3Q$=X$?AMWUKH.3Y4-8+Y'#J(7]H!+3%S79@E51; > [C^'O(^EL#%C@#_ZAEI.Z MDM,1H1@*$U"PP?IACIS\7I50S*; HP2&6NQ*>AG.*=\8F,O/>23P0G$-"QB2 MH2_#))6+!=R-"ZH5BE!N5@[Q/!Z3IT5L\=R=?*^_N L)YFV\/7WM[#3 \18X MP&YNL"Z=MQ90/8*@?64!P3ZMR(U=0R2J.1[.F0U\LQ8%L0,L8T!Y$@N8_:?4 MPS>CWK* [P>OP"C@GL("#A>7XXY\9:UC)GY.EO.[;K[^-N MM / UO'R*T>2)/<7[$?L05[4#%IQ8V:7XA3(42/25?74^2 ?]],O4R<7]/L7 M F_>OB3UHDJ6^^8^G[2] K'-AJ-F48B_U+(&-PI&I+<$>E-V .N-3WM3@G75J"0#DP9 MY2];"544=!ZO;/A0'QQFP/?<0/(!U:9Q?6Q"5[6R#\9\V%]-1O#47J'$4-.O M28WB\NW6[ASMM4:Y49OIZJ9$IS1G"95>?N>#MM2- M+?X7"4V%BRG"M;8_SL1UBXRJ2GN_OXU_AV3PH2&NPAQX: .2TP*15C^F%DAK.(EU,Y9S\:0H&%2XYS",J="K$3]W9&O,0=VB$>O7JY7*O,6;!J=' M)Q;#IRJKH*NPVK]F,GX)PPPBW9\*1DDH>G-_UA;W++4&S2A#B>Z*@3QXLD^$ MQ]$RFNZG[GI7%N":>"4BBZ;TFO?2T4$O-Y68[U=F64#QT.O"6\N:'IG%+BFG M[%QJ2V+R\PHFSR]+"3]1'Z)-6-FT'$L@"&RN=RAZY!9)ANX)5$@H/NN8WV,^ M-X%/>2'\+COR*Z(5 6J\GZ0L0_N4Z;H7W#P?>FLM9^ZMON2^AWA03>I_P"VQREC8[^.!_Z:Y'XG5NCL<2S6^571WAN] MGXNCS9\Y2AL?VGU2UXD%_/O<++%'QUL-#]''B2DOD#,\_Z%=_?SW%? 'ZD%1 MXWZB-O;TH:C6CC#+<(9/P<,4[.WQ>!BDQY6A,^C5J77")Q;P @FSD(?IE)4- DC?:WXGD@<;##H/:[MNVT,CM8 M<+'ADOBO* J*V_GI?*+OX67QH3>%(Q.6/X[^JKBXO(II)S"$.R!.>VH.F=1, M$ P8SRPC!A^EBA.>-R^1Q!IXG/DZ<2=D0DL]9D)_4Y0#O39].<)ROQ^O$;93 M^%YBZ671>VVL(=TS7UQ^270GQ/%XHD5#Q.02/']D6PG^UA3U_@)#8-P*-*4% M#F]R@F6$'[8,>;#)W]^':C%C5IOAS."FZ6:[C,;J_4(FIBSAARBJ>##=XG-Q,#Q=&[34ECAV;>(GF&:8JL"NU MPY;ZJ\"M:%'=[X!@J_#0@RN]Q"_'"O4[RP1SL_.$,FWK,_4XZ!>&U[EA!/1F M 5_V,6-1*Z4X.' #9_0)2Y]I!)JN[8SU??]WGB28>8Z[?59\:"!HTR5;J8XBGJ M1;J?'P&47UMYR#Y8+WR2&.?=]_V'KACME,DNL+ W^E%1UEUOM)["2V_TC<,7 MQ-U'U4?5MXZ@%/%D<1H'$_ F, 0Q+&#]'/+?I^_HPO] R.&)=B/_KTGFAOB? M,DU3]T'J#.SY9,:^LW40<9^7IA][% MF]I>V+XEX;S) B88^.E=D(H7>FL;ON_IOY13AXUA1R6$0[(!S;6V!4W*T6/N MN3NI.!GK+R2R&>.BFS/WE]S%%U,&VA ;C>?W43K[:EX_Z.'V16B,;M0__7)) M+;-)/YHA2B&$99R@R3S7?OC6-4.(%A>L6G*II4&&.E_EI=%MZS5Q;OC/#T2_"2B-8 C*4#(9!\UF M\C,IW KI9FW(7=J.[T9&<$[@+:4?8ZZU9ZZ^^$+)Y!F'6YOC!QHQ;/I>;;_R M[O;:Z%-=.5-73BAUM4'9*&X=&1 Y8](2MP=G";H01L&<1A2?MFHN2&Q^RHP* M(PY4VKKV:76=;?SBG']K=KW4/;=UB'BJV_UT;IEF'"V)\$L8XC%AUE2A^$ G M"F%%H<2*1>F;)ME*ZFSN?X\\2U(O>.Z$I*K8_?GU#3M7?SL;:N5:U3DMYKA4D#B>V/J2R@)4"),B86)YKDJ&IA*1)QE;^[;%#.\2-& M6ZJO4 3[PUO[\B(+Z/IL+[TWS5$E@ V'!K,H:]$D7IPI3;)#)'')[BC-N,B[ MT+;AKM!0?+>DJ+NZ<<@HU)7O,@29)V>Z%NM^RN73LWQM2$SOM94)8LB48M?: M["2H3J'%N0,P7@BX:7H$Y8PT%_?!$JMD5DWMNJSN$PG'5EJ6>]YUM?GF0'UZ M@5ZL;<)OK-_\$I;TKU.+UW^ M3-KL5&4:"V@5&:S8/W.JT.[3-0O'U/F:Q9M%-SSR941?W3L;*K_^,I-DT: @ M'-V6FV!LKH ./BKX]$&8YKM?5W2=CMP-N=&*N %H2&PT6+, K^$_$_33^*9S M#7L8>ZBQ,4*?IEG 9P>&+?IB6K5.4W32W0O;F/F/!8[OM3?,G:O0&#(ZEZB M,RV\.)WOAZ0I)4A % M&(ZY[>HS["^H%CZMASU$JJZJG(E\78UY>4FBT/@Z-DUM;S7WX8B"D**NGK!D M>:\R0;FK!PO#WLX7=M -C^X@:*'V2?:G/BXS#=O9O!AK] MKNBY(2+:O[?;GZPZ=?/C2X4.;JY*N<'HQ18^3/Q "K5JCK1E)/$O1FX9L@"N M-V0,\Z!)& QJ>N!C&,0J\Q$T0YUH[97\-QV?T<=>-$.WX&C*4/L2%#3'G'U/7Q-'"7*8"8N!XI)AM$SPMB2!7Q[ M@+^@3V(Z4N-VX*$A6?M0 MZ7T"II>?W]#(T;T9JV)^TYSK+<".UYBBPBIY6V&*@[22[HK92;!#DS&ZUQYU MZ\2/*';?\!)RU(^K$-3MONEE@>*(Z9!72;_-D<06E!>EQ? MRN[UGIP&945O0:=DB@:WLO=+<57+Z5.OM ^^?SLGPVY.%M?ED-.0CU2Z\= = MDD?_0%&-UK;/>3[';(K2D-#;23E"6-$_/=?:\:9T,%*G^%$K090IYO5[,ML% M9$]&VM0!%K!22U9F8N8*-A&Z FA0$5^;I2MPG6/];T-X"6N98NH:,]Z3$[]D M/K/$2"4,>8**;U'4P0QQ#0T4>_W1H)&9-CN=;XAJO8"J[3.87\J]:] U? AI M4W\:]4=9$]4ZA81%Q1\P$P;G)UHLP/2TPP8!VJ?. F2BR)YT06V8P>7[*NQ\ M(LS^AO9=>+@?58T*ZK,4%%EHL3L3R'X/Z%+?%/PZ:;5;;WX]*VDS.OU=QZ&] MI&)-%H *>/.%<.@#3W[B-"[PVYB6PYF!E9W1GZM^YR1JD5/(B]69P1JSJ1[: M[IFVQ]^@FV;=;>V6ELW];%U+J[ADLTEQB.6WA!DZQ&4&3X5(&X::&_A@,?9X M>@QJ= ,AF/?!UG]99<#(\X$0C/]C ZJ1J@("I]:]:MY G\4\HPQ"57XQR&D"#W:%? M*\0$48Y!7T^!5S'6S3/,#&'1J!:SG4V.].FR^E0RL/G?SV M&/MTP&9V#FJ]\^A'W6&SL9G3C -*A,%3MQ!ND4WVIU1U$#%D?J=!)@%Y*\LZ0;O!K80A!MI23':YD+BKUMBP?C=!WYSQQ2>UF&"E ME60C_O;QRS'V?;>)E3\$CWV(L-#R^L(5Y/+Y.*R30N2H/E $NH7$D,2=8P&= M.QM+"MF'?_D:IQ6:?:N(],J+:)V1OIKA_KJO0-'N]%5L_IH0GGJCQ"(W(3YX73LA3][Q!,6G:./V*?1FW?U!*P"CTZ!LB&,G'/?Z(#!'^2I)Z&[0C@F]Y!R'ZOJ9&#E/PZ=TY;_=;,RKB(W(&%(YY) M7IGL6$F3LJ@GZK[76\LUCVI96"X\8+L**[7K@HQN6/; NF8]MD>$!8RV8V?@ M$LO_=G3TYL0HR.UK\8W MRBU_%*?3SRWP[:*!TGO@T4FKX\"L2%\*31*6%L(=X]X.?%1GV,^(?9GY\Q :4AX>Q>4-PB9D*CHM9BMS$H$0R!ELX;V8YBX M]?1).LW)%O0E_R3,^5H;?P\X7 N*##6/G#HF>LH[:W)2E__.N>&$*T'\CZ$/ MYI FLNIRGPW4SP(J_5MS*RL83\$FQ>BGE0FX2[2#=<@G=PQVA@2$/\F,*K>Q M@$:VIB(ZC%%!-TAW/!%80FOF(;P'1G11:"R]HZ5;5P>!$[4>.583=8VFEY,[ MMAR HAF5=R6'F?57BANV[ BE/(E:;Z+P>)L..2LVF&=$SB' 6^#'%U+9:55QDTO[+WT9U_C)#+S1JTE3TG?"51!RD?V M552*UU8V6),^(WY*1,J6GH=#]XRKG88(KT3L M'ON5Y9+GO&,>4KZ6L64ZX)D7V/=M2% T-X/B/&,Z&*K[@ 6(-)S!:3 S&@2Q MRS,F;23^$5"?/-5"0$R"B:T[JXS(^/%;HP5?V.L=DW[]$;\XE]6_4YBQ6UCX&[OX8BN32!SJ.=' MP(JG9 0Y[+D*HQX'3)9T=( E*V*HSB&C&=08OJW6OH;H!#JXN^3AS@E3U9H\ M95I1O)5JPT/K8O&%6&M=FNX+\_M7UH)1*2)3#/$%"D?]"_#QYI&^$RMLQ)>U MP^UU7>,52.IKB0[R9B;7QZ4F!T?Q7>=,:!&Z7O(GK?,9X_B$DWY$()$YP,?Q&T&G%DR9##V3A2!W[,S MRPL8I*B_"^(5VG#-?W5)/]KQ-,ZYS$:.?(6*)-0FGQWW<&_?L#V+@T'_66,#>2!ANGC++ M\"OQN+.PP.ZRR$.#CS:8UY&]2(;8+A8@&\'\@%]!4-^P /1PRBL8#B..8?%O ]!%^^T$38EH2Y M('[E#584OM1?B=0>B_H3SP(:2#N\A$T;4)4%2.'))LQ$3S;\DG)>'Z$2EN7/ M-E)ELS\^^[L9E[$"IU=A0'N ,/,CZ0XF>FKO'S]N%VUK1_(G_0X4E_?'(PEN M/0=PAM2DD*$"\GB='M',RWY0Y"SCW/LQ.,^08Q8E/AZ=ECEWX0;.'>46I145 M9?A9NJJN,L/-NLBR-R=C;'Y2+]3/-^?V8>G0F]A9O5U)@R^?Z>*K^(! SL_: MO$_Y?KHQ[NN<:Q-#BC6'9YWB MC, IFD=[KX&4[GT/%=$9$;8M]*HZD?_VPUJ]OB6ZE2*SAXAQID->/VZ^\9%^DDCO7_S-?,#ZAYA9*W)?69M M3)_" H)UA'[R^T;DMY5B7JNN\=IT"/2+(O>#=YJ4&!')G;@6<6BIB,'@'&:Z]YBN%+$">/K7]G/F*\!=G M)M6A5CL)N-I57"7C[H/[BH+ *OAJ]"3.#D33),GH<)(]Z8!1-NX*53FRGJ>P M9+A=JZO+O(*F%^&7_&7;W M5\!+_&=VY'?$'S\XNAIVW3!5V%/'#)M/2\8V[,8:?S&0@A9,Z.8A-5]^\D]. M2K&]Y0*FN1BG_V$;\O O!(,O#C)UH_/C1WF_XSKD\B3)T<4.,8;??)!Z7$X1)1' M:RA:V"(50>-H^1I;D"9X^Q#2U#8!'9V2R'B%7+'%]"@SA";B&,S0N1:Y?(XTR M\1KD8KI\DY]K0W/;MQ09,Q\]D4*;&Y+H5'I/6HX#/: MQPW;TDZDS3!S&N?$]./OO9IR-!PWW\FW?3,'_C IS^E&N*%'R*Y^FKC>A=1@ MWYP 1V9?+Z;+A*'#O5D!+;2@&)(>J&U_?88.Q__X'C.7PC PB<%W-9' EQU_ MUPEV_%G P3?3'0$G64#K'3QC"U7HJK#MP@+"&J$A_ \0UHS![O"9RN_^\5"$ M'(VPC84E)O\K%O [#45YC#NTUHX$HTU80,;"GQ.Z^!,H*H@MV&NZ,ETOV@4QJV(_\/Y/J1Q^65L@^3%+,>; GJ06X MB+]($*&DI6'5>HV-?YARC\E]&8?XMBIO#?>?:4KNFY_AL;*BMJX6F0Y#@IOU M28Q2O.D@@XQO@@MHEH"38 'EWH7X)0-?3*]R6-6^*G>V2X,>_!J_5,\AKPW( M7+G$><-M7%;)\4I014V,G1ZG^.O YQ\COJ"^#?_[+;AS_KPNG2EQOCQRXQG) M9NT"!4[>/88RZ6='2X95SUK^L? W,5GTO*&*X_RVU/Q+\'$ HFCOX)L0&XKJ MD;&G^>0;)PK>NQ>\1PG^XS;8EL$M!..@'V1B/8UFAC+T6< []4@WYA6: V3D M&8'Q"J$FKO_=Q+K]$W;I$$XC M=:HMDS- P=IJXEQU899K ^?@VI6X%8LMS7.+0RJ&MR]&Z';_T&RHDN2XIQ?[ M]5!ST@LBV1OOG%FMO$)SH5]C<--,6EH-+].TKZ1N/5_[U=DAF!+IU19?W&<= M)!;CZ5;8)/TMT5?^F4/@G_R>7R%XD8 CW[WQW&Y/"6&J3)TU@Z%*0WK)F9O] MGEEN?G4*RW(9D_-C%*'YL_:IZC'#4GO-0NT#\ M* IK,\X52)*/%!]N,HF2. :*TLR:D(+U)^8:*J8_>?#<4#!(GZD>6!D[>_^/ MN\0JY6N$4_&B.GK,_$<\FXK%5H+A+LL^=\A:5:W%BD8>?>=]NY-_5 MI+J9<98I ?JUOS_[1*W: 1-6DRF3A=[W[!L5=,6.:42S7TUHQ3O=>R4WD*6H M)Y(A?Z/5ON@[P5 X.-WFLDMMI<*W2'!M3WT !;G7[=ZAJX?]#QPA%T]^4K33 MDFJ]XWK[?6_'C0(QS:^/OGK)H6_=-[JFXA#6VDL(*PEN:TZ6,!>4WS@*HZ?? M332U@@5PNU'"F +*A_%D_;^BUQQ)K6Z0Q?=>I*5 D\)+$ :O;[&N&(,=SK] M,W(P=CC 37*AC'D&AI/Q9'QOQ5<60)/O0FU_Q7L-,OX^S;WZ'#/N.?/N]@5H M@.K;M$=,O25N;WF:Q-?I'(V2>HW=3.6*1RLS%_8OO[]T6% MLGE&34T?Y?1" E9AXWA)L_9,6(^N\% 76(!A/083G$0GPEWR(@N(#]L,8P$? MU%LRF4HT?__,OASHFDPX:I,[ ;]L$I^)W(#5>^(J&68#(0N8G:\+!1NB?Y<' MR_'E_[(\N,T!3<'."$!5=S#3.U9A(5"4V.Z]?NX_6>B8K+:+6C^/SY9AB,!1 MDEVA$9AI3K!:.$QUQ%]+^K]9Q'@,SD''=^D*W/R7;]^@MV%T;^K 5.^-HYOB MFRYX$SC ,^B@6U2.E7[RNP"$BT\U>N^,"8F&$XF9+*-Q7Z_&SJ=^,Y,@81LD MZ+99_8$?-9AIX6M=--509(137G5@1*C-G-^ MV#O]@+/J.=2T3LI[:P/VS8+"2?V%6RR@N8TN%>*EC*@P?)QMHJ+93O 43G1S M\X:>$-%H]+"Z.I%X9M)NTD1U<&)BH-S&9L+6YDJ_C@^ M0\F*.J$[)KJ'M'Y_4BG_W;#&>!9(RL> JD'3W[)F"* L,@I2>.,L_3V DR% MD^X>Z"\\(42:H=,1^W_>&5F]^[LMVNY(_'/Y91%AL_474U\'\;EA#%%WNI K MLAR.M:0;#=W^U'J1Q$=R+;'KH81T5WVUL_WUFDH9:H55"X\*/1@[="7S1O^] M 9SMA[,6E32EC(0.\>[Z]RI%"A=*RWL#2&'S'!NG,#,I].MP*+\&]&(V;1N4 M6,!2$XT'7Y:'C\6L7H(EURFZ+G[T"0C+F"*.5M5TGKF?)#6=N+F=#&',(JR2 M]_;B.V5U!/&CU\!!%E#X*P;SA$P91HYHM!D59D\R4=52\EEF(%=@A7/5-=$W,H,E)_C4-A. S]E[I_L M5;_W7GZ\E'&TVB^\?E6D[P+##SV!H9IE1J*1A^%@OYVJ1K1J!3T0-@>W:&S7 M*B/GNKZX%V#15C74_$S7W.1QGD_Y$0(/WFK<"J3N4Z66^%QXU*S0N3:XU-C; MN^&/:=4L3<]R%K'(*W5+;5NM?I/K/'8N9JB@R+4V9K:(/2_T38&E[KFY/ZL# MOUZ,6UFU*/[N7!8SK?M@1C>@=D \LW_747"FU*K,J!,HIU6MIB<^/Q.M%O'\ M.D>Q6DV3DFZ^=PRR,OSW;IDE0]V.L;K'%$96?^6X]_9X[G_W&74?/SV(&7$@ MSY=-P]QFBN@9ZZ6 X,4.7Z,-;C4C@CEN1&J]JT=*Q&0[6ZU%XTSMW52,!)Y. M%LB$JZ1+&@^:0_WV+HY%NKM;A^]90-^+Y)-L[LX(5$XTL(!GR/E4_/08$E0 M6$"J.;65J:,*(C*_,0)J\I&@6AS$U8J:3\2I:#O%Q00 C(\#8:I0+8SB8R1/]^Y\G!+I.S04R=3A)I0&8ROPS/;JW"%!)WCQD%J;A- 0$Z MSD\Q80W2_Z6X]XYJHGW71F-%0:H4*1(+O0K20?(JTH70.\1&%Q$4"1B)(KU% M04"1\DHO0D":TB)=0$6Z@)0$E2(E 0P#3"9G^.WO6^><;[][K_VM;Z]S_IBL M69.9>=I]7_=UW?/,,X"O&14J+_,.U6TN!-+:A!6/+] ;5I_2EB:N#(V;;WB/ MU:WWB03R/_[6>8HCWWZ7?6P[YU\ODJZGX1,Q]-/@7H+>GIS1$"2NZ3@QZJ]_ M>_IJ&-O8/^<[B#_.D(AX0,4>,AU;@;7>S7AR/U3H5.O]7\B#V.(!^?XGQ*:[ M,%86,VI5S'2Y+WS.:>O#""@KKTYZSG(*8C'=H0D?KI+_'FK2#-*J%+1+.'?J MD>&VC8T%X XI?F7IAMZBML:8B$M\4%_.8=(/ @B'H[=^L_X,_4U8M EQF3QM M+SY%*/YAOWL@K!-Y A2@[=)-&=FZ\M@#-D_LJ&/Q+3S8,[^.ODX3%*L>EJL1 MEC_O-*AH)RC&/Y%&>.,XXYV1F!_I4=M8FR:89\S]7&;7< 0RXBSVRHW[]6^: MC%;#^!OUHQ&$Q^HM<>^-4*LI-]*X JEKB/Z(B4A>HQ5!O:0.%,,T*'3A=5.S MP*\/ZS)PU(1AJ.8Y,IQVC4+'B-;Z!-5;\4BE/W3Y\==OR1+5*$ M6R@)3_6-!O..DI8ID!Q^L>S#2% +YVY(6-X"A"EAL +5'3N2X3AY"EH0FP;- MF%#G(S9/8CH:Z$7!*G><%G?4HJ\%E"P%UY_O[>&UF!B?-%-Y:]0;$^,8@\A@ M(L1@##1KF(B1!.S2:186[M"%93R"B1=AKR-A]=HW3 M:;)FJ-N'NFC9^: TQJ7@2_V#$E]$W-Y^)R*34HK_&G***'O@6.3B? MWK>JZ%^4-#IX2.XO=I7U[A-BC]AN/I5E>)-FX?97H=MSONG130%7JF>KD'PJ M*0;3'HJ*:9'&YCM<]"O'3E+4B(63KMAXA]&*X[@-^?+O;[U#+^17]_&GYSM. MC#N3+<S'T^V E4UEG55090D%3EQO5+'%'9%&.U:;4!)\LJ# M3B%2FR)"(87<+&P]5FM8"W3/:I=%#-7$2_]A&PV?D#?J"U">=.X=:#VA*!MY M^= +^QU?^S0<['7)XK1XJ,>S \FX7!MZ 59FC5OX5L[?.\.PZY1*Y3; )FS' M1 !GD6#N&%T,-O'3?S,1BQYYF.@9:C &?)KS;0[JG>\@,/140AFM,%0I,1&] M\OCKZ-TS0IQ0FH\J\/"?)B%5&.&%H>ETZ#L+-0]3GD.]1-@VY5SV8R)N_"+! M$H@S7G;=G.2,FHU$KJ3L#9HXMPP'>4W*N. M['/#4:GY[ :+M]XD#H0_>*2@D*G<%J4=OJCULT.-F=.] M$/MP:#UI;<-Y(=TI>>?2S4#ZLY\=US1&><4?RO06VB:6FUV<= NUF==8P98M M5D&$A[)>MF$(3R5ZX*_VZX!,T)R?MT&:=WB>Y6>,N4EU@GAS_DK%/'GE83N, M-].P$!D%8"^Z1H+C_Q([)0,(;:EE1.IXO\:A&.5A+$!.1[JL9UXK!7:HLE<] M)\]&C:)Y%IW2H_P4;KL_?7-GPGG:E\LL6">AJOUV V63/LP:3GU1/!XO1$CW\X_%G_,((L\DY!61^LLUK_3 MXYX+K \>.GHL-+_UOJ,OO2HR;L@^X*?K9*ZCSV6Q^_5I^))[]F-W#$5HZM$X M_7!*$N\GSW2/%^I2VD3?B"ZRCP;CAN*G.\G/O6_39UXK] *G M+Z1*7G?Q:Q51I0APWM"X$?<6\!#T4$P+\''K$PCOM+;::4$I='8IESWIOE8@ MK66[.*716R"T677"9Z08#9@#CZF3W7@V'>,'9&2,&_\H3I)R\L++VRI3'KW. MCB9RA!/94]].W%XY.?=4+\1;CIX2X1'N??P8-@Y:U#V+.POHG*A\^9U?K+6X2@J"E>TZ>'XVYCSN5/ M9.:&R0EU(V]K%XL/]MIIE-QPTRK8!*UPQSLT1?%IYOE9K)I3/B\Y M_*+S)P.BSN3?>0<2!:1D+XZVF[(NJ>13-[_GYX$E YA!..:$RX,<:S1#BN76 MKGID-T392TC*@^Q,1.YKFBP3L0]4A -/*8,-DD1^(.Z8.ILZN+]O:'B/9KWH M[^>_7Z7ZNPM:X<4SO6-*LL9R;Y6[A62U*RV,H!!(S &K;4I;B]_LCYZ(RBL# M),UIATNND1]B[!P$+$=JG+7?^[U1=85$#\[)@+81_?21-RC>\_Y:A)C7Z=_;?5\(=+/YSB[ M,%0>6RZG)I0I8]UN9>MMG78&WTC_<^VBNI4=X3BFCD2]_/M5!)!'R_XLF>JG MH,.6ZX*^)1+CD3WFIC1I)H8/RJ]/6ET\<[=7ON-#P%E[BFW8W@,"[LVKT%E@ MFW)4_D1M2^SL0XE!8/LQEQL&&[X*C=RY?&6-?E+7_GOY&1F)MC*QQRV^B_I. MJU&A8*VQ@-'!A#S^@E5U<<$%6+'^O2.52^K48[S<>T"/ M^HBB[\TJ3Z$QZE#+JRAO),,E^SSQV>_?A$DF D)WT[\Q$=7O&/GX/X'8+RV& M%7_>;F*2#^PX[H4!N#5876'X5Q7OX7IW5A%F!)Y$89SEB*I_+'2*MHXEM$]K M?&U"73N979N_H(5SNNN]DQ2-#Z#'>ZO$YB?/NKSX91HSS-8XT<\H"O0P(;WD9T$>G=G#D=G$5MB M49\Z_@;U>;H\XI:_P_V/]MH.(@> W[O7X19]S*F?7T'E+F6S40]M1>/=U_;Y M\G_V+'$$)9(A_$G,Q.>#=5OWJW%&(S&C*KL/"E(>((]] T*W!2_%TV-J_,!= M2S.K\+$TJ &ZZMCHOF&RUO,M8I>_00VX3%14JQ+P]WS>\S_J1 M0:%X.^:G>;O^>/:MNNJZF5U>D1.C#>YBF[TL&!/AA0*D@F-5,*+8>O2H+E=8 M;UWP,Q??&=[:>(&Z$1W8M70G Y4F T3[O\U>B)&77)U7"^$X^_7@YEI*G9A?JE M%F8535YTOU8T,3GN,#YI\'32R7&BXZFSLW/["9NX(Z<3S\2I[.-1L;5 [&^Z M2P]B9(7!E<1* L&,A$^R&U-PH0LU%??.<-PT#U=[N6OJ+]=M8E7'*;" M"M94$5"+ARPO4LN@7L\N(@,=),1$J$S\XQ^E3,1^)H('?$&8\9'*??^OA4:9 MB).HB6K(/)I.@ NG_:MPEAC9#[]G4#[]VUK("134U[U7LN@IXH%_\QKAJ9PA M LB#@=@6J9/04=*N-&IYD4(<'^MB(H[7V@&O8 * Q+>9D>&&>3D=>EQ'4R5$ MEY\>^I)3O)"^M?^!7JZVL?K$L<#8IS(*[3E#^/_$8=;LR[@9P_@.UYR#I(5/ M+=)X\A UAXE0WOSWA_Z L@.&547CC&7.U3SHS#(@SD08N--@(<21$\%$;*<3 M?Z9 K,]V?;$/(%:VW>O /#V;VOT8KIJ087R3]JP\#Y+5MZ$SK;%XO&^6B3CJ M'2:437$U1%=7U25KCZO,W3WFC?#*>WJV^IP$2:>X2"@@OL%,V_G^!]F=+2;B MB3[^1W/8-Q+=:&]&X9)[F?TZ-V;2'Q1"4<]WA(;%[CJ$#30DUJ[D1#49!\SF M1&0+ICUPO%$S2E1A&<:A*::O9-,M^3X,YE@-O%D]>&7:I=Y=^%C^(7L@<%NQ M(*F8F9\,Y M^[T?2!WDNMC*4)KVY3U9=C1-26A) M[;[Z[7M^]X=EM6JC8U2\Y50;6>ROCJ93?T0?RX/-;QNFMD\B\+,$)])*-%D# MY8L>)[67ET #,^PU?$.X@-E)A-E:YUJTDXF9:G[HA:DJTS$[$LD%<;>B1O0T0+YK8@F M6>]\T!8X3O2YZ[,S PM%@:DIQPD'GRU3WF"GK2>JNYZ=3K0#G9/O%F]R?NR;;B3X_FO=VM#"W8C6$-=25KG2^5>9J7D%MZ+D&QM_SAGUO[20/]$/L=)N+Y-75&)J:3P%#%"I&^ M*/_3X=QZN-O]%8+NH/)48ZU[_X".H M33%CU#R(#A(EE$[X*-Y*?MO0L5%>%7OSIKO!G4Z'_9Q;!UC DP-4@Q/7 M(L*Z\+PT7B6#\S3KMEMAEVV[U@#]]/M*B9/VP:YEF9SDP+A!BX253T2_6B_# M+GBJ M&28B^PS M[L?^CAS%+SF*9%%Z6?!L5+YWEL)W3*,MANI652K)KZ\ M]K#8S&-6G?WHP0-/4=GH?YIWXE3"1(1B=N\@VQ+#ZO"MK*B?@8A V9+ M?^O*$7NT_G$^BNOY_S%!M.BYI?Z=1_]Z&+0QSD2P:,+\6@YG#Q=11.:$,FN= MH(C?VS!/?)+)1/SDUX4Y^-LA:C038>Y4[J*K 9O*/LC/]I_2*1%CC6%]^/6[ MF.HB1KI_!&:G4N>"*\%S@8F04&U ?>LEP>V1)X%)^/WX90>:)Y1U;PF*^KV] ME]J'F=['>:HDU$G@QR^.F1,7\+F*8$X%; B5'-),Q&@P/UZ-(8_ZT1F 9B1@ MG9D()Q$EP!US+>P#9AT[@\ OA\* 9Y:1BGOP[X_AR[(E\#WO8.'P,4Q^[U[J MJ#X4!^H'F2K 2&N"G:6(FRIL]&=;JDI4=(L4X^FJ=&H][QW:_*,B>27:5(-5 M736LV"Z,F+^804\M\0H=2:PKRO?E5W?R*"ERNUSMA'' _$4?NY^N=$Y63)W+ MB&84O2;+C;E!WA*@ "R)[SP3*BV"?.] _I'=_9R"ZP_]CQ3("$8=_;S(E]!' MT_BN%6BNE+GPQ3+@B2Z* !@>[6X2Z&A")F04F*)Z S2$L+%Z$P^M!;WL^VBE MK%_0+"^N53I$GWC7:Q'I96 \; \=7;PHRI;XH-;'*%A9^ M\F8^JNN:K]3(:[?GZ@EO?0Y[M.OJ/R](]MLTEL+?L1//= M^U0RLT3LA,H2;L2VWI JOE[IT&!N4W4BM#+S9I'0<'%8._1IAFJWAL3)4"M2 M9M'Q8?S^<4*ZD;=NU>3P&):IO:0LJ"R<-MIDH"S>9PSNC#F:_M5RQ3[=LKU8 MV#U1X7;%U.6\I1G@870[_9SXUL#OJT<9SX'O/RB M'B$9V77CMTW']=\UAJ1U$KE%TH3?5XD;:(B M_;X'-1:HF#^?B+N02E9.$#@A9\YYP. $3J[Z5H[T9]ISZN9KH7M>?4J*X$;3,1E MYRX,8+6( M\0YQ7B:$P$!0VRP&?ZJC,1'<0+3,0/@C,D,=F-WI%>)X'Z@9R0 M#=Z>]):) 'GS6O$U3$2G*2JR@;/=GQOK05\S&OGCO^)JZES97!^K\LJNP2MC M8KKKJ/ 7FYL<$H=$BE:G'#-0@PV0+7[V&6D].,.0$1L&5VOH2BK#UG[[SV8F M=3>R284FD@#PIBNO)KJ7UGFO%!>C9 M:-D ^Q142UC"=WRGKAAP-X8BJM!M\>F\$\XR\^E7=\O7%N!N33(V]]P,2[*0.F9: BS:VQ&-"B#_;. MVU6.UC0ZFW8W#,G5GJ).]ON*596*+W5N-/+?])CEDH4C 9F.9$,M)&!GF C6 MD[ X?%JVG@ZQPC GF4?K@]H;U*'2\-U,]LEME2,.+/)0" MO7JP8PG*MQICWO9JAEEVZNBESDKU1REK#16$]VTDA'&RF0>5MHZ425FT#R:4 M#M\.$LN<7S/.&2"!NNUD3P8W :X;62\/O\YW&H; ;SCYUNY6@O#QR>"8FCOG M5_7CN2X8V>D^VB3.2\3M] ,I:_N8B(577U TN7[\IVU_X)7_2?Q"42^)QOL1 MM>VX$[WK $LU=(L4]#54M(@*[T]<01UK$5EZ^<2N[FU+&FPS+6>JCG4X+#5T MIWB*"-TBIZ]D^$7FRP;]?&.OKL[?+]\(N?$8BV6F]$B6Z!;&R6YQ')MU.T[= ME8C2:]V6."[6=\-RM S-4635HLA#/F$J0.BRS[KEILTG97 NJ$JU<.Y@R6 D MJ[$52F".0XU2H?MY/IL6%A3_94/:VD9ZI*/AW@+YSD!FJ2';XU8RV?#HX[:N MN\]'CJD>,;"^7> X5LHHM6#C*CTJ]Q<"[B;$A1X*Z0T1$)]IE3>$*?UR3_Y2 MZ/+YB=\DWB!)VDKG\Z5%\>S4$$\_3S+P*;#]V,"K9N4)^2O=9Y+#&?::ATG" MI-EL4F5:\ZX^MJ6=(DE0F_-[K:!&54;?!<(?ZX-+/5W_J<1ZK5RB3*J9\IP$9.D#H MO=^V:7%2Q(UW3,3%MCBIOSDWU!C5,-TG4:W68E!U BN8N9G#81]1O.!%N/N$ MH<&!.H6E%0,#TQ[9R>*-*I[*]_ MJWB;"(EDP='/&N9A,GO3$QXUP&%2099A[U6>&B*6FI=K2KR*K 91A-.Y'4'VN 3 Y#T+YS!CPT@-H.P"PUZJ/\%7\2*/\[5XA. M8_J0'9SK30.HV2@4U;8Y=$5>GG0#'W-?87Z_G[\U-2S:J^EQ>L,(3M]W/T=H M]>-'(906"H!D(@Z_Q[<:M)QUFT1U.A,CD-7T*,]8?P^:>J)?4Q!%O#98U*\K MZS6HA>'R3K?<@/%HCKGM.NG7!^@>$W&= *@1 MZ4C&2\5-@A#N9HH]H[1%S#OY8LA!$I=<>0TA*M0=/$W_7 AJ5&8O33.LT!)8 M/%ENI,G@VKL(8YZNA.O(@<-91=X[^I'9J?G?QA=#W;)\#Z7E%"Z.5CHZ.#A. M&E1..CF.3XK9T>OJ:&?T#S5QYUL:E#[++7VD8.FHJ:E=-U-\B-?2:#_ITZNY M-9";!6)-H:PES0B!]N2U<<4NH?1H$$V[2T''W+M@@.("1#76-A_Z=H6.%A2Z M=8M XG$WDU9[?QT=<$_2W/_Q0&Z=#;[P,]^=5Y$K?@^V<5^1/U_"'/H4##Z5 M3,1 #M / R9Z'W[#&C-E#W*ETP.!@5T9&$BT=45!$6!WUA<.5AB>>WA1G/5( M$))M*=@IZ.=470X1V[9E.7C;[:',^LZG\I^9)3H^Z0I+;P[&$5*152K66<9F MC@6^,S!=?P$WQ7&/>>Z#KI)JT"!W(\0:1)F98)G+B6O2W!4![4=P* HZ 75< M=873IKYV\%!+0;[/M,KHVN;D+OZ\K>$Y-\=^]@ZYCXV49P['N-U@2.IR)2.>#RFKL>FN2308&Q*L7B_"G9WKPF/-@,8G<,T.U1>TH M$^-) %LN?IU" *#03XTE%!&68/V+^2 [XA_7',)_KH#NSG;D6#ZGPU4;_P_ M^L+>)QPD\:TV,"3W[LWLF56(92+ZXI@(VPDI^L8*\CW<6LQ_J=@#7O_O8J/_ M==6OO=?! #5G^@HP3ID26J,G#M40QJ/))JY.WWTGDNK+O=PD@?@2[S(5LY!K M9 (+\,!B>.[MB/N33W&R_?RNB_QV@>?>\^\4)8]:X\.0U9CE.6HZ_0H@.XMY MA#F(.\\2&2:*/6#BBC*MMI(@#=_^>?_=".XBT>>0G9]SA]#J:[&=)&*)2]@Z M9>G^D#*+6OIROUW4Y[79M[>&[*&3<-=SA7W$4RW85IPIJLW- M_1_P$ZR0_ ;.EGHXRX.N*]68Q!+' D3.=ON:G>\8O+V.6W$;G3.DB3UKJ^IY MTR=Z ]73W0T[F#K$:DVMMVM!LJM@HD@UR$A*,GE9->< ,&],_?*6'M!RRL^T MC8G@DJ".?&X&!\ 5][P9;/B1%RJ^>%G>&>CI/;MG)1H+66.>1' /,4H;X(J= MV5MNRT\R>0KVX;6XMS6>AU8,HRMF_;'S]:,_HBZN)NG;_\=#*-/$-8*J:M/ MV[@HT>T^(^QW_9PO(]\7O$/R1F]KD @Y=*V M )^7 PJ1F0BI-O]=#5(\'JHK/=/^GPWS_]V03.@'DWYJ-[B1,*$)'JVB_ MR0*MR ._4=PM8D#V&KEZ09?[*X_ B*K*H*XXUMYA>&+JMD3X&;G-/N'&'CV3 MHM['])^5G%3V_\07N4JD9,7J6^J9""7D3_U_/I'W'P(#OG2%SVWZ8=X6:N/D M_S?.^!]@P) 17.&3^%:[H'*#2;-Z1@(D/MX7="I1(>@!D1$"J:+F31ICC7.ZG$ [AU*BH^#^)AIUN4BUC.J>#O/,=70!4A].M M\Y\/OR).N_6*-3?7/9)36^=R__[-5H+T]7K8B6T<]:W];EAX>YSU>V*#]'S;F-QZ!FHW!4&T( M1W!80)+2SQW6$W9N"(RH)VRZ&EJWI)ZBR56K MV*79#7TW.I-DS&HPR?T*P404=O*5E4MDU 29W=J9"MY $#O@TC ?_!/P)T![ MZOTU,KZ=R =0QO2I6[%^M8Z@=KZ;3X"#B\N2G7(K^Y!3IU3DST3!.1Z_#3Z' MPI5$PN2.[*J.,HU%B=J8\/:+:F_E"9'^DZD#G[P&6W^=[]0[:J>9=KAB?UF) MG,CK&/,LK8I[VV(I&29A*_WAM/./8$E['-!6GOTT=*[;_85<;XNK6Z&Z0E%D M67R!7/U)--)$A9R84+FJ*F-MLW2WK%B-["V&/X&GMI-JZQEQ4RDS-;'ZSA3,=T[+%&;J!-Z#][X:N5$!PE?0)E7.[,!&92E M7U@>J3S[-%7Q3!Z'0\>PQ*7 ..AI/Y0!WNW0Y A^>AVK'G$.P&U(?5K'Z8>> MR#X=M##P^9S&FT-.P[8N>OE+@T5Q628^N?>^D_E4*#\(\U>B%S"M(8=#DN?? MA:E0ONOC4M3Z[H:>" 443B8*_7G[Z;X TB31VRJWM"O5Z86#=?%BK>4EJSL^ M)G*P[4!*J+?_ST_ <:"[10]1"1TY;$O3;+31QT785^U"4XW./D[F18B,Z9LZ M^<78M.DEEHZZ^OMK?)_?]%9?E N4J02%&+GXV43H;/UPD")WV!=1R:$_9F?L MTGXAHR&E9JVP*@_'+39YX8ZW9QZ M]#6HM$VI"/FIR8#ZY%&3==M@7N>XBN_S]W\=57 MY-VI8+,TB]68T8;"2-&"PJEVQ;1^WM'ZNP:+M4]P[;H!,.'CG MF\*!B4$(N/L3HL5.;._FO^F==='R=R44\:!Y/%3 M7#JP=",AY+FUCSK^TPO2WR16\YJ"Q[0#L97?[D]&BIBCG]V0N:AI7-Q +8N@ MQRD%$%2*NZP" I/-7:H@$1+Y(GB;B<@UI,'P?81P'+]>00 L\,*DA6>@,1/1 M=K9C!BPCKJK%+3$1L7\HJ!TU$ 7O<80P$9\D%4&CPHM,A"%2%Y:T#\29B%\; MV\DP+-F#/MXD>+VM[(3?/EVU9 MEOE+L+UK[ASV%I^[SD,==DT+FSNUOE9W\BLM TKZ^R6M3"Q=2IF('G^0%TF. M[D@,IKDY+0IZ1?QIW99]CV!:\W-@:G07]?EDL?732 M/,%BIQ=E=V .!5C# 7(A';P$]]/Y#CQ83EP-C8,2R83"Z:!V'?5V4-.T_=,K M0?2I'N4W:=D*15R_AGVNOTZ=/??M!$7&JBC=/$MZ-$G0)E7#W"*B<$[06&QF M@\3SD$TYZ2Q%CHF(\<$^>75-,L+MJ!K M!@Y%)JJ21\P#PI_G":JE4]MA$_*EK#%XX&LQ@ &6L+>83=YL?^?@7TBVEM/) MY@A1-MIIL1V$RO>49=G=K-SF?B#GUA:46&@(CZC"72;B2WL7O'>\![_P8QX% M)+HCP0U4@O]^"(8ESPYCE0'R3+B;AK.K_2>UAL+W^3WDQ%-B9LK&8A/$6(Z4 MHK9P([$$__?'^FNY'5^P,NP8KU"S2;$%2T[X.)0WBF=QIT;M-U\O3HOJ-S+G M;*JMU_AQ##2G.1KU^,L^5LV.O6WE>%77KEZ^$=K82HH#QQ*AEVZR 7:Z:T70OT&HF6>U[Z8]M=P[JKT\:E-PTE M[/3$I:HL^DV>N/79O[ZJH%D7&CRC==0+'+Q".1(]V:-2\[WO5SE^4 M5)-4F>$2K509FQ*KNUDFJ9*:7^X^G]='G&^Q8UZ#.)%2>X>\&GY0 0%$1VN">[MQ2P8A<\H)X$9^KM)Q2V MZA*,-X9[4_;H2\4@[9C9=97&.W6_>4@OR%FD:IC<*R(!#>&])91AQC>VU=[/ ML-/E+O<6EQ[/'\DF_& 9GZ'QY8"\P5#L_'(>$Q&U1H&9RX4E%$46!4BM,8[W MC\.FQS[3X0\]& '[!EQ%OR![2L V_@>EC'FD3C8+M4!W/3=I>VWM0 MY0A3'D/\0G98+PJX#9W%;TP3?[G%7"YR M^& >3AMXRO=(4Z8S[)PLHCW<-K42>_6.[W8SK3Y>55$4Z.^@">'[4Y,NO#1&@ <\F./%+/?J39.\PE MJ2JL&RWS<7-?] B^SF=[4:X#<505*D92+_N/VW?@WPJ QPFS]NTY(M[5"S-< M.'O_-Z 3;91PC]5E46BF0WN@U'O'[+L=_N>4A/^N3:9\L]_?/40'NW&J]MU+]6,50&ZP2Y*RNM3' MCQ_+;/5LF8BG;@5,A)M S@Y:_$I-0L:4@5EH<0^QD^^D.R\],"XLR1)-]=SH M@0DK+ ?"7X<-8:@6:_S0T([DR@%D>WXUH(<,1T=R/L;)!I-[7M:NZ'70&QZ/ MB+T?_>/>).KVS/O'D;GZ]Y*%%M8DK MAYN/^6E81SF1^03L)?M\A]_67_"IJ>(H,/99DW[7V;-X/RW&5D#A_/G"FDBY M,>4\DPNG3=(4[A297\@[(GZBK"YY:A4OGE./ 05>S'UFH5]V&WR,MI.^'>]8.+$XE)>870IS&ANLCRQ:V M_59,Q.716[=J96U3;]9EF.(E?@E>>S;:(L]XC;/\5WY:5%<4&L-336<2M*[D M\) \,1/6K:%3\Q]F1 Q5TM3XT^T;LK/ITYK4'\EOGHD%*SETYX,&5.>W4XL[ MW^TF(B,VG%\4C>B *GG6^RZI:N:YW?.TB[R_6."4'V [Y\QI6U>J%9>H,=S> M8S!JG3\4?SO[14P@A<:1KEA=8!>I51.2<6]QI&VHA'7S]4?*;&F]^=MY=,:= MK/2&>09AKVY,A"\I'E//N7QQMG_B^-Q5:@-VH\--"7BO^GY MH#,,LA*8VF!0X"R]A_$W$^'#>$ _#_N&":@PU.18BKWA-%PCS$3$;4V+5M)N MEU'8F BV:5.6N-K///UNS['";3,<-9,QHITZ9I28H*-!-4B?(5+UQ):I*7$0 M"8B/=2D"LC 5ZT8E( ^@9@M:.+Z^6<&A9MDENU$<.@__QJ+:Z1F>L0I$G;]4 M'J)-*FF$1Y+QK0+TG9O[W!]*/%28Z0CH49[26?_VO)]B" HKT3S)R.6UW4O0 M*!-1W=TM6WZ6G-Z]QKN4<3B:/([S?N";:UKJ@I5T':O!\X :M8W#O^HOTPX* M,?X4_&E)2_4\S%U>75!FR"7TN&.BUU8 MVZ@N@\S3V)*N+!FJI6U^LJUN]9>%NI40Q:"[$QF;)C!:FEWZ;_G$-8$3D":! MPNV[5M DJFZLBS"!^8 4"#N&]6Q#<:\V*:H1?/K8LG.MJ.5#.B!VP%-1K+5_PJ6+89,*N6(-75,P3VUE_= MH74S$5)2<& TP_OY[RCBJ_L9?^8(D(7]SGY+^Y728$S@ 1!B(BC',9/.4/S, M\@83\7#O[=/GO/A_=QM9QCZIO$F;U98?_UR,C"\>4.FC?TVFG%C%>R''5Z>G MOA^MX-:YJWTI(O%+92+'>6G+E$HMSQ/?97>A7(*?=QI8:R<)H[S0PMV[QJ C->VU*'&6(0QQT_X&):F%U9Y*Z69C8^U;8T)I191$ M?_.@N'GS=.<&@FEE2ZSBF4'QAJ@)RLP.)C?NBU5@\.VUG6]P+^?OVYMY_M^U M67S_H.!7(?\RKKR#YX,#PB3VAE M6&^FNI3A2S,"G\-^ZH5O%=<5P;>>!R_2289;^TMK)/-ILUW>A9O_LER(CB.E=MSVV'ZG6JF3*I];\ZK_1BV MBB,U\M:@9/+V9H."6FA NAC>R\B)RU;U%ZU(47M..A:5^IH8H=9''9TC$S.# M+(J,X>!H0Y1U%><)A$H MPM31D+'+]Z:T[;,QO$MO?>K5-IR]_W*,*2]\EA?Y]?#-+DC_88$^7[E)2IFD M9E^&F;[:GAOQ?G)ONZWX T_^T[\?MWS2]87)>-T JB_V!56V[O\ M_(\],WQ(P;,M5<5K)X;P.ANHKFAM76E*F_[>'5J?HN6B-XIO5<+/)B$Y\+,O MIU6!G+DU-MPM&A/1V<^%0U._Q)-=_P*J#0;NF9[41@_4:M8:_:R+-L_>^459 MHGFX29S,OHQ20OWV&K(4K';4H?>]S2;HP3U"V,*^O ML5[^VU*!<_I$1;#@)>_F[<6^C,S\D[>2]IP )__]_RO[_?&.. M_U]02P,$% @ 5()[6&<48(\)2P !U$ ! !F;W)M,C M9E\P,#(N M:G!GQ+M[.%1M'"X\I9(DR?DX%1)"RCEFWA+"BZ3((9/DG"8A(V.FR"''(KP1 M$Y+D,#F7TV <*FDPCB/&S%3.65.,Q9SVO'OO:W][?_O[KNO;A^_::Z[GCYGG MF6<]]SR_W_V[[[5F\2?Y$/XTQ/+?=_]+Q[^3_*_. ML8/?"9'8"TG<622TXRADI\0.(8D=_!X(% +9L?L_#8#\YV/'3J%=N_<([Q79 M)RH8T'@0LG.'D-#.74*[=^_:)>B-%?1#=DGL/G1$_^P>26/BW> MJWJNMDOZTC"@=OK&W3B1?3*RM[*VN6!KYW+Y MBJO;57TN+9+1/7T)4#ZQMWA?3)J!C1UYK_0_B.R_V_ XOZGD/T7 M8/\7+@IDO] .P>8)24#@$![O>$D*Y/]DT]+LH&VGY)84_(*^J<@CZEDKNX&E M?$C9^2TWUB@?DGT3;.=#;GS';M\96=Z*5(;+\/P);_#3+CR';/HF-_4I'[)( MM,?_&(W@>&[E\R$&F'SJ[SLH%][')>KV\ W2^OR",1]R[$\:8:6)R( $("=HI$LW ]7M4@OA.%Z[F[($+77D58-8[5 M^-:=TJU^ R*)]Q-6:XKI9V*/7>!4_JRUN?#B;]E!E-I? ] I;88W(0!63W,2 M#VJ93;68>#Q!/,-QHLW >V#:=4!3\YL@X]\+1?(MHY(N[6VN9+^B$+D;_BF' M$5^T$^&^2<"?#/WG&%'#+J F,J7KI_?X57D?P*7:4_I48/^F^#7DQ_OH#CU4U7=.70'LVI9I;X8JDWL&Q*VEU>U_UL:),';= M9ZE:Q)HRRLE*V>9"WPZ*TT_9>#.>[+%E9#2N-5/KA?M:Q250+MWS1+/(#3XD M;=70W^07K+G9:9TX9]%#TO4/=.2V%"]7T>-1-5B!DX? M#HDBU.,?HTUIU-1M?+I>:$2A#2TOP5R9/J,K)K/Y-],HB0*MF[A*8UAG10V:1?SOJ>_AYMF@.L[YJUTT$2K:"@Z M.+S\F\4[V2QS_3>66N_Z1;N\?-++$ROC:6BVI+W\0_@F3&Z=8]-Q3 MS[)3ZK1EY)1*9>G:\"'E8KJ$/&>-C Q!8FT[A5I/7CS=B]7]7">]R^8(R;R/ ML88F@DZ^/ =L/M0AVAIV&,A_5H+;+G1?/M[/"S9'_+&#_Y@OYA7&[O'1!*/[ MO&J?Y6VO6M+2RI!@W\F8W[W3/Z6Z3^U53513B2:JA"V^X,DI11H>^X2=S^9# MJ(>P3*D$=?-H)!^"ML41O^,9-I>@)'%#DM,U/H3 G=_LF&=-U%7R(; E[%Q+ MP6+S!^[D,G?,=YF:"&\@Q7'42SB*#UO>A&/41%=QG MH=&S^7LIK\E;?>3FNQ:%QK'J^H0"=-4JI!1DS"'3 M2/'X,MVC Z=2NPM9PX=T=X^AG=Z4>I"^K[PSN\X\=-8XOZZ@U-_CE- ; MJ-J64Z?^IPP^I/4NUGS_@22(\P_;#-_L%S>3JBUY7FI;?%X-*HKQF2 MNEV7!H$[9;E.FA5)%4KUQS*TJKTRHF_6O7V_XN6C9.WCMGM_@3;Q4D5:=G;W M]3N3'D\K[$X](QA5SJT)N?7[NZ??RE.^U!%B;USZN-Q\PKSH4+K2MFG=U^,_ M0-,K**^6#+.:F!>^6B-=UBL+&!!C0M@ M[DD*B&3&D?M.IH=&+**M:'JI+ 6='-[S4J_J!G)@RW@6Q>S:V0J[8TWO<\\J MGE5 /F$0F06TFJ>EG+\ ; ),*B3?^ $'2(<54'__P M%K&TW<#J'M9K_$?7&H?<\]@GP/>&CV=BHLUS"KR \T'\*O5IVA:RR!3:O6,^ MNW.^)O#W=SZD"$E6LCG<[]T9@W-T#-'RU@CS4](5WU._OZE1B2#F(A27JZ'Y MD6D(3.Z;U)S3O[KO:IJ5*5WU8=_0B[*,[@]VN;KMM=+Y;SYXO\\409V12.F[ M\2/WY[/@GW)O?)FUW0%>9^.(]/!])J"_G%=?C:RHAUS /]?#I$8ZZ=S\RGCB M!Q\ ^!%LOTADMM*\2^=FH%T=6J I/F0<=^ 7^A9.V K?(]\0$BIYGIFP,?NJ MQ2T31O1EK1VT+_7VRFLFC-QN6+P]HA;W7:+#-J;Z-.L=<,<3<0A,HJG@WZ*] M,N=JB@$C1I]'5/KNS$1U8*5("4>DW*N&/GKU[LGKNB?FVI@Z1,%9A4'U*J>[ MPZ;S'*3]S37\*=J#=JU6SS^'MUKUKQO%$ M37*C99[DW,1NWR,>N:IZI& 7_.,^>H!LSXM+A.\AKD4:IL2N*H>*N?HOL5K1 M19'Q<2S3HB H_D:90ATKV,3W=W'*B5^_&1FG)CMA'EH!RO7-Y<%/UCEN6RGW M_JO4O?6,^0/NS#FDD@3_AO_*, MS3GEQ*"7-;4VS5?US;MOV0B[A]/J62Z6& MIEFDGFX0?(84'6[,.M.D#UO@8)_CJ5A0W8GS%"Z/G=S4X.7?J@2.VQR&1-^- M13>;?@_;M/&V:1XGQ&+G'WLS(9/F3LE];(Z4_8>V7Z2Y[WMTQT&V)C58)4LY_[?XO[9)2T8N[9IL0=L ;@:Q+@>.7 M1W>7O&U]=^NVSSJ$A]X0BE\CW4?^0Z4B/V+3;/M6Y/VV=1/%MA$P@+RK&24FI?S+;O"PQJF3?AA-$T)RY@ MC_ AO61"-KN,#_F86HAUA'.>ZDCUWLI^\4#XC@7)WW=( ;5PAFG%AU1C/QEN MBIWA0^QO;QMO"7[HOWVLI"[N^-_5'&Y=O[U8-"?Q\7 [/L]\PW&L4(KB-_2 MMG5>S=5K0??["OW>+C;7RNFNKYX;5QS0?O_>1WFPNMMVUX+\CNFCI]*$TMY( M_^R?PW4Q'V"D.19*V"'1[^/(_>+ATSH_WBWTUQKH# MM3E'5"Y<[IV[@WK[)#X[3RW@<=>- +EP8]VKG_5_1OUH_[X-;&4$Q*55S(6? MZ-_M>'>^T%S%)Z.+_&(T^O*/_;K&HB*DI\?#/Q_":3F[.-MI?^1#:'9H%3ZD MQ!W8Y$/VX[3W0=3@)#FR^P/Z9_ T'+^&$"0NY: M!N87_):Z?+WMWS"T/J"C2PGZK!7]V])WO[ZMIM65 M4SDGKORED;+0)(BJ,LB!PN52T>P?5[7>=DAJ?P8:G_G)C7?_F-QOZ"?_JES: M3?P!<=0YR]96J\)6K4Q>K3H=/6'<2XX(>UX3D/;RFY^62=6 ?L]P>,(W_P5Z M^'XKC>--W]063:V:&,>;ICV.E[2K)O\W4K$JR^3$#J']>S5@+S;[G6[%W,QV M??NL_>8V'V+]IN@I(8 /:1K8WI+4+:IDOG#[/@7.LWUY%(12AR@Z?+Q-;"[= MDO@$O$\Z#XRM-BAD)IW84"Q[/QKQCQY2N>:GCUK133)LS+?)9,0@_?):P%:@ M0%O;8X-JN\;-9<25H'L7B7C'NJC5RX2Y5S?QJW#Z/41;APP0?H"3>6#JZ?9# M#ZBD.7*.%*\BQ2V*:(>R[G.+VIS#Z*2I-5I_>IM5#3A-F\FHQP<7'1Z/0+T: M12(-=^?N>1_RW/GUTQ]N.:^C_)_&:V7^%MA"<*(';9,,.ZF%T0LSWGMG;0_S M[W= F5WT>)!UX?X)BURGW.MW.G=SX7:EG1Y#'WG]=/W3D_C%!V_*OR OF9^A4$?.1H/#)9:/Q*!F VJG 4FQ\[(OB$'&'N;ES^=.L9P(%?Z?C MV@R^Q^)4-^UT3L;/ 6>CS7V*<9^/)9YW7P(+W]%?I.USFK>[=Y@9]=BD M-+&>IS5P:M+WN+][QQYI;5I]$30Q)-O_@V/(H_+TKALRX@;$<59X94HWHVXE M(LS$RXM>.5*\OI64U'&081*5">2TR=,PDO0:)=J)"8-<48GE: MSV%1V0'N1D8UB$RBO?(S>F#,A4O=OJYR_V:-LW$L F,[7*4G%5P5HOGK6&>Y6S9:#0EJUST]2;Z+7<#^75PPYS*.RK@ MT[C7?,@0$Q"PU?ZFIX+J'YR( $U/\_;EUU[XQ,#'%<0UC0N@:I>^WR_%T#), M^";2Y;=?9*$L'%%( )STII:MN6^PP;@DG@BS_+D/$--%029W&/.&[O?2[9$A M--)#W-X(!AT+[< ?N:(0'EPBJK?76E=!IR7C@Y+-H6+7[2B>J TM\\&V[*HJ MX-(#KT_JPN_D"(,^S "6-JC,3.SOA(JCC5^AW,ZGL/L]-GL^9%3'O%YH:G)U M6<[;AN%*SF(QAR5GRM(_O,\*2!JTN%L6GQXXO-UX[)NZL?K>W_TYUS2JU]3O M5=>YW3=PLG!T4S=N;UX#@\99*]B7LKUZZ3P84+X23L.G;5\9S^TP&VT3!@@] MLA.7%L/L7W>4T0O/6+T?5U$VLE4Y?B,K9I%".?I;-$+K84%@,*<=#CAG4J[. M\XX5'=(0$+P4^9,0>7WZ'\1=CJ#Z/PM#&?,^.752!]BJ1"@>,4+0 MZ=B-$NJZ_SJ/J4V?Z%7TG'&C372+01T[6H .W/WMR/X,\RMX;SXD /3M[G?. MN/"S[EU+V^3VL]PZ]:EFRM.ZBG#$S[P19 K:EHCZE W@=S$[PKLG3[B)6.KW M]HL5NGZNNR5V0L8X.J?EJM_7RZVW)'C1\:G5#@6!F]H^BSXO)N\/YD" MWG?96'C#A@5(S8SAKEV.F$'&Z%F0K@L@42F6=YQ6<<)K?>#W]X14R=$X7HJVV@ M0Y4W&-6#$%F?<>H>J%[ AS'@$&^+&5[A'%6RZP[P23AQ8^#+8$7@_5>[;Z]6 MWPSR(Y_T.;7Z]'HS+^0+QXEY( .1TG^3<,%1^VOP]6 ?6LI ;>1IGGS_1'ER MI;E9[W=@4,;'WJC4&J]6B_)STQD\^8]M%1HPO#/*U!:KSOTJZLT*J6'=ATV7 M#Y=N;K)N@,T,: JVOCJS!R?C5#Y(3\UA]FU5-8 K57P(W:IB*3=7OOYQD_[5 MU:-_[M6).*Y2]=7XD#T2V*X!+' %JFLQ:PR>^/+7"9LN9>FS\)XWI6YS0IMG M3YS;D>L_ /TER5(B+Q M+49XGZ"W0683O7J)^:[X,D27\F!B^>M@C,E05:2BZ'+TV13ZR/;7Z&K=ET_= MCS7G7O@F'8[X!1_6$(^CXT1^H_^DGFQ 99Y$RW>;9J@J%KADG)9'2"#4^AGZ M.0$>I:]G5:7-U9<=G>TBH_VTM:D 4NY/VIIVWYT.6?7!L&B7+_IRV])E"95: M814:B!.EUE L;(39_(H$XK M[8_8WC#I%>(=\!+P2?D\3H$CHSK$.313)B=B85*?@LA]<\#[CRY%.U-?'$DI M=FP[8JSPHB8LW4K>A%UC.VT/3?)'^_;+^_MF#)3W1K>[SX6A7J@M64H;[LLB MNE98NZ04&A_ONUT09'$II((7!P7^PH*:FZL"#;-;A.FV*E_&&[F_]G C53R1 M(OL0S]&!/FH3]9W;NMXZH;<1$GNVYF=]^P=VQ%VK(/$\I3?F>;N?=MYHY.HF M,FHN7'2:>,%3U@9?\"'Q=@(U&LVM@Z^X@0@^I#ST/J%)@LR#4+],_#%^;+)? MQKW/]+6H;O=0)^TX42\"F/0(SI$S^T71H;0K#1[!%TPAVP_M+[0+ M#V&U/,#(NG4;:G5>"2K&R[DQVA>6KO4E'/[B)NEFO])254U%>W77 +F(/H2,VGU"%TYH)LJ MSG'#!^G1^!"1+IFRLH7-*-=+@WL>!B@M2O>$-=R5NSDC52 B\3&C*DI;BW.; ML(,0^'Y8-94VT6M"/W\^PT0G:^]PT6NG[\HC8GG_'F MQCN,*FHZS]]+L<^T[TJOU[7!_8Y6C_IHVLZY-CWA@T#CPHTP<\W"N;"KMUQZ MOJ:-'M&[)U%A5[\I0.KU?B?*/""Q2.AG-$+QCK?]BSMY>\PB[[PXF]9)7[CB M+L@]HGKOQ1[:G3;/)S_E_G85\_'QWO=JY.>+BG$B_I[-,'1WAU0(M-XF=:7# MG#=T*$AE]SM NJ:R G6FLWZYY5@M Y>LO*20QC*++.R= M(HQN*%O;^R!9J*AN'0\Z'7J(^P\R8!0;A$_(KQY2P90QCY%.[KF>>T:J%//.*^*@TP"-!5D.#=^.337ZG:3M$E2VZ2.9^T7@?%?[11 MC*LOBJ:(Q6!7I@$X0S:)9X[6&C?,3/0V(*^WBBL$-LLV3WA(K]P;S_T4*9]% MIR..)[],V_])^\G3M[_N[J%C?$\DAB23VF"?3F'VTF]E)OUV/#UPVMY?3FE- M_XO^5*[?"V#PQ+V0_)_0I7'WN+)]5T]4"L<3?>Z@S(\)BSPJ]7BU[-9S0U_N M'ZYWJ-MQXIW-Q_*LR/XV/1Q3):;+M.92KN<_-]UO>SX8./4M+R7$;\K:);?F M^&#M6)G;R4'F/U^\]90S>AFU[S^#]^^4)A8G$6E^?Z \?/];D8*CY@7LJQ4-7F/^)"Y>>@#G"+/ M%.7$.M\$G@:RZ;*]9S(/@#AZSM=VV8?F.I6HI^LHO8;,_;U^QTH,!J)Y'YOO M6I[RE&_:>JUIM^?W-/23)::3#VF.)THW$.J0JZJ&U;5/JZO5P5"&YJU5CQMB M1(I'^_/FQI XZ1J561-*U,4_\G+^!,HWI2"2J)7C'3MI;6/AX^7'/XV7A][, M'XERI$Q_X4.DV^<# KXL$OU"8%>-R]J:%C =&.HVLM-I3#E31 @X4ED37+L-W8V^*6NB2Z3:]^%U>?[M2YB^T,YWZTEVGNYKO MW:E(NCB\ON7RQ;-0^&(3/AD^A\\B:O3H36:NC'1I]0LTJ MF?,\Y_XY*EL=+H1='Z;EW^9>A>DL M.@@D%M &_==Z]3FG0&,_O23ZNQ=+ "*HQ2G)E3="[RDOW-V;W640Y6R7,F2O MV']X_TFX0@$K&IR;PW.T"/)US5="#WW_+M%Y_7+4DKCC"_1KP@"\S,]K^023 MH/'U+D^QGWE E&N=Z_9\KL+O^;C&CN=^'YJ,'Y_Z1M7&IW^^NW(9(/?Z34Z] M<2WV7+YJQNQB: [CZB\O;Z_GLT*N(94C1H;3BUJGRLMGA\D.;'7,"+!$G9R? MFTC5U0B241N]-6W7!GQYV_/L T**^$9YE[LT+(#RH^-"UHGG]T[Z*0ET46*1 M"N@61LL4G08I_;W4@WMR+*@]U?"_C"9XL@"FTH#60#VP2.&(UU\9"UTUIZY. M/O40M755KD,6EF2ZP\1X(V'N6'\;@2E+82YV[N:1;-'G<\_L@=_3D5DX)RFD M]TZHNWR[F$(+K6T.<['S1V?7^F?4/?ZQW1K3_ M2?*2G.V5J[=:31L+F%$,$^[M _O3 M!]^^S.ITVR[!]'O+,#42^! _Y3/$CB-#&P[0:P\QJFLCR.IC<7P(U_CJ>$#] MSIF\+_"@E, BL>*VSL^R&@]Y?B>Q73 ^Y';/!?54EA6WU#?RZBMKJ$B;WR[F MR6FU &&'C*M^KEW3CW)EE1[=T>9RMQ5BS(WCHW6%3^+M=?!N#]\;"VNAMLB= MX^67W _X);TM2^J_W#5V1=/\W+/%%N<7ZM+[GL;G9,YG*B[>*,N@G;"6%4[N MBW61_&?BQ>BH9F5:GFI5+/*;:3[_'>3SHSSZI(XTA02X-S:)ZW3X*) MX^T39U]%NX!N;"W..2:!2%!"7QW=((B@FJU'T8<,VF-L\QS(/BF\C][@VY&% M\R/$$YZW=>:>W[2V3K_0Q2D V6P(9HI:1XJ_A3F"&>)#ZB?2,5(H;9>)4+2^ M#UU/8@;E':-8B&'-TG]-_'U^&'WV[P:H_2L_\GI/9(_.9[1E%UD[69R5PA-\G,#CCF5[F\;@_G!*WN4F M6]3@CJ.YB=7:P5[/7IK*XGQK+0!Y O M1 ] G9),ZC+@R@C)E/@WSX &IEQ^7=5H1;]&NOO(HW*3-WVO_.FET==L"0LD MGIB6*;-_]8D-4I2CIU(8&8I5BIR7%WZMS?85BN?1N+9'"4^@H)$0ZQZX >CU M81L3^ON0\=A#'3+38#P1<D$VD3IV# M4K/(CO!#%ZHZ]_$(>2:',VF0\*S[#//]DE]C]1&#,,VQ,L_T/\'/M$;PCI=_ M3U\N=BT,OONC\Y)3;IE6CL^Q_(9G_EO>&5\7L1=0;M;5!X0_:[J5NB9<==+_ M6>[Q8O%R"FHIPWRH8E^XVXSQKORQ:^Z9WO$+\!R=PPNPN-R.';?:);:UIN[K M?=K]O_L&P/](LX:3-DI2G$A(4@DG]J^$.5?UQ]=C]^@_G-PO\,46ORM5AEX> M^FO)\11J(>9NM'F Q5XYZ:UJMA5/$(:-H?C5;&"-=9&;'\&'/,A-IR.FYGNA M2I%\B!0GI(GY8ST,]I#1"M_36[SHVK&OO?&.KLSVF?*B1:\C&7^)*%X&^]H% MYD0/3'J)(Q-Q#B*-W-OA%[P*V'(-LHLAYJ1Z+O MQYQH-S.J]0'JG<#HJD],\1X 805-;E",/<4@3NAW5(?YLM*E%=)M0$@8D%)$::&>]N]/!F MYRX1G8'9ZH!85:_8$DWM*8$6>H5KS,R ^Y+BO/>"27.B"&'[*A2!D4?$)KAY M)&5$B"NC\)9#!ID* Y7JO+9963!H]WPZYVQ4>0U.OGFD#>X7$QMQTR]EW!5R M*>)M>)]"A<,GM9\CCGHY5$^/Q=9I3^KE(9.1\=M2ZW:_[Z2OEGI0MC$RB[[K M-!?0T.+9G^/=&L/!BN'G^,6-X@?6)Y8ZF8[QL(O#:V\&LFX75WT MT_[-S0P]?6XK'X*$RO'Z$0J$FU2Q:134DJG1+9Z".38^P5A+6?,?+1WGR7+, M&L8YLG/?F;P__9NP\KG5OT5W9?=8/WLQ8S!: MYK]IZV[UZ17%MN/R^DRKMJ (5&/RFF=7MW#E#//Y6L9OZ(2%OHWI(LB'Z/.P MVV-;EH D;Y]Q%#.$5K*(-L()!LIEH:"^VA]>SFW -MA1F7INC_8-0;\R1@K*><:MN M@O' ?%>+Q@H5H#):%U_^D8[DE@M\&!CY7&- M-N,&>FE%XF,&GF?IU /]8;L["D/H:Z+?VO/[[_X*6?ICYV9[_(UMZ\*SB5,+ M&_;NY5%28YSL?+);JX<.982R'GNFL9CM/? ^\G!&@N->P=[9(?-XWW";$S^F MS>]MYW,TP% VBC=CUKQRA6V+F58Q =96&GB2H/$2! M3T!;,JA"*'LB)4- #('WK7+*LI8\"F:"FF4G]#T&I<[],@#(=S&K6TK/OOFO MRLJQ;;XPCE1.O6G^VDP5+'C" =6T$D"5%FM8XU_ M:+@DGA%S3[SY$!I!;C,. XR4HRX/K6OJS16M]3"#7*/(.@GS>7?%WM?@@,M( MBHT5N!@^1TW9=NL2G^+I@=?6@'E'\ ASGD9:E00V>\R:']Y&7S4W?HF:L.*^ MH5J.P0-F7"XRC?X!4 7$[9A^W_(EPJV&H>*.C-^T8R57@].G?E?J!K _:1_# M^1=L!;:\G_&:M^]@3?]9;][RXCT8U97;XSOUV#RCO>]D;/_+=:DB=QXG*0-V M*_S77[P7F)PMXW+,,+R9NBI"AV86:7)SVK39^H&(?9C=''^P$#AC!5#[*C.3 MC7$'._3!YKFOKRCBZ7JJX^8:T;XOT0;#&SC)Z6 %V42H&SF2O5!-2_(86_5I M>GX=B6N@@B$68XS!I6[ZGRM@.MM"KP>: M;+9)#,%*+M_?_035Y@S@NV$G &YO9D;CC,+'8&\HL,*' "\&@R-"1-FHA*3L M%KM#/SQJ;OZ 1CKE? CY.E:5G1VJAC.*"\_("T4@'R,\K[FO8MH;&QOAT0_D MV#WS/Y:_!9@L9R19H)11+U]CTY-N'X##J!D[-HYUF'(S^9"@6!M6'H*B>K&( MVNWPDJ/%+44' 06=VYOQAK)CZP19E/:Y(8YVU0+F>.AYKVON,X.55G1Y=5F% MF^5.^9-_ 1#W3P!!"3.,:"3UDBBIC/*5'^PC0;@=:)W7F $*O'L=K&>*,[CX MC$@&74\9[0EDY! M60ZOO4X/O-HJWU,J*SVHH>$GM14:55.SJ%8RLUXW3GKN;N%Q7ZV&>JV*@X]9 MG2C>CI"4'S@=,#H/G3=GF8T+^2#+Z5XN9!7-Y*X- ^46FWD.8!"J M]06<8.XASN7%=2@LX0ZM-B+B67R(1+;+J&PO3&O,'!ERK K2R3M!VW.C[6% MO.TU<.TX/#(TA0J_^" XXS?\*Q\BAYU[RSM"YD-NXBS4\'[T?*K#[;/;9V<$PI$PC,H3=8O *_X7L^OY#UO+(]BR+;%.S MO4H>F?^E <\D;P=L#R-(.LT<:2(CD%L(OX5+;7%\#LC2.[+9IGQ(=V:\P+-# M,2I!4%D#W(.B4TQH#U6>1,M4!@]L$WO'QXMT6YE.W:)29$.1>9_39 MUXOU935O\8$\,EL+VV7?%LIT8CT@@+[T-3G,5Z@,3 ;$TA!IF*-H-W 0L+D MML\AQ#%?W6!R#L>6SX_P3CDQ$_M(#F1?)J\@MH**NA/;[$1((1,WMW,&B\D> M9^)F]E5!>"2(L6%E@5)YH)/PM8Z)1E:(,\S28\BIW$) M'?J 4R-P,PHHV5*4P*+C@RWA82\%5G5:5A%V)!7T[/ZSD'L^T4,($%((@*-; M%]/$%%V9?WOX?9PH"K6W>Q=2:&VABWJ*G,%\K8!H(XYQU+CU\-#%QC4*NX>@ ML +W>X^1P'1W:# 34YGY\"0/MUY;\VA&*+P;OJ=A+;59EG @L;W2*-7'G$49 M3,S-Y1W9WX$VOCVBAO%\>JE@WK;7Q."%5U;4;4UW3\\/QRL-:C;J1I6RFK:I M@%LH:XA;25KG!H4P3U_AU@OD!_P1?!=& 4/A0Y3:)-CZWWB#,+-1F @")-"0 MQ$IJ\B%.,!@PA\CDZ0 !\1S-JFG4A&LK=A>*#[D&-&YFFL.-'QN$Z(A:-HZ6 M&"^7!A_V[#=O-H<+U*H]$_.0&<#*!R.9 S1\4@<4M"?B#G68H76YSSI.V[R] MADO"2<%4.9( A])1#D31E3>^ORT2!0NJSXJ&=.RO?_^^_AUS-AU9Y1YX2!EI MQY8F7]:RX[35-7'J4\=LK7JO'?M>,*9&U:&T. X4:5Z;N5\9%$)]V]A";1P) MA380C,+Z3$V[%HN$O=\O8>TBT7P(6QOM,0$[PQO$"6%.@WE_DQL0!SD70<0< M52G$P_');4][1""K)?U';A%2Q;XT!&FP)G6,;OW/R]U?5R9>\ 8)#0$I M& .T/[>Q0S&$(O.X+ A1#^_'BG&T@4+>LPE\;,T"9:(+EX0]I#$:^:,E]X+L MQ=0KS(35-/OK3_^Z5;T:58S[D/+<^*)* 5#M6Q;W4#3US-5V2FAE6<0SPT:VZZQC@QJ5R[E>T9&-39U# ;5 MD\-9/Y\$6#R8SPA?75_KL]!FBM+T.%(AK&SN&W,QM@[*?@[QH$,4#&<0^F=$ M67',I%2T/5/T(C-]K9L/29K=R\5A5#W1QJUC)4#&BP@<]!JJLE^AG5?$*MHQ M7K,>&M+E_.F.N>OPJ7-017H>1\J-]1$\9AX%Z"% 4\"-#E]%SB%2!3N7A#;U MFR,<1&43^1!1S"F.!;>D$7IH,G#"S)0IW=-"(E(57U?2E$.(HN6H>.>Q]>1& M(=]*Q0_KRW%ON0E7-!2[;)&RAA'987=;77_\=)J]/3[^*5AI.38T=*3E]D2S M6TQ$\]=M: L?,C^A"F5PVA=(CFUL+-R.\QQ + M/YXIS+H%0-'CJ /5)369,0QE M#ST)REL;;!1+6\SFW(?W9%U&T>TH%I+[FH"D/L9)8X/@!]!G&[A9J^;2;'6T M?1L8SM1I4RU'NSL= KLC0=L2M$/]:)OD,?Q;^]=!0S),6.9KDDRS4M8-ZL6G M^NST@2D'C2\T6:D"1]?9S*?1[1Z7M->JIK91CB, M94YB8FU^\"$39?@NPJ0V;Y\EVQ(S4:0#&H=6@JES>[(#&(.GEGMFM4!L&5J( MBV\@22Q0#'/:OS=3O#.943T8N=2Y>Y5OIPPNAHZ&FCM$E2[%#SIH>9;K_^+: M,&57[>>H8NBSX ;P:\V2*;6-7^$"-K;@,CWFHVJ#D5ESDF$,4O9;5]E"68V, MV]BPN?P;D4,_CC2+A]^2N2&Z^OQ2A?Q=P^C;(V.O*"D+.5MEBL@(\O3%2^GX M6+W6F!GCK6.\O[?OI7#:0$%^[;X,&@.*G=!ZO1ZL) K:-[$MO&H($%Q!0K%- M$)8F=MH9H#XR4);LI/RJW+W:G&S(U42?I>/K4&S;U L -E%]E'.6+MH:,W!- MY?.OP#'%=7HW2]FN>\"Y^5!U.[>L<64GZE7S"\O(?4X'\T7.#>PO5G-6NZ3U M2?&7S8YG*4H:4B]*Z*\HJ??&>BFV[MR\TC^30:\ICJL>/#>/V!\MQTM>_?]T MW>-2+!R__%$\%1ZH-UE <^O'I70< LG5'$MP!JBG(Q/-Q2O0.L-M3@""/EX) M$"X2@-SF:HUD9(3V!/GHTPT)HTJI*/V*HY<#G_7MN#C6 V)Y(H_9T@N/YQ0= M[&E7\C+7L4GQ=(<^'&TM)?\9[M Z5 )DTW^5E0?C)#JTP$TGYI.QB3X^1*;- M3?=Y:&@40^]@.ZLTI+Q^KFR@:3G4P8MS+SVG,KG<;5\8#WFLQB)#@M5B5@GN3V]J] M",">.F7L,;(Q*-E-"4C#B"ULXA0Z5###'K>S -:#? 1#O74OLD!I#'WD) M]G>:81[Z2>?%ZZZM.WC3VL[*%.PR:NG]T5[(&59K6B'YN@H*0RSZ*%.#.(46 MIU,SJ8W&:2?C6-[N+22*^B7PTA#07HD\=ML>+;3VN MGOE4Z>%^FS<46*URJ60J''!H2F 'BMFP$L'G=%(!\$_G".QSK1T K4N#;KEH#':.L_Z+,? M@%^X&)WJF1''C5"!U-9+]L!VXJ=].P5U]Y:Y2]4WM *W@!,$^(OO!"U[80> M8F821QLOLZ!R&"$"6O_I+=+\T !VO5HVRL]I[G$Z&'1_W;+'(W0S3NW#<$-K M@?OX3^Z&_W)K^9ZLL.S6'Y?J0UO['$FS8]JM5*O7%98$Z^S&U1_^;0W3M=M< M0&_./PG0V9BH!ZG,:7HKJK8!P 'ML%/!"$D^I(X/J9^EJV<*R@IE68*\>S3[ M8_.GX)NRIX@';QE[NI]>6]\#28W-?-U(CW&0[/46&Z\VT'LT M>]C6T%[,\BI3+U7'\,S5+/K$Y=;TU1/^UL %N#^5(DZ\G]F+5X(G&%84T!%) M EO38OT\E*8G N+/@P]E/M!C8_HH2=TF/ TPI\WE[23Z+X />=R VN3HI P0 M9V4_C$16K-L:M+:^*3^Y]^(8:=K#43]HH: U*\3>O4P:FSMCSRWRK&RM#BTK MW%B+&J,B+-==]U8P092G M OYBTZWRDAH]IR-L\AF]WD=&-_1 AS5I6@O3*!L;\]I+;O6VG]ABOO'*$;8Z M2H^.(#JE$?;SQ%&*<]0,F(P#W;,0Z@5:T01"AV.:ZDTV]RQ^G8 /+#+-).;[ M/8/I =R9%Z[-SE/+QWR"*MP]@HVR+-W,ZU9@K0>C!< 3 M",%K2?FD?K@XRH;E M* %I1!"'(*1Y=)-Z2F\%26H[R/,Q$]BF?$Y6<7C+:3 M4AHN: Q-7\KZK!G!#+OU*W;""8QB8M@\$2+;$77&#L#U*&N:>]*Q:9=X@__^ M&],-6>.%M@%(7>GAO:Q5@$W,__4T,H8/$3',RQ-G=925HV[S(2YFXSESRS,: MUFWO&UL:43H5?S;P&H/&LFN!6Z\6FT;RVG_-=-Q6EW&]&VJO4=5;'.BPV506Q%4 MB2=J]:=#O(^-33M>>"J(Z.N!U4,F#R07^9!#/"&./IB)!0[]Z$^ZI M5J5'$:4S>\2NJS.+4FD".E9UC+UA_(W"T2Y!U;N*^8/1>FJ)WSLNOL+E\/2Y M#W@Z01YYW21A$-N#$&^S-D'.#KFA M:IB\!_JB@WM3P!,]2K0.&=QQL5+11&@FXTJUSSG0NB@WXO*9AA MW&YXH)-*\";BG4VW^!X>Z5X4#,JD9J+=:-ATBD92F^UKSE_ YQ %];81T)C. MG4B?[L[/P#&P$H42/X9OK;-[)T)7#=+_.NH<^D=KM5G3.%0]6GW/S'<\:L9H MYH?4ML<\]WV3=Z[WYNUT+ALJ<*4'"'.%!!&8.!@WCDS"J? AP8(D#,SEG1GG M'>D'ZAVX)1S+4& \UK>G2*V=F4@(,'[8EED[^#)XNZ\X-@S[2LF3)-8S7#LY M7:DBB HB$,::919K/#L M8%1T*.U3VU4<\.03+9ES=D\\]Y7'U2K5Y'\J?Y*$>8-P:"1<&3."D( =6:3X ME]+39>>$NW'B[M=",*+C&VO*8"7=HGPE53P)[1D)5-+55/3)Z^U'9.GG_UA6 M5):"JK3&1NI*"(UZ(/@..$\T:WK*%)H[4,ZHX*BS M)3GN(P;+.C87@/918R.J,D8!)/7=XQT&5P%FY.4/3H#%FW4PXL7J72SJ M+7;-JJ0Z/7<+G95 OS4>,]7@S*YF.6ZVCGM,>MRB<4B>Z_=6QEL;P=-KI&0< MX.CT0.4TTZV')!N$/82!HZ$C&'@P>1DKAQ8#?!EYR3!%CC&(IXN%.";93C2V M(XDM_F#)A+G?*Z)R4DHD?+]W8-ZLVH-/.ASRS* .F4V(Q_I!I]BTS+2\_J)# M0!&.UC/2L0,,804V 2/?!"R\5R4;B.INJ?Y96PKZH$U1>/^4[&!)8E18] D2 M-D@S9>7O$7LU@B!6)= [Z.V(.5+7JM-5T(*^*GH9:"82*$@B;R<(AW?!,Z 2 MV !DRK WY^+8;;1T>/%B"S)=P,^9B+K-7O&4?"\9!3ZDNZ PUA#5(8M"]&B7 MG V3@D$;'PL,;G\\3]6!N;._%ZH DT;;MG$+?\&#X+O ;$8>L< 3>PAMJ[]H M#*^=?5H,&L4ZDHC#L\$"$PSEG %_#D^!GQT42!?K"$SECCSZC/V%CG4W"]U"SN"C_ )?5:M_H:2DA$Y;*5:Z6\A.+<0^CL%&T[BR?:D^8K\*\?:TZ78;9[,]%>K/[K.>-5^B M>"P%A2H=)&X5^P"B#,+CC;6'&&W0GO;OXTT'&I")_Q;<4$2J@*#\G](-F2H) M90LJ4N% &$8.;0)FOUPR/KIF!R!Z3:Z#>:_!**+WD8=( QUA3P%KUC7B_LZ0 M W0%7B:(+E"5*=3%TP'\"YG9K/R)Z@XUM,,H[- ,B& (Q%L? M59F*A@ RI55ZC]#!18:91)YK>36JN?L2+/LU N4_3TS;;F_P2&\(FU#[,..$ M7/M$N10:'E+>'FW_W-UZ&Q[MZ?KL>63(W< FVZ#?C:V$O"_<8T,"C?@<4>N= M(]L]J+ YQTI@(/:CI0!X"EIZ+E,(;?4;=@0%&\%"P3AQ:12U__[/>/I'PZN< MLTSC/H_18YN>S([WF_GM4_G?SP$G^IK^?6IEUV]N'EJ>GBF^W+$/J"F>2T7L MQPS=CUJUH"&%0!M7A#@H)'"GT@V$1+.U[I!T&R+O 'G5AQR1+NX*X!^O?9]H M$#,Z$WKFXOBLF,=E6TYO02_!?RW-[#=F%"Z_L99,$,,8@VJ\$14);G:;_9RR MABL8P!1\=2*QT08\J^9M O2UTZ^=MAI%:\]QW;J]CQ>%RO945BXI>-F^\92? M=2_-,L4-8N#3F+'[F:O(,@P9)B(@_6HW6O,*B8'?@S8=H:?V;R<^K40-T*)2 M#P8A&C*J7Z*EFX&,2B13^M<-IO_#2M#>NXWI_="PG=1]G7)3X[3-6ZD/_S>A+.3-V5]?'PEV[ZFT!5W#(5H@?J"?*=EE5E-0[8E:(WI(A7WN MD&(*I^+7'8YBE687XXZW73/*\XO$BGH36;D;1]BF'"A<:0-/\>@[TZJGLDP] MX NZ,"4:N+TNKI%F.I$FYHN_M:Z1+^0X; MXT\V#P4AE:L0N0KP!XW#<^+)]_K0&.:81D97 MSRYE+33?S^RQL'$GFZO2'83[8I73IM2VH\E0546MI!K;3,/.64*9JGFJTC)LPSC8.'S%VB MD"(T'M(T)3-Q1@N:/$T')0MEDI.*PC1N(D7QB C4**;#CU+\J4A#=_L?V'?[ MXKU9%]^UGG>M]7V?S[/>9U&Z>A5KDLX1$:OW^8D,*-&AW^A DG@B6L-_3)_D M%Z'6T[O]S37VGB4.@TT>C+7)H]7@$V$[(Y=X*D/YGE\ZA$8 IB.:7X6\(=MP M-&)K&QV?FCB.;9H1-]:.BCU8BPNW*H\['ZNYO-_0]E4TJXL5AD>Q7)K MXFK$,] ">(PH19G/6=2.(K'J5 NA_HZ"D#ZHM?@K>?/+YZ7)(*-25O5K$@R3[[63K-HD;;SH.+D!'V0)ZV]G/ MKWMAG4&@?%)A&0?&(3G%L%*6@-KNRSDD47:$L4_<1)T^'@4@\CP4FPU>8(&2 M4DJS 5-U>('BN6>!?XK$=L:X!:!533*VA3X%TTQ^4D+^8;O) 49%I29+RV^) M"U6'(@I&6<+W+UNWN_BYK*\Y6SRC[J%.(%JDKMV5Y\AY"J8=)8.HRIL)I-ZH''R/O^4N, -85/'RTJ]8CX;GZ;([[-!> MP$)#7O,I^"\/ AX)&&.C(\FHTU<>OKM#[KD2_8XMCZ/U9=9H^S7IK&NQO\C= M7LBT0X&X.5#3)H]XBF. 3IA.OAE8BQXBVNE6](_ =*P*5FE2+E3L<7L[N,+DFOE!!87.Q%\N8E)WHQ./#;JFD6;K_Z(O7B:IUQ#Z%FLJH4UQLQ%J,GKM9_2P_I)SG,^!T>]$&HFIPZX+LJ M]#%OG,#4A$D%E)Z_W%38]<3"K1#U81@LZ0Y[; CA>N)C;*M8[,H_CE 7FN>P M>!L2ZN:>NHK,R/0P[L"EA;/(>GUJ,Y7;&G^Y.J8=734J1EPBQ!DWD%<\"'YI MA6UV- _PHTJ;C]G "35!LY(RNZ2#JBE%AO. >6<[JR M)A(XD#2Q;F!X4Q 2 M<'V0VFS8_A LC)8Q4^VS0QW2OE>-KL-\IW.:C5UQ!463GR B3.[$44#.*.%M M,_9AMA!C=0ZJ,S4JWRMIO>"*L,H6OU@M*EQP2IP"](V-,_89U'JEQF,I6HOD MLLJRDZ"OH1T8\T\0+*,8A>W91\922N!K=:)NQ(^(3>2+\>EAX'DUW^Y",HKW ML\K%OQN]'RCC3BINF*CWSNSX.#$2/'6M;F9B>QNWG1JZ>KZ+RH,-B"5CM&7. MF(C^HH>51\:Z#:MDF#5@KX"TJY^TF7AZ@!@WN9H]B2_C>1)WZ.C=\K1.XS^E M#6](APC9GPLPCG*3M!'D/\K)3239&LX^"^WU-3NJ$Y=VAJ[,N>[;\?)EY?M7 MS(&*Z+8/]Q(R' <8UO)!:4T;N; M*7GY1VX8$:^2@$Z(+LEF0SC(TF$$_&W\9$F^<3>H5,5["Q%;<":X5L -@9.( MC>_A>_LY3@\)^R6H>&AXZQV+[ % 6\A\8EL)*UE:\_NK)1(#M'$KPH+N0$.: M#7AL2CE55*/4YO/;.!MRFN-!ZF*7??4T-2E#N=)$CL3R!QOZQX_65;'^6OSH M\_V$^_C2TQSTL_/W$KR1#6/GDAKJDSQSOJY@+S)YC* !=F!]0S5^E@L7=3-, M-7INE=)*L2(&ZUC=$;FTC:!$32YNY[8Q5/1MAD1 GZ=SZM:MYG4MX_/F5]T# M9#Z!]1?D!#RRI0\W39WH#<[&S&NT1_CT,!EM*>-8Z"+T M-#"AF7!@Z3P^#!_^IWU(*K$B Z1M3+JGU9$XY$>=Y("#^SA5I;]:R1' M-"6>,E@%Z4USYELI6?E$7[PNK6-B+QBA4A3!?0"LD&]&_%IWK%SW!]3.$,>S MI_3$IWP#EC@.5?%VUZC"EE'CH%!R@PNE7=NP5CO6. &2#%5N?!=R_ M^^6%4-T!H?%PA;I00!^UZB9;\W8:3 F(TWD+%5N,7[J["30^,:J:!6BVDK\Q MSOV;)))U2ZL4Y^U]I"\.]=4'L2,]LR^H]=?Y=.KBBYSX,9E\+)/+Z%>]BZ^B MUB0E+")<-/06?LRCE>2K7/O5IYCGF[^5W9SB;5CP-1\",)N,;OYV MF,:PK5\)(X@Y>%V8]FA2LY([I.BT=Q+H*X)NEI^AI)C@8JIP?KB N4ADI'UL+'Z\E!%EO/,V.)W6AM&,)AIG7DI#Q8 -(JJ MS0LX5XZ53E)@!+A,VIV9V1Y4S#E^$$N)7#E(VB>SMRCZ:V>U%[8XD-C%)K4] MI#,?B<7_66K"NC;%^Z*0ERL&?:,UA0=34PZ@/T'\^0;*#>-6?<;WA\"#) M+.4?46"E[LN/^K0W)@BGY 6I6+=B1(<(;@*C:Q]QWX,)31;1;OF"\RZIZ:*N MGR[Y)?PDM[_.+G6]U&6\%W,U2E9\[FZ==I^7+SY'/E'M8KCM2'WE!J:0D.NM MHX+_5XU[:R_FW9JZE_510J0T$*Q_4^^8%V;1A[S\+ZST!4+68O[[@3GN,-\5KT^?A*[7.E MQ\4:1 [/*JO[M^6)7&;DVG0* M$0=SGPUS\Y^:\9(\DVR=6KH;N7;-CXHR+R]#Q-!\K7F+EI:SX2U>0SM<=ATG M-JWD)X>M?M??5G1(_@R_YO3^-:3>M'-3"Y\@OB'.:R!J&D%TCK"M<_GV-3]^ MB%GVLN5]]PEJ,>0+R=LS0>B<33!_-&_*W\A(=GZPKA/V:JH1]KL>YDWRDFS% M?#1I^ U$G30[L7+/>)T<$DZ07+AJ?M8TZ$VJ/=[5]U^?6OP_/@?BT\C?4$L# M!!0 ( %2">U@]&U(RQ5H )ER 0 9F]R;3(P+69?,# T+FIP9^R\ M#503Y[HV/(J*@!C^) I"5%2TB*D"4B%DJE11$:-214%(+2H_*69;I$0)&04A M_ BI92N[6(F(@):?B(!4A 1(@%I*^2<"E?RUBOS(C$(8R63RC?N<]SW[/;M[ MK7/><[[O/=^[3EC/RIJ99SW/<]_/?=_7=4UF,#PS* &+?;OW[@;FS9L'?$;\ M 89AP/?]T7_H\WZ0_^@8\PR-@.5B(';^,:-Y:X#YEO.,+.<99 % .8M_*<. MP#]_YLTW6K!PD?%B$U,SHD.-!3!_GI'1_ 5&"Q[X;5NGW^99&)J2UZ^PF[=>N<-&S]P]]CF M^=%V+]]/=NWVV[-W7^"G1XX&'3L>''[J])F(R*CHV/-Q7\5S+EQ,OI*2RD]+ MS_@FY\_7;^3^Y=N\.X5WBXI+[MW__F%5=US5+92VM;3\^_:FGMZ]_ M0/YL<$BEUOSV^XN7HZ_&D#=OIV>TL^B[N?=VS0.,_J?I?VB7)6'7_ 4+C!88 MO[=KWOSX]QTL%RQGFQSO)D_GO'#ZB'KYV;P3N9ASV&8#8F2%7-3S&<5E[Q)Z"&FG>35 M:JC66(_ILPS G/FH 4A9AI3BWY!U?X(4G<\41*"-B//N7**?_J,K@K\?8?S5 M]QN,7C#_7QH:/R5A"8?\- (I-8,"!QJ J[BI_@?Z1HZW.FA"H-N'_R@VT__% M (0_IAV'AT-0?Z1V/RJ [6GY;2]<,:X,O6)RL=7;9PIXFWD\-7.5R0 ^;1KF-:']4E>S^R>_*\ ?>^_=4UOZF9QT[VZ8+_;& LY/2.9$*E,U@E5_R)&[//8L*$+^66@4P8P#2:O$M2%#Z=!J=RJ7#MJ7E#*7"9/AX M6W&TQ%)LAE*DE:.\#U&!FI%V;><06>HMRJLGS%S8IB]DTTFHM[HSF6NF6\NQ M"P$'@[16Z+"&S1>2N;[(4H8C]ADBFA0A)8=1_W-1NLVO\IB9]5YY\F2Z^2[5 MK8CCR!=V"FQM7E7G]WXGSU4<\U,]%M7 I!'VOW&K)':\#0:@Z32^A>/7(GGD M4WL99HX1&Y>-VK MD?7HXX+QV;J!$I9:834*F>)&:,)>I(0_PR9A'R'.,CTY0()L\M=T#I.TDX3# M8I62B6$U8QG7'@U02\R)J0_CR_!?#, *6H#.6X$=@@>N(?8JSVP#2502\YJ&U!250TB+W;I&XPD1 MMD&4Q9S^6C*@_09@KYG^!W#JY03; '2QF:G,!VS,9DI; M@U"3P,^HE\2T*KBV!;P*UBA2):>9:T?1]R9*!20[VD&("F= M]ZL!<#0 IZA#L9JSCV'YD6[LD*HS50('@'P)N7X['*%>,(M@F_MY'Z"=N.E" M^*7R$_Q#N0%0.>0PD%WB O)E;FC"W1U0\=@=ER,A%^[V>EA:!Y\ >'?^R"2_ MOS=]!ITJ)=S[*<2:] [I R/TIT&E4&+* U&&MEA?SS-&JS1MK5/6V G8[LKF! MJBRJ;*!3I;"6LHI#Q^GD_B\\_!/#F^9>%]T9S:6O@VM>7U>4]3$M M$[<):A7-[6%.-AD " R'\.2+H&H7-]H W$W!?Z7,OM5Z&H!13U'QO=ND;Z$_ MN%+X!R/,16< [W+_PT.7L0=CU>0V$@F+U5>*EZ)2[66T "F12LP\!(-#LXU# MG2TQ;BH .9IN+!->B:>O1W9_0\67BX46*5[&LH_<33GFXVKX]5+4UP'3, M]0NDB3P0A\0W=KZC=:(;0#T7;P/G"N(^ '2SN+6(#'5]R<:,>L%WBP3_&EU^ M&[V]M.J_^_Q7Z4/BH&P1RVYX//R(.*$[VKVS:BIU@.K2B7>]K=1&KGXN^2G3 M>S;\L^%:UV\>TBWU!L!2[P[I?SKT\"=_6;)^"]2 [#+XT\US[E[#,"U MA^-X_00X'1AD]O%"FT/_]L9EZ3P,P%-BK*8]T,28F 2--T"?U^D^$'OH\XBU M$HFNO MJXYC&DID1264HD'A]E\W!>?_B*"5 M/=C6)%PBB98LXN[.;!);2."*:V4LL3=<+$2VNL8>(TH*FS\K-NIS[^#AYNQF M.P+&3L(O"GW*'FF_QI[J#N#M0EO>!]S=^A*NBXIAWJ(FHT6("VXRKCO$H1X9 MX#EQ=Z/.JN<)._4WZL.+1B76^"*!@+*DFF&#]JK(6:Z!37/QF9B#"&7YA899 M(F=G0V LGDRG(#X=V)G3F^:JI,8L9UKH2+,PD'=+;Y."OQQPA+ M'33)+,>\D7BB[)]FFV FL")S6,M'500RGG;_ !]W?LILCNGB'3% MSJ*;ZZ,T&W[4??O-)?J/O37,9PK-XGZZ.>F*PHP6YX1]C"8B]FKG)CVDE"35 M_,AU0/PT05<\!%D\:S0+\6W*:^7'%T:): M/OO'R?-64JU2ND_("=P?8#/*%)KCU<^R#+@,0 MP2KW53X798+1,8'-=:VE):AQ8+]X<>1E?-F8W6SV>0.0*K3D64H Z%:.N?TM-I<#[A1FX"6CF7CI,&M3'U'NKV,\><]F: +?#R)&2M)J. M!&TB@807N;'ZJ]QX54)[C%%3_C)D6Y7J,3=0,[4$E3?3-SQ"KZGTO)?2.D%Z MV6>]F+7:W)[1[W$?/"- UX,RTL)VF"J%[&GV.G<6Q0BWQ+N"0"M!T]YJ ["( M&TJV,R^9B$7D6DY-7QP!MZ3!7.4.M.G<.0TEC;*TAK1P%++CVFN8%.PC.#>9 M^KI&D"VTC"O-LM_?=8F.HW*E\-E-E:L@#5^#^>EOT4W&ZJ;:0A..PXZEX2KJ MH+!):(%OQ+L=/T KBQL4Z9@Y.97KHHP):5&0XRB.'*@Y-_AEUO0XZA&S]6US MF&4?%J3)3*-153%^0;V/Z,O1'&T@6A7U/?=X#]V10VGFK8-G6Q/VU(=26Q3) MP'20I8YFR,Z N'LLXFC2 M3MH4C-]7^H0UG:7S8/9$#B)2*29J#<""=W M/XZ=BJ]"]3KC8 []C0-)5C>5 M?GXJ!;(Q%S2RTRA54U;FOM7(K9=]53D46=ZHH"F"VK$[92KD)+7HN7#E4#]8B7\]5/CLYF ME8SYO='YZ2\9@*BI%,?5O5RFDF*+K47;U8ED1JZJNY].125M/%,QPDSE!A [ M\KN>T.[A0BLL%'$4W4$IZMVWN:=+,'_]S1JVPW,NW>6BV ,NR?@\E9TN=D!L MW/:] Y= RC];1,+<%75HH1(:[&SCK86=VRC/(EKR-\EG0/,=:@?&<72'CM @ M-/$*_*=\$$V,N3^>OX2E>TYEHO>5'0S916HR^TQR\Y \Y6P,&_/5AAX]/IW6 M"/K.=)"T'FB!IM,6[Z2[H:$PJ[,&4C,^'RF12:RX]-UH[.GX[YM,!\=P#TD/ MS4<58DZ1Q@<=CJY]Q#-^V.6Z*27_VK);WU$R;BC@?9U7M1'^TC%27L:Q;QKP6EIY"[F)FT3H#G!W5L$C_(+G> <1 M8@'EG.2/D2]J[3:G:Y@+4<*M&YQ;.X=>*Q@&X$KN,?VW^%KN/KD[TQ*EMN&6 M7>Y&<*=Z=@*)@35M V*JG!90@H54"G>R/B,][YR'[81%LELN1_LQY\1SL20^ M%JZA$.'TL&\3U3TK_&-$< G;D:"26$5>_$5PKV4A+HPU__V;,;O87W<^FGN9 M.N-CW.+E7COB*)].W/VV1G0=/*,PXZ0.MT&/_%IBF'OZ,+<"[*+^>RK&5()+ MQH\&>865LU1@*F6!V!3O.,PIGMWW)&E $R!0!V70C=$J&*9,&) M"+U^U^L'I[$Z8,.=C+\V%_749>&;"T+X(#3W3I\-S>P<.Z+-XH;";CC##3?2=C _#O:$;/>'_#;_R:08D:+!88@,?[-AC]Y5_=UWHB M2J>\V18*R6_Q\8QH5>2_9QY E 2J@O%!H3G/$^_-]T2I=_"G81_"Y,EYB!M! M-]7S?O?F>C @-]/X5.3S*4S5]YN$;R+T8;>38+Z+E^^_#7)_0\]X/[' M*]/1,P!4^H<>Z/X''F9-S&TPTI F!7_C \]_\H&?5O*W#B;_DX-%503+O_H/ M-O.//2SNO'.)_N%_DB$#HHGGL$@C3!&OPWN(A$0U#MD+MS51 MK3D&H)7NT'6>?<4 +"V&#][\%#&6@?,PK_ZS'C%?OGX1TAL1<=LG*ZOZD//P MZ_77!Z@5]V[/S]CP[VJDDZC?+.8WW6T 9C?NHBPF/)J&YX'X[QMN+PU7^V%9 MN8VEJ;\W6#&=P_O%6[VS''XRFF;6Z_W MCM;$,<;#7PU 9STQ^@L&OEX:JJ$O1*8VPF;$$E03@S^$WV ;TK0CZ_%=F M]-&YV/&+[$PH(M'[0/_Z1P\:JOTSA\W,8X]7/\P_YQ+<]/V8R:*F^&USP9)F MQ:"+5'. OJH*/7X[*[S5DDOK_N6Q9G3Z%!6=M"L MFTC)$\02+-MI6YOS6'OMO[^4N$L;(GPW*\2QIT0(=?_M@?RG0YB//OM%WXRY M+1GUV59S%VWN5+TH+]R%K/\I@+D/3;DWM*V@A&,?FP A!<,P-3/0BR M\K\<<8(P-W:C:&Y]'15?-&X L!\*\16URB"]=2C9 !@1VX.?.&AV);'JC%J!G%)>9TP'GF9@Y$=WOSGWL M./Z/_9,"2;=AID1(L.X067-68@#:,T#53=Y"J-NC&X(]F0;@]Q8@031X%GHY M NG>.AL :[^_/0A;9@"6#,,N>'I%I@&X7&< #,#F#80\B4&)*Y_(B5QI? X9 M@%R;>:\E_^V)_UL]P=R*;24;:_/U%:Y#)C:^1;R?#]_?\N/RFX)YZ."QE5=/ M\GY^LHE[RKQ=7G] $5=4VM4,"T,%UF@"$]J)T@K(N0M1=M!!-Q\*S M+Z[3-Q]+%UG[(@?RJ14W?+P^6G-C,N*&?>2=5.<]3Z\"B26_M1L VET#(+;' M-KPY;0#R#T,*?IO7_37.ZO0^EV%[2)4Y]\WHY@7N06#D-)QGE?7 M])Z8UQ[E[*:+.[']7H),]T2[D=<#FJ/]-##FWK.H!R>&.Q+.+8B5=7Q[EQ.K M#4 6/KJ50- 71XXO\^& *RWH7A0YCS+IK([YO/?H ]BF@ZUYHM_\\@!Z/W91 MP6EE0DHD+2(^8NT ONS;8->+ ?1='P#T^_^R/IL+6XERNA&<2C4 ILA'XOF8 MTP\9+IF)3J'Y)NILCG.R6MAR_&3^BD.G,B)/"]IB5E;ZVV^ZUFZ_=<_5BJN? M)ITR "GSX$+\$H] 4*D0"3< -_, K6 ]\]WOSGI8H?++H6)O+S-B5- K_$CAF %R\N^10^S<4O[#4 7$_TT-^XU:7% /Q]=P%ZD&(* MCAJKJ=AV V +OGM\FQ3YCPR$_JYS(6YCW"R8FX<2^;(4:A'@9R.-AFC?0B__ M+)R50BF.^R5O?V+H5)+F>N;?]_QOZ_^OLWYPW\/O/OP@7#<7PU:10_5U*9BGA%*$K]./[:W@E/Z:=_9LFI_ MLYMZYM&_/!]S.5GBVO&;.W0G>B+T&7--QL/,\C/AZ2J/L[=H+[+68W Q(8* MZWWH?;@JM*9*TB7>P-TFWQ1'6?(JWZ-7=)Y-X?@?J>KCDLL56=1/D*R4 6'9 M"4)-^D1\>KK776 U]'1SYOVQ38^V!?4^__#*[!6+/:N2EBZF6?@=]/M\P[S_ MH?K>-RWE"@3)H "* ?CRSX=@P10J>%5H %X?S@!>T/]7MB;ZEK<9[U=8BB21 M[&S05&R)/P6MQ%M%C;>"B/ITI3Y&X^JF;FND )%L-=,.VP+7MO@[>/OUX$[< MC[NX>Q/,I]@M^MT M1,B\?7:;]'"#*(L( @CO4TP+P PA^@WS(=4 ^!"X\/?G -V:#%3QQT,5_I^; MX3/Y9]U1DK/\C1" =S!%O.53XP6;#U0=/I55<%ORC2 M0)BA6-&BRA08I<%AU.#37"F123,?H6A'RU8L8#?7H[3'J?&:V@<+_2\^D> MW+.$W"C .T#XD+?B68[&,;>8:P?'C6&?H/Z425_=YLU"Q%,M3#H[/2B>AW:4 MJ=![YZ\\A"O>O:Z/,I]LIE>"TJF41T?K$I]7<3+4%#F(1I*&_C)##'H!^Y1 M\&_TUR3O)@X:_Y@'8M:25KL;E1I"\RP?%9I5!X1(XR^R4W$2=S?LG%4?=%H# M.E:4Z'9C!U")FC+DHO&I$235N]F UIBW2I)AOBT3'M,%H03^"=1AETNC+TJR M)^J]U3DL]FSG1)42RE28BRVCQ(O0]E*.]Y$![A9>GO,5?I)K3/ETEENCG1^? MYED497=*P"+"(/N$%P?-,P:>6OV!G]=[28DLBP M#Q!5WTGXMZ%:/F:-.!U%=K7F^HQ\IY7'>QW]-M$U]Z:#[$'BK=/G=5]=,MUP MYY^;B%^M&+9O"W/MH[&)LOI$ZZ"_+W;A,)I &WP3=S5$05FMS$I&*N:MIMI@ M9#13S4SA;?^AZ[PP@U(COT2+=Q3$:*@FK!O!<8HT&J7@1/311]W1%L'V_C4 M]^4=/B#!L[__X[. ;O/_)Y/4V[5+[2@98C=>5Q@9R>;;-B@-@!5WK5Y8W6D= MF0O_-,>KO3UN)YPT*XZNBQDK;#[SH'_3ZF^:7Y \UCR^TFGT^ZF_>-X@5A' M3:2\S9(,&[]'*812=>"XL(8\$5Z!0JJ7,H%-P+V]2!BNDUYLPVSF0TL]KU2;,$.>H+X% M(?K2O? SM$8]'.)#]A,V7UQ4R)DW728D++EJS?%7E4C-3J'KBD8G=31>I] 4 M\T/.#A\<<$*F)O05O%^"G5L[O.3[T'6J3/:\-DH&;1VRET<-&9776J :E2_' M[9->VN&JT?S- ME16]OXU42)X& ?R[F>:N;R3J7@,K0(]^#<#$V9H'G"PZTC M&Q'C9LI"-*214G7T%AS>G.<;E:QJN\0%-??%KFCN7CFS#1D7FD\0+-T$#5=-RA?W#^H'&WPJRF7/?$3"5QH MU)F0-GY'*']X%DC,W?6?.DTT:JPM1HS3>5LX?LH2&7N0I9F=, !JD,*AJ/VR ML65EV &$--&BALPYJ5(546^D.M**J',,F*+-0)^6O0IN*,$V298\'ZR0W'D5 M?+;@B]EVUGV?CL*0!\8#?8=V 39_;8=.!#C4-+3\?#>M_';>B\.%L8O+U1?N M#M6?C4D;WKW[P*+=D?.#790,OO"1I(62H2!A)HA_(Q,^8 "&22=@JDRRB,-4 MDY+B:A%"BEKK]B:&-]/=NB:X?JJ&(]/E+*VBM^;6EAH'^\,/ZV.\@WHGXKR= M/ =%$Y-G"V_83/R?+0+_.Y, .9>V,H"E=^?^T;9Y&( H9G;OW:]#H28/D*6[ M>5S#V5RN4 LPZ\=6ZJ%3D267\ZG#->MVY:WGM,M>K4EUM2^\U#B?:H^M>( B M,%.K0+=7H/$[Y4HT72/)<+3KK1:N"/&GIIRE[;K'78'^*9]\4V;;.C+FW;%> M*G,M&O.\(;?UNE[V8)@"!DBNVD?Q#J)M.F-N.)JEZ5P9&E7GUWC!W?5X-35] M"!)P]Y:-?\D9;@U;UP6>AE+!JN\,P,/<[&DSB.^9I-!"2+8('M.TTC<@/_/< M$"L'"C-S![@P+H#!^*%_BK>;"-O/>+^ -8()2[5@:%C&M)"<(:$;V&UR5(ID MXXRD=DWG$$N[$?D)-=)R>PIK'\.I.65#J%2KJZL%;>+LGZ3V8&RUV9:O/,R= MF\26MD%=+=L*3H$A1$[\X1Z]6\]X1E&?/[J-8D-SN4V4%!8R%80H9 8@4[RA MB^NF"?4/0V-5.L5R[@5X5J8PY:Z&R^AKT%,T4IFOJF'AV9F;D@ROMF87,V]1 M)H7$C3GU9QC MD?J'ZM(]F-^]R$?DK?[GPN^&C;LDQ!8?_W7OVH&!PTU+*GJ<[-[Y_]>,T7_G M)/I-?WM;F-NF6\GKB8=L>>NX;'2O6G1)LEP,$"HI5"E, BW>/QYXK)^WB*4) MAN-;?5B:>'[]ZC(.= RU1FYJMB6UQ$%)8L_J_NK)B$^[:UA4YX ?0E9,>BPO M.7R)!JH\L7PF9J/ VZ+5& =UT=$X3JJ13 V5A($_#'#C M$7D+PG%N7C_>,K*QNJ%K.F:;:[1ZP'NX%/W$TN]/Z_(2.$YYI][5[B!"N)+7 M*:8\0,YFZ@YRPM74"1%2T@@ZND)G#, RKGD_S5-$D((-3U!A!7=3+2I79D) M-%3%YN-K=VF>&ZLITNV*$_!7)8MR"J/)@ MQ&*D\$QA:BK=%6RB+.=ZZF_3C7G=^8M1/L'*W@:@]V.*.7*EYU45TIE2'DDUA:%C=L^*CR8E/CE\R66RX=7'U>JO8T$Z9XZ92IY:;ZD*.!\E M-*61X/8FQ[7\HUVWV/60*'KH5D618^W]7_>6-4%W+B7<(#3DPF7ZJ^>]%9G; MPM:A_:3D7J7P4OUIQ+<&(M5?H[V!O33O)8%C7EE_=GOS%07^%'H6?Q2F9HB= M(HD58B?+./&-(UO[N?,T+C[.VGA]T0S5GA/2$F:/ADA$5'P16;: MG$>N5)$JK^3DJ.D-]SF'Y5(#0-*>B!S9W.^>Q3/NX;_T:Q&A:USU([FZO1R< MDHU_I+^-K^7N0:D(B["_NH'M"PNDBLRP54\0_N0A^*:V!H7*T2?:= 1,H[%. MJSOMN8Z(J)FQE!/1^&AD%-T1=TU7LKV>ANGH/?.;7 +AJ;(B9&UY$G M0W2',#KZ2DT=]M;PTWADKB\ZH]O'W8O>5W?.CW93\+ MJ^.OG$0Z&P]+K*JA^4QL6R6%7.])"\3 @,"61VZRP.3 M*FB>L><0C4S>&PE:0,IO%!;+SJ"LD\4M$!6SXDMOC*R$?_G+CR-N=7D?X1_Y M12V<31/MGS57>A>Y%(=PBFGAK>(-4-.Z(AB%%/!^,@"U M\1-3*M*5>!=E9_(;=#Q0_P2,FG33IF6VAJLIZ?5[OX\,6]R 6JHYFZ:JXW,9 M VN1)73[T+!^UQIIU.TP@'<-"]!7T:U1)RU;7T9 ,VCRJ #QDTHJAS&H"U\W MZN7ZJ$AULUV2)JP*+=)P&6CBG3%\0_>DNT[70#G^\ >X3[R^)WR ^T%<:8+. M/V ?GK@97[Z=9/[7A_3"1198#/QRHMNYA=\MB:181(>9P]WHN7NHF3JMJI<6 MJ^E,'J*VL\Q+YM,XSK;ICOOUSYL?] MT^-TOR;* R[!I)JVB"2?,59PYCBTTPBHC46FI)U9PN7G2[?3@A+*N%^@;XM9 M]??8;1 3;M$C3K1B9Y]K=\U3P)-.(=86"BJ_D]C0%B)F:G:R)*K!5M,$ MFF$+5:1TW'7 0\$7+L<2TJ0:2*S!_? B]O$1B7CX] ME9K'SJSY%+UNSYG/6HX=SUH[YWE%HBP$*YE9TS%4F9UQ6\S**#N1=&K(11WU M6(XY(]9-;R/#5NB_H4@UVNO52/$MM0%8'!E,5*HH.%K10J?TU9\F1,J-8)+, M.]'Z,)]9";=HTQZ.F< OKA/HN \>25&2KN1;"K3?HI>+T5PE?R*3\,(O3#,N M5,3="M<4%ZHZ*7B[HF9;J>X8YHK.$.,324L0.NO(O,;,5OE /D5.7S9V/_[. M6+Y=U0]FZO:8G7/>-Y?FJ)F8I; 1M*.;&H!F8R1$,R6CV'"/(O&3+#5[Z(E& MU/:W.Y+UW[,K\ VC^?0> M^NK(?#LDOLTA7+DT6?4"32S!O/MBN"'Q%>CL_D==]4X0+&_E?52/S*;%N<2X M->(.R*+,;3?5#4=H\837)=6(8K)&Q1BV,@ :;:6KZ#*^!:6J%T&90%K")LVQHE)*XEXD=0SNI]QSB^:FONB61I5@RY.%%)#*3?F.HKO:R!S=+9YQ&Z@VG61CZ\L MZ"O_@JC&:Q<,L/R3[,9QSHEN\YI788H!VX:3:16 Z5A>']B:/ MA#0Y2[4*>,_S;?[M4\LYA=KK2$F&^ /T[4Z"]%P*0$K5ZSJEC"61-XB IJ_% M%0HS,05;BT1DNS,7C8I7UW3CCI&4]V\Y=3;?$)/@I<)X]<)^]%?K?:4!2!>:8?&(F6]_V72G*2=0LSE3 M&; 5).V;-QW4RD WO-_'88USRU2JQ.&L"+?G4)6UC9J3P4[BK;X^/4/U'L;@[SQ(EQS-:I_QK*^6?/:X/,?/QPM]= M4%A 3<<@I9"^# U743/Q5?H"52]MF89AQ3T Y__Y(7#;Y4%5^3/ M;@>K7V+6.9_HBW@;L4-HX04D.1@.5L1W/K)!/)NL\$ M0R_]!V)$+Q#Z-8])N<"#AMIJ!_P3(KF>IVME1]^,QR;?J[.E>:O M[N-NC]/?TC3$'D3.7%<+5C+19A^S)N0L#&Z18%:-FIT+(*TZDW()N";OBN)39K)&AR M$$&T+XWM'VD^^NB7/T4:O023*?!1, 5:-@.F>/+6H/-T?EQK- #1J,FMU"N2 MA6 D,_T&9$S%+5 #H(YOU/NJZ4(-9<$^ ["43D7'U:3+,^4?8VO0G'-*C<8 MS$//2EO.H;Z! O^&;X(>A"C">@E"?T\",QQ"FDC$S76=5@ M)I,/S5Z9#O5L/>A_/WH5I?@B?U*C6Q[%?/_3_YD./^U-U#<"T?CW59Q/9*BN MC*S?H78 Q_ 7Y4B9D>K&J['#/O5Y$IQD^XXDA5:5-QO!9J\NM-2OW]N_UQK MUM*"I[Y$3+CH+Y>@Q8$I-?',FQ+?SS,0H2I_ EHM9KQ_?'3J&EJJ=4U[3 M8N"Q9A8!$%4#Y@(98(62O47\>=,)=ZA-_, MIKQB.M*8B&>;? AJ8:R("G-!X^&V-F%5KI1#([/6UY1PWK:*/7OKW53^UV?! M) CVHZ01>H<;48!]C,Q.;E>)'#G%PUKA^R?1\)Y\I[YRHGH?K.NC,;['98[+ M"O\^YX;.T7>K5/I0X MKJ(,Y6HO(B^JE%1SU%_=EC(CLL(8+U2X=;BW#H\Y]&[)]D6IX\!]D6E?C'O[,"E1EAJRC&]1%P*6[G MZV?<(GDP-?E8YUA,Q(AIVR'; 3O^9*+N7(ON\V!L9Z(/-SHX@3E_L)4V+T$U MG>\BL"2<\J>QH4\_J/-)Z)RXH%N#*IHA^*!BN%1;B1")% $/JW+3J1,86?<1 MA]*:UW:9W3&57G^AD.N1JVU!WZI"G1IQ)^0S>"I9#*)R95"3Q!+]4M&2UU%R M=6JS*S:KNZ\?-%XTJ3DE9!TMRM"7A-P2-YX$4X['EUW1E :[?7Z MUH6BR+JO2FA#D>+1. FZX>6$O4IBP?T ?M2@.\Y=T1-G ++#+-%XS=25;>3\ M-;?(:E(2?=.XEX1/=T"K/A:'+.IE?DP(W6I7AA2.#JJ]\=7<[$^&O+Q/JB<+2A9-="Q>1S@JMMHRXF&3UOCUM8FPJ=')<\ M,P"X!752A.Z]X2S^H>$Q$6F7R>GD@#WEY2H[LG9_[O+^H!?FWOCBDO(HX7Q( MM9\R9+TSX?U;OXIGN=KC?!D#?OBVW5\R:*T=E1N +VY*[+;=P+=2M2 EF/4A M:JK8$2++V2FNLLKRTN\G#$)?%#P#/H$$;0J^'FYD[O@;T '7@>^ M$F%G\K9S]@V?J.N;Z>2'46"@A@XV]']1W4"?F=E8/Y\: ZJ\>^H_BBL/;TI5 MKU;'@/ZNE[NQG?H:R2DBQ/B9TT(*QH'IE\LXI(/HR4*T9/?5\8O:FM,5W&BX M,ZT^!BZ4SO&R5%F4X'Z:OQITX#@WTYV11^DJA5DPZZ(*/I-RG_/P+:,:GJF* M/D(H20&Z[C G7G,@Y3ZV%^THXA[47^>1N7[Z1[P-7%N]L AEL&ZC/8I@O;@ MH0N1)U)H.;Z%D G,[X7I8:;=[E1'=-P//G/S+DIMJKNNE% R?;E>--.1T#:EV]6"0!H_&63/26C3SH&3QO!+*63R M&SH/%BGELE!/E6<+06!&Z'1[]#@LD!H LT7?%KV"K+[ *&J)+=?G-")*B9.8 MH=D&8-\5HU=4&Z@I&/R\@=3&VXC&%G#W/T1JTVA;"!8GF)R?5\Q/O'.,8RR3 MF-/IG)=2\6*87J*"TO)7]9\7F45[?H]OABL>WSL>D'"&PD#69Q6_(MN)TG^7 M=%5/?753J]5G%"!3K43,*& "^!:O0U-TV]#8-KHK^KO*!;)*+#F&QJD4*=KB M6?69@N^E;-:FBU>$2UV3)()I"N.8*S>@)"H^WF*'\^_B:P3*'4#P<=^V;\^( !^'QJ*(DHR\GH.<18 M>KBD9:'@XP?(^F]%:&XS[@H7%\94_%QW?4!8^BH8LQV0VWHZ\*]"RFP"8),X MNJ9<1;4VCVXZFN](%-P;I$%6TSEL>3;)'G-#))C-V^9\'[BM)3%(0Y;5(C._ M&0 R1H6'2.GT32!IVH$B'9DO&5A:$'Y!XQIR6 S+^4//C*9"S7!3/]TBM+0Q M6"2;,GFO2\L-S9!Y6\ '(^C\;ZPD._N&M@: MMN%Q/;P^IYPSTC,E)22*>[O0.)*^&OG$L[. P5+*L?$V_%!T%B\&&_OXLFO M_3I&L16;C\5R[>EV_6*K7SE0*$2. E?B3BA%59)4[Z=ZTA$>TG7>6[]X+(S> M/5,Z7MQ_)U>WR.S5%Y\U2/P3S 2=% >H:;4'9,U 2)_6H@5P:4@?=OR"SF:, M[O@(:9,*KP;[H[Z']-1?*1XRU_=VTTQ78AAZ:IX9"P?S@H&2:0V'D(]ZB@4X9 MU8Y[DH@=P6).I%F4ZTS6D8A=KF@[,?9'!'@;:_<(M _0HRR MY M)1(=OHZ,-E#UG -*J610+-.=X?_VRJ'#-,*$%+'#'8R%4E0MH]2$2S 1@L;>2M0Q-5T"#!/2>F"!D0MATQSA13.-KV M5L=5"%6 ^8UGG%#WYR&M8D>HR>)V=S4QH]@:$4[N M(A0KYH$>1_RTY:A6L51R2D\-TN?1O%7"#$6U/!5;!FOE4HF197THLEZG8C11 M^<*EYX7I7OO#%MFEUM[CB,+0;L3H6)]'*,CHR_6]8C3CIE9,GH1[59Y2QF6* M;7ZOC.X-!TV2D0CMEV@ K#D$TX(]GM8]UM^+N^6\!V5K['O+Q[TV&34A+>51 M<^*J<^$^6I%CKB=1O;QNM0Y_I>:2"?>OU">)US"Q [TTLNX$UV)@2FS&<9*! M5N)-(4+;XJ^Y1DJ2"2<=6TR%)SRI) M]J_C>5LDL,C4 #1Y8Z$%O#;F0^.)W#(L7M"RA=HBP)8,A M8X*1=EXETSV)DEH2U%L^,WJ2+_,*DMZC;8<'-*T']P]8B9/R>C@7K* ';6_Z MIS!+&Y2OLDV'^3*P.G[PBVIH\*VV%@79:B8)WO,$5P MIZ=&L"PL*C@[%QYN R;?&,O.M ;Z\TH+A,)^' *\)6Z0OY"W@ M]84M9*<+J]I:V(NY8?!:K]?W52R%!6?G7)2FA\NXD_C=&&XGGV[7L %C5']?L&LCYI*J/MKUDM"Z\PEAF -Z! MX+,V_$?2Y',#4 (]4U^B__P_%%W99#C^\5";/LF#H5_U0[G=+P/@;^9ET#.G M3PU CUD&\"X$-YDU .M)NJ70X"W\9^%<$UP/6& MP?]P% ?JT:1X/0J>T))O$:NY'W81!UBW*6_[,?O/RLL*CL/:Z9J,: M+BY7DY8XQ._JX?JM&:V[KJ^XP^L\-@O"@134^?>2YF,X[01/KEB0J\045G'" MY&X.0O.G#85@!^#7URGO[\PNTF>;F7C4]$TSS#O8ZO+@B!YY0&^]4UR$>OC) M:+W'!=;W'>\*WO\WC:6TDR)L(1(Q@8CP@;P#Y4K(B/<4(D/AS,'Y_NS+VT8< M!WC+N52T$\EIHMAB_B)N7+_[5!K92,/.=O^!1T'CFRYZC"1'P+V?Y'5[4&VC M\P+D&1ZL=/4,>\@?-YFG9F0IK,7.6#3,GYQW%_554Z]"T8*K!([3?*)$'%!= MI$@JKS="IK0G47O==HX!4)5D*@F9+E<*!1ZW#@\Q+@^1KU8'0'N0%P+5<'O" MI%_3"!6.2)L.W?=B3R/]%SFHO$MYR$_B!NKV1"ILZ$Y1D"GFK/.(IE2%Y59P M@Y#L^P5/X;?JW06Z(]B'8K0*KFA3F;>EUC M.#FM\EG>\M[762TIM?Q5#0W? M;&37@^SRR!NS7G>])!82Y5WA TISEK/JEP9B^QM0LBJ+K)ZZI%#SI:Z'B=(6 MO8WGCEZL_3JJDB/QR_TD.=!XM[B_PMJW9_T3VX?CO%794](Y=\^Y >&]8\'8 M806\IR&A46@5CK;H?+CGX:!F21K3O#Y.MP)]J8WKF1$DV\FOXLO0=9+3T*!3 MJ^3AYO!]I2*3B2V^^SQ/M)[5H)@(1:0-%,.9Q+?1WZ!M980OU^3$\QPKQE*4 MW;QE--\-'AN7&A1QY)'1.BNNTB>29RZ<99%:^93?FGZB^92^U>R04C5WTJ+@>;SZ,QT4K M8'_&5?$RM @QTD@F=+JC'!>5HI5DSXW7U]$BAX0RRN (Y2I]7K+RY>1/O"6_ MHH(F-]3Z4S1=-P_J[W@$!*JRC1O8A=NCGNJI[&GAY3I/J3D4#.=*)2O1W$_A M7ZZ)(H5+ZT.0P":(3''JW.?J-V\&FH M#=+7@J="C1B91^50)#MU;OVWGFEB.KJ'.>YU79O#9JO!P<_-QH5#3GO[#A24 M#-.OQ<+?F-,OT#Z-._7PRH6ZZ*@OQ[:RO+R8V'$=]+Z4TEBZ/Z$];UYK-%#S M+8H*?Z)B+D7/R@^@);K-'+9:TJ(8; _N9I]=WR=>C[<*5U:S[;D>2$DSU8'S MS0IE@^01\6# M-(_KA-; 8IVRI)%*XG75@4GT#SE@"\5*[(JZJ9@I!H#%'MHKMN,8JVUOW7O. M\=9L@JJ")F82(\6K$,4E\:JQBW.H1K:M#I3J#QS>W$A7#H#*>\S*S;D:TF!G MTS;%\O"!&>90@H8DHURFS\L-@#O3)U?!LS)A*MVFEW9$W6&D3A2D59>;R9BD MS9/\=!JI8&B0-61S\;LYD0!SOK?W)%NUH@:RB;*[(80#IU#G[ *E:X+ZAE#W M.;94@EY0091(B=F, ;!]AMY03^WKK8]7)U*/#=0[%]0.3K_:7%& 9%]737XY MVQ0\DU(C3^6>=KQ^44P>B+MP9XLPD^M#B(KKZ/T2-$3Y558Y;T">]R/JBPQK MR%41S%7B)TP&LQN! 4&H(J2!IVF$J1FOG@IB[F"#A*).:AJKU)"RSBY MK8XF"/37>^C[8+X@KB2!L:A=-4R9N.5[4Y]O )29 6N]S^-=Z]ZU[H>[[OV6[$KVJ5-[[[-__TKE<.?*5/Y9+&-,U,.U M\$")<*>H"OU!6\KR8$ !/9,CW R;O-(:KAESK93 +C3L"@FFFB'SAT)?AF[[ M16_:1 8B2P)'#17O9HNP1;"/,AZFMH3ZITS$Z<4.+/D=%F14)HQDVX/R"Q6Q MLG%VYK[2H;SD/WGR *J(OYA?!5_-E?%,WL1&.N.R_OFPI+$W=%-]EG. TQ39 M0WL?,XJ&JOR;Q\4A0O)"*)LZ@V6#?H>4J'9N[R+;WULY/#V6"[-ZFU^+8?-(F=-OOC^BO*IYO^CM()D$6.;>Q ML?E(TM-Z7-QB5L@0K MR<%/>Y,4H/)I >>RYK#:N692Y)GB=W2?P@">PU75$:Q#&8E-MBL8(ZVL[Y!\ M.><;U+&3M(E6Q(A&OT>*Y1R[X>G(2W:[5#]2UI9>N*8WZFNH5&GF(VS%*K;& M1\QJ%YB["Z)S3GJL7@?[[^S^JUHU65AR!]'?BA33BX?G\(Z8:X0U.'I M>TA*G"4J?\LX31$7K&_;QK]HNAVB,:#@QZ\3*!%$T>F%7:C;O?"A>IAV^M5? M=9?O,A?>P4O;S:67E'P;P;GN5=1B=@6K'S01Q!0E>:\'3=%P-XUR"AY\,.NN=8ZL0]4"F"1X[10X+]J: 6Z*+%"[V M?@?_4KR51HVD3MQ((;FH#^N 7W.P?E!]&(2W";3A$GA'OZOVNN"](U3'T5[G M_./YYQ ?U*HN"Y#S9T//WN.3#M !H_PO^\1--W.KE[X];#^NL]'I2 )S67C_1\B1HUU@/\^.!';#$57]L MIIM,!WSMD Y@7V4]Y4Z<)!I#\+X*Z-.E%+*4]XHKYC9C2R^W8+/Q+U4PTIKX M<]+4OO@Z?([)JLYORLV[E7N;P578"#W3!>8D [BWZ05TBT+S&$<=!^R1$96+ M?!,[/>^S+3L#=91)++/7O(^8P"7=RJ,T]N0,.*OO6=-(FZ0OQ"TJV M_8K^+16UN"RL;O:=4UX::5?@&'R_*\+;Q"2WOB;I&*&%TZ=0<+/Y-02+,GFN_] M.UR7#PL49_#N89CS'J%*.<8QOD=YBFL3G!S#UD?*L>OPY\;7M(%NS68T$5' M.D!$G?/A$5)<5'E%&FB !SJ:R*%!\1T['YD\O;BZ_7&@?=#)2>-,A%?A M^=(AL:>FWTEJ MXX1S[%Y>BWWU$V?YQ1NT[TZL_%RS356M_9#3-_?*?B/#]ZU*3\UA9J**7(;# MV[?:PF7\1R4"3(9P&05G D, (];XU'"4[F0LKU.>08)G *(9JEQ#A(F>? MA:+;TLGN/1-F/R_N.M%FRW2M18)5?6.3%!P\QQ7K8'[!4>:F*<,[0)B.D8HO0^\%>)*#Y9C5& M[6^2+7WPD^BJ#@@UW0/H6WI]3P'NZEO^,+-D]7; L#F/UTKL2Y(6%BCB\,1L M7,M:-IRGSL;!0Y@.3[7H@"PB7(#^J"V##@KZ!,+(M' V#T,SA@,5+3UKW@1B&?(N7NU>QMN0>) A36; MTV"CJ@]2?3R'!DD%,QC'Y89-(Y(+IP/3)R$":HH\U*P:DL [P3?9,NIY00S2 MX%JXH)OI*5,2?T3FR=NRP&BD^$!E3.&,3CDH=\+VAF'7"1C!"S6KJ?6Q?IL>KIM7;Z)EI^J=-WJY^M-SX-S)%%?]SR7X%8"W4_O3 M1*&@TEHA2 4MR):0T!C>().@5OF*Q+0$%\0O465(040RJ$]?X2($9S+MX%NY M%6&(N"F^52;(8,U3164HNK$%C"1-Z$>1+[WELASZYIKRU:W2>*J"J)RG>B'4 M 34^31P]-$I;B5DQ3:L1B@:'R*9.K'-Z2N@HXY[K8"7Q#A;$?!4FU* MF)\@1G)VH[7KNB<]1J[KSYRU)Q@8!9N6O5^X:];Z\X;8S)T:H$#VY3,_.LT] MUIO79#A7W]QNPT(DF+CJF+7_]]_I_9U]"G=EBHR4,E809B-U1 +V2F+%7Q%+ MKRK6EM%F^+6$M'9 M43*NTE[%;3Q]8&0Y(TK6UD(U073 9GAS;E)QM.U[K 22=JILMJAX.4SP=G3U M%JO-?>C8$Y% 6BJX[[C\I/8>V7)ES1T_/VJL^RM2P*,EV:O2 MM^0MUKOQ*W?%*KV+OY[O=2G%!@1P0(6=:&"9ZD.!YD=T09H(\WT 5UZ1%R1, M0I9O(V-"_5/E/0?@0H[MVZ'+ZVX-V3H5.JF^OSZA5'I8;UP9$ M8F/'".V/_E.]YP:?^*]VSE>[&E7]4@=PXOI.W!]K<=ZOO__+IT9F5TP__O^T(HS0FT+,EB$ '1.$%8S!/!_0, MX0&@'@YYSQXMU82SGG%-2,ZJIJ<2*RB&V\>5<2]X06(N-M-Z\0,I+T- 9%DB M=J+IC:?+E+4J<7"G4S=IN9QK,^3[X;>\JU>2HN[2VD[MFRFAU5_-5=\*"[MV MZ!BA:]KM+PD2QWNS$N/DJY?K@.:[B(D.:/N&\S5C"KGJ!A_GB_1I;1HX^+?@ M !'=RDL1H+#KUVSZ(TO_<\[G:>LQIYAI]GD=0(O0%W$MT2"X4\81VD=AQI[2 M=9YL_A)&O5146Y\&QHR+H8 Z;3$:7\GX*"0O@@^7E88A)8UDXP[6W#V,2N+L M/0,,SPUP6W-VA,FN#L)YYH[>@97X0OE!HPY6)39+C%A_\,%\!754*0?GX8$D MU!"RP5GD%4."FE;A>%^K(JJ9:L;J&EB&"&Z$H=':8@$-[P/3Q&QJ"%PFY/2I M6P.1(!5!W0@?SI$1,HEV-<9>]AM'(E=U8'.1\@GB3NUM@?1Z7MN%H_Q%P]PZ MXN@62!X1^#0>7:D"&K1WR7KO!@O=X4.YF81L)EB*")IR(\G\3;# "1;>MII$QBS3U'QMV@+XMP>4&7QK MMCI+F[\?;KX?L+3-:P5R&K1=QG%:N:V<]&#M9:?+2Y\/OW;]2>_O4R!.?_*Z M*[==1. L1K7L8Y/$BAFNS8?V2TR0Q,UT_XU(+TS=IFK%U1R-B"RYE5J);H:_ MO2(3]-L)N09.W2Q7!D%*9E=N2)1[]I0U HD1'@ZZOS" M3E#*(SHX(AZPI_P"#U;(Z)_1K1W^K9Z6[X;FG)X>7$6LXHT^5H4H/J;B.'8C M6:8[!VX"YFZ@<0GM&7TD(GLR%[! MSC@!/0YQV5Q&6\R]@[VAWD\O+7M%NS7T>4\,6),X*DL^X)&>X_KO%21W4Z%9]7:R6??EGKJ\777,8:PJP:[PK)M$U M%-:?+:OJ>LML0I75FYG'MHMC]>NUE21K M*2'-8?&3UU!4VATT#/%70>JN0N"+6GVJ^F[8( MI'-2XU\H[#(JJ"W$T]A2N@8\6%+->Y0UP#RQ^+/?L]N.*\5KJ M/G4J[DXDZXW@_I4/)5$'O<1K-X^K?]'^5AFG].K^/5UU8H32A]*=7]6>&0@+ M>U?QJV7KD?K=<+C[^N@#"7@MV;4\*U7.9Q>3)%(5 F MP+V[<_>;=U@[:'RY&:>S-7/N132K(PDJ_[-' MT>.E_;?3UWI2$!X>\+HZEETM//DH.8EJBH#JAWA XQES/K?FY;)!.O1FP"Q0 M'L?Q]LR,7-W% V,YJ=,7BGF,QSLZ:@AF)N+L3 3Y^V/J=\3]P91%^N IF16 M(W>"*7G P9Q#GE(QAA7TKR:]R2O6G^*^ZL?_W_,>T@+-U@%_H3K@ %&S *Q/ MQ KPEUG]7UE=W1I;E<8:D!FOY0L./J:> 1WXQLSHQW#OZ&?-L0CD:J_,1L1C MZX#91YEK:'=CN55F_-P$7J.48Q%;-5C7?T54\-:6.7U)O"G)N^+E;I[[+UMO MZTT'_[_M;??VMZ*IM1S-C!CN]+KX4&]N^9G^S95WC0_<'/X),';*MTL!]"]M MD>H]\]+[Q$-GCV,_$M7S=4"UG_8Z.+F5L8C_B/><^B9$+=5FDGPT!*PETEY% M5!9H'!E)S;Z&HP6:-8-YZM1*K!.<<8)^?'U/#2]MP/Q^]PEZK']7PW'Z[2'? MNEPH+O[ '5J]NF>JSN>7@-B$&3N;!P6[_JNNM)2@C%.!+0[.*N>"CYDDND-! M43C4&#Y)Z*L<:718HKW/7XHU$\U_0D"8@QE+5"]:!NS@MBR^#]/-3.YI)%(0 M,_/P/C7?M"XTX"_)K,FU%)D@W3O_<85-TX -G3BY$K,;49OJ@)(/VO.0:BG_ M&QWP^2EO.4=]!4]5*L>"^;W*HTU)UY@.YT)6WJ!)++:ZTUO2GZ1.[D57WD/* M&@?LJ-\.?GEPY6S47M4[=?8A^12<7)0!U6!0M_ \Y@]@X/#KA%T2("X45N)UL-Y'R^PEC"3'_9. M@'UE+25*.,JX(W8KL4T 9 K,&4,;+]%U\+EFS<[C"143C\8E4)'0M MV,1?_: K8=QT*D12Y]/*3<>\<"[Q^-C,/2.Q) 5+.1D">'L8CE2V( XS=XXU3R]'UW)!LD<#R!)?@;_";3]Y8 M@3SP&UJAB\HF>U00X*BM!Z4%[?T;RIHT!UG"]B'U]*Y^LR=GP1KNZ)!U#C_M M>+W2=_Z<>.0=O;CCZ$F7?J_;\@ARNV87_=H90.]P MU>^U-\E.FZ2\+,E,UE*F%T?$-8 .0\A2GRRRVQ!K)1)0O@?U5/54:[Y[H9F- M;GQ]8C53'[ZLKD=JX?$=*O<\PPN'X 1N"ZC/ZM !-DP;Z1MFF%R38RO4-!\; M&3"^K^&J+R 799QYC,_J51W\-2BEAZ_/>LZU8UDPMZL^9B70W13^&7P]&GD9 MHC)GP\*FQ24'9@3U2QKBG[S=Z16]<3KWR\;O,S[UU#R< M6!NK?J5-KRTP_^!:]+##&^H/4Y_LFHC-H/?9#LR;*!^?'[XGP,IL/GW&CK"J M]1W%.;MN_*+W=Y\B4/Q!(XT[ U63#9BG8&*S(!V:"45),HE$ECW2J[Y/7J0B M-(^+GT/F* NI@"4!6EPZ'Z;.[V-P9#4#WMTD[SCI.Y/&0E-D,JJ(ULIFE*N/(K&:H+<,7&,32KH:EDLER-+Z%FJ: MHR(NLW)SK8*0I0.^$1P5?'G$D^R 6K>7=C%WE@;( TR:"JT;X+&4 0"^89_H M7^7KS.?&EPY!!^OC.BE<,1LS_LCHWS# ZA/<[Q8C++E;&^%)K])#XQ=>EYIH M\+#FS/AZ6L.QC_Z/TMOS]QSUZJ1[[6X6MXP8]P57ZH OL$(NNK^X6+./);0] M$_HV)O%D.:3Q9_UIDTU/K'!2Q8;L'CFNV+O1)O1E8LCRX2F+&?D[*?GG^*=Z M3FU(849#L8'BG7BI3$AF,E:*P*K6=)*?RDT1AUH1I9+49:0M<)(O9&DF&;VYS-I$0*'T5)NR9A9BW-7:\$Z/K:E2$3$^/ M*-B@-Y/U\HODAK(B?9 :_M*X#.X,7@VGWTX!C3I:8G_87BV7^*G#5#H@"XV#*<$0<6]8M,"(;QAK.Y6!.2.Y%*)Q[9.5S84.[9@7@QNA M*CN34$Y?6PD%V:@_XA%B.K8N9?5#]ZQI1*--M.N"TK?H+U?#ZZIIRN.0(U^MX;]ZBU \6SU9;574;*_1 MW@2C[&(U?O/H[J-.535/TEHZWHKW/MM71NM9$=KH?FSM5>Z!Z([\)+]H.8"6 M(XXX4VU7O=D]-J!QK8>^O+9LU!GFR=E-?37CEA+&BQ]ZOO!]"C83 MR3PEIX/R7A&Q?S>8U?^^%9^\;'F[T1UU*;8@:D^^T('0<:)MUDCN\;>1(X7.KVL+(M6GCO(.'\\F*N_@ MU?;NYRKWGGH/0VLPNL?HRWB#]>Q>TK M&;;8=)NV:OG]ZDY><=;P:Z-;.>'[T=7:BB^W/;_L#V$BXZ1C!MI:\$"$FY!E MT7DA_V9HH":<:='M>?-S966"/65G=VTR1;[VS[**D?ZQ!\FW1P86]=92RBMV M1O36KJ7LZ1H[ZCE>N?@8X>$@[S(DXPM^:ILFQ[UIU0&6Y5)/'4":"7[-"$P_ MS_K;YVO]L.1KQB+SSU^]\>W6!NYKRY88D[U8$DF=)(MLBNY&#JG2FN80JWS0 MV2_6\U6>0FZ&@P7"D8UXG!3+):C5&>SCQH9>TKQ[L:&IM]^&QC#UA!QL".%,)KL@R4[HA(\FTK^MQZL!\\*X(+7T-^6_YC4N>.P#L#.0L:0S.^F#OCD3(0K640=T,Z1>:(N)[C8 MQAM9 /@_]/1VP0Q"XZI[;309T3S4;UE/4H1=8-W)\+0'A2:,OMP%EC>O..F? M3]UDI1>%61!,\%'UM^J IZLA) ^4S8(%6L"+A^KC V7^XR3^C:7DG[_Q9=;_ M9 J2$4W2+A;1ON=,'_^_7MI UB%;D^')R8 "HM . M;61A875D7S P,2YJ<&?M>F547,NZ;4,#C3N$QJ%Q"YJ@P8*%X!*@@>#NWA \ MD !- XT3G. 6W(,&=[<02&/!$BP$$N"Q]]GGG/O.WN?>^][[]\:M'O//6O55 MU9R?5-4:?;MXNPX@?J*HH@A 0T,#F-W] +!@X^*3 M$^#CX>CIJ&EI&5GXV!F9>2"TM!P/.7GX!82%A1G8Q:1$!27Y MA(0%?QL$#1L'!Q\/GXJ @$J0B99)\/^XW78!2+ !V>B_@&C, '02-" )VFT? M@ $ 0,-$^[T!_FAHZ$ ,3"P0-@XNWEV'!F( .AH0B(X!Q,3$P+A[&WCW'H!! M@DG*)""+1:9E#F)V)Q<,3WCZ^?C#_\)<1D:]> M1T4C$Y.24U+3TC/R"]X6%A67E);5UM4W-#8UM[3V]/9]Z!\8'!J>GIF=FU]8 M7%K>^(S:W-K>V?VR=WQR>G;^_>+'Y=5OO- 0+2_M[_D17+'"QT# X@!^HT7 M&KKO;QU(,#"9!+!(9;5 YNYDS(*AV.1R"7DUW3@0(>UO%!8>4[B4+,(;K,>_ M4?N=V7^/6-C_%;-_$/LGKV4 /A#MSGE $H TX.**(S\$]_\;E.4LZ^?8DEUV MM@G"#)<]VT3[Q<]+/51]M.&%M;Q33T_S5Y^-JO6&/<2?K.V_7&)N%%_?(3^* ML'D4;98! < )G.GI3_5K)KTK$BG6(M13( 7\)W:-S50DPI414HQ#!(JXZ MEGMB:-=%^2,GO_'S :#8>:E.C#-[&6>/"ML\/)!\0OS^Y5ZF^T4$O5- XV54 M&[A_(]-_II4B[8HS;S(9+>D(3'M.OF?Q7ZC0U!K1F$/=,5++=$3\[AI$(8B, M;L]*T(I)K-=;1W"OV?45B\:_3"C)1]N2> \T>JC52Y+W"9L#M^V.#.Y5*!)LZLK1] M:;T[>&SDQTJ"'56T50MW/4+"T#"(_4E4=97_K;?^#?09IVVIUVX!J0>/7)?E M+DY]4+> :JA7.GU^7:FZ4,,5M4XYEV^33DJX?#O"TLNFFRJEJ,RVI M-#7LVW7/L@(M#JT@S8-H&YW8B7C8@.FKC"^U4@I@^OR6%%RD_DTGI!15UA2\ M?RJV,%U%S^H]XYROEVQ2^3CS"0"2_?''M3W3]#F>//Z4+%G.)R @$9UQDQAM M@-&B53).2U&II.SJ[?V ME^=(S=HTL99E=:N.9>W@.Y3L;P\DTO]!',,5U(% M/Z$E*(2^W4J;[Y6?B HK%RZLFC&)'R.,\%Y18$WF,[6$/8[!<_+WA:IJ9S>= MU0+7/E5MCM?!I@IT]'WV5U;\, >D,Y9:QTI+^=D=:7BXRFP*9440&8UT?]X1 ZHU[;RCQ:44@#PDEM1_^YRX#V#FM;F M%I5*9GJ[.+-TZ\61<1@=.+"LHS^K!&P;Q12+RK K$OS:_P %88CP,J2OOYNR MQ3;RY1OG#O42BV)RI*I\UDW7?7(+5;\1D>,,IYP.>BCX?$^TB"W"0R0<4I;V MXO3^FV:B5 9?J@EU@4R+5N/?52H\%S>B.%]N3:-G:#"7/)6X3("F-#9)'T2R MY&P*'9I@BLAQ](2 <@OO>#10/\D4>W9^'11)4=9:MQV\<'X5\PSUF^C8[[< ;JKEP,8">[J.&"B4BLGU?*NNQ7,IX,Y.OO6U M3/\:N[LK#X\J?IX-*_13>%Q_J]/ODI3X&0@GNFKLU^1_&'LP;?3UVGB+Z-57 M>(T+("P^=J-+P!G(Z)[]L>PFJ\AX>5][?%(QOO&TT\W"PW, ?!6>L7JGP9T M:>M?/I3R(5#9@F\38QK+>OX>#(ON,?]I-/Q'R0IST:,YWO/DWVURIWJ9XF: J3W%W2RZB>WH.6&?$PQ([&%[L1B))2,)?3-'_1O>CJ@!E.' MC,V63A:]0W&L363-09:%WK#?%ZVR7FKT:6&3P:0\X!;P/!WSI89K\8H\8^\ M:;GE+(#KP]]H/[/20RJC$MN<_ZZ##O%_(V+N--+*^#>E\@Y%,*U;P(3PK])S MI/>N+P;4?EGMA,DX_Y!#1HPUY(8)80?4&(Z[@15?GW"<%-P"LNUO 2^B)YKG M\QK3"KK%2,J$C\JP7_FJK=[XC6.*B;RV:B>&"6'8&Y%GEBR.MPPC/!=/X6YV MZ!?)#+].-7YN:FTIW0(D9VXNR:_&.^;-:U+LMB(MMQ1KD;G$NHVKB #Z>K2 M/T]7^JC2WK7D@R7D81:ST"9^&4#HE'ZI>V!RQLG;KKJ0Y#7[RW8+NU]SP-&G M* C&3S(E*H5G\3LY)*^W,ZY&"SX8R2NAOYR2Z<9GB8M4*00I&BCF0/, MSO#$<6]^I&@@&&R_$5^BP6%58T&.]B,#T/0/FG]3]Q;P7D%;S:&O:UJ-OW&% M*1;I09(< F)( "'ZBP+5>\12[K6'6K]PEF<4VL?!Q M_<\IR4(S TI&0FG::R[94H-Z9/]]QOO8;++;1/&$;Z\YT(/_=>7URX45^O9> MU3M*D)=Q0Y=--:( GWTMA906[ MG+-:,ICD6C($ @6TM9R/WFK_?' V* M]0LD)B*2%A:8=>&5E2-MBM/UYC)6>J(LFZCJI[92)4"E/P?!F+/_X@-MSFR M)9%@R7)$%W=FYIGYI'M&]D^]5QJ)5E/#2LA3+$UL)H&$A6KF$-[+?Y"FUPT^ M'9/^FJ ;W! 2/OK ER9#EEJQD*HM"%^FG]!#0=1A_A:P5/EBA#F_1E&N4]1M MQ0>UX$N.YOGG)>2V;A5G89!%.1>G+PLCO)=5@-)R8K3A1KJ B7\1B?-,$_@/ M >+^>%D\]1_UP= *3Z"^T;WZ(YEKN0.W0'N<A*X> M,8>P_86HM0M]E$<0WAL@=*S>NVF3F]HKEX[_^03>D/ M(WVKJSVCP2%W:V\P23IH52*$*>"A1V_E(S5[YC Q^GDSZ_C^:&HA)!K+C@^@ M2VH7*/]G_<)4?ZS/?-@EPZ ;\O3]<%[Z-HOLPJB5Q/><+R "D M_ME.WAT;(UT'K<]VFU;@\'Q3SW:N@J)0UAMOA$HLUIAR$",>5(T5P@O[D\?U MG+T#\$8\A9]I)NN22H\_DE&$G143:')I[ -1X+.KGYJ8$'_HH\N9[#+A2<4 M%FK]BB;HIOLXJYAJW9MR/:C[TC]<&TOC7Z^S1WFLK)IC$<3G*@ M5 F0_K.YRI:=!5_\D!#1>AQ8.AV]3K&]B-W[7;L%?&.6ZU>>0/..CP0*/ &: M#A'^]:]Q78&J6H&%\.BTB\&%-Q3[^- T/3Q7?5#,56\&([[4LT0]-G6%A+5T M[ZS$C6IB9/^+;'HF8G[\ $,_#-("F'KLXZ_O2(V4>:,EL7 M<$Q)8(XZT98,Z9^36FL,YNJ*?S+$%=%D,HU"%H W [D2%@Z9=1_:2^7!*$7N MX32QAD) "0BBF0Z W9_M-?)#P']1LQ]% VS_G"P<:!0407NA9^3U?ZNP?PDS ME8)Q%EC0B*7/TU-15?BW:KC9.JH8PA#K.H& 3YL_(H#-TZ?I7I'J&<6-+03,6!B29JC\%W*[K1 M.U84RMO=%C=BPT$(6Q6'>X\];9JO!B?P0:Q(HE2Q!A<]3P-%I9,9!;:_'4R\ MJ*W\6:_!4LWO;9RU^PR >L<8B&DXXW3?HB42.L&(YQA<-[ E('$)MHP7N%"B MO=BNKCPO5Z0U5M0=V@IO^]'QJ %]W\A2B2?L.UT"P"3&#*".=F7;P2_DXH67 MSB<"MLA@Y<-(,9PXVART85^LK=;PCPXF,N&0=65^YZC0& ]^ E!4<4%;)40E M?' Q?M[K6M1Q"QACX69(>X P"+ IH_,0%E1BK>PQ+N#">X$^;D#*+SL@$W < MG@$HN [W:KI/JTAUF$XEY,+;G/8=6!^7W&H=NHEO4356;&QJY_/=$T.%Y/.G MFG%^^-OU=7J9YN \S\ 8\\:]\=+G$Q6$'$3'$OB[=+,?AV9^>6)G2(WG%KQ:I M5-6*?(8K^.'AP3*?C%R'S7Z-)8A M!,*H;6'@N&#\'"+ H-S1L\)EE$9Y9@([T$A3O.ZS9 AH])PNC<,W>:/C<,+- MHJE*[G(J@&_R)"Z5X3XH6\WAPV<:^\-?@V;-OK ,JGQ"-#U YSQT^YL=CMS7&=F$-,'J-\9)K MHBF0:V*I5SL&PW@T^^([$ ^?QG(JQN]$2#*D+BP4/PG_R7:\2ZN= E;]/>9-_V?+'P'3>XN9X159W8HPR,OAZO ;CW=&D7-JI::5M M_"DL6]_S%ZS_4Y5]Z)NB+POO5HW>U&&-2'AB*+*Q#&5U"F"X]R#$]ASE:/ , M^.C]\O&X=SRM3C,BI1S5TO,-OII[/GI]("2/ M8T]A&]BF$B?12AO7ZH^8[1I+[+V(Y;<]LJKBX,5"?;ELS28A((-);3=(9![0=27Q?; M&%#;F%,+.G=9",*&!MYS^PANLPA&D)JYX'J@?0W7/6HPX/6F@5(^@U41/M** M#\<(6TOO1L]M.L;,&DNZIQ7E\_3@C<^+X>'"UY#=3L3=MN0PI>OD3>8KU,M: MWWA2QI/'PKA%(RI)3P2*[E#^_5;X=Y3N^=2N+;VQ6^0:[K9F.=W:V0:N(J2I M6W2_-A#5#+F2KHQ(UJ7@UAS286EH$^42Q&;NQXY5S_7F>U7#1)KAOK$.[9/:">U%7+PZNPL]SWO//F1J.( M"Y'G7&*R1T+$!YI!<=T8)I5+A&*6C4W)U$:%/3[ MP*V0R@ /\:M92\-ZJ+G(B$@-GZ7 :+-S;TG7_GY"@C*VBW +7V3^R6L6Y#J/ M.TMN+8:IC/F1*MDY??)3N[H<04_KXLU1))Y\(M5RH0J(5F#"V NX;U3G<.7= M#!^!X4:1^6>M4MQ\#Y3:TPITL+!7Z+,166EI-%A97[P"B_)T*LM/"8 MXNTC!U$VNPU8(],J;CG)0I%?N6OYE^/5P&S59J13!!>T@#Y\?Q!5";"A8[L1 M^FX')W)RR6\6;(O_8=)"-? \M2I@7E>%M==^V4KN8VP%LFJ]@@4XXKTZK#0T M!-[E;_3(!C%D23E21 =;LT,XP#BGO:> MK!JNR-,,T"C8O=NTLDZ>"OER$21_.=@J#1J0]FJBOX6G#/?GI?SI M/Q=TGP0JK,KS3<.5K,RA]%@"@2#9BEAN7%:3F^*$J<5/IFH: M[.!O5 1^XAS[P8[2IQ-;C;S3&C2P*AQ/-:CMM KZDJ^]RF'[,L\1Q %A IQ M5HM;EM^XHF>__R2F:ARAZOOU94EW''9]S#0DA+-6=L)#*,Z-BZ:2V>2A6D>& M8*2!"6%VV=L#W*7'TOH^.H?01O^0UA0_4QRS#+K"Z:?T-**,84J6NLZ_Y&F_ M(S_2V!A8PI57K)7,BN=D!U$Y/2'"7C]E+5$LQ].- RY$7);J6LK=B^@ OAO\@%^('WYYL6D[5E>&3& M0?YC@2Z+ABO&C#8_'SLSK>48E5+E_$S_ M"D?M(^8P'C'.L+Z+/#UD8GXC\3 ,9\!4JC34KTPQVE> M;3Y.;#IO!H58VR;BJ8@1$B1C-[D$?T4J=9CF&-2]3E)];97&&,\8CU\J27LV M<%H<[/CE%N#P\^'RY].FRP!?;]>CZ\!2M(QEA1OZQ1'\>/5O0\*CRFZ:'$Y\ M_)[O?%%LE8[^5EH7LEE?U<;J MRG@\%*?Z:\D'29(@HJ+[ T9P/PCW M6X =F&JY!4BPZZ%!WQ_"]]A:(%RP[+VZ7":B/2CI:BC5F/CI$&_L<-42M5!H M^@,/MY9!E.C$\S[=G.4>&W=KIPM5*NWQBK("MU4Q]FS^8!)E BZNAHC%SG>1 MNXK'4<_"-]%/HC$4H1 M1]^)GXI\3/+B+1]>E.Z[I4QDELPZ_"9S$I/3BT[N,UX S+J.9,5HQ 4>[;&2 M:,8^TR@S!GT_5=3*A#(8C)/LITT+$;N?UVK#^:FL17N. M3VT; (_7&&!\B)\AO$;T6DK,%MFFQ[< M&L'['8Q-TN]#.4HA' 4CN^+D+V^ MC6938C>A\TH3#?TXU9D/HS42@XKZ&-T6[HF7^,C 4K99V\@K;.I1JIU$"_%A M(3@IU$4<7Q/=%&KBX*]W71%#J\;WX_,$8[4,=']B0Y=ILLH\O2KO0>,I3PR+ M9C_50'PAU%U4C*FF"V6W_\QR/FC.U]?9UFE&I%F;+HUK""F['!B=<%XN[KW_ M?*6]$B?&*9;^(19!_7I\H%#.< CEF&O3DXM:^5.26H[0'J*+.):@92/_@PN@ MQ^;/&711846$A/+:XQ6"Q!4!V?"4E<&[.ZF:E@G:>EWB8=Q[49YE_9J5"JRQ$4_1O<;%C)X\0^,'+EU_=0+,'%WJ2J,L(B[<&9< M9M=A6E3^F05C#B&@I%GQ,X>FS;RH@5T(>K'90$*D *AO%+(O!+]R5^2O"=MD MMD_9CB98?3S)A!/F7OS,K[P%],A\V<9Q M,_B/&/TFLL;UQSGPK=XW(\M%HR M'B-IL"6IT&@6!3]S;OE% %!UIB_?>+:P MH'\,.0QW_:KQ,9$EO&E7%WZ7L<(XVC<2;8Z7M7ST&],F;X7(N;!\=FA#SPIG MO,3J5][81Z!4&RFCS=9?+$G4\DMW9+\O:MQ]B\5R!7R01[?Z[+3TIV9S M0> MA/L,N#4N-F":7E(PR=Z4JIZ!@R*%%K')$2X90+@>UM!TDIQ13&K)@/T5D@_K MU'@O[_;*=Z8&B[_ZO*@@$701#O]:?;)*[55*C9>_K[=HWX7U?^'Q: MD41:DV%2$G.>EJ51&QVGE85M"@FX_%RA!N$1$':(W>;YT!>-UOF@,4_QZ_0, M/!^%;.=U)UZXF6\71-KT;#_6G'FV/X?\OG#_0XNND+(N=/(<;<+ 3FK V$U? MQ\S!D?ZR*BQHRDG[N0#1\">!2YF]1YXG.>KUBUXQE\(?HME#F5M480QC^'2X M7.@"1\2!8I7L\YV3!VS1JW5K59M*;J&*'P=XM1Z^)EJI2 MH6)8DR0;<+H[)?E.\K6W6"+LW(7)Y%;J3K[Z>$,6OIK-;$U5&]+/B_$&C5XX M>G?,IE*Y;;G/E*Q?^90+[->,E(J4];=1+.%=EC=3C*N/MWE@3WR)]DFMJ"KF MYGITRUE0J.5GAD6%9J&=DS&DU^#:+P0+/R*I0&YEH$. MYQ6^H@6TH\U&@V3WK1Z&+_N?ELYI8NJWR*E4#_BQ:3@ 8\P O5QA% M)YLT<@ZO _W[\9&I"B\&4I:%S4J;VBQHUWV1R.F&8OJWZ--/9X5?:-?*XHXU M$7FUD\^K8K[K63"-75Q"+= MO8\59VV/'=)1E[)9"\S

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form20-f_htm.xml IDEA: XBRL DOCUMENT 0001786286 2023-01-01 2023-12-31 0001786286 dei:BusinessContactMember 2023-01-01 2023-12-31 0001786286 2023-12-31 0001786286 2022-12-31 0001786286 2022-01-01 2022-12-31 0001786286 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2020-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2020-12-31 0001786286 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2021-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-12-31 0001786286 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-01-01 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 DPRO:DragonflyInnovationsIncMember 2023-01-01 2023-12-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2023-01-01 2023-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ShareOptionsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-12-31 0001786286 DPRO:CustomerRelationshipIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-01-01 2023-12-31 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-03-27 2022-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-08-23 2022-08-23 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2022-05-30 2022-05-30 0001786286 DPRO:GuaranteedInvestmentCertificateOneMember 2022-08-23 2022-08-23 0001786286 DPRO:InventoryMember 2023-01-01 2023-12-31 0001786286 DPRO:InventoryMember 2022-01-01 2022-12-31 0001786286 DPRO:InventoryMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteOneMember 2023-01-01 2023-12-31 0001786286 DPRO:NoteTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:NoteOneMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteTwoMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteThreeMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteTwoMember 2021-09-09 2021-09-09 0001786286 ifrs-full:AccumulatedImpairmentMember DPRO:NoteTwoMember 2022-01-01 2022-12-31 0001786286 DPRO:NoteThreeMember 2021-11-17 2021-11-17 0001786286 DPRO:NoteThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:PublicCompanySharesMember 2023-12-31 0001786286 DPRO:PrivateCompanySharesMember 2023-12-31 0001786286 DPRO:PublicCompanySharesMember 2022-12-31 0001786286 DPRO:PrivateCompanySharesMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 2021-10-25 2021-10-27 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 DPRO:RentalServicesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-01-01 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-12-31 0001786286 DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GoodwillMember 2022-12-31 0001786286 DPRO:PatentMember 2023-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001786286 ifrs-full:BrandNamesMember 2023-12-31 0001786286 ifrs-full:GoodwillMember 2023-12-31 0001786286 DPRO:VitalAndDronelogicsMember 2022-12-31 0001786286 DPRO:VitalAndDronelogicsMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2022-12-31 0001786286 DPRO:DronelogicsMember 2021-12-31 0001786286 DPRO:VitalMember 2022-12-31 0001786286 DPRO:VitalMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2021-01-01 2021-12-31 0001786286 DPRO:BrandAndSoftwareMember 2022-01-01 2022-12-31 0001786286 DPRO:BrandAndSoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:BuildingsMember 2023-12-31 0001786286 ifrs-full:BuildingsMember 2022-12-31 0001786286 ifrs-full:BottomOfRangeMember 2023-12-31 0001786286 ifrs-full:TopOfRangeMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2022-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-01-01 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-01-01 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2022-12-31 0001786286 DPRO:VehicleLoanMember 2023-01-01 2023-12-31 0001786286 DPRO:VehicleLoanMember 2023-12-31 0001786286 DPRO:VehicleLoanMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-19 0001786286 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-18 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-01 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-23 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-22 2021-04-23 0001786286 DPRO:CommonStock1Member 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-12-31 0001786286 DPRO:CommonStock1Member 2022-01-01 2022-12-31 0001786286 DPRO:StockOptionsMember 2023-01-01 2023-12-31 0001786286 DPRO:StockOptionsMember 2022-01-01 2022-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2023-01-01 2023-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:USDWarrantsMember 2023-01-01 2023-12-31 0001786286 DPRO:BrokerWarrantsMember 2023-01-01 2023-12-31 0001786286 2021-03-21 2021-03-22 0001786286 ifrs-full:BottomOfRangeMember 2021-03-21 2021-03-22 0001786286 ifrs-full:TopOfRangeMember 2021-03-21 2021-03-22 0001786286 2021-03-22 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceOneMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceOneMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceTwoMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceThreeMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceFourMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceFourMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceFiveMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceFiveMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceSixMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceSixMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceSevenMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceSevenMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceEightMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceEightMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceNineMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceNineMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceTenMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceTenMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceElevenMember 2023-01-01 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember DPRO:ExercisePriceElevenMember 2023-12-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-01-01 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-01-01 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2021-12-31 0001786286 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:Range1Member 2023-01-01 2023-12-31 0001786286 DPRO:Range1Member 2023-12-31 0001786286 DPRO:Range1Member 2022-12-31 0001786286 DPRO:Range2Member 2023-01-01 2023-12-31 0001786286 DPRO:Range2Member 2023-12-31 0001786286 DPRO:Range2Member 2022-12-31 0001786286 DPRO:Range6Member 2023-01-01 2023-12-31 0001786286 DPRO:Range6Member 2023-12-31 0001786286 DPRO:Range6Member 2022-12-31 0001786286 DPRO:Range7Member 2023-01-01 2023-12-31 0001786286 DPRO:Range7Member 2023-12-31 0001786286 DPRO:Range7Member 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001786286 ifrs-full:WarrantsMember 2021-12-31 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 DPRO:WarrantOneMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantOneMember 2023-12-31 0001786286 DPRO:WarrantTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantTwoMember 2023-12-31 0001786286 DPRO:WarrantThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantThreeMember 2023-12-31 0001786286 DPRO:WarrantFourMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantFourMember 2023-12-31 0001786286 DPRO:WarrantFiveMember 2023-01-01 2023-12-31 0001786286 DPRO:WarrantFiveMember 2023-12-31 0001786286 DPRO:DronesMember 2023-01-01 2023-12-31 0001786286 DPRO:VitalMember 2023-01-01 2023-12-31 0001786286 DPRO:CorporatesMember 2023-01-01 2023-12-31 0001786286 DPRO:DronesMember 2022-01-01 2022-12-31 0001786286 DPRO:VitalMember 2022-01-01 2022-12-31 0001786286 DPRO:CorporatesMember 2022-01-01 2022-12-31 0001786286 DPRO:DronesMember 2021-01-01 2021-12-31 0001786286 DPRO:VitalMember 2021-01-01 2021-12-31 0001786286 DPRO:CorporatesMember 2021-01-01 2021-12-31 0001786286 DPRO:CAMember 2023-12-31 0001786286 DPRO:CAMember 2022-12-31 0001786286 DPRO:CAMember 2021-12-31 0001786286 DPRO:USCountryMember 2023-12-31 0001786286 DPRO:USCountryMember 2022-12-31 0001786286 DPRO:USCountryMember 2021-12-31 0001786286 DPRO:CAMember 2023-01-01 2023-12-31 0001786286 DPRO:CAMember 2022-01-01 2022-12-31 0001786286 DPRO:CAMember 2021-01-01 2021-12-31 0001786286 DPRO:USCountryMember 2023-01-01 2023-12-31 0001786286 DPRO:USCountryMember 2022-01-01 2022-12-31 0001786286 DPRO:USCountryMember 2021-01-01 2021-12-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2023-01-01 2023-12-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2022-01-01 2022-12-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2023-12-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2022-12-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2023-01-01 2023-12-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2022-01-01 2022-12-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2023-12-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2022-12-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveConsultantAgreementMember 2023-01-01 2023-12-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveConsultantAgreementMember 2022-01-01 2022-12-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveConsultantAgreementMember 2023-12-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveConsultantAgreementMember 2022-12-31 0001786286 DPRO:CEOAndDirectorMember 2023-01-01 2023-12-31 0001786286 DPRO:CEOAndDirectorMember 2022-01-01 2022-12-31 0001786286 DPRO:CEOAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:CEOMember 2023-01-01 2023-12-31 0001786286 DPRO:CEOMember 2022-01-01 2022-12-31 0001786286 DPRO:CEOMember 2021-01-01 2021-12-31 0001786286 DPRO:DirectorsMember 2023-01-01 2023-12-31 0001786286 DPRO:DirectorsMember 2022-01-01 2022-12-31 0001786286 DPRO:DirectorsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001786286 ifrs-full:CurrentMember 2023-12-31 0001786286 ifrs-full:CurrentMember 2022-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2022-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2022-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2023-12-31 0001786286 ifrs-full:LaterThanThreeMonthsMember 2022-12-31 0001786286 DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:TradePayablesAndAccruedLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:CustomerDepositsMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:CustomerDepositsMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:CustomerDepositsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DeferredIncomeMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DeferredIncomeMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DeferredIncomeMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:LoanPayableMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:LoanPayableMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:LoanPayableMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DerivativeLiabilityMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DerivativeLiabilityMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 DPRO:DerivativeLiabilityMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LeaseLiabilitiesMember ifrs-full:LiquidityRiskMember 2023-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2023-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2023-01-01 2023-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2022-01-01 2022-12-31 0001786286 DPRO:ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember 2023-01-01 2023-12-31 0001786286 DPRO:PrefundedWarrantsMember 2024-02-06 0001786286 DPRO:PrefundedWarrantsMember 2024-02-06 2024-02-06 0001786286 ifrs-full:OrdinarySharesMember DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember 2024-02-26 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:PrefundedWarrantsMember 2024-02-26 0001786286 DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:PrefundedWarrantsMember 2024-02-26 0001786286 DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember ifrs-full:WarrantsMember 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:RangesOfExercisePricesOfWarrantsOneMember 2024-02-26 2024-02-26 0001786286 DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:PrefundedWarrantsMember 2024-02-06 0001786286 DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember DPRO:PrefundedWarrantsMember 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember DPRO:UnderwrittenSharePlacementMember DPRO:NonadjustmentEventsMember DPRO:RangesOfExercisePricesOfWarrantsTwoMember 2024-02-26 2024-02-26 iso4217:USD shares iso4217:USD shares iso4217:CAD shares iso4217:CAD pure false FY 0001786286 20-F false true 2023-12-31 --12-31 2023 false false 001-40688 Draganfly Inc. A1 235 103rd St E. Saskatoon SK S7N 1Y8 CA Paul Sun 800 979.9794 235 103rd St E Saskatoon SK S7N 1Y8 CA Common Shares DPRO NASDAQ 49229563 No No Yes Yes Non-accelerated Filer true false false false International Financial Reporting Standards false true DALE MATHESON CARR-HILTON LABONTE LLP Vancouver, Canada 1173 3093612 7894781 649612 2088965 1596536 1055942 169300 1342215 2307724 6681975 13516712 680801 404691 56426 179801 189403 192583 721687 344746 8330292 14638533 2638981 2816676 104715 194758 12112 63690 85058 81512 4196125 57314 362001 133962 7398992 3347912 5059 95562 428022 244681 7922576 3597652 97070976 83600089 6870139 7264340 -103588356 -79976546 54957 152998 407716 11040881 8330292 14638533 5287093 5550432 5103399 1267749 2054627 1950466 6554842 7605059 7053865 4490728 6814384 4410777 2064114 790675 2643088 35960 179482 135966 510677 593277 175098 600933 522349 370094 1825137 3722237 2962767 6303879 5397961 6455998 4145586 6821583 4445949 1554823 651302 510895 2021664 3311024 3952595 704994 396388 143904 6976792 6105020 2768010 24680445 27700623 21921276 211110 5502688 8149812 83280 44345 5074 -249563 745102 362448 -944 -10755 -101351 -309385 -891471 5232 2446 24148 -228572 6454914 4579763 -943243 -35371 4968 -23611810 -27654364 -16202972 -94861 447542 136475 -3180 -98483 -332640 -23709851 -27305305 -16399137 0.56 0.56 0.82 0.82 0.59 0.59 42192384 42192384 33556969 33556969 27787348 27787348 17218695 36943304 3024007 -36119210 104 3848205 1200000 2303999 1241250 3545249 11584657 36092187 36092187 4678821 -864060 3814761 448660 1752052 -1752052 1939534 4929790 4929790 405499 1937866 -923743 1014123 371901 1757988 1757988 3952595 3952595 -16202972 -16202972 -332640 -332640 136475 136475 33168946 81038365 6406117 -52322182 -332640 136579 34926239 12500 51875 -25000 26875 16538 87170 87170 1072595 2427801 -2427801 5122 5122 3311024 3311024 -27654364 -27654364 -98483 -98483 447542 447542 34270579 83600089 7264340 -79976546 -431123 584121 11040881 34270579 83600089 7264340 -79976546 -431123 584121 11040881 650729 1748946 1748946 222136 222136 12800000 11376230 11376230 2072886 -224868 1848018 1508255 2640733 -2640733 2021664 2021664 -23611810 -23611810 -3180 -3180 -94861 -94861 49229563 97070976 6870139 -103588356 -434303 489260 407716 49229563 97070976 6870139 -103588356 -434303 489260 407716 -23611810 -27654364 -16202972 35960 179482 135966 510677 593277 175098 -216238 211110 5502688 8149812 331671 1976514 101351 309385 891471 87415 6454914 4579763 -228572 4355156 -34427 -926 -18426 24148 2021664 3311024 3952595 -16144362 -20138311 -14642965 1223112 -681838 -596336 -872265 -150241 -2157203 965509 2958581 -3401868 -170782 1661697 -1044133 -90043 22624 -213315 43984 -21543 51186 -15044847 -16349031 -22004634 466643 490391 79713 212579 46976 10755 4684 623706 -63838 -842297 2002678 -379577 768655 -3305606 13125176 44255651 2070154 5122 3814762 87170 4929790 26875 1014123 60000 6747 6746 48747 330159 150275 128996 10718116 -48098 46267059 -94861 447542 136478 -4706308 -15628474 20956819 7894781 23075713 1982416 3093612 7894781 23075713 57041 51338 31010 <p id="xdx_808_ecustom--DisclosureOfNatureAndContinuanceOfOperationsAndGoingConcernExplanatory_zkbEJyajCZh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_825_z1lNFDqcYVI8">NATURE AND CONTINUANCE OF OPERATIONS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103<sup>rd</sup> St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $<span id="xdx_907_eifrs-full--RetainedEarnings_iNI_di_c20231231_z5h69R4TZKFe" title="Accumulated deficit">103,588,356</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These consolidated financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -103588356 <p id="xdx_809_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zhWraaDTEIRj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_828_zwt2e7BAjyE7">MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eifrs-full--StatementOfIFRSCompliance_zwfkXUOPDwxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zfE3mezYnqM6">Statement of Compliance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_z2KEcLJgO4Jh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zW2ka5XVXzV">Basis of consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z7Xjl56rqHEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLWIc8ChbXsd" style="display: none">SCHEDULE OF WHOLLY OWNED SUBSIDIARIES</span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of Incorporation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zlBp0Z6ezOVk" title="Name of subsidiary">Draganfly Innovations Inc. (DII)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zAsXQtdj51Z8" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zC1OBdZ9d667" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdBPsVmR5FDd" title="Name of subsidiary">Draganfly Innovations USA, Inc. (DI USA)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdmrPAZWzms6" title="Country of incorporation of subsidiary">US</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zsRtQUjSCGq" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zOe0RukvpTqb" title="Name of subsidiary">Dronelogics Systems Inc. (“Dronelogics”)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zjGC1EFlr1zc" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zZ6gFRHejQTe" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A1_ziOguo1E41L" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany balances and transactions were eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zEt9qZZCjHI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z7cZdv6yqUIj">Foreign currency translation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currencies of the parent company and each subsidiary are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 75%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_ziEngJKAWqd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zt5CSom8MkFd">Share-based payments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: <span id="xdx_907_ecustom--AggregateSalePriceDescription_c20230101__20231231_zfePosX0B3K5" title="Aggregate sale price">(i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date</span>. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zdqMx8P7MJnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zCb4gwYjOkI4">Loss per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had <span id="xdx_90D_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zIyjV5T1Ciuf" title="Potentially dilutive loss per share">8,574,798</span> warrants, <span id="xdx_905_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKr96UAfF82" title="Potentially dilutive loss per share">897,158</span> options and <span id="xdx_904_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zD2i0bGfsT36" title="Potentially dilutive loss per share">1,112,967</span> RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zFpLMCCX5SQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zCOfA5yVQ7N">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets/liabilities</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Receivables</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes receivable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through other comprehensive income</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Trade payables</p></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans payable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial assets</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Classification and measurement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTPL</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTOCI</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at amortized cost</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment of financial assets at amortized cost</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial liabilities</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial liabilities into one of two categories as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z8ESf70VlLxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z0BbwSzpWzoa">Impairment of non-financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset with an indefinite useful life; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset not yet available for use;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zMryyiVrYby5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zMqMzoFshNCd">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Current income tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt; line-height: 110%"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Deferred income tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zFuJdWKppmoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zyZM09xPq3Ek">Inventory</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zmqG8P9VncW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zDAfImcteTt">Revenue recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sales of goods</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Services</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_z6InypqVFrw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zSTqxdcTXbBf">Deferred Income</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory_zzKzTUFOayBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zyNGw59hjSwe">Cost of Goods Sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zod1bihYnc37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zvhLKTgHNuKd">Intangible Assets and Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.</span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory_zk1EEuGy9486" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zNkOgZhVUsod" style="display: none">SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of intangible asset</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful live</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationship</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipIntangibleAssetsMember_zRgDffaWndMb">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zpHf1gpVSxNe">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zHD5xe31BZhd">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Patents</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zorDHcx5t3t4" title="Intangible assets, useful life">5</span> years</td></tr> </table> <p id="xdx_8A4_zoXhq56hPD2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_znXgeSQlo1G7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z3aoUE1Mwa42">Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:</span></p> <p id="xdx_897_ecustom--DisclosureOfClassOfEquipmentExplanatory_zpj5MkugDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zg4d2qkRont1" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of equipment</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation rate</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhuGDgHYUnN5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td> <td> </td> <td id="xdx_98A_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_z8pxDhVuiUkk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--DepreciationDescription_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zNKmpwaELXlk" title="Depreciation rate, description">Expected lease term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td> </td> <td id="xdx_980_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zcSvBGJrh6uj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> </table> <p id="xdx_8AA_zDBtGN6yWLm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zjj7L1iF8RV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_z6W3zt1EV3L">Research and development expenditures</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the technical feasibility of completing the intangible asset so that it will be available for use or sale;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its intention to complete the intangible asset and use or sell it;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its ability to use or sell the intangible asset;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its ability to measure reliably the expenditure attributable to the intangible asset during its development.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt; line-height: 110%"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zkzSsBakIQJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z48eWksFp5s5">Government Assistance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants are recognized when there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zVXwznTApgjc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z4WgyhvpFPJ">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DescriptionOfNatureOfImpendingChangeInAccountingPolicy_zgwhlgncXEX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zMMWnd6Sadza">New accounting standards issued not yet effective</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements.</span></p> <p id="xdx_85A_zU4GxyhjpM26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eifrs-full--StatementOfIFRSCompliance_zwfkXUOPDwxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zfE3mezYnqM6">Statement of Compliance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The material accounting policy information set out below was consistently applied to all years presented unless otherwise noted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements were authorized for issue by the Board of Directors on March 27, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_z2KEcLJgO4Jh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zW2ka5XVXzV">Basis of consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z7Xjl56rqHEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLWIc8ChbXsd" style="display: none">SCHEDULE OF WHOLLY OWNED SUBSIDIARIES</span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of Incorporation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zlBp0Z6ezOVk" title="Name of subsidiary">Draganfly Innovations Inc. (DII)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zAsXQtdj51Z8" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zC1OBdZ9d667" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdBPsVmR5FDd" title="Name of subsidiary">Draganfly Innovations USA, Inc. (DI USA)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdmrPAZWzms6" title="Country of incorporation of subsidiary">US</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zsRtQUjSCGq" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zOe0RukvpTqb" title="Name of subsidiary">Dronelogics Systems Inc. (“Dronelogics”)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zjGC1EFlr1zc" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zZ6gFRHejQTe" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A1_ziOguo1E41L" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany balances and transactions were eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z7Xjl56rqHEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zLWIc8ChbXsd" style="display: none">SCHEDULE OF WHOLLY OWNED SUBSIDIARIES</span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of Incorporation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zlBp0Z6ezOVk" title="Name of subsidiary">Draganfly Innovations Inc. (DII)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zAsXQtdj51Z8" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsIncMember_zC1OBdZ9d667" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdBPsVmR5FDd" title="Name of subsidiary">Draganfly Innovations USA, Inc. (DI USA)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zdmrPAZWzms6" title="Country of incorporation of subsidiary">US</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DragonflyInnovationsUSAIncMember_zsRtQUjSCGq" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zOe0RukvpTqb" title="Name of subsidiary">Dronelogics Systems Inc. (“Dronelogics”)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zjGC1EFlr1zc" title="Country of incorporation of subsidiary">Canada</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20231231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zZ6gFRHejQTe" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> Draganfly Innovations Inc. (DII) Canada 1 Draganfly Innovations USA, Inc. (DI USA) US 1 Dronelogics Systems Inc. (“Dronelogics”) Canada 1 <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zEt9qZZCjHI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z7cZdv6yqUIj">Foreign currency translation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions in foreign currencies are translated into the functional currency at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Gains and losses resulting from foreign exchange adjustments are included in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currencies of the parent company and each subsidiary are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 75%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all revenue and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translation of foreign operations in other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_ziEngJKAWqd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zt5CSom8MkFd">Share-based payments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may grant stock options or restricted share units (“RSU’s”) to its directors, officers, employees and consultants. The Company records share-based compensation related to stock options using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The RSU’s granted entitle an employee, director or officer to either the issuance of common shares or cash payments payable upon vesting with terms determined by the Company’s Board of Directors at the time of the grant. If on the grant date it is determined there is an obligation to settle in cash, the RSU’s are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and on the settlement date. Changes in fair value are recognized in profit and loss. Expense is recognized over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate sales price or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: <span id="xdx_907_ecustom--AggregateSalePriceDescription_c20230101__20231231_zfePosX0B3K5" title="Aggregate sale price">(i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date</span>. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In conjunction with private placements or brokered financings, the Company may issue compensatory warrants to agents as consideration for services provided. Awards of grants are accounted for in accordance with the fair value method of accounting and result in an increase in share issue costs and a credit to warrants within shareholders’ equity when warrants are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zdqMx8P7MJnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zCb4gwYjOkI4">Loss per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted income per share is calculated by dividing the profit attributable to common shareholders of the parent by the weighted average number of common shares outstanding during the year plus the weighted average number of common shares that would be issued on the conversion of all the dilutive potential common shares into common shares. The Company had <span id="xdx_90D_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zIyjV5T1Ciuf" title="Potentially dilutive loss per share">8,574,798</span> warrants, <span id="xdx_905_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKr96UAfF82" title="Potentially dilutive loss per share">897,158</span> options and <span id="xdx_904_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zD2i0bGfsT36" title="Potentially dilutive loss per share">1,112,967</span> RSU’s that would be potentially dilutive if the Company were not in a loss position and were to calculate diluted income per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8574798 897158 1112967 <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zFpLMCCX5SQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zCOfA5yVQ7N">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments are accounted for in accordance with IFRS 9 Financial Instruments: Classification and Measurement. A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets/liabilities</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Receivables</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes receivable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through other comprehensive income</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Trade payables</p></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans payable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized cost</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial assets</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Classification and measurement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the cash flows are not solely principal and interest, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTPL</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are recorded to profit or loss. Realized and unrealized gains and losses arising from changes in the fair value of financial assets held at FVTPL are included in the profit or loss in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTOCI</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at amortized cost</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment of financial assets at amortized cost</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are derecognized when the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recorded to profit or loss. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial liabilities</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial liabilities into one of two categories as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FVTPL - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans payable are included in this category.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_z8ESf70VlLxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z0BbwSzpWzoa">Impairment of non-financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset with an indefinite useful life; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset not yet available for use;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zMryyiVrYby5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zMqMzoFshNCd">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Current income tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income taxes relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt; line-height: 110%"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Deferred income tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zFuJdWKppmoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zyZM09xPq3Ek">Inventory</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of raw materials and finished goods for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Cost is determined using the first-in-first-out method. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of purchase include the purchase price, import duties and non-recoverable taxes and transport, handling and other costs directly attributable to the acquisition of finished goods, materials or services. The costs of conversion include direct materials and labour costs and a systematic allocation of fixed and variable overheads incurred in converting materials into finished goods. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zmqG8P9VncW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zDAfImcteTt">Revenue recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sales of goods</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred. The control transfer for Dronelogics Systems Inc. (“Dronelogics”) and Draganfly Innovations USA, Inc. is when the products are shipped to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. At this point revenue is recognized. For Draganfly Innovations Inc. transfer occurs for sales outside of North America when shipped and for sales within North America on delivery which occurs in proximity to shipping. Revenue is recognized when the transfer of control has occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some contracts include multiple performance obligations, such as the sale of hardware and support or maintenance. Where support or maintenance is performed by another party and does not include an integration service it is accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on stand-alone selling price. Where the stand-alone selling price is not directly observable, the price is estimated based on expect cost plus margin. Where the support or maintenance is provided by the Company, the contract is analyzed to identify the performance obligations and transaction price. The price is then allocated across the obligations identified in the contract. Revenue is recognized when the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Services</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized over time as the services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides rental of equipment which is measured based on rates through contracts or other written agreements with customers. Revenue is recognized in the period when services are performed and only when there is reasonable assurance that the revenue will be collected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory_z6InypqVFrw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zSTqxdcTXbBf">Deferred Income</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A payment received is included as deferred revenue when products have yet be shipped to the customers as of the period end or there are unfulfilled obligations related to the revenue received. The amount to be recognized within twelve months following the year-end date is classified as current.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory_zzKzTUFOayBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zyNGw59hjSwe">Cost of Goods Sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, or lower of cost and net realizable value adjustments as required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zod1bihYnc37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zvhLKTgHNuKd">Intangible Assets and Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications, brands and software.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets with finite useful lives are amortized on a straight-line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.</span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory_zk1EEuGy9486" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zNkOgZhVUsod" style="display: none">SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of intangible asset</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful live</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationship</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipIntangibleAssetsMember_zRgDffaWndMb">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zpHf1gpVSxNe">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zHD5xe31BZhd">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Patents</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zorDHcx5t3t4" title="Intangible assets, useful life">5</span> years</td></tr> </table> <p id="xdx_8A4_zoXhq56hPD2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutIntangibleAssetsAndGoodwillExplanatory_zk1EEuGy9486" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zNkOgZhVUsod" style="display: none">SCHEDULE OF INTANGIBLE ASSETS WITH FINITE USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of intangible asset</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful live</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationship</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipIntangibleAssetsMember_zRgDffaWndMb">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zpHf1gpVSxNe">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zHD5xe31BZhd">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Patents</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PatentMember_zorDHcx5t3t4" title="Intangible assets, useful life">5</span> years</td></tr> </table> P5Y P5Y P5Y P5Y <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_znXgeSQlo1G7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z3aoUE1Mwa42">Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the consolidated statement of comprehensive loss during the financial period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the consolidated statement of comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:</span></p> <p id="xdx_897_ecustom--DisclosureOfClassOfEquipmentExplanatory_zpj5MkugDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zg4d2qkRont1" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of equipment</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation rate</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhuGDgHYUnN5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td> <td> </td> <td id="xdx_98A_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_z8pxDhVuiUkk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--DepreciationDescription_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zNKmpwaELXlk" title="Depreciation rate, description">Expected lease term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td> </td> <td id="xdx_980_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zcSvBGJrh6uj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> </table> <p id="xdx_8AA_zDBtGN6yWLm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_897_ecustom--DisclosureOfClassOfEquipmentExplanatory_zpj5MkugDsf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zg4d2qkRont1" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class of equipment</b></span></td> <td style="width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation rate</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhuGDgHYUnN5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td> <td> </td> <td id="xdx_98A_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_z8pxDhVuiUkk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--DepreciationDescription_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zNKmpwaELXlk" title="Depreciation rate, description">Expected lease term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td> </td> <td id="xdx_980_ecustom--DepreciationPercentage_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zcSvBGJrh6uj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td></tr> </table> 0.30 0.20 Expected lease term 0.30 <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zjj7L1iF8RV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_z6W3zt1EV3L">Research and development expenditures</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the technical feasibility of completing the intangible asset so that it will be available for use or sale;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its intention to complete the intangible asset and use or sell it;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its ability to use or sell the intangible asset;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">how the intangible asset will generate probable future economic benefits. The Company can also demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">its ability to measure reliably the expenditure attributable to the intangible asset during its development.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>2. MATERIAL ACCOUNTING POLICY INFORMATION AND BASIS OF PREPARATION (CONT’D)</b><span style="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt; line-height: 110%"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zkzSsBakIQJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z48eWksFp5s5">Government Assistance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants are recognized when there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zVXwznTApgjc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z4WgyhvpFPJ">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset is recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease term is the non-cancellable period of a lease plus periods covered by an optional lease extension option if it is reasonably certain that the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification is accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> New accounting standards issued not yet effective   Accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s consolidated financial statements. <p id="xdx_805_ecustom--DisclosureOfManagementJudgementAndAssumptionsExplanatory_zbMJTWRkfDLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_824_zC04uL807d43">MANAGEMENT JUDGEMENT AND ASSUMPTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Significant estimates and assumptions</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in accordance with IFRS requires the Company to make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share-based payments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the Company is likely to recognize their recovery from the generation of taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price less costs to sell. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market- driven changes that may reduce future selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments in Private companies</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where the fair value of investments in private companies recorded on the consolidated statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible, but where observable market data is not available, judgment is required to establish fair value and this value may not be indicative of the eventual recoverable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected credit losses on trade receivables and notes receivable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When determining expected credit losses (“ECLs”), the Company considers the historic credit losses observed by the Company, customer-specific payment history and economic conditions. When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL’s, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical experience, informed credit assessment and forward-looking information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollar</b>s</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. MANAGEMENT JUDGEMENT AND ASSUMPTIONS (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Useful lives of equipment and intangible assets</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Significant judgments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments applied to the Company’s consolidated financial statements include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the classification of financial instruments;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assessment of revenue recognition using the five-step approach under IFRS 15; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the functional currency of each entity in the group.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_802_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zxJ6YE00whVh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_824_z3rLXU44JHY6">CASH AND CASH EQUIVALENTS</span></b></span></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zmvL7mMl1nH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zol6mSkylLmb" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20231231_zdP5r71gnf4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zWAsjxt0R3al" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--BalancesWithBanks_iI_pp0p0_maCACEzFWG_zWTs1nJIwJq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in banks</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,093,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,500,607</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCashAndCashEquivalents_iI_pp0p0_maCACEzFWG_zQ1rxCYJ17bg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranteed investment certificates</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">394,174</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iTI_pp0p0_mtCACEzFWG_zXEwmKVqN4mf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Cash and cash equivalents</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,093,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,894,781</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zjBORvtmBbM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2022 the Company renewed a GIC for $<span id="xdx_909_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220327__20220327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zlkfeRwwkls9" title="Purchase of financial instrument">142,852</span> for <span id="xdx_909_ecustom--FinancialInstrumentTerm_dtY_c20220327__20220327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_z4e6InnjgOD" title="Financial instrument term">1</span> year at a rate of <span id="xdx_904_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20220327__20220327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zU7fuFer0hlg" title="Average effective Instrument rate">1.00</span>% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $<span id="xdx_90C_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zvYVguzQpe55" title="Purchase of financial instrument">143,436</span> and purchased a new GIC for $<span id="xdx_90A_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zrHGVmZIIUTc" title="Purchase of financial instrument">143,436</span> for <span id="xdx_903_ecustom--FinancialInstrumentTerm_dtY_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zs1jAI1VBDpl" title="Financial instrument term">1</span> year at a rate of <span id="xdx_900_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zUEjaojtEe5i" title="Average effective Instrument rate">4.5</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 30, 2022 the Company renewed the GIC for $<span id="xdx_908_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220530__20220530__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zU4pdraAdw2h" title="Purchase of financial instrument">140,493</span> for <span id="xdx_909_ecustom--FinancialInstrumentTerm_dtY_c20220530__20220530__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zCzDY7lzJtoh" title="Financial instrument term">1</span> year at a rate of <span id="xdx_908_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20220530__20220530__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_znNdX4Ihi1sf" title="Average effective Instrument rate">0.75</span>% per annum. On August 23, 2022 the Company redeemed the renewed GIC for $<span id="xdx_901_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateOneMember_z46iXG1eMAvi" title="Purchase of financial instrument">140,738</span> and purchased a new GIC for $<span id="xdx_90D_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateOneMember_ztLmIjZ7rS0c" title="Purchase of financial instrument">140,738</span> for <span id="xdx_906_ecustom--FinancialInstrumentTerm_dtY_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateOneMember_z5myICV5hxrj" title="Financial instrument term">1</span> year at a rate of <span id="xdx_901_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20220823__20220823__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateOneMember_zuRSTfwN66aa" title="Average effective Instrument rate">4.5</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All GIC’s were required to be maintained and renewed upon maturity until such time as the associated credit cards were cancelled. These credit cards were cancelled and all related GIC’s were not renewed during the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zmvL7mMl1nH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zol6mSkylLmb" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20231231_zdP5r71gnf4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zWAsjxt0R3al" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--BalancesWithBanks_iI_pp0p0_maCACEzFWG_zWTs1nJIwJq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in banks</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,093,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,500,607</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCashAndCashEquivalents_iI_pp0p0_maCACEzFWG_zQ1rxCYJ17bg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranteed investment certificates</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">394,174</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iTI_pp0p0_mtCACEzFWG_zXEwmKVqN4mf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Cash and cash equivalents</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,093,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,894,781</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 3093612 7500607 394174 3093612 7894781 142852 P1Y 0.0100 143436 143436 P1Y 0.045 140493 P1Y 0.0075 140738 140738 P1Y 0.045 <p id="xdx_802_ecustom--DisclosureOfAmountsReceivableExplanatory_zVroPWqj1708" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_827_zsSTSqNVYH7e">RECEIVABLES</span></b></span></p> <p id="xdx_892_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_z7TZ7tWUcbcl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z0l1gr06Jlo5" style="display: none">SCHEDULE OF AMOUNTS RECEIVABLE</span></span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zzLduDAOCSpi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20221231_z7xbvDWLTY34" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--TradeReceivables_iI_pp0p0_maTAORzmqg_zW5PJv8w5I15" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">610,443</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,343,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--TaxesReceivable_iI_pp0p0_maTAORzmqg_zNb0l3pVZHC5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,169</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">745,170</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--TradeAndOtherReceivables_iTI_mtTAORzmqg_zu3z9Jn25Np8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Trade and other receivables</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">649,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,088,965</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_z6JN8KSIpGq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023 the Company recorded a provision for doubtful accounts of $<span id="xdx_90C_ecustom--ProvisionForDoubtfulAccount_c20230101__20231231_z76WvtaQbTT2" title="Provision for doubtful account">216,238</span> (2022 - $<span id="xdx_90A_ecustom--ProvisionForDoubtfulAccount_dxL_c20220101__20221231_zgdeExwZYYyk" title="Provision for doubtful account::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0931">nil</span></span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies a direct customer analysis approach to measure expected credit losses. The Company assesses collectability of receivables of each customer on an individual basis using quantitative and qualitative information available to management. The historical loss rates are adjusted to reflect the current and forward-looking information on economic factors affecting the ability of the customers to make regular monthly payments on the receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include business closure and/or the failure to make monthly contractual payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_892_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_z7TZ7tWUcbcl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z0l1gr06Jlo5" style="display: none">SCHEDULE OF AMOUNTS RECEIVABLE</span></span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zzLduDAOCSpi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20221231_z7xbvDWLTY34" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--TradeReceivables_iI_pp0p0_maTAORzmqg_zW5PJv8w5I15" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">610,443</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,343,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--TaxesReceivable_iI_pp0p0_maTAORzmqg_zNb0l3pVZHC5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,169</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">745,170</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--TradeAndOtherReceivables_iTI_mtTAORzmqg_zu3z9Jn25Np8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Trade and other receivables</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">649,612</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,088,965</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 610443 1343795 39169 745170 649612 2088965 216238 <p id="xdx_807_eifrs-full--DisclosureOfInventoriesExplanatory_zqQykZ69ePIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_823_zhs2MtaLrHv2">INVENTORY</span></b></span></p> <p id="xdx_89D_ecustom--DisclosureOfInventoriesInformationExplanatory_zEOkXvbfG6k1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8BF_zx57rQBLWGji" style="display: none">SCHEDULE OF INVENTORIES</span></b></span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20231231_zcBBRUoKfOa1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">2023</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20221231_zwVZgkn8iwWe" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">2022</span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40E_eifrs-full--FinishedGoods_iI_maIznKa_zHs2Dgjt4GSj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">904,858</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">542,934</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_maIznKa_zw1p2l1XNGVd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Parts</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">691,678</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">513,008</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40E_eifrs-full--Inventories_iTI_mtIznKa_zf05uCWeKnv1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,596,536</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,055,942</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> </table> <p id="xdx_8A1_zo3eYbjHEOs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90C_eifrs-full--CostOfSales_c20230101__20231231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_zElUsO0WnTW5" title="Cost of sales">3,738,980</span> (2022 - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eifrs-full--CostOfSales_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_zhsway0JLng7" title="Cost of sales">6,048,348</span>; 2021 – $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_zQ77dnLuuX36" title="Cost of sales">3,420,713</span>) of inventory was recognized in cost of sales including an allowance for obsolete and slow-moving inventory of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90A_eifrs-full--ReversalOfInventoryWritedown_c20230101__20231231_znpouEquJmul" title="Reserve inventory write down">331,671</span> (2022 - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_902_eifrs-full--ReversalOfInventoryWritedown_c20220101__20221231_zq6rvXhZXYwk" title="Reserve inventory write down">1,976,514</span>; 2021 - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVOVE9SWSAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90E_eifrs-full--ReversalOfInventoryWritedown_dxL_c20210101__20211231_z1tKaHezY9S1" title="Reserve inventory write down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0956">nil</span></span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eifrs-full--DisclosureOfCostOfSalesExplanatory_zOsNeOi52l23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zNUsLZfrULq8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 11pt">SCHEDULE OF COST OF SALES</span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20230101__20231231_z7NqwYnKnnmc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_z1fL4xSg4GTi" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20211231_zUSzojJuJLBi" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40C_eifrs-full--CostOfInventoriesRecognisedAsExpenseDuringPeriod_maCOSzMEq_zMXuYxlv1sY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Inventory</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,738,980</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,048,348</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">3,420,713</td> <td style="width: 1%"> </td></tr> <tr id="xdx_408_ecustom--ConsultingAndServices_maCOSzMEq_zJyAMoESncb2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting and services</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">549,448</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">730,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">679,345</td> <td> </td></tr> <tr id="xdx_406_ecustom--OtherCostOfSales_maCOSzMEq_zGTEifynw3Sk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,300</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,866</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">310,719</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--CostOfSales_iT_mtCOSzMEq_zVgl00TWSsxi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,490,728</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,814,384</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">4,410,777</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8A0_zX1i5VLWuWLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfInventoriesInformationExplanatory_zEOkXvbfG6k1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8BF_zx57rQBLWGji" style="display: none">SCHEDULE OF INVENTORIES</span></b></span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20231231_zcBBRUoKfOa1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">2023</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20221231_zwVZgkn8iwWe" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">2022</span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40E_eifrs-full--FinishedGoods_iI_maIznKa_zHs2Dgjt4GSj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">904,858</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">542,934</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_maIznKa_zw1p2l1XNGVd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Parts</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">691,678</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">513,008</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40E_eifrs-full--Inventories_iTI_mtIznKa_zf05uCWeKnv1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,596,536</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,055,942</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> </table> 904858 542934 691678 513008 1596536 1055942 3738980 6048348 3420713 331671 1976514 <p id="xdx_89A_eifrs-full--DisclosureOfCostOfSalesExplanatory_zOsNeOi52l23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zNUsLZfrULq8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 11pt">SCHEDULE OF COST OF SALES</span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20230101__20231231_z7NqwYnKnnmc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_z1fL4xSg4GTi" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20211231_zUSzojJuJLBi" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40C_eifrs-full--CostOfInventoriesRecognisedAsExpenseDuringPeriod_maCOSzMEq_zMXuYxlv1sY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Inventory</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,738,980</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,048,348</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">3,420,713</td> <td style="width: 1%"> </td></tr> <tr id="xdx_408_ecustom--ConsultingAndServices_maCOSzMEq_zJyAMoESncb2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting and services</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">549,448</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">730,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">679,345</td> <td> </td></tr> <tr id="xdx_406_ecustom--OtherCostOfSales_maCOSzMEq_zGTEifynw3Sk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,300</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,866</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">310,719</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--CostOfSales_iT_mtCOSzMEq_zVgl00TWSsxi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,490,728</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,814,384</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">4,410,777</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 3738980 6048348 3420713 549448 730170 679345 202300 35866 310719 4490728 6814384 4410777 <p id="xdx_804_ecustom--DisclosureOfNotesReceivableExplanatory_zx3pHseKB0n4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_82C_zQeyeYQR7cfi">NOTES RECEIVABLE</span></b></span></p> <p id="xdx_89A_ecustom--DisclosureOfNotesReceivablesExplanatory_zR3HsdyrPncg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z9TRwCILslwh" style="display: none">DISCLOSURE OF NOTES RECEIVABLE</span></span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Principal</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(Impairment)/Recovery</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Repayments</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance December</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31, 2023</b></span></p></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_985_ecustom--NoteReceivableMaturityDate_dd_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z4l8YIJkSJRg" style="width: 27%; text-align: center" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2023-12-15</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableInterestRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zGSZyo1NPcZk" style="width: 5%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zZsWsCCi1Lsh" style="width: 5%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">190,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zKvEugW2HwJd" style="width: 5%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">      <span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NoteReceivableAccretionAmount_pdp0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zug7yXu1m0yf" style="width: 5%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">       <span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zba7FfGGPjJ" style="width: 5%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(101,351</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zqeD8KBI9Fw8" style="width: 5%; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(63,838</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NoteReceivable_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zyDt5QaZLFY4" style="width: 5%; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">        <span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98A_ecustom--NoteReceivableStartDate_dd_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zXTkMMK6sXei" style="padding-bottom: 1.5pt; text-align: center" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2024-09-22</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--NoteReceivableInterestRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zejYVisUm3y2" style="padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zi6NFaqfCN6i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,003,682</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zZ8nYXhwPBIa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1002">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--NoteReceivableAccretionAmount_pdp0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zMDZ9AVuuoLf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zBoYjacHwuOl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1006">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zs7sqGNK8PW9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--NoteReceivable_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zkkE1auJIHa4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1010">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231_zLCHuaFk2ck6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,194,078</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231_zIiA5IJNWUU6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1014">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NoteReceivableAccretionAmount_pp0p0_c20230101__20231231_zLJnGQQxxP69" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231_z798wyD8bEc1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(101,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231_z7enFBIhqAG" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(63,838</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NoteReceivable_pp0p0_c20230101__20231231_z0ldb8mgodki" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Principal</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(Impairment)/Recovery</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Repayments</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance December</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31, 2022</b></span></p></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_986_ecustom--NoteReceivableMaturityDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zqLIIKuRb4He" style="width: 27%; text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2023-03-31</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z1kAWPUBXv9a" style="width: 5%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zRVpTlvqmEia" style="width: 5%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">190,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zaVsteOCUfi3" style="width: 5%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zI67dmjSL465" style="width: 5%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">12,764</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zR9kvPG515H2" style="width: 5%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7VXED4wax4k" style="width: 5%; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(33,860</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7slDg57B9O1" style="width: 5%; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98F_ecustom--NoteReceivableStartDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zsJwC8tJfcv7" style="text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2024-09-22</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zeEIy5cn7D8f" style="text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zkzTkrscFWui" style="text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,003,682</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zSOkUFeiKgL5" style="text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">48,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zQB1btVMupka" style="text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">27,971</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zAMgPkA6JKi6" style="text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(1,080,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_z1fx5AR3TbBa" style="text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zwpAFaTIBZa3" style="text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98E_ecustom--NoteReceivableStartDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zqOnWQzrUIL6" style="padding-bottom: 1.5pt; text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2022-04-26</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zWzosLQPKzE5" style="padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zuF12iFlWhe2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_z0pCFljQy6pb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">37,177</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zs7uAPeMV3lc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--ImpairmentLoss_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zHrD7JngLTOg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">771,260</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zWdkaWclUn11" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(808,437</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_znqJt9D43b32" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1070">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231_zMkG9PPYK9A9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,194,078</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231_zhAHkJiLtNt9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">86,169</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivableAccretionAmount_pp0p0_c20220101__20221231_zDxjD1F4kQnc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">40,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231_zcvM1cohfc9f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(309,385</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231_zRxBGdHEKQKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(842,297</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivable_pp0p0_c20220101__20221231_zRR6lVc7WMi5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><span id="xdx_F05_zrTnqNVWWok9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F16_z2HUFnnamsh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.</span></td> </tr></table> <p id="xdx_8AD_zL8dc395kfbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss with an initial maturity date of October 31, 2022. During the year ended December 31, 2022 the parties agreed on an amended maturity date of January 31, 2023. During the year ended December 31, 2023 the parties agreed to extend the maturity date to December 15, 2023. As the borrower has not repaid the loan it was impaired to $<span id="xdx_908_eifrs-full--ReversalOfImpairmentLoss_dxL_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zKFTIQnAJbM">nil</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2 was issued on September 9, 2021, bears interest at <span id="xdx_909_ecustom--NoteReceivableInterestRate_pid_dp_uPure_c20210909__20210909__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_zizpYZjEvEpi" title="Note receivable interest rate">5</span>%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. Management has determined that it is unlikely that the loan will be repaid and the loan was impaired to $<span id="xdx_908_eifrs-full--ImpairmentLoss_dxL_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedImpairmentMember_zomrCACP3mr4" title="Impairment::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1087">nil</span></span> during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3 was issued on November 17, 2021 bearing interest at <span id="xdx_902_ecustom--NoteReceivableInterestRate_pid_dp_uPure_c20211117__20211117__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zy96JySV79K7" title="Note receivable interest rate">8</span>% and was due April 26, 2022. At December 31, 2021, management determined that it was unlikely that the loan would be repaid and the loan was written down to $<span id="xdx_906_ecustom--LoansWrittenDown_dxL_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zeNLLgGOENIc" title="Loans written down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1091">nil</span></span>. During the year ended December 31, 2022, the parties agreed on a repayment plan, with the loan and interest being repaid in the amount of $<span id="xdx_90F_eifrs-full--RepaymentsOfCurrentBorrowings_c20220101__20221231_zk1LVDUvtxRj">808,437</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_89A_ecustom--DisclosureOfNotesReceivablesExplanatory_zR3HsdyrPncg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z9TRwCILslwh" style="display: none">DISCLOSURE OF NOTES RECEIVABLE</span></span></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Principal</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(Impairment)/Recovery</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Repayments</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance December</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31, 2023</b></span></p></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_985_ecustom--NoteReceivableMaturityDate_dd_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z4l8YIJkSJRg" style="width: 27%; text-align: center" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2023-12-15</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableInterestRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zGSZyo1NPcZk" style="width: 5%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zZsWsCCi1Lsh" style="width: 5%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">190,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zKvEugW2HwJd" style="width: 5%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">      <span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--NoteReceivableAccretionAmount_pdp0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zug7yXu1m0yf" style="width: 5%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">       <span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zba7FfGGPjJ" style="width: 5%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(101,351</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zqeD8KBI9Fw8" style="width: 5%; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(63,838</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--NoteReceivable_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zyDt5QaZLFY4" style="width: 5%; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">        <span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98A_ecustom--NoteReceivableStartDate_dd_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zXTkMMK6sXei" style="padding-bottom: 1.5pt; text-align: center" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2024-09-22</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--NoteReceivableInterestRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zejYVisUm3y2" style="padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zi6NFaqfCN6i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,003,682</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zZ8nYXhwPBIa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1002">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--NoteReceivableAccretionAmount_pdp0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zMDZ9AVuuoLf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1004">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zBoYjacHwuOl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1006">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zs7sqGNK8PW9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--NoteReceivable_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zkkE1auJIHa4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1010">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableFaceAmount_pp0p0_c20230101__20231231_zLCHuaFk2ck6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,194,078</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableInterestAmount_pp0p0_c20230101__20231231_zIiA5IJNWUU6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1014">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NoteReceivableAccretionAmount_pp0p0_c20230101__20231231_zLJnGQQxxP69" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20230101__20231231_z798wyD8bEc1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(101,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20230101__20231231_z7enFBIhqAG" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(63,838</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--NoteReceivable_pp0p0_c20230101__20231231_z0ldb8mgodki" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Principal</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(Impairment)/Recovery</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Repayments</span></td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance December</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31, 2022</b></span></p></td><td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_986_ecustom--NoteReceivableMaturityDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zqLIIKuRb4He" style="width: 27%; text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2023-03-31</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z1kAWPUBXv9a" style="width: 5%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zRVpTlvqmEia" style="width: 5%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">190,396</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zaVsteOCUfi3" style="width: 5%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zI67dmjSL465" style="width: 5%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">12,764</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zR9kvPG515H2" style="width: 5%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7VXED4wax4k" style="width: 5%; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(33,860</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7slDg57B9O1" style="width: 5%; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98F_ecustom--NoteReceivableStartDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zsJwC8tJfcv7" style="text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2024-09-22</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zeEIy5cn7D8f" style="text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zkzTkrscFWui" style="text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,003,682</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zSOkUFeiKgL5" style="text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">48,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zQB1btVMupka" style="text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">27,971</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zAMgPkA6JKi6" style="text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(1,080,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_z1fx5AR3TbBa" style="text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zwpAFaTIBZa3" style="text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98E_ecustom--NoteReceivableStartDate_dd_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zqOnWQzrUIL6" style="padding-bottom: 1.5pt; text-align: center; padding-left: 5.4pt" title="Maturity date"><span style="font-family: Times New Roman, Times, Serif">2022-04-26</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--NoteReceivableInterestRate_pid_dp_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zWzosLQPKzE5" style="padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zuF12iFlWhe2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_z0pCFljQy6pb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">37,177</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--NoteReceivableAccretionAmount_pdp0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zs7uAPeMV3lc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--ImpairmentLoss_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zHrD7JngLTOg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">771,260</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_zWdkaWclUn11" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(808,437</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--NoteReceivable_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_znqJt9D43b32" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1070">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--NoteReceivableFaceAmount_pp0p0_c20220101__20221231_zMkG9PPYK9A9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif">1,194,078</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--NoteReceivableInterestAmount_pp0p0_c20220101__20221231_zhAHkJiLtNt9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif">86,169</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivableAccretionAmount_pp0p0_c20220101__20221231_zDxjD1F4kQnc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif">40,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20220101__20221231_zcvM1cohfc9f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif">(309,385</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--RepaymentsOfNotesReceivable_iN_pp0p0_di_c20220101__20221231_zRxBGdHEKQKf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Repayments"><span style="font-family: Times New Roman, Times, Serif">(842,297</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--NoteReceivable_pp0p0_c20220101__20221231_zRR6lVc7WMi5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><span id="xdx_F05_zrTnqNVWWok9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F16_z2HUFnnamsh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.</span></td> </tr></table> 2023-12-15 0 190396 101351 63838 2024-09-22 0.05 1003682 1194078 101351 63838 2023-03-31 0 190396 12764 33860 169300 2024-09-22 0.05 1003682 48992 27971 1080645 2022-04-26 0.08 37177 771260 808437 1194078 86169 40735 309385 842297 169300 0.05 0.08 808437 <p id="xdx_80B_eifrs-full--DisclosureOfPrepaymentsAndOtherAssetsExplanatory_zsVY0AolPy9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_82F_zPqOerdixyui">PREPAIDS</span></b></span></p> <p id="xdx_895_ecustom--DisclosureOfPrepaidExpensesAndDepositsExplanatory_zmvmqF80fmF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_ziCi4WniAbwb" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20231231_z4mIUXTyt8ti" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20221231_zBloKQi1GTCg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--CurrentInsuranceExpenses_iI_pp0p0_maCPEzQCZ_zRNKgKOcqBk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">838,445</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,148,455</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentPrepaidInterest_iI_pp0p0_maCPEzQCZ_zxoVxLDr27L8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid interest</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">810</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,889</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentPrepaidMarketingServices_iI_pp0p0_maCPEzQCZ_zPBxfLP7P1Me" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid marketing services</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,539</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">733,417</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentPrepaidRent_iI_pp0p0_maCPEzQCZ_zbqoLgbWRMZ1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid rent</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,768</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,485</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--CurrentPrepaidSubscriptions_iI_pp0p0_maCPEzQCZ_zvrlxYYJVfD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid subscriptions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,007</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentDeposits_iI_pp0p0_maCPEzQCZ_zh5gTSiz6Vtb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits<sup id="xdx_F4F_zzcI7sz0LhAj">(1)</sup></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">361,646</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">382,284</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iTI_pp0p0_mtCPEzQCZ_zbNbZk4DMb56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Prepaid expenses and deposits</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,342,215</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,307,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: center; width: 0.5in"><span id="xdx_F09_zwPTSL7vdJF3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F15_zgjY7Hv8N9Jj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A deposit in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBSRVBBSUQgRVhQRU5TRVMgQU5EIERFUE9TSVRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_ecustom--WriteDownOfDeposit_iN_di_c20220101__20221231_zFzdEMhPkPr2" title="Purchase of inventory">228,572</span> related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_ecustom--DisclosureOfPrepaidExpensesAndDepositsExplanatory_zmvmqF80fmF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_ziCi4WniAbwb" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20231231_z4mIUXTyt8ti" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20221231_zBloKQi1GTCg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--CurrentInsuranceExpenses_iI_pp0p0_maCPEzQCZ_zRNKgKOcqBk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">838,445</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,148,455</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentPrepaidInterest_iI_pp0p0_maCPEzQCZ_zxoVxLDr27L8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid interest</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">810</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,889</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentPrepaidMarketingServices_iI_pp0p0_maCPEzQCZ_zPBxfLP7P1Me" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid marketing services</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,539</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">733,417</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentPrepaidRent_iI_pp0p0_maCPEzQCZ_zbqoLgbWRMZ1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid rent</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,768</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,485</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--CurrentPrepaidSubscriptions_iI_pp0p0_maCPEzQCZ_zvrlxYYJVfD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid subscriptions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,007</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentDeposits_iI_pp0p0_maCPEzQCZ_zh5gTSiz6Vtb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits<sup id="xdx_F4F_zzcI7sz0LhAj">(1)</sup></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">361,646</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">382,284</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iTI_pp0p0_mtCPEzQCZ_zbNbZk4DMb56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Prepaid expenses and deposits</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,342,215</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,307,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: center; width: 0.5in"><span id="xdx_F09_zwPTSL7vdJF3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F15_zgjY7Hv8N9Jj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A deposit in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBSRVBBSUQgRVhQRU5TRVMgQU5EIERFUE9TSVRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_ecustom--WriteDownOfDeposit_iN_di_c20220101__20221231_zFzdEMhPkPr2" title="Purchase of inventory">228,572</span> related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 838445 1148455 810 1889 71539 733417 21768 12485 48007 29194 361646 382284 1342215 2307724 -228572 <p id="xdx_809_eifrs-full--DisclosureOfInvestmentPropertyExplanatory_z4cOpHCSqIHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82F_zUBZ8GNtgph4">INVESTMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_89F_ecustom--DisclosureOfInvestmentExplanatory_z5k0MeCNgkS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zzdrWuYMMrT8" style="display: none">SCHEDULE OF INVESTMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif">Balance at December 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--InvestmentProperty_iS_c20220101__20221231_zvbHBwa3UK9j" title="Balance">291,066</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_di_c20220101__20221231_zl1Qzgw0pdJ4" title="Change in fair value">(98,483</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--InvestmentProperty_iS_c20230101__20231231_ztyQFFRkClMc" title="Balance">192,583</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_di_c20230101__20231231_z1FqzIrykQ6f" title="Change in fair value">(3,180</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iE_c20230101__20231231_zatJ3GHvHtF6" title="Balance">189,403</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_z1E1hbUpTpa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--DisclosureOfFairValueOfInvestmentExplanatory_zYxMnO2JiLre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of investments is comprised of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zfGRRjGN15V" style="display: none">SCHEDULE OF FAIR VALUE OF INVESTMENT</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iI_c20231231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zL40x4QvvoNh" title="Public company shares">57,143</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--InvestmentProperty_iI_c20231231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_zCh580dAlYDf" title="Private company shares">132,260</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iI_c20231231_z5AR7Sfmsnq7" title="Fair value of investments">189,403</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--InvestmentProperty_iI_c20221231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zAXGdNtVMo23" title="Public company shares">57,143</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--InvestmentProperty_iI_c20221231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_zjwQs2B3V39g" title="Private company shares">135,440</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2022</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--InvestmentProperty_iI_c20221231_zJST0DOWVgxa" title="Fair value of investments">192,583</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_z04BSO33Qaj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company holds <span id="xdx_909_ecustom--NumberOfSharesPurchased_pid_c20230101__20231231_zx0rZl2u9xHb">1,428,571</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares (2022 – <span id="xdx_901_ecustom--NumberOfSharesPurchased_pid_c20220101__20221231_zeQJs0hAmZte">1,428,571</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and <span id="xdx_90D_ecustom--NumberOfSharesPurchased_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zAgFi2amATJ6">nil </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2022 – <span id="xdx_900_ecustom--NumberOfSharesPurchased_pid_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zTy1tzZjUug5" title="Number of shares purchased">1,428,571</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) warrants of Windfall Geotek Inc. a publicly traded company. At December 31, 2023 the fair value of the shares was based on the quoted price of $<span id="xdx_90A_ecustom--QuotedExercisePrice_iI_c20231231_zsGR6JqFKeKk" title="Quoted exercise price">0.04</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2022 - $<span id="xdx_90E_ecustom--QuotedExercisePrice_iI_c20221231_zIsIjY4SPchb">0.04</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). As of the issue date of these consolidated financial statements the quoted price of the shares was $<span id="xdx_902_ecustom--QuotedExercisePricePerShare_iI_c20231231_zx1uzNUPwXHh" title="Quoted price per share">0.03</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The warrants expired on <span id="xdx_908_ecustom--WarrantExpiration_dd_c20230101__20231231_zAs8ma7J9tab">March 17, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The fair values of the warrants as of December 31, 2022 were estimated using the Black-Scholes Option Pricing Model with the following assumptions:</span></p> <p id="xdx_89D_ecustom--DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory_zotTLyRBSc8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zMetGIfPXEO6" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 22%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zRvsFBgSzWc6" title="Risk free interest rate">4.07</span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z7CROCLvUeHf" title="Expected volatility">116.00</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4pOUDT4Nj2k" title="Expected life">0.21</span> years</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHlVl3ZioT43" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8AC_zB7rU3pMdGya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 27, 2021, the Company purchased <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVTVE1FTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_ecustom--NumberOfSharesPurchased_c20211025__20211027_zFxAHVxJxzQf" title="Number of shares purchased">50,000</span> common shares of a private company for USD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVkVTVE1FTlRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90F_ecustom--NumberOfSharesPurchasedValue_uUSD_c20211025__20211027_zfPCCAVNTOd2" title="Number of shares purchased value">100,000</span>. In determining the fair value of the investment (classified at level 3 in the fair value hierarchy), the Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_89F_ecustom--DisclosureOfInvestmentExplanatory_z5k0MeCNgkS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zzdrWuYMMrT8" style="display: none">SCHEDULE OF INVESTMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif">Balance at December 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--InvestmentProperty_iS_c20220101__20221231_zvbHBwa3UK9j" title="Balance">291,066</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_di_c20220101__20221231_zl1Qzgw0pdJ4" title="Change in fair value">(98,483</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--InvestmentProperty_iS_c20230101__20231231_ztyQFFRkClMc" title="Balance">192,583</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_di_c20230101__20231231_z1FqzIrykQ6f" title="Change in fair value">(3,180</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iE_c20230101__20231231_zatJ3GHvHtF6" title="Balance">189,403</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 291066 98483 192583 3180 189403 <p id="xdx_892_ecustom--DisclosureOfFairValueOfInvestmentExplanatory_zYxMnO2JiLre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of investments is comprised of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zfGRRjGN15V" style="display: none">SCHEDULE OF FAIR VALUE OF INVESTMENT</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iI_c20231231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zL40x4QvvoNh" title="Public company shares">57,143</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--InvestmentProperty_iI_c20231231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_zCh580dAlYDf" title="Private company shares">132,260</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--InvestmentProperty_iI_c20231231_z5AR7Sfmsnq7" title="Fair value of investments">189,403</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--InvestmentProperty_iI_c20221231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zAXGdNtVMo23" title="Public company shares">57,143</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--InvestmentProperty_iI_c20221231__ifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_zjwQs2B3V39g" title="Private company shares">135,440</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2022</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--InvestmentProperty_iI_c20221231_zJST0DOWVgxa" title="Fair value of investments">192,583</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 57143 132260 189403 57143 135440 192583 1428571 1428571 1428571 0.04 0.04 0.03 2023-03-17 <p id="xdx_89D_ecustom--DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory_zotTLyRBSc8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zMetGIfPXEO6" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 22%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zRvsFBgSzWc6" title="Risk free interest rate">4.07</span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z7CROCLvUeHf" title="Expected volatility">116.00</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4pOUDT4Nj2k" title="Expected life">0.21</span> years</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHlVl3ZioT43" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> 0.0407 1.1600 P0Y2M15D 0 50000 100000 <p id="xdx_804_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_ztEQj7v13dB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_824_zty5tT9Co3Mg">EQUIPMENT</span></b></span></p> <p id="xdx_89B_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z25r98ZGbYik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8BA_z4Ju3QVgjqll" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerEquipmentMember_zPjqr8dDFdyh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--FurnitureAndEquipmentMember_zs4DSO8BIyTe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zFTKgG2WLbwi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_zx9ez78Xg713" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zY0g3v3MrC4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_zJOzMvP9Atw8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Computer Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Furniture and Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Leasehold Improvements</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20220101__20221231_ecustom--PropertyPlantAndEquipmentCost_iS_zgyAwJrlUIUk" style="vertical-align: bottom; background-color: White"> <td style="width: 34%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,110</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">342,472</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,352</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,967</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,033</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">466,934</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zY3gW0TOhk93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,240</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,080</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1189">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">588,320</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DisposalsPropertyPlantAndEquipment_iN_di_zFiXVbow4d59" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(36,099</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1197">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(89,106</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_43C_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iS_zADwhfMBNbo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">834,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">966,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iS_zRhZuuVUt5U8" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">834,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">966,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zlOp9CkYMTMl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,611</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,941</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,530</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,310</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">490,394</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DisposalsPropertyPlantAndEquipment_iN_di_zSpIbQC0LYoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-indent: 1.55pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(115,204</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(136,204</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_438_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iE_z6Q2JntvA1V3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,273</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,040,192</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,530</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,343</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,320,338</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iE_zdP5UdQiDVEd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment, ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,273</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040,192</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,343</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,320,338</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43A_c20220101__20221231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zPsAjZUQ7z2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,291</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,352</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,234</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--PropertyServiceChargeIncomeExpense_zoj1veQWGpbk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">433,855</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">469,917</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment_iN_di_zDP9GwrIVDKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,920</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,737</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_431_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zrtSYnWpcoXa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">502,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1265">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">561,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zEjNROZaNBLh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">502,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--PropertyServiceChargeIncomeExpense_zCvqmxGp958b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,762</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,361</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,790</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1280">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,497</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">154,410</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment_iN_di_zejWR5onjcrc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,582</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(69,748</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1288">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(76,330</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_43B_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zaKuO1mktA56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,178</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">545,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,790</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1294">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639,537</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43A_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zWWbYExClOSl" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,178</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">545,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,790</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">639,537</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Net book value:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43F_c20220101__20221231_eifrs-full--PropertyPlantAndEquipment_iE_zVBqso5pMbI3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,664</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,663</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1307">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1308">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,364</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">404,691</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_430_c20230101__20231231_eifrs-full--PropertyPlantAndEquipment_iE_zlX0edLJk14d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,095</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">494,789</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79,740</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1315">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,177</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">680,801</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--PropertyPlantAndEquipment_iE_zW0ynV22i5U7" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,095</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">494,789</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,740</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,177</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">680,801</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zsByAEp9SI46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022 $<span id="xdx_905_ecustom--NonCashTransferOfEquipmentFromInventory_c20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--RentalServicesMember_zNss3GWPAtV5" title="Non - cash transfer of equipment from inventory">508,607</span> of inventory that was used for rental services was transferred to equipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_89B_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z25r98ZGbYik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8BA_z4Ju3QVgjqll" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerEquipmentMember_zPjqr8dDFdyh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--FurnitureAndEquipmentMember_zs4DSO8BIyTe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zFTKgG2WLbwi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_zx9ez78Xg713" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zY0g3v3MrC4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_zJOzMvP9Atw8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Computer Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Furniture and Equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Leasehold Improvements</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20220101__20221231_ecustom--PropertyPlantAndEquipmentCost_iS_zgyAwJrlUIUk" style="vertical-align: bottom; background-color: White"> <td style="width: 34%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,110</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">342,472</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,352</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,967</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,033</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">466,934</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zY3gW0TOhk93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,240</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,080</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1189">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">588,320</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DisposalsPropertyPlantAndEquipment_iN_di_zFiXVbow4d59" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(18,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(36,099</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1197">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(89,106</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_43C_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iS_zADwhfMBNbo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">834,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">966,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iS_zRhZuuVUt5U8" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,662</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">834,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">966,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zlOp9CkYMTMl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,611</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,941</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,530</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,310</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">490,394</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DisposalsPropertyPlantAndEquipment_iN_di_zSpIbQC0LYoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-indent: 1.55pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(115,204</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(136,204</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_438_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iE_z6Q2JntvA1V3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,273</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,040,192</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,530</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,343</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,320,338</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20230101__20231231_ecustom--PropertyPlantAndEquipmentCost_iE_zdP5UdQiDVEd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment, ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,273</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040,192</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,530</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,343</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,320,338</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43A_c20220101__20221231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zPsAjZUQ7z2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,291</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,352</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,234</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--PropertyServiceChargeIncomeExpense_zoj1veQWGpbk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">433,855</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">469,917</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment_iN_di_zDP9GwrIVDKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,920</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,737</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_431_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zrtSYnWpcoXa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">502,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1265">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">561,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zEjNROZaNBLh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">502,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--PropertyServiceChargeIncomeExpense_zCvqmxGp958b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,762</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,361</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,790</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1280">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,497</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">154,410</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--AccumulateddepreciationOfDisposalOfPropertyPlantAndEquipment_iN_di_zejWR5onjcrc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Disposals</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,582</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(69,748</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1288">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(76,330</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_43B_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zaKuO1mktA56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,178</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">545,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,790</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1294">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639,537</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43A_c20230101__20231231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zWWbYExClOSl" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,178</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">545,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,790</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">639,537</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Net book value:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43F_c20220101__20221231_eifrs-full--PropertyPlantAndEquipment_iE_zVBqso5pMbI3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,664</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,663</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1307">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1308">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,364</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">404,691</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_430_c20230101__20231231_eifrs-full--PropertyPlantAndEquipment_iE_zlX0edLJk14d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,095</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">494,789</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79,740</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1315">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,177</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">680,801</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_436_c20230101__20231231_eifrs-full--PropertyPlantAndEquipment_iE_zW0ynV22i5U7" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,095</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">494,789</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,740</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,177</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">680,801</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 54110 342472 4352 29967 36033 466934 60240 528080 588320 18688 36099 4352 29967 89106 95662 834453 36033 966148 95662 834453 36033 966148 58611 320941 86530 24310 490394 21000 115204 136204 133273 1040192 86530 60343 1320338 133273 1040192 86530 60343 1320338 25291 102277 4352 24737 13234 169891 32627 433855 3435 469917 15920 33342 4352 24737 78351 41998 502790 16669 561457 41998 502790 16669 561457 22762 112361 6790 12497 154410 6582 69748 76330 58178 545403 6790 29166 639537 58178 545403 6790 29166 639537 53664 331663 19364 404691 75095 494789 79740 31177 680801 75095 494789 79740 31177 680801 508607 <p id="xdx_80B_eifrs-full--DisclosureOfIntangibleAssetsAndGoodwillExplanatory_zZkFcJZLxxIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_828_zj2dyu6doin6">INTANGIBLE ASSETS AND GOODWILL</span></b></span></p> <p id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zCpDof319L19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none"><span id="xdx_8B7_zHTdtmLcr5wg">SCHEDULE OF INTELLECTUAL PROPERTY</span></span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--PatentMember_zzspTfFS40Fg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Patents</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--CustomerrelatedIntangibleAssetsMember_zPo47lkuQBfl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Customer Relationships</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B5_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BrandNamesMember_zi6k8yUUEhg8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Brand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_zDecpj5AI4bi" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software </b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--GoodwillMember_zUlNM6Onkav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BF_z9MgMy8azwoe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zdwbEsJnfgFe" style="vertical-align: bottom; background-color: White"> <td style="width: 34%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">552,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,940,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,754,340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zOUoRte6Atgj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">552,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,940,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,754,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGQtfnRERUoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1346">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1347">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1348">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1350">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhlKcAd5lvCb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange translation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1353">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,576</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">257,782</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17wq1SY30xi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Impairment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1361">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(462,577</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,198,191</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,685,339</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zB6B5vMyBvp6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1369">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">123,683</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">362,614</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcIi4J3X707h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><b>Impairment</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(87,415</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1376">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1377">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1378">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(87,415</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_z0MLs3p7TJt5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><b>Balance at December 31, 2023</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>41,931</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>109,585</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1383">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>123,683</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>275,199</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td></tr> <tr id="xdx_432_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_z1IGGOxMVvjb" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,585</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1390">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,683</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1392">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,199</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_437_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zUISrgj09glg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,414</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,235</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">220,030</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqaxPfydDXPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1402">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1406">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AccumulatedAmortizationForeignExchangeTranslation_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0VReQLZJq5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange translation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">431</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,295</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1413">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,726</span></td><td style="padding-left: -10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--AccumulatedAmortizationImpairment_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTntdRPlYBA3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Impairment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1416">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1417">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,600</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(221,825</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1420">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(230,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zSgd2NOS6lR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">87,731</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1425">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,151</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,813</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEVEwXB0Ds3b" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,854</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,106</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1434">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zyFZC33pHbUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">109,585</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,257</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1441">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">218,773</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 0pt"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net book value:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20221231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zFiWX6H04rS3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">109,269</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1446">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">70,532</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1448">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,801</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20231231_ecustom--IntangibleAssetsIncludingGoodwill_iI_z9sFxPW78ha2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_435_c20231231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zVPN8hliw23i" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Net book value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_z4u6MVjPbkC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of <span id="xdx_90A_eifrs-full--DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_iI_pid_dp_uPure_c20221231__ifrs-full--CounterpartiesAxis__custom--VitalAndDronelogicsMember_zebS0bgOXjei" title="Percentage of cash flow projection">2%</span> (2021 – <span id="xdx_90A_eifrs-full--DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalAndDronelogicsMember_z0WgiQU4rH79" title="Percentage of cash flow projection">2%</span>).</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Budgeted cash flows calculated using a weighted average revenue EBITDA margin of <span id="xdx_901_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20221231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_z0rorbKCtqnb">6.5%</span> (2021 – <span id="xdx_906_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zdJiUepDOPp2">14%</span>) for Dronelogics and <span id="xdx_909_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20221231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zWieF9LIR1we">0%</span> (2021 – <span id="xdx_909_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zt0KlAa2zozi" title="Weighted average revenue">42%</span>) for Vital Intelligence Inc. (“Vital”) respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash flows were discounted at the weighted average cost of capital of <span id="xdx_90B_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20221231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zHfnHWjFNDW" title="Percentage of weighted average cost of capital">19%</span> (2021 – <span id="xdx_907_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zunfts61H4w4" title="Percentage of weighted average cost of capital">17%</span>) for Dronelogics and <span id="xdx_90E_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20221231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zSvS1RQpsy26" title="Percentage of weighted average cost of capital">29%</span> (2021 – <span id="xdx_905_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_z0vECFLsOKWf" title="Percentage of weighted average cost of capital">24%</span>) for Vital based on peer group averages and adjusted for the Company’s risk factors.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the annual goodwill impairment test, the Company determined that the goodwill for Dronelogics and Vital required impairment, as such the Company recorded an impairment charge of $<span id="xdx_901_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_z0SsEycHLLi8" title="Impairment of goodwill">2,166,563</span> (2021 – <span id="xdx_908_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_ziAnxN9Wjv0k" title="Impairment of goodwill">nil</span>) for Dronelogics and $<span id="xdx_906_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zoRo3w0Vlax9" title="Impairment of goodwill">4,031,628</span> (2021 - $<span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zZnaTN1hGwk4" title="Impairment of goodwill">4,579,763</span>) for Vital. In addition to the goodwill, the Company deemed that the brand and software for Vital required impairment, as such the Company recorded an impairment charge of $<span id="xdx_90D_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--BrandAndSoftwareMember_z29FJDobcaS8" title="Impairment of goodwill">15,971</span> and $<span id="xdx_90A_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--BrandAndSoftwareMember_zt9uonFWmkG3" title="Impairment of goodwill">240,752</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A <span id="xdx_901_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_c20221231_zlcXbzkZJoMl" title="Assumption discount rates">10%</span> reduction in the Value in use for the discounted cash flow model would result in a reduction of $<span id="xdx_90D_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_c20221231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zsvbwVRaIHK8" title="Reduction in value">104,248</span> for Dronelogics (2021 – $<span id="xdx_902_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_z0psfWtHeuUd">597,100</span>) and $<span id="xdx_90D_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_dxL_c20221231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zpYrmYnEBFSf" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1498">Nil</span></span> for Vital (2021 - $<span id="xdx_901_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zcVw8GiZt4kl">570,133</span>).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zCpDof319L19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none"><span id="xdx_8B7_zHTdtmLcr5wg">SCHEDULE OF INTELLECTUAL PROPERTY</span></span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--PatentMember_zzspTfFS40Fg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Patents</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--CustomerrelatedIntangibleAssetsMember_zPo47lkuQBfl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Customer Relationships</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B5_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BrandNamesMember_zi6k8yUUEhg8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Brand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_zDecpj5AI4bi" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software </b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--GoodwillMember_zUlNM6Onkav2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BF_z9MgMy8azwoe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zdwbEsJnfgFe" style="vertical-align: bottom; background-color: White"> <td style="width: 34%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">552,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,940,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,754,340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zOUoRte6Atgj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">552,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,940,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,754,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGQtfnRERUoe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1346">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1347">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1348">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1350">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--ImpairmentLossRecognisedInProfitOrLossForeignExchangeTranslation_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhlKcAd5lvCb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange translation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1353">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,576</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">257,782</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17wq1SY30xi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Impairment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1361">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(462,577</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,198,191</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,685,339</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_zB6B5vMyBvp6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1369">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">123,683</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">362,614</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcIi4J3X707h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><b>Impairment</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(87,415</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1376">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1377">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1378">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(87,415</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_z0MLs3p7TJt5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><b>Balance at December 31, 2023</b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>41,931</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>109,585</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1383">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>123,683</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>275,199</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td></tr> <tr id="xdx_432_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_z1IGGOxMVvjb" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,585</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1390">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,683</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1392">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,199</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_437_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zUISrgj09glg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,414</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,235</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">220,030</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqaxPfydDXPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1402">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1406">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AccumulatedAmortizationForeignExchangeTranslation_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0VReQLZJq5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange translation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">431</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,295</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1413">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,726</span></td><td style="padding-left: -10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--AccumulatedAmortizationImpairment_iN_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTntdRPlYBA3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Impairment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1416">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1417">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,600</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(221,825</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1420">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(230,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zSgd2NOS6lR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">87,731</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1425">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,151</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,813</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEVEwXB0Ds3b" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Charge for the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,854</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,106</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1434">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zyFZC33pHbUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,931</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">109,585</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,257</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1441">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">218,773</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 0pt"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net book value:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_434_c20221231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zFiWX6H04rS3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">109,269</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1446">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">70,532</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1448">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,801</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20231231_ecustom--IntangibleAssetsIncludingGoodwill_iI_z9sFxPW78ha2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_435_c20231231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zVPN8hliw23i" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Net book value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56426</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 41931 197000 23000 552000 5940409 6754340 41931 197000 23000 552000 5940409 6754340 4684 4684 1571 29576 257782 288929 24571 462577 6198191 6685339 41931 197000 123683 362614 87415 87415 41931 109585 123683 275199 41931 109585 123683 275199 41931 60414 3450 114235 220030 27317 4719 147446 179482 431 13295 13726 8600 221825 230425 41931 87731 53151 182813 21854 14106 35960 41931 109585 67257 218773 109269 70532 179801 56426 56426 56426 56426 0.02 0.02 0.065 0.14 0 0.42 0.19 0.17 0.29 0.24 2166563 4031628 4579763 15971 240752 0.10 104248 597100 570133 <p id="xdx_805_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_zLhhd9YxSJii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_823_z6vGZ5WDVu3k">RIGHT OF USE ASSETS</span></b></span></p> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssets_zo6uUS29yNNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_z4cx7h0Zi5Xg" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 78%">Balance at December 31, 2021 and 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_c20230101__20231231_zB9yaNpUyPr5" style="width: 18%; text-align: right" title="Right of use assets, Cost, Balance">683,117</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Additions</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20230101__20231231_zR9GJRMZDxUl" style="text-align: right" title="Right of use assets, Cost, Additions">740,355</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Lease adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--RightofuseAssetsLeaseAdjustment_c20230101__20231231_zM1dm8j0YS8g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets, Cost, Lease adjustment"><span style="-sec-ix-hidden: xdx2ixbrl1509">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iE_c20230101__20231231_zeCm7sQOo53k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Cost, Balance">1,423,472</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--RightofuseAssetsAccumulatedAmortization_iS_c20220101__20221231_zcRe5yBBqD8a" style="text-align: right" title="Right of use assets, Accumulated depreciation, Balance">215,011</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Charge for the year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231_zemA0WzOfJTg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">123,360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--RightofuseAssetsAccumulatedAmortization_iS_c20230101__20231231_zKuSNsGpo2Oh" style="text-align: right" title="Right of use assets, Accumulated depreciation, Balance">338,371</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Charge for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_c20230101__20231231_z5vllAlEszr2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">363,086</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Foreign exchange</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">328</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_ecustom--RightofuseAssetsAccumulatedAmortization_iE_c20230101__20231231_zLvbm6tCu1Qc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Balance">701,785</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Net book value:</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eifrs-full--RightofuseAssets_iI_c20221231_zNWAmfpgN9Kc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets">344,746</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eifrs-full--RightofuseAssets_iI_c20231231_z3p1loPdkNF2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets">721,687</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zlOmDiXZIVV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssetsRelatedToLeases_zwd7rLeRJ7g7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated statement of financial position shows the following amounts related to leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zuucCv4o66Sj" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20231231_zwrsXxtvjUwe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20221231_zD6hSROgnH3c" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--RightofuseAssets_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zJY3peDuhV9b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">721,687</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">342,361</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--RightofuseAssets_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z1nfcJrl9FWj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1532">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,385</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--RightofuseAssets_iI_zFany1QmfUji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">721,687</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">344,746</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A2_z0lo1BJdeKqf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions to the right of the assets during the 2023 financial year were $<span id="xdx_903_eifrs-full--AdditionsToRightofuseAssets_c20230101__20231231_zB5cPgyCeUn6" title="Additional right of the assets">740,355</span> (2022 - $<span id="xdx_908_eifrs-full--AdditionsToRightofuseAssets_dxL_c20220101__20221231_zpmekKFkYyx9" title="Additional right of the assets::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1540">nil</span></span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssets_zo6uUS29yNNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_z4cx7h0Zi5Xg" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 78%">Balance at December 31, 2021 and 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_c20230101__20231231_zB9yaNpUyPr5" style="width: 18%; text-align: right" title="Right of use assets, Cost, Balance">683,117</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Additions</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20230101__20231231_zR9GJRMZDxUl" style="text-align: right" title="Right of use assets, Cost, Additions">740,355</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Lease adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_ecustom--RightofuseAssetsLeaseAdjustment_c20230101__20231231_zM1dm8j0YS8g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets, Cost, Lease adjustment"><span style="-sec-ix-hidden: xdx2ixbrl1509">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iE_c20230101__20231231_zeCm7sQOo53k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Cost, Balance">1,423,472</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--RightofuseAssetsAccumulatedAmortization_iS_c20220101__20221231_zcRe5yBBqD8a" style="text-align: right" title="Right of use assets, Accumulated depreciation, Balance">215,011</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Charge for the year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20220101__20221231_zemA0WzOfJTg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">123,360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--RightofuseAssetsAccumulatedAmortization_iS_c20230101__20231231_zKuSNsGpo2Oh" style="text-align: right" title="Right of use assets, Accumulated depreciation, Balance">338,371</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Charge for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_c20230101__20231231_z5vllAlEszr2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">363,086</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Foreign exchange</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Charge for the year">328</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance at December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_ecustom--RightofuseAssetsAccumulatedAmortization_iE_c20230101__20231231_zLvbm6tCu1Qc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets, Accumulated depreciation, Balance">701,785</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Net book value:</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eifrs-full--RightofuseAssets_iI_c20221231_zNWAmfpgN9Kc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Right of use assets">344,746</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eifrs-full--RightofuseAssets_iI_c20231231_z3p1loPdkNF2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Right of use assets">721,687</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 683117 740355 1423472 215011 123360 338371 363086 701785 344746 721687 <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssetsRelatedToLeases_zwd7rLeRJ7g7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated statement of financial position shows the following amounts related to leases:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zuucCv4o66Sj" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS RELATED TO LEASES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20231231_zwrsXxtvjUwe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20221231_zD6hSROgnH3c" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--RightofuseAssets_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zJY3peDuhV9b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">721,687</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">342,361</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--RightofuseAssets_iI_hifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z1nfcJrl9FWj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1532">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,385</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--RightofuseAssets_iI_zFany1QmfUji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">721,687</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">344,746</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 721687 342361 2385 721687 344746 740355 <p id="xdx_806_eifrs-full--DisclosureOfLeasesExplanatory_zQisoaoHv1C" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_825_z4ZumZdeKX6f">LEASE LIABILITES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DepreciationLeaseLiability_c20230101__20231231_zRgPb8khRK0g" title="Depreciation lease liability">The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years</span>. The leases are calculated using incremental borrowing rates ranging from <span id="xdx_903_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pid_dp_uPure_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxuCbPpGRvc6">11.7%</span> to <span id="xdx_906_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pid_dp_uPure_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zznCQr5SiyVl" title="Weighted average lessee's incremental borrowing rate applied to lease">13.3%</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory_zAi76H2qi9n5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zVH70xpn58M9" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pp0p0_c20220101__20221231_zsfgplEWntEh" style="width: 18%; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif">489,123</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20220101__20221231_zU0HmAWEw3W9" style="text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif">39,795</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Lease payments</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20220101__20221231_zwNxXN8nKfal" style="border-bottom: Black 1.5pt solid; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif">(150,275</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--LeaseLiabilities_iS_pp0p0_c20230101__20231231_zj1c9SUm8Ik9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20230101__20231231_zmkR2BMJjVV3" style="font-weight: bold; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif">96,423</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--AdditionsLeaseLiabilities_pp0p0_c20230101__20231231_zoTs7UwvR05a" style="font-weight: bold; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif">734,903</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Lease payments</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20230101__20231231_zUtZhDFlJDKl" style="font-weight: bold; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif">(423,410</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ForeignExchangeTranslation_pp0p0_c20230101__20231231_ziE4UKgcCJy5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Foreign exchange"><span style="font-family: Times New Roman, Times, Serif">3,464</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pp0p0_c20230101__20231231_zuo8oxC51qvi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Balance - Ending of period"><span style="font-family: Times New Roman, Times, Serif">790,023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Which consists of:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current lease liability</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20231231_zYVOMy8RE3Yi" style="width: 16%; font-weight: bold; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">362,001</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20221231_zndipakBv9Xh" style="width: 16%; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">133,962</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Non-current lease liability</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_iI_pp0p0_c20231231_zCpl551FC0z8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Non-current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">428,022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">244,681</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pp0p0_c20231231_zDEH7sAQAkha" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif">790,023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pp0p0_c20221231_zwucHbfcSuYc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_8A9_zvzDBAmB5mmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_zdiSIAIVllFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zvbA8riENP02" style="display: none">SCHEDULE OF OPERATING MATURITY ANALYSIS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Maturity analysis</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20231231_zges1WKERFC4" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20221231_zNNIySyzdrFg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zTXs03k4de13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less than one year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>429,948</b></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zJ9eJX95KyAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">One to three years</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>355,879</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,078</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zTW2inlaogH" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Four to five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>141,519</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zIGwGplLCf8l" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total undiscounted lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>927,346</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">440,268</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--LeaseImplicitInterest_iI_zNsHALcFRdi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Amount representing interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(137,323</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(61,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_zjt19y5fnr6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif">Lease liability</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>790,023</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zjkuIoXV5Hol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable lease payments of $<span id="xdx_90C_ecustom--VariableLeasePayments_iI_c20231231_zdDr56kkdSEk" title="Variable lease payments">43,542</span> (2022 - $<span id="xdx_90B_ecustom--VariableLeasePayments_iI_c20221231_z99XgrrSXfu8" title="Variable lease payments">22,539</span>) have been recognized in profit and loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years 0.117 0.133 <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilitiesExplanatory_zAi76H2qi9n5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zVH70xpn58M9" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pp0p0_c20220101__20221231_zsfgplEWntEh" style="width: 18%; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif">489,123</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20220101__20221231_zU0HmAWEw3W9" style="text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif">39,795</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Lease payments</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20220101__20221231_zwNxXN8nKfal" style="border-bottom: Black 1.5pt solid; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif">(150,275</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--LeaseLiabilities_iS_pp0p0_c20230101__20231231_zj1c9SUm8Ik9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20230101__20231231_zmkR2BMJjVV3" style="font-weight: bold; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif">96,423</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--AdditionsLeaseLiabilities_pp0p0_c20230101__20231231_zoTs7UwvR05a" style="font-weight: bold; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif">734,903</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Lease payments</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20230101__20231231_zUtZhDFlJDKl" style="font-weight: bold; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif">(423,410</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ForeignExchangeTranslation_pp0p0_c20230101__20231231_ziE4UKgcCJy5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Foreign exchange"><span style="font-family: Times New Roman, Times, Serif">3,464</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pp0p0_c20230101__20231231_zuo8oxC51qvi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Balance - Ending of period"><span style="font-family: Times New Roman, Times, Serif">790,023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Which consists of:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Current lease liability</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20231231_zYVOMy8RE3Yi" style="width: 16%; font-weight: bold; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">362,001</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20221231_zndipakBv9Xh" style="width: 16%; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">133,962</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Non-current lease liability</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_iI_pp0p0_c20231231_zCpl551FC0z8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Non-current lease liabilities"><span style="font-family: Times New Roman, Times, Serif">428,022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">244,681</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pp0p0_c20231231_zDEH7sAQAkha" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif">790,023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pp0p0_c20221231_zwucHbfcSuYc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> 489123 39795 150275 378643 96423 734903 423410 3464 790023 362001 133962 428022 790023 378643 <p id="xdx_89E_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_zdiSIAIVllFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zvbA8riENP02" style="display: none">SCHEDULE OF OPERATING MATURITY ANALYSIS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Maturity analysis</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20231231_zges1WKERFC4" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20221231_zNNIySyzdrFg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zTXs03k4de13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Less than one year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>429,948</b></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,340</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zJ9eJX95KyAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">One to three years</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>355,879</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,078</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zTW2inlaogH" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Four to five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>141,519</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zIGwGplLCf8l" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total undiscounted lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>927,346</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">440,268</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--LeaseImplicitInterest_iI_zNsHALcFRdi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Amount representing interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(137,323</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(61,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_404_eifrs-full--LeaseLiabilities_iI_zjt19y5fnr6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif">Lease liability</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>790,023</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">378,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 429948 147340 355879 209078 141519 83850 927346 440268 -137323 -61625 790023 378643 43542 22539 <p id="xdx_803_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zWCGRKqFBnI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_82B_zchv3VIXeoNi">TRADE PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_89F_ecustom--DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory_z2125tP6OTJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b><span id="xdx_8B9_zzKvMOSSWRd" style="display: none">SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES</span></b></span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20231231_zynVg6IoC9c9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zRHqPWBgFbJ9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_maTAOCPzzq7_zrFxCuINyqve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade accounts payable</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,259,623</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">751,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCurrentLiabilities_iI_maTAOCPzzq7_z1H838zv3AXd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued liabilities</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,345,649</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,031,545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GovernmentGrants_iI_maTAOCPzzq7_zhBL4OWFKaxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government grant payable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,709</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,709</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--TradeAndOtherCurrentPayables_iTI_mtTAOCPzzq7_zkr5p2RaQv1i" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables and accrued liabilities</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,816,676</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zcespODyER67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory_z2125tP6OTJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b><span id="xdx_8B9_zzKvMOSSWRd" style="display: none">SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES</span></b></span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20231231_zynVg6IoC9c9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zRHqPWBgFbJ9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_maTAOCPzzq7_zrFxCuINyqve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade accounts payable</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,259,623</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">751,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCurrentLiabilities_iI_maTAOCPzzq7_z1H838zv3AXd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued liabilities</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,345,649</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,031,545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GovernmentGrants_iI_maTAOCPzzq7_zhBL4OWFKaxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government grant payable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,709</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,709</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--TradeAndOtherCurrentPayables_iTI_mtTAOCPzzq7_zkr5p2RaQv1i" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables and accrued liabilities</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,816,676</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1259623 751422 1345649 2031545 33709 33709 2638981 2816676 <p id="xdx_80B_eifrs-full--DisclosureOfDeferredIncomeExplanatory_zYDTAlpC5Cph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_829_zGeKchl9Kzvc">DEFERRED INCOME</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.</span></p> <p id="xdx_898_ecustom--ScheduleOfDeferredIncomeExplanatory_zKF4IiqxEPB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zx9qWYa9YW6a" style="display: none">SCHEDULE OF DEFERRED INCOME</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20231231_zgh9aTJBhhH1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zomEtBa7cy0d" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--DeferredRevenueBeginning_iI_maDIGzFyA_zXwAuzY7ivEk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred, revenue beginning</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,233</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--RevenueRecognized_iI_maDIGzFyA_z2xBOTwA9V3f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue recognized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(64,816</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--UnearnedRevenuesReceived_iI_maDIGzFyA_zX3xtYL1aYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unearned revenues received</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,800</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,396</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredIncomeGross_iTI_mtDIGzFyA_zdC2OyJCtyad" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred income gross </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--DeferredIncomeIncludingContractLiabilities_iI_maAADIIzUaf_zLtzUBzKJfGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current portion</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,112</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DeferredIncomeIncludingContractLiabilitiesNonCurrent_iI_maAADIIzUaf_z0w0RMM9QbX4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long term portion</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,562</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AccrualsAndDeferredIncomeIncludingContractLiabilities_iTI_mtAADIIzUaf_zZ6hxvtWAGy" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred Income net</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zPEDgdoMtBI5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue of $<span id="xdx_90A_ecustom--DeferredRevenues_iI_c20231231_zA6ZChgfgl8e" title="Deferred revenue">12,112</span> as of December 31, 2023 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangement and will be recognized according to the terms of that arrangement over the next 5 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_ecustom--ScheduleOfDeferredIncomeExplanatory_zKF4IiqxEPB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zx9qWYa9YW6a" style="display: none">SCHEDULE OF DEFERRED INCOME</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20231231_zgh9aTJBhhH1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zomEtBa7cy0d" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--DeferredRevenueBeginning_iI_maDIGzFyA_zXwAuzY7ivEk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred, revenue beginning</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,233</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--RevenueRecognized_iI_maDIGzFyA_z2xBOTwA9V3f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue recognized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(64,816</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--UnearnedRevenuesReceived_iI_maDIGzFyA_zX3xtYL1aYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unearned revenues received</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,800</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,396</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredIncomeGross_iTI_mtDIGzFyA_zdC2OyJCtyad" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred income gross </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--DeferredIncomeIncludingContractLiabilities_iI_maAADIIzUaf_zLtzUBzKJfGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current portion</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,112</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DeferredIncomeIncludingContractLiabilitiesNonCurrent_iI_maAADIIzUaf_z0w0RMM9QbX4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long term portion</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,562</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AccrualsAndDeferredIncomeIncludingContractLiabilities_iTI_mtAADIIzUaf_zZ6hxvtWAGy" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deferred Income net</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 63690 5233 -64816 -4939 108800 63396 107674 63690 12112 63690 95562 107674 63690 12112 <p id="xdx_802_eifrs-full--DisclosureOfLoansAndAdvancesToCustomersExplanatory_zvLh3SxcBVlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_824_zST6PsTNHwO9">LOANS PAYABLE</span></b></span></p> <p id="xdx_891_ecustom--DisclosureOfLoansPayableExplanatory_z5pNHpDJW5t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B9_zDN7YjFS3G7" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF LOANS PAYABLE</span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zRcgrOaMVLF4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20220101__20221231_zCy56KZz56kb" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--LoansPayableAmount_iS_z709OxkE0NBe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,317</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--IssuanceOfLoansPayable_zYnSf0PU9Lw" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1653">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1654">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--FairValueAdjustmentOnLoans_zElO3ULU0eci" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Fair value adjustment</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_ecustom--RepaymentOfLoansPayable_zS2eLOja1pTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Repayment of loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,747</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,746</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_ecustom--AccretionExpenses_zA8aooBYaHrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accretion expense</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,234</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,891</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--LoansPayableAmount_iE_zGhok68F2rxi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zTB31zv5hN7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zkbdammAybFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zqsxTcmCzwoi" style="display: none">SCHEDULE OF LOANS</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Start Date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Carrying Value December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Carrying Value December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif">CEBA</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zohlx7DeKhg4" title="Start Date">2020-05-19</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zyEPDo0EXr82" title="Maturity Date">2024-03-28</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z1EjTVZaMQK1" title="Rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zRnGYqK1YwY5" style="width: 16%; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z1JHepPlgrs9" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,383</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">CEBA</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_z3Z5fAoHDUPl" title="Start Date">2021-04-23</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_z5tZfPPXkS5a" title="Maturity Date">2024-03-28</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zLJEE29DET56" title="Rate">0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zEi1qB5Dy1Yb" style="text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_znsRjbZ0cXhj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,383</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicle loan</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zsYgm7Ze0q2a" title="Start Date">2019-08-30</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zozlN5iv8KWc" title="Maturity Date">2024-09-11</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z4gI8pxFVJQ3" title="Rate">6.99</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zBVLX2aC6TVl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">5,058</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zZQLjKNBGBY2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,805</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231_zhqhVetI8Z87" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Total Carrying Value"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231_zvZgr42GAcd5" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_z9Gw5lFFt7G9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. LOANS PAYABLE (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 19, 2020, Dronelogics received a $<span id="xdx_905_eifrs-full--LoansReceived_iI_pp0p0_c20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zAfXqJsH8O93" title="Loan received">40,000</span> CEBA loan. This loan is currently interest-free and <span id="xdx_90A_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20200519_z8GBl8WS89Qb" title="Interest rate">25</span>% of the loan, up to $<span id="xdx_903_ecustom--LoansForgivableAmount_pp0p0_c20200518__20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zGeOyI6FBFM6" title="Loans forgivable amount">10,000</span>, is forgivable if the loan is repaid on or before January 18, 2024. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of <span id="xdx_90E_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zzCrfGgySaG7" title="Interest rate">5</span>%. On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $<span id="xdx_90D_eifrs-full--ProceedsFromIssueOfBondsNotesAndDebentures_pp0p0_c20201201__20201204__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zoiEGYXiu8G1" title="Proceeds from loan">20,000</span>, of which, an additional $<span id="xdx_90E_ecustom--LoanForgiveness_iI_pp0p0_c20201204__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zLHlre9VJAkd" title="Loan forgiveness">10,000</span> is forgivable if the entire loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 23, 2021, Draganfly Innovations Inc. received a $<span id="xdx_903_eifrs-full--UnsecuredBankLoansReceived_iI_pp0p0_c20210423__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z6s1zqEzYQV2" title="Unsecured loan received">60,000</span> CEBA loan. This loan is currently interest free and up to $<span id="xdx_90A_ecustom--LoansForgivableAmount_pp0p0_c20210422__20210423__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_ztm2GD8Z3Ig6" title="Loans forgivable amount">20,000</span> is forgivable if the loan is repaid on or before January 18, 2024. The repayment date was extended by the Government of Canada so the amount is now due March 28, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--DisclosureOfLoansPayableExplanatory_z5pNHpDJW5t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B9_zDN7YjFS3G7" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF LOANS PAYABLE</span></b></span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zRcgrOaMVLF4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20220101__20221231_zCy56KZz56kb" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--LoansPayableAmount_iS_z709OxkE0NBe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Opening balance</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,317</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--IssuanceOfLoansPayable_zYnSf0PU9Lw" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1653">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1654">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--FairValueAdjustmentOnLoans_zElO3ULU0eci" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Fair value adjustment</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_ecustom--RepaymentOfLoansPayable_zS2eLOja1pTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Repayment of loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,747</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,746</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_ecustom--AccretionExpenses_zA8aooBYaHrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accretion expense</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,234</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,891</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--LoansPayableAmount_iE_zGhok68F2rxi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 86571 93317 -4891 -6747 -6746 5234 4891 85058 86571 <p id="xdx_899_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zkbdammAybFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zqsxTcmCzwoi" style="display: none">SCHEDULE OF LOANS</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Start Date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maturity Date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Carrying Value December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Carrying Value December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif">CEBA</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zohlx7DeKhg4" title="Start Date">2020-05-19</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zyEPDo0EXr82" title="Maturity Date">2024-03-28</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z1EjTVZaMQK1" title="Rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zRnGYqK1YwY5" style="width: 16%; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z1JHepPlgrs9" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,383</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">CEBA</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_z3Z5fAoHDUPl" title="Start Date">2021-04-23</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_z5tZfPPXkS5a" title="Maturity Date">2024-03-28</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zLJEE29DET56" title="Rate">0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zEi1qB5Dy1Yb" style="text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">40,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_znsRjbZ0cXhj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,383</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicle loan</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--BorrowingsMaturityStartDay_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zsYgm7Ze0q2a" title="Start Date">2019-08-30</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zozlN5iv8KWc" title="Maturity Date">2024-09-11</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z4gI8pxFVJQ3" title="Rate">6.99</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zBVLX2aC6TVl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif">5,058</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zZQLjKNBGBY2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,805</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20231231_zhqhVetI8Z87" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Total Carrying Value"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20221231_zvZgr42GAcd5" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,571</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2020-05-19 2024-03-28 0 40000 37383 2021-04-23 2024-03-28 0 40000 37383 2019-08-30 2024-09-11 0.0699 5058 11805 85058 86571 40000 0.25 10000 0.05 20000 10000 60000 20000 <p id="xdx_800_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z75bW6mOUosl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_82C_zGAatIeu8ci1">SHARE CAPITAL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized share capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited number of common shares without par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issued share capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_pid_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zFwqawLvI7t8" title="Number of stock issued for restrcited share units">1,508,255</span> common shares for the vesting of restricted share units.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20231231_z5x2wfsN97a9">8,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif">common shares in a financing for $<span id="xdx_900_ecustom--SharesIssuedForFinancingCost_c20230101__20231231_zzljHzjsmZra">10,856,166 </span></span><span style="font-family: Times New Roman, Times, Serif">with share issuance costs of $<span id="xdx_900_ecustom--IssuedCapitalCost_iI_pp0p0_c20231231_zRt3ybfqjmB">1,953,032 </span></span><span style="font-family: Times New Roman, Times, Serif">for net proceeds of $<span id="xdx_908_eifrs-full--ProceedsFromIssuingShares_c20230101__20231231_zj6fO5ymMKl3"><span style="font-family: Times New Roman, Times, Serif">8,903,134</span></span>.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issued <span id="xdx_908_ecustom--SharesIssuedForFinancingATMShares_pid_uShares_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zKRgBMCPDrGb" title="Shares issued for financing - ATM, shares">650,729</span> common shares in an ATM (“At – the - market”) financing for $<span id="xdx_902_ecustom--SharesIssuedForFinancingATM_c20230101__20231231_zO711opu2ZW7" title="Shares issued for financing - ATM">1,748,946</span> with share issuance costs of $<span id="xdx_905_ecustom--ShareIssueRelatedCostATM_c20230101__20231231_zYGv1y9K5oh9" title="Share issue costs">222,136</span> for net proceeds of $<span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20230101__20231231_z0XFVcViRcQ8" title="Proceeds from issue of shares">1,526,810</span>.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issued <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zmNuubzfgrpj" title="Number of shares issued">4,800,000</span> common shares in a financing for proceeds of $<span id="xdx_90F_ecustom--SharesIssuedForFinancing_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zSGUxi9imTz9">4,858,995</span> with share issuance costs of $<span id="xdx_905_eifrs-full--ShareIssueRelatedCost_pp0p0_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zVBtnY1mVovk">889,623</span> for net proceeds of $<span id="xdx_90C_eifrs-full--ProceedsFromIssuingShares_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zXxn9rGONnIf" title="Proceeds from issuing shares">3,969,372</span>. Of the total share issuance costs $<span id="xdx_902_eifrs-full--OtherOperatingIncomeExpense_pp0p0_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zOZyAOMaIVSg" title="Other income (expense)">793,979</span> were expensed in other income (expense).</span> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_uShares_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zuPmWXJtI3b1" title="Number of shares exercise">16,538</span> common shares for the exercise of warrants for $<span id="xdx_903_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_c20220101__20221231_zv83BeQMQM1j" title="Exercise of warrants">87,170</span>.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issued <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesExerciseOfOptions_pid_uShares_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zMbqWS5pH3o8">12,500</span> common shares for the exercise of stock options for $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValueExerciseOfOptions_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zsC1vd8Hg2Kc" title="Stock issued during period value exercise of options">26,875</span>.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issued <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_pid_uShares_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zzE6VYig81nb" title="Restricted share units">1,072,595</span> common shares for the vesting of restricted share units.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Options</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_ecustom--DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory_znqOjCNviiQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following options outstanding and exercisable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zlPe6bgcSDf6" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Grant Date</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expiry Date</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Remaining Contractual Life (years)</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options Outstanding</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options Exercisable</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z1QLjQhrBjIl" title="Grant Date">October 30, 2019</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zJbLrg2BkL7i" title="Expiry Date">October 30, 2029</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zUFHDJAIY0Nf" style="width: 13%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zeopAXSJwvL1" title="Remaining Contractual Life (years)">5.84</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsNVMdEmfXq2" style="width: 12%; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">278,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkRAp4vi7JEa" style="width: 12%; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">278,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zFg7rlurPo61" title="Grant Date">November 19, 2019</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zjNIOxmdat91" title="Expiry Date">November 19, 2029</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zDVzINEgpTsk" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zQreqOBbXZEb" title="Remaining Contractual Life (years)">5.89</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z3MhiAi8Lo28" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zvYtJKLGiP1" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkPt484jO1u4" title="Grant Date">April 30, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zcE3avxd2Rqd" title="Expiry Date">April 30, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zE6LLYMGK4Od" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zG5DK7WjboA6" title="Remaining Contractual Life (years)">6.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z1K3a1HVlJ27" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zb9wlyWlmW9a" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zMsgO39OSl6g" title="Grant Date">April 30, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z4u2xeaCjFzi" title="Expiry Date">April 30, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zARKzbom7e41" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">3.85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zbyudBBYHXml" title="Remaining Contractual Life (years)">6.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zbZ8COn1S3oe" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z4vSfZWERhEc" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsbpwnqJc15k" title="Grant Date">July 3, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z0ZsC9Lve5fa" title="Expiry Date">July 3, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z8XfxTAFE5Cb" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">3.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zhS90LM4BTU" title="Remaining Contractual Life (years)">1.51</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zJpDGb1P4Tg9" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zA4rOuLpRz21" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zVagmm361d7d" title="Grant Date">November 24, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zzPghL3Z5SVf" title="Expiry Date">November 24, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_znD5EVeg4aai" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z9niqZ6NEi8b" title="Remaining Contractual Life (years)">6.90</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zYtGwMXkRq99" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zZZAVaa0T7Qc" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z9ofVwuyCnY" title="Grant Date">February 2, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zt1nvBeRs3P1" title="Expiry Date">February 2, 2031</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zBQ8oAkUc47l" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">13.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zdE7u6Xaihj9" title="Remaining Contractual Life (years)">7.10</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsvS2NWaEhl2" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zxwJabYpNXkk" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zrbvAUBNtyB7" title="Grant Date">March 8, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z2WCy0ohPoO8" title="Expiry Date">March 8, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zRJlfhMVcevl" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">13.90</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zfYKbk7yyQac" title="Remaining Contractual Life (years)">2.19</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zypiKVAemjnb" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zs5gePh8JPU4" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zHJflEIG1zb7" title="Grant Date">April 27, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zUJDkR2IvwJk" title="Expiry Date">April 27, 2031</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zTe7otj3Ndhd" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">10.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zLhVbe9je3wd" title="Remaining Contractual Life (years)">7.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zqPo5GxhLBkl" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">146,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zFzted5i2fw8" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">97,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z3FauAh1JQ52" title="Grant Date">September 9, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zuHXnvnDhG8" title="Expiry Date">September 9, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zYfm7vux3xRi" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">4.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zfGvHKrztcve" title="Remaining Contractual Life (years)">2.69</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zdhhApXBUZK2" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">25,826</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zculnhYo3864" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">17,217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zviikucN39z6" title="Grant Date">November 9, 2023</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zXP3WZsy0uz8" title="Expiry Date">November 9, 2033</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zT4gwiNL31ua" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">0.626</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkVsJFm5ZKEj" title="Remaining Contractual Life (years)">9.87</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zAfNvg2TydX7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zOoqAYGko6wk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zQHSCOTMnWkd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">897,158</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zH7KOxA8WNc3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">819,875</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zfZpfGTePde2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zqnyTBsK0hIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8B2_zQIUti7B2MI7" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING</span></span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20220101__20221231_z4nkqvMoAf3h" title="Number of options outstanding, Beginning Balance">1,035,991</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20220101__20221231_zEmF1YlhZNgg" style="width: 16%; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231_zh58Mc6JLhB2" title="Number of options outstanding, Exercised">(12,500</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20220101__20221231_zoHOf7bo1N8l" style="text-align: right" title="Weighted average exercise price, Exercised"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231_zuODuYqLzwbi" title="Number of options outstanding, forfeited">(146,334</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20220101__20221231_zoQLJC2nNvUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif">4.77</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20230101__20231231_zUsoKrLkh307" title="Number of options outstanding, Beginning Balance">877,157</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zrOq12GhXyQh" style="text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forfeited</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20230101__20231231_zOFcCji4Lpy3" title="Number of options outstanding, forfeited">(9,999</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_c20230101__20231231_zphxYaiVvNm3" style="font-weight: bold; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif">3.77</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--NumberOfShareOptionsIssuedInSharebasedPaymentArrangement_uShares_c20230101__20231231_zvzzcx3QC5uk" title="Number of options outstanding, issued">30,000</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20230101__20231231_z1cEE6sBVbWh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted average exercise price, Issued"><span style="font-family: Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding, December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_c20230101__20231231_zxyP4m3qyZS4" title="Number of options outstanding, Ending Balance">897,158</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_c20230101__20231231_z3R6NH9SNKve" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted average exercise price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">4.48</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zlO5W1X5yVvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230101__20231231_zdX9Zg9OdgRb" title="Number of options outstanding, Granted">30,000</span> options to an advisor to the board. Each option is exercisable at $<span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20230101__20231231_zuRKvIYb9Bgj" title="Weighted average exercise price, Granted">0.626</span> per share for <span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dtY_c20230101__20231231_zeE25CJtEzC4" title="Stock option exercisable year">10</span> years.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No options were granted by the Company for the year ended December 31, 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company recorded $<span id="xdx_90C_eifrs-full--AdjustmentsForSharebasedPayments_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--StockOptionsMember_zkzUXBdX3o84">151,174</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2022- $<span id="xdx_90C_eifrs-full--AdjustmentsForSharebasedPayments_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--StockOptionsMember_z433EUMjILr">502,837</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:</span></p> <p id="xdx_892_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_zr2Vm8fmaoO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zEmocTHjtxN8" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">December 31, <span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">December 31, <span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231_zLhFKN9SoDEj" title="Risk free interest rate">4.58</span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_c20220101__20221231_z7qpzOsgjErl" title="Risk free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl1929">-</span></span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231_zVSQzAAiXMvc" title="Expected volatility">115.1</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_c20220101__20221231_zRGtFDTOgHr3" title="Expected volatility"><span style="-sec-ix-hidden: xdx2ixbrl1933">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--ExpectedLifeOfOptions_dtY_c20230101__20231231_zZEHP9m5wDYg" title="Expected life">10</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--ExpectedLifeOfOptions_c20220101__20221231_zKE4pzfQAgL7" title="Expected life"><span style="-sec-ix-hidden: xdx2ixbrl1937">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231_zaycOjwnHI68" title="Expected dividend yield">0</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20220101__20221231_zzqi2zvgyMw1" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1941">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20231231_zoDlkGv9aEAg" title="Exercise price">0.63</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20221231_zdBTXOpLers1" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_z8V5oLjCXZUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Share Units</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company in its discretion and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory_zF5xvyGpcY83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following RSUs outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zJPsY7PMKpF2" style="display: none">SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of RSU’s</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zjgeStHn2W3k" style="width: 18%; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">514,832</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zammJyDlWMV2" style="text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif">(1,072,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zAFNQ0eBrZvk" style="text-align: right" title="Number of RSUs,Issued"><span style="font-family: Times New Roman, Times, Serif">1,820,972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zrfIoyfC9Dzf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif">(64,334</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zJXHwKWJPbDa" style="text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">1,198,875</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zjPO3PktV5Ni" style="font-weight: bold; text-align: right" title="Number of RSUs,Vested"><span style="font-family: Times New Roman, Times, Serif">(1,508,255</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued </b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_znWvkaA1ypAj" style="font-weight: bold; text-align: right" title="Number of RSUs,Issued"><span style="font-family: Times New Roman, Times, Serif">1,685,316</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forfeited</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zGBKsDWvr1Nk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of RSUs ,Forfeited"><span style="font-family: Times New Roman, Times, Serif">(262,969</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding, December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zzRb6fwezzm6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of RSUs outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif">1,112,967</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A2_zbGT5rGcRRj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, <span id="xdx_903_ecustom--NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zqzltxG3UWC9" title="Number of accelerated vesting shares">1,508,255</span> RSU’s fully vested according to the terms and the Company granted <span id="xdx_907_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zr48eku7GGZh" title="Number of accelerated issued shares">1,687,014</span> RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, <span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zxmhLK4ZL9I4" title="Number of accelerated Forfeited shares">264,668</span> RSU’s were forfeited by employees who have left the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, <span id="xdx_909_ecustom--NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zs51cPtKpdxe" title="Number of accelerated vesting shares">1,072,595</span> RSU’s fully vested according to the terms and the Company granted <span id="xdx_90C_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zMXT0pXZWfeg" title="Number of accelerated issued shares">1,820,972</span> RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months from the grant date. In addition, <span id="xdx_908_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zfCeb3B0aD35" title="Number of accelerated Forfeited shares">64,334</span> RSU’s were forfeited by employees who have left the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company recorded share-based payment expense of $<span id="xdx_904_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pp0p0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zAax7vj78ZI7">1,866,490 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2022: $<span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pp0p0_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zilUcvnCFceh">2,808,187) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for RSU’s, based on the fair values of RSU’s granted which are calculated using the closing price of the Company’s stock on the day prior to grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_90D_ecustom--WarrantsIssued_pid_c20230101__20231231_ztNFETgTIqni">1,600,000</span> warrants for a purchase price of $<span id="xdx_904_ecustom--WarrantExercisePrice_iI_uUSDPShares_c20231231_zN2vYrO9i2Zi" title="Warrant exercise price share">0.5499</span>USD with an exercise price of $<span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_uUSDPShares_c20230101__20231231_zPhnPhbAJz1f" title="Exercise price">0.0001</span>USD per unit. The Company also issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_901_ecustom--WarrantsIssued_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zV5MTM7ZHKHi">6,400,000</span> warrants at an exercise price $<span id="xdx_904_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231_zS0L2Ca3jX21" title="Warrants exercise price">0.6123</span>USD. Being in a currency that is not the Company’s functional currency these warrants are required to be recorded as a financial liability. As a financial liability, the portion of the warrants related to the future exercise price will be revalued at every reporting period to fair market value with the change in fair value being recorded in profit or loss. All of the above warrants have a <span id="xdx_904_ecustom--WarrantsTerm_iI_dtY_c20231231_zme3s3wNvBKb" title="Warrants term">5</span> year term, expiring <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_900_ecustom--WarrantsMaturityDate_iI_dd_c20231231_z7IRsjd9eak" title="Warrants expiration date">October 30, 2028</span> and vest immediately. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_90B_ecustom--UnderwriterWarrantsIssued_c20230101__20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4NK1piNIUyj" title="Underwriter warrants issued">320,000</span> underwriter warrants were issued as part of the transaction with an exercise price of $<span id="xdx_907_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFKh11cCzuM8" title="Warrants exercise price">0.6875</span>USD and a term of <span id="xdx_90F_ecustom--WarrantsTerm_iI_dtY_uUSDPShares_c20231231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zzYn9lMsARKl" title="Warrants term">3</span> years. These warrants were treated as share issue costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period. At the date of issue the warrants were valued with a risk free rate of <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--USDWarrantsMember_z722os4Jv4wb" title="Risk free interest rate">4.8</span>%, volatility of <span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--USDWarrantsMember_zr18fDYvtj2b" title="Volatility rate">115.35</span>%, expected life of <span id="xdx_90C_ecustom--ExpectedLifeOfOptions_pid_dtY_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--USDWarrantsMember_z3UAsbrq7s95" title="Warrants term">5</span> years and an expected dividend yield rate of <span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--USDWarrantsMember_zRq85VlSP7v9" title="Expected dividend yield rate">0</span>%. The broker warrants were valued with a risk free rate of <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BrokerWarrantsMember_ztdQuSyjn3Ri" title="Risk free interest rate">4.87</span>%, volatility of <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BrokerWarrantsMember_zywoPWph1S0j" title="Volatility rate">138.83</span>%, expected life of <span id="xdx_90E_ecustom--ExpectedLifeOfOptions_pid_dtY_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BrokerWarrantsMember_zxHJtMrKOFUk" title="Expected life">3</span> years and an expected dividend yield of <span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--BrokerWarrantsMember_zSrrPF57VrOh" title="Expected dividend yield">0</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--DisclosureOfWarrantDerivativeLiabilityExplanatory_zaEA4o755mGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Derivative Liability</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_znNowVQP1OOk" style="display: none">SCHEDULE OF WARRANT DERIVATIVE LIABILITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zSxbJLt7BLr7" style="width: 18%; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">4,865,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrants outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_iN_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z7DdXrXLSgUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">(4,865,772</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z0TmA5eYiXCh" style="text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2021">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants issued</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zCHGfaPn2Prd" style="font-weight: bold; text-align: right" title="Warrants issued">3,985,015</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrants outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_iN_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zzQ1Bca9ioRc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Change in fair value of warrants outstanding">211,110</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iE_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zzOJt1caMuKb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Ending of the period">4,196,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Derivative liability balance at</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--Warrants_iI_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z0QeWXWCVlK7" style="width: 16%; text-align: right" title="Warrants">4,196,125</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--Warrants_iI_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zd3bavJ5MRyf" style="width: 16%; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2031">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Contingent consideration</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zirrTqw9tpw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Contingent consideration"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_ziRqnqq93gp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Contingent consideration"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--BusinessAcquisitionDerivativeLiability_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zYhZ7dGrbJlh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Derivative liability">4,196,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--BusinessAcquisitionDerivativeLiability_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zftRnKVSX0Jf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Derivative liability">57,314</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zo0ueXlUkiB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The contingent liability is related to an acquisition on March 22, 2021, whereby <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_90C_ecustom--WarrantsIssued_c20210321__20210322_zfXJ1E9zqPnj" title="Warrants issued">1,200,000</span> warrants were issued and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_903_ecustom--WarrantsHeldInEscrow_c20210321__20210322_zDBUSyIn5rO1" title="Warrants held in escrow">900,000</span> were held in escrow and classified as a contingent liability that were to be released upon completion of certain milestones. The milestones were related to the recognition of revenue on the related acquisition in range of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_907_eifrs-full--RevenueOfAcquiree_c20210321__20210322__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0d2ARTFt6uh" title="Revenue on acquisition">2,000,000</span> to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_908_eifrs-full--RevenueOfAcquiree_c20210321__20210322__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zxPeCk0NiMad" title="Revenue on acquisition">6,000,000</span> which was not met. The warrants expired on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_904_ecustom--WarrantsMaturityDate_iI_dd_c20210322_zCqzYuusJF31" title="Warrants expiration date">March 25, 2023</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory_zVArDFdxGYcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of these warrants and their fair values are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zwWxyT35t3K3" style="display: none">SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Issue Date</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants Outstanding at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Fair Value at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Fair Value at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zTwaxEK7qtdd">February 5, 2021</span> (1)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">US$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zW9LQWQhmlUj" title="Exercise price">3.55</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zKLqGFKVEMua" style="width: 9%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2056">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_ztQe28Y7zesi" style="width: 9%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEpKDUp_zqyEhiFaeCfg" style="width: 9%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">1,319,675</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zh99oekSLNIe" style="width: 9%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2062">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_z3bRx3z8dKv8">March 5, 2021</span> (2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$<span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zJ529EHX0CM3" title="Exercise price">3.55</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zBkGbjtUGZq8" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zhV8ymwE6fR4" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2069">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIpKDUp_z5ii9GUBk4Vl" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">5,142,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zRM3GPcsPbte" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2073">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDUp_zaEqND6UnAj9" title="Issue date">October 30, 2023</span> (3)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zMhJtLRpYw04" title="Exercise price">0.6123</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zUUDrcvLMobc" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,400,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zLkiS6D3LgGk" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">3,180,543</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zYE8wv23U3A4" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2083">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zbd8koEa5QQh" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDYp_zonbDIssAT0f" title="Issue date">October 30, 2023</span> (4)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zGxN367WR84a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zw8hVSNBPDyd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">1,600,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zEpaSh6p4l1k" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">1,015,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zI3VOm0zoiT5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_z2uaBcJQLqg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231_zqffJTYbDM31" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">8,000,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231_fKDUp_z6NpYVZIDs12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231_fKDUp_zqVJaVP7GvKj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,461,999</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231_fKDUp_zrMuuMyi4GY3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2104">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span id="xdx_F0F_zPWgxtaThH8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="text-align: justify"><span id="xdx_F1F_zkJ3kGWADzXa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants expired on February 5, 2023.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F0B_zO9GQKqYgPIh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="text-align: justify"><span id="xdx_F11_zpDeT2r2fdPd" style="font-family: Times New Roman, Times, Serif">The warrants expired on March 5, 2023.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F0D_ztPcaVpvA4ah" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="text-align: justify"><span id="xdx_F10_z0hcIpGW1Hnk" style="font-family: Times New Roman, Times, Serif">The warrants expire October 30, 2028.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F01_zyfbhHlkGsu5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td> <td style="text-align: justify"><span id="xdx_F1D_zkozRzAN0aHc" style="font-family: Times New Roman, Times, Serif">The warrants have no expiry date.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p id="xdx_8AB_znOalFQS8Kbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory_zwaB6NzQKZea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2Y0FJlarLy9" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; font-weight: bold; text-align: right"><span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zIrJ2GdZPO92" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.84</b></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span>%</td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbqwPhXP0SS8" title="Risk free interest rate">4.07</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zBOGIBcX8PAk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>113.78</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zMCYt02yUXze" title="Expected volatility">91.66%</span>-<span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTITlCSvSZa" title="Expected volatility">93.48</span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span id="xdx_90D_ecustom--ExpectedLifeOfOptions_dtY_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zxgGhTtqSv79">4.8 </span>years</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbaHQdl5jlG4" title="Expected life">0.10</span>-<span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z8YyU0K05sgf" title="Expected life">0.18</span> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zMDdalFEmFzb" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztkmhAlNzAhh" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8A9_zxc0X0ydNeSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--DisclosureOfChangeInWarrantsExplanatory_zvyKa9ycc8Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfMNuR8FwUY5" style="display: none">SUMMARY OF CHANGES IN WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztSXu5E0tVwc" style="width: 16%; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">8,414,819</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zNozlun19t56" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.99</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_di_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z18jmtpYlltb" style="text-align: right" title="Warrants, Excercised"><span style="font-family: Times New Roman, Times, Serif">(16,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zSDgoQiwsfmb" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif">4.51</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_di_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zpTeqUeJbZy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">(481,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zWcvCLxy0PCk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif">4.61</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z7q3YcEDZYKl" style="text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">7,916,797</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zb1v6r8sFkPb" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">5.08</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zJNk5Tyoa0O5" style="font-weight: bold; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">8,320,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_za9Riv4UW3Lh" style="font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif">0.50</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zJRS0kdTvdbb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif">(7,661,999</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z0LvAOM6a8b7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif">5.89</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbD7Q98Fkz5l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Warrants Outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif">8,574,798</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zwhLcB0bcbIi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zlGXOVF8xY9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory_zZpiLBHEwtpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following warrants outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zXH4yMfChtHk" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Date issued</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expiry date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of warrants outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zWovUGw722ah" title="Date issued">July 29, 2021</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zRlm3S7mt8R4" title="Expiry date">July 29, 2024</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 3%; text-align: left">US$</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zJbx4UjqkDQk" title="Exercise price">5.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zvQbFa28qWI2" style="width: 20%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z7ddupP6kHHe" title="Date issued">September 14, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z3Jj9AASrew9" title="Expiry date">September 14, 2024</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z3IbNtoTvlci" title="Exercise price">5.00</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z8dx7tY0U5q3" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">4,798</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zUloZhQ0Zs0c" title="Date issued">October 30, 2023</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zGuJ2a2cB8o9" title="Expiry date">October 30, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zYj0FYK0RHF9" title="Exercise price">0.6875</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zI6LIk8s8NSe" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">320,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zK4t2YZoSHg7" title="Date issued">October 30, 2023</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zZldeZgEPIB8" title="Expiry date">October 30, 2028</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zFAxxJNH7SDj" title="Exercise price">0.6123</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_z0OTMHmFdPLg" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">6,400,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zjzojD1QXWIc" title="Date issued">October 30, 2023</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">No expiry date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left">US$</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zMYqZVKqORWj" title="Exercise price">0.0001</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_z8U2IryTFWqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">1,600,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zCOYExpaeMah" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">8,574,798</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zLdOzLRvIvB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining contractual life of warrants outstanding as of December 31, 2023, was </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231_zHAbAV46Yts1">4.63</span> years (December 31, 2022 – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNIQVJFIENBUElUQUwgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_zbQ5xY8PZ3Vk">0.47 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1508255 8000000 10856166 1953032 8903134 650729 1748946 222136 1526810 4800000 4858995 889623 3969372 793979 16538 87170 12500 26875 1072595 <p id="xdx_894_ecustom--DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory_znqOjCNviiQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following options outstanding and exercisable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zlPe6bgcSDf6" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Grant Date</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expiry Date</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Remaining Contractual Life (years)</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options Outstanding</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options Exercisable</span></td><td style="text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z1QLjQhrBjIl" title="Grant Date">October 30, 2019</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zJbLrg2BkL7i" title="Expiry Date">October 30, 2029</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zUFHDJAIY0Nf" style="width: 13%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zeopAXSJwvL1" title="Remaining Contractual Life (years)">5.84</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsNVMdEmfXq2" style="width: 12%; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">278,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkRAp4vi7JEa" style="width: 12%; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">278,332</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zFg7rlurPo61" title="Grant Date">November 19, 2019</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zjNIOxmdat91" title="Expiry Date">November 19, 2029</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zDVzINEgpTsk" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zQreqOBbXZEb" title="Remaining Contractual Life (years)">5.89</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z3MhiAi8Lo28" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zvYtJKLGiP1" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkPt484jO1u4" title="Grant Date">April 30, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zcE3avxd2Rqd" title="Expiry Date">April 30, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zE6LLYMGK4Od" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zG5DK7WjboA6" title="Remaining Contractual Life (years)">6.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z1K3a1HVlJ27" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zb9wlyWlmW9a" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">85,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zMsgO39OSl6g" title="Grant Date">April 30, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z4u2xeaCjFzi" title="Expiry Date">April 30, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zARKzbom7e41" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">3.85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zbyudBBYHXml" title="Remaining Contractual Life (years)">6.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zbZ8COn1S3oe" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z4vSfZWERhEc" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">110,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsbpwnqJc15k" title="Grant Date">July 3, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z0ZsC9Lve5fa" title="Expiry Date">July 3, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z8XfxTAFE5Cb" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">3.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zhS90LM4BTU" title="Remaining Contractual Life (years)">1.51</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zJpDGb1P4Tg9" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zA4rOuLpRz21" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zVagmm361d7d" title="Grant Date">November 24, 2020</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zzPghL3Z5SVf" title="Expiry Date">November 24, 2030</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_znD5EVeg4aai" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">2.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z9niqZ6NEi8b" title="Remaining Contractual Life (years)">6.90</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zYtGwMXkRq99" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zZZAVaa0T7Qc" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z9ofVwuyCnY" title="Grant Date">February 2, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zt1nvBeRs3P1" title="Expiry Date">February 2, 2031</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zBQ8oAkUc47l" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">13.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zdE7u6Xaihj9" title="Remaining Contractual Life (years)">7.10</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zsvS2NWaEhl2" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zxwJabYpNXkk" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zrbvAUBNtyB7" title="Grant Date">March 8, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z2WCy0ohPoO8" title="Expiry Date">March 8, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zRJlfhMVcevl" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">13.90</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zfYKbk7yyQac" title="Remaining Contractual Life (years)">2.19</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zypiKVAemjnb" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zs5gePh8JPU4" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zHJflEIG1zb7" title="Grant Date">April 27, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zUJDkR2IvwJk" title="Expiry Date">April 27, 2031</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zTe7otj3Ndhd" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">10.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zLhVbe9je3wd" title="Remaining Contractual Life (years)">7.33</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zqPo5GxhLBkl" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">146,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zFzted5i2fw8" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">97,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_z3FauAh1JQ52" title="Grant Date">September 9, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zuHXnvnDhG8" title="Expiry Date">September 9, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zYfm7vux3xRi" style="text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">4.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zfGvHKrztcve" title="Remaining Contractual Life (years)">2.69</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zdhhApXBUZK2" style="text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">25,826</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zculnhYo3864" style="text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">17,217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--StockOptionsGrantDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zviikucN39z6" title="Grant Date">November 9, 2023</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--StockOptionsExpiryDate_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zXP3WZsy0uz8" title="Expiry Date">November 9, 2033</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uCADPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zT4gwiNL31ua" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif">0.626</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zkVsJFm5ZKEj" title="Remaining Contractual Life (years)">9.87</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zAfNvg2TydX7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zOoqAYGko6wk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20231231__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zQHSCOTMnWkd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Options Outstanding"><span style="font-family: Times New Roman, Times, Serif">897,158</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_uShares_c20231231__custom--PlanNamesAxis__custom--IncentiveShareCompensationPlanMember_zH7KOxA8WNc3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Options Exercisable"><span style="font-family: Times New Roman, Times, Serif">819,875</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2019-10-30 2029-10-30 2.50 P5Y10M2D 278332 278332 2019-11-19 2029-11-19 2.50 P5Y10M20D 50000 50000 2020-04-30 2030-04-30 2.50 P6Y3M29D 85000 85000 2020-04-30 2030-04-30 3.85 P6Y3M29D 110000 110000 2020-07-03 2025-07-03 3.20 P1Y6M3D 100000 100000 2020-11-24 2030-11-24 2.50 P6Y10M24D 32000 32000 2021-02-02 2031-02-02 13.20 P7Y1M6D 30000 30000 2021-03-08 2026-03-08 13.90 P2Y2M8D 10000 10000 2021-04-27 2031-04-27 10.15 P7Y3M29D 146000 97326 2021-09-09 2026-09-09 4.84 P2Y8M8D 25826 17217 2023-11-09 2033-11-09 0.626 P9Y10M13D 30000 10000 897158 819875 <p id="xdx_896_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zqnyTBsK0hIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8B2_zQIUti7B2MI7" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING</span></span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20220101__20221231_z4nkqvMoAf3h" title="Number of options outstanding, Beginning Balance">1,035,991</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20220101__20221231_zEmF1YlhZNgg" style="width: 16%; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231_zh58Mc6JLhB2" title="Number of options outstanding, Exercised">(12,500</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20220101__20221231_zoHOf7bo1N8l" style="text-align: right" title="Weighted average exercise price, Exercised"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231_zuODuYqLzwbi" title="Number of options outstanding, forfeited">(146,334</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20220101__20221231_zoQLJC2nNvUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif">4.77</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20230101__20231231_zUsoKrLkh307" title="Number of options outstanding, Beginning Balance">877,157</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zrOq12GhXyQh" style="text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forfeited</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20230101__20231231_zOFcCji4Lpy3" title="Number of options outstanding, forfeited">(9,999</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_c20230101__20231231_zphxYaiVvNm3" style="font-weight: bold; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif">3.77</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--NumberOfShareOptionsIssuedInSharebasedPaymentArrangement_uShares_c20230101__20231231_zvzzcx3QC5uk" title="Number of options outstanding, issued">30,000</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20230101__20231231_z1cEE6sBVbWh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted average exercise price, Issued"><span style="font-family: Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding, December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_c20230101__20231231_zxyP4m3qyZS4" title="Number of options outstanding, Ending Balance">897,158</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_c20230101__20231231_z3R6NH9SNKve" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted average exercise price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">4.48</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1035991 4.60 12500 2.15 146334 4.77 877157 4.60 9999 3.77 30000 0.63 897158 4.48 30000 0.626 P10Y 151174 502837 <p id="xdx_892_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_zr2Vm8fmaoO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zEmocTHjtxN8" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">December 31, <span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">December 31, <span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231_zLhFKN9SoDEj" title="Risk free interest rate">4.58</span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_c20220101__20221231_z7qpzOsgjErl" title="Risk free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl1929">-</span></span></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231_zVSQzAAiXMvc" title="Expected volatility">115.1</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_c20220101__20221231_zRGtFDTOgHr3" title="Expected volatility"><span style="-sec-ix-hidden: xdx2ixbrl1933">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--ExpectedLifeOfOptions_dtY_c20230101__20231231_zZEHP9m5wDYg" title="Expected life">10</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--ExpectedLifeOfOptions_c20220101__20221231_zKE4pzfQAgL7" title="Expected life"><span style="-sec-ix-hidden: xdx2ixbrl1937">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231_zaycOjwnHI68" title="Expected dividend yield">0</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20220101__20221231_zzqi2zvgyMw1" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl1941">-</span></span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20231231_zoDlkGv9aEAg" title="Exercise price">0.63</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20221231_zdBTXOpLers1" title="Exercise price"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.0458 1.151 P10Y 0 0.63 <p id="xdx_89C_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory_zF5xvyGpcY83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following RSUs outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zJPsY7PMKpF2" style="display: none">SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of RSU’s</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zjgeStHn2W3k" style="width: 18%; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">514,832</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zammJyDlWMV2" style="text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif">(1,072,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zAFNQ0eBrZvk" style="text-align: right" title="Number of RSUs,Issued"><span style="font-family: Times New Roman, Times, Serif">1,820,972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zrfIoyfC9Dzf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif">(64,334</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zJXHwKWJPbDa" style="text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">1,198,875</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zjPO3PktV5Ni" style="font-weight: bold; text-align: right" title="Number of RSUs,Vested"><span style="font-family: Times New Roman, Times, Serif">(1,508,255</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued </b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_znWvkaA1ypAj" style="font-weight: bold; text-align: right" title="Number of RSUs,Issued"><span style="font-family: Times New Roman, Times, Serif">1,685,316</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forfeited</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zGBKsDWvr1Nk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of RSUs ,Forfeited"><span style="font-family: Times New Roman, Times, Serif">(262,969</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding, December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zzRb6fwezzm6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of RSUs outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif">1,112,967</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 514832 1072595 -1820972 64334 1198875 1508255 1685316 262969 1112967 1508255 1687014 264668 1072595 1820972 64334 1866490 2808187 1600000 0.5499 0.0001 6400000 0.6123 P5Y 2028-10-30 320000 0.6875 P3Y 0.048 1.1535 P5Y 0 0.0487 1.3883 P3Y 0 <p id="xdx_891_ecustom--DisclosureOfWarrantDerivativeLiabilityExplanatory_zaEA4o755mGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Derivative Liability</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_znNowVQP1OOk" style="display: none">SCHEDULE OF WARRANT DERIVATIVE LIABILITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zSxbJLt7BLr7" style="width: 18%; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">4,865,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrants outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_iN_di_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z7DdXrXLSgUc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">(4,865,772</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z0TmA5eYiXCh" style="text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2021">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants issued</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zCHGfaPn2Prd" style="font-weight: bold; text-align: right" title="Warrants issued">3,985,015</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrants outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_iN_di_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zzQ1Bca9ioRc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Change in fair value of warrants outstanding">211,110</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iE_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zzOJt1caMuKb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Ending of the period">4,196,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Derivative liability balance at</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--Warrants_iI_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_z0QeWXWCVlK7" style="width: 16%; text-align: right" title="Warrants">4,196,125</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--Warrants_iI_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zd3bavJ5MRyf" style="width: 16%; text-align: right" title="Warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2031">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Contingent consideration</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zirrTqw9tpw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Contingent consideration"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2033">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_ziRqnqq93gp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Contingent consideration"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--BusinessAcquisitionDerivativeLiability_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zYhZ7dGrbJlh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Derivative liability">4,196,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--BusinessAcquisitionDerivativeLiability_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zftRnKVSX0Jf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Derivative liability">57,314</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4865772 4865772 3985015 -211110 4196125 4196125 57314 4196125 57314 1200000 900000 2000000 6000000 2023-03-25 <p id="xdx_894_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory_zVArDFdxGYcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of these warrants and their fair values are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zwWxyT35t3K3" style="display: none">SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Issue Date</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants Outstanding at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Fair Value at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Fair Value at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; text-align: right; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zTwaxEK7qtdd">February 5, 2021</span> (1)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">US$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zW9LQWQhmlUj" title="Exercise price">3.55</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zKLqGFKVEMua" style="width: 9%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2056">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_ztQe28Y7zesi" style="width: 9%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEpKDUp_zqyEhiFaeCfg" style="width: 9%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">1,319,675</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_fKDEp_zh99oekSLNIe" style="width: 9%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2062">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_z3bRx3z8dKv8">March 5, 2021</span> (2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$<span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zJ529EHX0CM3" title="Exercise price">3.55</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zBkGbjtUGZq8" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zhV8ymwE6fR4" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2069">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIpKDUp_z5ii9GUBk4Vl" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">5,142,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_fKDIp_zRM3GPcsPbte" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2073">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDUp_zaEqND6UnAj9" title="Issue date">October 30, 2023</span> (3)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zMhJtLRpYw04" title="Exercise price">0.6123</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zUUDrcvLMobc" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,400,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zLkiS6D3LgGk" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">3,180,543</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zYE8wv23U3A4" style="text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2083">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range6Member_fKDMp_zbd8koEa5QQh" style="text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--WarrantsIssuanceDate_dd_c20230101__20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDYp_zonbDIssAT0f" title="Issue date">October 30, 2023</span> (4)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zGxN367WR84a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zw8hVSNBPDyd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">1,600,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zEpaSh6p4l1k" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">1,015,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_zI3VOm0zoiT5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range7Member_fKDQp_z2uaBcJQLqg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20231231_zqffJTYbDM31" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">8,000,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20231231_fKDUp_z6NpYVZIDs12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20221231_fKDUp_zqVJaVP7GvKj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,461,999</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--CurrentWarrantFairValue_iI_uUSD_c20221231_fKDUp_zrMuuMyi4GY3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2104">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify; width: 0.25in"><span id="xdx_F0F_zPWgxtaThH8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="text-align: justify"><span id="xdx_F1F_zkJ3kGWADzXa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants expired on February 5, 2023.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F0B_zO9GQKqYgPIh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="text-align: justify"><span id="xdx_F11_zpDeT2r2fdPd" style="font-family: Times New Roman, Times, Serif">The warrants expired on March 5, 2023.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F0D_ztPcaVpvA4ah" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="text-align: justify"><span id="xdx_F10_z0hcIpGW1Hnk" style="font-family: Times New Roman, Times, Serif">The warrants expire October 30, 2028.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span id="xdx_F01_zyfbhHlkGsu5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td> <td style="text-align: justify"><span id="xdx_F1D_zkozRzAN0aHc" style="font-family: Times New Roman, Times, Serif">The warrants have no expiry date.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p> 2021-02-05 3.55 1319675 2021-03-05 3.55 5142324 2023-10-30 0.6123 6400000 3180543 2023-10-30 0.0001 1600000 1015582 8000000 4196125 6461999 <p id="xdx_895_ecustom--DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory_zwaB6NzQKZea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z2Y0FJlarLy9" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk free interest rate</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; font-weight: bold; text-align: right"><span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zIrJ2GdZPO92" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.84</b></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span>%</td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbqwPhXP0SS8" title="Risk free interest rate">4.07</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zBOGIBcX8PAk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>113.78</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zMCYt02yUXze" title="Expected volatility">91.66%</span>-<span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTITlCSvSZa" title="Expected volatility">93.48</span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span id="xdx_90D_ecustom--ExpectedLifeOfOptions_dtY_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zxgGhTtqSv79">4.8 </span>years</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbaHQdl5jlG4" title="Expected life">0.10</span>-<span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z8YyU0K05sgf" title="Expected life">0.18</span> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zMDdalFEmFzb" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztkmhAlNzAhh" title="Expected dividend yield">0</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> 0.0384 0.0407 1.1378 0.9166 0.9348 P4Y9M18D P0Y1M6D P0Y2M4D 0 0 <p id="xdx_896_ecustom--DisclosureOfChangeInWarrantsExplanatory_zvyKa9ycc8Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zfMNuR8FwUY5" style="display: none">SUMMARY OF CHANGES IN WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztSXu5E0tVwc" style="width: 16%; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">8,414,819</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zNozlun19t56" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">4.99</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_di_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z18jmtpYlltb" style="text-align: right" title="Warrants, Excercised"><span style="font-family: Times New Roman, Times, Serif">(16,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zSDgoQiwsfmb" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif">4.51</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_di_uCADPShares_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zpTeqUeJbZy8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">(481,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20220101__20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zWcvCLxy0PCk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif">4.61</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z7q3YcEDZYKl" style="text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif">7,916,797</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zb1v6r8sFkPb" style="text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">5.08</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zJNk5Tyoa0O5" style="font-weight: bold; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">8,320,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_za9Riv4UW3Lh" style="font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif">0.50</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zJRS0kdTvdbb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif">(7,661,999</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z0LvAOM6a8b7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif">5.89</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zbD7Q98Fkz5l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Warrants Outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif">8,574,798</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zwhLcB0bcbIi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 8414819 4.99 16538 4.51 481484 4.61 7916797 5.08 8320000 0.50 7661999 5.89 8574798 0.63 <p id="xdx_89C_ecustom--DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory_zZpiLBHEwtpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had the following warrants outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zXH4yMfChtHk" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Date issued</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expiry date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Number of warrants outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zWovUGw722ah" title="Date issued">July 29, 2021</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zRlm3S7mt8R4" title="Expiry date">July 29, 2024</span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 3%; text-align: left">US$</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zJbx4UjqkDQk" title="Exercise price">5.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zvQbFa28qWI2" style="width: 20%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z7ddupP6kHHe" title="Date issued">September 14, 2021</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z3Jj9AASrew9" title="Expiry date">September 14, 2024</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z3IbNtoTvlci" title="Exercise price">5.00</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z8dx7tY0U5q3" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">4,798</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zUloZhQ0Zs0c" title="Date issued">October 30, 2023</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zGuJ2a2cB8o9" title="Expiry date">October 30, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zYj0FYK0RHF9" title="Exercise price">0.6875</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zI6LIk8s8NSe" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">320,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zK4t2YZoSHg7" title="Date issued">October 30, 2023</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--WarrantExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zZldeZgEPIB8" title="Expiry date">October 30, 2028</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left">US$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zFAxxJNH7SDj" title="Exercise price">0.6123</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_z0OTMHmFdPLg" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">6,400,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--CompensationWarrantsIssuedDate_dd_c20230101__20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zjzojD1QXWIc" title="Date issued">October 30, 2023</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">No expiry date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left">US$</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--CompensationWarrantsExercisePrice_iI_pid_uUSDPShares_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zMYqZVKqORWj" title="Exercise price">0.0001</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_z8U2IryTFWqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">1,600,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zCOYExpaeMah" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">8,574,798</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2021-07-29 2024-07-29 5.00 250000 2021-09-14 2024-09-14 5.00 4798 2023-10-30 2026-10-30 0.6875 320000 2023-10-30 2028-10-30 0.6123 6400000 2023-10-30 0.0001 1600000 8574798 P4Y7M17D P0Y5M19D <p id="xdx_80F_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zhdgrG4YvPg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. <span id="xdx_827_zMefxZKioSH9">SEGMENTED INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. SEGMENTED INFORMATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, lead director, chief operating officer and chief financial officer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zyzmX7ljzKPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zE90DrRp8bT3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF SEGMENTED INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231__ifrs-full--SegmentsAxis__custom--DronesMember_zQqs9H7J6twl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Drones</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231__ifrs-full--SegmentsAxis__custom--VitalMember_zuuTsgAIe9n5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20230101__20231231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zRB8j0VI5Jz6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Corporate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_z6JuFE0QmcK2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_zFkCpHW5Kctk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Sales of goods</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,905,417</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">381,676</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,287,093</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--RevenueFromRenderingOfServices_zIVM2aAVpGja" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision of services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,267,749</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2213">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,267,749</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zYDePuVaHLub" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,173,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">381,676</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2219">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,554,842</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--SegmentGainIncomeLoss_iN_di_z0IQhrbtwmGa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Segment loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,743,176</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(140,366</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,323,731</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,926,541</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncomeCost_iN_di_zfP4hDthMh25" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance and other costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(80,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,069</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(83,280</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDepreciationExpense_zbKG5RLNCDib" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,530</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_zVnXYlP6Uf59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--ImpairmentOfGoodwillAndIntangibles_zeaLRe83op9b" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Impairment of goodwill and intangibles</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_zdQhIP5S4UV9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2248">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zp76FkWSE9G3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss (recovery) on write-off of notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2252">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2253">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ReserveInventoryWriteDown_zWnt4sbQhZd8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write down of inventory</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2258">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--WriteDownOfDeposit_iN_di_zq91W4hAEmI5" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write down of deposit</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--ProfitLoss_iN_di_zSeKfgfUOY31" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,530,126</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(140,366</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,222,051</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,611,810</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20220101__20221231__ifrs-full--SegmentsAxis__custom--DronesMember_zF1gKm9tRiYl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Drones</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231__ifrs-full--SegmentsAxis__custom--VitalMember_zSxnmB3CJXk4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zGGxea0g1m66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Corporate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_z3BgiNY7Hca1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_z7QNSyyv7EB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Sales of goods</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,388,262</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,170</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,550,432</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--RevenueFromRenderingOfServices_z9YBIyhUipe1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision of services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,054,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,054,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zZWNHjTmLSof" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,442,889</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,170</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2284">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,605,059</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--SegmentGainIncomeLoss_iN_di_z005UVEmW3ha" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Segment loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,929,789</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">602,580</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,926,884</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,459,253</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncomeCost_iN_di_zZM0pN2KgvO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance and other costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,529</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,186</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDepreciationExpense_zvejhUERKHvg" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">586,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2298">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2299">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">593,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_zAuhALbJgUg1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2304">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ImpairmentOfGoodwillAndIntangibles_zHRQElnTE4Ih" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment of goodwill and intangibles</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,166,563</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,288,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2309">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,454,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_z5QpnNFSSfB1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2312">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,502,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,502,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zmpy28U0Gyg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write-off of notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,080,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2318">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(771,260</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">309,385</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ReserveInventoryWriteDown_zw8yjRB1FC91" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write down of inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,754</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,724,760</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2324">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,976,514</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--WriteDownOfDeposit_iN_di_zOZ07cfA6zD8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write down of deposit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2327">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_iN_di_z1wk8bfOQLra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,190,889</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,844,263</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,619,212</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,654,364</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20211231__ifrs-full--SegmentsAxis__custom--DronesMember_zhUjbF9o1qjh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Drones</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231__ifrs-full--SegmentsAxis__custom--VitalMember_zCQ9yCNfrqn6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Vital</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zej5t6xXnEXh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Corporate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20211231_zZLGwXAKA3X4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_zWWz9aeDIpQg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Sales of goods</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">4,957,134</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">146,265</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">5,103,399</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromRenderingOfServices_z3sTt04F1Zo8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Provision of services</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,950,466</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2343">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,950,466</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_z1wmOdVqr661" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,907,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">146,265</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,053,865</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--SegmentGainIncomeLoss_iN_di_zvct5VHUxUQ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,819,739</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">257,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,498,164</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">18,575,560</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--FinanceIncomeCost_iN_di_zQeYvbtH0Obj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finance and other costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2358">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,346</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,074</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eifrs-full--AdjustmentsForDepreciationExpense_z7zsi7adE8E2" style="vertical-align: bottom; background-color: White"> <td>Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2363">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2364">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,098</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--AdjustmentsForAmortisationExpense_zoKsyI8fRZal" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,966</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2368">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,966</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--ImpairmentOfGoodwillAndIntangibles_z4g5lvJh8Bbd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Impairment of goodwill and intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2372">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,579,763</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2374">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,579,763</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_zF2IhtEuknUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2378">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,149,812</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,149,812</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zViZtJFe3qZ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Loss on write-off of notes receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2382">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">891,471</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">891,471</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--ProfitLoss_iN_di_zZciS3bouXai" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,147,075</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,837,419</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,218,477</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,202,972</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A3_z5J2MnWsQLc2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eifrs-full--DisclosureOfGeographicalAreasExplanatory_z83aAsKxoob4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zbGobz6iOwdk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF GEOGRAPHIC REVENUE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_z541CViBGseg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zr2NfQ9jOhlg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td id="xdx_49D_20210101__20211231_zFRKLGBTylN1" style="text-align: right">2021</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Geographic segmentation is as follows:</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--GeographicNoncurrentAssets_c20231231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zRdybk7ekAJi" style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,441,701</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--GeographicNoncurrentAssets_iI_c20221231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zBlU8ToQkV9e" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,121,821</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_98A_ecustom--GeographicNoncurrentAssets_iI_c20211231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zC8LcIWIBBe3" style="text-align: right; width: 11%">3,441,872</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--GeographicNoncurrentAssets_iI_c20231231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zQaGasQhapK6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,616</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--GeographicNoncurrentAssets_iI_c20221231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zP74Z3iRt2Mf" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_981_ecustom--GeographicNoncurrentAssets_iI_c20211231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zuW85Lp9j2Qf" style="border-bottom: Black 1.5pt solid; text-align: right">5,112,659</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--GeographicNoncurrentAssets_iI_c20231231_zOg6bte0h6P6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Non-current assets"><span style="font-family: Times New Roman, Times, Serif">1,648,317</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--GeographicNoncurrentAssets_iI_c20221231_zJJPZAryvIHk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-current assets"><span style="font-family: Times New Roman, Times, Serif">1,121,821</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_98B_ecustom--GeographicNoncurrentAssets_iI_c20211231_zsujRPqq9EK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-current assets">8,554,531</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--RevenueAbstract_iB_zXjN1xybnNb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--GeographicalAreasAxis__custom--CAMember_zHPEEpE69S9e" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,162,672</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,919,038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td>$</td> <td style="text-align: right">4,982,373</td> <td> </td></tr> <tr id="xdx_408_eifrs-full--Revenue_hifrs-full--GeographicalAreasAxis__custom--USCountryMember_zpbblPzgsmP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,170</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">686,021</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,071,492</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--Revenue_zVu7wqaWdAo5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,554,842</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,605,059</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">7,053,865</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8A8_zMX9oSzoWBQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_898_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zyzmX7ljzKPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zE90DrRp8bT3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF SEGMENTED INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231__ifrs-full--SegmentsAxis__custom--DronesMember_zQqs9H7J6twl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Drones</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231__ifrs-full--SegmentsAxis__custom--VitalMember_zuuTsgAIe9n5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20230101__20231231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zRB8j0VI5Jz6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Corporate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_z6JuFE0QmcK2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_zFkCpHW5Kctk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Sales of goods</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,905,417</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">381,676</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,287,093</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--RevenueFromRenderingOfServices_zIVM2aAVpGja" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision of services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,267,749</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2213">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,267,749</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zYDePuVaHLub" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,173,166</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">381,676</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2219">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,554,842</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--SegmentGainIncomeLoss_iN_di_z0IQhrbtwmGa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Segment loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,743,176</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(140,366</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,323,731</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,926,541</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncomeCost_iN_di_zfP4hDthMh25" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance and other costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(80,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,069</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(83,280</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDepreciationExpense_zbKG5RLNCDib" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,530</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,677</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_zVnXYlP6Uf59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--ImpairmentOfGoodwillAndIntangibles_zeaLRe83op9b" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Impairment of goodwill and intangibles</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_zdQhIP5S4UV9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2248">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(211,110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zp76FkWSE9G3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss (recovery) on write-off of notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2252">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2253">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ReserveInventoryWriteDown_zWnt4sbQhZd8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write down of inventory</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2258">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">331,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--WriteDownOfDeposit_iN_di_zq91W4hAEmI5" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write down of deposit</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--ProfitLoss_iN_di_zSeKfgfUOY31" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,530,126</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(140,366</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,222,051</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,611,810</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20220101__20221231__ifrs-full--SegmentsAxis__custom--DronesMember_zF1gKm9tRiYl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Drones</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231__ifrs-full--SegmentsAxis__custom--VitalMember_zSxnmB3CJXk4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Vital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zGGxea0g1m66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Corporate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_z3BgiNY7Hca1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_z7QNSyyv7EB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Sales of goods</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,388,262</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,170</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,550,432</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--RevenueFromRenderingOfServices_z9YBIyhUipe1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision of services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,054,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,054,627</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zZWNHjTmLSof" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,442,889</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,170</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2284">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,605,059</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--SegmentGainIncomeLoss_iN_di_z005UVEmW3ha" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Segment loss</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,929,789</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">602,580</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,926,884</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,459,253</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncomeCost_iN_di_zZM0pN2KgvO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance and other costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,529</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,186</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDepreciationExpense_zvejhUERKHvg" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">586,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2298">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2299">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">593,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdjustmentsForAmortisationExpense_zAuhALbJgUg1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2304">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">179,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ImpairmentOfGoodwillAndIntangibles_zHRQElnTE4Ih" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment of goodwill and intangibles</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,166,563</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,288,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2309">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,454,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_z5QpnNFSSfB1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2312">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,502,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,502,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zmpy28U0Gyg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write-off of notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,080,645</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2318">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(771,260</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">309,385</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--ReserveInventoryWriteDown_zw8yjRB1FC91" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on write down of inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,754</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,724,760</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2324">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,976,514</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--WriteDownOfDeposit_iN_di_zOZ07cfA6zD8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write down of deposit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2327">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_iN_di_z1wk8bfOQLra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,190,889</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,844,263</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,619,212</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,654,364</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20211231__ifrs-full--SegmentsAxis__custom--DronesMember_zhUjbF9o1qjh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Drones</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231__ifrs-full--SegmentsAxis__custom--VitalMember_zCQ9yCNfrqn6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Vital</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231__ifrs-full--SegmentsAxis__custom--CorporatesMember_zej5t6xXnEXh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Corporate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20211231_zZLGwXAKA3X4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromSaleOfGoods_zWWz9aeDIpQg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Sales of goods</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">4,957,134</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">146,265</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">5,103,399</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromRenderingOfServices_z3sTt04F1Zo8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Provision of services</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,950,466</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2343">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,950,466</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_z1wmOdVqr661" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,907,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">146,265</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,053,865</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--SegmentGainIncomeLoss_iN_di_zvct5VHUxUQ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,819,739</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">257,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,498,164</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">18,575,560</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--FinanceIncomeCost_iN_di_zQeYvbtH0Obj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finance and other costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2358">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,346</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,074</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eifrs-full--AdjustmentsForDepreciationExpense_z7zsi7adE8E2" style="vertical-align: bottom; background-color: White"> <td>Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2363">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2364">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,098</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--AdjustmentsForAmortisationExpense_zoKsyI8fRZal" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,966</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2368">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,966</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--ImpairmentOfGoodwillAndIntangibles_z4g5lvJh8Bbd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Impairment of goodwill and intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2372">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,579,763</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2374">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,579,763</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_iN_di_zF2IhtEuknUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2378">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,149,812</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,149,812</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eifrs-full--GainsLossesOnLoansAndReceivables_iN_di_zViZtJFe3qZ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Loss on write-off of notes receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2382">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">891,471</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">891,471</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--ProfitLoss_iN_di_zZciS3bouXai" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,147,075</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,837,419</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,218,477</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,202,972</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 4905417 381676 5287093 1267749 1267749 6173166 381676 6554842 -14743176 140366 -8323731 -22926541 80211 3069 83280 499530 11148 510677 35960 35960 211110 211110 -101351 -101351 331671 331671 -15530126 140366 -8222051 -23611810 5388262 162170 5550432 2054627 2054627 7442889 162170 7605059 -9929789 -602580 -12926884 -23459253 3529 40186 44345 586185 593277 179482 179482 2166563 4288351 6454914 5502688 5502688 -1080645 771260 -309385 251754 1724760 1976514 -228572 -228572 -14190889 -6844263 -6619212 -27654364 4957134 146265 5103399 1950466 1950466 6907600 146265 7053865 -7819739 -257656 -10498164 -18575560 -16272 21346 5074 175098 175098 135966 135966 4579763 4579763 8149812 8149812 -891471 -891471 -8147075 -4837419 -3218477 -16202972 <p id="xdx_89A_eifrs-full--DisclosureOfGeographicalAreasExplanatory_z83aAsKxoob4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zbGobz6iOwdk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF GEOGRAPHIC REVENUE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_z541CViBGseg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zr2NfQ9jOhlg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td id="xdx_49D_20210101__20211231_zFRKLGBTylN1" style="text-align: right">2021</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Geographic segmentation is as follows:</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--GeographicNoncurrentAssets_c20231231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zRdybk7ekAJi" style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,441,701</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--GeographicNoncurrentAssets_iI_c20221231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zBlU8ToQkV9e" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,121,821</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_98A_ecustom--GeographicNoncurrentAssets_iI_c20211231__ifrs-full--GeographicalAreasAxis__custom--CAMember_zC8LcIWIBBe3" style="text-align: right; width: 11%">3,441,872</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--GeographicNoncurrentAssets_iI_c20231231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zQaGasQhapK6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,616</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--GeographicNoncurrentAssets_iI_c20221231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zP74Z3iRt2Mf" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_981_ecustom--GeographicNoncurrentAssets_iI_c20211231__ifrs-full--GeographicalAreasAxis__custom--USCountryMember_zuW85Lp9j2Qf" style="border-bottom: Black 1.5pt solid; text-align: right">5,112,659</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--GeographicNoncurrentAssets_iI_c20231231_zOg6bte0h6P6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Non-current assets"><span style="font-family: Times New Roman, Times, Serif">1,648,317</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--GeographicNoncurrentAssets_iI_c20221231_zJJPZAryvIHk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-current assets"><span style="font-family: Times New Roman, Times, Serif">1,121,821</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_98B_ecustom--GeographicNoncurrentAssets_iI_c20211231_zsujRPqq9EK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-current assets">8,554,531</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--RevenueAbstract_iB_zXjN1xybnNb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--GeographicalAreasAxis__custom--CAMember_zHPEEpE69S9e" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Canada</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,162,672</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,919,038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td>$</td> <td style="text-align: right">4,982,373</td> <td> </td></tr> <tr id="xdx_408_eifrs-full--Revenue_hifrs-full--GeographicalAreasAxis__custom--USCountryMember_zpbblPzgsmP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,170</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">686,021</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,071,492</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eifrs-full--Revenue_zVu7wqaWdAo5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,554,842</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,605,059</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">7,053,865</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 1441701 1121821 3441872 206616 5112659 1648317 1121821 8554531 6162672 6919038 4982373 392170 686021 2071492 6554842 7605059 7053865 <p id="xdx_80C_eifrs-full--DisclosureOfOtherOperatingExpenseExplanatory_zupLnxMLcQI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19. <span id="xdx_825_zRaNphUKoQ51">OFFICE AND MISCELLANEOUS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_ecustom--DisclosureOfOtherAndMiscellaneousExplanatory_zCdNjBzX9Wl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B1_zhmcOMlu5pUl" style="display: none">SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td id="xdx_49B_20230101__20231231_z4Libfjx3hgi" style="text-align: right">2023<b> </b></td> <td> </td> <td> </td> <td colspan="2" id="xdx_491_20220101__20221231_z8Zw5zlGENt" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20210101__20211231_zxI31yzSNSLh" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td colspan="9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdvertisingExpense_maMOOEzdlr_zRyfZxn5psbb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising, Marketing, and Investor Relations</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><b>$</b></td> <td style="text-align: right; width: 11%"><b>4,243,432</b></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,431,818</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,165,791</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--ComplianceFees_maMOOEzdlr_zg4JompHhhhd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Compliance fees</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>193,250</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,826</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">432,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--ImpairmentOfAccountsReceivable_maMOOEzdlr_zG3rPdU6XFrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment of accounts receivable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>216,238</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2435">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2436">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ContractWork_maMOOEzdlr_zvX8aOjIDPU" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Contract Work</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>772,003</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,798</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,975</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--OtherExpenseByFunction_maMOOEzdlr_znHbQw6XsbJe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>878,956</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">371,519</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">556,358</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--MiscellaneousOtherOperatingExpense_iT_pp0p0_mtMOOEzdlr_zqhbTSkF22Xk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and Miscellaneous Expenses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><b>$</b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>6,303,879</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,397,961</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,455,998</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zg2L1VspmrB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--DisclosureOfOtherAndMiscellaneousExplanatory_zCdNjBzX9Wl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B1_zhmcOMlu5pUl" style="display: none">SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td id="xdx_49B_20230101__20231231_z4Libfjx3hgi" style="text-align: right">2023<b> </b></td> <td> </td> <td> </td> <td colspan="2" id="xdx_491_20220101__20221231_z8Zw5zlGENt" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20210101__20211231_zxI31yzSNSLh" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td colspan="9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdvertisingExpense_maMOOEzdlr_zRyfZxn5psbb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising, Marketing, and Investor Relations</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><b>$</b></td> <td style="text-align: right; width: 11%"><b>4,243,432</b></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,431,818</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,165,791</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--ComplianceFees_maMOOEzdlr_zg4JompHhhhd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Compliance fees</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>193,250</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,826</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">432,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--ImpairmentOfAccountsReceivable_maMOOEzdlr_zG3rPdU6XFrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment of accounts receivable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>216,238</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2435">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2436">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ContractWork_maMOOEzdlr_zvX8aOjIDPU" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Contract Work</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><b> </b></td> <td style="text-align: right"><b>772,003</b></td> <td> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,798</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,975</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--OtherExpenseByFunction_maMOOEzdlr_znHbQw6XsbJe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>878,956</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">371,519</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">556,358</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eifrs-full--MiscellaneousOtherOperatingExpense_iT_pp0p0_mtMOOEzdlr_zqhbTSkF22Xk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and Miscellaneous Expenses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><b>$</b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>6,303,879</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,397,961</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,455,998</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4243432 4431818 5165791 193250 152826 432874 216238 772003 441798 300975 878956 371519 556358 6303879 5397961 6455998 <p id="xdx_800_eifrs-full--DisclosureOfRelatedPartyExplanatory_zvORs2XV1pJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20. <span id="xdx_828_zUlEmwRZCrw3">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management at fees set out in the Agreement. For the year ended December 31, 2023, the Company incurred fees of $<span id="xdx_901_eifrs-full--ProfessionalFeesExpense_c20230101__20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--BusinessServicesAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zWyhNN53DP8l">429,766 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(December 31, 2022 - $<span id="xdx_90A_eifrs-full--ProfessionalFeesExpense_c20220101__20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--BusinessServicesAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zIQJ3DAZ8b9l">442,485</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">) which are included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $<span id="xdx_904_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--BusinessServicesAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zoK2xzlyC7ml">3,780 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(December 31, 2022 - $<span id="xdx_903_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--BusinessServicesAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zdzwHg5EDF69">30,804</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company and all fees are set in the Consultant Agreement. For the year ended December 31, 2023, the Company incurred fees of $<span id="xdx_90E_eifrs-full--ProfessionalFeesExpense_c20230101__20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--IndependentConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zjwHJWUxGuo9" title="Incurred fees">592,500</span> (December 31, 2022 - $<span id="xdx_903_eifrs-full--ProfessionalFeesExpense_c20220101__20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--IndependentConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zCNOBpXAhAO7" title="Incurred fees">566,487</span>) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $<span id="xdx_906_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--IndependentConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_z3MJYzaQBcd5" title="Indebted amount">35,417</span> (December 31, 2022 - $<span id="xdx_90D_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_dxL_c20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--IndependentConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zJifd0apwim5" title="Indebted amount::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2462">nil</span></span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the year ended December 31, 2023, the Company incurred fees of $<span id="xdx_90A_eifrs-full--ProfessionalFeesExpense_c20230101__20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--ExecutiveConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zTPOzJFXfKV2" title="Incurred fees">215,019</span> (December 31, 2022 - $<span id="xdx_909_eifrs-full--ProfessionalFeesExpense_c20220101__20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--ExecutiveConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zTB629aUhSx1" title="Incurred fees">383,288</span>) included in professional fees. As at December 31, 2023, the Company was indebted to this company in the amount of $<span id="xdx_905_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20231231__ifrs-full--ServiceConcessionArrangementsAxis__custom--ExecutiveConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zegZWrRezMUa" title="Indebted amount">9,287</span> (December 31, 2022 - $<span id="xdx_90C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20221231__ifrs-full--ServiceConcessionArrangementsAxis__custom--ExecutiveConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zuw5WPKHgSM8" title="Indebted amount">20,745</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trade receivables/payables and accrued receivables/payables:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023, the Company had $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90A_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20231231_zY2HoX0L6yBg">190,664 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2022 - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFJFTEFURUQgUEFSVFkgVFJBTlNBQ1RJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_909_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20221231_zwkjHqdD9d7f">51,549</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20. RELATED PARTY TRANSACTIONS (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key management compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zph6hEkX8Eui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023 and 2022 included:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zPWYB0Ry6kx2" style="display: none">SCHEDULE OF KEY COMPENSATION AWARDS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31,</b></span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td id="xdx_492_20230101__20231231_zsJF7knf8tIh" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zBcudRQWWwo3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zAx1dwY5vjta" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationDirectorFees_maKMPCzUDQ_zBU0aBNsmiJj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Director fees</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><b>$</b></td> <td style="text-align: right; width: 11%"><b>600,933 </b></td> <td style="width: 1%"> </td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">522,349</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">370,094</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--KeyManagementPersonnelCompensationSalaries_maKMPCzUDQ_zwiHrr48CTui" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Salaries</span></td> <td> </td> <td><b> </b></td> <td style="text-align: right"><b>979,154 </b></td> <td> </td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">843,917</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">722,068</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzUDQ_zh1FNo83clkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based payments</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1,109,232 </b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,106,906</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,475,949</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--KeyManagementPersonnelCompensation_iT_pp0p0_mtKMPCzUDQ_zBbc2stDPPNk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b>$</b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>2,689,319</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,473,172</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,568,111</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_zrwI7x9wrRk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zTcfN55i5hZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other related party transactions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B6_zegD4raxOH8c" style="display: none">SCHEDULE OF KEY MANAGEMENT TRANSACTIONS</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="11" style="border-bottom: Black 1.5pt solid; text-align: right"><b>For the years ended December 31,</b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_497_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zdykyExNLbj" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbpsRZkciYk4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zuUwlqHf4Wm" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOAndDirectorMember_zP96gZUvaaAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company controlled by CEO and director</span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%"><b>592,500</b></td> <td style="width: 1%"> </td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">566,487</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">290,225</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOMember_zxnFBrDxVBuf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company that the CEO holds an economic interest in</span></td> <td> </td> <td> </td> <td style="text-align: right"><b>429,766</b></td> <td> </td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">442,485</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">315,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zi8ZrWEhZSh8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company controlled by a director</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>215,019</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">383,288</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">205,691</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--KeyManagementPersonnelCompensation_zBj2soUpkmwj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company, total</span><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1,237,285</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,392,260</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">811,559</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A2_zYb1ZJQbHNja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> 429766 442485 3780 30804 592500 566487 35417 215019 383288 9287 20745 190664 51549 <p id="xdx_896_eifrs-full--DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_zph6hEkX8Eui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the year ended December 31, 2023 and 2022 included:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zPWYB0Ry6kx2" style="display: none">SCHEDULE OF KEY COMPENSATION AWARDS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td colspan="9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31,</b></span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td id="xdx_492_20230101__20231231_zsJF7knf8tIh" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zBcudRQWWwo3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zAx1dwY5vjta" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationDirectorFees_maKMPCzUDQ_zBU0aBNsmiJj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Director fees</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><b>$</b></td> <td style="text-align: right; width: 11%"><b>600,933 </b></td> <td style="width: 1%"> </td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">522,349</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">370,094</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--KeyManagementPersonnelCompensationSalaries_maKMPCzUDQ_zwiHrr48CTui" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Salaries</span></td> <td> </td> <td><b> </b></td> <td style="text-align: right"><b>979,154 </b></td> <td> </td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">843,917</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">722,068</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_maKMPCzUDQ_zh1FNo83clkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based payments</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1,109,232 </b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,106,906</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,475,949</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--KeyManagementPersonnelCompensation_iT_pp0p0_mtKMPCzUDQ_zBbc2stDPPNk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"><b>$</b></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>2,689,319</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,473,172</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,568,111</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 600933 522349 370094 979154 843917 722068 1109232 2106906 2475949 2689319 3473172 3568111 <p id="xdx_89D_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zTcfN55i5hZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other related party transactions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B6_zegD4raxOH8c" style="display: none">SCHEDULE OF KEY MANAGEMENT TRANSACTIONS</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="11" style="border-bottom: Black 1.5pt solid; text-align: right"><b>For the years ended December 31,</b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_497_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zdykyExNLbj" style="border-bottom: Black 1.5pt solid; text-align: right"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zbpsRZkciYk4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zuUwlqHf4Wm" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOAndDirectorMember_zP96gZUvaaAk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company controlled by CEO and director</span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%"><b>592,500</b></td> <td style="width: 1%"> </td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">566,487</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">290,225</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOMember_zxnFBrDxVBuf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company that the CEO holds an economic interest in</span></td> <td> </td> <td> </td> <td style="text-align: right"><b>429,766</b></td> <td> </td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">442,485</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">315,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zi8ZrWEhZSh8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Management fees paid to a company controlled by a director</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>215,019</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">383,288</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">205,691</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--KeyManagementPersonnelCompensation_zBj2soUpkmwj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company, total</span><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1,237,285</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,392,260</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">811,559</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 592500 566487 290225 429766 442485 315643 215019 383288 205691 1237285 1392260 811559 <p id="xdx_80A_eifrs-full--DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_zU67aRZ208l8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21. <span id="xdx_825_z17hX28ZGmcg">FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Credit risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk of an unexpected loss if a customer or third party fails to meet its contractual obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivables</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables primarily consist of trade receivables, accrued receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date abut past events, current conditions and forecasts of future economic conditions. Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory_zDXg2FpdiMZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s aging of receivables was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zD8oTNwtb7F4">SCHEDULE OF AGING OF RECEIVABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20231231_zRrdJRmwU0s5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20221231_zuofUKFPXHo5" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zfGVczNLxyA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0 – 30 days</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>271,622</b></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,020,091</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_zEZlxXL6UZA9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31 – 60 days</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>109,928</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,378</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_ze8NWJT0n2Dc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61 – 90 days</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>64,259</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">343,364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsMember_zp6pGwGuPZle" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91 + days</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>203,803</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">609,132</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_zyUwUBpXSFKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total receivables</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>649,612</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,088,965</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_z765PPvVqPm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory_z8SczL9maxeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zrfD6nAnIqri">SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zFZZEUqPjHTg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1 year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zWlK13x56ad7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1 – 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20231231_zBC8rBxKSMO2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradePayablesAndAccruedLiabilitiesMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zE8zDe5AkjM1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade payables and accrued liabilities</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2532">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CustomerDepositsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z9AtZLoFYoD1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,715</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2536">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredIncomeMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zESdC5EdCSkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,112</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LoanPayableMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z0yUORgb6yl1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2544">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeLiabilityMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoxRFUZfQwx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2548">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKpVY0qcW0zh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liability</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">429,948</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">497,398</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">927,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_zlsgwoklsb11" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Financial liabilities</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,466,939</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">592,960</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,059,899</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zQybd7xPXFwd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign exchange risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_zRJqJlKI9U76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zcd6ecewPZ6a" style="display: none">SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20230101__20231231_zlbHRxvyCImf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zWwoCrzgE4ql" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ForeignExchangeGain_zrsuSqw8KGSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange rate</span></td><td style="padding-bottom: 1.5pt; width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">530,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">969,977</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zH1J6E2LYdp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair value</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the consolidated statements of financial position. These financial assets are measured at fair value through profit and loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zj1K1DDgj3M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zFgok9q3T3x2">SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zmmc98HZHdq3" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 1</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_z48lS8jpOxld" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 2</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zi7Uz3doCIf1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 3</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B6_zdp6svHyLqA" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43E_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_zZAhkGW4hRbk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity securities in investee companies</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right">       <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">132,260</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">189,403</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43E_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zO0yVvqQmCR5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Notes receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_438_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zq7glj0TrMP3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2576">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2577">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_437_c20231231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zOHna4wC0Hme" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,413</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2582">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,328,385</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,385,528</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zUSXmWZUmYO9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 1</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zlKdBHUesNv1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 2</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_znv9RcsppF84" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 3</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_zOsjlo0A3Qzc" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_433_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_zZ9IzG7og9ok" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity securities in investee companies</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right">    <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><p style="margin: 0">135,440</p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zKjkkrpiyLn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2591">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zuVXHVdt53Y1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2596">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20221231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zrAgZOLNrsd6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">362,054</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">419,197</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AD_zuoJUNKaOfTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; width: 12%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type</b></span></p></td> <td style="padding-bottom: 1.5pt; text-align: left; width: 2%; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 18%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation technique</b></span></p></td> <td style="padding-bottom: 1.5pt; text-align: left; width: 2%; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 24%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key inputs</b></span></p></td> <td style="padding-bottom: 1.5pt; text-align: left; width: 2%; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inter-relationship between significant inputs and fair value measurement</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant derivative liability</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key observable inputs</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●    Share price</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●    Risk free interest rate</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●    Dividend yield</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key unobservable inputs</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●    Expected volatility</span></p></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated fair value would increase (decrease) if:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">●<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">     The price was higher (lower)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●     The risk-free rate was higher (lower)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●     The dividend yield was lower (higher)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●     The expected volatility was higher (lower)</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory_zpZ6wYP6M3F" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zWAy78SEEGhh" style="display: none">SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Unobservable Inputs</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Change</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Impact on comprehensive loss</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Year ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Year ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt">Volatility</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span id="xdx_90E_ecustom--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage_dp_c20230101__20231231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_z2WxR5mHIva7">20</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">%</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities_c20230101__20231231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_zRUd2xDnPkVh" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Impact on comprehensive loss">291,149</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities_c20220101__20221231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_zQ2mlJ3EmjF5" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Impact on comprehensive loss"><span style="-sec-ix-hidden: xdx2ixbrl2611">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zuD4JVNwis14" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital Management</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Year Ended December 31, 2023</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eifrs-full--DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory_zDXg2FpdiMZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s aging of receivables was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zD8oTNwtb7F4">SCHEDULE OF AGING OF RECEIVABLES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20231231_zRrdJRmwU0s5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20221231_zuofUKFPXHo5" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zfGVczNLxyA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0 – 30 days</span></td><td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>271,622</b></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,020,091</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_zEZlxXL6UZA9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31 – 60 days</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>109,928</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116,378</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_ze8NWJT0n2Dc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61 – 90 days</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>64,259</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">343,364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_hifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsMember_zp6pGwGuPZle" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91 + days</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>203,803</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">609,132</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialAssets_iI_zyUwUBpXSFKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total receivables</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>649,612</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,088,965</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 271622 1020091 109928 116378 64259 343364 203803 609132 649612 2088965 <p id="xdx_899_ecustom--DisclosureOfMaturityAnalysisForFinancialLiabilitiesHeldForManagingLiquidityRiskExplanatory_z8SczL9maxeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is an analysis of the contractual maturities of the Company’s financial liabilities at December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zrfD6nAnIqri">SCHEDULE OF CONTRACTUAL MATURITIES OF FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zFZZEUqPjHTg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1 year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zWlK13x56ad7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1 – 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20231231_zBC8rBxKSMO2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--TradePayablesAndAccruedLiabilitiesMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zE8zDe5AkjM1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade payables and accrued liabilities</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2532">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,981</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--CustomerDepositsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z9AtZLoFYoD1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,715</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2536">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DeferredIncomeMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zESdC5EdCSkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,112</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--LoanPayableMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z0yUORgb6yl1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loans payable</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2544">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,058</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeLiabilityMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoxRFUZfQwx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2548">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eifrs-full--FinancialLiabilities_iI_hifrs-full--ClassesOfFinancialInstrumentsAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKpVY0qcW0zh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liability</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">429,948</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">497,398</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">927,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--FinancialLiabilities_iI_zlsgwoklsb11" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Financial liabilities</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,466,939</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">592,960</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,059,899</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2638981 2638981 104715 104715 12112 95562 107674 85058 85058 4196125 4196125 429948 497398 927346 7466939 592960 8059899 <p id="xdx_893_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_zRJqJlKI9U76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zcd6ecewPZ6a" style="display: none">SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20230101__20231231_zlbHRxvyCImf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zWwoCrzgE4ql" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ForeignExchangeGain_zrsuSqw8KGSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange rate</span></td><td style="padding-bottom: 1.5pt; width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">530,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">969,977</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 530758 969977 <p id="xdx_894_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zj1K1DDgj3M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zFgok9q3T3x2">SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zmmc98HZHdq3" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 1</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_z48lS8jpOxld" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 2</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zi7Uz3doCIf1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 3</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4B6_zdp6svHyLqA" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43E_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_zZAhkGW4hRbk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity securities in investee companies</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right">       <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">132,260</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">189,403</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43E_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zO0yVvqQmCR5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Notes receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_438_c20231231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zq7glj0TrMP3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2576">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2577">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,196,125</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_437_c20231231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zOHna4wC0Hme" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,413</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2582">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,328,385</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,385,528</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zUSXmWZUmYO9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 1</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zlKdBHUesNv1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 2</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_znv9RcsppF84" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Level 3</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_4BB_zOsjlo0A3Qzc" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_433_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_zZ9IzG7og9ok" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity securities in investee companies</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right">    <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><p style="margin: 0">135,440</p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zKjkkrpiyLn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Notes receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2591">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_43B_c20221231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zuVXHVdt53Y1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Derivative liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2596">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,314</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_431_c20221231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zrAgZOLNrsd6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,143</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">362,054</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">419,197</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 57143 132260 189403 4196125 4196125 57413 4328385 4385528 57143 135440 192583 169300 169300 57314 57314 57143 362054 419197 <p id="xdx_899_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory_zpZ6wYP6M3F" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zWAy78SEEGhh" style="display: none">SCHEDULE OF FAIR VALUE FOR DERIVATIVE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Unobservable Inputs</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Change</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Impact on comprehensive loss</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Year ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Year ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31, 2022</p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt">Volatility</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span id="xdx_90E_ecustom--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedPercentage_dp_c20230101__20231231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_z2WxR5mHIva7">20</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">%</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities_c20230101__20231231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_zRUd2xDnPkVh" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Impact on comprehensive loss">291,149</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInOtherComprehensiveIncomeAfterTaxLiabilities_c20220101__20221231__ifrs-full--UnobservableInputsAxis__ifrs-full--HistoricalVolatilityForSharesMeasurementInputMember_zQ2mlJ3EmjF5" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Impact on comprehensive loss"><span style="-sec-ix-hidden: xdx2ixbrl2611">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 0.20 291149 <p id="xdx_804_eifrs-full--DisclosureOfIncomeTaxExplanatory_z1A50KqsUKv5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22. <span id="xdx_82F_zoX6ewbI6IG8">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutIncomeTax_zx6TZnFmXMO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_znmhSEoKVSG5" style="display: none">SCHEDULE OF INCOME TAX</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20230101__20231231_zrRGzcbX5qBk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231_z0riTxB9axAi" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zXNChWGlTlG8" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eifrs-full--AccountingProfit_zJIYCb8Bv4Ra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before income taxes</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,611,810</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,654,364</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">16,202,972</td> <td style="width: 1%"> </td></tr> <tr id="xdx_401_eifrs-full--ApplicableTaxRate_pid_dp_uPure_zCaP8kqYz2Rh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Canadian statutory rates</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">27</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr id="xdx_407_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_zd4P95OtMrVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected income tax recovery</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">6,330,400</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,338,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">4,196,600</td> <td> </td></tr> <tr id="xdx_406_eifrs-full--TaxEffectOfForeignTaxRates_zn8qfENpLXAh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impact of different foreign statutory tax rates</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2629">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">34,900</td> <td> </td></tr> <tr id="xdx_406_ecustom--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLosses_zsYJewQZvMqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-deductible items</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">(509,800</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,214,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right">116,400</td> <td> </td></tr> <tr id="xdx_40D_ecustom--TaxEffectRatesShareIssueCosts_zlERBTkic7S7" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Share issue costs</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">773,400</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">887,600</td> <td> </td></tr> <tr id="xdx_402_ecustom--TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns_zgg4ODocYv47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments to prior years provision versus statutory tax returns</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">(87,600</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(742,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right">376,500</td> <td> </td></tr> <tr id="xdx_40A_ecustom--TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn_zJeE7EwWK2Yj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differences between prior year provision and final tax return</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(153,400</span></td><td style="font-weight: bold; text-align: left">)<span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">867,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">(206,000</td> <td>)</td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectFromChangeInTaxRate_zOrRu5J4j9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in deferred tax asset not recognized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,353,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,251,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(5,406,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zkTZMWlKshJ9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2653">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8AD_zAFiLCI2dnoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_zBSbhYP2xGVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zouBTBHWJgR4" style="display: none">SCHEDULE OF DEFERRED TAXES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20231231_zQsZSiqOZbt8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20221231_zWfoJzOd5tGb" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20211231_zsJDA0FC5ruc" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income tax assets (liabilities):</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40E_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_maDTAzLpO_zeE9PnrLUiD8" style="vertical-align: bottom; background-color: White"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Share issuance costs</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">995,000</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">568,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">728,000</td> <td style="width: 1%"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxAssetsNoncapitalLosses_iI_maDTAzLpO_zd6JL03gZFyl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-capital losses</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,377,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,602,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">7,043,000</td> <td> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsPropertyAndEquipment_iI_maDTAzLpO_zjAdRsssSxmj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,115,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">962,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">449,000</td> <td> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsCapitalGainReserve_iI_maDTAzLpO_zHjRJ02OoNz" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capital gain reserve</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2671">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2672">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">74,000</td> <td> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsScientificResearchAndExperimentalDevelopment_iI_maDTAzLpO_zgkqOwr5Ubhe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Scientific Research and Experimental Development</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">367,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">291,000</td> <td> </td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxAssets_iTI_mtDTAzLpO_maNDTAzIOr_zOqjwgB58x22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred income tax assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,852,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,499,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">8,585,000</td> <td> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsDeferredIncomeTaxNotRecognized_iI_maNDTAzIOr_zOzrhkH8gK01" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income tax not recognized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,852,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16,499,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(8,585,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_408_eifrs-full--NetDeferredTaxAssets_iTI_mtNDTAzIOr_zuUtSs7uD30b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2688">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2689">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8A8_z7rnntKiBA74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has non-capital loss carry forward of approximately $<span id="xdx_908_eifrs-full--TaxEffectOfTaxLosses_c20230101__20231231__ifrs-full--MaturityAxis__custom--ExpiringInTwoThousandThirtyToTwoThousandFortyThreeMember_zfsHIuPzN0k4" title="Non-capital loss carry forward">67,701,122</span> which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2030 to 2043. The Company has non-capital loss carry forward of $<span id="xdx_90B_eifrs-full--TaxEffectOfTaxLosses_uCAD_c20230101__20231231__ifrs-full--MaturityAxis__custom--ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember_z6NK1JNjkOzb" title="Non-capital loss carry forward">8,241,878</span> CAD ($<span id="xdx_90B_eifrs-full--TaxEffectOfTaxLosses_uUSD_c20230101__20231231__ifrs-full--MaturityAxis__custom--ExpiringInTwoThousandFortyToTwoThousandFortyThreeMember_zarInnRMu93j" title="Non-capital loss carry forward">6,231,434</span> USD) which may be carried forward to apply against future year income tax for tax purposes in the United States, subject to the final determination by the tax authorities, expiring in the years 2040 to 2043.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutIncomeTax_zx6TZnFmXMO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_znmhSEoKVSG5" style="display: none">SCHEDULE OF INCOME TAX</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20230101__20231231_zrRGzcbX5qBk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231_z0riTxB9axAi" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zXNChWGlTlG8" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eifrs-full--AccountingProfit_zJIYCb8Bv4Ra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before income taxes</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,611,810</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,654,364</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">16,202,972</td> <td style="width: 1%"> </td></tr> <tr id="xdx_401_eifrs-full--ApplicableTaxRate_pid_dp_uPure_zCaP8kqYz2Rh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Canadian statutory rates</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">27</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr id="xdx_407_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_zd4P95OtMrVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected income tax recovery</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">6,330,400</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,338,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">4,196,600</td> <td> </td></tr> <tr id="xdx_406_eifrs-full--TaxEffectOfForeignTaxRates_zn8qfENpLXAh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impact of different foreign statutory tax rates</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2629">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">34,900</td> <td> </td></tr> <tr id="xdx_406_ecustom--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLosses_zsYJewQZvMqk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-deductible items</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">(509,800</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,214,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right">116,400</td> <td> </td></tr> <tr id="xdx_40D_ecustom--TaxEffectRatesShareIssueCosts_zlERBTkic7S7" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Share issue costs</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">773,400</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">887,600</td> <td> </td></tr> <tr id="xdx_402_ecustom--TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns_zgg4ODocYv47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments to prior years provision versus statutory tax returns</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right">(87,600</td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(742,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right">376,500</td> <td> </td></tr> <tr id="xdx_40A_ecustom--TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn_zJeE7EwWK2Yj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differences between prior year provision and final tax return</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(153,400</span></td><td style="font-weight: bold; text-align: left">)<span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">867,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">(206,000</td> <td>)</td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectFromChangeInTaxRate_zOrRu5J4j9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in deferred tax asset not recognized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,353,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,251,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(5,406,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zkTZMWlKshJ9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2653">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 23611810 27654364 16202972 0.27 0.27 0.27 6330400 7338900 4196600 34900 -509800 -1214400 116400 773400 1400 887600 -87600 -742400 376500 -153400 867500 -206000 -6353000 -6251000 -5406000 <p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_zBSbhYP2xGVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zouBTBHWJgR4" style="display: none">SCHEDULE OF DEFERRED TAXES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20231231_zQsZSiqOZbt8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20221231_zWfoJzOd5tGb" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20211231_zsJDA0FC5ruc" style="border-bottom: Black 1.5pt solid; text-align: right; padding-bottom: 1.5pt">December 31, 2021</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income tax assets (liabilities):</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40E_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_maDTAzLpO_zeE9PnrLUiD8" style="vertical-align: bottom; background-color: White"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif">Share issuance costs</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">995,000</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">568,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 11%">728,000</td> <td style="width: 1%"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxAssetsNoncapitalLosses_iI_maDTAzLpO_zd6JL03gZFyl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-capital losses</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,377,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,602,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">7,043,000</td> <td> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsPropertyAndEquipment_iI_maDTAzLpO_zjAdRsssSxmj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,115,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">962,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">449,000</td> <td> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsCapitalGainReserve_iI_maDTAzLpO_zHjRJ02OoNz" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capital gain reserve</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2671">-</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2672">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">74,000</td> <td> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsScientificResearchAndExperimentalDevelopment_iI_maDTAzLpO_zgkqOwr5Ubhe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Scientific Research and Experimental Development</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">367,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">291,000</td> <td> </td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxAssets_iTI_mtDTAzLpO_maNDTAzIOr_zOqjwgB58x22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred income tax assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,852,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,499,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right">8,585,000</td> <td> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsDeferredIncomeTaxNotRecognized_iI_maNDTAzIOr_zOzrhkH8gK01" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred income tax not recognized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,852,000</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16,499,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(8,585,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_408_eifrs-full--NetDeferredTaxAssets_iTI_mtNDTAzIOr_zuUtSs7uD30b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2688">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2689">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 995000 568000 728000 20377000 14602000 7043000 1115000 962000 449000 74000 365000 367000 291000 22852000 16499000 8585000 -22852000 -16499000 -8585000 67701122 8241878 6231434 <p id="xdx_806_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zC8NRQFibfvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23. <span id="xdx_821_zCtf0AiiqwJk">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant exercise</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 6, 2024 <span id="xdx_90A_ecustom--NumberOfWarrantsExercised_iI_c20240206__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_zMKOCVThv8Mk" title="Number of warrants exercised">1,600,000</span> pre-funded warrants were exercised for proceeds of $<span id="xdx_90D_eifrs-full--ProceedsFromExerciseOfWarrants_uUSD_c20240206__20240206__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_z5N1goqTOZDc" title="Proceeds from exercise of warrants">160</span> USD ($<span id="xdx_907_eifrs-full--ProceedsFromExerciseOfWarrants_uCAD_c20240206__20240206__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_zjVOHrFlHo5a" title="Proceeds from exercise of warrants">216</span> CAD) and an equal number of shares were issued at a value of $<span id="xdx_90C_eifrs-full--IssueOfEquity_uUSD_c20240206__20240206__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_z3rSK58p5dMg" title="Number of shares issued, value">578,200</span> USD ($<span id="xdx_904_eifrs-full--IssueOfEquity_uCAD_c20240206__20240206__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_znlKNeIBWmTd" title="Number of shares issued, value">773,624</span> CAD).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issuance</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 26, 2024, the Company announced that it completed an underwritten share placement of <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zmTCWcuLBRtk" title="Number of shares issued">11,200,000</span> units with <span id="xdx_907_ecustom--DescriptionOfSharesIssuance_pid_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z5DXOpf9scmj" title="Description of shares issuance">each unit consisting of one common share and one warrant to purchase one common share and <span id="xdx_904_ecustom--NumberOfWarrantsExercised_iI_pid_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_z7bpnAFgywU8" title="Number of warrants exercised">2,200,000</span> units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share.</span> Each unit was sold at a price of $<span id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zVZ3XSBnprrl" title="Share price">0.27</span> USD for gross proceeds of $<span id="xdx_90A_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn5n6_uUSD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z0iE0G4IAm7k" title="Proceeds from issue of ordinary shares">3.6</span> million ($<span id="xdx_909_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn5n6_uCAD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zCeeikT0pUoi" title="Proceeds from issue of ordinary shares">4.8</span> million CAD). Net proceeds of $<span id="xdx_901_ecustom--NetProceedsFromIssueOfOrdinaryShares_pn5n6_uUSD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zc1DHkxO67cd" title="Net proceeds from issue of ordinary shares">3.3</span> million USD ($<span id="xdx_90B_ecustom--NetProceedsFromIssueOfOrdinaryShares_pn5n6_uCAD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zgFYi7RWep91" title="Net proceeds from issue of ordinary shares">4.4</span> million CAD) was received after share issue costs of $<span id="xdx_909_ecustom--ProceedsFromIssueOfOrdinarySharesAfterIssueCosts_pp0p0_uUSD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zTUezLstAVUa" title="Proceeds from issue of ordinary shares">329,000</span> USD ($<span id="xdx_904_ecustom--ProceedsFromIssueOfOrdinarySharesAfterIssueCosts_pp0p0_uCAD_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z5Qw58mynRNi" title="Proceeds from issue of ordinary shares">442,000</span> CAD). The pre-funded warrants have an exercise price of $<span id="xdx_905_ecustom--WarrantExercisePrice_iI_pid_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember_zELq0Wysh4wl" title="Warrant exercise price">0.0001</span> USD and were exercised on the date of issue. The remaining warrants have an exercise price of $<span id="xdx_909_ecustom--WarrantExercisePrice_iI_pid_uUSDPShares_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--RangesOfExercisePricesOfWarrantsTwoMember_zOOH4v4ptAp1" title="Warrant exercise price">0.36</span> USD and are exercisable immediately with a term of <span id="xdx_90A_ecustom--DescriptionOfExercisableTermOfWarrants_pid_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--RangesOfExercisePricesOfWarrantsOneMember_zzPKnJd5DLwc" title="Description of exercisable term of warrants">5 years</span>. As part of this transaction <span id="xdx_905_ecustom--NumberOfWarrantsExercised_iI_c20240206__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember_z8HamHRCAZYb" title="Number of warrants exercised">670,000</span> warrants were issued to the underwriter with an exercise price of $<span id="xdx_900_ecustom--WarrantExercisePrice_iI_pid_c20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrefundedWarrantsMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--RangesOfExercisePricesOfWarrantsTwoMember_zDynOa1RrAud" title="Warrant exercise price">0.3375</span> USD and will have a term of <span id="xdx_902_ecustom--DescriptionOfExercisableTermOfWarrants_pid_c20240226__20240226__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustmentEventsMember__ifrs-full--ComponentsOfEquityAxis__custom--UnderwrittenSharePlacementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--RangesOfExercisePricesOfWarrantsTwoMember_zcJ08okJNSfb" title="Description of exercisable term of warrants">3 years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> 1600000 160 216 578200 773624 11200000 each unit consisting of one common share and one warrant to purchase one common share and 2,200,000 units consisting of one pre-funded warrant to purchase one common share and one warrant to purchase one common share. 2200000 0.27 3600000 4800000 3300000 4400000 329000 442000 0.0001 0.36 5 years 670000 0.3375 3 years These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date. A deposit in the amount of $228,572 related to the purchase of inventory related to the Vital Intelligence Inc. acquisition was written off during the year ended December 31, 2022 as there was uncertainty related to whether the Company would recover the value. The warrants expired on February 5, 2023. The warrants expired on March 5, 2023. The warrants expire October 30, 2028. The warrants have no expiry date.

/?#:[C\[@!^@B ./#1#JP[] MEW#O^-4EMM>VO_+>*,=^I'_]L1L0B2133?IM,%K]_;OE#@=D^/N[SH]E/TQ% 6V1'X63U<#U"6*N[4V#T*4XB28$ZJQ@HG0Y M8;1!?N@^HU$0AC(39796,=&-[:]1./3G&YM\,_"69/GW_XK=Z$UJRN)A5$S> M#C<#+WB10_>R4TT3&Y,="R/+7W8#/W+]F"[MR6JRHQLN$;:0_.4^(%LX^;.# ML%!R2PY7$S$/!"],EHKE.$%,O[^>!I[KO-$]&F^3&9 )W-FA2Q"=8K2STVF) MJ*HZ;FWD^?8Z$8C_CI?I#^2S5AC&VUV"KI@.X U39@*+94%\@]=5<^V1X59 MN!US>]4TM1ER$!GZR4/"^10TK6D20_^9D!9@X::5:UC7Z@\B%)[H$Z[NXN8U M3299..Y2R(_+=C4R(XRV$ DM:%K3)*C [^C HBGD&M:& M'NUB[A+MD64)1N MV,'RQ?4\,2K"KG4M7G>]B2:KQW#_)>$*9K2O:3HC1#36D6L_N9X;B?<31O.: M)K/ ]A)-[;=DOZ*[N^/@&"T/WW/%\X./4-.4>VB%,$;+(3$7M\)-J+AU7:P, M;#_( MXL!JK]G^25H!3H:ZQM=,[@*D]M:JPV MV,RXG1JSX&!SE1U'B34'FRJOCP++#LAK9@\%5AYL2NP>"BT^X-2$/95:?[!) M0OHJM@2A>A&DMQ:K$$9 E3'KMQ"AAR.C@YZ[MAZ*;-<+QS:F?W\6>^?K&;ZN MG<39H&7LD1E\V02>]S9Y\=&2VK_NTK4Q.7SVWQ?N*Y+CU#[]2Y7IBQMMB!B3 MXY_H)ZO8&Q'LY(DI,VKMI'4].R3&ZU%GE:9",(!F.U]V =7]G?KY56C)RW,- M,HQ2QX4L9^1&J1UW:TOE(6.%2T,N&J%^_XLLQ("N"K;6U-U2YC1@]ZU_V04A ML4;GME=BFNR^=7NX9!DN[%B7/4A4;2\(B6HR65TXLX!HPD=0XZB35L1@W6N7 MT[UCKO^Z0WZ8F/P]M*-1@_)B"QZJ>2*(343D=H,BUP%(DBCG[5>D)0T:IW]Q U'N(EM8S,7S6Z!3=-@CP<4+A%[H:RS"A MTO#U.\G+[/J"K@J6=$",T.AMZME)P&%Y>P,Z4MV^?UF4A1U56*G(\Y 3Q;9W M0*F,42H:1/U%AKQ$2P]5._J7%Q;2R L&4#[AO;]Q$207'-7GSQ]/T>62M,D# M[%\[^GN?G+\^NTXJ8P5!1U)'P@/U.KK1F^7;WEOH5B!!,)*::S]9F0%VKQUO M\66>-/#20]9.U/FUGS0!W.ZU3S9['2@]54YG-1,M-T,U4ROD$WC%P7HKN"66 MWAH ?6MG]CP*G*^3-'MG$D=)=BW92ZEN_(JPXX:EQ+7,J$V15ACCEY*PD\ ME"HBZ#WZT;-286%(#=>HGT:)=T:M3R8OYK)$0 =0)5:5-EGQ& J"IF1/:$C? M^H^Q@L H^3-,/$CM$[]'P1K;NXWKS- S\F-Y-4(T0OU6:6%\U\'G+V^:R@Q7 M.S'_0&^TI@+Y5AIZ\&+CI3P-D%%43#T3W)6)7RLS?=!(BJ/VY&_3Y<:I/V1A M37;@R2I_JR\1LR :0L%%NQ]A.W$_[YU!+LJ60*GB[2@_=OUD'@YXHI00?<7O MOSK);V9V5(8PB='JOR<\P)=Z4!^03:_I3_KD8H.#>+V9XF#E4D63UH61OT:L M_A%U%Z0$]3J,"KGQ%%P?[4-?2]P9%?=4YBQ,XG-+^PJ+>M=Z< H//I'J;;*(#+MPMM=&J3Y@[6GV3'OJANT287EI03R2U-E.E M,"P]<_&0JJ9_2(@F1Y93T_2+AN1-?X=12$A-C((1^<59%_0:(7^)EH>!* G@ M,GN1&]'6^]*'[SK?TSJ)208(^3%MN9_)82Y>X)Q]WJ/U! ,,0&:)W!09\L,) M&?(??R8?LI["1.D[C.393\A+QO^3M+EH\F,#L^K[$;WA7"X)^N$^S:1X8Y:*%S^=KXZ,@D!_/6)BOOKAO\>,NB8+[WMFXWI'[*QQL6:#M/Q@(YAU@ M(JE__^[=3S]IP9D(.!I&:!N"L,ZTUH\W3V+8L&=(V$/_7A/T^Q\69'SKU84Q M(->GK6S($7)C"Y ''PS92KB$:V*&Y?NQ[(*#G&@-Q_\40W!G$ZM)0Z 5@4KL? M@GV^-1#\7PT!GT6N)O3G&^1YU*5J^R#9+VH/Y,!OAG" 3;(!/$CN#7KD&(*S M(=,%R(G?#>1$CG!-S)@B[ 9+H@E@ !MRC8$,^&@( QC$:H6^[R^AP!^;@DTL MHW"_H%03Z@,W=&POG=& _([AA.0TAZ*OV\(54JR5 W\@&X/QSS2&HJ_;Z!50 MVS#VW1CCL\EPMQUV:RCZNLU=$;T-PY_.G#Y3-X[9?N!\*RCOBM&RRYV[^@(Y0SNJU;"12T\&=/Q/X?2LD['E<*FX-O MNHS@!8=B0SCP7HX#[^$$%5UUT00* MM6[+N)"RIM&ED\7(9@OU>0LHMKK-W2*Z&H9V%-!KFTW@.S\G,*&4+!UFY,<*AO&^VP>Q4A?-(%B MK-N.+*1,TZ9Q*%C$#MTH;@G%6K==R:-3VSZ]!NW3:\E]6K=]R:)/$\QI[#VM MHO;DN6N;G>O'[0#.>3($? [532=;)NE7F9*9 _)#,0<83:'8Z[9*N90VC7J\ M=&D)WF1*Q]IMQ\Q#AEM W O*"]T6*Y1^+3<37Y#G_<,/7OPYLL/ 1\O4A.!= M3C"[0!FBVXH%4:Z%&Y\#+R: X22.%G.+H^2:0M'7;;)R*=43NII&BA_/*;HT M64D)_!Y0'NBV7R%T:PKDBQ M).4^HYX=V?L9\EC!Z@%EA6[K%D*WME0%W"6' MU#K@1PE<-(0"K]ODY5"I!>_YUO:\0T$='MX7#:%XZS9[.51JP;N_19A6M+[' MP4NTV>?D\G!G=(#BK]L6!E"MAP^OIP(!:88BEPD%K<'%*,S@ )->7;57'(=& MD:0*@+^T,8,!O/90%NBVB\4T-\R$2;1!.*N!)9.AT^=%?(A[01FBVSB&TJ_G M2,Y4:^">R&?MH-";8087T:@GE2U^\EQGX 4V5]\_:P:%V@R;MX!"+4C?V?Y7 M'.\BYXT6AT:(WOR$QS4(L+F T"Y8X8U+(6*'C]%L-W2Q*[ ^9J\7)5]7(OK MK>#V@W+)#$,9@H$F/2H\Y=^AY=W;C+XP00,S%N@UNB,?^LI7JP#=H:S2;5I+ M(])X/'A2KI9HWV'@^\ACWS07MX3R0;?)S:.S8;PV<&I!^X**$A>Y,8 QW7I %F[T5G M#:!PZS:X"ZC2@^LH<#@!%[E&4'QUV\\,ZO1@/'#Q=LCP'ETT@>*KVT@NI*P MW?_Z,4<&&?;KX:^%?SP;3?:)G5/\0.9!O&F0^A6/$SU[>N=]Y_O.L5OR]HX? M!IZ[I-K9Z0]A)UAUCB-VCD-6%B-WA<.$69']&OC!]BT1IN]_^O ]$:E5['E_ MTA:GG[XGNN.?IR:)L"6_3UH9G^, L/[5%T^]5*KT%>[D[N 8Q')\E9C'.V%7 M<(*G(4P$8F$P-X<^K8,=8)?/N;-FX!!H0[A40&-5CN2?8NU-9Y,_QT&$PHP ML+WYM#FS-?A*72_ 7!J,E_S]3*<8[6QWV7_=(3_D+P)6#[#SQ9#UP*?TE+D$Y%G]MPFR/!,2 M;C#3A@10?^V2 SHE-M%7%QO;OP^"Y8OK%:739M0G86>PG:R=BV DC.;F,PJC MY%V/O4R*5/?+UE!^Z7=LL&DUF$$S=[V)@E4<(K&JDF\+98Y"5P:0.2PZ#6:- MF"&R;%#HC "RX1O0$^EA&[V14W?DVD^NYT;$EH?HBOQ^4!8K]&14\LM#4#%X M+>[-'$F6\GI!&:K0%1E&0K PF)7[ M&??0CFY!X8!@THW#*-@6IT-?(L7H!V6E>O]+B37)Q<)@5O;V1S\- MTB\K]> M3*-T:5 B)3N#!(^Q,J- V:S0_5*"S?(X*;H[.,P]L/UPOV4P[@T*6T+15^A( M@://I,+X977<%;#[;-.$\:/6!EQ1P ' U]DFL%.6N+9P>83L$,GQ-=\%RDF% MOI;RG&0AT +>R;&M#,?4QY)4LR&NVB-PND*1M!\%':',5^CV*65"@O!0%O9P M_+98>V$UA@*OT!D#PS 0TU)QW3TC_!20?=?TEII*<;:88H-MJ:0HY[)K[]RH\#63TS7]>4,H@Q0ZHQA8Y^(+BB@TF",S M B1^1I-54G_AB1P"2Z)ULBKYGF[J>=W 4??:N06@WFC>1;;KHV7?QCXM;\)G MV&5;*)<4^I' 7"JFTV#66(X3;V./YF*F5W?!EN"[H:]X/:-4%^?&C$"Z0QFH MT*T$9* $&@;S=$]L%&'W*8ZH8;X()B\^PN%D-;49>1F74'%[0SFJWE<$U#P M6%RSJGFFK05=1:>]*]@#U%*08,D@T^9F?H&?DQ MHO$Q<]LCNCF-I!?HML4]]&?;#7[/DJ4+Z-M!J3NPJU^&?BJ*> M^E/PR_&/ X/Y? 0PS(2\>GG.7+5"V@W"B$B;+0B1/6NF/^U>]CPKH%*>FQ]3 M;OIH354T0_EYCXEDIS+.X^=9,_U9_K+\+*!2W^IDQ"),=@C;M&;P/J^=HSS2 M]NSF^K/Z@>SADV'\.69M:8WG,,%U/WNNJZVHN;8$?Q#V.?<:FV*#^=1#!%7' MA?*IL+FV!/U2?.)0;#*?7%I--<#A#&UC/R$9QC!N/VUI^N4X!\# 8!8._3#& MMN\@ -OR;?4EXY?B%8M8@_GSX(8.\CS;1T&<5A"XI)K',4AO?0GZI7@(!\1@ MKE+%%H4A0=CV!@B% %8RN^C+X2_%/P'I!C.-1@20B=%2BCWTC+P@*:71$#<( M0$4LY2)>J/(L4KTV]VBS_;7HPFJU.V,G<_E!I&7S8^D%TYU[X\2 :S/$T[WX:K92U"?(2=8^VY(,^/2&Z@)S@9Y M"5=L^0_H2^"O8RU7!;8M M1SPUT0VEXX65U6UP7+"'<,?54!ZA # #R*DL/I M#";^%^Q&*%BMZ.?/*L8S="=A+WUY^G+L !%C_%++1$O=!\\(^U1CO">[B"CM MB---7\)_R04% $'1&DI$IQ>\^%012^J1,99-44-]6?'R*X5-J-+=:;C=$54W M+<-Y* 1M^@B*3^M;$AW?3GG9?(2 M@T2#3Y%3$*CH4NW0RH!,[_)!_.671PLB6%F)@9!D#7%? Q+(9?D.!415^4CR MYX.Q@!A,'BM2(IP)X/RY800&+Q<>ZX71Z<:3E &6! 4!:S46\(HL<[#H9],H*RJT4]V@IXX1T90IJF<:\=)H/:/N$,(]EY^U,811?]!@%&@]$9 J+F,:5 MLVK98N84-M=?Y4V2.QRB#;8%.*6RQ8P#=-9?[$V2C6! C&;J>65M"">+>^BO M""?-/A[I1O-L+W?)M0"MPIO<#- HTJ'_C/:)OH>#?.@3%3B67:9EA]9?4J[L M(JX&9AO$1719+R$>T*'T5Z0K*PYR8!G,_G-O#UOCU:A'\>Q!KH);V6&^0]@- MEN2[.#+4:3Z.J9SM=8QP$D=A9/OT 3<>1SF=M&E9)9@LI%TWWQF^G72^J98_ M]!<;9#E$7$.78LQR\0CZ:-.NX&P#4%'/9ED&=>:-A7#6DE<6:G*+:N) O?=. M #X, KP//RGAN&&2SI19VTE:BM!_+6W*LF$TWF/T/) MJTBBD@*,#EK+U$J>YER:#4SXNA"R_BO"CAL2TX#8"!%V'?+5>10X7Q]]MS!G MM4!016-HK69;>OG!D&EF&^3/169OA(VDM8JM(HXUHR70SZ43ZL7TJ8QIHI(G MX:ZGZ7VQ,2LE/"%+OWC*T-6QX15#H9$>Y(ZEH!+T%9FMF3>.6ZM ?N2B>K+IVN$GV69"O M(-=';V'8LFX"!ND-P\X*!>?-5RX.7%&5U^JPMR6&?^@[&-DAZJ'TW\4&!_%Z MD[L 3RY*;(=UX&2#<$N,I[=LK*396P6R*TT$4%:U0U$A6DF.<^MUF,8+)3F& M1F:;UIIJJJ",;@E)T\Z\*]V@KJ($A:)2P)(BJJ""1..25L(Q$M;B&2D<16\I MX7I<(QQX&KXNLZ+%!CW8^"N*H&8?O[O>XK[5[]!8@.CC2ZD;S8+^>NOMULJ9 MYMPCEQ=V$Y^[1 J;ZZVL*PD\AV"=EY0&1 C^^5YWB=U208)TVA5UB#1 QM;D/KQA93N0^NY&+0'3+C@1HB\R$,SB>>EL)+ M8:EOHJ!E7M=CJ$9%#0W(6BR'9<"GRWB/Y_ECB-3;1;1K#YV\MI#5)C&( 7F- ME1A=AN:6"8&U#7#DAM"'S0&=]6=#RG.+SV\.1E?J!3ZGOX<(;8Y;3D8*.^O/ ME:Q;1C@8&>B_O;.7/?3$*DA^_*O^',;2;#JC0[\/@\$'>GF5/A!2^#S@R+6? M7"\YHABLDAE 6X9#/=R4Q\I AF?>Y*$YUC[I5^1^NGB^)]-46]I#/4SDT6^P MSG1ZOF?WQMPX'U%7;9D/-9Z%0'Q:PV'60XZ'IYO@#!>/I"V/0AG_H>BU M^($W!7D2M6^P[$??3#D-]R_M6OYR'RL1,OU(Q4WUY4K4PRT> ::#2<5;&Y[ M1/MBGG[G^MIY8WUY%'7KH44@7.E%Z3EB^:I?<'] 45]]^1O*_ %LB Q6@H0@ M5/(+ZTP14<9G#DCZ7J)@/6MWJ'.:W"E/5E\"_-7UU_MJC*)7ZH"=]>6CU+.] MRX'4FL5\R,$XY&0,::3I$EF.$\1^Q'U"G.GQA(ZH-VE%DJ$B-Z\T 8?3FXU2JSA) ?B-BM3>GY:$DG1)RV"+L,3^!!Y0;Y:+ M8K'B@FB@RZN(@G1BS%S.)(Q7V$UOLDPY+L,HT\]+[5&KO%T!.H*^G)VZH^?D M,+O*!SP+($AKK-<1[,P=25\&4NWAS@#$%%TI'GRX-!A07-"8V5I?"E%56 , M=5=] 3*-L;.Q:=;N% =D\XK>II[M1Y:_I*E6.XI(]UAKP H+,.4MZCI&UY>W M5)-PU8K&=0LC#AR$E@G,]!(R5"25=7X&*IX*PP_K$L_ZT3?X&N&T&(>$6_[: M??)0>N5=RWXG/2A4CA1&0-:^S95$]EIWMPPNAV>(#@L,*E3Y?E"Y41AGJ4!N M6/@8&.PU0[M4J:M!B1*UWA,.BJ6\$2R6BF MRHDTQ=^6$^54(::J$X4[$E2,%,:9UN5$ 2"FRHF2ZLW)^X)A&-/ 5T)+L-T& M?E(PB^5-$7:#D"9U:Q+KQ9FG6&BB!L9\X_'@GPS*.[- MNL D<6=1;[;G8D1#'@ZIYJS,;4Y[*.N:]4)58%TA'E>JRL"0JVYWPL6D6?=6 M&=5&#K.K=%OT5ROD1*=WU6=$Q/?Q5Q.?XF/Y2_H/O31ZMCU1.EVIX< %=PQS M8%3 SF!#.1]#5TS*'7VG '$PX,E)C1^!2H]I[J_:<;[*_4E^"ZJZRRATQ)5V MDX(VDC(%=,F,<'3EK)>HF_RSB8&&Q135POZ*I;-9!>KCW':&5'[H#XD@)4)$_H->FWP.,Y\_?7UT6?\](U2D M)ZAC]2,'0,'S;L$(Y*#3//Y5)/ Y2:I7ZJ&0G8O]&079\D]-(-M_14Y,RQMV MR3I=!_C->G49TL!H:@#F%]*1 98QYTP!\"9 MHB=>3$1%X4/B#ZM4(PUOX=^ MR+EBD\&?3\>I#GX37!CZ2_?97<:VQY;QRS;ZD>8(]^5D,]7.&Y+JTPQ$TES0 M4C^VQ1)Q+KX%$V]6;*WEOQ6/+;473?0#RQ':B[EFBK4W)+/'"0@D-M=. M/ZR%HG NKKE9-RNL#\BFN@Y;5,\:Z$>4(ZAG,\W4BV]2WUT0 ^7.*PY=R\P^ MTPR>VU^[S5=9^\U16ZN'78QZ-Y@C#SD1.O!^;!?FWY.VC*9@].MW9'-Q#$03 MUX(W_?1)DYRL5JZ#<#CP!5(/Z ;F0_V.8B'&@0PA6O@R10C?XR#>)3&$ (YP M.X!Y4;_?5H(7 )J;WHV2FZ'3Q(1-P&C7[WF5DOE"VII'V'(B8E]Y;]3I*P*ZL"T8[_HC!>7PYE#:,.R) MH4!F1&]Z>-7*6Q$&]XF.00]=[5"! ('"=DD.P:8;TJL9GF^E<.H<6?&.2F?PV0' M3M)#-H%'$)U%0HM"<@PP(Y68W?*,+(>1=D:.49260I1F7U%/,-.4V.=U,(V- MAW96Y314:9;Q1@"S3HE17P?KQ/@TS,*"#8!ZM/?^" 'WP)W!C%/B'Y!GG"0J MVI==\MA5V17'Z SFF1(?0QV+C8M*T^O,?HH]&X_<,(+<='&:@_FBQ 518BV) M*->_XS&-859;, ^4N")JV<]T.D /^Z@$)X2=P"Q1XI:09PD0A5IYL[+#IX2X M./Q^;=N[/8.\*#S\YL2I_2_^/"J;C.?*]NTNFL%K;6MQ$A5/6M-A?J$1,I= M<4LPTO4[$[@H*DH PX*AM@9D"H4^#? M$T'83Z2'0@>[B;B/=S+A&//M3ZC/!;)UAUR B!CX(X]-XZ MUHM->++LT"&1'R:S;"(O[S"?R2I'3XY9YV((Z]G(?6'Z_<.$.%EZQ2WUAX#+ M<"%["5A(3M/I>S,4'A)L>^1?=MQ]84/]X//$)P-VX>P;3N)K9_H8$.!;*MFW MD$J6748H0GCK^@E$=$V)MXU\#[W))B4W;@@(32NCZW6TIX'M'KAHHS?5! 1B MP)R\%I0/$R!:[EOHAJ(@)F9KO4U59O+HH0?3Z)>O'N MQ6@1]%^I$P81K M26_:3 T\A8*EEZ]D _%L?S_!X79'Z^Z1":?EU 7:1LFA]*;A5&(5D^-R,.I3 MY$&:"Z^]WER< ,N3M.;GL7+CGQU_S[XP^7]\=)ST[:M>$2KNFDM\F,1_R[ M84;31AP;]--AE\!"9.K!W[ET#IPK85Y[_5':)D-D++H MVY'KY/P/[]Y.;?;OD"9$G"CQEU-B/U$-O!=L;==G\T_-US2+03%G"[FOAOZ& M2];N3\ZCM MN-=C-]4882&D /'J;OF ZS =RSQNXCZZ+T2A_(!1KDA M=W!#/W0): ML)T&Y&>=6T47<+Y<7'2;BS+^4X!-Q>4JQ-M&^IL.V_7P:XRR+L+1#>AI/5 B^)3 C\,[SV M>B^II(Y&,=E-5Y],9L'UP5PTT7LM):F(%!"G"^ %U:@%"._;Z+V#*@?Q&7E- M!X_&'GKWT],O[^CQO0QV$>)<03$;Z[V#DD)=0'#SQ;6D.,!KK_<&2HH)8K*U M;#7)/+A%)8K:Z;UP*K'E%)&I<=M9X*T? 7>=;%N]5TJE-YT\N7KW'!'\G.9Z M+Y&J[#C:F7!080&%;!A-]5X?E=AV&,1J ;X7X[16'@?Q4QN]]T+@Z%;)7F/\)KK&. S0 ML?UEAXZ"EJ2AAAN-+"4Y3O&N-A@=F_%)[B>RS$Y": L N@&7COIUPV7+F0<3 M"$7#.UKQO,9!M)^:P 4GT1W(L@8\1-5XQL&F\2UPB>VU[:^\MQ^<8)ON?V,[ MHD7U_64W\"/7CVG!X6F.+86C[-^ MQQKW.MW)>#$_(_R=2VIO.)G^>IB-)G_441K0P0('XTH%K&+?4*A62.5E)3NA0#2' ;T): MJPVN:^^MB5_GR[Q.8,S9!!Z(&8)=V[,QY;T,_J4&><,I?WMFA&TY6 M4XP(\.=J=68W>'^Y&SQ8B_YL:(TZ5K<[>:3;P7UG.AD-NW]TAN/!9/:0; C) M?G!GS8=SND],9_VIE>X4U54G=X7#1'@B^S7P@^U;=^&2Q-6)!=.]Q0;87\0Y] ?[:]XHC-7][] M?+D*N];\4ZK3TQ_Z_WP7M:66 M27CZIMQAQ>]NQB+@\(!U#$%0,4'>A_XS&2L[J8RT_YISJH\_DW-E,OM#C:P? M)P.6]((>)I\?A^FZJ,RAP>IMQB)A,H][./ 1,6&%)';C:1T7K9/#(@_J^T/,/2GHX.9W-D'P!'Y@>2B$J)HA_XM]PEX7:T.^7 MPL.@4]3%XX!V&@ MI0ZI__0X_5)G$60L,Y81D[&"PPB.E@EK:4@&\M#(8FK!<9^YZ$TU6C^%^QD5K-!?<,1O>?UK0B(W'^6&5*G)07\P. M[J5F=C1Y"?XS)GN\2SG[C,Y"!X(X2B@*5O&!HA)KLO3P9BQ2D3!P5V9%:$U8 MJB-DAVCDIF\7%5XAO<\%48SZ%EFBHZ%U-QP-%ZKND2YF!EZES'XF+])DTF66 M7T%',Q:6@'W<=<5$PX050T.YT=1^2V_7_*7E.#A&RP.I;O$BRL5 +&96K]^9 M6G\D5[%I#%*W.WOL]XXK:ZAJ:8E) *\VF:%,7H )'0?'W(&>$NM1/(X9RU-> M!+@K%@J?"0NXAU8(8[0<^N171==C[W-!$[W^H#^;D:4Y''*5FPN\&,TL<;SP_%Z6Z]FK]>$N_00 M6C[3K)=P$73C,"+2B$NIQ,#1KFXER\%HPK).GB[JVCMB0Q KJ>'1*;[YRV M,G'*PG&T+_O:Q(0?Q P$U(AM *WIY1/508X[7]%VD O?F??OZ9UIHI@?\_], MVQ9NI_WY4N]3G^E;.$.[ $=4H=NSO\Q9#QM+^Y*O^Z27@="$!3Y9K5R'^@<> M"!'((U-$05SH)\O%%4T&@V$WK0#P,)QW^Z.1->Y/'LMYQFZKO+%5GA"PSU[W MUX02Y(=E3''Q.%>WNJ'0F;"R9\BS(_KR*([>%IC8'X1(1C;NAUS0TZP_LNCA M/;5FBS^H1WP\M[KEXE%S>Q^=6M9 )0)2_A8 V#H$\+B0XCR M\=*O!<&R-N[12QW \7\P>D[#@Y P__64VG/\CDX]OVHK/ M,K$(H1)2+QS&Y!7?0Y'M>F)G(L M!4=.LL%L3I]1]UQZH4+*K*' MT59S6=E1 $3.9#E H8/=75KY\?* & 28_#]RUWXWQ@1@)W7G>E(24L\'P&]# MF"T[=:+=8JE*X@^>[) Z09/Z!]EK@IH$"_X-H&S5_ZA:H[(EBWE&O @@:3SH M*.4#D^R$YF>$GX(0)6W;)YI]&_ODOT.BT2>(U22-W&&! EC_@W*-"B V19O M:55\WE6'!LI/_0_C-7LXEG9VMT6&AMN=[>+4HA@'_NI L%PB;GT? (P!)SG8CEQ@.*5_T/238J7CPL6[P#G6R?;+3,0<*O*#JO8@&!JW2 D*ABM8Q3. T]P)9FDKE<8$,IN,[W1 M5:EO_1Y10Q&QFKX %:26NZ8K5QQKBV15KAI9R_A0J6JY4[IDT%QSPD4F>J>T;4+ELN:]:%O06[W?W 5D?/B7O'MN9R+\R=DYL&'H4]3$-RE:Y=\6$QZV*N(0:T!6%7>/D#^6FDOSN4S5%4_T.K0U+K! M:$PLDGI$DQ70PW)))K=WJ^-%I2@U1T>H7O(E;[Y7"/YYJS'S(N_[$68*Z>8>0Q:\;+3^RJTCB+BF=F7T'!!0YFQ M^@"/39>F2OAYUPQP\-3XHI7@*XWQ0$RO__2_N8\ M3.[3=T'HRMJCP'',6 >BQ\!+$F?.4LBXE]FKH>#%U>-SX WHOOK>!0?JO^G' MY'7>@GYFB#W@^6X@/8UYH >VBS_;7ER!)>(A#%)4)=D#A:=93GVQ<1)D,PCP M%T2?U$1+ZQF178K>:\3;':"* (=0^=&UW374R=^RH)IP'!TO1MB'4:Z^)+U= MF-*S2/%1Q'R,G2F-!3U,-NY9KO+*<=2U?<.,TY$I"*4JOY8,G-:H,3+OGMF+ M-E=P6./[(?4II*^!)[>%]Y-)[\MP-%*N5(+?;NV7GRD?.AO>?%C2B[W%^7-N*;Q\%K[RSKR"9 M'9N^Z)^L+N=2X6:_:# S5I>(4[*7^&S8-(;"Y2>U?R9B$:0AY+6R-C>V(3:J M>E8S4#5A^TQF='AMFQ.S\7,N='K4M\BV>7@C7GG@QL5$P3LGLU_CB^WPD-+9 MC(1QQV"I PUOQN8JX*7T@I- MB6WUP\T7\.-WBS?]MZ2_(9S(O?E%,NHO*6& M-F2K!@I.?72;LU$G44K[E\>3QY4=!\=HF9%V]MZ="WI=S*Q>__ J>6K06MWN M[+'?.V[H0^4[NI@B\"8O,Y2J?3^9 ^9.0FZGEQW0C+U=GJNL[;X48X>8GHEEZF9MW.G0U:QEZB4V19)5Z@H)YMSO("$VG. M,6BK4ROK ,"0S]"!-HRE]$E!U>UD>?>=;!H($?Z,&\X M2>,V)G$41G92;(+>%;\B[+BA_,Y?WZ>T'Q6U20OK *F;+2TY<<;Q]@EA0LU% M$-&>.#3%KH/"/3P32*A6(91X'Q]]*63$&K[DOX7IY2??S5SI0$YVD? ]A!VGPDG MGH^7&V]R4@(<1_^C3\IE0 I1@W:*0RPT:;G8(!,C5@S,2EC'Q:_2U #Z@_X$EO2X6, ^, M<,RB-9WTF4N9Z:#])9=F/N_?TTRFY*[Z5"C55$=M:V[1&G):'$.?]E)0QE'! M'T.[M[7N&Q@(9"UQ6=VC8(WMW<9U;,_"1(4IP7W^&/I=G76S'X*9"=OZ9+4B MY@HA_(%,'GEDBBB(V;&!O^0J)DP&@V&WG\0$/@SGW?YH9(W[D\>*T8"WO1VD MXB4?OV2>G!(G'J+-6[,\M>8LS7T:R-3&T=N":(DAH8_>?; 79RZ#?-8?653G MFEJSQ1\TC'<\M[I4\[HMS[:H7I<1'/] ;P^$EM2$F"(,9 ;\_HTNS*8FG"<# Z/Q@]]0FV<%F'QE\=? MS]SPZTGXV8=,KN+!8#BVQEWZ*LIP/%_,'M/J650A//UE-IS_H_-@C:W[?O6" M)@TMGB+ 2JP7X3 F;R#'R>^SY3=V1*R9ODO7TM0.HUZ,)GBXW=DN1H+7N15P\G6B)_F3?0'OW@B=XT4F4X#0AX#.D-VY'P3,# 9%6Z;%6=7S0K M)JP.*:R?'R:8>X=DXE=.IO\ON1I7^T3BA?6OJOG\-Q=AQ6<']^P#:,F ,;1; M2XV\'7@!F<9268=$Z&3]U5.QASVD?JNF >Z*$#5ASQTGSR;3Q]<"^OYP3(ZF M4R1 X*/75#UU(H)N+PC*M_6C*HM%9F<4\=8F&06-2$TW0!&*4X,>CZF*]%':VI")&UU M!LT=*V-\V02>]S9Y(41FWSK>K\JBE9^KPC3O?NKW'D?)6O_R:3(:_=&9?!GW M>YWYX]U\V!M:LZ0(TWY(1S$#Y'SPSIX_G&)W.2LIS\DHI*("?F//T?D@/'Z9(K1F_7J%K&:X$3ZZ5ZP)1I$,1O.6VCF01%B.4S/9WS2Z6K=YXBZ$E!U9>C[ MP7.JMQ$3^@'1]#;6%L;OH\T0S4%6L,E R%7E,2CX]N/<*H/V>3=M=T\E 2\B M6AGF@8^\8.TZX?PMI(>$&&Y.#VV7+R"DA:0:?#4RMK?4"7\PBKB7&OFV9MC# M537%G$', L5@/G8IY?B-!E62=KL@)76"9XC0@!(' 8S)D@,94FNZ=A$HA:?! M\D&?@PIP0L.*^D%PN'%WAY3*H0^3#8E!#'GRKG:YD,;1!,_XR1%V^4[0%S?: M#%S?C=!CB A](_>9ZQ;+%4'.NL7RCV]]&2X^T3C4X:)/W^T9/(XZH^'GRGZR MV^UF8^$2,^0$ON-Z;KK_G:*21.^U0:,C*GQ LRVI+,:] B2JW')#,L\Y03:) MO1"YVEB-3>%7K?*=-058A-?K'JM9>EV<<'P5%WN(NGAL%U>K/Y!E9N6=4&I5GN MJ407FZR.;]5S/%&Y%X*RGJCNR)K/Z0_]?SX.IVG.\\WCU Z/$_6P(AR]30D% M$7WUX" ,4FXET2BF6!]U^XY$=-\<1)+> 9@X7HT7B$DNV H4V1=BA$*V923F,QN8[8'BS M;PS?'@H=["9/L0$ /FNM-5RO',0%U)K@M&)$EIT9[D4A9I"TX]P#JP_6HC^C ME?RL;G?R2/..[SO3R6C8_>.LH#]-/+ZSYL/$]36=]:?6;%_IOZ;\XYL;K,'* ML\>2*C1(;QI05S^1MT%,%:J>Z\64C6FQ*$+TT'>\>$D3][NVY\3>/I8A:7?* M["7;5?(FAI0KK8F9F&(KUE_B5CUV-Y>>I+NGN:75=K?@@GR5'%\6@6>YAR5; MOU;@$H3TOLF'-&0&NQ,9\Q9;78*.ID@)?#WD."N@T%PGXN&1+#$3+UOJ]UF! MY#''JF**#?9N9-_F%K.IJ+5^OU0Y5K$I-YA=F1>-Z?23%XW%;./UTN^D*L<^ M,1**W"G6>HV3(D5SVTO?C!4[501]VN&\ A%N\-HYU[[(4>QEBX]._(MG@=/G M@B>K"5ZZOHW?$C'C*JTU?: %CK:Z23;'-Y<)*+/##2V41OZA;O-G(O1)E6-6 M6-FO^:V_Y6[8 L:FU&6 ,:T?*@[BWB#=^7$759,+X]UW&Z&5!8HR44 (@;S4YZ5 M%;FHN@Y 22Z"&0BLC_DA/9^B(+(]W=4QN4R&]EZK3QR/,_2,_!@-R%*@!6(I 41C1':"+<)2\-!.Q$.UFN>RM+8VG#6?(06[R%!S' M6_^>YZVW'FBH[+PSZW?[P\\6+4NHV$U_FC/<\U#8QSC=%=O+[$RY6FNNK1GN M> YS\LHJ@UY%6U3RJM;IE<:=#/K?>(89D/.'AV0\*308![0?P4$>'9Y\6P M; =>C]:<%T)*3-2OJ*'I$\YRWS_[-?JRV'5EET2J] M9)\1?@I"=+%H:RD/'?AA[-',=&+"S1%^=IW"?30IDUSZ#[8)3^ MT9PSYBKUA5MHH:+U>HLF5,N76S1A47G/9>PDU>0/&I$HH)#9Y7JY*Z;=X+#" M@CF#:K>R.IG"9H'H0GBG-L3PN/%SP]9RK?2'#0HEYFS7*Z;RV]3]34C6;9R:7R]@6[$5H&+T5I]L>._'XMB'<#4F+.!6'V6$VJH($"L'+OP?:& M\^YH,G^<)=[;\631;S( ZV+B8+.,V<^T]93E$HV=I)LXT726;E(!A>P+-!?_ MR0[1F_V6>2&GPE(6Z[>;;/$^#1 M"TT XQQM>PO@87!!AUW]L#J7J+NIHB"[ (HKO\EHE:-_4=/%U'2TD4;_;:? MA'!E-]="6A7=J=%O+5X"(:Z9-OH+#5; -4>K2EQ)"['$GK4"8ONKF=CFZ56( M[DG5?+"CF!AY;SUVAA&O@_GN"!$%#6(]]"-$\.%E<_$ZM,"7("*A0; 'MH/2 M!"T0U-GF+4F9$]';J$Q+0'W916LX0U6YU@"YY3@8)># ,<_UT99Z7@5T!N4& M>Y6'VYWMXH3,(.2'!E^T!#+H%Q,\Q\54RH?X?$P=O'Y2]G6I(-!PAG:I8A;F M7,>,9<3MH4WCE%M$ *H-Y-7YT@?M83H[4+R=B%Y MNY"\74B.;A>2MPO)VX7D[4)2\86DFHLS,R\DK^/B3.&36F9=G"E]K@#C-YKX MF3@P+<>)M_091K3,OB--_H@C-SR\S'RR><0&;,?S8S \F);L!#J+QN^N-<>$*0M&T+$%(2904LRY[SA5SYIB,F=WN2\Z1+5O MHEL%HI_^O:7\\[\^3-[MZ_>ED/E3_AN6>''C9TGR' M6JLCI4(P],FGZ'N+!Y@9TV(W-Z/"%0O=LPI) I(-/$WV4]Y3=]!J^#S*-3:D MBI4$BQCT*M*6SS_Z8..OB);1$I4,$_4RI,:5/.Q,!!K!?X:8T8=%#0TI6R6/ M'C?&JE-3"S%+:7%!IL )Q+ M T?3.?EY&#VTQF;"V22DHZ+"8T2Y/ E+89I@NR&'FF-[!6;#;]QG[X%F0^<_ MSC[S;9@122T/Z@>8K/:8,R94U+ ]I@.;S*HQS@N$OU98@'(_6ZD2E+D^IIU8ITE.<;!#.'KC.G8+6INQMC@,*BP$ M7TQSZ7-JE]2H3L*U#?7>4V\V"B=^=T.OCH?^P';Q9]N+:7$_,OGG)#B7JZI M1S#$"R C$7+@Z,PV,7@KD C&;Z+<=OG=H# NO\Q^T/:WQP,W(](EDSM'+ M??)Q8 UGG<_6Z/'B(+Z=PS6$]^Y_&3Y[K=(/MSO;? MDJ!4=E8"[7B1(YT_7"PA7Y.*?)J8'DD"'Z6(X&7<&DUG&Z)IWOEBSF75S?%9( MMCM(^&25>GW"H=__*W8!QI:P:VL-+2%E-R,+D@X&$ZVV&UA=STZ\IFE^4M?> MN9'M";.YV)U:RCX(:08;5(6S!B1-\;J9PDFAA,)X:'X.U$'S$//MLJ5^0PP@ M@#DV%=-KL$700\>XL,EJYH9?!QB=Y0XEQ$_2P+%[2MM)32WT]Y8:KT56117 MVB('-(S((?/^''B$!1XY8*I( 7"T-N5BE4=+D4/F,(>1NR)6X80;XDRV'V2 M3E-L=Y^W,X51?-'+*PUG1'S#[A"%M<2*!*HA_P>KQDM,/[+WSX33&#L;6HN* M<:@P6YOO?.!.7RG$_XP#HF3W7XD*[H9HBEV'53^GL&4+;'KFW)O&E9@Y"6_A M^)YZM,1V!U"M"._]OD2,2Q#3J;]V>*/_Z1>'-E2 9KPR2O]5Z- MP[4NDUQPJ(A@A/;S6)ID@QTBS)F+C7%A5U,X+2?;.2X+Z337LT(=1G&$L 17 MF5WTAYX 9;703\E!09$I,(BQ[T9D>P&M*MJ%VT-_/H D_$**ZD%?90X^(C;, M)O!HE68)QDJF/3RY;:RJ=59E8QSK?@#D>*GK([BO('L&L_ B3J"^F^)1+24+VU5BV6 MW+7A:"A2OAD2.ED=SA..XU)N-0.'U%K,N/+*EL+-P(-8TX8N<5S_9B;CN:29 M<(+KN,8I=8$#EH3?3=K 51WE!I2%O Q.X6;0_'H9I9*/0E&>/W/U\2CD9WN] MQO042'->T3/R8S0@@MP-_(2 \(L;;;IQ&!%- H=2<2IE1[^"^)6RI-_B6B1C M'JI)<-OC72\.+QF) IP87:Y7NZ*:3<[M.5RSJ"@%E8G4]@L$%T( M[]06GJ0O6-F>$'/:MKBI$:$F?-G)[G\\>E7%F0=^UPXW"VS[X8H&7A\/6[K" M:>ZK3X8JJF.81&M#>[?C$D\2#+/BT&F1%,]#3A3;1TN&$X+^&_^%E45_-.IW M%X_6Z!B/KK[D8&3[:Y><'E88HF3)W ?!\L7U/(G4>< 8IITOV>-VAIS =USO MX((ZYM$>R)!2_Z&C&:7N2\@!UP" $G]3^"550CD9;;N"W[4Q?G/]M;4-8F*" MGER&O8S+D/P11T133G[VEZ?'Y*GPXB ,+T81A< K^^;UR%,#8!ELDYQ/%Q"$ M6-C>%&E0O<8$,F-^_'T!?6*>W;#CMV7"L\$2RQ0C2I\Z;Z#\J2^1+ M%5%I\G:YOSS *#D!+CT /46-D#KTW?8]I=C>PNY0LFW;6_2&XMN M@UEURW1K<:;;0=,"6(D7+=N;Z59,L\%,NMS%CUD^!TIX? -T-O_638::'#NO M+9Q>*MNKDNS4_:6KS:E3+Y;%;][5> ,?<>+EZZ_%G I/5P/5MWW%M+Z5%*M% /,Y5IAB(R;XE%TC&CD$ELO5I!30H$F&" M4')\"U_^R[>^!NYQ"30Y_/YLNI#(B*+VIG"0+8L"/JD-U?OL1D1X_&4/!S[R M@K7K\'. .>WU!_'Q)":[EPF)5I0(# 6Y/+@*H[*@X#8-:L),L[NS0IZ!X'+]%F1JRVQQ M M%T'_E=C=NX#Z.VD1CH$7O$QQ\&_D)(%87$=$E6%;%"-9 WRJGGU V*&@K\([M H23PPBB$<+^Q6%A9E__\.[N6OB MPRT(;FP*"EU"1,NG3U9=>T?53GE1N.C>DOA#63P,WOC+Q;3Q;P$K!LR5"?MI M<7P@/PBHG?)2GW!(2X(947^E4+K2<&2+7HCCU)*-M[MC 7>'>C3HF<=5(2&] M6Q ;*$6/\;O C."+G]&A?L#03UZ!GZP6[A;M?YSLA-:!S"AM"N*31\>$:()3 MO<(9U6@F*V*]I"<4IU;A1UZMPMGP_M."_O X/T84**Y4>#EU<+P NZ-Q:X_. M-%C%AYD2$X+*U'(_;]9C3B?I!/77:7S#V9E?>A+@7'.H]2&3;A%<(L(]:WG= MM!K;%40"@(4BL_GR<\GSNM;RWW$8<8)BA;VT&LGRC #19+[&T\"NJ_TY/<4; MK^'AKYME4?_)$Z:JKQ50;[ '\ MC#:NXT%2BBY;ZL_"*,NE8IH-9E(C!I\1=\P&VWB,^V->,OKO[RYM.M[EL?(, M]&_ ?M-X16B:OT3NAK".T"R-;I<).0ALFF*4N%E&KOWD>BY-*>,X7-[S'"[T M"4IK,1S?I[Z5SFAHW0U'P\50O9OEC 0$7Z7,?J8MTDL>\59FOJT9RU' I-QJ M9-%\Q;=*AS#__NL.^2&:^#)\!W0V)'1#5A+ L!BLD$[M-ZK0$NN M7'I'OD_V]->60[0:(U [#:DZIC[/:&1(T N2H@ M1HG&50?#I*M7UE"F4G48B 3+I$I3FK8/5]&D),( 5(=H5%6FOH$[_VZ,*9XR M#&=V,23X0Y;K @BN-,]H'/B./.]YO0P) )%EOQB(:]VH/V@N&%SC1OWABEU/ M#W848S=ZLWS;>PM=GNOI \SU]& M'F?#Q1\=:VR-_I@/;ZZG.N-[TG>BPT5P MAV@N*Q$LM)S@.8H(GY;6BECIBQ?D/:.'P(\V]-V=XVWN,<4Y(]J+C1UU24O; M];D#WP719AP\$*V3]*?_)"]"93Z4?'F&=C2DT5_WB)DF%6_4-JJ,BG^2W=_: M#/PM'$LR5*=M#,[;NFT,#SN>JH(@L/-V-_FI6WX80!L<8&:MUSAU<](4]3O; M7P*B7#B=3)&IHA61O_UETV%NT-@XB$9VE):EF_CH#V1C,<;9" 01#C9.H7- W<9VD1 M (^EOYYQ!1F01,Q@(7CTE_O*/T0/.0O,.5QX[E451$A;\D1 =J06A3J6 TE1 MWFGRW>%VY[F.&QT"%!@F&Z-M2ZI6$TU$C.ELP*E3*24-J_OA7\($@+\ M\Z6K]SR>L-]@_.\WY=U-0:7%"5A L M4W;I3&]Y8RFHG [F.P)$%!B_!BZ>"!BA,$2(/BV,$\)M[W@VTOK/UHZ8W,#F;S=[_REIF6Z;3 Z:$7(*4[QF=: M<9QH76=>,\9FP6C; L<(9_;F.$9.X7 +;"_I%.ETJ2O; M7-QB9O7ZG:GUAW4WZJ>O>%O=[NRQWVLR.U-,']BO(C.4:;M_,GPCFVGURXYB1^RDO GG=J@1\!NL"63* 3FIF%T/2.FM@L@ 5 M@_EY3X.(?'K*W&.[^% ]-LZW-20;LP8.LG PF'6\G:7L1FQ,*J;BG;> O7+) M"5% ]&AS4A-Z^[D3)3_8(H[>]2M/[^KU!_W9C&A9PW%W\M"OJ&"I#1]+I")A M;?]UY]D^_?[;F=.6J9ME([#@P]3K 4G9M7\^\0ZM79\^F\CT?[":ZU*3RD%8 MY!?A Z&J^G;ZN;V%^S^%H2E))>I\._V1AA4A9]*N".M'']G8/[(XY$0#T?;L MYOK]W!61%R&AS-V:/1ON<1"R7">%+?7[L&O:8PKHK_7X-^5P/*>7_*\7TTJ5 M-(6 0@2TVF1&T58+H@X1*45Q1?%15^,#3L0X\/=*,6@W@ ZE/S*WUNU"#D&# MK<7$@+(]"DP]&T3) ;65I*AUKZB$YK48G:/ ]L.]1'US] M-X-3E<&9956:1,C8](L:MMW(9!.ONR8C*QXR#&/;=RZ6&(-CK,:M-U3Y*"@R ME@:VBY,WCD^O.T[\Y/L,^'D=6F^QBM%0YJ#9I7??H"7 ;-UZVU6 @R+TJ7:# MZ-3VE4N9%1WS[5IM"C)H4HIUA9-9:UT_=8>SPAI_NI5ECI;\NUA+OFG'5;7C M6T;2^:HR;TNX)2BU(=NEK0E*)[+NWL;V5IBK5-S^BA@IH-3@#*;+"4.29XI[ MF,).GG *^553JA-C_^N2#7QI][<(KY'OO-W%(5GO(7V8F2IL3.AI7UA7_MUG,)3C') M5+1<3C,[5%1+/+<]FY5PQNO0CH0S,*RH)$U'-%0["7S_0ZAE:KLOVO_+I$K"Y:H\LEF2V@ MVX1DO,*P;VZ1HH^7;D96S'?5&D4W=R,T^EL4C7EJUO:+>!;A)BRE@F 6WD+Z M^%.NVE=A),MM&=V\]C>O_>V;-L8A!;4O M&IKOM63-W'B6-.X*,\QK*7"%U1XL-R#$N<^P>+E\VQ:X&SFS-WXQ3''@(+0, M!X1N&L!-E)R[P%^&!^.BAYX(Z43YX3\0+S%*FUR*\N@H7$BI="%Z"G*6T%DK M;=?!\HNG@#J#E\VC'R*'\'U)7W3E#^R@/NO"#MNR,^(^_B.%^L[7TRZ_^A,IHOA9#SO3!X7\X4U M[M%'8FD=O/Z_^K/N<&YVMES6Q)UOB+1T[9T;V=Z,< ,_9YQ,?\5N]';0'S(N M)ZB/K>3@IJW^+$GCF%HBA(B+*IXSM+5=/Y-8&MO>R%W19XE/$IC@L1=,*6=E MW5\UQ3JO31*YGLZZT;LY1"59JV;1M-UOFM;^GJSVAQ*:8M=!U*A@$ ]ZN4%Z MO&]/7BH"9K#[5I8@Z ,3\B.:(E55UEAE>5'K/CZ;Q<1G^^II:U9C_2[B:C*; M/0/X@"BRU,\^NG@)X%S(--:?!ZV("SE &N$"?:U5@@_9YOKS=55Q(@]*$[R@ M;ZG"69%MK3]@7A$G\I TP@CW66)-9%L#&?&Q?8S(0=($(^;N*YP/F<;0D[I] M1W4.D4;80&,<)1B1;0YE1?O.ZP)4FF!&GUIY<&:<-8302C-+"O#A 'B8M!KG MW=!WR$R) 9+>>@5;6LPL 8).@+O7P+IJC55CR,?9A8T$ (HVE6R80/*J4*\X M+I V9K0U/VR3,_G&P.V_[ES\!D0WV[@% 9>\Z=<#L,+[HG./.>NP>?_3NX^\ M.R*945H0WEF*+N-9757C$ E!/>.W*5BT3D0-%IQ49V52P9,)8=<6Q*O"B6D- M)[/3S@1$#OWD#T]VB);[EXTMC*GI2'^$\+GDP&T*A:T%PU9$RW+B8]^7BX^] MQ<->23RL 4>".F>9NI!4^1-$RZ,7S2FA%PIV%HP,1OP]55(OK>^3^B.GU$FJ M8CY=L81S] -:1D"!AB4>5O\S)^KWU IXRTOCQU0:?;0F>N/E&P:F2")\#0/Q MJF^GE?J@_MA($_;9$CQJF24Z"/ *N5'=NR1X6/VEE)O=)27Q_N9WR>3BI+D] M4N)S^F.63=@AI?EC\/X(IQJXBNN32ZD/ZG],U@3)+,$C19>R1>= 4N="_M"E MXY4?3G]P?^V"40V0*]J2DAOP)HT)\.> 4O=[BZ1.+6#&2Z4Z3[3$XXT*PVBU M.:,5/O)HBNQ?%OU>Q_KZ5W*KVT.A@]U$4B:KF1M^'6"$LL4C M"ZQM+D2EQKOB^]\J !NL@YV115_E=LB\/P<>89E'W[6J(#7 T:[Y*K8\NLI2 MH](Y[&,;F8IVFBY4V/8*+R0YU!J_@ _S[KG/[I(H'58X)?H59/7? ?8&.^,B&Z-MUL;OTU6W4V2^SKT M"8 1(94 D,2[/OINQ+.'?L[90X\/#];L#VH.=3]9X_O^O#,<=V;]^6(V[%+; M*(U[?1P/%S>;Z'ILH@Q)"X2WE(9N0!9$ZFQ8\=:$5('7DH.;F.1PO@87!A56YLQ=7405U-T449!= CN,@ M:A6552!S*-+T9F',KZD@[J??R20AA)>;, @3@PW/XVUE-3,%=!]<]1/FUX2H MG^9:;M$JYW4(HIZRI!42_)FLDD+_5C:V!SQ*2XI7E$1'9SQP53ZG(5E5^7P8 MI04E+4K1I9_/V@Z4&G,1*GZ@304Q:L7TMK^DHTC$]NA^UJT$93?%LS8E3$)0 MC*JD40/95QC#9>.D3AN9V;--J^2-7/LIN?#GW%G\PHWALF8S:[SH]/JSX6=K M,?S<[XR&UMUP-%S\<;NON-U7W.XK;O<5M_N*VWW%[;[B=E]QNZ^H_;Y"95!6 MJBL"V'K9LI57&DQJZK$E&6?GO>WZX2@(0R)J?AI4-/0'MHL_VQY])OZDJ3/. M4YD!S+]!D*7(Z/N!@KGO92M+1-8D9?"XS$ MN24HCY&!CKQDU]E[H08!/H1" M'DD*SVAB,%MVD)9<$Y3#IOV[KH3[3*>S79XH1 M@_W:EO-7[(:)M;0DI&6D9Q%$MD=,J= EF"8(+PA182HR/.VR])!M\EI7Q,W( M97@7AX3N,,S05N!X9BQ2:&=MI8#DEK <%J79^8SP4Q BXRX<+']Y$FE0+?!? M(9<.UKC7&5C#6>>S-7KLWXJ"7_O5@YIWSD1 UOU54QQ[1;#N,1/^=2#7YS.[W1<0K\M0EGWHOQOF]),X*4^UKQOE]Q'Q*G'^38SS;]+[1FN _JT1H \^4WKC8/L.XKP26]RT'9>E/#(-=A,;^T"L MSOO04G0I<1B:(B;MB9)OQ3UL _F9M<9/Q)C2O=_BCOYC5I $JW5+;E\%U!I1 M_4A<"Y9H!8/<_ZUD5=C.8#([./]OU9"NTL7?]>PD .&,-BEW/6\$4SPC MS;C>>4CG$[MYB*$0H.]T86S%KNMY%TI1C"8=4@W>Q1; #*BEU,5G7RR,&O-P N*?X'?9:P^U& MXG8C<;N1N-U(&.NXN=U(7)7[[78C89JS[G8C<;N1,(-!5Q@R9X+E M#T.9/F MM[%24VB3\[%AOK1 QQ,N68"_6GZL%A3-JD#=;6LK1J;Y#4WBPVVJ]-4(#VZ; M5^%8$L48=18,JT1?:P3@2I[(JC_#O>U/9"T0-C:CM,SN"X1/Q1DH]6F@P/YN M@L VQ(?6;H,F.6HE3LV/)LB6^2^ F2*#U^VKE9!;!>533'377O6C=EDH.#%= M'P&%9>>W4K*WJ*Y;5-HKEM4EQ$,-2NJBU_H;N*SD_(R MS5H5D%5,0CU&/A_8Q4L 3;33'^N:CE@ M01!C"+K9=OJ+NI8#-T^K8FS=9Y#D9MMI\Z!5Q39'J\%.5?7AR688Y2Y^$Q^IN'_N:A-\6WVUH/ M/3E8 C^Y7EZE@B=TSS-ZM)M_0O(,=LRGTQ0;PN?M3.$77P+SA6G.B%#C:"=3 MV@;^/ JV%\G#A3+)($^=#48_2-<@VU^3F=E90_U%!X%X%I!G ML/]L0;YZV!@9<43"ES#A8YBRV50\'. $&UPLESM[\2D"ZFX*OV6E/,=Q$+5J M3J%D@Q:]($I;%C74%B$NAUQ^,V53K>J=/F)D89?6NDL^_>B[G%60/&W'Z6# M&WXE<1?#8/YA9OF1NW2]F#J(,H&SP&.,V]N4#:V> XQ+:L;E:1J?&?,6'UJ" MCJ9P%R['.=#@R\JO5,8['M[4BFU[\H^J?1.H:-.ZYM*/-_G/NHRQJZ_GJ;5(Y,[ MEL15Y=#R$,E_)ZXJGFM4;IQV1*F6!LC@E70(:$N)2(GCK:;B]BV(@Q50H'9E M93XU"/# ]6W?(?+3#<*B"B.)K'&[M"0*%D*W(LC3C^Z50P[.!>U:$I[*I-#@ MW6:* P>A93@@--/Y$UE(982WY7 ZM:E8II#VAC#/]6E 8$DB) M+@[(8]^*$HM"&M3CG7QXACQ:,H_NC@*P"YNWH$8AGX#6'0BT$!->$E'!;_(' M0T'G-A7M V/1\#8EN4>UHIH=GP#CETWABNA'#CMX?*EO/+?#Y<=1%_H@)+%7/.3XY768RE& ML<;0%W^@8C6VYV7X,U_\^>OFU>MREQ@4*@=&/5]1&CR#!8-?JUF:XFK%LDM^ M3E\(0.W%L2L!KJILS_F,9VAKNWYRN>1'V':BV/9&[HI,?D\+#1#*TL$X.:H/ MJR^\0+(J4$T &KR-6,M_QV%T>-XB)[!<[Z*X+Y311CS; (7"0-6=_^($?7FP MS#L>V="?_1+AL!$5=MUNNF#@#-;1C@5%QC<_BIE".Z'; \0@U>KO+S+? MF!?Y1V#]H4PTPGLF \F5:E"7+Z"='OC*XB$E&X)1H!)BA$M,'I[2["C&1!\65PB_: K%5'<\%(]01=@^^H3T M%_*Q4RHM5Y'CM ='[6M&64BRP6I$#X4.=I-];[*:N>'7 4;H4#1W1J@O.$=Y M1T>Y\:"<-B+VJ0ID;9$$:A?2(E:? X\PP2-;1Q4Y (X&E0(CW"KEX3+0V#O, M/[T%8F^(&Z604(.7U0P](Y_F95C.7[%+#G+> MPBEH#&6/$0X2)K$&,P@D-2LSS;^PXVS0,O9H0!1: M4_CH3=@JP-MD^/U[.4=B,T_MO,L]M=/]U.\]COJ=R: S[]\_],>+?J\S' \F MLP=K,9R,C\_O&/?HSCB(,N^FG%Y*R2!A/86);'!O5V6&,6V?R9:C(C_;ZS5& M:WMOY*7[)KTE.ZR1Y$:L&X=1L$4XE'IDI^SHIE2%*B$MW*=VRN)Q>X9'LLI: M-;%N^Q,]^_U=6,;ZO-WU\I%!L,$/]!PF"GA1/^#/,7\S^Y+140I,NP_<\O]TB:?92K[*BOO)(%> 4F*P.L&>!=@@<9NJ"#)IO5+>GJ>M]1"A MS7$3S@!*Z ZMZ"$H0PY2OSL9LJ"M0UPY(;E9*&P/69(4TK$E-1OA&%SI8J8:2DB5$Q1._.Z&YHX- M_0'!)"EF,EGUB([^;-,WOKA&BM0P;:H&60*?*U4!SI 8!;9/[Y-FR$&$?L9F M48QB8=\6%*N4H$:_(+!??"7&-A%A8N[1^[\O- *Z%[SXC*V>T[X-12L%)"@U M=H_?H9O$+@A=5O6#HH9M*"S)FKM^X5=;*7GE1@R_Q;%9ME4;*DD63EP)'S4& M"]VC8(WMW<9U]MXN3J30>UZDT'U_!Y'